Send us a Message
Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   
Search RGD Grant Resources Citing RGD About Us Contact Us
Genes Variants Community Projects QTLs Strains Markers Genome Information Ontologies Cell Lines References Download Submit Data
OntoMate (Literature Search) JBrowse (Genome Browser) Synteny Browser (VCMap) Variant Visualizer Multi-Ontology Enrichment (MOET) Gene-Ortholog Location Finder (GOLF) InterViewer (Protein-Protein Interactions) PhenoMiner (Quatitative Phenotypes) Gene Annotator OLGA (Gene List Generator) AllianceMine GViewer (Genome Viewer)
Aging & Age-Related Disease Behavioral & Substance Use Disorder Cancer & Neoplastic Disease Cardiovascular Disease Coronavirus Disease Developmental Disease Diabetes Hematologic Disease Immune & Inflammatory Disease Infectious Disease Liver Disease Neurological Disease Obesity & Metabolic Syndrome Renal Disease Respiratory Disease Sensory Organ Disease
Find Models Genetic Models Autism Models Rat PhenoMiner (Quantitative Phenotypes) Chinchilla PhenoMiner Expected Ranges (Quantitative Phenotype) PhenoMiner Term Comparison Hybrid Rat Diversity Panel Phenotypes Phenotypes in Other Animal Models Animal Husbandry Strain Medical Records Phylogenetics Strain Availability Calendar Rats 101 Submissions Photo Archive
Pathways
Rat Community Forum Directory of Rat Laboratories Video Tutorials News RGD Publications RGD Presentations Archive Nomenclature Guidelines Resource Links Laboratory Resources Employment Resources
Advanced Search (OLGA)

CHEBI ONTOLOGY - ANNOTATIONS

The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term:ortho-fused polycyclic hydrocarbon
go back to main search page
Accession:CHEBI:35427 term browser browse the term
Synonyms:related_synonym: ortho-fused polycyclic hydrocarbons


show annotations for term's descendants           Sort by:
1H-indene term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Ugt1a2 UDP glucuronosyltransferase 1 family, polypeptide A2 increases glucuronidation ISO UGT1A3 protein results in increased glucuronidation of indene CTD PMID:15843492 NCBI chr 9:96,239,019...96,256,264
Ensembl chr 9:96,144,786...96,256,264 		JBrowse link
G Ugt2b7 UDP glucuronosyltransferase family 2 member B7 increases glucuronidation ISO UGT2B7 protein results in increased glucuronidation of indene CTD PMID:15843492 NCBI chr14:21,251,535...21,274,451
Ensembl chr14:21,251,535...21,274,451 		JBrowse link
7,12-dimethyltetraphene term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Abca8a ATP-binding cassette, subfamily A (ABC1), member 8a increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of ABCA8A mRNA CTD PMID:19480007 NCBI chr10:95,501,798...95,571,770
Ensembl chr10:95,501,798...95,571,873 		JBrowse link
G Abcb1b ATP-binding cassette, sub-family B member 1B increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of ABCB1B mRNA CTD PMID:32553695 NCBI chr 4:26,197,706...26,280,156
Ensembl chr 4:26,106,903...26,279,567 		JBrowse link
G Abcc6 ATP binding cassette subfamily C member 6 affects response to substance ISO ABCC6 gene SNP affects the susceptibility to 9,10-Dimethyl-1,2-benzanthracene CTD PMID:25622337 NCBI chr 1:105,583,681...105,637,895
Ensembl chr 1:105,583,682...105,637,895 		JBrowse link
G Abhd3 abhydrolase domain containing 3, phospholipase increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of ABHD3 mRNA CTD PMID:21527772 NCBI chr18:1,996,010...2,051,311
Ensembl chr18:1,993,525...2,075,492 		JBrowse link
G Acad8 acyl-CoA dehydrogenase family, member 8 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of ACAD8 mRNA CTD PMID:32553695 NCBI chr 8:33,641,420...33,665,542
Ensembl chr 8:33,641,420...33,665,542 		JBrowse link
G Acat1 acetyl-CoA acetyltransferase 1 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of ACAT1 protein CTD PMID:38307155 NCBI chr 8:62,876,003...62,905,080
Ensembl chr 8:62,876,003...62,905,042 		JBrowse link
G Acat2 acetyl-CoA acetyltransferase 2 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of ACAT2 protein CTD PMID:39910959 NCBI chr 1:50,100,840...50,118,886
Ensembl chr 1:50,100,817...50,135,095 		JBrowse link
G Actb actin, beta affects expression ISO 9,10-Dimethyl-1,2-benzanthracene affects the expression of ACTB mRNA CTD PMID:21785161 NCBI chr12:16,776,664...16,779,634
Ensembl chr12:16,776,661...16,780,242 		JBrowse link
G Actg2 actin gamma 2, smooth muscle increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of ACTG2 mRNA CTD PMID:19480007 NCBI chr 4:117,579,513...117,604,379
Ensembl chr 4:117,579,514...117,604,295 		JBrowse link
G Actn1 actinin, alpha 1 multiple interactions
increases expression 		EXP [9,10-Dimethyl-1,2-benzanthracene co-treated with Isoflavones] results in increased expression of ACTN1 protein
9,10-Dimethyl-1,2-benzanthracene results in increased expression of ACTN1 protein 		CTD PMID:22248470 NCBI chr 6:104,731,485...104,826,312
Ensembl chr 6:104,731,485...104,826,172 		JBrowse link
G Actn3 actinin alpha 3 decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of ACTN3 mRNA CTD PMID:19480007 NCBI chr 1:211,588,473...211,604,401
Ensembl chr 1:211,588,474...211,604,401 		JBrowse link
G Actn4 actinin alpha 4 increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of ACTN4 mRNA CTD PMID:12376462 NCBI chr 1:93,310,294...93,379,369
Ensembl chr 1:93,310,278...93,379,320 		JBrowse link
G Actr3b actin related protein 3B increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of ACTR3B mRNA CTD PMID:19480007 NCBI chr 4:9,995,553...10,089,422
Ensembl chr 4:9,996,155...10,089,553 		JBrowse link
G Adamts1 ADAM metallopeptidase with thrombospondin type 1 motif, 1 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of ADAMTS1 mRNA CTD PMID:32553695 NCBI chr11:38,418,565...38,427,384
Ensembl chr11:38,418,101...38,427,390 		JBrowse link
G Adamts9 ADAM metallopeptidase with thrombospondin type 1 motif, 9 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of ADAMTS9 mRNA CTD PMID:32553695 NCBI chr 4:126,847,726...127,019,924
Ensembl chr 4:126,847,729...127,019,876 		JBrowse link
G Adcy5 adenylate cyclase 5 decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of ADCY5 mRNA CTD PMID:12376462 NCBI chr11:78,976,861...79,123,343
Ensembl chr11:78,976,861...79,123,343 		JBrowse link
G Adgrl4 adhesion G protein-coupled receptor L4 increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of ADGRL4 mRNA CTD PMID:19480007 NCBI chr 2:243,014,927...243,117,226
Ensembl chr 2:243,014,796...243,117,222 		JBrowse link
G Adh5 alcohol dehydrogenase 5 (class III), chi polypeptide decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of ADH5 protein CTD PMID:39910959 NCBI chr 2:229,648,557...229,660,964
Ensembl chr 2:229,648,501...229,665,232 		JBrowse link
G Adh7 alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide increases expression
multiple interactions 		ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of ADH7 mRNA
[9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein] which results in increased expression of ADH7 mRNA 		CTD PMID:32553695 NCBI chr 2:229,422,125...229,436,584
Ensembl chr 2:229,421,252...229,436,691 		JBrowse link
G Adm adrenomedullin increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of ADM mRNA CTD PMID:19480007 NCBI chr 1:174,164,178...174,182,372
Ensembl chr 1:174,178,773...174,182,371 		JBrowse link
G Aen apoptosis enhancing nuclease increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of AEN mRNA CTD PMID:32553695 NCBI chr 1:142,224,499...142,233,902
Ensembl chr 1:142,224,493...142,233,898 		JBrowse link
G Afp alpha-fetoprotein multiple interactions EXP [9,10-Dimethyl-1,2-benzanthracene co-treated with Tartrazine] results in increased expression of AFP protein CTD PMID:34972512 NCBI chr14:17,857,584...17,875,645
Ensembl chr14:17,857,584...17,875,649 		JBrowse link
G Ago2 argonaute RISC catalytic component 2 increases expression
multiple interactions 		ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of AGO2 mRNA; 9,10-Dimethyl-1,2-benzanthracene results in increased expression of AGO2 protein
Butyric Acid affects the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of AGO2 mRNA]; Butyric Acid affects the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of AGO2 protein]; Glucaric Acid affects the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of AGO2 mRNA]; Glucaric Acid affects the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of AGO2 protein]; Niacinamide affects the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of AGO2 mRNA]; Niacinamide affects the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of AGO2 protein] 		CTD PMID:24792773 NCBI chr 7:106,907,209...106,994,124
Ensembl chr 7:106,918,125...106,993,980 		JBrowse link
G Agxt alanine--glyoxylate aminotransferase decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of AGXT protein CTD PMID:38307155 NCBI chr 9:101,122,793...101,132,746
Ensembl chr 9:101,122,793...101,132,745 		JBrowse link
G Ahcyl1 adenosylhomocysteinase-like 1 affects expression ISO 9,10-Dimethyl-1,2-benzanthracene affects the expression of AHCYL1 mRNA CTD PMID:21785161 NCBI chr 2:197,982,335...198,016,770
Ensembl chr 2:197,982,344...198,033,930 		JBrowse link
G Ahr aryl hydrocarbon receptor increases activity
decreases expression
multiple interactions
affects localization
affects binding
increases expression
affects response to substance 		ISO
EXP 		9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein
9,10-Dimethyl-1,2-benzanthracene results in decreased expression of AHR mRNA
9,10-Dimethyl-1,2-benzanthracene promotes the reaction [AHR protein results in increased expression of CCL5 mRNA]; AHR protein affects the reaction [9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of DAZL mRNA]; AHR protein affects the reaction [9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of DDX4 mRNA]; AHR protein affects the reaction [9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of PRDM1 mRNA]; biochanin A inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene promotes the reaction [AHR protein binds to CYP1A1 promoter]]; Eugenol inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein]; isoliquiritigenin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene affects the localization of AHR protein]
9,10-Dimethyl-1,2-benzanthracene binds to and results in increased activity of AHR protein; [9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein] which results in decreased expression of CXCL10 mRNA; [9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein] which results in increased expression of ADH7 mRNA; [9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein] which results in increased expression of AHRR mRNA; [9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein] which results in increased expression of ALDH3A1 mRNA; [9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein] which results in increased expression of ARL6IP5 mRNA; [9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein] which results in increased expression of BTG2 mRNA; [9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein] which results in increased expression of CCL2 mRNA; [9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein] which results in increased expression of CCNG1 mRNA; [9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein] which results in increased expression of CCNO mRNA; [9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein] which results in increased expression of CENPB mRNA; [9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein] which results in increased expression of CXCL5 mRNA; [9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein] which results in increased expression of CYP1A1 mRNA; [9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein] which results in increased expression of DDIT4 mRNA; [9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein] which results in increased expression of DOK1 mRNA; [9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein] which results in increased expression of FOSL1 mRNA; [9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein] which results in increased expression of GCHFR mRNA; [9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein] which results in increased expression of GPRC5A mRNA; [9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein] which results in increased expression of IER3 mRNA; [9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein] which results in increased expression of INHBB mRNA; [9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein] which results in increased expression of LPL mRNA; [9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein] which results in increased expression of NFE2L2 mRNA; [9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein] which results in increased expression of NQO1 mRNA; [9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein] which results in increased expression of PGD mRNA; [9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein] which results in increased expression of PHLDA1 mRNA; [9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein] which results in increased expression of PHLDA3 mRNA; [9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein] which results in increased expression of PTGS2 mRNA; [9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein] which results in increased expression of PTX3 mRNA; [9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein] which results in increased expression of SPP1 mRNA; [9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein] which results in increased expression of SULF2 mRNA; [9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein] which results in increased expression of TIPARP mRNA; [AHR mRNA affects the susceptibility to 9,10-Dimethyl-1,2-benzanthracene] which results in decreased expression of CYP1A1; AHR mRNA promotes the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of ARTN protein]; AHR mRNA promotes the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of IL4RA]; AHR mRNA promotes the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of TSLP]; galangin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene affects the localization of AHR protein]
9,10-Dimethyl-1,2-benzanthracene binds to AHR protein
9,10-Dimethyl-1,2-benzanthracene results in increased expression of AHR mRNA; 9,10-Dimethyl-1,2-benzanthracene results in increased expression of AHR protein
AHR affects the susceptibility to 9,10-Dimethyl-1,2-benzanthracene; AHR mRNA affects the susceptibility to 9,10-Dimethyl-1,2-benzanthracene
9,10-Dimethyl-1,2-benzanthracene binds to and results in increased activity of AHR protein; AHR protein promotes the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CDH13 mRNA]; betulin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of AHR protein] 		CTD PMID:3024361 PMID:9855628 PMID:10953044 PMID:12117779 PMID:12200463 More... NCBI chr 6:57,961,423...57,998,901
Ensembl chr 6:57,961,423...57,998,901 		JBrowse link
G Ahrr aryl-hydrocarbon receptor repressor multiple interactions
increases expression 		ISO [9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein] which results in increased expression of AHRR mRNA; [CYP1B1 protein affects the susceptibility to 9,10-Dimethyl-1,2-benzanthracene] which affects the expression of AHRR mRNA
9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of AHRR mRNA 		CTD PMID:27891153 PMID:32553695 NCBI chr 1:30,822,219...30,917,251
Ensembl chr 1:30,810,866...30,952,866 		JBrowse link
G Ak2 adenylate kinase 2 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of AK2 protein CTD PMID:39910959 NCBI chr 5:146,609,469...146,649,008
Ensembl chr 5:146,630,445...146,650,610 		JBrowse link
G Akr1b10 aldo-keto reductase family 1 member B10 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of AKR1B10 mRNA CTD PMID:26198647 NCBI chr 4:64,005,632...64,027,860
Ensembl chr 4:64,007,420...64,020,847 		JBrowse link
G Akr1c14 aldo-keto reductase family 1, member C14 increases expression
multiple interactions 		EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of AKR1C14 mRNA
[AKR1C14 protein co-treated with NADP co-treated with quinone] results in increased reduction of and affects the activity of 9,10-Dimethyl-1,2-benzanthracene 		CTD PMID:18205319 PMID:21910479 NCBI chr17:71,066,197...71,083,184
Ensembl chr17:71,066,200...71,083,157 		JBrowse link
G Akr7a2 aldo-keto reductase family 7, member A2 multiple interactions ISO AKR7A2 protein results in increased reduction of and affects the activity of 9,10-Dimethyl-1,2-benzanthracene CTD PMID:21910479 NCBI chr 5:156,835,589...156,844,127
Ensembl chr 5:156,835,551...156,844,109 		JBrowse link
G Akt1 AKT serine/threonine kinase 1 increases expression
increases phosphorylation 		ISO
EXP 		9,10-Dimethyl-1,2-benzanthracene results in increased expression of AKT1 protein modified form
9,10-Dimethyl-1,2-benzanthracene results in increased expression of AKT1 mRNA
9,10-Dimethyl-1,2-benzanthracene results in increased phosphorylation of AKT1 protein 		CTD PMID:21785161 PMID:24576726 NCBI chr 6:137,534,810...137,555,131
Ensembl chr 6:137,535,390...137,552,610 		JBrowse link
G Alas2 5'-aminolevulinate synthase 2 increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of ALAS2 mRNA CTD PMID:19480007 NCBI chr  X:22,890,650...22,914,046
Ensembl chr  X:22,890,689...22,914,043 		JBrowse link
G Alb albumin increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of ALB protein CTD PMID:38307155 NCBI chr14:17,891,564...17,907,043
Ensembl chr14:17,891,582...17,911,865 		JBrowse link
G Aldh3a1 aldehyde dehydrogenase 3 family, member A1 increases expression
multiple interactions 		ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of ALDH3A1 mRNA
[9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein] which results in increased expression of ALDH3A1 mRNA 		CTD PMID:32553695 NCBI chr10:46,392,464...46,402,151
Ensembl chr10:46,392,411...46,402,151 		JBrowse link
G Aldoa aldolase, fructose-bisphosphate A increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of ALDOA protein CTD PMID:22248470 NCBI chr 1:190,832,820...190,838,021
Ensembl chr 1:190,832,820...190,838,211 		JBrowse link
G Anapc5 anaphase-promoting complex subunit 5 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of ANAPC5 mRNA CTD PMID:21785161 NCBI chr12:39,409,519...39,442,518
Ensembl chr12:39,385,399...39,442,762 		JBrowse link
G Angptl4 angiopoietin-like 4 multiple interactions
increases methylation 		EXP [9,10-Dimethyl-1,2-benzanthracene results in increased methylation of ANGPTL4 promoter] which results in decreased expression of ANGPTL4 mRNA CTD PMID:21489049 NCBI chr 7:15,252,450...15,259,971
Ensembl chr 7:15,252,473...15,258,681 		JBrowse link
G Ankh ANKH inorganic pyrophosphate transport regulator increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of ANK mRNA CTD PMID:19480007 NCBI chr 2:79,883,350...80,011,222
Ensembl chr 2:79,883,544...80,011,699 		JBrowse link
G Anxa1 annexin A1 multiple interactions
increases expression 		EXP [9,10-Dimethyl-1,2-benzanthracene co-treated with Isoflavones] results in increased expression of ANXA1 protein
9,10-Dimethyl-1,2-benzanthracene results in increased expression of ANXA1 mRNA; 9,10-Dimethyl-1,2-benzanthracene results in increased expression of ANXA1 protein 		CTD PMID:12376462 PMID:22248470 NCBI chr 1:227,287,713...227,306,739
Ensembl chr 1:227,287,717...227,306,831 		JBrowse link
G Anxa2 annexin A2 multiple interactions EXP [9,10-Dimethyl-1,2-benzanthracene co-treated with Isoflavones] results in increased expression of ANXA2 protein CTD PMID:22248470 NCBI chr 8:78,986,252...79,022,638
Ensembl chr 8:78,986,242...79,022,631 		JBrowse link
G Anxa8 annexin A8 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of ANXA8 mRNA CTD PMID:32553695 NCBI chr16:9,403,267...9,418,317
Ensembl chr16:9,403,353...9,418,310 		JBrowse link
G Apaf1 apoptotic peptidase activating factor 1 multiple interactions
decreases expression 		ISO [Butyric Acid co-treated with Niacinamide co-treated with Glucaric Acid] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of APAF1 mRNA]; [Butyric Acid co-treated with Niacinamide co-treated with Glucaric Acid] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of APAF1 protein]; Butyric Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of APAF1 mRNA]; Butyric Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of APAF1 protein]; Glucaric Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of APAF1 mRNA]; Glucaric Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of APAF1 protein]; Niacinamide inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of APAF1 mRNA]; Niacinamide inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of APAF1 protein]
9,10-Dimethyl-1,2-benzanthracene results in decreased expression of APAF1 mRNA; 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of APAF1 protein 		CTD PMID:25478867 NCBI chr 7:27,381,392...27,466,772
Ensembl chr 7:27,381,855...27,466,772 		JBrowse link
G Apex1 apurinic/apyrimidinic endodeoxyribonuclease 1 multiple interactions
increases expression 		ISO Metformin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of APEX1 mRNA] CTD PMID:25697376 NCBI chr15:26,618,146...26,620,330
Ensembl chr15:26,618,224...26,620,329 		JBrowse link
G Apoa1 apolipoprotein A1 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of APOA1 protein CTD PMID:39910959 NCBI chr 8:55,423,945...55,425,729
Ensembl chr 8:55,423,825...55,425,729 		JBrowse link
G Apoa4 apolipoprotein A4 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of APOA4 protein CTD PMID:39910959 NCBI chr 8:55,435,779...55,438,160
Ensembl chr 8:55,434,168...55,438,164 		JBrowse link
G Apobec1 apolipoprotein B mRNA editing enzyme catalytic subunit 1 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of APOBEC1 mRNA CTD PMID:32553695 NCBI chr 4:157,472,879...157,500,496
Ensembl chr 4:157,472,868...157,498,909 		JBrowse link
G Apoc1 apolipoprotein C1 affects expression ISO 9,10-Dimethyl-1,2-benzanthracene affects the expression of APOC1 mRNA CTD PMID:21785161 NCBI chr 1:88,475,018...88,479,052
Ensembl chr 1:88,474,663...88,478,155 		JBrowse link
G Apoe apolipoprotein E affects expression ISO 9,10-Dimethyl-1,2-benzanthracene affects the expression of APOE mRNA CTD PMID:21785161 NCBI chr 1:88,481,889...88,485,816
Ensembl chr 1:88,481,385...88,485,855 		JBrowse link
G Aqp1 aquaporin 1 decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of AQP1 mRNA CTD PMID:12376462 NCBI chr 4:85,812,784...85,824,964
Ensembl chr 4:85,812,784...85,830,504 		JBrowse link
G Aqp3 aquaporin 3 (Gill blood group) increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of AQP3 mRNA CTD PMID:19480007 NCBI chr 5:61,035,165...61,040,683
Ensembl chr 5:61,035,166...61,040,685 		JBrowse link
G Aqp5 aquaporin 5 decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of AQP5 mRNA CTD PMID:19480007 NCBI chr 7:132,601,528...132,605,060
Ensembl chr 7:132,601,059...132,605,062 		JBrowse link
G Ar androgen receptor multiple interactions
increases activity 		ISO
EXP 		9,10-Dimethyl-1,2-benzanthracene binds to and results in decreased activity of AR protein; 9,10-Dimethyl-1,2-benzanthracene inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; 9,10-Dimethyl-1,2-benzanthracene inhibits the reaction [Metribolone results in increased activity of AR protein]
9,10-Dimethyl-1,2-benzanthracene results in increased activity of AR protein 		CTD PMID:10771140 PMID:18324785 PMID:33049310 NCBI chr  X:67,135,317...67,304,476
Ensembl chr  X:67,135,317...67,304,467 		JBrowse link
G Arf3 ARF GTPase 3 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of ARF3 protein CTD PMID:39910959 NCBI chr 7:131,765,039...131,792,075
Ensembl chr 7:131,750,672...131,770,123 		JBrowse link
G Arhgap11a Rho GTPase activating protein 11A increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of ARHGAP11A mRNA CTD PMID:32553695 NCBI chr 3:121,045,187...121,071,985
Ensembl chr 3:121,045,187...121,061,468 		JBrowse link
G Arhgap6 Rho GTPase activating protein 6 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of ARHGAP6 mRNA CTD PMID:32553695 NCBI chr  X:28,525,912...29,062,344
Ensembl chr  X:28,525,917...29,061,244 		JBrowse link
G Arhgdia Rho GDP dissociation inhibitor alpha multiple interactions ISO [Dietary Fats co-treated with Dietary Sucrose co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in decreased expression of ARHGDIA protein CTD PMID:39910959 NCBI chr10:106,352,858...106,356,347
Ensembl chr10:106,353,491...106,356,347 		JBrowse link
G Arhgdib Rho GDP dissociation inhibitor beta increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of ARHGDIB mRNA CTD PMID:21527772 NCBI chr 4:171,554,139...171,573,057
Ensembl chr 4:171,554,140...171,573,068 		JBrowse link
G Arl16 ARF like GTPase 16 affects expression ISO 9,10-Dimethyl-1,2-benzanthracene affects the expression of ARL16 mRNA CTD PMID:21785161 NCBI chr10:106,235,792...106,237,968
Ensembl chr10:106,235,792...106,237,968 		JBrowse link
G Arl3 ARF like GTPase 3 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of ARL3 protein CTD PMID:39910959 NCBI chr 1:255,342,078...255,388,087
Ensembl chr 1:255,342,076...255,388,279 		JBrowse link
G Arl6ip5 ARF like GTPase 6 interacting protein 5 multiple interactions
increases expression 		ISO [9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein] which results in increased expression of ARL6IP5 mRNA
9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of ARL6IP5 mRNA 		CTD PMID:32553695 NCBI chr 4:131,365,320...131,395,311
Ensembl chr 4:131,367,289...131,400,130 		JBrowse link
G Arnt aryl hydrocarbon receptor nuclear translocator increases expression
multiple interactions 		EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of ARNT protein
betulin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of ARNT protein] 		CTD PMID:33759307 NCBI chr 2:185,686,703...185,745,546
Ensembl chr 2:185,680,683...185,745,546 		JBrowse link
G Arrdc3 arrestin domain containing 3 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of ARRDC3 mRNA CTD PMID:32553695 NCBI chr 2:12,873,202...12,885,716
Ensembl chr 2:12,873,202...12,885,875 		JBrowse link
G Artn artemin multiple interactions
increases expression 		ISO AHR mRNA promotes the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of ARTN protein] CTD PMID:27869817 NCBI chr 5:136,750,188...136,755,645
Ensembl chr 5:136,750,188...136,753,457 		JBrowse link
G Asah1 N-acylsphingosine amidohydrolase 1 affects expression ISO 9,10-Dimethyl-1,2-benzanthracene affects the expression of ASAH1 mRNA CTD PMID:21785161 NCBI chr16:57,669,927...57,701,349
Ensembl chr16:57,669,750...57,718,305 		JBrowse link
G Asip agouti signaling protein multiple interactions ISO 9,10-Dimethyl-1,2-benzanthracene affects the reaction [A gene mutant form results in decreased expression of GJA4 protein]; 9,10-Dimethyl-1,2-benzanthracene inhibits the reaction [A gene mutant form results in decreased expression of ATM mRNA]; 9,10-Dimethyl-1,2-benzanthracene inhibits the reaction [A gene mutant form results in decreased expression of BRCA1 protein]; 9,10-Dimethyl-1,2-benzanthracene inhibits the reaction [A gene mutant form results in decreased expression of PRKDC mRNA]; 9,10-Dimethyl-1,2-benzanthracene promotes the reaction [A gene mutant form results in increased expression of PARP1 mRNA]; 9,10-Dimethyl-1,2-benzanthracene promotes the reaction [A gene mutant form results in increased expression of PARP1 protein]; [A gene mutant form co-treated with 9,10-Dimethyl-1,2-benzanthracene] affects the expression of GJA4 protein; A gene mutant form affects the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of GJA1 mRNA]; A gene mutant form affects the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of H2AX protein]; A gene mutant form affects the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of RAD51 protein]; A gene mutant form inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of BRCA1 protein]; A gene mutant form inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of RAD51 mRNA]; A gene mutant form inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of XRCC6 protein] CTD PMID:25447408 PMID:25448685 NCBI chr 3:163,933,768...164,021,377
Ensembl chr 3:164,015,903...164,021,378 		JBrowse link
G Ass1 argininosuccinate synthase 1 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of ASS1 mRNA CTD PMID:32553695 NCBI chr 3:35,144,765...35,194,632
Ensembl chr 3:35,144,999...35,194,627 		JBrowse link
G Atad2 ATPase family, AAA domain containing 2 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of ATAD2 mRNA CTD PMID:32553695 NCBI chr 7:91,523,626...91,566,238
Ensembl chr 7:91,523,626...91,566,238 		JBrowse link
G Atg10 autophagy related 10 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of ATG10 mRNA CTD PMID:32553695 NCBI chr 2:23,843,695...24,133,459
Ensembl chr 2:23,844,482...24,133,368 		JBrowse link
G Atm ATM serine/threonine kinase multiple interactions
increases expression
decreases expression 		EXP
ISO 		9,10-Dimethyl-1,2-benzanthracene results in increased expression of and results in increased phosphorylation of ATM protein
9,10-Dimethyl-1,2-benzanthracene results in increased expression of ATM protein
9,10-Dimethyl-1,2-benzanthracene results in decreased expression of ATM mRNA
9,10-Dimethyl-1,2-benzanthracene inhibits the reaction [A gene mutant form results in decreased expression of ATM mRNA]
9,10-Dimethyl-1,2-benzanthracene results in increased expression of ATM mRNA 		CTD PMID:23969067 PMID:25448685 NCBI chr 8:62,724,939...62,829,040
Ensembl chr 8:62,727,291...62,828,629 		JBrowse link
G Atp5f1a ATP synthase F1 subunit alpha increases expression
multiple interactions 		EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of ATP5F1A protein
[9,10-Dimethyl-1,2-benzanthracene co-treated with Isoflavones] results in increased expression of ATP5F1A protein 		CTD PMID:22248470 NCBI chr18:73,567,537...73,575,473
Ensembl chr18:73,567,526...73,575,922 		JBrowse link
G Atp5f1b ATP synthase F1 subunit beta multiple interactions
decreases expression
increases expression 		EXP
ISO 		[9,10-Dimethyl-1,2-benzanthracene co-treated with Isoflavones] results in increased expression of ATP5F1B protein
9,10-Dimethyl-1,2-benzanthracene results in decreased expression of ATP5F1B protein
9,10-Dimethyl-1,2-benzanthracene results in increased expression of ATP5F1B protein 		CTD PMID:22248470 PMID:39910959 NCBI chr 7:1,100,058...1,106,461
Ensembl chr 7:1,099,860...1,106,462 		JBrowse link
G Atp5if1 ATP synthase inhibitory factor subunit 1 increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of ATP5IF1 mRNA CTD PMID:12376462 NCBI chr 5:150,022,960...150,026,677
Ensembl chr 5:150,022,960...150,026,677 		JBrowse link
G Atp6ap2 ATPase H+ transporting accessory protein 2 affects expression ISO 9,10-Dimethyl-1,2-benzanthracene affects the expression of ATP6AP2 mRNA CTD PMID:21785161 NCBI chr  X:12,856,708...12,883,670
Ensembl chr  X:12,855,859...12,905,875 		JBrowse link
G Atrnl1 attractin like 1 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of ATRNL1 mRNA CTD PMID:32553695 NCBI chr 1:266,676,051...267,216,847
Ensembl chr 1:266,675,852...267,216,842 		JBrowse link
G Axin1 axin 1 decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of AXIN1 mRNA CTD PMID:36863560 NCBI chr10:15,667,894...15,720,092
Ensembl chr10:15,667,958...15,720,092 		JBrowse link
G Axl Axl receptor tyrosine kinase increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of AXL mRNA CTD PMID:21527772 NCBI chr 1:90,392,864...90,424,123
Ensembl chr 1:90,392,864...90,424,009 		JBrowse link
G Basp1 brain abundant, membrane attached signal protein 1 increases expression
multiple interactions 		EXP
ISO 		9,10-Dimethyl-1,2-benzanthracene results in increased expression of BASP1 mRNA
[Dietary Fats co-treated with Dietary Sucrose co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in decreased expression of BASP1 protein 		CTD PMID:12376462 PMID:39910959 NCBI chr 2:77,546,628...77,594,297
Ensembl chr 2:77,546,092...77,597,178 		JBrowse link
G Bax BCL2 associated X, apoptosis regulator increases expression
multiple interactions
decreases expression 		ISO
EXP 		9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of BAX mRNA; 9,10-Dimethyl-1,2-benzanthracene results in increased expression of BAX mRNA
[Ruthenium binds to Phloretin] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of BAX protein]; Taurine inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of BAX mRNA]; Taurine inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of BAX protein]
9,10-Dimethyl-1,2-benzanthracene results in decreased expression of BAX mRNA; 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of BAX protein
[9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of BAX protein; [Butyric Acid co-treated with Niacinamide co-treated with Glucaric Acid] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of BAX mRNA]; [Butyric Acid co-treated with Niacinamide co-treated with Glucaric Acid] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of BAX protein]; [Tetradecanoylphorbol Acetate co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in decreased expression of BAX protein; beta-elemene inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of BAX protein]; Butyric Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of BAX mRNA]; Butyric Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of BAX protein]; dieckol inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of BAX mRNA]; geraniol inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in decreased expression of BAX protein]; Glucaric Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of BAX mRNA]; Glucaric Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of BAX protein]; Niacinamide inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of BAX mRNA]; Niacinamide inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of BAX protein]
alpha-naphthoflavone inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of BAX mRNA] 		CTD PMID:20562217 PMID:22760862 PMID:24269759 PMID:25478867 PMID:30101532 More... NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:105,076,473...105,086,429 		JBrowse link
G Bbc3 Bcl-2 binding component 3 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of BBC3 mRNA CTD PMID:32553695 NCBI chr 1:86,141,450...86,150,666
Ensembl chr 1:86,141,603...86,150,666 		JBrowse link
G Bbs9 Bardet-Biedl syndrome 9 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of BBS9 mRNA CTD PMID:32553695 NCBI chr 8:29,288,846...29,713,889
Ensembl chr 8:29,289,997...29,713,880 		JBrowse link
G Bcl2 BCL2, apoptosis regulator multiple interactions
increases expression 		ISO
EXP 		[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of BCL2 mRNA; [9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of BCL2 protein; [9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate] results in increased expression of BCL2 protein; [Butyric Acid co-treated with Niacinamide co-treated with Glucaric Acid] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of BCL2 mRNA]; [Butyric Acid co-treated with Niacinamide co-treated with Glucaric Acid] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of BCL2 protein]; [Ellagic Acid co-treated with Resveratrol] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of BCL2 mRNA]; [Plant Extracts co-treated with Resveratrol] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of BCL2 mRNA]; [Tetradecanoylphorbol Acetate co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased expression of BCL2 protein; beta-elemene inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate] results in increased expression of BCL2 protein]; Butyric Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of BCL2 mRNA]; Butyric Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of BCL2 protein]; dieckol inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of BCL2 mRNA]; Eugenol inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of BCL2 mRNA]; Eugenol inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of BCL2 protein]; geraniol inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased expression of BCL2 protein]; Glucaric Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of BCL2 mRNA]; Glucaric Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of BCL2 protein]; Niacinamide inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of BCL2 mRNA]; Niacinamide inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of BCL2 protein]
[Ruthenium binds to Phloretin] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of BCL2 protein]; Ghee inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of BCL2 mRNA]; Taurine inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of BCL2 mRNA]; Taurine inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of BCL2 protein]
9,10-Dimethyl-1,2-benzanthracene results in increased expression of BCL2 mRNA; 9,10-Dimethyl-1,2-benzanthracene results in increased expression of BCL2 protein 		CTD PMID:20103723 PMID:20537511 PMID:21088903 PMID:22760862 PMID:25478867 More... NCBI chr13:23,204,464...23,366,900
Ensembl chr13:23,204,464...23,366,900 		JBrowse link
G Bcl6 BCL6, transcription repressor increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of BCL6 mRNA CTD PMID:32553695 NCBI chr11:90,358,753...90,382,049
Ensembl chr11:90,358,753...90,382,047 		JBrowse link
G Bdnf brain-derived neurotrophic factor increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of BDNF mRNA CTD PMID:32553695 NCBI chr 3:116,619,633...116,670,212
Ensembl chr 3:116,619,633...116,670,657 		JBrowse link
G Becn1 beclin 1 increases expression
decreases expression
multiple interactions 		EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of BECN1 mRNA; 9,10-Dimethyl-1,2-benzanthracene results in increased expression of BECN1 protein
9,10-Dimethyl-1,2-benzanthracene results in decreased expression of BECN1 protein
1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of BECN1 protein]; [1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt co-treated with Doxorubicin] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of BECN1 protein]; Doxorubicin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of BECN1 protein] 		CTD PMID:24576726 PMID:39214269 NCBI chr10:86,731,649...86,747,002
Ensembl chr10:86,731,650...86,747,002 		JBrowse link
G Bmi1 BMI1 proto-oncogene, polycomb ring finger increases expression
multiple interactions 		ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of BMI1 mRNA; 9,10-Dimethyl-1,2-benzanthracene results in increased expression of BMI1 protein
Butyric Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of BMI1 mRNA]; Butyric Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of BMI1 protein]; Glucaric Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of BMI1 mRNA]; Glucaric Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of BMI1 protein]; Niacinamide inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of BMI1 mRNA]; Niacinamide inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of BMI1 protein] 		CTD PMID:24792773 NCBI chr17:86,240,683...86,250,044
Ensembl chr17:86,243,491...86,250,024 		JBrowse link
G Brat1 BRCA1-associated ATM activator 1 affects expression ISO 9,10-Dimethyl-1,2-benzanthracene affects the expression of BRAT1 mRNA CTD PMID:21785161 NCBI chr12:19,043,004...19,065,686
Ensembl chr12:19,042,591...19,055,369 		JBrowse link
G Brca1 BRCA1, DNA repair associated affects response to substance
increases expression
multiple interactions 		ISO
EXP 		BRCA1 protein affects the susceptibility to 9,10-Dimethyl-1,2-benzanthracene
9,10-Dimethyl-1,2-benzanthracene results in increased expression of BRCA1 protein
9,10-Dimethyl-1,2-benzanthracene inhibits the reaction [A gene mutant form results in decreased expression of BRCA1 protein]; A gene mutant form inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of BRCA1 protein]
9,10-Dimethyl-1,2-benzanthracene results in increased expression of BRCA1 mRNA 		CTD PMID:21507987 PMID:23969067 PMID:25448685 NCBI chr10:86,917,693...86,978,012
Ensembl chr10:86,917,693...86,977,763 		JBrowse link
G Bscl2 BSCL2 lipid droplet biogenesis associated, seipin increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of BSCL2 mRNA CTD PMID:22003191 NCBI chr 1:215,160,764...215,172,540
Ensembl chr 1:215,160,957...215,172,536 		JBrowse link
G Bsg basigin increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of BSG protein CTD PMID:39910959 NCBI chr 7:10,643,788...10,651,005
Ensembl chr 7:10,643,789...10,651,005 		JBrowse link
G Btg2 BTG anti-proliferation factor 2 increases expression
multiple interactions 		ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of BTG2 mRNA
[9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein] which results in increased expression of BTG2 mRNA 		CTD PMID:32553695 NCBI chr13:48,083,931...48,087,690
Ensembl chr13:48,083,931...48,087,690 		JBrowse link
G C1qb complement C1q B chain affects expression ISO 9,10-Dimethyl-1,2-benzanthracene affects the expression of C1QB mRNA CTD PMID:21785161 NCBI chr 5:154,402,276...154,407,827
Ensembl chr 5:154,402,279...154,407,840 		JBrowse link
G C1qc complement C1q C chain affects expression ISO 9,10-Dimethyl-1,2-benzanthracene affects the expression of C1QC mRNA CTD PMID:21785161 NCBI chr 5:154,410,845...154,414,208
Ensembl chr 5:154,410,848...154,414,468 		JBrowse link
G C1s complement C1s affects expression ISO 9,10-Dimethyl-1,2-benzanthracene affects the expression of C1S mRNA CTD PMID:21785161 NCBI chr 4:159,116,549...159,128,736
Ensembl chr 4:159,116,549...159,128,736 		JBrowse link
G C3 complement C3 increases expression
decreases expression 		EXP
ISO 		9,10-Dimethyl-1,2-benzanthracene results in increased expression of C3 mRNA
9,10-Dimethyl-1,2-benzanthracene results in decreased expression of C3 protein 		CTD PMID:19480007 PMID:38307155 NCBI chr 9:2,174,412...2,201,339
Ensembl chr 9:2,174,412...2,201,339 		JBrowse link
G Ca3 carbonic anhydrase 3 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of CAR3 protein CTD PMID:20045496 NCBI chr 2:88,491,666...88,501,299
Ensembl chr 2:88,491,670...88,500,524 		JBrowse link
G Calb1 calbindin 1 multiple interactions ISO [Dietary Fats co-treated with Dietary Sucrose co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in decreased expression of CALB1 protein CTD PMID:39910959 NCBI chr 5:34,172,612...34,199,555
Ensembl chr 5:34,172,664...34,200,160 		JBrowse link
G Calm2 calmodulin 2 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of CALM2 protein CTD PMID:39910959 NCBI chr 6:12,845,170...12,857,830
Ensembl chr15:64,519,554...64,520,657
Ensembl chr 6:64,519,554...64,520,657 		JBrowse link
G Calr calreticulin increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of CALR mRNA CTD PMID:21785161 NCBI chr19:40,213,367...40,218,262
Ensembl chr19:40,213,239...40,219,236 		JBrowse link
G Capza2 capping actin protein of muscle Z-line subunit alpha 2 multiple interactions EXP [9,10-Dimethyl-1,2-benzanthracene co-treated with Isoflavones] results in increased expression of CAPZA2 protein CTD PMID:22248470 NCBI chr 4:46,944,040...46,979,930
Ensembl chr 4:46,895,701...46,979,938 		JBrowse link
G Car2 carbonic anhydrase 2 increases expression
decreases expression 		EXP
ISO 		9,10-Dimethyl-1,2-benzanthracene results in increased expression of CAR2 mRNA
9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CA2 protein 		CTD PMID:19480007 PMID:39910959 NCBI chr 2:88,462,883...88,478,012
Ensembl chr 2:88,462,872...88,478,064 		JBrowse link
G Cask calcium/calmodulin dependent serine protein kinase increases expression
decreases expression 		EXP
ISO 		9,10-Dimethyl-1,2-benzanthracene results in increased expression of CASK mRNA
9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of CASK mRNA 		CTD PMID:12376462 PMID:32553695 NCBI chr  X:11,572,328...11,915,831
Ensembl chr  X:11,572,636...11,911,948 		JBrowse link
G Casp2 caspase 2 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of CASP2 protein CTD PMID:21785161 NCBI chr 4:72,116,265...72,134,023
Ensembl chr 4:72,116,246...72,134,022 		JBrowse link
G Casp3 caspase 3 multiple interactions
increases cleavage
decreases expression
decreases activity
increases expression 		ISO
EXP 		[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased cleavage of and results in increased activity of CASP3 protein; [9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of CASP3 protein; [Butyric Acid co-treated with Niacinamide co-treated with Glucaric Acid] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased activity of CASP3 protein]; [Butyric Acid co-treated with Niacinamide co-treated with Glucaric Acid] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CASP3 mRNA]; [Butyric Acid co-treated with Niacinamide co-treated with Glucaric Acid] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CASP3 protein]; alpha-naphthoflavone inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased cleavage of CASP3 protein]; amarogentin inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased cleavage of and results in increased activity of CASP3 protein]; aspartyl-glutamyl-valyl-aspartal inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased cleavage of CASP3 protein]; benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased cleavage of CASP3 protein]; beta-elemene inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of CASP3 protein]; Butyric Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased activity of CASP3 protein]; Butyric Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CASP3 mRNA]; Butyric Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CASP3 protein]; CYP1B1 protein affects the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased cleavage of CASP3 protein]; dieckol inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CASP3 mRNA]; Glucaric Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased activity of CASP3 protein]; Glucaric Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CASP3 mRNA]; Glucaric Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CASP3 protein]; Niacinamide inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased activity of CASP3 protein]; Niacinamide inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CASP3 mRNA]; Niacinamide inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CASP3 protein]; pifithrin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased cleavage of CASP3 protein]; Plant Extracts inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased cleavage of and results in increased activity of CASP3 protein]; pyrene inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased cleavage of CASP3 protein]
1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CASP3 protein]; 1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt promotes the reaction [Doxorubicin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CASP3 protein]]; Doxorubicin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CASP3 protein]; Taurine inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CASP3 mRNA]; Taurine inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CASP3 protein]
9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CASP3 mRNA; 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CASP3 protein
9,10-Dimethyl-1,2-benzanthracene results in increased expression of CASP3 protein 		CTD PMID:16517061 PMID:21785161 PMID:23969067 PMID:25478867 PMID:30101532 More... NCBI chr16:52,395,539...52,413,794
Ensembl chr16:52,395,540...52,413,732 		JBrowse link
G Casp9 caspase 9 decreases activity
decreases expression
multiple interactions 		ISO
EXP 		9,10-Dimethyl-1,2-benzanthracene results in decreased activity of CASP9 protein
9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CASP9 mRNA; 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CASP9 protein
Taurine inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CASP9 mRNA]; Taurine inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CASP9 protein]
[9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of CASP9 protein; [Butyric Acid co-treated with Niacinamide co-treated with Glucaric Acid] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased activity of CASP9 protein]; [Butyric Acid co-treated with Niacinamide co-treated with Glucaric Acid] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CASP9 mRNA]; [Butyric Acid co-treated with Niacinamide co-treated with Glucaric Acid] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CASP9 protein]; beta-elemene inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of CASP9 protein]; Butyric Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased activity of CASP9 protein]; Butyric Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CASP9 mRNA]; Butyric Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CASP9 protein]; dieckol inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CASP9 mRNA]; Glucaric Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased activity of CASP9 protein]; Glucaric Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CASP9 mRNA]; Glucaric Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CASP9 protein]; Niacinamide inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased activity of CASP9 protein]; Niacinamide inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CASP9 mRNA]; Niacinamide inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CASP9 protein] 		CTD PMID:25478867 PMID:30101532 PMID:32662567 PMID:33347706 Ensembl chr 5:159,391,188...159,409,648 JBrowse link
G Cast calpastatin decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CAST protein CTD PMID:39910959 NCBI chr 2:5,707,633...5,817,213
Ensembl chr 2:5,707,640...5,817,180 		JBrowse link
G Cat catalase multiple interactions
increases activity
decreases expression
decreases activity 		ISO
EXP 		[9,10-Dimethyl-1,2-benzanthracene co-treated with [Tetradecanoylphorbol Acetate co-treated with argemone oil]] results in decreased activity of CAT protein; [9,10-Dimethyl-1,2-benzanthracene co-treated with [Tetradecanoylphorbol Acetate co-treated with sanguinarine]] results in decreased activity of CAT protein; [9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate] results in decreased activity of CAT protein; [[9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate] co-treated with argemone oil] results in decreased activity of CAT protein; [[9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate] co-treated with sanguinarine] results in decreased activity of CAT protein; beta-elemene inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate] results in decreased activity of CAT protein]; dieckol inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CAT protein]; geraniol inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CAT protein]
9,10-Dimethyl-1,2-benzanthracene results in increased activity of CAT protein
9,10-Dimethyl-1,2-benzanthracene results in decreased activity of CAT protein
[9,10-Dimethyl-1,2-benzanthracene co-treated with Tartrazine] results in decreased activity of CAT protein; [Ruthenium binds to Phloretin] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CAT protein]; allyl isothiocyanate inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased activity of CAT protein]; betulin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased activity of CAT protein]; brucine inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased activity of CAT protein]; tangeretin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased activity of CAT protein]; Vitamin K inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased activity of CAT protein]; zingerone inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased activity of CAT protein] 		CTD PMID:20691676 PMID:23033690 PMID:24995432 PMID:25744308 PMID:30027798 More... NCBI chr 3:110,297,340...110,329,526
Ensembl chr 3:110,297,342...110,329,526 		JBrowse link
G Cbln2 cerebellin 2 precursor decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CBLN2 mRNA CTD PMID:19480007 NCBI chr18:82,215,210...82,222,648
Ensembl chr18:82,215,220...82,222,648 		JBrowse link
G Cbx5 chromobox 5 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of CBX5 protein CTD PMID:39910959 NCBI chr 7:136,203,827...136,254,575
Ensembl chr 7:136,211,649...136,229,118 		JBrowse link
G Ccl2 C-C motif chemokine ligand 2 multiple interactions ISO [9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein] which results in increased expression of CCL2 mRNA
9,10-Dimethyl-1,2-benzanthracene inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased secretion of CCL2 protein] 		CTD PMID:32553695 PMID:36416909 NCBI chr10:67,503,077...67,504,875
Ensembl chr10:67,503,077...67,504,875 		JBrowse link
G Ccl3 C-C motif chemokine ligand 3 multiple interactions
increases expression 		EXP citronellol inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CCL3 mRNA] CTD PMID:31926054 NCBI chr10:68,948,889...68,950,439
Ensembl chr10:68,948,889...68,950,439 		JBrowse link
G Ccl5 C-C motif chemokine ligand 5 multiple interactions
increases expression 		ISO
EXP 		9,10-Dimethyl-1,2-benzanthracene promotes the reaction [AHR protein results in increased expression of CCL5 mRNA]
9,10-Dimethyl-1,2-benzanthracene results in increased expression of CCL5 mRNA 		CTD PMID:12200463 PMID:19480007 NCBI chr10:68,820,330...68,824,906
Ensembl chr10:68,738,651...68,824,884 		JBrowse link
G Ccl9 C-C motif chemokine ligand 9 decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CCL6 mRNA CTD PMID:19480007 NCBI chr10:68,863,994...68,868,928
Ensembl chr10:68,863,995...68,868,877 		JBrowse link
G Ccn2 cellular communication network factor 2 increases expression EXP
ISO 		9,10-Dimethyl-1,2-benzanthracene results in increased expression of CCN2 mRNA
9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of CCN2 mRNA 		CTD PMID:19480007 PMID:32553695 NCBI chr 1:22,621,498...22,624,614
Ensembl chr 1:22,621,501...22,624,976 		JBrowse link
G Ccn3 cellular communication network factor 3 increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of CCN3 mRNA CTD PMID:19480007 NCBI chr 7:87,983,788...87,990,810
Ensembl chr 7:87,982,216...87,994,581 		JBrowse link
G Ccnb1 cyclin B1 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of CCNB1 protein CTD PMID:20025956 NCBI chr 2:33,646,252...33,655,225
Ensembl chr 2:33,646,252...33,655,225 		JBrowse link
G Ccnd1 cyclin D1 increases expression
multiple interactions
increases expression 		ISO
EXP
IEP 		9,10-Dimethyl-1,2-benzanthracene results in increased expression of CCND1 mRNA
1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CCND1 protein]; Doxorubicin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CCND1 protein]; Doxorubicin promotes the reaction [1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CCND1 protein]]
DMBA increases expression of Ccnd1 mRNA and protein in rat mammary gland
[9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate] results in increased expression of CCND1 mRNA; beta-elemene inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate] results in increased expression of CCND1 mRNA]
9,10-Dimethyl-1,2-benzanthracene results in increased expression of CCND1 mRNA; 9,10-Dimethyl-1,2-benzanthracene results in increased expression of CCND1 protein 		CTD
RGD		 PMID:12097258 PMID:12376462 PMID:21785161 PMID:29663660 PMID:32662567 More... RGD:2292404 NCBI chr 1:209,518,288...209,527,986
Ensembl chr 1:209,518,288...209,527,810 		JBrowse link
G Ccng1 cyclin G1 increases expression
multiple interactions 		ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of CCNG1 mRNA
[9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein] which results in increased expression of CCNG1 mRNA 		CTD PMID:32553695 NCBI chr10:25,678,503...25,684,876
Ensembl chr10:25,677,885...25,683,766 		JBrowse link
G Ccno cyclin O increases expression
multiple interactions 		ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of CCNO mRNA
[9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein] which results in increased expression of CCNO mRNA 		CTD PMID:32553695 NCBI chr 2:46,364,074...46,367,113
Ensembl chr 2:46,350,717...46,367,113 		JBrowse link
G Cct2 chaperonin containing TCP1 subunit 2 multiple interactions ISO [Dietary Fats co-treated with Dietary Sucrose co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in decreased expression of CCT2 protein CTD PMID:39910959 NCBI chr 7:54,578,654...54,591,428
Ensembl chr 7:54,578,663...54,592,977 		JBrowse link
G Cd109 CD109 molecule increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of CD109 mRNA CTD PMID:32553695 NCBI chr 8:88,334,736...88,449,463
Ensembl chr 8:88,334,736...88,449,462 		JBrowse link
G Cd14 CD14 molecule increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of CD14 mRNA CTD PMID:32553695 NCBI chr18:28,609,558...28,611,409
Ensembl chr18:28,608,883...28,611,292 		JBrowse link
G Cd3d CD3 delta subunit of T-cell receptor complex increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of CD3D mRNA CTD PMID:19480007 NCBI chr 8:54,184,573...54,190,112
Ensembl chr 8:54,175,155...54,196,722 		JBrowse link
G Cd3g CD3 gamma subunit of T-cell receptor complex increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of CD3G mRNA CTD PMID:19480007 NCBI chr 8:54,177,572...54,184,087
Ensembl chr 8:54,177,977...54,183,918 		JBrowse link
G Cd44 CD44 molecule increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of CD44 mRNA CTD PMID:32553695 NCBI chr 3:109,610,824...109,699,776
Ensembl chr 3:109,612,054...109,699,424 		JBrowse link
G Cd5 Cd5 molecule increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of CD5 mRNA CTD PMID:19480007 NCBI chr 1:216,790,245...216,811,209
Ensembl chr 1:216,790,245...216,811,209 		JBrowse link
G Cd52 CD52 molecule decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CD52 mRNA CTD PMID:19480007 NCBI chr 5:151,603,537...151,605,096
Ensembl chr 5:151,603,524...151,605,086 		JBrowse link
G Cd59b CD59b molecule multiple interactions EXP [9,10-Dimethyl-1,2-benzanthracene results in increased mutagenesis of and results in decreased activity of PIGA protein] which affects the localization of CD59 protein; [9,10-Dimethyl-1,2-benzanthracene results in increased mutagenesis of PIGA gene] which results in decreased expression of CD59 protein CTD PMID:19965957 PMID:20202993 NCBI chr 3:110,914,008...110,932,489
Ensembl chr 3:110,914,091...110,935,310 		JBrowse link
G Cd6 Cd6 molecule increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of CD6 mRNA CTD PMID:19480007 NCBI chr 1:216,867,767...216,906,642
Ensembl chr 1:216,867,771...216,879,432 		JBrowse link
G Cd74 CD74 molecule affects expression ISO 9,10-Dimethyl-1,2-benzanthracene affects the expression of CD74 mRNA CTD PMID:21785161 NCBI chr18:56,527,071...56,536,406
Ensembl chr18:56,527,132...56,536,410 		JBrowse link
G Cd80 Cd80 molecule increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of CD80 mRNA CTD PMID:32553695 NCBI chr11:75,760,073...75,798,978
Ensembl chr11:75,760,147...75,797,540 		JBrowse link
G Cd81 Cd81 molecule affects expression ISO 9,10-Dimethyl-1,2-benzanthracene affects the expression of CD81 protein CTD PMID:38307155 NCBI chr 1:207,665,274...207,681,094
Ensembl chr 1:207,664,885...207,681,092 		JBrowse link
G Cd93 CD93 molecule increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of CD93 mRNA CTD PMID:19480007 NCBI chr 3:156,345,019...156,351,537
Ensembl chr 3:156,345,019...156,351,537 		JBrowse link
G Cdh1 cadherin 1 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CDH1 mRNA; 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CDH1 protein CTD PMID:29663660 NCBI chr19:51,402,178...51,471,572
Ensembl chr19:51,402,034...51,471,565 		JBrowse link
G Cdh13 cadherin 13 multiple interactions
decreases expression 		EXP AHR protein promotes the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CDH13 mRNA]; alpha-naphthoflavone inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CDH13 mRNA] CTD PMID:12559965 PMID:19480007 NCBI chr19:63,258,251...64,296,122
Ensembl chr19:63,258,122...64,296,119 		JBrowse link
G Cdk4 cyclin-dependent kinase 4 increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of CDK4 mRNA CTD PMID:12376462 NCBI chr 7:64,771,453...64,774,891
Ensembl chr 7:64,771,147...64,775,163 		JBrowse link
G Cdkal1 CDK5 regulatory subunit associated protein 1-like 1 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of CDKAL1 mRNA CTD PMID:32553695 NCBI chr17:34,927,221...35,479,827
Ensembl chr17:34,950,157...35,479,905 		JBrowse link
G Cdkn1a cyclin-dependent kinase inhibitor 1A increases expression
decreases expression
multiple interactions 		ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of CDKN1A mRNA
9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CDKN1A mRNA; 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CDKN1A protein
[Butyric Acid co-treated with Niacinamide co-treated with Glucaric Acid] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CDKN1A mRNA]; [Butyric Acid co-treated with Niacinamide co-treated with Glucaric Acid] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CDKN1A protein]; [epigallocatechin gallate co-treated with Polylactic Acid-Polyglycolic Acid Copolymer analog] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CDKN1A mRNA]; [Plant Extracts co-treated with Glucaric Acid] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CDKN1A mRNA]; [Resveratrol co-treated with Ellagic Acid] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CDKN1A mRNA]; [theaflavin co-treated with Polylactic Acid-Polyglycolic Acid Copolymer analog] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CDKN1A mRNA]; Butyric Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CDKN1A mRNA]; Butyric Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CDKN1A protein]; Eugenol inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CDKN1A protein]; Glucaric Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CDKN1A mRNA]; Glucaric Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CDKN1A protein]; Niacinamide inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CDKN1A mRNA]; Niacinamide inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CDKN1A protein]; theaflavin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CDKN1A mRNA]
9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of CDKN1A mRNA; 9,10-Dimethyl-1,2-benzanthracene results in increased expression of CDKN1A mRNA; 9,10-Dimethyl-1,2-benzanthracene results in increased expression of CDKN1A protein 		CTD PMID:20043298 PMID:20103723 PMID:21527772 PMID:21785161 PMID:23717041 More... NCBI chr20:7,150,820...7,161,373
Ensembl chr20:7,153,958...7,164,969 		JBrowse link
G Cdkn2a cyclin-dependent kinase inhibitor 2A increases response to substance
multiple interactions
increases methylation
decreases expression 		ISO CDKN2A gene polymorphism results in increased susceptibility to 9,10-Dimethyl-1,2-benzanthracene
Butyric Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CDKN2A mRNA]; Butyric Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CDKN2A protein]; Butyric Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased methylation of CDKN2A promoter]; Glucaric Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CDKN2A mRNA]; Glucaric Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CDKN2A protein]; Glucaric Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased methylation of CDKN2A promoter]; Niacinamide inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CDKN2A mRNA]; Niacinamide inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CDKN2A protein]; Niacinamide inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased methylation of CDKN2A promoter]
9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CDKN2A mRNA; 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CDKN2A protein 		CTD PMID:11544531 PMID:24792773 NCBI chr 5:109,100,763...109,114,448
Ensembl chr 5:109,100,772...109,119,248 		JBrowse link
G Cdkn2b cyclin-dependent kinase inhibitor 2B increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of CDKN2B mRNA CTD PMID:19480007 NCBI chr 5:109,123,308...109,134,906
Ensembl chr 5:109,114,322...109,134,855 		JBrowse link
G Celf5 CUGBP, Elav-like family member 5 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of CELF5 mRNA CTD PMID:32553695 NCBI chr 7:8,876,551...8,901,078
Ensembl chr 7:8,876,564...8,901,069 		JBrowse link
G Cenpb centromere protein B multiple interactions ISO [9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein] which results in increased expression of CENPB mRNA CTD PMID:32553695 NCBI chr 3:138,850,003...138,852,796
Ensembl chr 3:138,841,679...138,854,372 		JBrowse link
G Cep112 centrosomal protein 112 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of CEP112 mRNA CTD PMID:32553695 NCBI chr10:93,865,630...94,332,679
Ensembl chr10:93,865,699...94,332,680 		JBrowse link
G Cercam cerebral endothelial cell adhesion molecule decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CERCAM mRNA CTD PMID:19480007 NCBI chr 3:33,515,513...33,553,817
Ensembl chr 3:33,486,664...33,553,813 		JBrowse link
G Cfd complement factor D decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CFD mRNA CTD PMID:19480007 NCBI chr 7:10,463,773...10,465,496
Ensembl chr 7:10,463,775...10,465,572 		JBrowse link
G Cfdp1 craniofacial development protein 1 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of CFDP1 protein CTD PMID:39910959 NCBI chr19:56,627,596...56,733,099
Ensembl chr19:56,626,963...56,733,098 		JBrowse link
G Cgref1 cell growth regulator with EF hand domain 1 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of CGREF1 mRNA CTD PMID:32553695 NCBI chr 6:31,151,795...31,163,801
Ensembl chr 6:31,151,795...31,163,800 		JBrowse link
G Chchd6 coiled-coil-helix-coiled-coil-helix domain containing 6 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of CHCHD6 mRNA CTD PMID:32553695 NCBI chr 4:123,360,729...123,581,429
Ensembl chr 4:123,349,187...123,581,421 		JBrowse link
G Chek1 checkpoint kinase 1 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of CHEK1 protein CTD PMID:20025956 NCBI chr 8:44,609,417...44,629,867
Ensembl chr 8:44,609,417...44,629,359 		JBrowse link
G Chi3l1 chitinase 3 like 1 affects expression ISO 9,10-Dimethyl-1,2-benzanthracene affects the expression of CHI3L1 mRNA CTD PMID:21785161 NCBI chr13:48,193,839...48,201,822
Ensembl chr13:48,193,800...48,201,825 		JBrowse link
G Cidec cell death-inducing DFFA-like effector c decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CIDEC mRNA CTD PMID:19480007 NCBI chr 4:148,124,924...148,137,806
Ensembl chr 4:148,124,925...148,137,806 		JBrowse link
G Cirbp cold inducible RNA binding protein increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of CIRBP protein CTD PMID:39910959 NCBI chr 7:10,184,515...10,189,623 JBrowse link
G Cisd1 CDGSH iron sulfur domain 1 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of CISD1 protein CTD PMID:38307155 NCBI chr20:17,254,462...17,267,843
Ensembl chr20:17,254,187...17,271,042 		JBrowse link
G Ckap2 cytoskeleton associated protein 2 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of CKAP2 mRNA CTD PMID:32553695 NCBI chr16:76,542,114...76,567,297
Ensembl chr16:76,542,104...76,567,352 		JBrowse link
G Clca1 chloride channel accessory 1 decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CLCA1 mRNA CTD PMID:19480007 NCBI chr 2:236,599,022...236,624,714
Ensembl chr 2:236,599,022...236,624,714 		JBrowse link
G Cldn3 claudin 3 increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of CLDN3 mRNA CTD PMID:12097258 NCBI chr12:27,345,075...27,346,547
Ensembl chr12:27,345,076...27,348,841 		JBrowse link
G Clec10a C-type lectin domain containing 10A increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of CLEC10A mRNA CTD PMID:32553695 NCBI chr10:55,374,914...55,379,110
Ensembl chr10:55,374,887...55,379,108 		JBrowse link
G Clstn3 calsyntenin 3 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of CLSTN3 mRNA CTD PMID:32553695 NCBI chr 4:159,017,795...159,051,069
Ensembl chr 4:159,017,795...159,051,069 		JBrowse link
G Cndp2 carnosine dipeptidase 2 multiple interactions ISO [Dietary Fats co-treated with Dietary Sucrose co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in decreased expression of CNDP2 protein CTD PMID:39910959 NCBI chr18:80,314,799...80,331,900
Ensembl chr18:80,314,801...80,331,900 		JBrowse link
G Cnn1 calponin 1 multiple interactions ISO [Dietary Fats co-treated with Dietary Sucrose co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in decreased expression of CNN1 protein CTD PMID:39910959 NCBI chr 8:28,908,437...28,917,099
Ensembl chr 8:28,908,330...28,919,482 		JBrowse link
G Cnn3 calponin 3 increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of CNN3 mRNA CTD PMID:12376462 NCBI chr 2:212,203,661...212,234,772
Ensembl chr 2:212,226,640...212,234,815 		JBrowse link
G Col1a2 collagen type I alpha 2 chain decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of COL1A2 mRNA CTD PMID:19480007 NCBI chr 4:33,518,557...33,553,484
Ensembl chr 4:33,518,420...33,553,995 		JBrowse link
G Col4a6 collagen type IV alpha 6 chain decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of COL4A6 mRNA CTD PMID:32553695 NCBI chr  X:109,554,945...109,905,987
Ensembl chr  X:109,552,651...109,905,944 		JBrowse link
G Col5a1 collagen type V alpha 1 chain decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of COL5A1 mRNA CTD PMID:12376462 NCBI chr 3:31,606,475...31,755,097
Ensembl chr 3:31,606,486...31,753,020 		JBrowse link
G Col5a3 collagen type V alpha 3 chain decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of COL5A3 mRNA CTD PMID:19480007 NCBI chr 8:27,580,768...27,626,002
Ensembl chr 8:27,580,768...27,626,122 		JBrowse link
G Colec10 collectin subfamily member 10 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of COLEC10 mRNA CTD PMID:32553695 NCBI chr 7:87,634,686...87,695,465
Ensembl chr 7:87,634,654...87,699,534 		JBrowse link
G Comt catechol-O-methyltransferase decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of COMT mRNA CTD PMID:38307155 NCBI chr11:96,072,371...96,091,956
Ensembl chr11:96,072,489...96,092,533 		JBrowse link
G Coro1a coronin 1A increases methylation
multiple interactions 		EXP 9,10-Dimethyl-1,2-benzanthracene results in increased methylation of CORO1A promoter
[9,10-Dimethyl-1,2-benzanthracene results in increased methylation of CORO1A promoter] which results in decreased expression of CORO1A mRNA 		CTD PMID:21489049 NCBI chr 1:190,726,129...190,731,133
Ensembl chr 1:190,726,130...190,731,102 		JBrowse link
G Cox6c cytochrome c oxidase subunit 6C increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of COX6C protein CTD PMID:38307155 NCBI chr 7:69,014,410...69,027,145
Ensembl chr 7:69,014,417...69,027,166 		JBrowse link
G Cpa6 carboxypeptidase A6 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of CPA6 mRNA CTD PMID:32553695 NCBI chr 5:13,309,660...13,671,429
Ensembl chr 5:13,309,660...13,671,429 		JBrowse link
G Cpb1 carboxypeptidase B1 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of CPB1 mRNA CTD PMID:32553695 NCBI chr 2:104,684,275...104,744,824
Ensembl chr 2:104,684,275...104,714,662 		JBrowse link
G Cpox coproporphyrinogen oxidase increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of CPOX mRNA CTD PMID:32553695 NCBI chr11:55,405,778...55,415,761
Ensembl chr11:55,405,784...55,415,761 		JBrowse link
G Crabp2 cellular retinoic acid binding protein 2 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of CRABP2 mRNA CTD PMID:21527772 NCBI chr 2:175,714,862...175,719,208
Ensembl chr 2:175,707,312...175,728,385 		JBrowse link
G Creb3l3 cAMP responsive element binding protein 3-like 3 multiple interactions ISO [CYP1B1 protein affects the susceptibility to 9,10-Dimethyl-1,2-benzanthracene] which affects the expression of CREB3L3 mRNA CTD PMID:27891153 NCBI chr 7:9,273,320...9,281,755
Ensembl chr 7:9,273,338...9,281,778 		JBrowse link
G Crp C-reactive protein multiple interactions ISO [9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of CRP protein; Cisplatin inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of CRP protein]; Cisplatin promotes the reaction [NPPC protein inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of CRP protein]]; NPPC protein inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of CRP protein]; NPPC protein promotes the reaction [Cisplatin inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of CRP protein]] CTD PMID:37352108 NCBI chr13:87,694,062...87,695,978
Ensembl chr13:87,657,317...87,707,514 		JBrowse link
G Cs citrate synthase multiple interactions ISO [Dietary Fats co-treated with Dietary Sucrose co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased expression of CS protein CTD PMID:39910959 NCBI chr 7:1,348,389...1,374,624
Ensembl chr 7:1,342,942...1,375,938 		JBrowse link
G Csde1 cold shock domain containing E1 affects expression ISO 9,10-Dimethyl-1,2-benzanthracene affects the expression of CSDE1 mRNA CTD PMID:21785161 NCBI chr 2:193,234,546...193,271,301
Ensembl chr 2:193,243,526...193,271,301 		JBrowse link
G Csf1r colony stimulating factor 1 receptor multiple interactions EXP [9,10-Dimethyl-1,2-benzanthracene co-treated with Fluoxetine] affects the expression of CSF1R protein; [9,10-Dimethyl-1,2-benzanthracene co-treated with Raloxifene Hydrochloride co-treated with Fluoxetine] affects the expression of CSF1R protein; [9,10-Dimethyl-1,2-benzanthracene co-treated with Raloxifene Hydrochloride] affects the expression of CSF1R protein CTD PMID:31332895 NCBI chr18:56,834,152...56,860,804
Ensembl chr18:56,817,049...56,860,806 		JBrowse link
G Csf2 colony stimulating factor 2 increases expression
multiple interactions 		ISO
EXP 		9,10-Dimethyl-1,2-benzanthracene results in increased expression of CSF2 mRNA
Vitamin K inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CSF2 mRNA] 		CTD PMID:14678569 PMID:33063951 NCBI chr10:38,887,692...38,889,673
Ensembl chr10:38,887,692...38,890,031 		JBrowse link
G Csf3 colony stimulating factor 3 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of CSF3 mRNA CTD PMID:14678569 NCBI chr10:84,157,485...84,159,860
Ensembl chr10:84,157,211...84,159,860 		JBrowse link
G Csn1s1 casein alpha s1 decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CSN1S1 mRNA CTD PMID:19480007 NCBI chr14:20,622,858...20,638,849 JBrowse link
G Csn2 casein beta decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CSN2 protein CTD PMID:22248470 NCBI chr14:20,601,824...20,609,061
Ensembl chr14:20,601,824...20,609,060 		JBrowse link
G Cth cystathionine gamma-lyase increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of CTH mRNA CTD PMID:32553695 NCBI chr 2:249,634,731...249,661,066
Ensembl chr 2:249,634,731...249,661,066 		JBrowse link
G Ctnnb1 catenin beta 1 increases expression
decreases expression
multiple interactions 		ISO
EXP 		9,10-Dimethyl-1,2-benzanthracene results in increased expression of CTNNB1 mRNA
9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CTNNB1 protein
9,10-Dimethyl-1,2-benzanthracene results in increased expression of and affects the localization of CTNNB1 protein; mithramycin A inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of and affects the localization of CTNNB1 protein]; SP1 protein affects the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CTNNB1 protein] 		CTD PMID:29663660 PMID:36863560 NCBI chr 8:129,517,576...129,544,661
Ensembl chr 8:129,517,545...129,544,662 		JBrowse link
G Ctsd cathepsin D increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of CTSD mRNA CTD PMID:12097258 NCBI chr 1:206,956,945...206,968,821
Ensembl chr 1:206,956,944...206,968,821 		JBrowse link
G Ctsl cathepsin L increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of CTSL protein CTD PMID:39910959 NCBI chr17:770,104...776,266
Ensembl chr17:770,093...777,113 		JBrowse link
G Ctsw cathepsin W increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of CTSW mRNA CTD PMID:19480007 NCBI chr 1:212,201,904...212,208,028
Ensembl chr 1:212,201,904...212,205,292 		JBrowse link
G Ctsz cathepsin Z increases expression
multiple interactions 		ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of CTSZ protein
[Dietary Fats co-treated with Dietary Sucrose co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased expression of CTSZ protein 		CTD PMID:39910959 NCBI chr 3:183,643,077...183,653,847
Ensembl chr 3:183,643,077...183,657,012 		JBrowse link
G Cubn cubilin decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of CUBN mRNA CTD PMID:32553695 NCBI chr17:81,293,619...81,501,694
Ensembl chr17:81,293,619...81,501,694 		JBrowse link
G Cxcl10 C-X-C motif chemokine ligand 10 multiple interactions
increases expression 		ISO [9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein] which results in decreased expression of CXCL10 mRNA; [CYP1B1 protein affects the susceptibility to 9,10-Dimethyl-1,2-benzanthracene] which affects the expression of CXCL10 mRNA
9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of CXCL10 mRNA 		CTD PMID:27891153 PMID:32553695 NCBI chr14:15,989,066...15,991,263
Ensembl chr14:15,989,018...15,991,261 		JBrowse link
G Cxcl13 C-X-C motif chemokine ligand 13 affects expression ISO 9,10-Dimethyl-1,2-benzanthracene affects the expression of CXCL13 mRNA CTD PMID:21785161 NCBI chr14:13,912,858...13,917,920
Ensembl chr14:13,912,858...13,917,920 		JBrowse link
G Cxcl3 C-X-C motif chemokine ligand 3 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of CXCL1 mRNA CTD PMID:32553695 NCBI chr14:17,571,900...17,573,624
Ensembl chr14:17,571,900...17,573,624 		JBrowse link
G Cxcr6 C-X-C motif chemokine receptor 6 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of CXCR6 mRNA CTD PMID:32553695 NCBI chr 8:132,311,834...132,317,001
Ensembl chr 8:132,306,600...132,322,498 		JBrowse link
G Cyb5a cytochrome b5 type A multiple interactions
increases expression 		EXP
ISO 		tangeretin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYB5A protein]; Taurine inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYB5A protein] CTD PMID:24995432 PMID:27091720 PMID:39910959 NCBI chr18:80,487,923...80,520,544
Ensembl chr18:14,453,966...14,455,094
Ensembl chr18:14,453,966...14,455,094 		JBrowse link
G Cyb5b cytochrome b5 type B increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYB5B protein CTD PMID:39910959 NCBI chr19:51,972,611...52,006,477
Ensembl chr19:51,972,547...52,026,980 		JBrowse link
G Cyb5r3 cytochrome b5 reductase 3 affects expression ISO 9,10-Dimethyl-1,2-benzanthracene affects the expression of CYB5R3 mRNA CTD PMID:21785161 NCBI chr 7:116,186,729...116,204,290
Ensembl chr 7:116,186,729...116,204,306 		JBrowse link
G Cycs cytochrome c, somatic increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYCS protein CTD PMID:39910959 NCBI chr 4:80,982,667...80,984,767
Ensembl chr 4:80,982,668...80,984,816
Ensembl chr18:80,982,668...80,984,816 		JBrowse link
G Cyp1a1 cytochrome P450, family 1, subfamily a, polypeptide 1 increases response to substance
increases metabolic processing
increases expression
multiple interactions
affects response to substance
increases activity 		ISO
EXP 		CYP1A1 protein results in increased susceptibility to 9,10-Dimethyl-1,2-benzanthracene
CYP1A1 protein results in increased metabolism of 9,10-Dimethyl-1,2-benzanthracene
9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP1A1 mRNA; 9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP1A1 protein
7-ketocholesterol inhibits the reaction [[Benzo(a)pyrene co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased expression of CYP1A1 mRNA]; 7-ketocholesterol inhibits the reaction [[Benzo(a)pyrene co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased expression of CYP1A1 protein]; 9,10-Dimethyl-1,2-benzanthracene results in increased expression of and results in increased activity of CYP1A1 protein; [Benzo(a)pyrene co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased expression of CYP1A1 mRNA; [Benzo(a)pyrene co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased expression of CYP1A1 protein; betulin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP1A1 protein]; Estradiol inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP1A1 mRNA]; Resveratrol inhibits the reaction [[Benzo(a)pyrene co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased expression of CYP1A1 protein]
CYP1A1 protein affects the susceptibility to 9,10-Dimethyl-1,2-benzanthracene
9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of CYP1A1 mRNA; 9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP1A1 mRNA; 9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP1A1 protein
2'-hydroxychalcone inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP1A1 mRNA]; 2-((2,6-dichlorophenyl)amino)benzeneacetic acid 4-(3H-1,2-dithiol-3-thione-5-yl)phenyl ester inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased activity of CYP1A1 protein]; 2-((2,6-dichlorophenyl)amino)benzeneacetic acid 4-(3H-1,2-dithiol-3-thione-5-yl)phenyl ester inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP1A1 mRNA]; 3-(3-methoxyphenyl)-N-(3,4,5-trimethoxyphenyl)acrylamide inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased activity of CYP1A1 protein]; 3-(3-methoxyphenyl)-N-(3,4,5-trimethoxyphenyl)acrylamide inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP1A1 mRNA]; 5-androstene-16-fluoro-17-one inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP1A1 mRNA]; 7-ketocholesterol inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP1A1 protein]; 9,10-Dimethyl-1,2-benzanthracene results in increased expression of and results in increased activity of CYP1A1 protein; [CYP1A1 protein co-treated with Trichloroepoxypropane] results in increased metabolism of 9,10-Dimethyl-1,2-benzanthracene; [CYP1A1 protein results in increased metabolism of 9,10-Dimethyl-1,2-benzanthracene] which results in increased expression of TP53 protein modified form; [Tetrachlorodibenzodioxin promotes the reaction [CYP1A1 protein results in increased metabolism of 9,10-Dimethyl-1,2-benzanthracene]] which results in increased chemical synthesis of 7,12-dimethylbenz(a)anthracene-3,4-dihydrodiol; biochanin A inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene promotes the reaction [AHR protein binds to CYP1A1 promoter]]; biochanin A inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased activity of CYP1A1 protein]; biochanin A inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP1A1 mRNA]; CYP1A1 protein results in increased metabolism of and results in increased activity of 9,10-Dimethyl-1,2-benzanthracene; Dehydroepiandrosterone inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased activity of CYP1A1 protein]; Dehydroepiandrosterone inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP1A1 mRNA]; EPHX1 protein promotes the reaction [CYP1A1 protein results in increased metabolism of 9,10-Dimethyl-1,2-benzanthracene]; Eugenol inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP1A1 mRNA]; Eugenol inhibits the reaction [CYP1A1 protein results in increased metabolism of and results in increased activity of 9,10-Dimethyl-1,2-benzanthracene]; isoliquiritigenin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP1A1 mRNA]; isoliquiritigenin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP1A1 protein]; Metformin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of and results in increased activity of CYP1A1 protein]; Metformin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP1A1 mRNA]; Resveratrol inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP1A1 mRNA]; S-sulindac inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased activity of CYP1A1 protein]; S-sulindac inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP1A1 mRNA]
1-(1-propynyl)pyrene inhibits the reaction [CYP1A1 protein results in increased metabolism of 9,10-Dimethyl-1,2-benzanthracene]; 9,10-Dimethyl-1,2-benzanthracene results in increased expression of and results in increased activity of CYP1A1 protein; [9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein] which results in increased expression of CYP1A1 mRNA; [[benzo(c)phenanthrene results in increased expression of CYP1A1 protein] promotes the reaction [CYP1A1 protein results in increased metabolism of 9,10-Dimethyl-1,2-benzanthracene]] which results in increased chemical synthesis of 9,10-Dimethyl-1,2-benzanthracene analog; [AHR mRNA affects the susceptibility to 9,10-Dimethyl-1,2-benzanthracene] which results in decreased expression of CYP1A1; [benzo(c)phenanthrene promotes the reaction [CYP1A1 protein results in increased metabolism of 9,10-Dimethyl-1,2-benzanthracene]] which results in increased chemical synthesis of 9,10-Dimethyl-1,2-benzanthracene analog; [CYP1A1 protein co-treated with Trichloroepoxypropane] results in increased metabolism of 9,10-Dimethyl-1,2-benzanthracene; [CYP1B1 protein affects the susceptibility to 9,10-Dimethyl-1,2-benzanthracene] which affects the expression of CYP1A1 mRNA; [Tetrachlorodibenzodioxin promotes the reaction [CYP1A1 protein results in increased metabolism of 9,10-Dimethyl-1,2-benzanthracene]] which results in increased chemical synthesis of 9,10-Dimethyl-1,2-benzanthracene analog; EPHX1 protein promotes the reaction [CYP1A1 protein results in increased metabolism of 9,10-Dimethyl-1,2-benzanthracene] 		CTD PMID:7756127 PMID:8674863 PMID:8961944 PMID:9168260 PMID:10051580 More... NCBI chr 8:66,991,940...66,998,014
Ensembl chr 8:66,991,970...66,998,012 		JBrowse link
G Cyp1a2 cytochrome P450, family 1, subfamily a, polypeptide 2 increases activity
multiple interactions
increases expression 		ISO
EXP 		9,10-Dimethyl-1,2-benzanthracene results in increased activity of CYP1A2 protein
9,10-Dimethyl-1,2-benzanthracene results in increased expression of and results in increased activity of CYP1A2 protein
9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP1A2 protein
2-((2,6-dichlorophenyl)amino)benzeneacetic acid 4-(3H-1,2-dithiol-3-thione-5-yl)phenyl ester inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP1A2 mRNA]; 3-(3-methoxyphenyl)-N-(3,4,5-trimethoxyphenyl)acrylamide inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased activity of CYP1A2 protein]; 3-(3-methoxyphenyl)-N-(3,4,5-trimethoxyphenyl)acrylamide inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP1A2 mRNA]; [CYP1A2 protein co-treated with Trichloroepoxypropane] results in increased metabolism of 9,10-Dimethyl-1,2-benzanthracene; EPHX1 protein promotes the reaction [CYP1A2 protein results in increased metabolism of 9,10-Dimethyl-1,2-benzanthracene]; isoliquiritigenin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP1A2 mRNA]; S-sulindac inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP1A2 mRNA]
CYP1A2 protein results in increased activity of 9,10-Dimethyl-1,2-benzanthracene 		CTD PMID:8961944 PMID:15606143 PMID:16054776 PMID:17183067 PMID:18678235 More... NCBI chr 8:66,971,261...66,978,149
Ensembl chr 8:66,971,261...66,978,149 		JBrowse link
G Cyp1b1 cytochrome P450, family 1, subfamily b, polypeptide 1 increases activity
increases metabolic processing
increases expression
multiple interactions
affects response to substance
increases response to substance 		ISO
EXP 		9,10-Dimethyl-1,2-benzanthracene results in increased activity of CYP1B1 protein
CYP1B1 protein results in increased metabolism of 9,10-Dimethyl-1,2-benzanthracene
9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP1B1 mRNA
2'-hydroxychalcone inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP1B1 mRNA]; 2,4,3',5'-tetramethoxystilbene inhibits the reaction [[CYP1B1 protein results in increased metabolism of 9,10-Dimethyl-1,2-benzanthracene] which results in increased expression of TP53 protein modified form]; 2,4,3',5'-tetramethoxystilbene inhibits the reaction [CYP1B1 protein results in increased metabolism of 9,10-Dimethyl-1,2-benzanthracene]; 2-((2,6-dichlorophenyl)amino)benzeneacetic acid 4-(3H-1,2-dithiol-3-thione-5-yl)phenyl ester inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP1B1 mRNA]; 3-(3-methoxyphenyl)-N-(3,4,5-trimethoxyphenyl)acrylamide inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased activity of CYP1B1 protein]; 3-(3-methoxyphenyl)-N-(3,4,5-trimethoxyphenyl)acrylamide inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP1B1 mRNA]; 5-androstene-16-fluoro-17-one inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP1B1 mRNA]; [[benzo(c)phenanthrene results in increased expression of CYP1B1 protein] promotes the reaction [CYP1B1 protein results in increased metabolism of 9,10-Dimethyl-1,2-benzanthracene]] which results in increased chemical synthesis of 9,10-Dimethyl-1,2-benzanthracene analog; [CYP1B1 protein results in increased metabolism of 9,10-Dimethyl-1,2-benzanthracene] which results in increased expression of TP53 protein modified form; alpha-naphthoflavone inhibits the reaction [[CYP1B1 protein results in increased metabolism of 9,10-Dimethyl-1,2-benzanthracene] which results in increased expression of TP53 protein modified form]; alpha-naphthoflavone inhibits the reaction [CYP1B1 protein results in increased metabolism of 9,10-Dimethyl-1,2-benzanthracene]; CYP1B1 protein results in increased metabolism of and results in increased activity of 9,10-Dimethyl-1,2-benzanthracene; Eugenol inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP1B1 mRNA]; Eugenol inhibits the reaction [CYP1B1 protein results in increased metabolism of and results in increased activity of 9,10-Dimethyl-1,2-benzanthracene]; isoliquiritigenin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP1B1 mRNA]; isoliquiritigenin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP1B1 protein]; S-sulindac inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP1B1 mRNA]
9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP1B1 mRNA; 9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP1B1 protein
Estradiol inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP1B1 mRNA]; POMC protein promotes the reaction [CYP1B1 protein results in increased metabolism of 9,10-Dimethyl-1,2-benzanthracene]
1-ethynylpyrene inhibits the reaction [CYP1B1 protein results in increased metabolism of 9,10-Dimethyl-1,2-benzanthracene]; 9,10-Dimethyl-1,2-benzanthracene results in increased expression of and results in increased activity of CYP1B1 protein; [9,10-Dimethyl-1,2-benzanthracene co-treated with Dietary Fats] results in decreased expression of CYP1B1 mRNA; [CYP1B1 protein affects the susceptibility to 9,10-Dimethyl-1,2-benzanthracene] which affects the expression of AHRR mRNA; [CYP1B1 protein affects the susceptibility to 9,10-Dimethyl-1,2-benzanthracene] which affects the expression of CREB3L3 mRNA; [CYP1B1 protein affects the susceptibility to 9,10-Dimethyl-1,2-benzanthracene] which affects the expression of CXCL10 mRNA; [CYP1B1 protein affects the susceptibility to 9,10-Dimethyl-1,2-benzanthracene] which affects the expression of CYP1A1 mRNA; [CYP1B1 protein affects the susceptibility to 9,10-Dimethyl-1,2-benzanthracene] which affects the expression of EGR2 mRNA; [CYP1B1 protein affects the susceptibility to 9,10-Dimethyl-1,2-benzanthracene] which affects the expression of ERDR1X mRNA; [CYP1B1 protein affects the susceptibility to 9,10-Dimethyl-1,2-benzanthracene] which affects the expression of HBB-B1 mRNA; [CYP1B1 protein affects the susceptibility to 9,10-Dimethyl-1,2-benzanthracene] which affects the expression of HOXB6 mRNA; [CYP1B1 protein affects the susceptibility to 9,10-Dimethyl-1,2-benzanthracene] which affects the expression of HSPA1A mRNA; [CYP1B1 protein affects the susceptibility to 9,10-Dimethyl-1,2-benzanthracene] which affects the expression of IL6 mRNA; [CYP1B1 protein affects the susceptibility to 9,10-Dimethyl-1,2-benzanthracene] which affects the expression of NR4A1 mRNA; [CYP1B1 protein affects the susceptibility to 9,10-Dimethyl-1,2-benzanthracene] which affects the expression of POLR2A mRNA; [CYP1B1 protein affects the susceptibility to 9,10-Dimethyl-1,2-benzanthracene] which affects the expression of RAG1 mRNA; [CYP1B1 protein affects the susceptibility to 9,10-Dimethyl-1,2-benzanthracene] which affects the expression of SOX19 mRNA; [CYP1B1 protein affects the susceptibility to 9,10-Dimethyl-1,2-benzanthracene] which affects the expression of SPP1 mRNA; [CYP1B1 protein affects the susceptibility to 9,10-Dimethyl-1,2-benzanthracene] which affects the expression of TNF mRNA; [Ellagic Acid co-treated with Plant Extracts] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP1B1 mRNA]; [Ellagic Acid co-treated with Resveratrol] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP1B1 mRNA]; [Glucaric Acid co-treated with Plant Extracts] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP1B1 mRNA]; [Glucaric Acid co-treated with Resveratrol] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP1B1 mRNA]; [Resveratrol co-treated with Plant Extracts] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP1B1 mRNA]; alpha-naphthoflavone inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased activity of CYP1B1 protein]; benz(a)anthracene promotes the reaction [CYP1B1 protein results in increased metabolism of 9,10-Dimethyl-1,2-benzanthracene]; chelerythrine inhibits the reaction [CYP1B1 protein results in increased metabolism of 9,10-Dimethyl-1,2-benzanthracene]; CYP1B1 protein affects the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased cleavage of CASP3 protein]; CYP1B1 protein affects the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased phosphorylation of TRP53 protein]; Dehydroepiandrosterone inhibits the reaction [benz(a)anthracene promotes the reaction [CYP1B1 protein results in increased metabolism of 9,10-Dimethyl-1,2-benzanthracene]]; Dehydroepiandrosterone inhibits the reaction [CYP1B1 protein results in increased metabolism of 9,10-Dimethyl-1,2-benzanthracene]; Dehydroepiandrosterone inhibits the reaction [Tetrachlorodibenzodioxin promotes the reaction [CYP1B1 protein results in increased metabolism of 9,10-Dimethyl-1,2-benzanthracene]]; pifithrin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased activity of CYP1B1 protein]; POR protein affects the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP1B1 protein]; PRKCB protein inhibits the reaction [CYP1B1 protein results in increased metabolism of 9,10-Dimethyl-1,2-benzanthracene]; PRKCB protein inhibits the reaction [Tetrachlorodibenzodioxin promotes the reaction [CYP1B1 protein results in increased metabolism of 9,10-Dimethyl-1,2-benzanthracene]]; pyrene inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased activity of CYP1B1 protein]; Tetrachlorodibenzodioxin promotes the reaction [CYP1B1 protein results in increased metabolism of 9,10-Dimethyl-1,2-benzanthracene]; Tetradecanoylphorbol Acetate inhibits the reaction [CYP1B1 protein results in increased metabolism of 9,10-Dimethyl-1,2-benzanthracene]; Tetradecanoylphorbol Acetate inhibits the reaction [Tetrachlorodibenzodioxin promotes the reaction [CYP1B1 protein results in increased metabolism of 9,10-Dimethyl-1,2-benzanthracene]]
9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of CYP1B1 mRNA; 9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP1B1 mRNA; 9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP1B1 protein
CYP1B1 protein results in increased susceptibility to 9,10-Dimethyl-1,2-benzanthracene; CYP1B1 results in increased susceptibility to 9,10-Dimethyl-1,2-benzanthracene
CYP1B1 protein results in increased activity of 9,10-Dimethyl-1,2-benzanthracene 		CTD PMID:7505439 PMID:7588239 PMID:8033136 PMID:8674863 PMID:9168260 More... NCBI chr 6:21,093,927...21,103,091
Ensembl chr 6:21,078,146...21,103,142 		JBrowse link
G Cyp2b1 cytochrome P450, family 2, subfamily b, polypeptide 1 increases activity
multiple interactions 		EXP 9,10-Dimethyl-1,2-benzanthracene results in increased activity of CYP2B1 protein
beta-Naphthoflavone inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased activity of CYP2B1 protein] 		CTD PMID:16054776 NCBI chr 1:90,646,098...90,669,762 JBrowse link
G Cyp2b2 cytochrome P450, family 2, subfamily b, polypeptide 2 increases activity
multiple interactions 		EXP 9,10-Dimethyl-1,2-benzanthracene results in increased activity of CYP2B2 protein
beta-Naphthoflavone inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased activity of CYP2B2 protein] 		CTD PMID:16054776 NCBI chr 1:90,722,243...90,736,272 JBrowse link
G Cyp2b3 cytochrome P450, family 2, subfamily b, polypeptide 3 multiple interactions ISO CYP2B6 protein results in increased metabolism of and results in increased activity of 9,10-Dimethyl-1,2-benzanthracene CTD PMID:32159784 NCBI chr 1:90,780,468...90,859,852 JBrowse link
G Cyp2c6 cytochrome P450, family 2, subfamily C, polypeptide 6 multiple interactions
increases expression 		ISO CYP2C19 protein results in increased metabolism of and results in increased activity of 9,10-Dimethyl-1,2-benzanthracene
9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP2C29 mRNA 		CTD PMID:32159784 PMID:38307155 NCBI chr 1:247,879,058...247,916,804
Ensembl chr 1:247,879,078...247,916,798 		JBrowse link
G Cyp2d4 cytochrome P450, family 2, subfamily d, polypeptide 4 increases response to substance ISO CYP2D6 protein results in increased susceptibility to 9,10-Dimethyl-1,2-benzanthracene CTD PMID:20507880 NCBI chr 7:115,762,662...115,771,832
Ensembl chr 7:115,761,696...115,771,837 		JBrowse link
G Cyp2e1 cytochrome P450, family 2, subfamily e, polypeptide 1 affects response to substance
increases expression 		ISO
EXP 		CYP2E1 protein affects the susceptibility to 9,10-Dimethyl-1,2-benzanthracene
9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP2E1 mRNA 		CTD PMID:18622027 PMID:24576726 NCBI chr 1:205,269,967...205,280,365
Ensembl chr 1:205,267,505...205,293,495 		JBrowse link
G Cyp2s1 cytochrome P450, family 2, subfamily s, polypeptide 1 multiple interactions ISO [CYP2S1 protein co-treated with cumene hydroperoxide] results in increased oxidation of 9,10-Dimethyl-1,2-benzanthracene CTD PMID:19713358 NCBI chr 1:90,437,741...90,453,073
Ensembl chr 1:90,438,224...90,453,073 		JBrowse link
G Cyp3a2 cytochrome P450, family 3, subfamily a, polypeptide 2 increases response to substance ISO CYP3A4 protein results in increased susceptibility to 9,10-Dimethyl-1,2-benzanthracene CTD PMID:20507880 NCBI chr12:14,321,771...14,343,886
Ensembl chr12:14,321,771...14,343,857 		JBrowse link
G Dars1 aspartyl-tRNA synthetase 1 affects expression ISO 9,10-Dimethyl-1,2-benzanthracene affects the expression of DARS1 mRNA CTD PMID:21785161 NCBI chr13:42,410,351...42,465,467
Ensembl chr13:42,379,162...42,465,467 		JBrowse link
G Dazl deleted in azoospermia-like decreases expression
multiple interactions 		ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of DAZL mRNA; 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of DAZL mRNA
AHR protein affects the reaction [9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of DAZL mRNA]; alpha-naphthoflavone inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of DAZL mRNA] 		CTD PMID:20562217 NCBI chr 9:18,193,363...18,210,100
Ensembl chr 9:18,193,363...18,210,100 		JBrowse link
G Dbi diazepam binding inhibitor increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of DBI mRNA CTD PMID:12376462 NCBI chr13:33,794,231...33,802,632
Ensembl chr13:33,759,845...33,821,450 		JBrowse link
G Dchs1 dachsous cadherin-related 1 decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of DCHS1 mRNA CTD PMID:19480007 NCBI chr 1:169,516,758...169,550,789
Ensembl chr 1:169,516,762...169,536,639 		JBrowse link
G Dcn decorin multiple interactions EXP [9,10-Dimethyl-1,2-benzanthracene co-treated with Isoflavones] results in increased expression of DCN protein CTD PMID:22248470 NCBI chr 7:34,167,973...34,208,004
Ensembl chr 7:34,163,011...34,218,926 		JBrowse link
G Dcxr dicarbonyl and L-xylulose reductase increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of DCXR mRNA CTD PMID:32553695 NCBI chr10:106,504,730...106,506,619 JBrowse link
G Ddit3 DNA-damage inducible transcript 3 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of DDIT3 mRNA CTD PMID:32553695 NCBI chr 7:65,001,695...65,006,517
Ensembl chr 7:65,005,501...65,006,509 		JBrowse link
G Ddit4 DNA-damage-inducible transcript 4 multiple interactions
increases expression 		ISO [9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein] which results in increased expression of DDIT4 mRNA
9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of DDIT4 mRNA 		CTD PMID:32553695 NCBI chr20:28,434,938...28,437,037
Ensembl chr20:28,434,944...28,437,037 		JBrowse link
G Ddit4l DNA-damage-inducible transcript 4-like increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of DDIT4L mRNA CTD PMID:32553695 NCBI chr 2:228,800,831...228,804,478
Ensembl chr 2:228,801,705...228,806,225 		JBrowse link
G Ddrgk1 DDRGK domain containing 1 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of DDRGK1 protein CTD PMID:38307155 NCBI chr 3:138,315,006...138,336,691
Ensembl chr 3:138,315,282...138,335,766 		JBrowse link
G Ddx21 DExD-box helicase 21 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of DDX21 protein CTD PMID:38307155 NCBI chr20:31,077,044...31,097,238
Ensembl chr20:31,077,045...31,097,238 		JBrowse link
G Ddx39b DExD-box helicase 39B multiple interactions
decreases expression
increases expression 		EXP
ISO 		[9,10-Dimethyl-1,2-benzanthracene co-treated with Isoflavones] results in increased expression of DDX39B protein
9,10-Dimethyl-1,2-benzanthracene results in decreased expression of DDX39B protein
9,10-Dimethyl-1,2-benzanthracene results in increased expression of DDX39B protein 		CTD PMID:22248470 PMID:39910959 NCBI chr20:3,577,200...3,589,651
Ensembl chr20:3,576,734...3,589,651 		JBrowse link
G Ddx4 DEAD-box helicase 4 decreases expression
multiple interactions 		ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of DDX4 mRNA; 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of DDX4 mRNA
AHR protein affects the reaction [9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of DDX4 mRNA]; alpha-naphthoflavone inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of DDX4 mRNA] 		CTD PMID:20562217 NCBI chr 2:45,961,174...46,016,097
Ensembl chr 2:45,961,174...46,015,951 		JBrowse link
G Ddx5 DEAD-box helicase 5 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of DDX5 mRNA CTD PMID:21785161 NCBI chr10:92,224,393...92,231,928
Ensembl chr10:92,224,395...92,231,300 		JBrowse link
G Des desmin decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of DES mRNA CTD PMID:12376462 NCBI chr 9:84,299,626...84,307,344
Ensembl chr 9:84,298,447...84,307,347 		JBrowse link
G Dhcr7 7-dehydrocholesterol reductase decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of DHCR7 mRNA CTD PMID:32553695 NCBI chr 1:208,444,434...208,460,408
Ensembl chr 1:208,444,434...208,461,382 		JBrowse link
G Dicer1 dicer 1 ribonuclease III increases expression
multiple interactions 		ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of DICER1 mRNA; 9,10-Dimethyl-1,2-benzanthracene results in increased expression of DICER1 protein
Butyric Acid affects the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of DICER1 mRNA]; Butyric Acid affects the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of DICER1 protein]; Glucaric Acid affects the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of DICER1 mRNA]; Glucaric Acid affects the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of DICER1 protein]; Niacinamide affects the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of DICER1 mRNA]; Niacinamide affects the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of DICER1 protein] 		CTD PMID:24792773 NCBI chr 6:129,392,298...129,457,252
Ensembl chr 6:129,396,014...129,457,252 		JBrowse link
G Dido1 death inducer-obliterator 1 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of DIDO1 mRNA CTD PMID:32553695 NCBI chr 3:188,150,100...188,203,445
Ensembl chr 3:188,150,100...188,194,823 		JBrowse link
G Dio3 iodothyronine deiodinase 3 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of DIO3 mRNA CTD PMID:32553695 NCBI chr 6:135,107,072...135,108,933
Ensembl chr 6:135,107,074...135,107,985 		JBrowse link
G Dnajb6 DnaJ heat shock protein family (Hsp40) member B6 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of DNAJB6 mRNA CTD PMID:21785161 NCBI chr 4:6,010,081...6,232,052
Ensembl chr 4:6,128,070...6,232,005 		JBrowse link
G Dnajc8 DnaJ heat shock protein family (Hsp40) member C8 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of DNAJC8 protein CTD PMID:39910959 NCBI chr 5:150,029,064...150,047,115
Ensembl chr 5:150,026,286...150,047,117 		JBrowse link
G Dnajc9 DnaJ heat shock protein family (Hsp40) member C9 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of DNAJC9 mRNA CTD PMID:32553695 NCBI chr15:3,970,843...4,003,009
Ensembl chr15:3,970,114...3,977,304 		JBrowse link
G Dnmt1 DNA methyltransferase 1 increases expression
multiple interactions 		EXP
ISO 		9,10-Dimethyl-1,2-benzanthracene results in increased expression of DNMT1 mRNA
Butyric Acid affects the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of DNMT1 mRNA]; Butyric Acid affects the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of DNMT1 protein]; Glucaric Acid affects the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of DNMT1 mRNA]; Glucaric Acid affects the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of DNMT1 protein]; Niacinamide affects the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of DNMT1 mRNA]; Niacinamide affects the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of DNMT1 protein]
9,10-Dimethyl-1,2-benzanthracene results in increased expression of DNMT1 mRNA; 9,10-Dimethyl-1,2-benzanthracene results in increased expression of DNMT1 protein 		CTD PMID:12097258 PMID:24792773 NCBI chr 8:27,716,797...27,763,405
Ensembl chr 8:27,716,797...27,763,119 		JBrowse link
G Dock9 dedicator of cytokinesis 9 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of DOCK9 mRNA CTD PMID:32553695 NCBI chr15:105,018,341...105,289,799
Ensembl chr15:105,024,912...105,289,799 		JBrowse link
G Dok1 docking protein 1 multiple interactions ISO [9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein] which results in increased expression of DOK1 mRNA CTD PMID:32553695 NCBI chr 4:117,095,171...117,098,251
Ensembl chr 4:117,095,175...117,097,825 		JBrowse link
G Dpt dermatopontin decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of DPT mRNA CTD PMID:19480007 NCBI chr13:79,656,341...79,684,759
Ensembl chr13:79,655,985...79,684,758 		JBrowse link
G Dpysl4 dihydropyrimidinase-like 4 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of DPYSL4 mRNA CTD PMID:21527772 NCBI chr 1:203,312,646...203,328,523
Ensembl chr 1:203,311,694...203,328,523 		JBrowse link
G Dynll2 dynein light chain LC8-type 2 affects expression ISO 9,10-Dimethyl-1,2-benzanthracene affects the expression of DYNLL2 mRNA CTD PMID:21785161 NCBI chr10:73,264,260...73,283,042
Ensembl chr10:73,264,261...73,272,285 		JBrowse link
G Dyrk3 dual specificity tyrosine phosphorylation regulated kinase 3 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of DYRK3 mRNA CTD PMID:32553695 NCBI chr13:45,146,383...45,157,082
Ensembl chr13:45,146,384...45,157,249 		JBrowse link
G E2f8 E2F transcription factor 8 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of E2F8 mRNA CTD PMID:32553695 NCBI chr 1:107,701,985...107,720,538
Ensembl chr 1:107,701,985...107,720,009 		JBrowse link
G Echs1 enoyl-CoA hydratase, short chain 1 multiple interactions ISO [Dietary Fats co-treated with Dietary Sucrose co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased expression of ECHS1 protein CTD PMID:39910959 NCBI chr 1:204,324,679...204,333,506
Ensembl chr 1:204,324,682...204,333,506 		JBrowse link
G Ecrg4 ECRG4 augurin precursor increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of ECRG4 mRNA CTD PMID:19480007 NCBI chr 9:53,485,040...53,504,691
Ensembl chr 9:53,485,040...53,504,703 		JBrowse link
G Eda2r ectodysplasin A2 receptor increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of EDA2R mRNA CTD PMID:32553695 NCBI chr  X:66,225,557...66,280,674
Ensembl chr  X:66,236,111...66,280,663 		JBrowse link
G Edf1 endothelial differentiation-related factor 1 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of EDF1 protein CTD PMID:39910959 NCBI chr 3:28,764,906...28,779,499 JBrowse link
G Ednrb endothelin receptor type B decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of EDNRB mRNA CTD PMID:19480007 NCBI chr15:87,055,490...87,086,765
Ensembl chr15:87,057,691...87,086,765 		JBrowse link
G Eef1a1 eukaryotic translation elongation factor 1 alpha 1 increases expression EXP
ISO 		9,10-Dimethyl-1,2-benzanthracene results in increased expression of EEF1A1 mRNA
9,10-Dimethyl-1,2-benzanthracene results in increased expression of EEF1A1 protein 		CTD PMID:12376462 PMID:20045496 NCBI chr 8:88,221,839...88,225,688
Ensembl chr 8:88,221,843...88,225,072 		JBrowse link
G Eef2 eukaryotic translation elongation factor 2 affects expression ISO 9,10-Dimethyl-1,2-benzanthracene affects the expression of EEF2 mRNA CTD PMID:21785161 NCBI chr 7:9,183,836...9,196,255
Ensembl chr 7:9,183,961...9,189,544 		JBrowse link
G Efemp1 EGF containing fibulin extracellular matrix protein 1 decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of EFEMP1 mRNA CTD PMID:12376462 NCBI chr14:106,811,769...106,890,961
Ensembl chr14:106,802,304...106,892,808 		JBrowse link
G Efnb2 ephrin B2 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of EFNB2 mRNA CTD PMID:32553695 NCBI chr16:87,485,215...87,529,224
Ensembl chr16:87,485,198...87,529,208 		JBrowse link
G Egfr epidermal growth factor receptor decreases expression ISO
EXP 		9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of EGFR mRNA
9,10-Dimethyl-1,2-benzanthracene results in decreased expression of EGFR mRNA 		CTD PMID:32553695 PMID:36863560 NCBI chr14:95,378,626...95,551,358
Ensembl chr14:95,378,626...95,551,358 		JBrowse link
G Egr1 early growth response 1 increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of EGR1 mRNA CTD PMID:19480007 NCBI chr18:26,737,078...26,740,877
Ensembl chr18:26,736,838...26,740,843 		JBrowse link
G Egr2 early growth response 2 multiple interactions ISO [CYP1B1 protein affects the susceptibility to 9,10-Dimethyl-1,2-benzanthracene] which affects the expression of EGR2 mRNA CTD PMID:27891153 NCBI chr20:21,050,149...21,055,201
Ensembl chr20:21,050,149...21,057,748 		JBrowse link
G Ei24 EI24, autophagy associated transmembrane protein increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of EI24 mRNA CTD PMID:32553695 NCBI chr 8:44,683,138...44,699,502
Ensembl chr 8:44,683,144...44,695,214 		JBrowse link
G Eif1a eukaryotic translation initiation factor 1A increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of EIF1A protein CTD PMID:39910959 NCBI chr18:41,512,298...41,524,645
Ensembl chr18:41,503,180...41,549,696 		JBrowse link
G Eif2s2 eukaryotic translation initiation factor 2 subunit beta decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of EIF2S2 protein CTD PMID:38307155 NCBI chr 3:163,834,846...163,855,733
Ensembl chr 3:163,834,851...163,855,570 		JBrowse link
G Eif3j eukaryotic translation initiation factor 3, subunit J increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of EIF3J protein CTD PMID:39910959 NCBI chr 3:129,438,715...129,460,953
Ensembl chr 3:129,438,722...129,462,246 		JBrowse link
G Eif4b eukaryotic translation initiation factor 4B affects expression ISO 9,10-Dimethyl-1,2-benzanthracene affects the expression of EIF4B mRNA CTD PMID:21785161 NCBI chr 7:135,085,259...135,107,054
Ensembl chr 7:135,085,066...135,107,064 		JBrowse link
G Eif4g2 eukaryotic translation initiation factor 4, gamma 2 affects expression ISO 9,10-Dimethyl-1,2-benzanthracene affects the expression of EIF4G2 mRNA CTD PMID:21785161 NCBI chr 1:174,616,102...174,628,252
Ensembl chr 1:174,616,103...174,628,252 		JBrowse link
G Emp1 epithelial membrane protein 1 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of EMP1 mRNA CTD PMID:21527772 NCBI chr 4:169,931,537...169,964,366
Ensembl chr 4:169,931,440...169,964,365 		JBrowse link
G Emp3 epithelial membrane protein 3 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of EMP3 mRNA CTD PMID:21527772 NCBI chr 1:105,525,086...105,528,370
Ensembl chr 1:105,525,088...105,528,265 		JBrowse link
G Eno1 enolase 1 multiple interactions
increases expression
decreases expression 		EXP [9,10-Dimethyl-1,2-benzanthracene co-treated with Isoflavones] results in increased expression of ENO1 protein
9,10-Dimethyl-1,2-benzanthracene results in increased expression of ENO1 mRNA
9,10-Dimethyl-1,2-benzanthracene results in decreased expression of ENO1 protein 		CTD PMID:12376462 PMID:22248470 NCBI chr 5:166,002,867...166,014,252
Ensembl chr 3:77,946,261...77,986,003
Ensembl chr 5:77,946,261...77,986,003 		JBrowse link
G Enox1 ecto-NOX disulfide-thiol exchanger 1 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of ENOX1 mRNA CTD PMID:32553695 NCBI chr15:58,924,519...59,488,919
Ensembl chr15:59,215,018...59,488,918 		JBrowse link
G Enox2 ecto-NOX disulfide-thiol exchanger 2 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of ENOX2 mRNA CTD PMID:32553695 NCBI chr  X:133,148,813...133,470,914
Ensembl chr  X:133,148,813...133,470,891 		JBrowse link
G Enpp2 ectonucleotide pyrophosphatase/phosphodiesterase 2 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of ENPP2 mRNA CTD PMID:32553695 NCBI chr 7:88,092,140...88,214,758
Ensembl chr 7:88,092,140...88,214,957 		JBrowse link
G Epb41l4b erythrocyte membrane protein band 4.1 like 4B decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of EPB41L4B mRNA CTD PMID:32553695 NCBI chr 5:76,486,886...76,647,752
Ensembl chr 5:76,486,902...76,647,752 		JBrowse link
G Ephx1 epoxide hydrolase 1 multiple interactions
increases expression
decreases expression
affects response to substance
increases response to substance 		ISO
EXP 		EPHX1 protein promotes the reaction [CYP1A1 protein results in increased metabolism of 9,10-Dimethyl-1,2-benzanthracene]; EPHX1 protein promotes the reaction [CYP1A2 protein results in increased metabolism of 9,10-Dimethyl-1,2-benzanthracene]
9,10-Dimethyl-1,2-benzanthracene results in increased expression of EPHX1 mRNA; 9,10-Dimethyl-1,2-benzanthracene results in increased expression of EPHX1 protein
9,10-Dimethyl-1,2-benzanthracene results in decreased expression of EPHX1 mRNA
EPHX1 protein affects the susceptibility to 9,10-Dimethyl-1,2-benzanthracene
EPHX1 protein results in increased susceptibility to 9,10-Dimethyl-1,2-benzanthracene; EPHX1 results in increased susceptibility to 9,10-Dimethyl-1,2-benzanthracene
[cyclohexene oxide results in decreased activity of EPHX1 protein] which results in decreased susceptibility to 9,10-Dimethyl-1,2-benzanthracene; EPHX1 protein promotes the reaction [CYP1A1 protein results in increased metabolism of 9,10-Dimethyl-1,2-benzanthracene]; EPHX1 protein promotes the reaction [CYP1A2 protein results in increased metabolism of 9,10-Dimethyl-1,2-benzanthracene]; EPHX1 protein results in increased metabolism of and results in increased activity of 9,10-Dimethyl-1,2-benzanthracene 		CTD PMID:8961944 PMID:11323178 PMID:12376462 PMID:15331171 PMID:17204581 More... NCBI chr13:95,246,079...95,275,852
Ensembl chr13:95,246,080...95,321,981 		JBrowse link
G Epo erythropoietin decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of EPO mRNA CTD PMID:19502547 NCBI chr12:24,841,285...24,844,725
Ensembl chr12:24,841,285...24,844,725 		JBrowse link
G Ercc1 ERCC excision repair 1, endonuclease non-catalytic subunit decreases expression
multiple interactions 		ISO 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of ERCC1 mRNA
[epigallocatechin gallate co-treated with polylactic acid-polyglycolic acid copolymer analog] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of ERCC1 mRNA]; [theaflavin co-treated with polylactic acid-polyglycolic acid copolymer analog] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of ERCC1 mRNA]; epigallocatechin gallate inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of ERCC1 mRNA] 		CTD PMID:23717041 NCBI chr 1:88,099,308...88,135,966
Ensembl chr 1:88,118,891...88,139,120 		JBrowse link
G Erp29 endoplasmic reticulum protein 29 multiple interactions EXP [9,10-Dimethyl-1,2-benzanthracene co-treated with Isoflavones] results in increased expression of ERP29 protein CTD PMID:22248470 NCBI chr12:40,750,177...40,756,607
Ensembl chr12:40,750,314...40,757,010 		JBrowse link
G Esco2 establishment of sister chromatid cohesion N-acetyltransferase 2 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of ESCO2 mRNA CTD PMID:32553695 NCBI chr15:44,210,124...44,230,785
Ensembl chr15:44,210,641...44,231,304
Ensembl chr15:44,210,641...44,231,304 		JBrowse link
G Esr1 estrogen receptor 1 decreases expression
multiple interactions 		EXP
ISO 		9,10-Dimethyl-1,2-benzanthracene results in decreased expression of ESR1 protein
9,10-Dimethyl-1,2-benzanthracene binds to and results in increased activity of ESR1 protein
[Estradiol co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in decreased expression of ESR1 protein; [Methylnitrosourea co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in decreased expression of ESR1 protein 		CTD PMID:16891317 PMID:33049310 NCBI chr 1:43,511,685...43,904,454
Ensembl chr 1:43,644,392...43,900,354 		JBrowse link
G Esr2 estrogen receptor 2 multiple interactions
decreases expression 		ISO
EXP 		9,10-Dimethyl-1,2-benzanthracene binds to and results in increased activity of ESR2 protein
9,10-Dimethyl-1,2-benzanthracene results in decreased expression of ESR2 mRNA 		CTD PMID:33049310 PMID:36863560 NCBI chr 6:100,589,553...100,645,240
Ensembl chr 6:100,545,206...100,644,709 		JBrowse link
G Evi2a ecotropic viral integration site 2A increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of EVI2A mRNA CTD PMID:32553695 NCBI chr10:64,983,727...64,987,627
Ensembl chr10:64,983,705...64,999,516 		JBrowse link
G Exoc3l4 exocyst complex component 3-like 4 decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of EXOC3L4 mRNA CTD PMID:19480007 NCBI chr 6:136,273,857...136,287,877
Ensembl chr 6:136,273,854...136,287,881 		JBrowse link
G Ezh2 enhancer of zeste 2 polycomb repressive complex 2 subunit multiple interactions ISO [sodium arsenite results in increased susceptibility to [9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate]] which results in increased expression of EZH2 protein CTD PMID:35364107 NCBI chr 4:77,624,223...77,698,598
Ensembl chr 4:77,624,223...77,687,183 		JBrowse link
G Ezr ezrin multiple interactions
increases expression 		EXP [9,10-Dimethyl-1,2-benzanthracene co-treated with Isoflavones] results in increased expression of EZR protein
9,10-Dimethyl-1,2-benzanthracene results in increased expression of EZR mRNA; 9,10-Dimethyl-1,2-benzanthracene results in increased expression of EZR protein 		CTD PMID:12376462 PMID:22248470 NCBI chr 1:49,373,033...49,416,573
Ensembl chr 1:49,373,035...49,416,573 		JBrowse link
G Fas Fas cell surface death receptor increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of FAS mRNA CTD PMID:32553695 NCBI chr 1:241,212,155...241,245,774
Ensembl chr 1:241,205,935...241,246,104 		JBrowse link
G Fasn fatty acid synthase multiple interactions
increases expression 		EXP [9,10-Dimethyl-1,2-benzanthracene co-treated with Isoflavones] results in increased expression of FASN protein
9,10-Dimethyl-1,2-benzanthracene results in increased expression of FASN protein 		CTD PMID:22248470 NCBI chr10:106,570,415...106,588,581
Ensembl chr10:106,570,413...106,588,583 		JBrowse link
G Fbn2 fibrillin 2 decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of FBN2 mRNA CTD PMID:19480007 NCBI chr18:53,696,197...53,901,992
Ensembl chr18:53,697,708...53,902,191 		JBrowse link
G Fcgbp Fc gamma binding protein increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of FCGBP protein CTD PMID:38307155 PMID:39910959 NCBI chr 1:92,502,461...92,540,658
Ensembl chr 1:92,499,498...92,540,658 		JBrowse link
G Fdps farnesyl diphosphate synthase decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of FDPS mRNA CTD PMID:32553695 NCBI chr 2:176,795,192...176,804,816
Ensembl chr 2:176,795,192...176,807,136 		JBrowse link
G Fetub fetuin B multiple interactions ISO [Dietary Fats co-treated with Dietary Sucrose co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in decreased expression of FETUB protein CTD PMID:39910959 NCBI chr11:91,586,750...91,599,789
Ensembl chr11:91,586,748...91,599,310 		JBrowse link
G Fga fibrinogen alpha chain decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of FGA protein CTD PMID:38307155 NCBI chr 2:170,672,169...170,679,572
Ensembl chr 2:170,672,012...170,679,577 		JBrowse link
G Fhit fragile histidine triad diadenosine triphosphatase decreases expression
increases methylation 		EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of FHIT mRNA; 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of FHIT protein
9,10-Dimethyl-1,2-benzanthracene results in increased methylation of FHIT intron; 9,10-Dimethyl-1,2-benzanthracene results in increased methylation of FHIT promoter 		CTD PMID:15937960 NCBI chr15:16,365,401...17,872,901
Ensembl chr15:16,747,338...17,872,621 		JBrowse link
G Fhl2 four and a half LIM domains 2 increases expression EXP
ISO 		9,10-Dimethyl-1,2-benzanthracene results in increased expression of FHL2 mRNA
9,10-Dimethyl-1,2-benzanthracene results in increased expression of FHL2 protein 		CTD PMID:19480007 PMID:39910959 NCBI chr 9:52,881,091...52,954,540
Ensembl chr 9:52,880,998...52,923,326 		JBrowse link
G Fhod3 formin homology 2 domain containing 3 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of FHOD3 mRNA CTD PMID:32553695 NCBI chr18:16,267,830...16,700,508
Ensembl chr18:16,267,977...16,700,508 		JBrowse link
G Fip1l1 factor interacting with PAPOLA and CPSF1 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of FIP1L1 protein CTD PMID:38307155 NCBI chr14:33,969,341...34,030,871
Ensembl chr14:33,971,914...34,029,753 		JBrowse link
G Fkbp3 FKBP prolyl isomerase 3 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of FKBP3 protein CTD PMID:39910959 NCBI chr 6:88,850,137...88,862,542
Ensembl chr 6:88,843,879...88,863,447 		JBrowse link
G Flnc filamin C increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of FLNC mRNA CTD PMID:21527772 NCBI chr 4:58,999,445...59,027,240
Ensembl chr 4:58,999,547...59,027,240 		JBrowse link
G Fn1 fibronectin 1 multiple interactions
decreases expression 		EXP [9,10-Dimethyl-1,2-benzanthracene co-treated with Isoflavones] results in increased expression of FN1 protein
9,10-Dimethyl-1,2-benzanthracene results in decreased expression of FN1 mRNA 		CTD PMID:12376462 PMID:22248470 NCBI chr 9:80,645,507...80,714,200
Ensembl chr 9:80,645,507...80,714,137 		JBrowse link
G Fnbp1 formin binding protein 1 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of FNBP1 protein CTD PMID:39910959 NCBI chr 3:34,706,814...34,826,770
Ensembl chr 3:34,706,814...34,822,117 		JBrowse link
G Fos Fos proto-oncogene, AP-1 transcription factor subunit increases expression
multiple interactions 		ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of FOS mRNA
[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of FOS mRNA; [Ellagic Acid co-treated with Plant Extracts] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of FOS mRNA]; [Ellagic Acid co-treated with Resveratrol] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of FOS mRNA]; [Glucaric Acid co-treated with Plant Extracts] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of FOS mRNA]; [Glucaric Acid co-treated with Resveratrol] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of FOS mRNA]; [Resveratrol co-treated with Plant Extracts] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of FOS mRNA]; Cisplatin inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of FOS mRNA]; Cisplatin promotes the reaction [NPPC protein inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of FOS mRNA]]; NPPC protein inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of FOS mRNA]; NPPC protein promotes the reaction [Cisplatin inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of FOS mRNA]] 		CTD PMID:20103723 PMID:37352108 NCBI chr 6:110,852,188...110,855,054
Ensembl chr 6:110,852,190...110,855,598 		JBrowse link
G Fosl1 FOS like 1, AP-1 transcription factor subunit increases expression
multiple interactions 		ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of FOSL1 mRNA; 9,10-Dimethyl-1,2-benzanthracene results in increased expression of FOSL1 protein
[9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein] which results in increased expression of FOSL1 mRNA 		CTD PMID:20025956 PMID:32553695 NCBI chr 1:212,183,885...212,192,391
Ensembl chr 1:212,183,833...212,192,391 		JBrowse link
G Foxa2 forkhead box A2 increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of FOXA2 mRNA; 9,10-Dimethyl-1,2-benzanthracene results in increased expression of FOXA2 protein CTD PMID:36863560 NCBI chr 3:155,923,305...155,927,508
Ensembl chr 3:155,923,307...155,928,757 		JBrowse link
G Foxn3 forkhead box N3 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of FOXN3 mRNA CTD PMID:21785161 NCBI chr 6:124,191,695...124,572,070
Ensembl chr 6:124,195,701...124,572,040 		JBrowse link
G Foxo3 forkhead box O3 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of FOXO3 protein CTD PMID:21785161 NCBI chr20:47,251,968...47,348,254
Ensembl chr20:47,255,878...47,346,845 		JBrowse link
G Frat2 FRAT regulator of WNT signaling pathway 2 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of FRAT2 mRNA CTD PMID:32553695 NCBI chr 1:250,603,450...250,605,779
Ensembl chr 1:250,603,088...250,606,921 		JBrowse link
G Fth1 ferritin heavy chain 1 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of FTH1 protein CTD PMID:38307155 NCBI chr 1:216,052,037...216,054,325
Ensembl chr 1:216,051,998...216,055,214 		JBrowse link
G Furin furin (paired basic amino acid cleaving enzyme) increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of FURIN mRNA CTD PMID:12376462 NCBI chr 1:143,757,389...143,770,430
Ensembl chr 1:143,757,391...143,773,497 		JBrowse link
G Fus Fus RNA binding protein affects expression
decreases expression 		ISO
EXP 		9,10-Dimethyl-1,2-benzanthracene affects the expression of FUS mRNA
9,10-Dimethyl-1,2-benzanthracene results in decreased expression of FUS mRNA 		CTD PMID:19480007 PMID:21785161 NCBI chr 1:192,007,011...192,020,887
Ensembl chr 1:192,007,006...192,020,884 		JBrowse link
G G3bp1 G3BP stress granule assembly factor 1 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of G3BP1 protein CTD PMID:38307155 NCBI chr10:40,087,533...40,120,931
Ensembl chr10:40,087,533...40,120,931 		JBrowse link
G Gaa alpha glucosidase increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of GAA protein CTD PMID:39910959 NCBI chr10:105,028,106...105,045,365
Ensembl chr10:105,028,307...105,045,366 		JBrowse link
G Gadd45a growth arrest and DNA-damage-inducible, alpha multiple interactions
increases expression 		ISO [epigallocatechin gallate co-treated with polylactic acid-polyglycolic acid copolymer analog] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of GADD45A mRNA]; [theaflavin co-treated with polylactic acid-polyglycolic acid copolymer analog] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of GADD45A mRNA]; epigallocatechin gallate inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of GADD45A mRNA]
9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of GADD45A mRNA; 9,10-Dimethyl-1,2-benzanthracene results in increased expression of GADD45A mRNA 		CTD PMID:23717041 PMID:32553695 NCBI chr 4:97,484,497...97,486,799
Ensembl chr 4:97,484,502...97,486,807 		JBrowse link
G Galnt13 polypeptide N-acetylgalactosaminyltransferase 13 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of GALNT13 mRNA CTD PMID:32553695 NCBI chr 3:59,312,628...59,969,633
Ensembl chr 3:59,383,516...59,965,379 		JBrowse link
G Gapdh glyceraldehyde-3-phosphate dehydrogenase decreases expression
increases expression
multiple interactions 		ISO
EXP 		9,10-Dimethyl-1,2-benzanthracene results in decreased expression of GAPDH mRNA
9,10-Dimethyl-1,2-benzanthracene results in increased expression of GAPDH protein
[9,10-Dimethyl-1,2-benzanthracene co-treated with Isoflavones] results in increased expression of GAPDH protein 		CTD PMID:19502547 PMID:22248470 NCBI chr 4:159,648,592...159,653,436
Ensembl chr 4:159,648,592...159,653,377 		JBrowse link
G Gar1 GAR1 ribonucleoprotein decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of GAR1 protein CTD PMID:39910959 NCBI chr 2:221,049,471...221,056,749
Ensembl chr 2:221,049,473...221,056,749 		JBrowse link
G Gas5 growth arrest specific 5 increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of GAS5 mRNA CTD PMID:19480007 NCBI chr13:75,836,963...75,840,284 JBrowse link
G Gbe1 1,4-alpha-glucan branching enzyme 1 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of GBE1 mRNA CTD PMID:32553695 NCBI chr11:22,181,194...22,446,640
Ensembl chr11:22,181,103...22,446,638 		JBrowse link
G Gbp5 guanylate binding protein 5 increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of GBP5 mRNA CTD PMID:19480007 NCBI chr 2:233,910,999...233,930,320
Ensembl chr 2:233,902,113...233,930,826 		JBrowse link
G Gc GC, vitamin D binding protein increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of GC protein CTD PMID:39910959 NCBI chr14:18,916,255...18,951,670
Ensembl chr14:18,916,246...18,951,673 		JBrowse link
G Gcat glycine C-acetyltransferase decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of GCAT protein CTD PMID:38307155 NCBI chr 7:112,475,572...112,481,920
Ensembl chr 7:112,475,496...112,482,664 		JBrowse link
G Gchfr GTP cyclohydrolase I feedback regulator increases expression
decreases expression
multiple interactions 		ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of GCHFR mRNA
9,10-Dimethyl-1,2-benzanthracene results in decreased expression of GCHFR protein
[9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein] which results in increased expression of GCHFR mRNA 		CTD PMID:32553695 PMID:38307155 NCBI chr 3:126,611,892...126,615,926
Ensembl chr 3:126,613,240...126,615,926 		JBrowse link
G Gda guanine deaminase decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of GDA mRNA CTD PMID:12376462 NCBI chr 1:228,333,401...228,408,901
Ensembl chr 1:228,333,364...228,409,348 		JBrowse link
G Gdf15 growth differentiation factor 15 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of GDF15 mRNA CTD PMID:32553695 NCBI chr16:18,838,436...18,842,022
Ensembl chr16:18,838,436...18,842,022 		JBrowse link
G Get3 guided entry of tail-anchored proteins factor 3, ATPase decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of GET3 mRNA CTD PMID:38307155 NCBI chr19:40,034,675...40,043,064
Ensembl chr19:40,034,967...40,043,061 		JBrowse link
G Ggt1 gamma-glutamyltransferase 1 increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of GGT1 mRNA CTD PMID:12376462 NCBI chr20:13,074,141...13,103,551
Ensembl chr20:13,074,141...13,088,050 		JBrowse link
G Ggta1 glycoprotein alpha-galactosyltransferase 1 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of GGTA1 mRNA CTD PMID:32553695 NCBI chr 3:39,130,466...39,208,652
Ensembl chr 3:39,130,467...39,206,870 		JBrowse link
G Gh1 growth hormone 1 decreases response to substance EXP GH1 gene mutant form results in decreased susceptibility to 9,10-Dimethyl-1,2-benzanthracene CTD PMID:12082019 NCBI chr10:91,727,883...91,729,860
Ensembl chr10:91,727,884...91,729,859 		JBrowse link
G Gimap5 GTPase, IMAP family member 5 increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of GIMAP5 mRNA CTD PMID:19480007 NCBI chr 4:79,025,151...79,031,917
Ensembl chr 4:79,024,304...79,039,030 		JBrowse link
G Gja1 gap junction protein, alpha 1 multiple interactions
decreases expression
increases expression 		ISO
EXP 		[9,10-Dimethyl-1,2-benzanthracene co-treated with Benzoyl Peroxide] affects the expression of GJA1 protein; [9,10-Dimethyl-1,2-benzanthracene co-treated with Benzoyl Peroxide] results in increased expression of GJA1 mRNA; [9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate] affects the expression of GJA1 protein; [9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate] results in increased expression of GJA1 mRNA; A gene mutant form affects the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of GJA1 mRNA]
9,10-Dimethyl-1,2-benzanthracene promotes the reaction [Cycloheximide results in decreased expression of GJA1 protein]; 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of and results in decreased stability of GJA1 mRNA; Chir 99021 promotes the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of GJA1 mRNA]; Chir 99021 promotes the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of GJA1 protein]; Dactinomycin promotes the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of GJA1 mRNA]; pyrazolanthrone inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of GJA1 protein]
9,10-Dimethyl-1,2-benzanthracene results in decreased expression of GJA1 mRNA; 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of GJA1 protein
9,10-Dimethyl-1,2-benzanthracene results in increased expression of GJA1 protein 		CTD PMID:7586191 PMID:24269759 PMID:25447408 PMID:36863560 NCBI chr20:36,302,490...36,315,010
Ensembl chr20:36,302,352...36,319,689 		JBrowse link
G Gja4 gap junction protein, alpha 4 decreases expression
multiple interactions
increases expression 		EXP
ISO 		9,10-Dimethyl-1,2-benzanthracene results in decreased expression of GJA4 mRNA; 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of GJA4 protein
9,10-Dimethyl-1,2-benzanthracene affects the reaction [A gene mutant form results in decreased expression of GJA4 protein]; [A gene mutant form co-treated with 9,10-Dimethyl-1,2-benzanthracene] affects the expression of GJA4 protein
9,10-Dimethyl-1,2-benzanthracene results in increased expression of GJA4 mRNA; 9,10-Dimethyl-1,2-benzanthracene results in increased expression of GJA4 protein 		CTD PMID:24269759 PMID:25447408 NCBI chr 5:144,917,791...144,920,324
Ensembl chr 5:144,914,147...144,921,216 		JBrowse link
G Gjb2 gap junction protein, beta 2 multiple interactions ISO [9,10-Dimethyl-1,2-benzanthracene co-treated with Benzoyl Peroxide] affects the expression of GJB2 protein; [9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate] affects the expression of GJB2 protein; [9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate] results in increased expression of GJB2 mRNA CTD PMID:7586191 NCBI chr15:35,375,977...35,393,817
Ensembl chr15:35,375,692...35,393,877 		JBrowse link
G Gjb5 gap junction protein, beta 5 multiple interactions
increases expression 		ISO [9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of GJB5 mRNA
9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of GJB5 mRNA 		CTD PMID:7586191 PMID:32553695 NCBI chr 5:144,965,133...144,968,051
Ensembl chr 5:144,964,751...144,984,021 		JBrowse link
G Gls glutaminase increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of GLS mRNA CTD PMID:21527772 NCBI chr 9:56,836,584...56,908,861
Ensembl chr 9:56,836,584...56,908,861 		JBrowse link
G Gmds GDP-mannose 4, 6-dehydratase decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of GMDS mRNA CTD PMID:32553695 NCBI chr17:32,304,029...32,830,708
Ensembl chr17:32,304,056...32,830,706 		JBrowse link
G Gng12 G protein subunit gamma 12 increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of GNG12 mRNA CTD PMID:19480007 NCBI chr 4:97,340,830...97,464,422
Ensembl chr 4:97,340,472...97,464,476 		JBrowse link
G Gp2 glycoprotein 2 increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of GP2 mRNA CTD PMID:19480007 NCBI chr 1:183,228,395...183,243,954
Ensembl chr 1:183,228,395...183,243,954 		JBrowse link
G Gpc6 glypican 6 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of GPC6 mRNA CTD PMID:32553695 NCBI chr15:100,437,415...101,435,038
Ensembl chr15:100,437,943...101,435,027 		JBrowse link
G Gphn gephyrin decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of GPHN mRNA CTD PMID:32553695 NCBI chr 6:102,687,405...103,216,679
Ensembl chr 6:102,687,423...103,216,674 		JBrowse link
G Gpr68 G protein-coupled receptor 68 increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of GPR68 mRNA CTD PMID:19480007 NCBI chr 6:125,865,205...125,895,674
Ensembl chr 6:125,864,942...125,895,674 		JBrowse link
G Gprc5a G protein-coupled receptor, class C, group 5, member A multiple interactions ISO [9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein] which results in increased expression of GPRC5A mRNA CTD PMID:32553695 NCBI chr 4:169,634,896...169,653,627
Ensembl chr 4:169,634,748...169,653,625 		JBrowse link
G Gpt glutamic--pyruvic transaminase affects activity
decreases activity
multiple interactions 		EXP 9,10-Dimethyl-1,2-benzanthracene affects the activity of GPT protein
9,10-Dimethyl-1,2-benzanthracene results in decreased activity of GPT protein
Vitamin K affects the reaction [9,10-Dimethyl-1,2-benzanthracene affects the activity of GPT protein] 		CTD PMID:32623939 PMID:33063951 NCBI chr 7:110,295,599...110,300,134
Ensembl chr 7:110,296,206...110,300,160 		JBrowse link
G Gpx1 glutathione peroxidase 1 multiple interactions
decreases expression
decreases activity 		EXP
ISO 		brucine inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased activity of GPX1 protein]
9,10-Dimethyl-1,2-benzanthracene results in decreased expression of GPX1 protein 		CTD PMID:30027798 PMID:39910959 NCBI chr 8:117,905,462...117,906,588
Ensembl chr 8:117,905,280...117,906,581 		JBrowse link
G Gpx2 glutathione peroxidase 2 increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of GPX2 mRNA; 9,10-Dimethyl-1,2-benzanthracene results in increased expression of GPX2 protein CTD PMID:18056462 NCBI chr 6:101,226,745...101,230,033
Ensembl chr 6:101,226,745...101,230,862 		JBrowse link
G Gpx3 glutathione peroxidase 3 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of GPX3 mRNA CTD PMID:38307155 NCBI chr10:39,529,335...39,537,406
Ensembl chr10:39,529,448...39,537,405 		JBrowse link
G Gsr glutathione-disulfide reductase multiple interactions
decreases expression
decreases activity 		ISO
EXP 		[9,10-Dimethyl-1,2-benzanthracene co-treated with [Tetradecanoylphorbol Acetate co-treated with argemone oil]] results in decreased activity of GSR protein; [9,10-Dimethyl-1,2-benzanthracene co-treated with [Tetradecanoylphorbol Acetate co-treated with sanguinarine]] results in decreased activity of GSR protein; [9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate] results in decreased activity of GSR protein; [[9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate] co-treated with argemone oil] results in decreased activity of GSR protein; [[9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate] co-treated with sanguinarine] results in decreased activity of GSR protein; dieckol inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of GSR protein]; geraniol inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of GSR protein]
9,10-Dimethyl-1,2-benzanthracene results in decreased activity of GSR protein
allyl isothiocyanate inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased activity of GSR protein]; brucine inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased activity of GSR protein]; tangeretin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased activity of GSR protein]; zingerone inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased activity of GSR protein] 		CTD PMID:20691676 PMID:23033690 PMID:24995432 PMID:25744308 PMID:30027798 More... NCBI chr16:65,185,574...65,228,742
Ensembl chr16:65,185,574...65,228,394 		JBrowse link
G Gss glutathione synthetase increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of GSS mRNA CTD PMID:12376462 NCBI chr 3:164,508,005...164,538,343
Ensembl chr 3:164,508,005...164,538,306 		JBrowse link
G Gsta1 glutathione S-transferase alpha 1 decreases activity
multiple interactions 		EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased activity of GSTA1 protein
brucine inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased activity of GSTA1 protein] 		CTD PMID:30027798 NCBI chr 9:31,199,887...31,216,606
Ensembl chr 9:31,199,888...31,211,528 		JBrowse link
G Gsta3l1 glutathione S-transferase alpha 3 like 1 decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of GSTA3L1 mRNA CTD PMID:19480007 NCBI chr 9:31,115,727...31,128,997
Ensembl chr 9:31,036,978...31,129,006 		JBrowse link
G Gsto1 glutathione S-transferase omega 1 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of GSTO1 protein CTD PMID:39910959 NCBI chr 1:256,662,377...256,672,515
Ensembl chr 1:256,662,531...256,676,167 		JBrowse link
G Gstp1 glutathione S-transferase pi 1 affects response to substance
multiple interactions
increases expression
decreases expression 		EXP
ISO 		GSTP1 protein affects the susceptibility to 9,10-Dimethyl-1,2-benzanthracene
[Dietary Fats co-treated with Dietary Sucrose co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased expression of GSTP1 protein
9,10-Dimethyl-1,2-benzanthracene results in increased expression of GSTP1 mRNA
9,10-Dimethyl-1,2-benzanthracene results in decreased expression of GSTP1 mRNA
9,10-Dimethyl-1,2-benzanthracene results in increased expression of and results in increased activity of GSTP1 protein 		CTD PMID:12097258 PMID:22406437 PMID:24576726 PMID:39910959 NCBI chr 1:210,767,237...210,770,242
Ensembl chr 1:210,767,237...210,769,705 		JBrowse link
G Gtdc1 glycosyltransferase-like domain containing 1 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of GTDC1 mRNA CTD PMID:32553695 NCBI chr 3:49,176,110...49,571,594
Ensembl chr 3:49,176,110...49,571,843 		JBrowse link
G Gtse1 G-2 and S-phase expressed 1 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of GTSE1 mRNA CTD PMID:32553695 NCBI chr 7:118,829,793...118,846,662
Ensembl chr 7:118,829,903...118,846,661 		JBrowse link
G H19 H19 imprinted maternally expressed transcript affects expression ISO 9,10-Dimethyl-1,2-benzanthracene affects the expression of H19 mRNA CTD PMID:21785161 NCBI chr 1:207,160,175...207,162,851 JBrowse link
G H1f4 H1.4 linker histone, cluster member multiple interactions
increases expression 		EXP [9,10-Dimethyl-1,2-benzanthracene co-treated with Isoflavones] results in increased expression of H1F4 protein
9,10-Dimethyl-1,2-benzanthracene results in increased expression of H1F4 protein 		CTD PMID:22248470 NCBI chr17:41,914,425...41,915,206
Ensembl chr17:41,914,431...41,916,129 		JBrowse link
G H2ac18 H2A clustered histone 18 multiple interactions
increases expression 		EXP [9,10-Dimethyl-1,2-benzanthracene co-treated with Isoflavones] results in increased expression of H2AC18 protein
9,10-Dimethyl-1,2-benzanthracene results in increased expression of H2AC18 protein 		CTD PMID:22248470 NCBI chr 2:186,497,271...186,497,865 JBrowse link
G H2ax H2A.X variant histone increases expression
increases phosphorylation
multiple interactions 		EXP
ISO 		9,10-Dimethyl-1,2-benzanthracene results in increased expression of H2AX protein
9,10-Dimethyl-1,2-benzanthracene results in increased phosphorylation of H2AX protein
9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of H2AX protein modified form; 9,10-Dimethyl-1,2-benzanthracene results in increased expression of H2AX protein
A gene mutant form affects the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of H2AX protein] 		CTD PMID:23969067 PMID:25448685 PMID:32553695 PMID:34510228 NCBI chr 8:53,568,718...53,570,072
Ensembl chr 8:53,568,281...53,573,079 		JBrowse link
G Hadha hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit alpha increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of HADHA protein CTD PMID:39910959 NCBI chr 6:31,907,801...31,947,434
Ensembl chr 6:31,907,291...31,947,698 		JBrowse link
G Hal histidine ammonia lyase multiple interactions ISO [9,10-Dimethyl-1,2-benzanthracene co-treated with [Tetradecanoylphorbol Acetate co-treated with argemone oil]] results in decreased activity of HAL protein; [9,10-Dimethyl-1,2-benzanthracene co-treated with [Tetradecanoylphorbol Acetate co-treated with sanguinarine]] results in decreased activity of HAL protein; [9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate] results in decreased activity of HAL protein; [[9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate] co-treated with argemone oil] results in decreased activity of HAL protein; [[9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate] co-treated with sanguinarine] results in decreased activity of HAL protein CTD PMID:20691676 NCBI chr 7:29,894,495...29,924,744
Ensembl chr 7:29,893,855...29,924,744 		JBrowse link
G Has2 hyaluronan synthase 2 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of HAS2 mRNA CTD PMID:32553695 NCBI chr 7:90,002,929...90,028,933
Ensembl chr 7:90,002,929...90,018,535 		JBrowse link
G Hba-a2 hemoglobin alpha, adult chain 2 decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of HBA1 mRNA CTD PMID:12376462 NCBI chr10:15,828,291...15,829,138
Ensembl chr10:15,828,377...15,829,141 		JBrowse link
G Hbb hemoglobin subunit beta multiple interactions ISO [CYP1B1 protein affects the susceptibility to 9,10-Dimethyl-1,2-benzanthracene] which affects the expression of HBB-B1 mRNA CTD PMID:27891153 NCBI chr 1:167,662,310...167,663,721
Ensembl chr 1:167,630,245...167,663,873 		JBrowse link
G Hbegf heparin-binding EGF-like growth factor increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of HBEGF mRNA CTD PMID:32553695 NCBI chr18:28,380,337...28,390,220
Ensembl chr18:28,380,337...28,390,220 		JBrowse link
G Hdac1 histone deacetylase 1 increases expression
multiple interactions 		ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of HDAC1 mRNA; 9,10-Dimethyl-1,2-benzanthracene results in increased expression of HDAC1 protein
Butyric Acid affects the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of HDAC1 mRNA]; Butyric Acid affects the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of HDAC1 protein]; Glucaric Acid affects the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of HDAC1 mRNA]; Glucaric Acid affects the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of HDAC1 protein]; Niacinamide affects the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of HDAC1 mRNA]; Niacinamide affects the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of HDAC1 protein] 		CTD PMID:24792773 NCBI chr 5:147,138,328...147,165,387
Ensembl chr 5:147,138,156...147,165,387 		JBrowse link
G Hells helicase, lymphoid specific increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of HELLS protein CTD PMID:20025956 NCBI chr 1:246,113,580...246,159,230
Ensembl chr 1:246,114,096...246,159,228 		JBrowse link
G Hes1 hes family bHLH transcription factor 1 increases expression
multiple interactions 		EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of HES1 protein
1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of HES1 protein]; [1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt co-treated with Doxorubicin] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of HES1 protein]; Doxorubicin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of HES1 protein] 		CTD PMID:39214269 NCBI chr11:84,210,632...84,213,045
Ensembl chr11:84,210,633...84,213,061 		JBrowse link
G Hif1a hypoxia inducible factor 1 subunit alpha increases activity
affects expression 		ISO 9,10-Dimethyl-1,2-benzanthracene results in increased activity of HIF1A protein
9,10-Dimethyl-1,2-benzanthracene affects the expression of HIF1A mRNA 		CTD PMID:19502547 PMID:21785161 NCBI chr 6:98,357,788...98,405,068
Ensembl chr 6:98,359,910...98,405,323 		JBrowse link
G Hist1h2bq histone cluster 1 H2B family member Q multiple interactions
increases expression 		EXP [9,10-Dimethyl-1,2-benzanthracene co-treated with Isoflavones] results in increased expression of HIST1H2BQ protein
9,10-Dimethyl-1,2-benzanthracene results in increased expression of HIST1H2BQ protein 		CTD PMID:22248470 NCBI chr17:41,859,955...41,869,889
Ensembl chr17:41,857,231...41,870,107
Ensembl chr17:41,857,231...41,870,107 		JBrowse link
G Hmgb2 high mobility group box 2 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of HMGB2 protein CTD PMID:39910959 NCBI chr16:37,721,374...37,723,950
Ensembl chr16:37,721,379...37,723,860 		JBrowse link
G Hmox1 heme oxygenase 1 decreases expression
multiple interactions 		EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of HMOX1 mRNA; 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of HMOX1 protein
betulin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of HMOX1 protein]; tangeretin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of HMOX1 mRNA]; tangeretin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of HMOX1 protein] 		CTD PMID:12097258 PMID:24995432 PMID:33759307 NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,472,884...13,479,818 		JBrowse link
G Hnrnpa2b1 heterogeneous nuclear ribonucleoprotein A2/B1 affects expression ISO 9,10-Dimethyl-1,2-benzanthracene affects the expression of HNRNPA2B1 mRNA CTD PMID:21785161 NCBI chr 4:81,867,354...81,875,886
Ensembl chr 4:81,869,661...81,877,572 		JBrowse link
G Hnrnpab heterogeneous nuclear ribonucleoprotein A/B increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of HNRNPAB protein CTD PMID:39910959 NCBI chr10:36,358,004...36,363,898
Ensembl chr10:36,358,006...36,364,307 		JBrowse link
G Hnrnpc heterogeneous nuclear ribonucleoprotein C multiple interactions ISO [Dietary Fats co-treated with Dietary Sucrose co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased expression of HNRNPC protein CTD PMID:39910959 NCBI chr15:27,253,098...27,282,779
Ensembl chr15:27,253,098...27,282,715 		JBrowse link
G Hnrnpd heterogeneous nuclear ribonucleoprotein D decreases expression
multiple interactions 		ISO 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of HNRNPD protein
[Dietary Fats co-treated with Dietary Sucrose co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased expression of HNRNPD protein 		CTD PMID:38307155 PMID:39910959 NCBI chr14:9,918,630...9,938,072
Ensembl chr14:9,919,739...9,938,066 		JBrowse link
G Hnrnpf heterogeneous nuclear ribonucleoprotein F multiple interactions ISO [Dietary Fats co-treated with Dietary Sucrose co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased expression of HNRNPF protein CTD PMID:39910959 NCBI chr 4:152,755,668...152,776,867
Ensembl chr 4:152,722,617...152,815,769 		JBrowse link
G Hnrnpk heterogeneous nuclear ribonucleoprotein K affects expression ISO 9,10-Dimethyl-1,2-benzanthracene affects the expression of HNRNPK mRNA CTD PMID:21785161 NCBI chr17:6,269,302...6,280,429
Ensembl chr17:6,268,385...6,280,565 		JBrowse link
G Hnrnpm heterogeneous nuclear ribonucleoprotein M multiple interactions
increases expression 		EXP [9,10-Dimethyl-1,2-benzanthracene co-treated with Isoflavones] results in increased expression of HNRNPM protein
9,10-Dimethyl-1,2-benzanthracene results in increased expression of HNRNPM protein 		CTD PMID:22248470 NCBI chr 7:15,140,877...15,178,871
Ensembl chr 7:15,129,287...15,178,871 		JBrowse link
G Hoxb6 homeo box B6 multiple interactions ISO [CYP1B1 protein affects the susceptibility to 9,10-Dimethyl-1,2-benzanthracene] which affects the expression of HOXB6 mRNA CTD PMID:27891153 NCBI chr10:81,755,263...81,763,999 JBrowse link
G Hp haptoglobin decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of HP mRNA CTD PMID:32553695 NCBI chr19:54,449,151...54,453,701
Ensembl chr19:54,446,217...54,467,518 		JBrowse link
G Hras HRas proto-oncogene, GTPase multiple interactions
increases mutagenesis
increases response to substance 		ISO 4-octylphenol affects the reaction [HRAS protein results in increased susceptibility to 9,10-Dimethyl-1,2-benzanthracene]; Estradiol affects the reaction [HRAS protein results in increased susceptibility to 9,10-Dimethyl-1,2-benzanthracene]
9,10-Dimethyl-1,2-benzanthracene results in increased mutagenesis of HRAS gene
[9,10-Dimethyl-1,2-benzanthracene co-treated with Benzoyl Peroxide] results in increased expression of HRAS mRNA; [9,10-Dimethyl-1,2-benzanthracene co-treated with Benzoyl Peroxide] results in increased mutagenesis of HRAS gene; [9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate co-treated with mezerein] results in increased expression of HRAS mRNA; [9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate] results in increased expression of HRAS mRNA; [9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate] results in increased mutagenesis of HRAS gene; [Ellagic Acid co-treated with Plant Extracts] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased mutagenesis of HRAS gene]; [Ellagic Acid co-treated with Resveratrol] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased mutagenesis of HRAS gene]; [Glucaric Acid co-treated with Plant Extracts] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased mutagenesis of HRAS gene]; [Glucaric Acid co-treated with Resveratrol] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased mutagenesis of HRAS gene]; [Resveratrol co-treated with Plant Extracts] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased mutagenesis of HRAS gene]; [Tetradecanoylphorbol Acetate co-treated with 9,10-Dimethyl-1,2-benzanthracene co-treated with geraniol] affects the localization of HRAS protein; [Tetradecanoylphorbol Acetate co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased expression of HRAS protein 		CTD PMID:1375869 PMID:3115617 PMID:11241758 PMID:11376698 PMID:12117780 More... NCBI chr 1:205,712,625...205,729,406
Ensembl chr 1:205,725,975...205,729,590 		JBrowse link
G Hrg histidine-rich glycoprotein increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of HRG protein CTD PMID:38307155 NCBI chr11:91,559,087...91,573,982
Ensembl chr11:91,559,091...91,573,982 		JBrowse link
G Hsp90aa1 heat shock protein 90 alpha family class A member 1 multiple interactions ISO [Dietary Fats co-treated with Dietary Sucrose co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in decreased expression of HSP90AA1 protein CTD PMID:39910959 NCBI chr 6:135,523,604...135,529,687
Ensembl chr 6:135,523,616...135,528,499 		JBrowse link
G Hsp90ab1 heat shock protein 90 alpha family class B member 1 multiple interactions
increases expression 		EXP [9,10-Dimethyl-1,2-benzanthracene co-treated with Isoflavones] results in increased expression of HSP90AB1 protein
9,10-Dimethyl-1,2-benzanthracene results in increased expression of HSP90AB1 protein 		CTD PMID:22248470 NCBI chr 9:22,930,249...22,935,929
Ensembl chr 9:22,931,070...22,935,926 		JBrowse link
G Hspa1a heat shock protein family A (Hsp70) member 1A multiple interactions ISO [CYP1B1 protein affects the susceptibility to 9,10-Dimethyl-1,2-benzanthracene] which affects the expression of HSPA1A mRNA CTD PMID:27891153 NCBI chr20:3,875,411...3,877,866
Ensembl chr20:3,855,780...3,877,979 		JBrowse link
G Hspa5 heat shock protein family A (Hsp70) member 5 multiple interactions
increases expression 		EXP [9,10-Dimethyl-1,2-benzanthracene co-treated with Isoflavones] results in increased expression of HSPA5 protein
9,10-Dimethyl-1,2-benzanthracene results in increased expression of HSPA5 protein 		CTD PMID:22248470 NCBI chr 3:38,453,016...38,457,475
Ensembl chr 3:38,453,041...38,458,790 		JBrowse link
G Hspa8 heat shock protein family A (Hsp70) member 8 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of HSPA8 mRNA CTD PMID:21785161 NCBI chr 8:50,080,514...50,084,376
Ensembl chr 8:50,080,199...50,084,372 		JBrowse link
G Hspa9 heat shock protein family A (Hsp70) member 9 multiple interactions ISO [Dietary Fats co-treated with Dietary Sucrose co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased expression of HSPA9 protein CTD PMID:39910959 NCBI chr18:26,810,004...26,832,958
Ensembl chr18:26,804,774...26,828,398 		JBrowse link
G Hspd1 heat shock protein family D (Hsp60) member 1 affects expression
decreases expression 		ISO
EXP 		9,10-Dimethyl-1,2-benzanthracene affects the expression of HSPD1 mRNA
9,10-Dimethyl-1,2-benzanthracene results in decreased expression of HSPD1 mRNA 		CTD PMID:12097258 PMID:21785161 NCBI chr 9:64,073,610...64,084,332
Ensembl chr 9:64,073,611...64,084,037 		JBrowse link
G Hspe1 heat shock protein family E (Hsp10) member 1 decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of HSPE1 mRNA CTD PMID:12097258 NCBI chr 9:64,084,327...64,087,415
Ensembl chr 9:64,085,068...64,087,502 		JBrowse link
G Hspg2 heparan sulfate proteoglycan 2 affects expression ISO 9,10-Dimethyl-1,2-benzanthracene affects the expression of HSPG2 mRNA CTD PMID:21785161 NCBI chr 5:154,960,818...155,061,971
Ensembl chr 5:154,960,846...155,061,971 		JBrowse link
G Icam1 intercellular adhesion molecule 1 decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of ICAM1 mRNA CTD PMID:12097258 NCBI chr 8:27,829,688...27,841,618
Ensembl chr 8:27,829,161...27,841,617 		JBrowse link
G Id3 inhibitor of DNA binding 3 decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of ID3 mRNA CTD PMID:12376462 NCBI chr 5:153,656,253...153,657,860
Ensembl chr 5:153,630,498...153,657,856 		JBrowse link
G Idh1 isocitrate dehydrogenase (NADP(+)) 1 multiple interactions ISO [Dietary Fats co-treated with Dietary Sucrose co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased expression of IDH1 protein CTD PMID:39910959 NCBI chr 9:74,027,887...74,057,442
Ensembl chr 9:74,027,892...74,049,555 		JBrowse link
G Ier3 immediate early response 3 multiple interactions
increases expression 		ISO [9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein] which results in increased expression of IER3 mRNA
9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of IER3 mRNA 		CTD PMID:32553695 NCBI chr20:2,933,173...2,934,377
Ensembl chr20:2,933,174...2,934,377 		JBrowse link
G Ier5 immediate early response 5 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of IER5 mRNA CTD PMID:21527772 NCBI chr13:69,820,450...69,822,542
Ensembl chr13:69,820,451...69,822,543 		JBrowse link
G Ift70b intraflagellar transport 70B increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of IFT70B protein CTD PMID:38307155 NCBI chr 3:81,263,074...81,265,645 JBrowse link
G Igf1 insulin-like growth factor 1 multiple interactions ISO IGF1 protein results in increased susceptibility to [9,10-Dimethyl-1,2-benzanthracene co-treated with Benzoyl Peroxide]; IGF1 protein results in increased susceptibility to [9,10-Dimethyl-1,2-benzanthracene co-treated with chrysarobin]; IGF1 protein results in increased susceptibility to [9,10-Dimethyl-1,2-benzanthracene co-treated with Okadaic Acid]; IGF1 protein results in increased susceptibility to [9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate] CTD PMID:10365914 NCBI chr 7:24,169,608...24,249,446
Ensembl chr 7:24,130,137...24,246,764 		JBrowse link
G Igf2 insulin-like growth factor 2 decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of IGF2 mRNA CTD PMID:19480007 NCBI chr 1:207,243,873...207,261,263
Ensembl chr 1:207,243,873...207,260,667 		JBrowse link
G Igf2r insulin-like growth factor 2 receptor multiple interactions ISO [Tetradecanoylphorbol Acetate co-treated with 9,10-Dimethyl-1,2-benzanthracene] promotes the reaction [Arsenic results in increased expression of IGF2R mRNA]; [Tetradecanoylphorbol Acetate co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased expression of IGF2R mRNA CTD PMID:38299738 NCBI chr 1:50,526,878...50,615,265
Ensembl chr 1:50,526,878...50,615,265 		JBrowse link
G Igsf10 immunoglobulin superfamily, member 10 decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of IGSF10 mRNA CTD PMID:19480007 NCBI chr 2:145,725,868...145,754,850
Ensembl chr 2:145,725,878...145,754,579 		JBrowse link
G Il10 interleukin 10 decreases expression
multiple interactions 		EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of IL10 protein
citronellol inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of IL10 protein] 		CTD PMID:31926054 NCBI chr13:45,024,921...45,029,586
Ensembl chr13:45,025,087...45,029,580 		JBrowse link
G Il12a interleukin 12A multiple interactions ISO IL12A results in decreased susceptibility to [9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate] CTD PMID:22359662 NCBI chr 2:155,275,734...155,282,997
Ensembl chr 2:155,275,625...155,282,997 		JBrowse link
G Il12b interleukin 12B multiple interactions ISO 9,10-Dimethyl-1,2-benzanthracene inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased secretion of IL12B protein] CTD PMID:36416909 NCBI chr10:29,390,300...29,405,194
Ensembl chr10:29,389,905...29,405,194 		JBrowse link
G Il17a interleukin 17A increases expression
multiple interactions 		EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of IL17A mRNA
Vitamin K inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of IL17A mRNA] 		CTD PMID:33063951 NCBI chr 9:30,640,844...30,644,331
Ensembl chr 9:30,640,844...30,644,331 		JBrowse link
G Il17ra interleukin 17 receptor A multiple interactions ISO IL17RA results in increased susceptibility to [9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate] CTD PMID:22359662 NCBI chr 4:155,339,742...155,362,382
Ensembl chr 4:155,339,400...155,362,382 		JBrowse link
G Il17rd interleukin 17 receptor D decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of IL17RD mRNA CTD PMID:32553695 NCBI chr16:2,235,172...2,489,827
Ensembl chr16:2,235,169...2,301,850 		JBrowse link
G Il18 interleukin 18 multiple interactions
increases expression 		ISO dieckol inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of IL18 mRNA] CTD PMID:33347706 NCBI chr 8:59,802,072...59,829,275
Ensembl chr 8:59,809,592...59,831,286 		JBrowse link
G Il1a interleukin 1 alpha multiple interactions ISO [9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of IL1A mRNA; [sodium arsenite co-treated with 9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate] results in increased expression of IL1A protein; Cisplatin inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of IL1A mRNA]; Cisplatin promotes the reaction [NPPC protein inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of IL1A mRNA]]; diacerein inhibits the reaction [[sodium arsenite co-treated with 9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate] results in increased expression of IL1A protein]; NPPC protein inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of IL1A mRNA]; NPPC protein promotes the reaction [Cisplatin inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of IL1A mRNA]] CTD PMID:35364107 PMID:37352108 NCBI chr 3:136,979,804...136,990,236
Ensembl chr 3:136,979,805...136,998,013 		JBrowse link
G Il1b interleukin 1 beta increases expression
multiple interactions 		EXP
ISO 		9,10-Dimethyl-1,2-benzanthracene results in increased expression of IL1B protein
9,10-Dimethyl-1,2-benzanthracene results in increased expression of IL1B mRNA; 9,10-Dimethyl-1,2-benzanthracene results in increased expression of IL1B protein
[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of IL1B mRNA; Cisplatin inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of IL1B mRNA]; Cisplatin promotes the reaction [NPPC protein inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of IL1B mRNA]]; dieckol inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of IL1B mRNA]; dieckol inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of IL1B protein]; NPPC protein inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of IL1B mRNA]; NPPC protein promotes the reaction [Cisplatin inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of IL1B mRNA]]
tangeretin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of IL1B protein] 		CTD PMID:24995432 PMID:33347706 PMID:37352108 NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:137,030,205...137,036,601 		JBrowse link
G Il1rl1 interleukin 1 receptor-like 1 increases expression
decreases expression 		ISO
EXP 		9,10-Dimethyl-1,2-benzanthracene results in increased expression of IL1RL1 protein
9,10-Dimethyl-1,2-benzanthracene results in decreased expression of IL1RL1 mRNA 		CTD PMID:19480007 PMID:20025956 NCBI chr 9:50,157,326...50,222,888
Ensembl chr 9:50,204,551...50,222,891 		JBrowse link
G Il1rn interleukin 1 receptor antagonist decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of IL1RN mRNA CTD PMID:32553695 NCBI chr 3:27,509,836...27,525,738
Ensembl chr 3:27,509,798...27,525,732 		JBrowse link
G Il2 interleukin 2 decreases expression
multiple interactions 		ISO 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of IL2 protein
[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of IL2 mRNA; [9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate] affects the expression of IL2 protein; Cisplatin inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of IL2 mRNA]; Cisplatin promotes the reaction [NPPC protein inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of IL2 mRNA]]; NPPC protein inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of IL2 mRNA]; NPPC protein promotes the reaction [Cisplatin inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of IL2 mRNA]]; Tacrolimus affects the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate] affects the expression of IL2 protein] 		CTD PMID:8931739 PMID:25770929 PMID:37352108 NCBI chr 2:121,932,968...121,937,672
Ensembl chr 2:121,932,968...121,937,672 		JBrowse link
G Il33 interleukin 33 increases expression EXP
ISO 		9,10-Dimethyl-1,2-benzanthracene results in increased expression of IL33 mRNA CTD PMID:19480007 PMID:27869817 NCBI chr 1:237,115,478...237,149,897
Ensembl chr 1:237,115,572...237,150,901 		JBrowse link
G Il4r interleukin 4 receptor multiple interactions
increases expression 		ISO AHR mRNA promotes the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of IL4RA] CTD PMID:27869817 NCBI chr 1:189,545,739...189,570,639
Ensembl chr 1:189,544,988...189,570,636 		JBrowse link
G Il6 interleukin 6 multiple interactions
increases expression 		ISO
EXP 		9,10-Dimethyl-1,2-benzanthracene inhibits the reaction [Lipopolysaccharides promotes the reaction [[REL protein binds to NFKB1 protein] which binds to IL6 promoter]]; 9,10-Dimethyl-1,2-benzanthracene inhibits the reaction [Lipopolysaccharides promotes the reaction [[RELA protein binds to NFKB1 protein] which binds to IL6 promoter]]; 9,10-Dimethyl-1,2-benzanthracene inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 mRNA]; 9,10-Dimethyl-1,2-benzanthracene inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 protein]; [9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of IL6 mRNA; [9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate] results in increased expression of IL6 protein; [CYP1B1 protein affects the susceptibility to 9,10-Dimethyl-1,2-benzanthracene] which affects the expression of IL6 mRNA; [Glucaric Acid co-treated with Resveratrol] inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased expression of IL6 mRNA]; [Glucaric Acid co-treated with Ursolic Acid] inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased expression of IL6 mRNA]; [Tetradecanoylphorbol Acetate co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased expression of IL6 mRNA; [Tetradecanoylphorbol Acetate co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased secretion of IL6 protein; beta-elemene inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate] results in increased expression of IL6 protein]; Cisplatin inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of IL6 mRNA]; Cisplatin promotes the reaction [NPPC protein inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of IL6 mRNA]]; dieckol inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of IL6 mRNA]; dieckol inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of IL6 protein]; Eugenol inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased secretion of IL6 protein]; Glucaric Acid inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased expression of IL6 mRNA]; NPPC protein inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of IL6 mRNA]; NPPC protein promotes the reaction [Cisplatin inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of IL6 mRNA]]; Resveratrol inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased expression of IL6 mRNA]; Ursolic Acid inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased expression of IL6 mRNA]
9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of IL6 mRNA; 9,10-Dimethyl-1,2-benzanthracene results in increased expression of IL6 mRNA; 9,10-Dimethyl-1,2-benzanthracene results in increased expression of IL6 protein
citronellol inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of IL6 protein]; tangeretin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of IL6 protein] 		CTD PMID:14678569 PMID:20043298 PMID:23835587 PMID:24995432 PMID:27891153 More... NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,889,999...5,894,610 		JBrowse link
G Immp2l inner mitochondrial membrane peptidase subunit 2 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of IMMP2L mRNA CTD PMID:32553695 NCBI chr 6:63,797,189...64,696,906
Ensembl chr 6:63,797,237...64,697,749 		JBrowse link
G Impa1 inositol monophosphatase 1 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of IMPA1 protein CTD PMID:38307155 NCBI chr 2:93,370,200...93,391,474
Ensembl chr 2:93,370,299...93,391,468 		JBrowse link
G Inhbb inhibin subunit beta B increases expression
multiple interactions 		ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of INHBB mRNA
[9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein] which results in increased expression of INHBB mRNA 		CTD PMID:32553695 NCBI chr13:33,083,671...33,089,373
Ensembl chr13:33,083,671...33,089,609 		JBrowse link
G Insig1 insulin induced gene 1 affects expression
decreases expression 		ISO
EXP 		9,10-Dimethyl-1,2-benzanthracene affects the expression of INSIG1 mRNA
9,10-Dimethyl-1,2-benzanthracene results in decreased expression of INSIG1 mRNA 		CTD PMID:12376462 PMID:21785161 NCBI chr 4:8,049,339...8,057,812
Ensembl chr 4:8,049,556...8,057,778 		JBrowse link
G Isg15 ISG15 ubiquitin-like modifier increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of ISG15 mRNA CTD PMID:21527772 NCBI chr 5:172,066,369...172,067,656
Ensembl chr 5:172,066,369...172,067,656 		JBrowse link
G Itgb3 integrin subunit beta 3 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of ITGB3 mRNA CTD PMID:32553695 NCBI chr10:90,009,927...90,067,787
Ensembl chr10:90,009,900...90,067,800 		JBrowse link
G Itgb6 integrin subunit beta 6 increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of ITGB6 mRNA CTD PMID:19480007 NCBI chr 3:65,454,964...65,579,179
Ensembl chr 3:65,456,713...65,530,333 		JBrowse link
G Itpr1 inositol 1,4,5-trisphosphate receptor, type 1 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of ITPR1 mRNA CTD PMID:32553695 NCBI chr 4:142,743,401...143,066,505
Ensembl chr 4:142,743,334...143,066,504 		JBrowse link
G Ivd isovaleryl-CoA dehydrogenase decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of IVD protein CTD PMID:38307155 NCBI chr 3:126,305,584...126,326,016
Ensembl chr 3:126,305,364...126,328,160 		JBrowse link
G Ivns1abp influenza virus NS1A binding protein affects expression ISO 9,10-Dimethyl-1,2-benzanthracene affects the expression of IVNS1ABP mRNA CTD PMID:21785161 NCBI chr13:65,977,069...65,996,685
Ensembl chr13:65,977,045...65,997,547 		JBrowse link
G Jag1 jagged canonical Notch ligand 1 multiple interactions
increases expression 		EXP 1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of JAG1 protein]; Doxorubicin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of JAG1 protein]; Doxorubicin promotes the reaction [1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of JAG1 protein]] CTD PMID:39214269 NCBI chr 3:144,859,453...144,894,883
Ensembl chr 3:144,859,453...144,894,872 		JBrowse link
G Jchain joining chain of multimeric IgA and IgM decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of JCHAIN mRNA CTD PMID:19480007 NCBI chr14:19,822,976...19,831,072
Ensembl chr14:19,822,976...19,838,307 		JBrowse link
G Jpt1 Jupiter microtubule associated homolog 1 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of JPT1 protein CTD PMID:39910959 NCBI chr10:101,243,428...101,261,464
Ensembl chr10:101,243,424...101,261,469 		JBrowse link
G Jpt2 Jupiter microtubule associated homolog 2 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of JPT2 protein CTD PMID:39910959 NCBI chr10:14,467,652...14,487,769
Ensembl chr10:14,467,661...14,535,664 		JBrowse link
G Jun Jun proto-oncogene, AP-1 transcription factor subunit increases expression
multiple interactions
decreases expression 		ISO
EXP 		9,10-Dimethyl-1,2-benzanthracene results in increased expression of JUN protein
[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of JUN mRNA; [Glucaric Acid co-treated with Resveratrol] inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased expression of JUN protein]; [Glucaric Acid co-treated with Ursolic Acid] inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased expression of JUN protein]; [Tetradecanoylphorbol Acetate co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased expression of JUN protein; Cisplatin inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of JUN mRNA]; Cisplatin promotes the reaction [NPPC protein inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of JUN mRNA]]; Glucaric Acid inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased expression of JUN protein]; NPPC protein inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of JUN mRNA]; NPPC protein promotes the reaction [Cisplatin inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of JUN mRNA]]; Resveratrol inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased expression of JUN protein]; Ursolic Acid inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased expression of JUN protein]
9,10-Dimethyl-1,2-benzanthracene results in decreased expression of JUN protein modified form 		CTD PMID:20025956 PMID:22406437 PMID:23835587 PMID:37352108 NCBI chr 5:115,009,900...115,012,993
Ensembl chr 5:114,973,151...115,013,285 		JBrowse link
G Kcp kielin cysteine rich BMP regulator increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of KCP protein CTD PMID:39910959 NCBI chr 4:59,048,209...59,083,522
Ensembl chr 4:59,047,968...59,083,531 		JBrowse link
G Kctd12 potassium channel tetramerization domain containing 12 multiple interactions
decreases expression 		ISO [Dietary Fats co-treated with Dietary Sucrose co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in decreased expression of KCTD12 protein
9,10-Dimethyl-1,2-benzanthracene results in decreased expression of KCTD12 protein 		CTD PMID:39910959 NCBI chr15:86,214,786...86,220,725
Ensembl chr15:86,214,840...86,224,539 		JBrowse link
G Keap1 Kelch-like ECH-associated protein 1 increases expression
multiple interactions 		EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of KEAP1 mRNA; 9,10-Dimethyl-1,2-benzanthracene results in increased expression of KEAP1 protein
betulin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of KEAP1 protein]; tangeretin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of KEAP1 mRNA]; tangeretin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of KEAP1 protein] 		CTD PMID:24995432 PMID:33759307 NCBI chr 8:28,044,555...28,054,042
Ensembl chr 8:28,044,555...28,054,042 		JBrowse link
G Kgd4 alpha-ketoglutarate dehydrogenase subunit 4 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of MRPS36 protein CTD PMID:39910959 NCBI chr 2:33,604,611...33,614,988
Ensembl chr 2:33,604,613...33,615,095 		JBrowse link
G Kif1a kinesin family member 1A increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of KIF1A mRNA CTD PMID:21527772 NCBI chr 9:101,010,447...101,094,891
Ensembl chr 9:101,010,447...101,094,777 		JBrowse link
G Kif21a kinesin family member 21A increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of KIF21A mRNA CTD PMID:32553695 NCBI chr 7:123,942,079...124,058,594
Ensembl chr 7:123,942,081...124,058,540 		JBrowse link
G Kit KIT proto-oncogene receptor tyrosine kinase decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of KIT protein CTD PMID:24576726 NCBI chr14:32,901,615...32,978,895
Ensembl chr14:32,903,033...32,978,812 		JBrowse link
G Kitlg KIT ligand increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of KITLG mRNA CTD PMID:24576726 NCBI chr 7:36,782,621...36,863,796
Ensembl chr 7:36,782,638...36,863,793 		JBrowse link
G Klf10 KLF transcription factor 10 decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of KLF10 mRNA CTD PMID:12097258 NCBI chr 7:71,352,612...71,358,680
Ensembl chr 7:71,350,573...71,358,948 		JBrowse link
G Klf4 KLF transcription factor 4 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of KLF4 mRNA CTD PMID:32553695 NCBI chr 5:75,074,107...75,079,182
Ensembl chr 5:75,074,236...75,078,592 		JBrowse link
G Klhl29 kelch-like family member 29 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of KLHL29 mRNA CTD PMID:32553695 NCBI chr 6:33,805,922...34,110,055
Ensembl chr 6:33,805,922...34,110,055 		JBrowse link
G Kmt2c lysine methyltransferase 2C decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of KMT2C mRNA CTD PMID:32553695 NCBI chr 4:10,353,698...10,755,965
Ensembl chr 4:10,353,735...10,568,620 		JBrowse link
G Kng1 kininogen 1 multiple interactions
increases expression 		EXP
ISO 		[9,10-Dimethyl-1,2-benzanthracene co-treated with Isoflavones] results in increased expression of KNG1 protein
9,10-Dimethyl-1,2-benzanthracene results in increased expression of KNG1 protein 		CTD PMID:22248470 PMID:39910959 NCBI chr11:91,317,354...91,340,148
Ensembl chr11:91,317,355...91,340,148 		JBrowse link
G Kng2 kininogen 2 increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of KNG2 mRNA CTD PMID:19480007 NCBI chr11:91,418,470...91,440,841
Ensembl chr11:91,414,207...91,441,259 		JBrowse link
G Krt1 keratin 1 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of KRT1 protein CTD PMID:38307155 NCBI chr 7:134,855,311...134,860,537
Ensembl chr 7:134,855,313...134,860,537 		JBrowse link
G Krt10 keratin 10 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of KRT10 protein CTD PMID:38307155 NCBI chr10:84,834,865...84,839,160
Ensembl chr10:84,834,840...84,839,160 		JBrowse link
G Krt13 keratin 13 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of KRT13 protein CTD PMID:38307155 NCBI chr10:85,552,287...85,556,499
Ensembl chr10:85,552,287...85,556,499 		JBrowse link
G Krt18 keratin 18 multiple interactions ISO [Dietary Fats co-treated with Dietary Sucrose co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in decreased expression of KRT18 protein CTD PMID:39910959 NCBI chr 7:135,036,168...135,039,844
Ensembl chr 7:135,035,982...135,039,848
Ensembl chr10:135,035,982...135,039,848 		JBrowse link
G Krt19 keratin 19 increases expression
multiple interactions 		EXP
ISO 		9,10-Dimethyl-1,2-benzanthracene results in increased expression of KRT19 protein
[9,10-Dimethyl-1,2-benzanthracene co-treated with Isoflavones] results in increased expression of KRT19 protein 		CTD PMID:22248470 PMID:39910959 NCBI chr10:85,576,235...85,580,952
Ensembl chr10:85,576,235...85,580,952 		JBrowse link
G Krt28 keratin 28 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of KRT28 protein CTD PMID:39910959 NCBI chr10:84,814,516...84,824,857
Ensembl chr10:84,814,516...84,824,857 		JBrowse link
G Krt5 keratin 5 multiple interactions
increases expression 		EXP [9,10-Dimethyl-1,2-benzanthracene co-treated with Isoflavones] results in increased expression of KRT5 protein
9,10-Dimethyl-1,2-benzanthracene results in increased expression of KRT5 mRNA 		CTD PMID:12376462 PMID:19480007 PMID:22248470 NCBI chr 7:134,724,840...134,730,569
Ensembl chr 7:134,724,840...134,730,569 		JBrowse link
G Krt76 keratin 76 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of KRT76 protein CTD PMID:39910959 NCBI chr 7:134,895,677...134,904,162
Ensembl chr 7:134,895,677...134,904,162 		JBrowse link
G Krt78 keratin 78 affects expression ISO 9,10-Dimethyl-1,2-benzanthracene affects the expression of KRT78 protein CTD PMID:38307155 NCBI chr 7:134,952,877...134,960,727
Ensembl chr 7:134,953,043...134,960,220 		JBrowse link
G Krt8 keratin 8 multiple interactions
increases expression 		EXP
ISO 		[9,10-Dimethyl-1,2-benzanthracene co-treated with Isoflavones] results in increased expression of KRT8 protein
[Dietary Fats co-treated with Dietary Sucrose co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in decreased expression of KRT8 protein
9,10-Dimethyl-1,2-benzanthracene results in increased expression of KRT8 protein 		CTD PMID:22248470 PMID:39910959 NCBI chr 7:135,002,886...135,010,339
Ensembl chr 7:135,002,894...135,010,403 		JBrowse link
G Krt80 keratin 80 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of KRT80 mRNA CTD PMID:21527772 NCBI chr 7:134,341,951...134,363,872
Ensembl chr 7:134,341,956...134,364,211 		JBrowse link
G Ktn1 kinectin 1 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of KTN1 protein CTD PMID:39910959 NCBI chr15:23,392,570...23,485,061
Ensembl chr15:23,394,315...23,482,263 		JBrowse link
G Lamc2 laminin subunit gamma 2 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of LAMC2 mRNA CTD PMID:21527772 NCBI chr13:67,835,199...67,894,694
Ensembl chr13:67,835,199...67,895,102 		JBrowse link
G Lamtor2 late endosomal/lysosomal adaptor, MAPK and MTOR activator 2 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of LAMTOR2 protein CTD PMID:38307155 NCBI chr 2:176,306,353...176,310,617
Ensembl chr 2:176,306,280...176,310,730 		JBrowse link
G Large1 LARGE xylosyl- and glucuronyltransferase 1 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of LARGE mRNA CTD PMID:32553695 NCBI chr19:11,609,004...12,057,174
Ensembl chr19:11,609,004...12,054,707 		JBrowse link
G Lck LCK proto-oncogene, Src family tyrosine kinase increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of LCK mRNA CTD PMID:19480007 NCBI chr 5:147,172,642...147,201,267
Ensembl chr 5:147,172,642...147,201,267 		JBrowse link
G Lgals3 galectin 3 affects expression ISO 9,10-Dimethyl-1,2-benzanthracene affects the expression of LGALS3 mRNA CTD PMID:21785161 NCBI chr15:23,099,795...23,111,731
Ensembl chr15:23,086,841...23,111,737 		JBrowse link
G Lgals7 galectin 7 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of LGALS7 mRNA
9,10-Dimethyl-1,2-benzanthracene results in increased expression of LGALS7 protein 		CTD PMID:21527772 PMID:39910959 NCBI chr 1:93,275,092...93,279,529
Ensembl chr 1:93,273,836...93,279,528 		JBrowse link
G Lgr5 leucine rich repeat containing G protein coupled receptor 5 decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of LGR5 mRNA CTD PMID:36863560 NCBI chr 7:52,973,151...53,107,964
Ensembl chr 7:52,974,332...53,108,163 		JBrowse link
G Limd1 LIM domain containing 1 increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of LIMD1 mRNA CTD PMID:19480007 NCBI chr 8:131,998,262...132,045,924
Ensembl chr 8:131,999,770...132,045,922 		JBrowse link
G Lin7a lin-7 homolog A, crumbs cell polarity complex component decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of LIN7A mRNA CTD PMID:12376462 NCBI chr 7:44,473,568...44,629,074
Ensembl chr 7:44,473,347...44,625,208 		JBrowse link
G Lmna lamin A/C multiple interactions EXP [9,10-Dimethyl-1,2-benzanthracene co-treated with Isoflavones] results in increased expression of LMNA protein CTD PMID:22248470 NCBI chr 2:176,237,564...176,265,301
Ensembl chr 2:176,237,564...176,288,072 		JBrowse link
G Lpl lipoprotein lipase decreases expression
multiple interactions 		EXP
ISO 		9,10-Dimethyl-1,2-benzanthracene results in decreased expression of LPL mRNA
[9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein] which results in increased expression of LPL mRNA 		CTD PMID:12376462 PMID:32553695 NCBI chr16:25,596,205...25,621,928
Ensembl chr16:25,596,211...25,622,107 		JBrowse link
G Lrrc59 leucine rich repeat containing 59 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of LRRC59 protein CTD PMID:38307155 NCBI chr10:80,069,162...80,083,820
Ensembl chr10:80,069,120...80,084,079 		JBrowse link
G Lsm4 LSM4 homolog, U6 small nuclear RNA and mRNA degradation associated increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of LSM4 protein CTD PMID:38307155 NCBI chr16:18,789,466...18,795,164
Ensembl chr16:18,789,467...18,794,886 		JBrowse link
G Lsm6 LSM6 homolog, U6 small nuclear RNA and mRNA degradation associated increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of LSM6 protein CTD PMID:38307155 NCBI chr19:46,002,592...46,017,152 JBrowse link
G Lsr lipolysis stimulated lipoprotein receptor increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of LSR mRNA CTD PMID:12376462 NCBI chr 1:95,313,830...95,329,471
Ensembl chr 1:95,313,033...95,329,354 		JBrowse link
G Lss lanosterol synthase decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of LSS mRNA CTD PMID:32553695 NCBI chr20:12,090,641...12,118,230
Ensembl chr20:12,073,543...12,118,253 		JBrowse link
G Ltc4s leukotriene C4 synthase increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of LTC4S mRNA CTD PMID:19480007 NCBI chr10:35,060,002...35,066,466
Ensembl chr10:35,061,437...35,063,768 		JBrowse link
G Ly6e lymphocyte antigen 6 family member E affects expression ISO 9,10-Dimethyl-1,2-benzanthracene affects the expression of LY6E mRNA CTD PMID:21785161 NCBI chr 7:108,815,970...108,820,444
Ensembl chr 7:108,816,887...108,820,443 		JBrowse link
G Lypd1 Ly6/Plaur domain containing 1 increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of LYPD1 mRNA CTD PMID:19480007 NCBI chr13:39,874,937...39,922,385
Ensembl chr13:39,879,096...39,922,338 		JBrowse link
G Lyrm4 LYR motif containing 4 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of LYRM4 mRNA CTD PMID:32553695 NCBI chr17:28,951,912...29,067,300
Ensembl chr17:28,951,924...29,143,177 		JBrowse link
G Lyve1 lymphatic vessel endothelial hyaluronan receptor 1 decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of LYVE1 mRNA CTD PMID:19480007 NCBI chr 1:174,393,387...174,410,977 JBrowse link
G Maea macrophage erythroblast attacher, E3 ubiquitin ligase affects expression ISO 9,10-Dimethyl-1,2-benzanthracene affects the expression of MAEA mRNA CTD PMID:21785161 NCBI chr14:81,581,784...81,615,246
Ensembl chr14:81,581,785...81,615,202 		JBrowse link
G Mafb MAF bZIP transcription factor B decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of MAFB mRNA CTD PMID:19480007 NCBI chr 3:169,417,890...169,419,810
Ensembl chr 3:169,416,945...169,419,975 		JBrowse link
G Magi1 membrane associated guanylate kinase, WW and PDZ domain containing 1 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of MAGI1 mRNA CTD PMID:32553695 NCBI chr 4:127,762,590...128,368,228
Ensembl chr 4:127,762,590...128,367,833 		JBrowse link
G Mapk1 mitogen activated protein kinase 1 multiple interactions
increases expression 		ISO
EXP 		[Tetradecanoylphorbol Acetate co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased phosphorylation of MAPK1 protein; geraniol inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased phosphorylation of MAPK1 protein]
9,10-Dimethyl-1,2-benzanthracene results in increased expression of MAPK1 protein 		CTD PMID:22760862 PMID:36863560 NCBI chr11:97,462,025...97,529,193
Ensembl chr11:97,462,025...97,527,825 		JBrowse link
G Mapk3 mitogen activated protein kinase 3 multiple interactions
increases expression 		ISO
EXP 		[Tetradecanoylphorbol Acetate co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased phosphorylation of MAPK3 protein; geraniol inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased phosphorylation of MAPK3 protein]
betulin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of MAPK3 mRNA] 		CTD PMID:22760862 PMID:33759307 NCBI chr 1:190,797,189...190,803,411
Ensembl chr 1:190,797,185...190,803,411 		JBrowse link
G Mapk8 mitogen-activated protein kinase 8 increases expression
multiple interactions 		EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of MAPK8 mRNA; 9,10-Dimethyl-1,2-benzanthracene results in increased expression of MAPK8 protein
betulin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of MAPK8 mRNA] 		CTD PMID:33759307 PMID:36863560 NCBI chr16:8,645,171...8,728,225
Ensembl chr16:8,645,198...8,728,427 		JBrowse link
G Mat2a methionine adenosyltransferase 2A affects expression ISO 9,10-Dimethyl-1,2-benzanthracene affects the expression of MAT2A mRNA CTD PMID:21785161 NCBI chr 4:106,048,043...106,053,612
Ensembl chr 4:106,038,254...106,053,645 		JBrowse link
G Mbl2 mannose binding lectin 2 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of MBL2 protein CTD PMID:39910959 NCBI chr 1:237,429,873...237,465,567
Ensembl chr 1:237,429,973...237,437,546 		JBrowse link
G Mcm3 minichromosome maintenance complex component 3 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of MCM3 protein CTD PMID:20025956 NCBI chr 9:30,715,602...30,733,746
Ensembl chr 9:30,715,602...30,733,746 		JBrowse link
G Mdh2 malate dehydrogenase 2 increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of MDH2 mRNA CTD PMID:12376462 NCBI chr12:26,530,886...26,543,841
Ensembl chr12:26,530,881...26,543,841 		JBrowse link
G Mdm2 MDM2 proto-oncogene increases expression
multiple interactions 		ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of MDM2 mRNA; 9,10-Dimethyl-1,2-benzanthracene results in increased expression of MDM2 mRNA
[epigallocatechin gallate co-treated with polylactic acid-polyglycolic acid copolymer analog] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of MDM2 mRNA]; [theaflavin co-treated with polylactic acid-polyglycolic acid copolymer analog] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of MDM2 mRNA]; theaflavin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of MDM2 mRNA] 		CTD PMID:23717041 PMID:32553695 NCBI chr 7:55,176,558...55,201,757
Ensembl chr 7:55,176,560...55,200,791 		JBrowse link
G Megf6 multiple EGF-like-domains 6 decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of MEGF6 mRNA CTD PMID:19480007 NCBI chr 5:170,020,699...170,121,557
Ensembl chr 5:170,020,778...170,121,554 		JBrowse link
G Mgarp mitochondria-localized glutamic acid-rich protein increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of MGARP mRNA CTD PMID:19480007 NCBI chr 2:137,582,152...137,590,294
Ensembl chr 2:137,582,152...137,590,481 		JBrowse link
G Mgmt O-6-methylguanine-DNA methyltransferase multiple interactions ISO MGMT protein results in decreased susceptibility to [Methylnitrosourea co-treated with 9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate] CTD PMID:12663516 NCBI chr 1:201,140,832...201,367,481
Ensembl chr 1:201,140,661...201,367,482 		JBrowse link
G Mgp matrix Gla protein increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of MGP mRNA CTD PMID:12376462 NCBI chr 4:171,497,472...171,500,888
Ensembl chr 4:171,497,471...171,500,859 		JBrowse link
G Mif macrophage migration inhibitory factor increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of MIF mRNA CTD PMID:12376462 NCBI chr20:12,767,138...12,791,222
Ensembl chr 4:134,041,774...134,042,121
Ensembl chr20:134,041,774...134,042,121 		JBrowse link
G Mir203 microRNA 203 affects expression
increases methylation
multiple interactions 		ISO 9,10-Dimethyl-1,2-benzanthracene affects the expression of MIR203 mRNA
9,10-Dimethyl-1,2-benzanthracene results in increased methylation of MIR203 promoter
Butyric Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene affects the expression of MIR203 mRNA]; Butyric Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased methylation of MIR203 promoter]; Glucaric Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene affects the expression of MIR203 mRNA]; Glucaric Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased methylation of MIR203 promoter]; Niacinamide inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene affects the expression of MIR203 mRNA]; Niacinamide inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased methylation of MIR203 promoter] 		CTD PMID:24792773 NCBI chr 6:137,020,691...137,020,805 JBrowse link
G Misp3 MISP family member 3 increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of MISP3 mRNA CTD PMID:19480007 NCBI chr19:41,043,408...41,046,761
Ensembl chr19:41,044,765...41,052,107 		JBrowse link
G Mki67 marker of proliferation Ki-67 multiple interactions
increases expression 		EXP 1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of MKI67 protein]; 9,10-Dimethyl-1,2-benzanthracene promotes the reaction [Estradiol results in increased expression of MKI67 mRNA]; [Estradiol co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased expression of MKI67 protein; [Ruthenium binds to Phloretin] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of MKI67 protein]; Doxorubicin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of MKI67 protein]; Doxorubicin promotes the reaction [1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of MKI67 protein]]; Plant Preparations inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene promotes the reaction [Estradiol results in increased expression of MKI67 mRNA]] CTD PMID:16891317 PMID:26945725 PMID:34896434 PMID:39214269 NCBI chr 1:199,926,150...199,952,847
Ensembl chr 1:199,926,150...199,952,593 		JBrowse link
G Mlf2 myeloid leukemia factor 2 affects expression ISO 9,10-Dimethyl-1,2-benzanthracene affects the expression of MLF2 mRNA CTD PMID:21785161 NCBI chr 4:159,425,542...159,430,584
Ensembl chr 4:159,411,732...159,430,571 		JBrowse link
G Mme membrane metallo-endopeptidase decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of MME mRNA CTD PMID:19480007 NCBI chr 2:149,806,826...149,957,381
Ensembl chr 2:149,872,291...149,953,463 		JBrowse link
G Mmp12 matrix metallopeptidase 12 increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of MMP12 mRNA CTD PMID:19480007 NCBI chr 8:12,866,652...12,876,554
Ensembl chr 8:12,866,641...12,884,478 		JBrowse link
G Mmp13 matrix metallopeptidase 13 increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of MMP13 mRNA; 9,10-Dimethyl-1,2-benzanthracene results in increased expression of MMP13 protein CTD PMID:19480007 NCBI chr 8:12,782,829...12,793,108
Ensembl chr 8:12,782,813...12,793,105 		JBrowse link
G Mmp14 matrix metallopeptidase 14 decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of MMP14 mRNA CTD PMID:19480007 NCBI chr15:31,857,824...31,867,049
Ensembl chr15:31,857,546...31,869,893 		JBrowse link
G Mmp2 matrix metallopeptidase 2 multiple interactions ISO [9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of and results in increased activity of MMP2 protein; [9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of MMP2 mRNA; Cisplatin inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of and results in increased activity of MMP2 protein]; Cisplatin inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of MMP2 mRNA]; Cisplatin promotes the reaction [NPPC protein inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of and results in increased activity of MMP2 protein]]; Cisplatin promotes the reaction [NPPC protein inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of MMP2 mRNA]]; NPPC protein inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of MMP2 mRNA]; NPPC protein promotes the reaction [Cisplatin inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of and results in increased activity of MMP2 protein]]; NPPC protein promotes the reaction [Cisplatin inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of MMP2 mRNA]] CTD PMID:37352108 NCBI chr19:30,327,643...30,355,856
Ensembl chr19:30,327,643...30,355,856 		JBrowse link
G Mmp7 matrix metallopeptidase 7 decreases expression
increases expression 		EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of MMP7 mRNA
9,10-Dimethyl-1,2-benzanthracene results in increased expression of MMP7 mRNA; 9,10-Dimethyl-1,2-benzanthracene results in increased expression of MMP7 protein 		CTD PMID:19480007 NCBI chr 8:13,133,043...13,140,761
Ensembl chr 8:13,133,043...13,140,755 		JBrowse link
G Mmp9 matrix metallopeptidase 9 affects expression
multiple interactions
increases expression 		ISO
EXP 		9,10-Dimethyl-1,2-benzanthracene affects the expression of MMP9 mRNA
[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of and results in increased activity of MMP9 protein; [9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of MMP9 mRNA; [sodium arsenite results in increased susceptibility to [9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate]] which results in increased expression of MMP9 protein; Cisplatin inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of and results in increased activity of MMP9 protein]; Cisplatin inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of MMP9 mRNA]; Cisplatin promotes the reaction [NPPC protein inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of and results in increased activity of MMP9 protein]]; Cisplatin promotes the reaction [NPPC protein inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of MMP9 mRNA]]; NPPC protein inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of and results in increased activity of MMP9 protein]; NPPC protein inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of MMP9 mRNA]; NPPC protein promotes the reaction [Cisplatin inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of and results in increased activity of MMP9 protein]]; NPPC protein promotes the reaction [Cisplatin inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of MMP9 mRNA]]
[9,10-Dimethyl-1,2-benzanthracene co-treated with Raloxifene Hydrochloride co-treated with Fluoxetine] affects the expression of MMP9 protein; [9,10-Dimethyl-1,2-benzanthracene co-treated with Raloxifene Hydrochloride] affects the expression of MMP9 protein; [Ruthenium binds to Phloretin] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of MMP9 protein]; Resveratrol inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of MMP9 protein] 		CTD PMID:12208745 PMID:21785161 PMID:31332895 PMID:34896434 PMID:35364107 More... NCBI chr 3:174,103,474...174,111,434
Ensembl chr 3:174,084,123...174,111,442 		JBrowse link
G Mpo myeloperoxidase multiple interactions
increases activity 		ISO
EXP 		[9,10-Dimethyl-1,2-benzanthracene co-treated with cumene hydroperoxide] results in increased activity of MPO protein
9,10-Dimethyl-1,2-benzanthracene results in increased activity of MPO protein 		CTD PMID:14972014 PMID:32623939 NCBI chr10:73,092,124...73,102,057
Ensembl chr10:73,092,400...73,102,056 		JBrowse link
G Mr1 major histocompatibility complex, class I-related increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of MR1 mRNA CTD PMID:21527772 NCBI chr13:69,850,420...69,868,302
Ensembl chr13:69,850,420...69,868,502 		JBrowse link
G Msra methionine sulfoxide reductase A decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of MSRA mRNA CTD PMID:32553695 NCBI chr15:42,514,818...42,853,278
Ensembl chr15:42,527,045...42,853,279 		JBrowse link
G Mt-co1 mitochondrially encoded cytochrome c oxidase I decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of COX1 mRNA CTD PMID:12376462 NCBI chr MT:5,323...6,867
Ensembl chr MT:5,309...6,853 		JBrowse link
G Mt1a metallothionein 1A decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of MT1 mRNA CTD PMID:19480007 NCBI chr19:10,831,959...10,832,975
Ensembl chr17:79,695,809...79,696,200
Ensembl chr  X:79,695,809...79,696,200
Ensembl chr19:79,695,809...79,696,200 		JBrowse link
G Mto1 mitochondrial tRNA translation optimization 1 decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of MTO1 mRNA CTD PMID:19480007 NCBI chr 8:88,188,918...88,215,516
Ensembl chr 8:88,190,259...88,215,509 		JBrowse link
G Mtor mechanistic target of rapamycin kinase decreases expression
increases expression 		ISO 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of MTOR protein modified form
9,10-Dimethyl-1,2-benzanthracene results in increased expression of MTOR protein modified form 		CTD PMID:21785161 NCBI chr 5:164,167,985...164,277,438
Ensembl chr 5:164,167,928...164,277,435 		JBrowse link
G Muc1 mucin 1, cell surface associated decreases expression
multiple interactions 		EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of MUC1 mRNA
[9,10-Dimethyl-1,2-benzanthracene co-treated with Tartrazine] results in increased expression of MUC1 protein 		CTD PMID:19480007 PMID:34972512 NCBI chr 2:176,933,312...176,938,497
Ensembl chr 2:176,933,047...176,938,491 		JBrowse link
G Myb MYB proto-oncogene, transcription factor increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of MYB mRNA CTD PMID:36863560 NCBI chr 1:17,759,309...17,793,306
Ensembl chr 1:17,759,309...17,792,547 		JBrowse link
G Myc MYC proto-oncogene, bHLH transcription factor multiple interactions
increases expression 		ISO [9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of MYC mRNA; [9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of MYC protein; Butyric Acid affects the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of MYC mRNA]; Butyric Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of MYC protein]; Cisplatin inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of MYC mRNA]; Cisplatin promotes the reaction [NPPC protein inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of MYC mRNA]]; Eugenol inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of MYC protein]; Glucaric Acid affects the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of MYC mRNA]; Glucaric Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of MYC protein]; Niacinamide affects the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of MYC mRNA]; Niacinamide inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of MYC protein]; NPPC protein inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of MYC mRNA]; NPPC protein promotes the reaction [Cisplatin inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of MYC mRNA]]
9,10-Dimethyl-1,2-benzanthracene results in increased expression of MYC mRNA; 9,10-Dimethyl-1,2-benzanthracene results in increased expression of MYC protein
9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of MYC mRNA; 9,10-Dimethyl-1,2-benzanthracene results in increased expression of MYC mRNA; 9,10-Dimethyl-1,2-benzanthracene results in increased expression of MYC protein 		CTD PMID:20537511 PMID:24792773 PMID:29663660 PMID:32553695 PMID:37352108 NCBI chr 7:95,483,105...95,488,031
Ensembl chr 7:95,483,105...95,488,028 		JBrowse link
G Myh11 myosin heavy chain 11 multiple interactions ISO [Dietary Fats co-treated with Dietary Sucrose co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased expression of MYH11 protein CTD PMID:39910959 NCBI chr10:1,250,554...1,345,681
Ensembl chr10:1,263,194...1,345,678 		JBrowse link
G Myh9 myosin, heavy chain 9 increases expression
multiple interactions 		EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of MYH9 protein
[9,10-Dimethyl-1,2-benzanthracene co-treated with Isoflavones] results in increased expression of MYH9 protein 		CTD PMID:22248470 NCBI chr 7:111,224,291...111,304,963
Ensembl chr 7:111,224,291...111,304,963 		JBrowse link
G Myl12a myosin light chain 12A multiple interactions ISO [Dietary Fats co-treated with Dietary Sucrose co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased expression of MYL12A protein CTD PMID:39910959 NCBI chr 9:118,338,592...118,346,277
Ensembl chr 9:118,338,604...118,342,634 		JBrowse link
G Myl9 myosin light chain 9 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of MYL9 protein CTD PMID:39910959 NCBI chr 3:165,742,020...165,748,409
Ensembl chr 3:165,742,046...165,748,410 		JBrowse link
G Mylk myosin light chain kinase decreases expression
multiple interactions 		ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of MYLK mRNA
[Dietary Fats co-treated with Dietary Sucrose co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in decreased expression of MYLK protein 		CTD PMID:32553695 PMID:39910959 NCBI chr11:79,288,243...79,535,450
Ensembl chr11:79,288,243...79,535,659 		JBrowse link
G Myod1 myogenic differentiation 1 decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of MYOD1 mRNA CTD PMID:36863560 NCBI chr 1:106,021,161...106,023,871
Ensembl chr 1:106,021,161...106,023,871 		JBrowse link
G N4bp1 Nedd4 binding protein 1 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of N4BP1 mRNA CTD PMID:32553695 NCBI chr19:36,396,082...36,446,835
Ensembl chr19:36,396,324...36,446,835 		JBrowse link
G Nasp nuclear autoantigenic sperm protein increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of NASP protein CTD PMID:39910959 NCBI chr 5:135,294,599...135,319,992
Ensembl chr 5:135,294,032...135,319,591 		JBrowse link
G Ncald neurocalcin delta decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of NCALD mRNA CTD PMID:32553695 NCBI chr 7:70,417,683...70,849,763
Ensembl chr 7:70,419,433...70,849,482 		JBrowse link
G Ncam1 neural cell adhesion molecule 1 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of NCAM1 mRNA CTD PMID:32553695 NCBI chr 8:58,762,088...59,062,131
Ensembl chr 8:58,762,116...59,061,971 		JBrowse link
G Ncmap noncompact myelin associated protein increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of NCMAP mRNA CTD PMID:19480007 NCBI chr 5:152,893,173...152,921,175
Ensembl chr 5:152,894,316...152,902,414 		JBrowse link
G Ndufb8 NADH:ubiquinone oxidoreductase subunit B8 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of NDUFB8 protein CTD PMID:38307155 NCBI chr 1:253,357,878...253,362,936
Ensembl chr 1:253,357,841...253,362,936 		JBrowse link
G Ndufv2 NADH:ubiquinone oxidoreductase core subunit V2 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of NDUFV2 protein CTD PMID:39910959 NCBI chr 9:113,137,305...113,157,571
Ensembl chr 9:113,137,306...113,157,520 		JBrowse link
G Nell1 neural EGFL like 1 increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of NELL1 mRNA CTD PMID:19480007 NCBI chr 1:108,845,462...109,709,858
Ensembl chr 1:108,845,462...109,709,858 		JBrowse link
G Nes nestin increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of NES protein CTD PMID:38307155 NCBI chr 2:175,735,715...175,745,631
Ensembl chr 2:175,736,551...175,746,228 		JBrowse link
G Neto2 neuropilin and tolloid like 2 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of NETO2 mRNA CTD PMID:21527772 NCBI chr19:37,517,518...37,588,961
Ensembl chr19:37,517,587...37,591,413 		JBrowse link
G Nfe2l2 NFE2 like bZIP transcription factor 2 increases expression
multiple interactions
increases activity
decreases expression 		EXP
ISO 		9,10-Dimethyl-1,2-benzanthracene results in increased expression of NFE2L2 protein
[9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein] which results in increased expression of NFE2L2 mRNA
9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of NFE2L2 mRNA
9,10-Dimethyl-1,2-benzanthracene results in increased activity of NFE2L2 protein
betulin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of NFE2L2 protein]; tangeretin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of NFE2L2 mRNA]; tangeretin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of NFE2L2 protein]
9,10-Dimethyl-1,2-benzanthracene results in decreased expression of NFE2L2 mRNA; 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of NFE2L2 protein 		CTD PMID:22406437 PMID:24995432 PMID:30114225 PMID:32553695 PMID:33759307 NCBI chr 3:81,001,529...81,031,165
Ensembl chr 3:81,001,529...81,029,090 		JBrowse link
G Nfkb1 nuclear factor kappa B subunit 1 multiple interactions ISO 9,10-Dimethyl-1,2-benzanthracene inhibits the reaction [Lipopolysaccharides promotes the reaction [[REL protein binds to NFKB1 protein] which binds to IL6 promoter]]; 9,10-Dimethyl-1,2-benzanthracene inhibits the reaction [Lipopolysaccharides promotes the reaction [[RELA protein binds to NFKB1 protein] which binds to IL6 promoter]]; [9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of NFKB1 mRNA; [Tetradecanoylphorbol Acetate co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased expression of NFKB1 protein; [Ursolic Acid co-treated with Glucaric Acid] inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased expression of NFKB1 protein]; Cisplatin inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of NFKB1 mRNA]; Cisplatin promotes the reaction [NPPC protein inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of NFKB1 mRNA]]; NPPC protein inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of NFKB1 mRNA]; NPPC protein promotes the reaction [Cisplatin inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of NFKB1 mRNA]] CTD PMID:14678569 PMID:23835587 PMID:37352108 NCBI chr 2:226,689,745...226,805,897
Ensembl chr 2:226,689,745...226,783,088 		JBrowse link
G Nfkbia NFKB inhibitor alpha multiple interactions
increases expression 		ISO
EXP 		9,10-Dimethyl-1,2-benzanthracene results in decreased expression of and results in increased phosphorylation of NFKBIA protein; [Tetradecanoylphorbol Acetate co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased expression of NFKBIA protein modified form; dieckol affects the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of NFKBIA protein]; dieckol inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased phosphorylation of NFKBIA protein]; Eugenol inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased expression of NFKBIA protein modified form]
9,10-Dimethyl-1,2-benzanthracene results in increased expression of NFKBIA mRNA
citronellol inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of NFKBIA mRNA] 		CTD PMID:20043298 PMID:31926054 PMID:33347706 NCBI chr 6:78,593,844...78,597,307
Ensembl chr 6:78,593,847...78,597,072 		JBrowse link
G Nfu1 NFU1 iron-sulfur cluster scaffold increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of NFU1 protein CTD PMID:39910959 NCBI chr 4:121,016,316...121,036,925
Ensembl chr 4:121,016,393...121,037,493 		JBrowse link
G Nid1 nidogen 1 affects expression
decreases expression 		ISO
EXP 		9,10-Dimethyl-1,2-benzanthracene affects the expression of NID1 mRNA
9,10-Dimethyl-1,2-benzanthracene results in decreased expression of NID1 mRNA 		CTD PMID:19480007 PMID:21785161 NCBI chr17:93,069,013...93,142,416
Ensembl chr17:93,069,278...93,142,386 		JBrowse link
G Nipsnap2 nipsnap homolog 2 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of NIPSNAP2 mRNA CTD PMID:21785161 NCBI chr12:32,542,171...32,580,345
Ensembl chr12:32,547,819...32,580,303 		JBrowse link
G Nkg7 natural killer cell granule protein 7 increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of NKG7 mRNA CTD PMID:19480007 NCBI chr 1:102,981,497...102,982,564
Ensembl chr 1:102,981,450...102,982,562 		JBrowse link
G Nlrp5 NLR family, pyrin domain containing 5 affects expression ISO 9,10-Dimethyl-1,2-benzanthracene affects the expression of NLRP5 mRNA CTD PMID:21785161 NCBI chr 1:76,811,044...76,872,964
Ensembl chr 1:76,810,108...77,077,580 		JBrowse link
G Nos2 nitric oxide synthase 2 increases expression
multiple interactions 		EXP
ISO 		9,10-Dimethyl-1,2-benzanthracene results in increased expression of NOS2 mRNA; 9,10-Dimethyl-1,2-benzanthracene results in increased expression of NOS2 protein
[Maxepa co-treated with Calcitriol] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of NOS2 mRNA]; citronellol inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of NOS2 protein]; tangeretin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of NOS2 protein]
[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of NOS2 mRNA; [9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of NOS2 protein; [9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate] results in increased expression of NOS2 protein; [Tetradecanoylphorbol Acetate co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased expression of NOS2 protein; beta-elemene inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate] results in increased expression of NOS2 protein]; Cisplatin inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of NOS2 mRNA]; Cisplatin inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of NOS2 protein]; Cisplatin promotes the reaction [NPPC protein inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of NOS2 mRNA]]; Cisplatin promotes the reaction [NPPC protein inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of NOS2 protein]]; Eugenol inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased expression of NOS2 protein]; NPPC protein inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of NOS2 mRNA]; NPPC protein inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of NOS2 protein]; NPPC protein promotes the reaction [Cisplatin inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of NOS2 mRNA]]; NPPC protein promotes the reaction [Cisplatin inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of NOS2 protein]] 		CTD PMID:20043298 PMID:20599847 PMID:24995432 PMID:31926054 PMID:32662567 More... NCBI chr10:64,313,335...64,349,221
Ensembl chr10:64,313,335...64,401,880 		JBrowse link
G Notch1 notch receptor 1 increases expression
multiple interactions 		ISO
EXP 		9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of NOTCH1 mRNA
9,10-Dimethyl-1,2-benzanthracene results in increased expression of NOTCH1 protein
1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of NOTCH1 protein]; Doxorubicin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of NOTCH1 protein]; Doxorubicin promotes the reaction [1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of NOTCH1 protein]] 		CTD PMID:32553695 PMID:39214269 NCBI chr 3:29,676,040...29,721,613
Ensembl chr 3:29,676,171...29,721,613 		JBrowse link
G Notch3 notch receptor 3 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of NOTCH3 mRNA CTD PMID:32553695 NCBI chr 7:11,783,550...11,834,585
Ensembl chr 7:11,784,272...11,834,778 		JBrowse link
G Npm1 nucleophosmin 1 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of NPM1 protein CTD PMID:39910959 NCBI chr10:18,245,739...18,255,913
Ensembl chr10:18,245,740...18,256,024
Ensembl chr  X:18,245,740...18,256,024 		JBrowse link
G Nppc natriuretic peptide C multiple interactions ISO Cisplatin promotes the reaction [NPPC protein inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of and results in increased activity of MMP2 protein]]; Cisplatin promotes the reaction [NPPC protein inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of and results in increased activity of MMP9 protein]]; Cisplatin promotes the reaction [NPPC protein inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of CRP protein]]; Cisplatin promotes the reaction [NPPC protein inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of FOS mRNA]]; Cisplatin promotes the reaction [NPPC protein inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of IL1A mRNA]]; Cisplatin promotes the reaction [NPPC protein inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of IL1B mRNA]]; Cisplatin promotes the reaction [NPPC protein inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of IL2 mRNA]]; Cisplatin promotes the reaction [NPPC protein inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of IL6 mRNA]]; Cisplatin promotes the reaction [NPPC protein inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of JUN mRNA]]; Cisplatin promotes the reaction [NPPC protein inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of MMP2 mRNA]]; Cisplatin promotes the reaction [NPPC protein inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of MMP9 mRNA]]; Cisplatin promotes the reaction [NPPC protein inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of MYC mRNA]]; Cisplatin promotes the reaction [NPPC protein inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of NFKB1 mRNA]]; Cisplatin promotes the reaction [NPPC protein inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of NOS2 mRNA]]; Cisplatin promotes the reaction [NPPC protein inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of NOS2 protein]]; Cisplatin promotes the reaction [NPPC protein inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of PCNA mRNA]]; Cisplatin promotes the reaction [NPPC protein inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of PCNA protein]]; Cisplatin promotes the reaction [NPPC protein inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of PTGS2 mRNA]]; Cisplatin promotes the reaction [NPPC protein inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of PTGS2 protein]]; Cisplatin promotes the reaction [NPPC protein inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of RELA protein]]; Cisplatin promotes the reaction [NPPC protein inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of TNF mRNA]]; Cisplatin promotes the reaction [NPPC protein inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of VEGFA mRNA]]; NPPC protein inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of and results in increased activity of MMP9 protein]; NPPC protein inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of CRP protein]; NPPC protein inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of FOS mRNA]; NPPC protein inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of IL1A mRNA]; NPPC protein inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of IL1B mRNA]; NPPC protein inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of IL2 mRNA]; NPPC protein inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of IL6 mRNA]; NPPC protein inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of JUN mRNA]; NPPC protein inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of MMP2 mRNA]; NPPC protein inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of MMP9 mRNA]; NPPC protein inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of MYC mRNA]; NPPC protein inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of NFKB1 mRNA]; NPPC protein inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of NOS2 mRNA]; NPPC protein inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of NOS2 protein]; NPPC protein inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of PCNA mRNA]; NPPC protein inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of PCNA protein]; NPPC protein inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of PTGS2 mRNA]; NPPC protein inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of PTGS2 protein]; NPPC protein inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of RELA protein]; NPPC protein inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of TNF mRNA]; NPPC protein inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of VEGFA mRNA]; NPPC protein promotes the reaction [Cisplatin inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of and results in increased activity of MMP2 protein]]; NPPC protein promotes the reaction [Cisplatin inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of and results in increased activity of MMP9 protein]]; NPPC protein promotes the reaction [Cisplatin inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of CRP protein]]; NPPC protein promotes the reaction [Cisplatin inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of FOS mRNA]]; NPPC protein promotes the reaction [Cisplatin inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of IL1A mRNA]]; NPPC protein promotes the reaction [Cisplatin inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of IL1B mRNA]]; NPPC protein promotes the reaction [Cisplatin inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of IL2 mRNA]]; NPPC protein promotes the reaction [Cisplatin inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of IL6 mRNA]]; NPPC protein promotes the reaction [Cisplatin inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of JUN mRNA]]; NPPC protein promotes the reaction [Cisplatin inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of MMP2 mRNA]]; NPPC protein promotes the reaction [Cisplatin inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of MMP9 mRNA]]; NPPC protein promotes the reaction [Cisplatin inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of MYC mRNA]]; NPPC protein promotes the reaction [Cisplatin inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of NFKB1 mRNA]]; NPPC protein promotes the reaction [Cisplatin inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of NOS2 mRNA]]; NPPC protein promotes the reaction [Cisplatin inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of NOS2 protein]]; NPPC protein promotes the reaction [Cisplatin inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of PCNA mRNA]]; NPPC protein promotes the reaction [Cisplatin inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of PCNA protein]]; NPPC protein promotes the reaction [Cisplatin inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of PTGS2 mRNA]]; NPPC protein promotes the reaction [Cisplatin inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of PTGS2 protein]]; NPPC protein promotes the reaction [Cisplatin inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of RELA protein]]; NPPC protein promotes the reaction [Cisplatin inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of TNF mRNA]]; NPPC protein promotes the reaction [Cisplatin inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of VEGFA mRNA]] CTD PMID:37352108 NCBI chr 9:94,767,986...94,772,186
Ensembl chr 9:94,767,986...94,772,186 		JBrowse link
G Npr3 natriuretic peptide receptor 3 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of NPR3 mRNA CTD PMID:32553695 NCBI chr 2:62,592,557...62,660,497
Ensembl chr 2:62,597,668...62,660,066 		JBrowse link
G Nptx1 neuronal pentraxin 1 increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of NPTX1 mRNA CTD PMID:19480007 NCBI chr10:105,309,578...105,318,829
Ensembl chr10:105,309,578...105,318,863 		JBrowse link
G Nqo1 NAD(P)H quinone dehydrogenase 1 increases activity
increases expression
multiple interactions
decreases expression 		ISO
EXP 		9,10-Dimethyl-1,2-benzanthracene results in increased activity of NQO1 protein
9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of NQO1 mRNA
9,10-Dimethyl-1,2-benzanthracene results in increased expression of NQO1 mRNA
9,10-Dimethyl-1,2-benzanthracene results in increased expression of and results in increased activity of NQO1 protein; Metformin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of and results in increased activity of NQO1 protein]; Metformin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of NQO1 mRNA]
acetylsalicylic acid lysinate promotes the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased activity of NQO1 protein]; tangeretin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of NQO1 mRNA]; tangeretin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of NQO1 protein]
9,10-Dimethyl-1,2-benzanthracene results in decreased expression of NQO1 mRNA; 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of NQO1 protein
[9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein] which results in increased expression of NQO1 mRNA; Resveratrol inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased activity of NQO1 protein] 		CTD PMID:18678235 PMID:18694800 PMID:24995432 PMID:25697376 PMID:32553695 NCBI chr19:52,205,374...52,220,267
Ensembl chr19:52,205,314...52,220,260 		JBrowse link
G Nr1i2 nuclear receptor subfamily 1, group I, member 2 multiple interactions ISO 9,10-Dimethyl-1,2-benzanthracene binds to and results in increased activity of NR1I2 protein CTD PMID:33049310 NCBI chr11:75,965,717...76,006,733
Ensembl chr11:75,965,632...76,002,380 		JBrowse link
G Nr2f1 nuclear receptor subfamily 2, group F, member 1 decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of NR2F1 mRNA CTD PMID:19480007 NCBI chr 2:9,776,179...9,785,924
Ensembl chr 2:9,776,179...9,785,924 		JBrowse link
G Nr4a1 nuclear receptor subfamily 4, group A, member 1 multiple interactions ISO [CYP1B1 protein affects the susceptibility to 9,10-Dimethyl-1,2-benzanthracene] which affects the expression of NR4A1 mRNA CTD PMID:27891153 NCBI chr 7:134,247,153...134,268,044
Ensembl chr 7:134,247,192...134,268,041 		JBrowse link
G Nsdhl NAD(P) dependent 3-beta-hydroxysteroid dehydrogenase NSDHL affects expression ISO 9,10-Dimethyl-1,2-benzanthracene affects the expression of NSDHL mRNA CTD PMID:21785161 NCBI chr  X:155,817,301...155,848,224
Ensembl chr  X:155,817,340...155,848,220 		JBrowse link
G Nsmf NMDA receptor synaptonuclear signaling and neuronal migration factor increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of NSMF mRNA CTD PMID:12376462 NCBI chr 3:28,260,018...28,268,790
Ensembl chr 3:28,260,004...28,268,789 		JBrowse link
G Ntf3 neurotrophin 3 increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of NTF3 mRNA CTD PMID:19480007 NCBI chr 4:160,601,161...160,670,623
Ensembl chr 4:160,600,770...160,676,349 		JBrowse link
G Nubpl NUBP iron-sulfur cluster assembly factor, mitochondrial decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of NUBPL mRNA CTD PMID:32553695 NCBI chr 6:75,294,609...75,516,603
Ensembl chr 6:75,294,632...75,516,601 		JBrowse link
G Nusap1 nucleolar and spindle associated protein 1 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of NUSAP1 mRNA CTD PMID:32553695 NCBI chr 3:127,057,220...127,092,779
Ensembl chr 3:127,057,265...127,087,237 		JBrowse link
G Ogg1 8-oxoguanine DNA glycosylase increases expression
multiple interactions 		ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of OGG1 mRNA
Metformin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of OGG1 mRNA] 		CTD PMID:25697376 NCBI chr 4:148,030,237...148,037,599
Ensembl chr 4:148,030,349...148,037,604 		JBrowse link
G Ogn osteoglycin decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of OGN mRNA CTD PMID:19480007 NCBI chr17:15,238,500...15,259,167
Ensembl chr17:15,238,500...15,259,252 		JBrowse link
G Olfml3 olfactomedin-like 3 multiple interactions EXP [9,10-Dimethyl-1,2-benzanthracene co-treated with Isoflavones] results in increased expression of OLFML3 protein CTD PMID:22248470 NCBI chr 2:193,932,665...193,935,494
Ensembl chr 2:193,932,665...193,935,494 		JBrowse link
G Orm1 orosomucoid 1 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of ORM1 protein CTD PMID:20025956 PMID:39910959 NCBI chr 5:81,788,509...81,791,661
Ensembl chr 5:81,788,395...81,791,667 		JBrowse link
G Otor otoraplin decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of OTOR mRNA CTD PMID:32553695 NCBI chr 3:150,868,886...150,872,141
Ensembl chr 3:150,868,886...150,872,141 		JBrowse link
G Pabpc1 poly(A) binding protein, cytoplasmic 1 affects expression
multiple interactions 		ISO
EXP 		9,10-Dimethyl-1,2-benzanthracene affects the expression of PABPC1 mRNA
[9,10-Dimethyl-1,2-benzanthracene co-treated with Isoflavones] results in increased expression of PABPC1 protein 		CTD PMID:21785161 PMID:22248470 NCBI chr 7:69,662,513...69,674,806
Ensembl chr 7:69,663,068...69,675,050 		JBrowse link
G Padi4 peptidyl arginine deiminase 4 decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of PADI4 mRNA CTD PMID:12376462 NCBI chr 5:158,324,417...158,357,466
Ensembl chr 5:158,324,417...158,360,422 		JBrowse link
G Padi6 peptidyl arginine deiminase 6 multiple interactions ISO [Dietary Fats co-treated with Dietary Sucrose co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased expression of PADI6 protein CTD PMID:39910959 NCBI chr 5:158,304,118...158,320,508
Ensembl chr 5:158,304,921...158,320,508 		JBrowse link
G Papss2 3'-phosphoadenosine 5'-phosphosulfate synthase 2 decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of PAPSS2 mRNA CTD PMID:19480007 NCBI chr 1:239,867,597...239,952,614
Ensembl chr 1:239,867,574...239,952,616 		JBrowse link
G Pard6g par-6 family cell polarity regulator gamma increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of PARD6G mRNA CTD PMID:32553695 NCBI chr18:75,772,992...75,840,041
Ensembl chr18:75,772,955...75,840,041 		JBrowse link
G Parp1 poly (ADP-ribose) polymerase 1 decreases expression
multiple interactions
increases expression 		EXP
ISO 		9,10-Dimethyl-1,2-benzanthracene results in decreased expression of PARP1 mRNA
9,10-Dimethyl-1,2-benzanthracene promotes the reaction [A gene mutant form results in increased expression of PARP1 mRNA]; 9,10-Dimethyl-1,2-benzanthracene promotes the reaction [A gene mutant form results in increased expression of PARP1 protein]
9,10-Dimethyl-1,2-benzanthracene results in increased expression of PARP1 mRNA; 9,10-Dimethyl-1,2-benzanthracene results in increased expression of PARP1 protein 		CTD PMID:23969067 PMID:25448685 NCBI chr13:94,839,484...94,871,295
Ensembl chr13:94,839,433...94,871,567 		JBrowse link
G Pcca propionyl-CoA carboxylase subunit alpha decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of PCCA mRNA CTD PMID:32553695 NCBI chr15:106,034,586...106,374,908
Ensembl chr15:106,034,610...106,374,908 		JBrowse link
G Pcdh18 protocadherin 18 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of PCDH18 mRNA CTD PMID:32553695 NCBI chr 2:135,982,929...135,996,917
Ensembl chr 2:135,983,144...135,996,826 		JBrowse link
G Pcna proliferating cell nuclear antigen multiple interactions
increases expression 		ISO
EXP 		[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of PCNA mRNA; [9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of PCNA protein; [9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate] affects the expression of PCNA protein; [9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate] results in increased expression of PCNA mRNA; [9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate] results in increased expression of PCNA protein; [Glucaric Acid co-treated with Plant Extracts] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of PCNA mRNA]; [Resveratrol co-treated with Ellagic Acid] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of PCNA mRNA]; [Resveratrol co-treated with Plant Extracts] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of PCNA mRNA]; [sodium arsenite results in increased susceptibility to [9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate]] which results in increased expression of PCNA protein; beta-elemene inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate] results in increased expression of PCNA mRNA]; Cisplatin inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of PCNA mRNA]; Cisplatin inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of PCNA protein]; Cisplatin promotes the reaction [NPPC protein inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of PCNA mRNA]]; Cisplatin promotes the reaction [NPPC protein inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of PCNA protein]]; Eugenol inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate] results in increased expression of PCNA protein]; Masoprocol affects the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate] affects the expression of PCNA protein]; NPPC protein inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of PCNA mRNA]; NPPC protein inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of PCNA protein]; NPPC protein promotes the reaction [Cisplatin inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of PCNA mRNA]]; NPPC protein promotes the reaction [Cisplatin inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of PCNA protein]]; Tacrolimus affects the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate] affects the expression of PCNA protein]; Tacrolimus affects the reaction [Tacrolimus affects the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate] affects the expression of PCNA protein]]
9,10-Dimethyl-1,2-benzanthracene results in increased expression of PCNA protein
mithramycin A inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of PCNA protein]
9,10-Dimethyl-1,2-benzanthracene promotes the reaction [Estradiol results in increased expression of PCNA mRNA]; Plant Preparations inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene promotes the reaction [Estradiol results in increased expression of PCNA mRNA]]; Taurine inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of PCNA protein] 		CTD PMID:20043298 PMID:20103723 PMID:22248470 PMID:25770929 PMID:26945725 More... NCBI chr 3:139,951,948...139,955,820
Ensembl chr 3:139,951,941...139,955,901 		JBrowse link
G Pcp4 Purkinje cell protein 4 increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of PCP4 mRNA; 9,10-Dimethyl-1,2-benzanthracene results in increased expression of PCP4 protein CTD PMID:19480007 NCBI chr11:49,229,185...49,331,186
Ensembl chr11:49,270,186...49,331,186 		JBrowse link
G Pcsk6 proprotein convertase subtilisin/kexin type 6 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of PCSK6 mRNA CTD PMID:32553695 NCBI chr 1:128,839,742...129,038,087
Ensembl chr 1:128,839,232...129,052,128 		JBrowse link
G Pde1a phosphodiesterase 1A decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of PDE1A mRNA CTD PMID:32553695 NCBI chr 3:85,152,053...85,432,289
Ensembl chr 3:85,154,184...85,519,212 		JBrowse link
G Pde4dip phosphodiesterase 4D interacting protein decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of PDE4DIP mRNA CTD PMID:32553695 NCBI chr 2:187,982,002...188,178,937
Ensembl chr 2:187,981,878...188,178,869 		JBrowse link
G Pdgfa platelet derived growth factor subunit A increases expression
increases expression 		EXP
IEP 		9,10-Dimethyl-1,2-benzanthracene results in increased expression of PDGFA mRNA; 9,10-Dimethyl-1,2-benzanthracene results in increased expression of PDGFA protein
DMBA increases expression of Pdgfa mRNA and protein in rat mammary gland 		CTD
RGD		 PMID:12376462 PMID:12376462 RGD:2292404 NCBI chr12:20,759,366...20,780,337
Ensembl chr12:20,754,208...20,780,322 		JBrowse link
G Pdia3 protein disulfide isomerase family A, member 3 multiple interactions
increases expression 		EXP [9,10-Dimethyl-1,2-benzanthracene co-treated with Isoflavones] results in increased expression of PDIA3 protein
9,10-Dimethyl-1,2-benzanthracene results in increased expression of PDIA3 protein 		CTD PMID:22248470 NCBI chr 3:128,841,781...128,865,733
Ensembl chr 3:128,841,917...128,867,327 		JBrowse link
G Pdia4 protein disulfide isomerase family A, member 4 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of PDIA4 protein CTD PMID:39910959 NCBI chr 4:78,134,144...78,153,191
Ensembl chr 4:78,134,144...78,153,191 		JBrowse link
G Pdpk1 3-phosphoinositide dependent protein kinase-1 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of PDK mRNA CTD PMID:32553695 NCBI chr10:13,610,000...13,687,226
Ensembl chr10:13,610,063...13,679,181 		JBrowse link
G Pebp1 phosphatidylethanolamine binding protein 1 increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of PEBP1 mRNA CTD PMID:12376462 NCBI chr12:44,946,307...44,967,890
Ensembl chr12:44,963,675...44,971,780 		JBrowse link
G Penk proenkephalin decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of PENK mRNA CTD PMID:19480007 NCBI chr 5:21,981,381...21,987,074
Ensembl chr 5:21,981,382...21,986,705 		JBrowse link
G Pfdn4 prefoldin subunit 4 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of PFDN4 protein CTD PMID:39910959 NCBI chr 3:179,721,765...179,729,901
Ensembl chr 3:179,719,344...179,729,901 		JBrowse link
G Pfkm phosphofructokinase, muscle increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of PFKM mRNA CTD PMID:19502547 NCBI chr 7:131,100,684...131,138,250
Ensembl chr 7:131,100,753...131,138,248 		JBrowse link
G Pfn1 profilin 1 multiple interactions ISO [Dietary Fats co-treated with Dietary Sucrose co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased expression of PFN1 protein CTD PMID:39910959 NCBI chr10:55,863,882...55,866,587
Ensembl chr10:55,863,881...55,868,611 		JBrowse link
G Pfn3 profilin 3 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of PFN3 protein CTD PMID:39910959 NCBI chr17:9,222,729...9,223,256
Ensembl chr17:9,222,719...9,223,249 		JBrowse link
G Pgam1 phosphoglycerate mutase 1 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of PGAM1 protein CTD PMID:39910959 NCBI chr 1:250,673,152...250,680,762
Ensembl chr 1:250,673,049...250,690,203 		JBrowse link
G Pgd phosphogluconate dehydrogenase multiple interactions ISO [9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein] which results in increased expression of PGD mRNA CTD PMID:32553695 NCBI chr 5:164,865,830...164,882,029
Ensembl chr 5:164,865,830...164,882,029 		JBrowse link
G Pglyrp1 peptidoglycan recognition protein 1 affects expression ISO 9,10-Dimethyl-1,2-benzanthracene affects the expression of PGLYRP1 mRNA CTD PMID:21785161 NCBI chr 1:87,659,863...87,665,048
Ensembl chr 1:87,651,271...87,665,048 		JBrowse link
G Pgm2 phosphoglucomutase 2 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of PGM2 protein CTD PMID:39910959 NCBI chr14:44,519,906...44,553,420
Ensembl chr14:44,519,906...44,553,770 		JBrowse link
G Phb1 prohibitin 1 increases expression
increases expression 		EXP
IEP 		9,10-Dimethyl-1,2-benzanthracene results in increased expression of PHB1 mRNA; 9,10-Dimethyl-1,2-benzanthracene results in increased expression of PHB1 protein
DMBA increases expression of Phb1 mRNA and protein in rat mammary gland 		CTD
RGD		 PMID:12376462 PMID:12376462 RGD:2292404 NCBI chr10:81,102,043...81,114,815
Ensembl chr10:81,102,028...81,116,233 		JBrowse link
G Phex phosphate regulating endopeptidase X-linked increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of PHEX protein CTD PMID:20025956 NCBI chr  X:41,422,561...41,671,226
Ensembl chr  X:41,426,101...41,671,226 		JBrowse link
G Phlda1 pleckstrin homology-like domain, family A, member 1 increases expression
multiple interactions 		ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of PHLDA1 mRNA
[9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein] which results in increased expression of PHLDA1 mRNA 		CTD PMID:32553695 NCBI chr 7:48,853,690...48,855,894
Ensembl chr 7:48,853,260...48,857,542 		JBrowse link
G Phlda3 pleckstrin homology-like domain, family A, member 3 affects expression
multiple interactions
increases expression 		ISO 9,10-Dimethyl-1,2-benzanthracene affects the expression of PHLDA3 mRNA
[9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein] which results in increased expression of PHLDA3 mRNA
9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of PHLDA3 mRNA 		CTD PMID:21785161 PMID:32553695 NCBI chr13:49,745,003...49,748,088
Ensembl chr13:49,742,591...49,749,621 		JBrowse link
G Piga phosphatidylinositol glycan anchor biosynthesis, class A multiple interactions
increases mutagenesis 		EXP 9,10-Dimethyl-1,2-benzanthracene results in increased mutagenesis of and results in decreased activity of PIGA protein; [9,10-Dimethyl-1,2-benzanthracene results in increased mutagenesis of and results in decreased activity of PIGA protein] which affects the localization of CD59 protein; [9,10-Dimethyl-1,2-benzanthracene results in increased mutagenesis of PIGA gene] which results in decreased expression of CD59 protein
9,10-Dimethyl-1,2-benzanthracene results in increased mutagenesis of PIGA; 9,10-Dimethyl-1,2-benzanthracene results in increased mutagenesis of PIGA gene 		CTD PMID:19965957 PMID:20202993 PMID:22923490 NCBI chr  X:33,672,832...33,687,747
Ensembl chr  X:33,674,923...33,687,636 		JBrowse link
G Pik3r5 phosphoinositide-3-kinase, regulatory subunit 5 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of PIK3R5 protein CTD PMID:20025956 NCBI chr10:53,631,469...53,699,550
Ensembl chr10:53,631,476...53,699,539 		JBrowse link
G Pin1 peptidylprolyl cis/trans isomerase, NIMA-interacting 1 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of PIN1 protein CTD PMID:39910959 NCBI chr 8:27,465,538...27,477,016 JBrowse link
G Pitx1 paired-like homeodomain 1 increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of PITX1 mRNA CTD PMID:19480007 NCBI chr17:8,794,051...8,805,477
Ensembl chr17:8,799,319...8,805,476 		JBrowse link
G Plau plasminogen activator, urokinase increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of PLAU mRNA CTD PMID:21527772 NCBI chr15:3,505,485...3,511,987
Ensembl chr15:3,505,487...3,512,030 		JBrowse link
G Plg plasminogen decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of PLG protein CTD PMID:38307155 NCBI chr 1:50,872,927...50,915,406
Ensembl chr 1:50,872,926...50,917,320 		JBrowse link
G Plin1 perilipin 1 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of PLIN1 protein CTD PMID:39910959 NCBI chr 1:143,073,612...143,086,199
Ensembl chr 1:143,074,214...143,086,206 		JBrowse link
G Plk2 polo-like kinase 2 increases expression
increases expression 		EXP
IEP
ISO 		9,10-Dimethyl-1,2-benzanthracene results in increased expression of PLK2 mRNA
DMBA increases expression of Plk2 mRNA and protein in rat mammary gland
9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of PLK2 mRNA 		CTD
RGD		 PMID:12376462 PMID:32553695 PMID:12376462 RGD:2292404 NCBI chr 2:43,702,536...43,708,305
Ensembl chr 2:43,701,865...43,708,296 		JBrowse link
G Plxna2 plexin A2 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of PLXNA2 mRNA CTD PMID:32553695 NCBI chr13:108,683,155...108,888,336
Ensembl chr13:108,691,530...108,887,453 		JBrowse link
G Pnisr PNN interacting serine and arginine rich protein increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of PNISR mRNA CTD PMID:19480007 NCBI chr 5:40,190,214...40,219,619
Ensembl chr 5:40,192,735...40,219,611 		JBrowse link
G Pnp purine nucleoside phosphorylase decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of PNP protein CTD PMID:39910959 NCBI chr15:26,644,147...26,651,808
Ensembl chr15:26,643,858...26,678,162 		JBrowse link
G Pogz pogo transposable element derived with ZNF domain increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of POGZ protein CTD PMID:39910959 NCBI chr 2:185,069,492...185,129,741
Ensembl chr 2:185,084,826...185,129,739 		JBrowse link
G Polm DNA polymerase mu increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of POLM mRNA CTD PMID:19480007 NCBI chr14:84,921,039...84,930,649
Ensembl chr14:84,921,045...84,930,622 		JBrowse link
G Polr2a RNA polymerase II subunit A multiple interactions ISO [CYP1B1 protein affects the susceptibility to 9,10-Dimethyl-1,2-benzanthracene] which affects the expression of POLR2A mRNA CTD PMID:27891153 NCBI chr10:54,951,162...54,977,179
Ensembl chr10:54,951,162...54,977,179 		JBrowse link
G Pomc proopiomelanocortin multiple interactions EXP POMC protein promotes the reaction [CYP1B1 protein results in increased metabolism of 9,10-Dimethyl-1,2-benzanthracene] CTD PMID:7588239 NCBI chr 6:32,659,137...32,665,175
Ensembl chr 6:32,659,346...32,665,173 		JBrowse link
G Por cytochrome p450 oxidoreductase multiple interactions
decreases abundance 		ISO POR protein affects the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP1B1 protein]
POR protein results in decreased abundance of 9,10-Dimethyl-1,2-benzanthracene 		CTD PMID:22595614 NCBI chr12:26,587,674...26,655,612
Ensembl chr12:26,587,674...26,635,809 		JBrowse link
G Pparg peroxisome proliferator-activated receptor gamma multiple interactions ISO 9,10-Dimethyl-1,2-benzanthracene binds to and results in increased activity of PPARG protein CTD PMID:33049310 NCBI chr 4:150,095,743...150,221,104
Ensembl chr 4:150,095,787...150,221,104 		JBrowse link
G Ppfibp2 PPFIA binding protein 2 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of PPFIBP2 mRNA CTD PMID:32553695 NCBI chr 1:170,916,649...171,062,096
Ensembl chr 1:170,916,649...171,065,618 		JBrowse link
G Ppm1d protein phosphatase, Mg2+/Mn2+ dependent, 1D increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of PPM1D mRNA CTD PMID:32553695 NCBI chr10:70,670,026...70,706,030
Ensembl chr10:70,670,020...70,706,256 		JBrowse link
G Ppm1l protein phosphatase, Mg2+/Mn2+ dependent, 1L decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of PPM1L mRNA CTD PMID:32553695 NCBI chr 2:155,876,605...156,149,371
Ensembl chr 2:155,876,605...156,149,371 		JBrowse link
G Ppp1cb protein phosphatase 1 catalytic subunit beta affects expression ISO 9,10-Dimethyl-1,2-benzanthracene affects the expression of PPP1CB mRNA CTD PMID:21785161 NCBI chr 6:29,681,099...29,712,835
Ensembl chr 6:29,681,100...29,712,924 		JBrowse link
G Ppp1r3c protein phosphatase 1, regulatory subunit 3C decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of PPP1R3C mRNA CTD PMID:32553695 NCBI chr 1:243,873,524...243,878,527
Ensembl chr 1:243,871,704...243,878,835 		JBrowse link
G Ppp2ca protein phosphatase 2 catalytic subunit alpha decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of PPP2CA protein CTD PMID:39910959 NCBI chr10:36,856,534...36,878,789 JBrowse link
G Ppp2r1b protein phosphatase 2 scaffold subunit A beta decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of PPP2R1B mRNA CTD PMID:19502547 NCBI chr 8:60,092,540...60,125,512
Ensembl chr 8:60,081,553...60,125,795 		JBrowse link
G Ppp2r2b protein phosphatase 2, regulatory subunit B, beta increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of PPP2R2B mRNA CTD PMID:19480007 NCBI chr18:34,904,686...35,357,299
Ensembl chr18:34,904,686...35,356,977 		JBrowse link
G Prdm1 PR/SET domain 1 decreases expression
multiple interactions 		ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of PRDM1 mRNA; 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of PRDM1 mRNA
AHR protein affects the reaction [9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of PRDM1 mRNA]; alpha-naphthoflavone inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of PRDM1 mRNA] 		CTD PMID:20562217 NCBI chr20:49,542,465...49,564,088
Ensembl chr20:49,542,465...49,564,088 		JBrowse link
G Prdm6 PR/SET domain 6 decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of PRDM6 mRNA CTD PMID:19480007 NCBI chr18:49,102,290...49,206,763
Ensembl chr18:49,102,641...49,206,761 		JBrowse link
G Prdx2 peroxiredoxin 2 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of PRDX2 protein CTD PMID:20045496 NCBI chr19:40,085,788...40,091,083
Ensembl chr19:40,084,430...40,091,006 		JBrowse link
G Prkca protein kinase C, alpha multiple interactions
increases expression 		EXP Ghee inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of PRKCA mRNA] CTD PMID:21088903 NCBI chr10:93,388,991...93,787,617
Ensembl chr10:93,388,991...93,787,572 		JBrowse link
G Prkcb protein kinase C, beta multiple interactions ISO PRKCB protein inhibits the reaction [CYP1B1 protein results in increased metabolism of 9,10-Dimethyl-1,2-benzanthracene]; PRKCB protein inhibits the reaction [Tetrachlorodibenzodioxin promotes the reaction [CYP1B1 protein results in increased metabolism of 9,10-Dimethyl-1,2-benzanthracene]] CTD PMID:10037446 NCBI chr 1:186,263,397...186,594,743
Ensembl chr 1:186,263,447...186,594,740 		JBrowse link
G Prkce protein kinase C, epsilon decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of PRKCE mRNA CTD PMID:32553695 NCBI chr 6:13,718,050...14,204,931
Ensembl chr 6:13,718,050...14,204,288 		JBrowse link
G Prkdc protein kinase, DNA-activated, catalytic subunit multiple interactions
decreases expression
increases expression 		ISO 9,10-Dimethyl-1,2-benzanthracene inhibits the reaction [A gene mutant form results in decreased expression of PRKDC mRNA]
9,10-Dimethyl-1,2-benzanthracene results in decreased expression of PRKDC mRNA
9,10-Dimethyl-1,2-benzanthracene results in increased expression of PRKDC protein 		CTD PMID:25448685 NCBI chr11:98,544,952...98,762,499
Ensembl chr11:98,544,954...98,762,108 		JBrowse link
G Prl prolactin increases metabolic processing
increases secretion
multiple interactions 		EXP PRL protein results in increased metabolism of 9,10-Dimethyl-1,2-benzanthracene
9,10-Dimethyl-1,2-benzanthracene results in increased secretion of PRL protein
[9,10-Dimethyl-1,2-benzanthracene co-treated with Estradiol] results in increased secretion of PRL protein; [Estradiol co-treated with Progesterone co-treated with Hydrocortisone co-treated with PRL protein] affects the metabolism of 9,10-Dimethyl-1,2-benzanthracene 		CTD PMID:3141044 PMID:8674863 NCBI chr17:38,287,355...38,298,234
Ensembl chr17:38,288,162...38,298,217 		JBrowse link
G Procr protein C receptor increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of PROCR mRNA CTD PMID:21527772 NCBI chr 3:164,714,727...164,718,994
Ensembl chr 3:164,711,636...164,718,989 		JBrowse link
G Prr15 proline rich 15 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of PRR15 mRNA CTD PMID:32553695 NCBI chr 4:84,762,357...84,765,403
Ensembl chr 4:84,761,523...84,768,442 		JBrowse link
G Prss1 serine protease 1 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of PRSS1 protein CTD PMID:39910959 NCBI chr 4:71,331,249...71,334,452
Ensembl chr 4:71,331,246...71,334,452 		JBrowse link
G Psat1 phosphoserine aminotransferase 1 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of PSAT1 protein CTD PMID:38307155 NCBI chr 1:222,623,553...222,646,187
Ensembl chr 1:222,623,556...222,655,693 		JBrowse link
G Psgb1 pregnancy-specific beta 1-glycoprotein increases expression
multiple interactions 		EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of CEACAM5 protein
zingerone inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CEACAM5 protein] 		CTD PMID:31476248 NCBI chr 1:87,051,246...87,060,681
Ensembl chr 1:87,051,246...87,060,681 		JBrowse link
G Psmb1 proteasome 20S subunit beta 1 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of PSMB1 protein CTD PMID:39910959 NCBI chr 1:65,115,770...65,136,516
Ensembl chr 1:65,114,724...65,136,640 		JBrowse link
G Psme1 proteasome activator subunit 1 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of PSME1 protein CTD PMID:39910959 NCBI chr15:33,038,962...33,041,849
Ensembl chr15:33,038,597...33,041,848 		JBrowse link
G Psrc1 proline and serine rich coiled-coil 1 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of PSRC1 mRNA CTD PMID:32553695 NCBI chr 2:198,710,427...198,715,001
Ensembl chr 2:198,705,839...198,714,997 		JBrowse link
G Ptbp1 polypyrimidine tract binding protein 1 increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of PTBP1 mRNA CTD PMID:12376462 NCBI chr 7:10,493,199...10,502,957
Ensembl chr 7:10,493,200...10,502,957 		JBrowse link
G Ptger1 prostaglandin E receptor 1 multiple interactions
increases response to substance 		ISO celecoxib inhibits the reaction [PTGER1 results in increased susceptibility to 9,10-Dimethyl-1,2-benzanthracene]; PTGS2 gene mutant form inhibits the reaction [PTGER1 results in increased susceptibility to 9,10-Dimethyl-1,2-benzanthracene] CTD PMID:21739481 NCBI chr19:41,374,983...41,379,593
Ensembl chr19:41,374,471...41,378,284 		JBrowse link
G Ptgs2 prostaglandin-endoperoxide synthase 2 multiple interactions
increases expression 		ISO
EXP 		[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of PTGS2 mRNA; [9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of PTGS2 protein; [9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate] results in increased expression of PTGS2 protein; [9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein] which results in increased expression of PTGS2 mRNA; [epigallocatechin gallate co-treated with Polylactic Acid-Polyglycolic Acid Copolymer analog] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of PTGS2 mRNA]; [Resveratrol co-treated with Glucaric Acid] inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased expression of PTGS2 mRNA]; [Tetradecanoylphorbol Acetate co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased expression of PTGS2 mRNA; [Tetradecanoylphorbol Acetate co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased expression of PTGS2 protein; [theaflavin co-treated with Polylactic Acid-Polyglycolic Acid Copolymer analog] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of PTGS2 mRNA]; [Ursolic Acid co-treated with Glucaric Acid] inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased expression of PTGS2 mRNA]; amarogentin inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of PTGS2 protein]; beta-elemene inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate] results in increased expression of PTGS2 protein]; Cisplatin inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of PTGS2 mRNA]; Cisplatin inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of PTGS2 protein]; Cisplatin promotes the reaction [NPPC protein inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of PTGS2 mRNA]]; Cisplatin promotes the reaction [NPPC protein inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of PTGS2 protein]]; dieckol inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of PTGS2 mRNA]; Eugenol inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased expression of PTGS2 protein]; Glucaric Acid inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased expression of PTGS2 mRNA]; NPPC protein inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of PTGS2 mRNA]; NPPC protein inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of PTGS2 protein]; NPPC protein promotes the reaction [Cisplatin inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of PTGS2 mRNA]]; NPPC protein promotes the reaction [Cisplatin inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of PTGS2 protein]]; Plant Extracts inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of PTGS2 protein]; PTGS2 gene mutant form inhibits the reaction [PTGER1 results in increased susceptibility to 9,10-Dimethyl-1,2-benzanthracene]; Resveratrol inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased expression of PTGS2 mRNA]; theaflavin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of PTGS2 mRNA]; Ursolic Acid inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased expression of PTGS2 mRNA]
9,10-Dimethyl-1,2-benzanthracene results in increased expression of PTGS2 mRNA; 9,10-Dimethyl-1,2-benzanthracene results in increased expression of PTGS2 protein
9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of PTGS2 mRNA; 9,10-Dimethyl-1,2-benzanthracene results in increased expression of PTGS2 mRNA
[Estradiol co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased expression of PTGS2 protein; citronellol inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of PTGS2 protein]; Ghee inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of PTGS2 mRNA]; Resveratrol inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of PTGS2 protein]; tangeretin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of PTGS2 protein] 		CTD PMID:12208745 PMID:16517061 PMID:16891317 PMID:20043298 PMID:21623034 More... NCBI chr13:64,714,063...64,722,320
Ensembl chr13:64,713,619...64,722,320 		JBrowse link
G Ptms parathymosin affects expression ISO 9,10-Dimethyl-1,2-benzanthracene affects the expression of PTMS mRNA CTD PMID:21785161 NCBI chr 4:159,408,647...159,412,837
Ensembl chr 4:159,408,649...159,415,212 		JBrowse link
G Ptn pleiotrophin decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of PTN mRNA CTD PMID:32553695 NCBI chr 4:66,260,764...66,342,614
Ensembl chr 4:66,260,764...66,342,482 		JBrowse link
G Ptp4a1 protein tyrosine phosphatase 4A1 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of PTP4A1 mRNA CTD PMID:32553695 NCBI chr 9:40,710,250...40,718,176
Ensembl chr 9:40,710,250...40,718,176 		JBrowse link
G Ptpn13 protein tyrosine phosphatase, non-receptor type 13 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of PTPN13 mRNA CTD PMID:32553695 NCBI chr14:6,412,841...6,587,238
Ensembl chr14:6,412,841...6,587,171 		JBrowse link
G Ptpn22 protein tyrosine phosphatase, non-receptor type 22 increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of PTPN22 mRNA CTD PMID:19480007 NCBI chr 2:194,055,165...194,103,209
Ensembl chr 2:194,045,746...194,103,209 		JBrowse link
G Ptprcap protein tyrosine phosphatase, receptor type, C-associated protein increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of PTPRCAP mRNA CTD PMID:19480007 NCBI chr 1:210,878,593...210,880,752
Ensembl chr 1:210,878,573...210,881,753 		JBrowse link
G Ptprg protein tyrosine phosphatase, receptor type, G decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of PTPRG mRNA CTD PMID:32553695 NCBI chr15:15,298,669...15,982,581
Ensembl chr15:15,302,133...15,982,668 		JBrowse link
G Ptprm protein tyrosine phosphatase, receptor type, M decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of PTPRM mRNA CTD PMID:32553695 NCBI chr 9:114,086,380...114,791,000
Ensembl chr 9:114,086,380...114,790,477 		JBrowse link
G Ptx3 pentraxin 3 increases expression
multiple interactions 		ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of PTX3 mRNA
[9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein] which results in increased expression of PTX3 mRNA 		CTD PMID:32553695 NCBI chr 2:152,797,563...152,803,372
Ensembl chr 2:152,781,955...152,803,372 		JBrowse link
G Rab12 RAB12, member RAS oncogene family affects expression ISO 9,10-Dimethyl-1,2-benzanthracene affects the expression of RAB12 mRNA CTD PMID:21785161 NCBI chr 9:113,927,119...113,953,722
Ensembl chr 9:113,927,119...113,953,695 		JBrowse link
G Rabep2 rabaptin, RAB GTPase binding effector protein 2 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of RABEP2 protein CTD PMID:39910959 NCBI chr 1:190,433,501...190,457,241
Ensembl chr 1:190,440,462...190,457,238 		JBrowse link
G Rabgap1l RAB GTPase activating protein 1-like decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of RABGAP1L mRNA CTD PMID:32553695 NCBI chr13:74,997,542...75,593,240
Ensembl chr13:74,997,542...75,533,816 		JBrowse link
G Rad51 RAD51 recombinase increases expression
multiple interactions 		EXP
ISO 		9,10-Dimethyl-1,2-benzanthracene results in increased expression of RAD51 mRNA
A gene mutant form affects the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of RAD51 protein]; A gene mutant form inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of RAD51 mRNA]
9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of RAD51 mRNA; 9,10-Dimethyl-1,2-benzanthracene results in increased expression of RAD51 mRNA; 9,10-Dimethyl-1,2-benzanthracene results in increased expression of RAD51 protein 		CTD PMID:23969067 PMID:25448685 PMID:32553695 NCBI chr 3:126,554,210...126,578,888
Ensembl chr 3:126,554,190...126,579,469 		JBrowse link
G Rad51ap1 RAD51 associated protein 1 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of RAD51AP1 protein CTD PMID:20025956 NCBI chr 4:161,445,610...161,458,661
Ensembl chr 4:161,445,512...161,458,680 		JBrowse link
G Rad51b RAD51 paralog B decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of RAD51B mRNA CTD PMID:32553695 NCBI chr 6:103,829,390...104,373,923
Ensembl chr 6:103,829,554...104,374,509 		JBrowse link
G Raf1 Raf-1 proto-oncogene, serine/threonine kinase multiple interactions ISO [Tetradecanoylphorbol Acetate co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased expression of RAF1 protein; geraniol inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased expression of RAF1 protein] CTD PMID:22760862 NCBI chr 4:150,352,158...150,412,813
Ensembl chr 4:150,352,160...150,412,813 		JBrowse link
G Rag1 recombination activating 1 multiple interactions ISO [CYP1B1 protein affects the susceptibility to 9,10-Dimethyl-1,2-benzanthracene] which affects the expression of RAG1 mRNA CTD PMID:27891153 NCBI chr 3:108,372,087...108,383,184
Ensembl chr 3:108,371,978...108,383,261 		JBrowse link
G Ran RAN, member RAS oncogene family increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of RAN mRNA CTD PMID:12376462 NCBI chr12:33,311,155...33,314,339
Ensembl chr12:33,311,158...33,314,317 		JBrowse link
G Rarres2 retinoic acid receptor responder 2 decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of RARRES2 mRNA CTD PMID:19480007 NCBI chr 4:78,853,450...78,856,652
Ensembl chr 4:78,853,453...78,856,457 		JBrowse link
G Rb1 RB transcriptional corepressor 1 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of RB1 mRNA CTD PMID:32553695 NCBI chr15:54,780,858...54,911,989
Ensembl chr15:54,780,858...54,911,857 		JBrowse link
G Rbp1 retinol binding protein 1 increases expression
increases expression 		EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of RBP1 mRNA; 9,10-Dimethyl-1,2-benzanthracene results in increased expression of RBP1 protein
DMBA increases expression of Rbp1 mRNA and protein in rat mammary gland 		CTD
RGD		 PMID:12376462 PMID:12376462 RGD:2292404 NCBI chr 8:107,904,589...107,926,109
Ensembl chr 8:107,887,417...107,983,847 		JBrowse link
G Rbp4 retinol binding protein 4 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of RBP4 protein CTD PMID:38307155 NCBI chr 1:245,306,349...245,313,551
Ensembl chr 1:245,306,349...245,313,898 		JBrowse link
G Rel REL proto-oncogene, NF-kB subunit multiple interactions ISO 9,10-Dimethyl-1,2-benzanthracene inhibits the reaction [Lipopolysaccharides promotes the reaction [[REL protein binds to NFKB1 protein] which binds to IL6 promoter]] CTD PMID:14678569 NCBI chr14:101,891,238...101,922,324
Ensembl chr14:101,891,243...101,921,938 		JBrowse link
G Rela RELA proto-oncogene, NF-kB subunit multiple interactions
increases expression 		ISO
EXP 		9,10-Dimethyl-1,2-benzanthracene inhibits the reaction [Lipopolysaccharides promotes the reaction [[RELA protein binds to NFKB1 protein] which binds to IL6 promoter]]; [9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of RELA protein; [Tetradecanoylphorbol Acetate co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased expression of RELA protein; Cisplatin inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of RELA protein]; Cisplatin promotes the reaction [NPPC protein inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of RELA protein]]; Eugenol inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased expression of RELA protein]; NPPC protein inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of RELA protein]; NPPC protein promotes the reaction [Cisplatin inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of RELA protein]]
citronellol inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of RELA protein]; tangeretin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of RELA mRNA]; tangeretin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of RELA protein]
9,10-Dimethyl-1,2-benzanthracene results in increased expression of RELA mRNA; 9,10-Dimethyl-1,2-benzanthracene results in increased expression of RELA protein 		CTD PMID:14678569 PMID:20043298 PMID:24995432 PMID:31926054 PMID:37352108 NCBI chr 1:212,354,336...212,364,815
Ensembl chr 1:212,333,035...212,364,817 		JBrowse link
G Rerg RAS-like, estrogen-regulated, growth-inhibitor decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of RERG mRNA CTD PMID:19480007 NCBI chr 4:171,712,794...171,821,268
Ensembl chr 4:171,712,794...171,820,903 		JBrowse link
G Rhoa ras homolog family member A decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of RHOA protein CTD PMID:38307155 NCBI chr 8:117,870,548...117,904,303
Ensembl chr 8:117,870,270...117,904,302 		JBrowse link
G Ripply3 ripply transcriptional repressor 3 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of RIPPLY3 mRNA CTD PMID:21527772 NCBI chr11:47,118,147...47,126,244
Ensembl chr11:47,118,147...47,131,954 		JBrowse link
G Rnd1 Rho family GTPase 1 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of RND1 mRNA CTD PMID:32553695 NCBI chr 7:131,700,321...131,707,392
Ensembl chr 7:131,700,321...131,707,392 		JBrowse link
G Rnf213 ring finger protein 213 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of RNF213 mRNA CTD PMID:32553695 NCBI chr10:105,154,873...105,254,148
Ensembl chr10:105,157,904...105,254,148 		JBrowse link
G Rpl15 ribosomal protein L15 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of RPL15 protein CTD PMID:38307155 NCBI chr15:9,934,663...9,937,946
Ensembl chr15:9,934,679...9,938,308 		JBrowse link
G Rpl34 ribosomal protein L34 multiple interactions ISO [Dietary Fats co-treated with Dietary Sucrose co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in decreased expression of RPL34 protein CTD PMID:39910959 NCBI chr 2:221,958,551...221,962,309
Ensembl chr17:79,783,869...79,820,922
Ensembl chr 2:79,783,869...79,820,922 		JBrowse link
G Rpl37a ribosomal protein L37A increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of RPL37A protein CTD PMID:39910959 NCBI chr 9:81,748,091...81,750,174
Ensembl chr 9:81,748,103...81,751,975 		JBrowse link
G Rpl4 ribosomal protein L4 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of RPL4 protein CTD PMID:39910959 NCBI chr 8:73,566,477...73,571,600
Ensembl chr 8:73,566,466...73,571,788 		JBrowse link
G Rpl6 ribosomal protein L6 increases expression EXP
ISO 		9,10-Dimethyl-1,2-benzanthracene results in increased expression of RPL6 mRNA
9,10-Dimethyl-1,2-benzanthracene results in increased expression of RPL6 protein 		CTD PMID:12376462 PMID:38307155 NCBI chr12:41,008,142...41,012,756
Ensembl chr12:41,008,142...41,025,733 		JBrowse link
G Rpl8 ribosomal protein L8 decreases expression
multiple interactions 		ISO 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of RPL8 protein
[Dietary Fats co-treated with Dietary Sucrose co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in decreased expression of RPL8 protein 		CTD PMID:38307155 PMID:39910959 NCBI chr 7:110,506,815...110,509,106
Ensembl chr 7:110,506,800...110,509,103
Ensembl chr 3:110,506,800...110,509,103 		JBrowse link
G Rps12 ribosomal protein S12 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of RPS12 protein CTD PMID:39910959 NCBI chr 1:23,499,943...23,502,234
Ensembl chr 1:23,500,073...23,502,235 		JBrowse link
G Rps27a ribosomal protein S27a increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of RPS27A protein CTD PMID:39910959 NCBI chr14:107,486,664...107,488,941
Ensembl chr 5:138,465,088...138,466,080
Ensembl chr14:138,465,088...138,466,080
Ensembl chr 5:138,465,088...138,466,080 		JBrowse link
G Rps6 ribosomal protein S6 decreases expression
increases expression 		EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of RPS6 mRNA
9,10-Dimethyl-1,2-benzanthracene results in increased expression of RPS6 mRNA 		CTD PMID:12097258 NCBI chr 5:106,417,680...106,420,540
Ensembl chr 5:106,417,680...106,420,566 		JBrowse link
G Rpsa ribosomal protein SA increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of RPSA protein CTD PMID:22248470 NCBI chr 8:128,728,761...128,732,736
Ensembl chr 8:128,728,862...128,732,737 		JBrowse link
G Rrm2 ribonucleotide reductase regulatory subunit M2 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of RRM2 mRNA CTD PMID:32553695 NCBI chr 6:47,044,755...47,075,370
Ensembl chr 6:47,067,690...47,075,370 		JBrowse link
G Rrm2b ribonucleotide reductase regulatory TP53 inducible subunit M2B increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of RRM2B mRNA CTD PMID:21704725 NCBI chr 7:70,962,008...70,993,726
Ensembl chr 7:70,965,590...70,993,670 		JBrowse link
G S100a11 S100 calcium binding protein A11 multiple interactions ISO [Dietary Fats co-treated with Dietary Sucrose co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in decreased expression of S100A11 protein CTD PMID:39910959 NCBI chr 2:181,875,132...181,880,542
Ensembl chr 2:181,875,130...181,880,541 		JBrowse link
G S100a6 S100 calcium binding protein A6 multiple interactions ISO [Dietary Fats co-treated with Dietary Sucrose co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in decreased expression of S100A6 protein CTD PMID:39910959 NCBI chr 2:178,398,189...178,399,763
Ensembl chr 2:178,398,481...178,399,762 		JBrowse link
G S100a8 S100 calcium binding protein A8 affects expression
decreases expression
multiple interactions 		ISO
EXP 		9,10-Dimethyl-1,2-benzanthracene affects the expression of S100A8 mRNA
9,10-Dimethyl-1,2-benzanthracene results in decreased expression of S100A8 protein
[9,10-Dimethyl-1,2-benzanthracene co-treated with Isoflavones] results in increased expression of S100A8 protein 		CTD PMID:21785161 PMID:22248470 PMID:38307155 NCBI chr 2:178,464,095...178,465,223
Ensembl chr 2:178,464,702...178,465,221 		JBrowse link
G S100a9 S100 calcium binding protein A9 decreases expression
multiple interactions 		ISO 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of S100A9 protein
[Dietary Fats co-treated with Dietary Sucrose co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased expression of S100A9 protein 		CTD PMID:38307155 PMID:39910959 NCBI chr 2:178,487,941...178,490,622
Ensembl chr 2:178,487,941...178,490,870 		JBrowse link
G S1pr1 sphingosine-1-phosphate receptor 1 decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of S1PR1 mRNA CTD PMID:12376462 NCBI chr 2:206,309,715...206,314,070
Ensembl chr 2:205,900,836...206,328,689 		JBrowse link
G Sac3d1 SAC3 domain containing 1 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of SAC3D1 mRNA CTD PMID:32553695 NCBI chr 1:212,843,463...212,845,842
Ensembl chr 1:212,843,463...212,845,883 		JBrowse link
G Sacs sacsin molecular chaperone increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of SACS mRNA CTD PMID:32553695 NCBI chr15:39,461,853...39,546,419
Ensembl chr15:39,472,905...39,546,419 		JBrowse link
G Sarnp SAP domain containing ribonucleoprotein increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of SARNP protein CTD PMID:39910959 NCBI chr 7:1,835,597...1,889,833
Ensembl chr 7:1,835,597...1,897,295 		JBrowse link
G Scarb1 scavenger receptor class B, member 1 decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of SCARB1 mRNA CTD PMID:12376462 NCBI chr12:36,957,302...37,023,982
Ensembl chr12:36,957,496...37,023,980 		JBrowse link
G Scd stearoyl-CoA desaturase increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of SCD mRNA CTD PMID:12097258 PMID:12376462 NCBI chr 1:253,218,968...253,232,101
Ensembl chr 1:253,218,970...253,231,785 		JBrowse link
G Scfd2 sec1 family domain containing 2 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of SCFD2 mRNA CTD PMID:32553695 NCBI chr14:34,037,392...34,369,423
Ensembl chr14:34,037,430...34,363,436 		JBrowse link
G Scmh1 Scm polycomb group protein homolog 1 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of SCMH1 mRNA CTD PMID:32553695 NCBI chr 5:139,276,352...139,401,118
Ensembl chr 5:139,314,447...139,403,081 		JBrowse link
G Sdc4 syndecan 4 affects expression ISO 9,10-Dimethyl-1,2-benzanthracene affects the expression of SDC4 mRNA CTD PMID:21785161 NCBI chr 3:173,574,239...173,592,923
Ensembl chr 3:173,574,239...173,593,670 		JBrowse link
G Sdcbp syndecan binding protein affects expression ISO 9,10-Dimethyl-1,2-benzanthracene affects the expression of SDCBP mRNA CTD PMID:21785161 NCBI chr 5:24,245,279...24,314,712
Ensembl chr 5:24,245,033...24,326,197 		JBrowse link
G Sec23a Sec23 homolog A, COPII coat complex component affects expression ISO 9,10-Dimethyl-1,2-benzanthracene affects the expression of SEC23A mRNA CTD PMID:21785161 NCBI chr 6:82,393,699...82,442,594
Ensembl chr 6:82,394,863...82,440,904 		JBrowse link
G Selenop selenoprotein P decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of SELENOP mRNA CTD PMID:12376462 NCBI chr 2:54,225,736...54,236,022
Ensembl chr 2:54,225,152...54,236,019 		JBrowse link
G Septin2 septin 2 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of SEPTIN2 protein CTD PMID:39910959 NCBI chr 9:101,465,535...101,498,766
Ensembl chr 9:101,465,650...101,498,759 		JBrowse link
G Sf3b5 splicing factor 3b, subunit 5 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of SF3B5 protein CTD PMID:39910959 NCBI chr 1:9,177,189...9,177,901
Ensembl chr 1:9,177,098...9,177,900 		JBrowse link
G Sfn stratifin increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of SFN mRNA CTD PMID:21527772 NCBI chr 5:151,110,582...151,111,854
Ensembl chr 5:151,110,530...151,111,995 		JBrowse link
G Sfpq splicing factor proline and glutamine rich decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of SFPQ protein CTD PMID:38307155 NCBI chr 5:144,621,678...144,637,930
Ensembl chr 5:144,622,476...144,637,926 		JBrowse link
G Sfrp2 secreted frizzled-related protein 2 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of SFRP2 mRNA CTD PMID:32553695 NCBI chr 2:171,387,536...171,395,081
Ensembl chr 2:171,387,385...171,395,079 		JBrowse link
G Slc12a2 solute carrier family 12 member 2 increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of SLC12A2 mRNA CTD PMID:12376462 NCBI chr18:53,546,263...53,614,478
Ensembl chr18:53,546,333...53,614,470 		JBrowse link
G Slc13a3 solute carrier family 13 member 3 decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of SLC13A3 mRNA CTD PMID:19480007 NCBI chr 3:174,561,174...174,623,893
Ensembl chr 3:174,561,168...174,623,895 		JBrowse link
G Slc16a2 solute carrier family 16 member 2 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of SLC16A2 mRNA CTD PMID:32553695 NCBI chr  X:72,791,096...72,914,299
Ensembl chr  X:72,781,876...72,914,498 		JBrowse link
G Slc16a3 solute carrier family 16 member 3 increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of SLC16A3 mRNA CTD PMID:19480007 NCBI chr10:106,712,328...106,756,168
Ensembl chr10:106,714,466...106,720,903 		JBrowse link
G Slc19a2 solute carrier family 19 member 2 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of SLC19A2 mRNA CTD PMID:32553695 NCBI chr13:79,135,118...79,149,316
Ensembl chr13:79,135,059...79,149,315 		JBrowse link
G Slc1a3 solute carrier family 1 member 3 decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of SLC1A3 mRNA CTD PMID:19480007 NCBI chr 2:59,482,707...59,557,808
Ensembl chr 2:59,482,709...59,557,808 		JBrowse link
G Slc25a10 solute carrier family 25 member 10 decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of SLC25A10 mRNA CTD PMID:12376462 NCBI chr10:106,264,396...106,271,895
Ensembl chr10:106,264,344...106,273,498 		JBrowse link
G Slc38a4 solute carrier family 38, member 4 decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of SLC38A4 mRNA CTD PMID:19480007 NCBI chr 7:130,022,039...130,082,169
Ensembl chr 7:130,023,980...130,082,097 		JBrowse link
G Slc39a11 solute carrier family 39, member 11 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of SLC39A11 mRNA CTD PMID:32553695 NCBI chr10:98,775,155...99,196,302
Ensembl chr10:98,776,525...99,107,368 		JBrowse link
G Slc46a3 solute carrier family 46, member 3 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of SLC46A3 mRNA CTD PMID:32553695 NCBI chr12:12,176,776...12,193,256
Ensembl chr12:12,176,807...12,193,255 		JBrowse link
G Slc7a3 solute carrier family 7 member 3 increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of SLC7A3 mRNA CTD PMID:19480007 NCBI chr  X:70,250,089...70,256,610
Ensembl chr  X:70,250,099...70,256,059 		JBrowse link
G Slit2 slit guidance ligand 2 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of SLIT2 mRNA CTD PMID:32553695 NCBI chr14:66,829,661...67,168,517
Ensembl chr14:66,829,661...67,167,146 		JBrowse link
G Slit3 slit guidance ligand 3 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of SLIT3 mRNA CTD PMID:32553695 NCBI chr10:20,075,929...20,660,704
Ensembl chr10:20,076,021...20,660,704 		JBrowse link
G Smyd3 SET and MYND domain containing 3 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of SMYD3 mRNA CTD PMID:32553695 NCBI chr13:93,241,274...93,798,221
Ensembl chr13:93,241,279...93,798,237 		JBrowse link
G Snai1 snail family transcriptional repressor 1 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of SNAI1 mRNA; 9,10-Dimethyl-1,2-benzanthracene results in increased expression of SNAI1 protein CTD PMID:29663660 NCBI chr 3:176,667,476...176,671,965 JBrowse link
G Snrnp70 small nuclear ribonucleoprotein U1 subunit 70 affects expression ISO 9,10-Dimethyl-1,2-benzanthracene affects the expression of SNRNP70 mRNA CTD PMID:21785161 NCBI chr 1:104,992,518...105,012,851
Ensembl chr 1:104,992,442...105,012,851 		JBrowse link
G Snu13 small nuclear ribonucleoprotein 13 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of SNU13 protein CTD PMID:39910959 NCBI chr 7:115,445,415...115,451,008
Ensembl chr 1:269,702,002...269,703,004
Ensembl chr 7:269,702,002...269,703,004 		JBrowse link
G Snx20 sorting nexin 20 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of SNX20 mRNA CTD PMID:32553695 NCBI chr19:34,609,397...34,618,569
Ensembl chr19:34,609,412...34,618,567 		JBrowse link
G Sod1 superoxide dismutase 1 increases expression
multiple interactions
decreases activity 		EXP
ISO 		9,10-Dimethyl-1,2-benzanthracene results in increased expression of SOD1 mRNA
9,10-Dimethyl-1,2-benzanthracene results in increased expression of SOD1 protein
brucine inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased activity of SOD1 protein] 		CTD PMID:24576726 PMID:30027798 PMID:39910959 NCBI chr11:42,942,742...42,948,399
Ensembl chr11:42,942,678...42,948,399 		JBrowse link
G Sod2 superoxide dismutase 2 multiple interactions
increases expression 		ISO
EXP 		[[9,10-Dimethyl-1,2-benzanthracene co-treated with 12-O-tetradecanoylphorbol-1,3-acetate] results in increased activity of TRP53 protein] inhibits the reaction [SP1 protein binds to SOD2 promoter]; [[[9,10-Dimethyl-1,2-benzanthracene co-treated with 12-O-tetradecanoylphorbol-1,3-acetate] results in increased activity of TRP53 protein] inhibits the reaction [SP1 protein binds to SOD2 promoter]] which results in decreased expression of SOD2 mRNA
9,10-Dimethyl-1,2-benzanthracene results in increased expression of SOD2 mRNA
[9,10-Dimethyl-1,2-benzanthracene co-treated with 12-O-tetradecanoylphorbol-1,3-acetate] results in decreased expression of and results in decreased activity of SOD2 protein; [9,10-Dimethyl-1,2-benzanthracene co-treated with 12-O-tetradecanoylphorbol-1,3-acetate] results in decreased expression of SOD2 mRNA; SOD2 protein inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased abundance of 4-hydroxy-2-nonenal]; SOD2 protein results in decreased susceptibility to [Tetradecanoylphorbol Acetate co-treated with 9,10-Dimethyl-1,2-benzanthracene] 		CTD PMID:11507057 PMID:22009531 PMID:24576726 NCBI chr 1:50,043,323...50,050,168
Ensembl chr 1:50,043,325...50,050,168 		JBrowse link
G Sorbs2 sorbin and SH3 domain containing 2 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of SORBS2 mRNA CTD PMID:32553695 NCBI chr16:53,167,795...53,481,300
Ensembl chr16:53,167,827...53,358,986 		JBrowse link
G Sp1 Sp1 transcription factor multiple interactions
increases expression 		ISO
EXP 		[[9,10-Dimethyl-1,2-benzanthracene co-treated with 12-O-tetradecanoylphorbol-1,3-acetate] results in increased activity of TRP53 protein] inhibits the reaction [SP1 protein binds to SOD2 promoter]; [[[9,10-Dimethyl-1,2-benzanthracene co-treated with 12-O-tetradecanoylphorbol-1,3-acetate] results in increased activity of TRP53 protein] inhibits the reaction [SP1 protein binds to SOD2 promoter]] which results in decreased expression of SOD2 mRNA; SP1 protein affects the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CTNNB1 protein]
9,10-Dimethyl-1,2-benzanthracene results in increased expression of SP1 mRNA; 9,10-Dimethyl-1,2-benzanthracene results in increased expression of SP1 protein 		CTD PMID:22009531 PMID:29663660 PMID:36863560 NCBI chr 7:135,419,864...135,450,513
Ensembl chr 7:135,420,050...135,450,513 		JBrowse link
G Sp3 Sp3 transcription factor increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of SP3 mRNA CTD PMID:36863560 NCBI chr 3:78,219,421...78,272,318
Ensembl chr 3:78,219,426...78,264,517 		JBrowse link
G Sparcl1 SPARC like 1 decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of SPARCL1 mRNA CTD PMID:19480007 NCBI chr14:5,937,484...5,968,532
Ensembl chr14:5,914,535...5,969,120 		JBrowse link
G Spink5 serine peptidase inhibitor, Kazal type 5 increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of SPINK5 mRNA CTD PMID:19480007 NCBI chr18:36,515,347...36,584,038
Ensembl chr18:36,515,347...36,583,799 		JBrowse link
G Spp1 secreted phosphoprotein 1 increases expression
multiple interactions 		EXP
ISO 		9,10-Dimethyl-1,2-benzanthracene results in increased expression of SPP1 mRNA; 9,10-Dimethyl-1,2-benzanthracene results in increased expression of SPP1 protein
[9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein] which results in increased expression of SPP1 mRNA; [CYP1B1 protein affects the susceptibility to 9,10-Dimethyl-1,2-benzanthracene] which affects the expression of SPP1 mRNA 		CTD PMID:19480007 PMID:27891153 PMID:32553695 NCBI chr14:5,613,569...5,620,695
Ensembl chr14:5,613,576...5,619,820 		JBrowse link
G Srsf1 serine and arginine rich splicing factor 1 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of SRSF1 protein CTD PMID:39910959 NCBI chr10:73,335,519...73,342,549
Ensembl chr10:73,336,422...73,342,548 		JBrowse link
G Srsf4 serine and arginine rich splicing factor 4 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of SRSF4 protein CTD PMID:39910959 NCBI chr 5:149,345,538...149,373,309
Ensembl chr 5:149,345,422...149,374,609 		JBrowse link
G Srsf5 serine and arginine rich splicing factor 5 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of SRSF5 mRNA CTD PMID:21785161 NCBI chr 6:106,333,998...106,341,467
Ensembl chr 6:106,336,756...106,341,931 		JBrowse link
G Srsf6 serine and arginine rich splicing factor 6 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of SRSF6 protein CTD PMID:39910959 NCBI chr 3:172,009,072...172,014,395
Ensembl chr 3:172,009,061...172,014,392 		JBrowse link
G Stat4 signal transducer and activator of transcription 4 increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of STAT4 mRNA CTD PMID:19480007 NCBI chr 9:56,964,617...57,080,523
Ensembl chr 9:56,911,523...57,077,346 		JBrowse link
G Stat5a signal transducer and activator of transcription 5A increases expression
increases expression 		EXP
IEP 		9,10-Dimethyl-1,2-benzanthracene results in increased expression of STAT5A mRNA; 9,10-Dimethyl-1,2-benzanthracene results in increased expression of STAT5A protein
DMBA increases expression of Stat5a mRNA and protein in rat mammary gland 		CTD
RGD		 PMID:12376462 PMID:12376462 RGD:2292404 NCBI chr10:86,285,859...86,310,187
Ensembl chr10:86,285,547...86,310,184 		JBrowse link
G Stk3 serine/threonine kinase 3 affects expression ISO 9,10-Dimethyl-1,2-benzanthracene affects the expression of STK3 mRNA CTD PMID:21785161 NCBI chr 7:67,938,341...68,208,472
Ensembl chr 7:67,938,378...68,208,508 		JBrowse link
G Stmn1 stathmin 1 increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of STMN1 mRNA CTD PMID:12376462 NCBI chr 5:151,964,308...151,970,843
Ensembl chr 5:151,964,351...151,970,842 		JBrowse link
G Stmn3 stathmin 3 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of STMN3 mRNA CTD PMID:21527772 NCBI chr 3:188,794,358...188,802,494
Ensembl chr 3:188,794,358...188,802,873 		JBrowse link
G Sub1 SUB1 regulator of transcription decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of SUB1 protein CTD PMID:38307155 NCBI chr 2:62,735,379...62,747,545
Ensembl chr 2:62,732,736...62,747,679 		JBrowse link
G Sulf2 sulfatase 2 multiple interactions
increases expression 		ISO [9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein] which results in increased expression of SULF2 mRNA
9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of SULF2 mRNA 		CTD PMID:32553695 NCBI chr 3:175,241,322...175,323,808
Ensembl chr 3:175,241,322...175,323,651 		JBrowse link
G Sult1a1 sulfotransferase family 1A member 1 decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of SULT1A1 mRNA CTD PMID:19480007 NCBI chr 1:190,702,592...190,706,112
Ensembl chr 1:190,702,592...190,706,131 		JBrowse link
G Sumo3 small ubiquitin-like modifier 3 affects expression
increases expression 		ISO 9,10-Dimethyl-1,2-benzanthracene affects the expression of SUMO3 mRNA
9,10-Dimethyl-1,2-benzanthracene results in increased expression of SUMO3 protein 		CTD PMID:21785161 PMID:39910959 NCBI chr20:11,009,730...11,020,502
Ensembl chr20:11,009,734...11,020,287 		JBrowse link
G Synm synemin increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of SYNM protein CTD PMID:39910959 NCBI chr 1:130,743,891...130,774,254
Ensembl chr 1:130,743,897...130,773,824 		JBrowse link
G Taf15 TATA-box binding protein associated factor 15 affects expression ISO 9,10-Dimethyl-1,2-benzanthracene affects the expression of TAF15 mRNA CTD PMID:21785161 NCBI chr10:68,770,408...68,802,458
Ensembl chr10:68,770,430...68,802,458 		JBrowse link
G Taf9b TATA-box binding protein associated factor 9b increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of TAF9B mRNA CTD PMID:19480007 NCBI chr  X:75,354,823...75,366,166
Ensembl chr  X:75,354,825...75,366,414 		JBrowse link
G Tagln transgelin multiple interactions EXP [9,10-Dimethyl-1,2-benzanthracene co-treated with Isoflavones] results in increased expression of TAGLN protein CTD PMID:22248470 NCBI chr 8:55,121,647...55,127,121
Ensembl chr 8:55,121,301...55,127,563 		JBrowse link
G Tapbp TAP binding protein affects expression ISO 9,10-Dimethyl-1,2-benzanthracene affects the expression of TAPBP mRNA CTD PMID:21785161 NCBI chr20:4,958,821...4,967,958
Ensembl chr20:4,959,926...4,971,834 		JBrowse link
G Tardbp TAR DNA binding protein increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of TARDBP protein CTD PMID:28476168 NCBI chr 5:164,330,452...164,348,435
Ensembl chr 5:164,334,924...164,345,204 		JBrowse link
G Tbc1d2 TBC1 domain family, member 2 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of TBC1D2 mRNA CTD PMID:32553695 NCBI chr 5:65,679,670...65,727,978
Ensembl chr 5:65,679,680...65,726,996 		JBrowse link
G Tbc1d5 TBC1 domain family, member 5 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of TBC1D5 mRNA CTD PMID:32553695 NCBI chr 9:3,740,032...4,256,971
Ensembl chr 9:3,750,325...4,253,581 		JBrowse link
G Tbxas1 thromboxane A synthase 1 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of TBXAS1 mRNA CTD PMID:32553695 NCBI chr 4:68,631,841...68,803,959
Ensembl chr 4:68,631,838...68,803,969 		JBrowse link
G Tceal3 transcription elongation factor A like 3 multiple interactions ISO [Dietary Fats co-treated with Dietary Sucrose co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in decreased expression of TCEAL3 protein CTD PMID:39910959 NCBI chr  X:104,802,966...104,804,926
Ensembl chr  X:104,802,806...104,805,331 		JBrowse link
G Tenm4 teneurin transmembrane protein 4 affects expression ISO 9,10-Dimethyl-1,2-benzanthracene affects the expression of TENM4 mRNA CTD PMID:21785161 NCBI chr 1:157,699,611...160,674,549
Ensembl chr 1:159,974,017...160,674,549 		JBrowse link
G Tesc tescalcin decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of TESC mRNA CTD PMID:19480007 NCBI chr12:44,182,741...44,216,574
Ensembl chr12:44,181,659...44,216,722 		JBrowse link
G Tfam transcription factor A, mitochondrial decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of TFAM protein CTD PMID:38307155 NCBI chr20:17,355,373...17,367,422
Ensembl chr20:17,355,363...17,369,877 		JBrowse link
G Tfrc transferrin receptor increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of TFRC protein CTD PMID:20025956 NCBI chr11:81,668,478...81,690,318
Ensembl chr11:81,668,478...81,690,318 		JBrowse link
G Tgfb1 transforming growth factor, beta 1 increases expression
multiple interactions 		ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of TGFB1 mRNA
dieckol inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of TGFB1 mRNA] 		CTD PMID:33347706 NCBI chr 1:90,324,312...90,340,627
Ensembl chr 1:90,324,046...90,340,899 		JBrowse link
G Thbs2 thrombospondin 2 decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of THBS2 mRNA CTD PMID:19480007 NCBI chr 1:64,343,523...64,372,918
Ensembl chr 1:64,343,523...64,372,918 		JBrowse link
G Timp1 TIMP metallopeptidase inhibitor 1 decreases expression
multiple interactions 		EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of TIMP1 mRNA
[9,10-Dimethyl-1,2-benzanthracene co-treated with Raloxifene Hydrochloride co-treated with Fluoxetine] affects the expression of TIMP1 protein 		CTD PMID:12097258 PMID:31332895 NCBI chr  X:3,766,509...3,772,578
Ensembl chr  X:3,766,510...3,771,135 		JBrowse link
G Tiparp TCDD-inducible poly(ADP-ribose) polymerase increases expression
multiple interactions 		ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of TIPARP mRNA
[9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein] which results in increased expression of TIPARP mRNA 		CTD PMID:32553695 NCBI chr 2:152,063,769...152,090,414
Ensembl chr 2:152,063,751...152,090,406 		JBrowse link
G Tkt transketolase decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of TKT mRNA CTD PMID:12376462 NCBI chr16:5,729,381...5,755,170
Ensembl chr16:5,729,991...5,756,431 		JBrowse link
G Tle4 TLE family member 4, transcriptional corepressor increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of TLE4 mRNA CTD PMID:12376462 NCBI chr 1:221,086,250...221,222,826
Ensembl chr 1:221,086,253...221,222,826 		JBrowse link
G Tln2 talin 2 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of TLN2 mRNA CTD PMID:32553695 NCBI chr 8:76,712,112...77,133,361
Ensembl chr 8:76,712,112...77,133,361 		JBrowse link
G Tmeff2 transmembrane protein with EGF-like and two follistatin-like domains 2 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of TMEFF2 mRNA CTD PMID:32553695 NCBI chr 9:57,937,873...58,225,372
Ensembl chr 9:57,937,873...58,225,372 		JBrowse link
G Tmem132c transmembrane protein 132C decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of TMEM132C mRNA CTD PMID:19480007 NCBI chr12:34,752,362...35,073,821
Ensembl chr12:34,751,807...35,073,903 		JBrowse link
G Tmem37 transmembrane protein 37 increases methylation
multiple interactions 		EXP 9,10-Dimethyl-1,2-benzanthracene results in increased methylation of TMEM37 promoter
[9,10-Dimethyl-1,2-benzanthracene results in increased methylation of TMEM37 promoter] which results in decreased expression of TMEM37 mRNA 		CTD PMID:21489049 NCBI chr13:33,737,096...33,743,602
Ensembl chr13:33,736,308...33,743,747 		JBrowse link
G Tmpo thymopoietin multiple interactions
increases expression 		EXP
ISO 		[9,10-Dimethyl-1,2-benzanthracene co-treated with Isoflavones] results in increased expression of TMPO protein
9,10-Dimethyl-1,2-benzanthracene results in increased expression of TMPO protein 		CTD PMID:22248470 PMID:39910959 NCBI chr 7:27,529,977...27,554,980
Ensembl chr 7:27,529,978...27,554,937 		JBrowse link
G Tmprss6 transmembrane serine protease 6 decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of TMPRSS6 mRNA CTD PMID:19480007 NCBI chr 7:111,871,504...111,902,127
Ensembl chr 7:111,871,031...111,902,116 		JBrowse link
G Tnf tumor necrosis factor multiple interactions
increases expression 		ISO
EXP 		[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of TNF mRNA; [9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate] results in increased expression of TNF protein; [CYP1B1 protein affects the susceptibility to 9,10-Dimethyl-1,2-benzanthracene] which affects the expression of TNF mRNA; [Tetradecanoylphorbol Acetate co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased secretion of TNF protein; beta-elemene inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate] results in increased expression of TNF protein]; Cisplatin inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of TNF mRNA]; Cisplatin promotes the reaction [NPPC protein inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of TNF mRNA]]; dieckol inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of TNF mRNA]; dieckol inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of TNF protein]; Eugenol inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased secretion of TNF protein]; NPPC protein inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of TNF mRNA]; NPPC protein promotes the reaction [Cisplatin inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of TNF mRNA]]
9,10-Dimethyl-1,2-benzanthracene results in increased expression of TNF mRNA; 9,10-Dimethyl-1,2-benzanthracene results in increased expression of TNF protein
citronellol inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of TNF protein]; tangeretin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of TNF mRNA]; tangeretin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of TNF protein] 		CTD PMID:20043298 PMID:24995432 PMID:27891153 PMID:31926054 PMID:32662567 More... NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,626,532...3,629,303 		JBrowse link
G Tnfaip3 TNF alpha induced protein 3 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of TNFAIP3 mRNA CTD PMID:32553695 NCBI chr 1:15,528,921...15,543,993
Ensembl chr 1:15,528,921...15,543,979 		JBrowse link
G Tnfrsf14 TNF receptor superfamily member 14 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of TNFRSF14 mRNA CTD PMID:21527772 NCBI chr 5:170,768,413...170,776,749
Ensembl chr 5:170,768,416...170,776,046 		JBrowse link
G Tnfsf9 TNF superfamily member 9 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of TNFSF9 mRNA CTD PMID:21527772 NCBI chr 9:2,031,011...2,033,345
Ensembl chr 9:2,030,953...2,033,339 		JBrowse link
G Tnmd tenomodulin decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of TNMD mRNA CTD PMID:32553695 NCBI chr  X:101,350,432...101,365,929
Ensembl chr  X:101,350,269...101,365,929 		JBrowse link
G Tp53 tumor protein p53 multiple interactions
increases phosphorylation
decreases expression
increases expression
increases activity 		ISO
EXP 		[9,10-Dimethyl-1,2-benzanthracene co-treated with 12-O-tetradecanoylphorbol-1,3-acetate] results in increased activity of TRP53 protein; [Butyric Acid co-treated with Niacinamide co-treated with Glucaric Acid] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of TRP53 mRNA alternative form]; [Butyric Acid co-treated with Niacinamide co-treated with Glucaric Acid] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of TRP53 protein]; [epigallocatechin gallate co-treated with Polylactic Acid-Polyglycolic Acid Copolymer analog] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of TRP53 mRNA]; [theaflavin co-treated with Polylactic Acid-Polyglycolic Acid Copolymer analog] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of TRP53 mRNA]; alpha-naphthoflavone inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased phosphorylation of TRP53 protein]; Butyric Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of TRP53 mRNA alternative form]; Butyric Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of TRP53 protein]; CYP1B1 protein affects the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased phosphorylation of TRP53 protein]; dieckol inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of TRP53 mRNA]; epigallocatechin gallate inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of TRP53 mRNA]; Eugenol promotes the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of TRP53 protein]; Glucaric Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of TRP53 mRNA alternative form]; Glucaric Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of TRP53 protein]; Niacinamide inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of TRP53 mRNA alternative form]; Niacinamide inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of TRP53 protein]; pifithrin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased phosphorylation of TRP53 protein]; pyrene inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased phosphorylation of TRP53 protein]; theaflavin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of TRP53 mRNA]
1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of TP53 protein]; 1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt promotes the reaction [Doxorubicin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of TP53 protein]]; [Ruthenium binds to Phloretin] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of TP53 protein]; Doxorubicin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of TP53 protein]; Doxorubicin promotes the reaction [1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of TP53 protein]]; Taurine inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of TRP53 mRNA]; Taurine inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of TRP53 protein]
9,10-Dimethyl-1,2-benzanthracene results in decreased expression of TP53 mRNA; 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of TP53 protein; 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of TRP53 mRNA; 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of TRP53 protein
9,10-Dimethyl-1,2-benzanthracene results in increased expression of TP53 mRNA
9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of TRP53 protein modified form; 9,10-Dimethyl-1,2-benzanthracene results in increased expression of TRP53 mRNA; 9,10-Dimethyl-1,2-benzanthracene results in increased expression of TRP53 mRNA alternative form; 9,10-Dimethyl-1,2-benzanthracene results in increased expression of TRP53 protein
9,10-Dimethyl-1,2-benzanthracene results in increased activity of TP53 protein
2,4,3',5'-tetramethoxystilbene inhibits the reaction [[CYP1B1 protein results in increased metabolism of 9,10-Dimethyl-1,2-benzanthracene] which results in increased expression of TP53 protein modified form]; [[9,10-Dimethyl-1,2-benzanthracene co-treated with 12-O-tetradecanoylphorbol-1,3-acetate] results in increased activity of TRP53 protein] inhibits the reaction [SP1 protein binds to SOD2 promoter]; [[[9,10-Dimethyl-1,2-benzanthracene co-treated with 12-O-tetradecanoylphorbol-1,3-acetate] results in increased activity of TRP53 protein] inhibits the reaction [SP1 protein binds to SOD2 promoter]] which results in decreased expression of SOD2 mRNA; [CYP1A1 protein results in increased metabolism of 9,10-Dimethyl-1,2-benzanthracene] which results in increased expression of TP53 protein modified form; [CYP1B1 protein results in increased metabolism of 9,10-Dimethyl-1,2-benzanthracene] which results in increased expression of TP53 protein modified form; alpha-naphthoflavone inhibits the reaction [[CYP1B1 protein results in increased metabolism of 9,10-Dimethyl-1,2-benzanthracene] which results in increased expression of TP53 protein modified form] 		CTD PMID:12734332 PMID:20043298 PMID:20655369 PMID:22009531 PMID:23717041 More... NCBI chr10:54,798,871...54,810,300
Ensembl chr10:54,798,851...54,810,299 		JBrowse link
G Tp53inp1 tumor protein p53 inducible nuclear protein 1 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of TRP53INP1 mRNA CTD PMID:32553695 NCBI chr 5:29,051,267...29,069,486
Ensembl chr 5:29,051,264...29,069,484 		JBrowse link
G Tpm3 tropomyosin 3 increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of TPM3 mRNA CTD PMID:12376462 NCBI chr 2:177,812,534...177,842,661
Ensembl chr 2:177,814,883...177,842,660 		JBrowse link
G Tppp3 tubulin polymerization-promoting protein family member 3 decreases expression
multiple interactions 		EXP
ISO 		9,10-Dimethyl-1,2-benzanthracene results in decreased expression of TPPP3 mRNA
[Dietary Fats co-treated with Dietary Sucrose co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in decreased expression of TPPP3 protein 		CTD PMID:19480007 PMID:39910959 NCBI chr19:50,255,809...50,259,655
Ensembl chr19:50,255,810...50,259,489 		JBrowse link
G Tra2b transformer 2 beta increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of TRA2B protein CTD PMID:38307155 NCBI chr11:92,293,403...92,311,651
Ensembl chr11:92,293,410...92,311,781 		JBrowse link
G Trib3 tribbles pseudokinase 3 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of TRIB3 mRNA CTD PMID:32553695 NCBI chr 3:161,269,939...161,275,533
Ensembl chr 3:161,269,955...161,274,802 		JBrowse link
G Trit1 tRNA isopentenyltransferase 1 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of TRIT1 protein CTD PMID:39910959 NCBI chr 5:140,578,459...140,623,881
Ensembl chr 5:140,580,453...140,623,881 		JBrowse link
G Trpc6 transient receptor potential cation channel, subfamily C, member 6 increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of TRPC6 mRNA CTD PMID:19480007 NCBI chr 8:14,044,216...14,148,808
Ensembl chr 8:14,043,877...14,149,304 		JBrowse link
G Tsc22d1 TSC22 domain family, member 1 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of TSC22D1 protein CTD PMID:39910959 NCBI chr15:58,159,612...58,260,244
Ensembl chr15:58,159,952...58,183,322 		JBrowse link
G Tslp thymic stromal lymphopoietin increases expression
multiple interactions 		ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of TSLP
AHR mRNA promotes the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of TSLP] 		CTD PMID:27869817 NCBI chr18:24,723,990...24,728,419
Ensembl chr18:24,720,257...24,728,420 		JBrowse link
G Tspan8 tetraspanin 8 affects expression ISO 9,10-Dimethyl-1,2-benzanthracene affects the expression of TSPAN8 mRNA CTD PMID:21785161 NCBI chr 7:53,331,019...53,365,402
Ensembl chr 7:53,330,963...53,365,401 		JBrowse link
G Tspo translocator protein multiple interactions EXP 9,10-Dimethyl-1,2-benzanthracene inhibits the reaction [PK 11195 binds to TSPO protein] CTD PMID:21037200 NCBI chr 7:116,600,214...116,610,461
Ensembl chr 7:116,600,210...116,610,460 		JBrowse link
G Tst thiosulfate sulfurtransferase multiple interactions ISO [Dietary Fats co-treated with Dietary Sucrose co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased expression of TST protein CTD PMID:39910959 NCBI chr 7:111,828,557...111,836,980
Ensembl chr 7:111,828,558...111,837,116 		JBrowse link
G Ttc27 tetratricopeptide repeat domain 27 affects expression ISO 9,10-Dimethyl-1,2-benzanthracene affects the expression of TTC27 mRNA CTD PMID:21785161 NCBI chr 6:26,310,696...26,454,045
Ensembl chr 6:25,781,638...26,454,036 		JBrowse link
G Tuba1b tubulin, alpha 1B multiple interactions ISO [Dietary Fats co-treated with Dietary Sucrose co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased expression of TUBA1B protein CTD PMID:39910959 NCBI chr 7:131,969,606...131,972,587
Ensembl chr 7:131,968,770...131,996,035 		JBrowse link
G Tuba4a tubulin, alpha 4A increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of TUBA4A mRNA CTD PMID:21527772 NCBI chr 9:84,158,871...84,174,041
Ensembl chr 9:84,158,280...84,162,584 		JBrowse link
G Tubb2b tubulin, beta 2B class IIb increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of TUBB2B mRNA CTD PMID:12376462 NCBI chr17:30,953,086...30,956,133
Ensembl chr17:30,952,923...30,955,990 		JBrowse link
G Tubb4b tubulin, beta 4B class IVb multiple interactions EXP [9,10-Dimethyl-1,2-benzanthracene co-treated with Isoflavones] results in increased expression of TUBB4B protein CTD PMID:22248470 NCBI chr 3:28,435,999...28,438,455
Ensembl chr 3:28,435,148...28,439,719 		JBrowse link
G Twist1 twist family bHLH transcription factor 1 multiple interactions
increases expression 		ISO mithramycin A inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of TWIST1 protein]
9,10-Dimethyl-1,2-benzanthracene results in increased expression of TWIST1 mRNA; 9,10-Dimethyl-1,2-benzanthracene results in increased expression of TWIST1 protein 		CTD PMID:29663660 NCBI chr 6:56,402,309...56,404,303
Ensembl chr 6:56,398,061...56,404,965 		JBrowse link
G Txn1 thioredoxin 1 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of TXN protein CTD PMID:39910959 NCBI chr 5:77,507,455...77,519,685
Ensembl chr 5:77,507,321...77,520,307 		JBrowse link
G Txnip thioredoxin interacting protein increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of TXNIP mRNA CTD PMID:32553695 NCBI chr 2:186,781,933...186,785,736
Ensembl chr 2:186,781,163...186,785,731 		JBrowse link
G Tyr tyrosinase multiple interactions ISO [9,10-Dimethyl-1,2-benzanthracene co-treated with [Tetradecanoylphorbol Acetate co-treated with argemone oil]] results in decreased activity of TYR protein; [9,10-Dimethyl-1,2-benzanthracene co-treated with [Tetradecanoylphorbol Acetate co-treated with sanguinarine]] results in decreased activity of TYR protein; [9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate] results in decreased activity of TYR protein; [[9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate] co-treated with argemone oil] results in decreased activity of TYR protein; [[9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate] co-treated with sanguinarine] results in decreased activity of TYR protein CTD PMID:20691676 NCBI chr 1:150,527,687...150,622,857
Ensembl chr 1:150,527,687...150,622,857 		JBrowse link
G Tyrobp transmembrane immune signaling adaptor Tyrobp decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of TYROBP mRNA CTD PMID:32553695 NCBI chr 1:94,800,372...94,804,307
Ensembl chr 1:94,800,117...94,804,299 		JBrowse link
G Uba1 ubiquitin-like modifier activating enzyme 1 multiple interactions ISO [Dietary Fats co-treated with Dietary Sucrose co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased expression of UBA1 protein CTD PMID:39910959 NCBI chr  X:4,062,216...4,084,192
Ensembl chr  X:4,062,182...4,084,246 		JBrowse link
G Ubap2l ubiquitin associated protein 2-like increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of UBAP2L protein CTD PMID:39910959 NCBI chr 2:177,736,378...177,791,746
Ensembl chr 2:177,736,696...177,791,646 		JBrowse link
G Ubd ubiquitin D increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of UBD mRNA CTD PMID:19480007 NCBI chr20:1,390,734...1,392,685
Ensembl chr20:1,390,600...1,413,965 		JBrowse link
G Ube2c ubiquitin-conjugating enzyme E2C increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of UBE2C mRNA CTD PMID:32553695 NCBI chr 3:173,925,975...173,928,375
Ensembl chr 3:173,925,934...173,932,678 		JBrowse link
G Ube2g1 ubiquitin-conjugating enzyme E2G 1 affects expression ISO 9,10-Dimethyl-1,2-benzanthracene affects the expression of UBE2G1 mRNA CTD PMID:21785161 NCBI chr10:57,723,660...57,805,284
Ensembl chr10:57,724,485...57,807,853 		JBrowse link
G Ube2l3 ubiquitin-conjugating enzyme E2L 3 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of UBE2L3 protein CTD PMID:38307155 NCBI chr11:97,300,584...97,343,084
Ensembl chr11:97,301,945...97,343,084 		JBrowse link
G Ube2n ubiquitin-conjugating enzyme E2N decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of UBE2N protein CTD PMID:38307155 PMID:39910959 NCBI chr 7:32,041,190...32,071,252 JBrowse link
G Uchl1 ubiquitin C-terminal hydrolase L1 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of UCHL1 protein CTD PMID:39910959 NCBI chr14:41,838,859...41,849,743
Ensembl chr14:41,838,861...41,849,417 		JBrowse link
G Ust uronyl-2-sulfotransferase decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of UST mRNA CTD PMID:32553695 NCBI chr 1:4,487,316...4,782,579
Ensembl chr 1:4,489,925...4,782,356 		JBrowse link
G Vapb VAMP associated protein B and C affects expression ISO 9,10-Dimethyl-1,2-benzanthracene affects the expression of VAPB mRNA CTD PMID:21785161 NCBI chr 3:182,954,247...182,997,018
Ensembl chr 3:182,954,240...183,028,619 		JBrowse link
G Vcan versican increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of VCAN protein CTD PMID:39910959 NCBI chr 2:22,497,035...22,595,955
Ensembl chr 2:22,497,035...22,595,955 		JBrowse link
G Vcp valosin-containing protein multiple interactions
increases expression 		EXP [9,10-Dimethyl-1,2-benzanthracene co-treated with Isoflavones] results in increased expression of VCP protein
9,10-Dimethyl-1,2-benzanthracene results in increased expression of VCP protein 		CTD PMID:22248470 NCBI chr 5:62,005,984...62,025,387
Ensembl chr 5:62,005,985...62,025,387 		JBrowse link
G Vegfa vascular endothelial growth factor A increases expression
multiple interactions 		ISO
EXP 		9,10-Dimethyl-1,2-benzanthracene results in increased expression of VEGFA protein
[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of VEGFA mRNA; Cisplatin inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of VEGFA mRNA]; Cisplatin promotes the reaction [NPPC protein inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of VEGFA mRNA]]; NPPC protein inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of VEGFA mRNA]; NPPC protein promotes the reaction [Cisplatin inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of VEGFA mRNA]]
[9,10-Dimethyl-1,2-benzanthracene co-treated with Raloxifene Hydrochloride co-treated with Fluoxetine] affects the expression of VEGFA protein
9,10-Dimethyl-1,2-benzanthracene results in increased expression of VEGFA mRNA 		CTD PMID:19480007 PMID:19502547 PMID:31332895 PMID:37352108 NCBI chr 9:22,452,854...22,468,194
Ensembl chr 9:22,439,392...22,468,194 		JBrowse link
G Vim vimentin increases expression
multiple interactions 		ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of VIM mRNA; 9,10-Dimethyl-1,2-benzanthracene results in increased expression of VIM protein
[sodium arsenite results in increased susceptibility to [9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate]] which results in increased expression of VIM protein 		CTD PMID:29663660 PMID:35364107 PMID:38307155 NCBI chr17:81,577,261...81,585,746
Ensembl chr17:81,568,272...81,585,746 		JBrowse link
G Vldlr very low density lipoprotein receptor increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of VLDLR mRNA CTD PMID:32553695 NCBI chr 1:234,239,769...234,272,150
Ensembl chr 1:234,240,121...234,272,154 		JBrowse link
G Vps13b vacuolar protein sorting 13 homolog B decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of VPS13B mRNA CTD PMID:32553695 NCBI chr 7:68,436,996...69,013,574
Ensembl chr 7:68,443,655...69,013,574 		JBrowse link
G Vsnl1 visinin-like 1 multiple interactions ISO VSNL1 protein results in decreased susceptibility to [9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate] CTD PMID:20419170 NCBI chr 6:39,757,721...39,878,556
Ensembl chr 6:39,757,722...39,878,556 		JBrowse link
G Vti1a vesicle transport through interaction with t-SNAREs 1A decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of VTI1A mRNA CTD PMID:32553695 NCBI chr 1:264,361,538...264,667,171
Ensembl chr 1:264,361,522...264,668,727 		JBrowse link
G Vtn vitronectin multiple interactions
increases expression 		ISO [Dietary Fats co-treated with Dietary Sucrose co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased expression of VTN protein
9,10-Dimethyl-1,2-benzanthracene results in increased expression of VTN protein 		CTD PMID:39910959 NCBI chr10:63,892,782...63,895,862
Ensembl chr10:63,892,766...63,895,860 		JBrowse link
G Vwf von Willebrand factor increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of VWF mRNA CTD PMID:19480007 NCBI chr 4:160,042,900...160,177,757
Ensembl chr 4:160,047,982...160,177,757 		JBrowse link
G Wdr1 WD repeat domain 1 increases expression
multiple interactions 		EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of WDR1 protein
[9,10-Dimethyl-1,2-benzanthracene co-treated with Isoflavones] results in increased expression of WDR1 protein 		CTD PMID:22248470 NCBI chr14:76,470,238...76,504,086
Ensembl chr14:76,470,176...76,504,080 		JBrowse link
G Xdh xanthine dehydrogenase decreases expression
increases expression 		EXP
ISO 		9,10-Dimethyl-1,2-benzanthracene results in decreased expression of XDH mRNA
9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of XDH mRNA 		CTD PMID:12376462 PMID:32553695 NCBI chr 6:27,282,319...27,344,022
Ensembl chr 6:27,282,057...27,344,350 		JBrowse link
G Xist X inactive specific transcript affects expression ISO 9,10-Dimethyl-1,2-benzanthracene affects the expression of XIST mRNA CTD PMID:21785161 NCBI chr  X:72,540,753...72,558,266 JBrowse link
G Xpa XPA, DNA damage recognition and repair factor affects response to substance ISO XPA protein affects the susceptibility to 9,10-Dimethyl-1,2-benzanthracene CTD PMID:10755388 NCBI chr 5:65,227,281...65,275,784
Ensembl chr 5:65,227,281...65,272,425 		JBrowse link
G Xpnpep1 X-prolyl aminopeptidase 1 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of XPNPEP1 protein CTD PMID:39910959 NCBI chr 1:262,006,761...262,057,479
Ensembl chr 1:262,006,761...262,092,425 		JBrowse link
G Xrcc1 X-ray repair cross complementing 1 decreases expression
multiple interactions 		ISO 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of XRCC1 mRNA
[epigallocatechin gallate co-treated with polylactic acid-polyglycolic acid copolymer analog] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of XRCC1 mRNA]; [theaflavin co-treated with polylactic acid-polyglycolic acid copolymer analog] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of XRCC1 mRNA]; epigallocatechin gallate inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of XRCC1 mRNA] 		CTD PMID:23717041 NCBI chr 1:89,268,721...89,296,619
Ensembl chr 1:89,268,644...89,296,613 		JBrowse link
G Xrcc3 X-ray repair cross complementing 3 decreases expression
multiple interactions 		ISO 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of XRCC3 mRNA
[epigallocatechin gallate co-treated with polylactic acid-polyglycolic acid copolymer analog] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of XRCC3 mRNA]; [theaflavin co-treated with polylactic acid-polyglycolic acid copolymer analog] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of XRCC3 mRNA]; epigallocatechin gallate inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of XRCC3 mRNA]; theaflavin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of XRCC3 mRNA] 		CTD PMID:23717041 NCBI chr 6:136,684,558...136,694,822
Ensembl chr 6:136,684,558...136,694,822 		JBrowse link
G Xrcc6 X-ray repair cross complementing 6 increases expression
multiple interactions 		EXP
ISO 		9,10-Dimethyl-1,2-benzanthracene results in increased expression of XRCC6 mRNA
A gene mutant form inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of XRCC6 protein]
9,10-Dimethyl-1,2-benzanthracene results in increased expression of XRCC6 mRNA; 9,10-Dimethyl-1,2-benzanthracene results in increased expression of XRCC6 protein 		CTD PMID:23969067 PMID:25448685 NCBI chr 7:115,423,026...115,443,884
Ensembl chr 7:115,422,662...115,443,884 		JBrowse link
G Ybx2 Y box binding protein 2 increases expression
multiple interactions 		ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of YBX2 protein
[Dietary Fats co-treated with Dietary Sucrose co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased expression of YBX2 protein 		CTD PMID:39910959 NCBI chr10:55,158,420...55,164,077
Ensembl chr10:55,158,420...55,164,077 		JBrowse link
G Ybx3 Y box binding protein 3 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of YBX3 protein CTD PMID:39910959 NCBI chr 4:166,861,180...166,884,532
Ensembl chr 4:166,861,181...166,884,691 		JBrowse link
G Ywhag tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, gamma decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of YWHAG protein CTD PMID:38307155 NCBI chr12:26,381,106...26,409,466
Ensembl chr12:26,380,816...26,409,465 		JBrowse link
G Ywhaz tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of YWHAZ mRNA CTD PMID:12376462 NCBI chr 7:69,826,404...69,848,702
Ensembl chr 7:69,826,404...69,849,007 		JBrowse link
G Zap70 zeta chain of T cell receptor associated protein kinase 70 increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of ZAP70 mRNA CTD PMID:19480007 NCBI chr 9:46,485,605...46,507,552
Ensembl chr 9:46,485,598...46,509,062 		JBrowse link
G Zbp1 Z-DNA binding protein 1 increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of ZBP1 mRNA CTD PMID:19480007 NCBI chr 3:182,411,665...182,427,604
Ensembl chr 3:182,411,665...182,422,839 		JBrowse link
G Zc3h15 zinc finger CCCH-type containing 15 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of ZC3H15 protein CTD PMID:39910959 NCBI chr 3:89,151,432...89,171,203
Ensembl chr 3:89,151,509...89,171,202 		JBrowse link
G Zc3h7b zinc finger CCCH-type containing 7B increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of ZC3H7B protein CTD PMID:38307155 NCBI chr 7:115,142,245...115,190,513
Ensembl chr 7:115,142,420...115,190,513 		JBrowse link
G Zeb2 zinc finger E-box binding homeobox 2 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of ZEB2 mRNA; 9,10-Dimethyl-1,2-benzanthracene results in increased expression of ZEB2 protein CTD PMID:29663660 NCBI chr 3:49,624,028...49,754,323
Ensembl chr 3:49,624,028...49,754,323 		JBrowse link
G Zfp428 zinc finger protein 428 multiple interactions ISO [Dietary Fats co-treated with Dietary Sucrose co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased expression of ZNF428 protein CTD PMID:39910959 NCBI chr 1:89,227,442...89,236,797
Ensembl chr 1:89,227,376...89,236,796 		JBrowse link
G Zfp521 zinc finger protein 521 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of ZFP521 mRNA CTD PMID:32553695 NCBI chr18:5,050,297...5,343,188
Ensembl chr18:5,056,236...5,343,054 		JBrowse link
G Zp3 zona pellucida glycoprotein 3 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of ZP3 protein CTD PMID:39910959 NCBI chr12:26,327,161...26,334,126
Ensembl chr12:26,327,161...26,334,126 		JBrowse link
anthracene term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Acp2 acid phosphatase 2, lysosomal multiple interactions
affects expression 		ISO [naphthalene co-treated with anthracene co-treated with phenanthrene co-treated with pyrene] affects the expression of ACP2 protein
anthracene affects the expression of ACP2 protein 		CTD PMID:28803881 NCBI chr 3:97,630,654...97,642,601
Ensembl chr 3:97,631,326...97,642,565 		JBrowse link
G Ahr aryl hydrocarbon receptor multiple interactions
affects binding
increases activity
affects localization 		ISO
EXP 		2-oxohexyl isothiocyanate inhibits the reaction [anthracene affects the localization of AHR protein]; [acenaphthene co-treated with anthracene co-treated with 1,12-benzoperylene co-treated with 1,2,5,6-dibenzanthracene co-treated with fluorene co-treated with naphthalene co-treated with phenanthrene] results in increased activity of AHR protein; [naphthalene co-treated with phenanthrene co-treated with anthracene co-treated with fluoranthene co-treated with pyrene] results in decreased expression of AHR protein; AHR protein affects the reaction [[naphthalene co-treated with phenanthrene co-treated with anthracene co-treated with fluoranthene co-treated with pyrene] results in decreased expression of AR protein]; AHR protein affects the reaction [[naphthalene co-treated with phenanthrene co-treated with anthracene co-treated with fluoranthene co-treated with pyrene] results in increased expression of ESR1 protein]; AHRR protein affects the reaction [[naphthalene co-treated with phenanthrene co-treated with anthracene co-treated with fluoranthene co-treated with pyrene] results in decreased expression of AHR protein]; alyssin inhibits the reaction [anthracene affects the localization of AHR protein]; sulforaphane affects the reaction [anthracene affects the localization of AHR protein]
anthracene binds to AHR protein
anthracene results in increased activity of AHR protein 		CTD PMID:3024361 PMID:17665671 PMID:19362136 PMID:28710019 PMID:30980910 NCBI chr 6:57,961,423...57,998,901
Ensembl chr 6:57,961,423...57,998,901 		JBrowse link
G Ahrr aryl-hydrocarbon receptor repressor multiple interactions ISO [naphthalene co-treated with phenanthrene co-treated with anthracene co-treated with fluoranthene co-treated with pyrene] results in decreased expression of AHRR protein; AHRR protein affects the reaction [[naphthalene co-treated with phenanthrene co-treated with anthracene co-treated with fluoranthene co-treated with pyrene] results in decreased expression of AHR protein]; AHRR protein affects the reaction [[naphthalene co-treated with phenanthrene co-treated with anthracene co-treated with fluoranthene co-treated with pyrene] results in decreased expression of CYP1A1 protein] CTD PMID:28710019 PMID:30980910 NCBI chr 1:30,822,219...30,917,251
Ensembl chr 1:30,810,866...30,952,866 		JBrowse link
G Ar androgen receptor multiple interactions ISO [naphthalene co-treated with phenanthrene co-treated with anthracene co-treated with fluoranthene co-treated with pyrene] results in decreased expression of AR protein; AHR protein affects the reaction [[naphthalene co-treated with phenanthrene co-treated with anthracene co-treated with fluoranthene co-treated with pyrene] results in decreased expression of AR protein]; anthracene inhibits the reaction [Androgens results in increased activity of AR protein]; anthracene inhibits the reaction [Metribolone results in increased activity of AR protein] CTD PMID:18324785 PMID:28377212 PMID:30980910 NCBI chr  X:67,135,317...67,304,476
Ensembl chr  X:67,135,317...67,304,467 		JBrowse link
G Arnt aryl hydrocarbon receptor nuclear translocator multiple interactions ISO [naphthalene co-treated with phenanthrene co-treated with anthracene co-treated with fluoranthene co-treated with pyrene] affects the expression of ARNT protein; [naphthalene co-treated with phenanthrene co-treated with anthracene co-treated with fluoranthene co-treated with pyrene] results in decreased expression of ARNT mRNA; [naphthalene co-treated with phenanthrene co-treated with anthracene co-treated with fluoranthene co-treated with pyrene] results in increased expression of ARNT mRNA CTD PMID:28710019 NCBI chr 2:185,686,703...185,745,546
Ensembl chr 2:185,680,683...185,745,546 		JBrowse link
G Bax BCL2 associated X, apoptosis regulator multiple interactions
affects expression 		ISO [naphthalene co-treated with anthracene co-treated with phenanthrene co-treated with pyrene] affects the expression of BAX protein
anthracene affects the expression of BAX protein 		CTD PMID:28803881 NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:105,076,473...105,086,429 		JBrowse link
G Casp3 caspase 3 increases expression
multiple interactions 		ISO anthracene results in increased expression of CASP3 protein
[naphthalene co-treated with anthracene co-treated with phenanthrene co-treated with pyrene] results in increased expression of CASP3 protein 		CTD PMID:28803881 NCBI chr16:52,395,539...52,413,794
Ensembl chr16:52,395,540...52,413,732 		JBrowse link
G Ccna2 cyclin A2 decreases expression
multiple interactions 		ISO anthracene results in decreased expression of CCNA2 protein
[naphthalene co-treated with anthracene co-treated with phenanthrene co-treated with pyrene] results in decreased expression of CCNA2 protein 		CTD PMID:28803881 NCBI chr 2:121,355,363...121,361,762
Ensembl chr 2:121,355,363...121,361,701 		JBrowse link
G Ccnd1 cyclin D1 increases expression
multiple interactions 		ISO anthracene results in increased expression of CCND1 protein
[naphthalene co-treated with anthracene co-treated with phenanthrene co-treated with pyrene] results in increased expression of CCND1 protein 		CTD PMID:28803881 NCBI chr 1:209,518,288...209,527,986
Ensembl chr 1:209,518,288...209,527,810 		JBrowse link
G Cdk2 cyclin dependent kinase 2 increases expression
multiple interactions 		ISO anthracene results in increased expression of CDK2 protein
[naphthalene co-treated with anthracene co-treated with phenanthrene co-treated with pyrene] results in increased expression of CDK2 protein 		CTD PMID:28803881 NCBI chr 7:1,714,392...1,721,964
Ensembl chr 7:1,714,392...1,721,878 		JBrowse link
G Comt catechol-O-methyltransferase multiple interactions ISO [naphthalene co-treated with phenanthrene co-treated with anthracene co-treated with fluoranthene co-treated with pyrene] affects the expression of COMT mRNA; [naphthalene co-treated with phenanthrene co-treated with anthracene co-treated with fluoranthene co-treated with pyrene] results in increased expression of and affects the activity of COMT protein CTD PMID:28710019 NCBI chr11:96,072,371...96,091,956
Ensembl chr11:96,072,489...96,092,533 		JBrowse link
G Cyp19a1 cytochrome P450, family 19, subfamily a, polypeptide 1 increases expression
multiple interactions 		ISO anthracene results in increased expression of CYP19A1 protein
[naphthalene co-treated with anthracene co-treated with phenanthrene co-treated with pyrene] affects the expression of CYP19A1 protein 		CTD PMID:28803881 NCBI chr 8:63,449,148...63,476,534
Ensembl chr 8:63,449,148...63,476,917 		JBrowse link
G Cyp1a1 cytochrome P450, family 1, subfamily a, polypeptide 1 multiple interactions
increases expression
increases activity 		EXP
ISO 		anthracene inhibits the reaction [Benzo(a)pyrene results in increased expression of CYP1A1 mRNA]
anthracene results in increased expression of CYP1A1 mRNA
[naphthalene co-treated with phenanthrene co-treated with anthracene co-treated with fluoranthene co-treated with pyrene] affects the expression of CYP1A1 mRNA; [naphthalene co-treated with phenanthrene co-treated with anthracene co-treated with fluoranthene co-treated with pyrene] affects the expression of CYP1A1 protein; [naphthalene co-treated with phenanthrene co-treated with anthracene co-treated with fluoranthene co-treated with pyrene] results in decreased expression of CYP1A1 protein; AHRR protein affects the reaction [[naphthalene co-treated with phenanthrene co-treated with anthracene co-treated with fluoranthene co-treated with pyrene] results in decreased expression of CYP1A1 protein]; alyssin inhibits the reaction [anthracene results in increased activity of CYP1A1 protein]; sulforaphane inhibits the reaction [anthracene results in increased activity of CYP1A1 protein] 		CTD PMID:15315710 PMID:19362136 PMID:21668866 PMID:28710019 PMID:30980910 NCBI chr 8:66,991,940...66,998,014
Ensembl chr 8:66,991,970...66,998,012 		JBrowse link
G Cyp1a2 cytochrome P450, family 1, subfamily a, polypeptide 2 increases activity
affects binding
multiple interactions 		ISO anthracene results in increased activity of CYP1A2 protein
anthracene binds to CYP1A2 protein
[acenaphthylene co-treated with acenaphthene co-treated with dibenzofuran co-treated with fluorene co-treated with phenanthrene co-treated with anthracene] results in increased expression of CYP1A2 mRNA
alyssin inhibits the reaction [anthracene results in increased activity of CYP1A2 protein]; sulforaphane inhibits the reaction [anthracene results in increased activity of CYP1A2 protein] 		CTD PMID:7750161 PMID:8001243 PMID:19362136 PMID:32278787 NCBI chr 8:66,971,261...66,978,149
Ensembl chr 8:66,971,261...66,978,149 		JBrowse link
G Cyp1b1 cytochrome P450, family 1, subfamily b, polypeptide 1 increases expression ISO anthracene results in increased expression of CYP1B1 mRNA CTD PMID:21668866 NCBI chr 6:21,093,927...21,103,091
Ensembl chr 6:21,078,146...21,103,142 		JBrowse link
G Esr1 estrogen receptor 1 multiple interactions ISO [naphthalene co-treated with phenanthrene co-treated with anthracene co-treated with fluoranthene co-treated with pyrene] results in increased expression of ESR1 protein; AHR protein affects the reaction [[naphthalene co-treated with phenanthrene co-treated with anthracene co-treated with fluoranthene co-treated with pyrene] results in increased expression of ESR1 protein] CTD PMID:30980910 NCBI chr 1:43,511,685...43,904,454
Ensembl chr 1:43,644,392...43,900,354 		JBrowse link
G Nfkb2 nuclear factor kappa B subunit 2 multiple interactions ISO [naphthalene co-treated with phenanthrene co-treated with anthracene co-treated with fluoranthene co-treated with pyrene] results in increased expression of NFKB2 protein CTD PMID:30980910 NCBI chr 1:255,106,010...255,114,649
Ensembl chr 1:255,107,374...255,114,637 		JBrowse link
G Nr1i3 nuclear receptor subfamily 1, group I, member 3 increases activity ISO anthracene results in increased activity of NR1I3 protein CTD PMID:28927721 NCBI chr13:86,165,327...86,170,362
Ensembl chr13:86,165,349...86,170,370 		JBrowse link
G Tnf tumor necrosis factor multiple interactions ISO TNF protein promotes the reaction [anthracene results in increased expression of CXCL8 mRNA] CTD PMID:18434080 NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,626,532...3,629,303 		JBrowse link
benzo[c]phenanthrene term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Ahr aryl hydrocarbon receptor multiple interactions ISO [Tetrachlorodibenzodioxin binds to and results in increased activity of AHR protein] which results in increased susceptibility to benzo(c)phenanthrene CTD PMID:9168260 NCBI chr 6:57,961,423...57,998,901
Ensembl chr 6:57,961,423...57,998,901 		JBrowse link
G Cyp1a1 cytochrome P450, family 1, subfamily a, polypeptide 1 multiple interactions
increases expression
increases activity 		ISO [CYP1A1 protein co-treated with Trichloroepoxypropane] results in increased metabolism of benzo(c)phenanthrene; EPHX1 protein promotes the reaction [CYP1A1 protein results in increased metabolism of benzo(c)phenanthrene]
benzo(c)phenanthrene results in increased expression of CYP1A1 protein
[[benzo(c)phenanthrene results in increased expression of CYP1A1 protein] promotes the reaction [CYP1A1 protein results in increased metabolism of 9,10-Dimethyl-1,2-benzanthracene]] which results in increased chemical synthesis of 9,10-Dimethyl-1,2-benzanthracene analog; [benzo(c)phenanthrene promotes the reaction [CYP1A1 protein results in increased metabolism of 9,10-Dimethyl-1,2-benzanthracene]] which results in increased chemical synthesis of 9,10-Dimethyl-1,2-benzanthracene analog; [CYP1A1 protein co-treated with Trichloroepoxypropane] results in increased metabolism of benzo(c)phenanthrene; EPHX1 protein promotes the reaction [CYP1A1 protein results in increased metabolism of benzo(c)phenanthrene]
CYP1A1 protein results in increased activity of benzo(c)phenanthrene 		CTD PMID:8961944 PMID:9168260 PMID:15606143 NCBI chr 8:66,991,940...66,998,014
Ensembl chr 8:66,991,970...66,998,012 		JBrowse link
G Cyp1a2 cytochrome P450, family 1, subfamily a, polypeptide 2 multiple interactions ISO [CYP1A2 protein co-treated with Trichloroepoxypropane] results in increased metabolism of benzo(c)phenanthrene; EPHX1 protein promotes the reaction [CYP1A2 protein results in increased metabolism of benzo(c)phenanthrene] CTD PMID:8961944 NCBI chr 8:66,971,261...66,978,149
Ensembl chr 8:66,971,261...66,978,149 		JBrowse link
G Cyp1b1 cytochrome P450, family 1, subfamily b, polypeptide 1 increases expression
multiple interactions 		ISO benzo(c)phenanthrene results in increased expression of CYP1B1 protein
[[benzo(c)phenanthrene results in increased expression of CYP1B1 protein] promotes the reaction [CYP1B1 protein results in increased metabolism of 9,10-Dimethyl-1,2-benzanthracene]] which results in increased chemical synthesis of 9,10-Dimethyl-1,2-benzanthracene analog 		CTD PMID:9168260 NCBI chr 6:21,093,927...21,103,091
Ensembl chr 6:21,078,146...21,103,142 		JBrowse link
G Cyp3a2 cytochrome P450, family 3, subfamily a, polypeptide 2 multiple interactions ISO [benzo(c)phenanthrene binds to and results in increased activity of NR1I2 protein] which results in increased expression of CYP3A4 mRNA CTD PMID:23845848 NCBI chr12:14,321,771...14,343,886
Ensembl chr12:14,321,771...14,343,857 		JBrowse link
G Ephx1 epoxide hydrolase 1 multiple interactions ISO EPHX1 protein promotes the reaction [CYP1A1 protein results in increased metabolism of benzo(c)phenanthrene]; EPHX1 protein promotes the reaction [CYP1A2 protein results in increased metabolism of benzo(c)phenanthrene] CTD PMID:8961944 NCBI chr13:95,246,079...95,275,852
Ensembl chr13:95,246,080...95,321,981 		JBrowse link
G Gstp1 glutathione S-transferase pi 1 affects metabolic processing
multiple interactions 		ISO GSTP1 gene polymorphism affects the metabolism of benzo(c)phenanthrene analog
GSTP1 protein affects the metabolism of [benzo(c)phenanthrene co-treated with Glutathione] 		CTD PMID:9403173 PMID:9850062 NCBI chr 1:210,767,237...210,770,242
Ensembl chr 1:210,767,237...210,769,705 		JBrowse link
G Hras HRas proto-oncogene, GTPase increases mutagenesis ISO benzo(c)phenanthrene analog results in increased mutagenesis of HRAS gene CTD PMID:7955041 NCBI chr 1:205,712,625...205,729,406
Ensembl chr 1:205,725,975...205,729,590 		JBrowse link
G Nr1i2 nuclear receptor subfamily 1, group I, member 2 multiple interactions ISO [benzo(c)phenanthrene binds to and results in increased activity of NR1I2 protein] which results in increased expression of CYP3A4 mRNA; benzo(c)phenanthrene binds to and results in increased activity of NR1I2 protein CTD PMID:23845848 NCBI chr11:75,965,717...76,006,733
Ensembl chr11:75,965,632...76,002,380 		JBrowse link
chrysene term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Aaas aladin WD repeat nucleoporin multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of AAAS mRNA CTD PMID:27858113 NCBI chr 7:135,342,901...135,362,545
Ensembl chr 7:135,342,901...135,362,545 		JBrowse link
G Abcb1a ATP binding cassette subfamily B member 1A increases expression ISO chrysene results in increased expression of ABCB1 mRNA CTD PMID:15566942 NCBI chr 4:26,312,403...26,488,456
Ensembl chr 4:26,312,409...26,397,135 		JBrowse link
G Abcc5 ATP binding cassette subfamily C member 5 decreases expression
multiple interactions 		ISO chrysene results in decreased expression of ABCC5 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of ABCC5 mRNA 		CTD PMID:26377693 PMID:27858113 NCBI chr11:93,975,579...94,071,659
Ensembl chr11:93,978,274...94,071,655 		JBrowse link
G Abi3bp ABI family member 3 binding protein increases expression
multiple interactions 		ISO chrysene results in increased expression of ABI3BP mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of ABI3BP mRNA 		CTD PMID:26377693 PMID:27858113 NCBI chr11:57,381,282...57,597,989
Ensembl chr11:57,381,422...57,598,120 		JBrowse link
G Ablim1 actin-binding LIM protein 1 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of ABLIM1 mRNA CTD PMID:27858113 NCBI chr 1:266,088,868...266,377,169
Ensembl chr 1:266,088,870...266,377,098 		JBrowse link
G Abraxas2 abraxas 2, BRISC complex subunit multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of ABRAXAS2 mRNA CTD PMID:27858113 NCBI chr 1:197,077,177...197,102,753
Ensembl chr 1:197,077,158...197,102,757 		JBrowse link
G Acin1 apoptotic chromatin condensation inducer 1 decreases expression
multiple interactions 		ISO chrysene results in decreased expression of ACIN1 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of ACIN1 mRNA 		CTD PMID:26377693 PMID:27858113 NCBI chr15:32,072,121...32,117,004
Ensembl chr15:32,072,123...32,117,166 		JBrowse link
G Ackr3 atypical chemokine receptor 3 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of CXCR7 mRNA CTD PMID:27858113 NCBI chr 9:98,247,300...98,258,877
Ensembl chr 9:98,246,605...98,260,214 		JBrowse link
G Acod1 aconitate decarboxylase 1 decreases expression ISO chrysene results in decreased expression of ACOD1 mRNA CTD PMID:26377693 NCBI chr15:86,286,531...86,295,803
Ensembl chr15:86,286,579...86,295,687 		JBrowse link
G Acot1 acyl-CoA thioesterase 1 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of ACOT1 mRNA CTD PMID:27858113 NCBI chr 6:109,367,274...109,375,268
Ensembl chr 6:109,367,268...109,380,749 		JBrowse link
G Acoxl acyl-CoA oxidase-like multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of ACOXL mRNA CTD PMID:27858113 NCBI chr 3:135,514,340...135,820,291
Ensembl chr 3:135,514,275...135,820,291 		JBrowse link
G Acta1 actin, alpha 1, skeletal muscle increases expression ISO chrysene results in increased expression of ACTA1 mRNA CTD PMID:26377693 NCBI chr19:68,781,168...68,784,194
Ensembl chr19:68,781,168...68,786,178 		JBrowse link
G Acta2 actin alpha 2, smooth muscle multiple interactions ISO [chrysene co-treated with Tobacco Smoke Pollution] results in increased expression of ACTA2 protein; chrysene promotes the reaction [Tobacco Smoke Pollution results in increased expression of ACTA2 protein] CTD PMID:33345606 NCBI chr 1:241,159,723...241,172,503
Ensembl chr 1:241,159,724...241,172,503 		JBrowse link
G Actn3 actinin alpha 3 increases expression ISO chrysene results in increased expression of ACTN3 mRNA CTD PMID:26377693 NCBI chr 1:211,588,473...211,604,401
Ensembl chr 1:211,588,474...211,604,401 		JBrowse link
G Ada adenosine deaminase increases expression ISO chrysene results in increased expression of ADA mRNA CTD PMID:26377693 NCBI chr 3:172,818,174...172,842,283
Ensembl chr 3:172,818,176...172,842,293 		JBrowse link
G Adam33 ADAM metallopeptidase domain 33 increases expression ISO chrysene results in increased expression of ADAM33 mRNA CTD PMID:26377693 NCBI chr 3:138,715,428...138,736,392
Ensembl chr 3:138,724,046...138,736,347 		JBrowse link
G Adamdec1 ADAM-like, decysin 1 increases expression ISO chrysene results in increased expression of ADAMDEC1 mRNA CTD PMID:26377693 NCBI chr15:47,076,011...47,097,065
Ensembl chr15:47,076,019...47,097,065 		JBrowse link
G Adamts14 ADAM metallopeptidase with thrombospondin type 1 motif, 14 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of ADAMTS14 mRNA CTD PMID:27858113 NCBI chr20:29,685,876...29,762,685
Ensembl chr20:29,685,876...29,762,682 		JBrowse link
G Add3 adducin 3 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of ADD3 mRNA CTD PMID:27858113 NCBI chr 1:262,152,722...262,260,504
Ensembl chr 1:262,154,996...262,260,504 		JBrowse link
G Adgrd1 adhesion G protein-coupled receptor D1 increases expression ISO chrysene results in increased expression of ADGRD1 mRNA CTD PMID:26377693 NCBI chr12:33,124,981...33,239,778
Ensembl chr12:33,125,915...33,272,509 		JBrowse link
G Adgrl4 adhesion G protein-coupled receptor L4 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of ADGRL4 mRNA CTD PMID:27858113 NCBI chr 2:243,014,927...243,117,226
Ensembl chr 2:243,014,796...243,117,222 		JBrowse link
G Adm adrenomedullin multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of ADM mRNA CTD PMID:27858113 NCBI chr 1:174,164,178...174,182,372
Ensembl chr 1:174,178,773...174,182,371 		JBrowse link
G Aen apoptosis enhancing nuclease increases expression
multiple interactions 		ISO chrysene results in increased expression of AEN mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of AEN mRNA 		CTD PMID:26377693 PMID:27858113 NCBI chr 1:142,224,499...142,233,902
Ensembl chr 1:142,224,493...142,233,898 		JBrowse link
G Agbl2 AGBL carboxypeptidase 2 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of AGBL2 mRNA CTD PMID:27858113 NCBI chr 3:97,220,654...97,255,905
Ensembl chr 3:97,220,781...97,255,904 		JBrowse link
G Ago2 argonaute RISC catalytic component 2 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of AGO2 mRNA CTD PMID:27858113 NCBI chr 7:106,907,209...106,994,124
Ensembl chr 7:106,918,125...106,993,980 		JBrowse link
G Ahcyl2 adenosylhomocysteinase-like 2 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of AHCYL2 mRNA CTD PMID:27858113 NCBI chr 4:59,348,747...59,498,503
Ensembl chr 4:59,348,217...59,498,502 		JBrowse link
G Ahnak AHNAK nucleoprotein multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of AHNAK mRNA CTD PMID:27858113 NCBI chr 1:215,311,289...215,400,010
Ensembl chr 1:215,321,931...215,400,675 		JBrowse link
G Ahr aryl hydrocarbon receptor multiple interactions
increases activity
affects response to substance
affects binding 		EXP
ISO 		chrysene binds to and results in increased activity of AHR protein
chrysene analog results in increased activity of AHR protein; chrysene results in increased activity of AHR protein
AHR affects the susceptibility to chrysene
[benz(a)anthracene co-treated with Benzo(a)pyrene co-treated with benzo(j)fluoranthene co-treated with benzo(k)fluoranthene co-treated with chrysene co-treated with fluoranthene co-treated with pyrene] promotes the reaction [indeno(1,2,3-cd)pyrene results in increased activity of AHR protein]; [benz(a)anthracene co-treated with Benzo(a)pyrene co-treated with benzo(j)fluoranthene co-treated with benzo(k)fluoranthene co-treated with chrysene co-treated with indeno(1,2,3-cd)pyrene co-treated with fluoranthene] promotes the reaction [pyrene results in increased activity of AHR protein]; [benz(a)anthracene co-treated with Benzo(a)pyrene co-treated with benzo(j)fluoranthene co-treated with benzo(k)fluoranthene co-treated with chrysene co-treated with indeno(1,2,3-cd)pyrene co-treated with pyrene] promotes the reaction [fluoranthene results in increased activity of AHR protein]; [benz(a)anthracene co-treated with Benzo(a)pyrene co-treated with benzo(j)fluoranthene co-treated with benzo(k)fluoranthene co-treated with indeno(1,2,3-cd)pyrene co-treated with fluoranthene co-treated with pyrene] promotes the reaction [chrysene results in increased activity of AHR protein]; [benz(a)anthracene co-treated with Benzo(a)pyrene co-treated with benzo(j)fluoranthene co-treated with chrysene co-treated with indeno(1,2,3-cd)pyrene co-treated with fluoranthene co-treated with pyrene] promotes the reaction [benzo(k)fluoranthene results in increased activity of AHR protein]; [benz(a)anthracene co-treated with Benzo(a)pyrene co-treated with benzo(k)fluoranthene co-treated with chrysene co-treated with indeno(1,2,3-cd)pyrene co-treated with fluoranthene co-treated with pyrene] promotes the reaction [benzo(j)fluoranthene results in increased activity of AHR protein]; [benz(a)anthracene co-treated with benzo(j)fluoranthene co-treated with benzo(k)fluoranthene co-treated with chrysene co-treated with indeno(1,2,3-cd)pyrene co-treated with fluoranthene co-treated with pyrene] promotes the reaction [Benzo(a)pyrene results in increased activity of AHR protein]; [Benzo(a)pyrene co-treated with benzo(j)fluoranthene co-treated with benzo(k)fluoranthene co-treated with chrysene co-treated with indeno(1,2,3-cd)pyrene co-treated with fluoranthene co-treated with pyrene] promotes the reaction [benz(a)anthracene results in increased activity of AHR protein]; [chrysene binds to and results in increased activity of AHR protein] which results in increased expression of CYP1A1 mRNA; alpha-naphthoflavone inhibits the reaction [[chrysene binds to and results in increased activity of AHR protein] which results in increased expression of CYP1A1 mRNA]; chrysene binds to and results in increased activity of AHR protein; chrysene promotes the reaction [AHR protein results in increased expression of CYP1A1 mRNA]
chrysene binds to AHR protein 		CTD PMID:3024361 PMID:8571374 PMID:11525907 PMID:12371477 PMID:12799773 More... NCBI chr 6:57,961,423...57,998,901
Ensembl chr 6:57,961,423...57,998,901 		JBrowse link
G Ahrr aryl-hydrocarbon receptor repressor multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of AHRR mRNA CTD PMID:27858113 NCBI chr 1:30,822,219...30,917,251
Ensembl chr 1:30,810,866...30,952,866 		JBrowse link
G Aif1 allograft inflammatory factor 1 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of AIF1 mRNA CTD PMID:27858113 NCBI chr20:3,651,435...3,657,341
Ensembl chr20:3,652,243...3,657,339 		JBrowse link
G Akap12 A-kinase anchoring protein 12 increases expression ISO chrysene results in increased expression of AKAP12 mRNA CTD PMID:26377693 NCBI chr 1:43,135,515...43,225,245
Ensembl chr 1:43,199,008...43,225,557 		JBrowse link
G Akap7 A-kinase anchoring protein 7 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of AKAP7 mRNA CTD PMID:27858113 NCBI chr 1:21,906,503...22,168,663
Ensembl chr 1:21,906,676...22,037,090 		JBrowse link
G Akr1c1 aldo-keto reductase family 1, member C1 increases expression ISO chrysene results in increased expression of AKR1C1 mRNA CTD PMID:17253728 NCBI chr17:70,720,397...70,747,285
Ensembl chr17:70,720,398...70,747,247 		JBrowse link
G Alg14 ALG14, UDP-N-acetylglucosaminyltransferase subunit decreases expression ISO chrysene results in decreased expression of ALG14 mRNA CTD PMID:26377693 NCBI chr 2:212,053,008...212,130,136
Ensembl chr 2:212,044,969...212,130,140 		JBrowse link
G Alkbh7 alkB homolog 7 decreases expression ISO chrysene results in decreased expression of ALKBH7 mRNA CTD PMID:26377693 NCBI chr 9:1,925,896...1,928,048
Ensembl chr 9:1,925,743...1,928,048 		JBrowse link
G Aloxe3 arachidonate epidermal lipoxygenase 3 increases expression ISO chrysene results in increased expression of ALOXE3 mRNA CTD PMID:26377693 NCBI chr10:54,329,224...54,353,167
Ensembl chr10:54,329,043...54,353,166 		JBrowse link
G Als2cl ALS2 C-terminal like increases expression ISO chrysene results in increased expression of ALS2CL mRNA CTD PMID:26377693 NCBI chr 8:119,746,498...119,762,824
Ensembl chr 8:119,743,248...119,762,843 		JBrowse link
G Angptl4 angiopoietin-like 4 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of ANGPTL4 mRNA CTD PMID:27858113 NCBI chr 7:15,252,450...15,259,971
Ensembl chr 7:15,252,473...15,258,681 		JBrowse link
G Ank3 ankyrin 3 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of ANK3 mRNA CTD PMID:27858113 NCBI chr20:18,601,307...19,224,790
Ensembl chr20:18,601,826...19,084,879 		JBrowse link
G Ankrd12 ankyrin repeat domain 12 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of ANKRD12 mRNA CTD PMID:27858113 NCBI chr 9:113,030,127...113,134,816
Ensembl chr 9:113,030,919...113,134,762 		JBrowse link
G Ankrd26 ankyrin repeat domain containing 26 decreases expression ISO chrysene results in decreased expression of ANKRD26 mRNA CTD PMID:26377693 NCBI chr 4:153,342,901...153,412,321
Ensembl chr 4:153,343,578...153,412,256 		JBrowse link
G Anpep alanyl aminopeptidase, membrane multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of ANPEP mRNA CTD PMID:27858113 NCBI chr 1:143,176,645...143,219,447
Ensembl chr 1:143,176,645...143,195,101 		JBrowse link
G Ap1s1 adaptor related protein complex 1 subunit sigma 1 increases expression ISO chrysene results in increased expression of AP1S1 mRNA CTD PMID:26377693 NCBI chr12:25,261,958...25,272,483
Ensembl chr12:25,262,036...25,272,483 		JBrowse link
G Apol9a apolipoprotein L9a multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of APOL9A mRNA CTD PMID:27858113 NCBI chr 7:111,021,452...111,030,380
Ensembl chr 7:111,021,453...111,028,213 		JBrowse link
G Ar androgen receptor multiple interactions
decreases activity
increases activity 		ISO
EXP 		chrysene binds to and results in decreased activity of AR protein; chrysene inhibits the reaction [Metribolone results in increased activity of AR protein]
chrysene results in decreased activity of AR protein
chrysene results in increased activity of AR protein 		CTD PMID:10771140 PMID:12799773 PMID:18324785 NCBI chr  X:67,135,317...67,304,476
Ensembl chr  X:67,135,317...67,304,467 		JBrowse link
G Areg amphiregulin multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of AREG mRNA CTD PMID:27858113 NCBI chr14:17,256,384...17,265,641
Ensembl chr14:17,256,384...17,265,641 		JBrowse link
G Arglu1 arginine and glutamate rich 1 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of ARGLU1 mRNA CTD PMID:27858113 NCBI chr16:87,455,097...87,479,148
Ensembl chr16:87,455,113...87,479,148 		JBrowse link
G Arhgap23 Rho GTPase activating protein 23 decreases expression ISO chrysene results in decreased expression of ARHGAP23 mRNA CTD PMID:26377693 NCBI chr10:82,891,021...82,993,230
Ensembl chr10:82,890,853...82,993,228 		JBrowse link
G Arhgef38 Rho guanine nucleotide exchange factor 38 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of ARHGEF38 mRNA CTD PMID:27858113 NCBI chr 2:224,284,238...224,413,974
Ensembl chr 2:224,284,238...224,413,974 		JBrowse link
G Arhgef40 Rho guanine nucleotide exchange factor 40 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of ARHGEF40 mRNA CTD PMID:27858113 NCBI chr15:27,146,155...27,170,012
Ensembl chr15:27,146,197...27,170,012 		JBrowse link
G Arl3 ARF like GTPase 3 decreases expression ISO chrysene results in decreased expression of ARL3 mRNA CTD PMID:26377693 NCBI chr 1:255,342,078...255,388,087
Ensembl chr 1:255,342,076...255,388,279 		JBrowse link
G Armc6 armadillo repeat containing 6 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of ARMC6 mRNA CTD PMID:27858113 NCBI chr16:19,225,058...19,235,479
Ensembl chr16:19,225,049...19,240,032 		JBrowse link
G Arrdc4 arrestin domain containing 4 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of ARRDC4 mRNA CTD PMID:27858113 NCBI chr 1:131,779,436...131,793,438
Ensembl chr 1:131,779,437...131,793,565 		JBrowse link
G Asgr2 asialoglycoprotein receptor 2 decreases expression
multiple interactions 		ISO chrysene results in decreased expression of ASGR2 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of ASGR2 mRNA 		CTD PMID:26377693 PMID:27858113 NCBI chr10:55,320,082...55,333,294
Ensembl chr10:55,320,091...55,333,263 		JBrowse link
G Asph aspartate-beta-hydroxylase multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of ASPH mRNA CTD PMID:27858113 NCBI chr 5:27,398,933...27,611,519
Ensembl chr 5:27,398,949...27,611,215 		JBrowse link
G Asprv1 aspartic peptidase, retroviral-like 1 increases expression ISO chrysene results in increased expression of ASPRV1 mRNA CTD PMID:26377693 NCBI chr 4:120,634,793...120,636,265
Ensembl chr 4:120,634,793...120,636,260 		JBrowse link
G Atf4 activating transcription factor 4 increases expression ISO chrysene results in increased expression of ATF4 mRNA CTD PMID:26377693 NCBI chr 7:113,684,681...113,686,739
Ensembl chr 7:113,684,681...113,686,739 		JBrowse link
G Atg4c autophagy related 4C, cysteine peptidase increases expression ISO chrysene results in increased expression of ATG4C mRNA CTD PMID:26377693 NCBI chr 5:118,977,594...119,050,894
Ensembl chr 5:118,982,918...119,052,695 		JBrowse link
G Atp13a3 ATPase 13A3 decreases expression
multiple interactions 		ISO chrysene results in decreased expression of ATP13A3 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of ATP13A3 mRNA 		CTD PMID:26377693 PMID:27858113 NCBI chr11:83,860,725...83,946,899
Ensembl chr11:83,870,218...83,944,662 		JBrowse link
G Atp2a2 ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of ATP2A2 mRNA CTD PMID:27858113 NCBI chr12:39,733,519...39,782,942
Ensembl chr12:39,733,458...39,782,934 		JBrowse link
G Atp5mg ATP synthase membrane subunit G decreases expression ISO chrysene results in decreased expression of ATP5MG mRNA CTD PMID:26377693 NCBI chr 8:54,122,457...54,130,407
Ensembl chr 8:54,122,457...54,132,831 		JBrowse link
G Atp6v0a1 ATPase H+ transporting V0 subunit a1 increases expression ISO chrysene results in increased expression of ATP6V0A1 mRNA CTD PMID:26377693 NCBI chr10:86,436,089...86,490,185
Ensembl chr10:86,436,141...86,490,181 		JBrowse link
G Atp6v0a4 ATPase H+ transporting V0 subunit a4 increases expression ISO chrysene results in increased expression of ATP6V0A4 mRNA CTD PMID:26377693 NCBI chr 4:67,727,145...67,809,092
Ensembl chr 4:67,727,145...67,809,092 		JBrowse link
G Atp6v0e1 ATPase H+ transporting V0 subunit e1 decreases expression ISO chrysene results in decreased expression of ATP6V0E mRNA CTD PMID:26377693 NCBI chr10:16,984,084...17,007,156
Ensembl chr10:16,984,084...17,028,858 		JBrowse link
G Atxn3 ataxin 3 increases expression ISO chrysene results in increased expression of ATXN3 mRNA CTD PMID:26377693 NCBI chr 6:126,837,107...126,872,919
Ensembl chr 6:126,839,327...126,872,781 		JBrowse link
G B4galt1 beta-1,4-galactosyltransferase 1 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of B4GALT1 mRNA CTD PMID:27858113 NCBI chr 5:60,731,601...60,778,456
Ensembl chr 5:60,731,602...60,778,445 		JBrowse link
G Batf basic leucine zipper ATF-like transcription factor multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of BATF mRNA CTD PMID:27858113 NCBI chr 6:111,084,717...111,107,052
Ensembl chr 6:111,084,717...111,107,052 		JBrowse link
G Bax BCL2 associated X, apoptosis regulator multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of BAX mRNA; [chrysene co-treated with Tobacco Smoke Pollution] results in increased expression of BAX protein; chrysene promotes the reaction [Tobacco Smoke Pollution results in increased expression of BAX protein] CTD PMID:27858113 PMID:33345606 NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:105,076,473...105,086,429 		JBrowse link
G Bche butyrylcholinesterase increases expression ISO chrysene results in increased expression of BCHE mRNA CTD PMID:26377693 NCBI chr 2:160,607,289...160,699,760
Ensembl chr 2:160,606,288...160,699,760 		JBrowse link
G Bckdhb branched chain keto acid dehydrogenase E1 subunit beta decreases expression ISO chrysene results in decreased expression of BCKDHB mRNA CTD PMID:26377693 NCBI chr 8:93,725,277...93,907,799
Ensembl chr 8:93,725,275...93,907,798 		JBrowse link
G Bcl11a BCL11 transcription factor A increases expression ISO chrysene results in increased expression of BCL11A mRNA CTD PMID:26377693 NCBI chr14:102,230,147...102,325,289
Ensembl chr14:102,231,113...102,325,623 		JBrowse link
G Bcl2 BCL2, apoptosis regulator multiple interactions ISO [chrysene co-treated with Tobacco Smoke Pollution] results in decreased expression of BCL2 protein; chrysene promotes the reaction [Tobacco Smoke Pollution inhibits the reaction BCL2 protein] CTD PMID:33345606 NCBI chr13:23,204,464...23,366,900
Ensembl chr13:23,204,464...23,366,900 		JBrowse link
G Bcl3 BCL3, transcription coactivator multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of BCL3 mRNA CTD PMID:27858113 NCBI chr 1:88,599,321...88,613,555
Ensembl chr 1:88,599,321...88,614,368 		JBrowse link
G Bcl6b BCL6B, transcription repressor multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of BCL6B mRNA CTD PMID:27858113 NCBI chr10:55,439,566...55,444,631
Ensembl chr10:55,432,382...55,444,631 		JBrowse link
G Bcl7b BAF chromatin remodeling complex subunit BCL7B multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of BCL7B mRNA CTD PMID:27858113 NCBI chr12:27,133,412...27,146,631
Ensembl chr12:27,133,412...27,146,636 		JBrowse link
G Bclaf1 BCL2-associated transcription factor 1 increases expression ISO chrysene results in increased expression of BCLAF1 mRNA CTD PMID:26377693 NCBI chr 1:16,904,572...16,937,106
Ensembl chr 1:16,914,118...16,936,801 		JBrowse link
G Bhlhe40 basic helix-loop-helix family, member e40 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of BHLHE40 mRNA CTD PMID:27858113 NCBI chr 4:143,174,450...143,180,150
Ensembl chr 4:143,174,048...143,180,783 		JBrowse link
G Birc5 baculoviral IAP repeat-containing 5 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of BIRC5 mRNA CTD PMID:27858113 NCBI chr10:103,567,369...103,580,069
Ensembl chr10:103,572,080...103,582,155 		JBrowse link
G Bloc1s2 biogenesis of lysosomal organelles complex-1, subunit 2 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of BLOC1S2 mRNA CTD PMID:27858113 NCBI chr 1:252,973,818...252,980,873
Ensembl chr 1:252,973,202...252,980,873 		JBrowse link
G Bmal1 basic helix-loop-helix ARNT like 1 decreases expression
multiple interactions 		ISO chrysene results in decreased expression of BMAL1 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of BMAL1 mRNA 		CTD PMID:26377693 PMID:27858113 NCBI chr 1:176,766,222...176,864,741
Ensembl chr 1:176,829,305...176,864,739 		JBrowse link
G Bmpr2 bone morphogenetic protein receptor type 2 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of BMPR2 mRNA CTD PMID:27858113 NCBI chr 9:68,685,942...68,801,353
Ensembl chr 9:68,685,988...68,801,350 		JBrowse link
G Brd7 bromodomain containing 7 increases expression ISO chrysene results in increased expression of BRD7 mRNA CTD PMID:26377693 NCBI chr19:34,882,238...34,910,944
Ensembl chr19:34,882,304...34,910,944 		JBrowse link
G Bscl2 BSCL2 lipid droplet biogenesis associated, seipin multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of BSCL2 mRNA CTD PMID:27858113 NCBI chr 1:215,160,764...215,172,540
Ensembl chr 1:215,160,957...215,172,536 		JBrowse link
G Btla B and T lymphocyte associated multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of BTLA mRNA CTD PMID:27858113 NCBI chr11:69,069,734...69,099,331
Ensembl chr11:69,052,644...69,093,224 		JBrowse link
G C2cd3 C2 domain containing 3 centriole elongation regulator decreases expression
multiple interactions 		ISO chrysene results in decreased expression of C2CD3 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of C2CD3 mRNA 		CTD PMID:26377693 PMID:27858113 NCBI chr 1:164,127,304...164,225,088
Ensembl chr 1:164,127,281...164,225,086 		JBrowse link
G C5 complement C5 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of HC mRNA CTD PMID:27858113 NCBI chr 3:38,668,174...38,759,468
Ensembl chr 3:38,668,174...38,759,468 		JBrowse link
G C5ar2 complement C5a receptor 2 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of C5AR2 mRNA CTD PMID:27858113 NCBI chr 1:86,058,557...86,073,583
Ensembl chr 1:86,057,256...86,061,372 		JBrowse link
G C7 complement C7 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of C7 mRNA CTD PMID:27858113 NCBI chr 2:55,815,687...55,892,605
Ensembl chr 2:55,816,807...55,892,672 		JBrowse link
G Ca14 carbonic anhydrase 14 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of CAR14 mRNA CTD PMID:27858113 NCBI chr 2:186,131,196...186,138,164
Ensembl chr 2:186,129,341...186,138,863 		JBrowse link
G Cabp5 calcium binding protein 5 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of CABP5 mRNA CTD PMID:27858113 NCBI chr 1:83,486,396...83,499,421
Ensembl chr 1:83,486,396...83,499,421 		JBrowse link
G Cacng1 calcium voltage-gated channel auxiliary subunit gamma 1 increases expression ISO chrysene results in increased expression of CACNG1 mRNA CTD PMID:26377693 NCBI chr10:93,152,558...93,165,246
Ensembl chr10:93,152,248...93,165,417 		JBrowse link
G Calml5 calmodulin-like 5 increases expression ISO chrysene results in increased expression of CALM4 mRNA CTD PMID:26377693 NCBI chr17:71,304,326...71,305,245
Ensembl chr17:71,304,326...71,305,245 		JBrowse link
G Capn3 calpain 3 increases expression ISO chrysene results in increased expression of CAPN3 mRNA CTD PMID:26377693 NCBI chr 3:127,860,002...127,913,677
Ensembl chr 3:127,861,589...127,911,638 		JBrowse link
G Capza2 capping actin protein of muscle Z-line subunit alpha 2 decreases expression ISO chrysene results in decreased expression of CAPZA2 mRNA CTD PMID:26377693 NCBI chr 4:46,944,040...46,979,930
Ensembl chr 4:46,895,701...46,979,938 		JBrowse link
G Carmil1 capping protein regulator and myosin 1 linker 1 decreases expression ISO chrysene results in decreased expression of CARMIL1 mRNA CTD PMID:26377693 NCBI chr17:41,235,819...41,516,204
Ensembl chr17:41,236,229...41,516,221 		JBrowse link
G Casp3 caspase 3 increases activity
multiple interactions 		ISO chrysene results in increased activity of CASP3 protein
chrysene promotes the reaction [Tobacco Smoke Pollution results in increased cleavage of CASP3 protein] 		CTD PMID:21571051 PMID:33345606 NCBI chr16:52,395,539...52,413,794
Ensembl chr16:52,395,540...52,413,732 		JBrowse link
G Casz1 castor zinc finger 1 increases expression ISO chrysene results in increased expression of CASZ1 mRNA CTD PMID:26377693 NCBI chr 5:164,527,083...164,677,037
Ensembl chr 5:164,527,112...164,677,014 		JBrowse link
G Cat catalase decreases activity ISO chrysene results in decreased activity of CAT protein CTD PMID:21571051 NCBI chr 3:110,297,340...110,329,526
Ensembl chr 3:110,297,342...110,329,526 		JBrowse link
G Cav1 caveolin 1 decreases expression
multiple interactions 		ISO chrysene results in decreased expression of CAV1 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of CAV1 mRNA 		CTD PMID:26377693 PMID:27858113 NCBI chr 4:46,606,538...46,639,616
Ensembl chr 4:46,600,738...46,639,740 		JBrowse link
G Cavin1 caveolae associated protein 1 increases expression ISO chrysene results in increased expression of CAVIN1 mRNA CTD PMID:26377693 NCBI chr10:86,384,401...86,398,240
Ensembl chr10:86,384,401...86,396,383 		JBrowse link
G Cbfa2t3 CBFA2/RUNX1 partner transcriptional co-repressor 3 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of CBFA2T3 mRNA CTD PMID:27858113 NCBI chr19:67,584,319...67,658,533
Ensembl chr19:67,589,258...67,658,136 		JBrowse link
G Ccbe1 collagen and calcium binding EGF domains 1 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of CCBE1 mRNA CTD PMID:27858113 NCBI chr18:61,849,821...62,093,876
Ensembl chr18:61,853,149...62,094,075 		JBrowse link
G Ccdc184 coiled-coil domain containing 184 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of CCDC184 mRNA CTD PMID:27858113 NCBI chr 7:131,178,732...131,180,136
Ensembl chr 7:131,176,373...131,183,680 		JBrowse link
G Ccdc82 coiled-coil domain containing 82 increases expression ISO chrysene results in increased expression of CCDC82 mRNA CTD PMID:26377693 NCBI chr 8:18,509,293...18,665,008
Ensembl chr 8:18,509,382...18,550,529 		JBrowse link
G Ccl4 C-C motif chemokine ligand 4 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of CCL4 mRNA CTD PMID:27858113 NCBI chr10:68,963,893...68,965,728
Ensembl chr10:68,950,289...68,965,722 		JBrowse link
G Ccl5 C-C motif chemokine ligand 5 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of CCL5 mRNA CTD PMID:27858113 NCBI chr10:68,820,330...68,824,906
Ensembl chr10:68,738,651...68,824,884 		JBrowse link
G Ccl9 C-C motif chemokine ligand 9 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of CCL6 mRNA CTD PMID:27858113 NCBI chr10:68,863,994...68,868,928
Ensembl chr10:68,863,995...68,868,877 		JBrowse link
G Ccm2l CCM2 like scaffold protein multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of CCM2L mRNA CTD PMID:27858113 NCBI chr 3:161,993,717...162,009,372
Ensembl chr 3:161,859,312...162,009,371 		JBrowse link
G Ccnd1 cyclin D1 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of CCND1 mRNA CTD PMID:27858113 NCBI chr 1:209,518,288...209,527,986
Ensembl chr 1:209,518,288...209,527,810 		JBrowse link
G Ccnd2 cyclin D2 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of CCND2 mRNA CTD PMID:27858113 NCBI chr 4:161,653,048...161,675,422
Ensembl chr 4:161,653,048...161,680,301
Ensembl chr 4:161,653,048...161,680,301 		JBrowse link
G Ccndbp1 cyclin D1 binding protein 1 decreases expression ISO chrysene results in decreased expression of CCNDBP1 mRNA CTD PMID:26377693 NCBI chr 3:128,416,105...128,427,985
Ensembl chr 3:128,416,054...128,436,008 		JBrowse link
G Ccng1 cyclin G1 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of CCNG1 mRNA CTD PMID:27858113 NCBI chr10:25,678,503...25,684,876
Ensembl chr10:25,677,885...25,683,766 		JBrowse link
G Ccnjl cyclin J-like multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of CCNJL mRNA CTD PMID:27858113 NCBI chr10:28,497,144...28,554,877
Ensembl chr10:28,496,990...28,554,877 		JBrowse link
G Ccnl1 cyclin L1 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of CCNL1 mRNA CTD PMID:27858113 NCBI chr 2:152,495,169...152,508,855
Ensembl chr 2:152,495,172...152,507,468 		JBrowse link
G Ccnl2 cyclin L2 increases expression ISO chrysene results in increased expression of CCNL2 mRNA CTD PMID:26377693 NCBI chr 5:171,698,951...171,711,037
Ensembl chr 5:171,699,689...171,711,231 		JBrowse link
G Ccr7 C-C motif chemokine receptor 7 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of CCR7 mRNA CTD PMID:27858113 NCBI chr10:84,594,399...84,604,514
Ensembl chr10:84,593,594...84,604,501 		JBrowse link
G Cd151 CD151 molecule (Raph blood group) multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of CD151 mRNA CTD PMID:27858113 NCBI chr 1:205,994,300...205,998,307
Ensembl chr 1:205,994,738...205,998,784 		JBrowse link
G Cd200 Cd200 molecule multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of CD200 mRNA CTD PMID:27858113 NCBI chr11:68,916,200...68,943,570
Ensembl chr11:68,916,224...68,943,569 		JBrowse link
G Cd248 CD248 molecule increases expression ISO chrysene results in increased expression of CD248 mRNA CTD PMID:26377693 NCBI chr 1:211,803,052...211,805,616
Ensembl chr 1:211,801,934...211,805,776 		JBrowse link
G Cd34 CD34 molecule multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of CD34 mRNA CTD PMID:27858113 NCBI chr13:109,008,786...109,029,317
Ensembl chr13:109,008,623...109,029,315 		JBrowse link
G Cd37 CD37 molecule multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of CD37 mRNA CTD PMID:27858113 NCBI chr 1:104,855,622...104,861,111
Ensembl chr 1:104,849,166...104,861,276 		JBrowse link
G Cd47 Cd47 molecule decreases expression ISO chrysene results in decreased expression of CD47 mRNA CTD PMID:26377693 NCBI chr11:64,374,816...64,438,763
Ensembl chr11:64,377,926...64,438,272 		JBrowse link
G Cd48 Cd48 molecule multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of CD48 mRNA CTD PMID:27858113 NCBI chr13:86,717,960...86,741,540
Ensembl chr13:86,717,961...86,742,942 		JBrowse link
G Cd55 CD55 molecule (Cromer blood group) increases expression ISO chrysene results in increased expression of CD55 mRNA CTD PMID:26377693 NCBI chr13:44,409,574...44,438,913
Ensembl chr13:44,409,587...44,438,107 		JBrowse link
G Cd69 Cd69 molecule multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of CD69 mRNA CTD PMID:27858113 NCBI chr 4:164,411,485...164,419,403
Ensembl chr 4:164,411,485...164,419,509 		JBrowse link
G Cd79b CD79b molecule multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of CD79B mRNA CTD PMID:27858113 NCBI chr10:91,739,134...91,742,312
Ensembl chr10:91,739,137...91,742,405 		JBrowse link
G Cd99 CD99 molecule (Xg blood group) multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of CD99 mRNA CTD PMID:27858113 NCBI chr20:56,000,494...56,005,140 JBrowse link
G Cdc14b cell division cycle 14B increases expression ISO chrysene results in increased expression of CDC14B mRNA CTD PMID:26377693 NCBI chr17:850,272...938,972
Ensembl chr17:850,390...971,164 		JBrowse link
G Cdc42 cell division cycle 42 decreases expression ISO chrysene results in decreased expression of CDC42 mRNA CTD PMID:26377693 NCBI chr 5:154,838,478...154,876,629
Ensembl chr 5:154,839,631...154,876,627 		JBrowse link
G Cdh1 cadherin 1 multiple interactions ISO [chrysene co-treated with Tobacco Smoke Pollution] results in decreased expression of CDH1 protein; chrysene promotes the reaction [Tobacco Smoke Pollution results in decreased expression of CDH1 protein] CTD PMID:33345606 NCBI chr19:51,402,178...51,471,572
Ensembl chr19:51,402,034...51,471,565 		JBrowse link
G Cdh13 cadherin 13 increases expression ISO chrysene results in increased expression of CDH13 mRNA CTD PMID:26377693 NCBI chr19:63,258,251...64,296,122
Ensembl chr19:63,258,122...64,296,119 		JBrowse link
G Cdh16 cadherin 16 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of CDH16 mRNA CTD PMID:27858113 NCBI chr19:367,202...377,710
Ensembl chr19:367,274...388,934 		JBrowse link
G Cdh3 cadherin 3 increases expression ISO chrysene results in increased expression of CDH3 mRNA CTD PMID:26377693 NCBI chr19:51,303,414...51,353,900
Ensembl chr19:51,300,083...51,354,257 		JBrowse link
G Cdhr4 cadherin-related family member 4 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of CDHR4 mRNA CTD PMID:27858113 NCBI chr 8:117,561,206...117,594,456
Ensembl chr 8:117,561,240...117,569,412 		JBrowse link
G Cdk14 cyclin-dependent kinase 14 decreases expression ISO chrysene results in decreased expression of CDK14 mRNA CTD PMID:26377693 NCBI chr 4:29,619,237...30,213,651
Ensembl chr 4:29,621,217...30,213,651 		JBrowse link
G Cdkn1a cyclin-dependent kinase inhibitor 1A multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of CDKN1A mRNA CTD PMID:27858113 NCBI chr20:7,150,820...7,161,373
Ensembl chr20:7,153,958...7,164,969 		JBrowse link
G Cebpd CCAAT/enhancer binding protein delta decreases expression ISO chrysene results in decreased expression of CEBPD mRNA CTD PMID:26377693 NCBI chr11:98,268,856...98,269,994
Ensembl chr11:98,265,651...98,280,824 		JBrowse link
G Celf5 CUGBP, Elav-like family member 5 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of CELF5 mRNA CTD PMID:27858113 NCBI chr 7:8,876,551...8,901,078
Ensembl chr 7:8,876,564...8,901,069 		JBrowse link
G Celsr2 cadherin, EGF LAG seven-pass G-type receptor 2 increases expression ISO chrysene results in increased expression of CELSR2 mRNA CTD PMID:26377693 NCBI chr 2:198,717,333...198,741,689
Ensembl chr 2:198,717,896...198,741,581 		JBrowse link
G Cep162 centrosomal protein 162 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of CEP162 mRNA CTD PMID:27858113 NCBI chr 8:97,029,677...97,088,243
Ensembl chr 8:97,029,677...97,088,207 		JBrowse link
G Cep41 centrosomal protein 41 decreases expression ISO chrysene results in decreased expression of CEP41 mRNA CTD PMID:26377693 NCBI chr 4:60,238,602...60,279,670
Ensembl chr 4:60,239,539...60,254,419 		JBrowse link
G Cep63 centrosomal protein 63 increases expression ISO chrysene results in increased expression of CEP63 mRNA CTD PMID:26377693 NCBI chr 8:112,041,586...112,093,061
Ensembl chr 8:112,041,594...112,084,646 		JBrowse link
G Ces2c carboxylesterase 2C multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of CES2C mRNA CTD PMID:27858113 NCBI chr 1:270,377,201...270,384,768
Ensembl chr 1:270,374,913...270,384,801 		JBrowse link
G Ces2e carboxylesterase 2E multiple interactions
increases expression 		ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of CES2E mRNA
chrysene results in increased expression of CES2E mRNA 		CTD PMID:26377693 PMID:27858113 NCBI chr19:163,899...179,274
Ensembl chr19:163,859...179,308 		JBrowse link
G Cfb complement factor B multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of CFB mRNA CTD PMID:27858113 NCBI chr20:3,975,271...3,981,138
Ensembl chr20:3,955,776...3,981,740 		JBrowse link
G Chd2 chromodomain helicase DNA binding protein 2 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of CHD2 mRNA CTD PMID:27858113 NCBI chr 1:136,597,993...136,726,874
Ensembl chr 1:136,599,900...136,710,335 		JBrowse link
G Chia chitinase, acidic multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of CHIA mRNA CTD PMID:27858113 NCBI chr 2:196,302,687...196,344,849
Ensembl chr 2:196,302,545...196,344,850 		JBrowse link
G Chka choline kinase alpha decreases expression ISO chrysene results in decreased expression of CHKA mRNA CTD PMID:26377693 NCBI chr 1:210,506,069...210,554,753
Ensembl chr 1:210,506,056...210,554,752 		JBrowse link
G Chst1 carbohydrate sulfotransferase 1 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of CHST1 mRNA CTD PMID:27858113 NCBI chr 3:99,003,987...99,030,214
Ensembl chr 3:99,009,958...99,031,262 		JBrowse link
G Cirbp cold inducible RNA binding protein multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of CIRBP mRNA CTD PMID:27858113 NCBI chr 7:10,184,515...10,189,623 JBrowse link
G Cish cytokine inducible SH2-containing protein decreases expression ISO chrysene results in decreased expression of CISH mRNA CTD PMID:26377693 NCBI chr 8:116,850,969...116,855,917
Ensembl chr 8:116,850,773...116,855,986 		JBrowse link
G Cited2 Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of CITED2 mRNA CTD PMID:27858113 NCBI chr 1:14,132,303...14,134,746
Ensembl chr 1:14,103,457...14,134,782 		JBrowse link
G Ckap2 cytoskeleton associated protein 2 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of CKAP2 mRNA CTD PMID:27858113 NCBI chr16:76,542,114...76,567,297
Ensembl chr16:76,542,104...76,567,352 		JBrowse link
G Clasrp CLK4-associating serine/arginine rich protein increases expression ISO chrysene results in increased expression of SFRS16 mRNA CTD PMID:26377693 NCBI chr 1:88,360,235...88,384,343
Ensembl chr 1:88,360,235...88,384,343 		JBrowse link
G Clec1a C-type lectin domain family 1, member A multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of CLEC1A mRNA CTD PMID:27858113 NCBI chr 4:164,561,385...164,588,593
Ensembl chr 4:164,563,374...164,587,269 		JBrowse link
G Clec4a1 C-type lectin domain family 4, member A1 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of CLEC4A1 mRNA CTD PMID:27858113 NCBI chr 4:157,845,811...157,857,926
Ensembl chr 4:157,845,752...157,858,273 		JBrowse link
G Clec4f C-type lectin domain family 4, member F decreases expression ISO chrysene results in decreased expression of CLEC4F mRNA CTD PMID:26377693 NCBI chr 4:117,686,686...117,696,407
Ensembl chr 4:117,686,686...117,696,438 		JBrowse link
G Clec4g C-type lectin domain family 4, member G multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of CLEC4G mRNA CTD PMID:27858113 NCBI chr12:6,578,266...6,582,913
Ensembl chr12:6,578,258...6,582,894 		JBrowse link
G Clk4 CDC-like kinase 4 increases expression ISO chrysene results in increased expression of CLK4 mRNA CTD PMID:26377693 NCBI chr10:36,024,364...36,042,366
Ensembl chr10:36,024,427...36,042,372 		JBrowse link
G Clstn2 calsyntenin 2 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of CLSTN2 mRNA CTD PMID:27858113 NCBI chr 8:106,899,894...107,516,402
Ensembl chr 8:106,899,894...107,040,053 		JBrowse link
G Cmpk2 cytidine/uridine monophosphate kinase 2 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of CMPK2 mRNA CTD PMID:27858113 NCBI chr 6:48,802,150...48,813,652
Ensembl chr 6:48,802,321...48,813,652 		JBrowse link
G Cobl cordon-bleu WH2 repeat protein multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of COBL mRNA CTD PMID:27858113 NCBI chr14:91,041,721...91,274,272
Ensembl chr14:91,041,721...91,274,257 		JBrowse link
G Col17a1 collagen type XVII alpha 1 chain increases expression ISO chrysene results in increased expression of COL17A1 mRNA CTD PMID:26377693 NCBI chr 1:256,472,648...256,518,857
Ensembl chr 1:256,472,648...256,518,851 		JBrowse link
G Col1a1 collagen type I alpha 1 chain multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of COL1A1 mRNA CTD PMID:27858113 NCBI chr10:80,380,458...80,397,461
Ensembl chr10:80,380,453...80,397,460 		JBrowse link
G Col1a2 collagen type I alpha 2 chain multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of COL1A2 mRNA CTD PMID:27858113 NCBI chr 4:33,518,557...33,553,484
Ensembl chr 4:33,518,420...33,553,995 		JBrowse link
G Col20a1 collagen type XX alpha 1 chain multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of COL20A1 mRNA CTD PMID:27858113 NCBI chr 3:188,477,663...188,512,326
Ensembl chr 3:188,465,648...188,511,078 		JBrowse link
G Col3a1 collagen type III alpha 1 chain multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of COL3A1 mRNA; [chrysene co-treated with Tobacco Smoke Pollution] results in increased expression of COL3A1 protein; chrysene promotes the reaction [Tobacco Smoke Pollution results in increased expression of COL3A1 protein] CTD PMID:27858113 PMID:33345606 NCBI chr 9:54,866,646...54,902,578
Ensembl chr 9:54,866,632...54,903,232 		JBrowse link
G Col4a4 collagen type IV alpha 4 chain decreases expression
multiple interactions 		ISO chrysene results in decreased expression of COL4A4 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of COL4A4 mRNA 		CTD PMID:26377693 PMID:27858113 NCBI chr 9:91,281,324...91,323,577
Ensembl chr 9:91,203,670...91,323,577 		JBrowse link
G Col4a6 collagen type IV alpha 6 chain increases expression ISO chrysene results in increased expression of COL4A6 mRNA CTD PMID:26377693 NCBI chr  X:109,554,945...109,905,987
Ensembl chr  X:109,552,651...109,905,944 		JBrowse link
G Col5a3 collagen type V alpha 3 chain multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of COL5A3 mRNA CTD PMID:27858113 NCBI chr 8:27,580,768...27,626,002
Ensembl chr 8:27,580,768...27,626,122 		JBrowse link
G Commd3 COMM domain containing 3 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of COMMD3 mRNA CTD PMID:27858113 NCBI chr17:86,235,863...86,239,610
Ensembl chr17:86,235,863...86,239,610 		JBrowse link
G Cope COPI coat complex subunit epsilon decreases expression ISO chrysene results in decreased expression of COPE mRNA CTD PMID:26377693 NCBI chr16:19,148,832...19,159,052
Ensembl chr16:19,148,832...19,159,212 		JBrowse link
G Coprs coordinator of PRMT5 and differentiation stimulator decreases expression ISO chrysene results in decreased expression of COPRS mRNA CTD PMID:26377693 NCBI chr16:82,423,426...82,428,821
Ensembl chr16:82,407,580...82,431,737 		JBrowse link
G Coq10b coenzyme Q10B multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of COQ10B mRNA CTD PMID:27858113 NCBI chr 9:64,048,168...64,068,082
Ensembl chr 9:64,048,103...64,068,322 		JBrowse link
G Coq8a coenzyme Q8A multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of COQ8A mRNA CTD PMID:27858113 NCBI chr13:94,436,680...94,465,535
Ensembl chr13:94,436,546...94,463,378 		JBrowse link
G Coro2a coronin 2A multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of CORO2A mRNA CTD PMID:27858113 NCBI chr 5:65,623,820...65,677,483
Ensembl chr 5:65,623,823...65,654,602 		JBrowse link
G Cplx2 complexin 2 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of CPLX2 mRNA CTD PMID:27858113 NCBI chr17:10,224,673...10,297,974
Ensembl chr17:10,228,449...10,297,467 		JBrowse link
G Cpne4 copine 4 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of CPNE4 mRNA CTD PMID:27858113 NCBI chr 8:114,056,152...114,531,855
Ensembl chr 8:113,993,703...114,531,855 		JBrowse link
G Cpne5 copine 5 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of CPNE5 mRNA CTD PMID:27858113 NCBI chr20:7,208,389...7,290,959
Ensembl chr20:7,208,389...7,292,064 		JBrowse link
G Cpt1c carnitine palmitoyltransferase 1c multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of CPT1C mRNA CTD PMID:27858113 NCBI chr 1:104,579,297...104,593,824
Ensembl chr 1:104,579,298...104,593,763 		JBrowse link
G Cpxm2 carboxypeptidase X (M14 family), member 2 increases expression ISO chrysene results in increased expression of CPXM2 mRNA CTD PMID:26377693 NCBI chr 1:196,266,930...196,377,350
Ensembl chr 1:196,266,930...196,377,347 		JBrowse link
G Cr2 complement C3d receptor 2 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of CR2 mRNA CTD PMID:27858113 NCBI chr13:109,207,034...109,244,980
Ensembl chr13:109,213,867...109,244,552 		JBrowse link
G Crct1 cysteine-rich C-terminal 1 increases expression ISO chrysene results in increased expression of CRCT1 mRNA CTD PMID:26377693 NCBI chr 2:181,329,392...181,330,877
Ensembl chr 2:181,329,392...181,330,877 		JBrowse link
G Crispld2 cysteine-rich secretory protein LCCL domain containing 2 increases expression ISO chrysene results in increased expression of CRISPLD2 mRNA CTD PMID:26377693 NCBI chr19:64,961,764...65,020,099
Ensembl chr19:64,961,771...65,020,349 		JBrowse link
G Crk CRK proto-oncogene, adaptor protein multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of CRK mRNA CTD PMID:27858113 NCBI chr10:61,028,736...61,054,971
Ensembl chr10:61,028,757...61,082,988 		JBrowse link
G Csnk1g2 casein kinase 1, gamma 2 increases expression ISO chrysene results in increased expression of CSNK1G2 mRNA CTD PMID:26377693 NCBI chr 7:9,727,430...9,746,341
Ensembl chr 7:9,727,431...9,745,741 		JBrowse link
G Cst8 cystatin 8 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of CST8 mRNA CTD PMID:27858113 NCBI chr 3:156,697,776...156,704,413
Ensembl chr 3:156,697,767...156,724,636 		JBrowse link
G Cxcl13 C-X-C motif chemokine ligand 13 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of CXCL13 mRNA CTD PMID:27858113 NCBI chr14:13,912,858...13,917,920
Ensembl chr14:13,912,858...13,917,920 		JBrowse link
G Cxcr5 C-X-C motif chemokine receptor 5 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of CXCR5 mRNA CTD PMID:27858113 NCBI chr 8:53,738,878...53,756,813
Ensembl chr 8:53,740,197...53,754,816 		JBrowse link
G Cxcr6 C-X-C motif chemokine receptor 6 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of CXCR6 mRNA CTD PMID:27858113 NCBI chr 8:132,311,834...132,317,001
Ensembl chr 8:132,306,600...132,322,498 		JBrowse link
G Cyld CYLD lysine 63 deubiquitinase multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of CYLD mRNA CTD PMID:27858113 NCBI chr19:34,487,491...34,547,311
Ensembl chr19:34,488,583...34,547,118 		JBrowse link
G Cyp17a1 cytochrome P450, family 17, subfamily a, polypeptide 1 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of CYP17A1 mRNA CTD PMID:27858113 NCBI chr 1:255,476,861...255,484,547
Ensembl chr 1:255,476,861...255,482,974 		JBrowse link
G Cyp1a1 cytochrome P450, family 1, subfamily a, polypeptide 1 multiple interactions
increases expression
decreases expression
increases activity 		ISO
EXP 		[benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with Benzo(a)pyrene co-treated with chrysene] results in increased expression of CYP1A1 mRNA; [benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with Benzo(a)pyrene co-treated with chrysene] results in increased expression of CYP1A1 protein; [chrysene binds to and results in increased activity of AHR protein] which results in increased expression of CYP1A1 mRNA; [CYP1A1 protein co-treated with Trichloroepoxypropane] results in increased metabolism of chrysene; alpha-naphthoflavone inhibits the reaction [[chrysene binds to and results in increased activity of AHR protein] which results in increased expression of CYP1A1 mRNA]; chrysene promotes the reaction [AHR protein results in increased expression of CYP1A1 mRNA]; EPHX1 protein promotes the reaction [CYP1A1 protein results in increased metabolism of chrysene]
chrysene results in increased expression of CYP1A1 mRNA; chrysene results in increased expression of CYP1A1 protein
chrysene results in decreased expression of CYP1A1 mRNA
chrysene results in increased activity of CYP1A1 protein
[chrysene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene] promotes the reaction [Benzo(a)pyrene results in increased expression of CYP1A1 mRNA]; [chrysene co-treated with benz(a)anthracene] promotes the reaction [Benzo(a)pyrene results in increased expression of CYP1A1 mRNA]; [chrysene co-treated with Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene] results in increased expression of CYP1A1 mRNA; [chrysene co-treated with Benzo(a)pyrene co-treated with benz(a)anthracene] results in increased expression of CYP1A1 mRNA; [chrysene co-treated with Benzo(a)pyrene] results in increased expression of CYP1A1 mRNA; chrysene inhibits the reaction [Benzo(a)pyrene results in increased expression of CYP1A1 mRNA]
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of CYP1A1 mRNA; [CYP1A1 protein co-treated with Trichloroepoxypropane] results in increased metabolism of chrysene; [fluoranthene co-treated with pyrene co-treated with benz(a)anthracene co-treated with chrysene co-treated with benzo(b)fluoranthene co-treated with benzo(k)fluoranthene co-treated with Benzo(a)pyrene] results in increased expression of CYP1A1 mRNA; EPHX1 protein promotes the reaction [CYP1A1 protein results in increased metabolism of chrysene] 		CTD PMID:7750161 PMID:8961944 PMID:10190573 PMID:12107646 PMID:12117779 More... NCBI chr 8:66,991,940...66,998,014
Ensembl chr 8:66,991,970...66,998,012 		JBrowse link
G Cyp1a2 cytochrome P450, family 1, subfamily a, polypeptide 2 multiple interactions
increases expression 		ISO
EXP 		[CYP1A2 protein co-treated with Trichloroepoxypropane] results in increased metabolism of chrysene; EPHX1 protein promotes the reaction [CYP1A2 protein results in increased metabolism of chrysene]
[chrysene co-treated with Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene] results in increased expression of CYP1A2 mRNA; [chrysene co-treated with Benzo(a)pyrene co-treated with benz(a)anthracene] results in increased expression of CYP1A2 mRNA; [chrysene co-treated with Benzo(a)pyrene] results in increased expression of CYP1A2 mRNA
chrysene results in increased expression of CYP1A2 mRNA
[CYP1A2 protein co-treated with Trichloroepoxypropane] results in increased metabolism of chrysene; [fluoranthene co-treated with pyrene co-treated with benz(a)anthracene co-treated with chrysene co-treated with benzo(b)fluoranthene co-treated with benzo(k)fluoranthene co-treated with Benzo(a)pyrene] results in increased expression of CYP1A2 mRNA; EPHX1 protein promotes the reaction [CYP1A2 protein results in increased metabolism of chrysene] 		CTD PMID:7750161 PMID:8961944 PMID:12107646 PMID:17253728 PMID:31087746 More... NCBI chr 8:66,971,261...66,978,149
Ensembl chr 8:66,971,261...66,978,149 		JBrowse link
G Cyp1b1 cytochrome P450, family 1, subfamily b, polypeptide 1 multiple interactions
increases expression 		EXP
ISO 		[benz(a)anthracene co-treated with benzo(b)fluoranthene] promotes the reaction [chrysene promotes the reaction [Benzo(a)pyrene results in increased expression of CYP1B1 mRNA]]; [chrysene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene] promotes the reaction [Benzo(a)pyrene results in increased expression of CYP1B1 mRNA]; [chrysene co-treated with benz(a)anthracene] promotes the reaction [Benzo(a)pyrene results in increased expression of CYP1B1 mRNA]; [chrysene co-treated with Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene] results in increased expression of CYP1B1 mRNA; [chrysene co-treated with Benzo(a)pyrene co-treated with benz(a)anthracene] results in increased expression of CYP1B1 mRNA; [chrysene co-treated with Benzo(a)pyrene] results in increased expression of CYP1B1 mRNA; chrysene inhibits the reaction [Benzo(a)pyrene results in increased expression of CYP1B1 mRNA]; chrysene promotes the reaction [Benzo(a)pyrene results in increased expression of CYP1B1 mRNA]
[benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with Benzo(a)pyrene co-treated with chrysene] results in increased expression of CYP1B1 mRNA; [benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with Benzo(a)pyrene co-treated with chrysene] results in increased expression of CYP1B1 protein
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of CYP1B1 mRNA
chrysene results in increased expression of CYP1B1 mRNA; chrysene results in increased expression of CYP1B1 protein 		CTD PMID:12107646 PMID:12117779 PMID:15315710 PMID:15566942 PMID:17253728 More... NCBI chr 6:21,093,927...21,103,091
Ensembl chr 6:21,078,146...21,103,142 		JBrowse link
G Cyp2e1 cytochrome P450, family 2, subfamily e, polypeptide 1 increases expression ISO chrysene results in increased expression of CYP2E1 mRNA CTD PMID:26377693 NCBI chr 1:205,269,967...205,280,365
Ensembl chr 1:205,267,505...205,293,495 		JBrowse link
G Cys1 cystin 1 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of CYS1 mRNA CTD PMID:27858113 NCBI chr 6:47,029,440...47,046,671
Ensembl chr 6:47,028,461...47,046,671 		JBrowse link
G Cysrt1 cysteine rich tail 1 increases expression ISO chrysene results in increased expression of CYSRT1 mRNA CTD PMID:26377693 NCBI chr 3:28,452,359...28,456,006
Ensembl chr 3:28,451,219...28,456,118 		JBrowse link
G Dancr differentiation antagonizing non-protein coding RNA increases expression ISO chrysene results in increased expression of DANCR mRNA CTD PMID:26377693 NCBI chr14:34,481,052...34,482,032 JBrowse link
G Dars1 aspartyl-tRNA synthetase 1 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of DARS1 mRNA CTD PMID:27858113 NCBI chr13:42,410,351...42,465,467
Ensembl chr13:42,379,162...42,465,467 		JBrowse link
G Dbp D-box binding PAR bZIP transcription factor increases expression
multiple interactions 		ISO chrysene results in increased expression of DBP mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of DBP mRNA 		CTD PMID:26377693 PMID:27858113 NCBI chr 1:105,312,256...105,317,205
Ensembl chr 1:105,312,108...105,317,205 		JBrowse link
G Dcaf12l2 DDB1 and CUL4 associated factor 12-like 2 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of DCAF12L2 mRNA CTD PMID:27858113 NCBI chr  X:128,167,040...128,169,829
Ensembl chr  X:128,167,040...128,169,829 		JBrowse link
G Dcaf4 DDB1 and CUL4 associated factor 4 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of DCAF4 mRNA CTD PMID:27858113 NCBI chr 6:108,885,970...108,912,116
Ensembl chr 6:108,885,932...108,912,110 		JBrowse link
G Dcc DCC netrin 1 receptor multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of DCC mRNA CTD PMID:27858113 NCBI chr18:67,144,272...68,248,159
Ensembl chr18:67,149,179...68,247,541 		JBrowse link
G Dcn decorin multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of DCN mRNA CTD PMID:27858113 NCBI chr 7:34,167,973...34,208,004
Ensembl chr 7:34,163,011...34,218,926 		JBrowse link
G Ddah1 dimethylarginine dimethylaminohydrolase 1 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of DDAH1 mRNA CTD PMID:27858113 NCBI chr 2:237,327,812...237,460,624
Ensembl chr 2:237,327,766...237,460,626 		JBrowse link
G Ddc dopa decarboxylase multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of DDC mRNA CTD PMID:27858113 NCBI chr14:90,592,304...90,682,830
Ensembl chr14:90,592,304...90,682,806 		JBrowse link
G Ddias DNA damage-induced apoptosis suppressor multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of DDIAS mRNA CTD PMID:27858113 NCBI chr 1:156,318,559...156,342,869
Ensembl chr 1:156,318,563...156,342,869 		JBrowse link
G Ddit4l DNA-damage-inducible transcript 4-like multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of DDIT4L mRNA CTD PMID:27858113 NCBI chr 2:228,800,831...228,804,478
Ensembl chr 2:228,801,705...228,806,225 		JBrowse link
G Ddx25 DEAD-box helicase 25 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of DDX25 mRNA CTD PMID:27858113 NCBI chr 8:42,152,046...42,168,635
Ensembl chr 8:42,152,047...42,168,080 		JBrowse link
G Ddx5 DEAD-box helicase 5 increases expression
multiple interactions 		ISO chrysene results in increased expression of DDX5 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of DDX5 mRNA 		CTD PMID:26377693 PMID:27858113 NCBI chr10:92,224,393...92,231,928
Ensembl chr10:92,224,395...92,231,300 		JBrowse link
G Def6 DEF6 guanine nucleotide exchange factor increases expression ISO chrysene results in increased expression of DEF6 mRNA CTD PMID:26377693 NCBI chr20:6,270,323...6,291,724
Ensembl chr20:6,269,357...6,291,771 		JBrowse link
G Dgat2 diacylglycerol O-acyltransferase 2 increases expression
multiple interactions 		ISO chrysene results in increased expression of DGAT2 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of DGAT2 mRNA 		CTD PMID:26377693 PMID:27858113 NCBI chr 1:162,866,237...162,896,655
Ensembl chr 1:162,866,237...162,896,566 		JBrowse link
G Dgka diacylglycerol kinase, alpha increases expression ISO chrysene results in increased expression of DGKA mRNA CTD PMID:26377693 NCBI chr 7:1,733,247...1,761,181
Ensembl chr 7:1,733,248...1,759,569 		JBrowse link
G Dgkq diacylglycerol kinase, theta increases expression ISO chrysene results in increased expression of DGKQ mRNA CTD PMID:26377693 NCBI chr14:1,203,380...1,217,536
Ensembl chr14:1,203,565...1,218,024 		JBrowse link
G Diaph1 diaphanous-related formin 1 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of DIAP1 mRNA CTD PMID:27858113 NCBI chr18:29,920,889...30,020,280
Ensembl chr18:29,920,889...30,020,280 		JBrowse link
G Dicer1 dicer 1 ribonuclease III increases expression ISO chrysene results in increased expression of DICER1 mRNA CTD PMID:26377693 NCBI chr 6:129,392,298...129,457,252
Ensembl chr 6:129,396,014...129,457,252 		JBrowse link
G Dido1 death inducer-obliterator 1 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of DIDO1 mRNA CTD PMID:27858113 NCBI chr 3:188,150,100...188,203,445
Ensembl chr 3:188,150,100...188,194,823 		JBrowse link
G Dipk1b divergent protein kinase domain 1B multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of DIPK1B mRNA CTD PMID:27858113 NCBI chr 3:29,852,710...29,862,248
Ensembl chr 3:29,853,973...29,862,255 		JBrowse link
G Dixdc1 DIX domain containing 1 decreases expression ISO chrysene results in decreased expression of DIXDC1 mRNA CTD PMID:26377693 NCBI chr 8:59,904,218...59,977,595
Ensembl chr 8:59,904,218...59,978,447 		JBrowse link
G Dmtf1 cyclin D binding myb-like transcription factor 1 decreases expression ISO chrysene results in decreased expression of DMTF1 mRNA CTD PMID:26377693 NCBI chr 4:25,864,891...25,905,916
Ensembl chr 4:25,865,447...25,905,943 		JBrowse link
G Dnaja1 DnaJ heat shock protein family (Hsp40) member A1 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of DNAJA1 mRNA CTD PMID:27858113 NCBI chr 5:60,638,404...60,649,315
Ensembl chr 5:60,638,410...60,650,160 		JBrowse link
G Dnajb4 DnaJ heat shock protein family (Hsp40) member B4 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of DNAJB4 mRNA CTD PMID:27858113 NCBI chr 2:243,790,296...243,819,042
Ensembl chr 2:243,790,297...243,819,042 		JBrowse link
G Dnajb5 DnaJ heat shock protein family (Hsp40) member B5 increases expression ISO chrysene results in increased expression of DNAJB5 mRNA CTD PMID:26377693 NCBI chr 5:61,972,637...61,981,887
Ensembl chr 5:61,972,706...61,981,860 		JBrowse link
G Dnajc8 DnaJ heat shock protein family (Hsp40) member C8 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of DNAJC8 mRNA CTD PMID:27858113 NCBI chr 5:150,029,064...150,047,115
Ensembl chr 5:150,026,286...150,047,117 		JBrowse link
G Dnm2 dynamin 2 increases expression ISO chrysene results in increased expression of DNM2 mRNA CTD PMID:26377693 NCBI chr 8:28,254,344...28,336,297
Ensembl chr 8:28,254,529...28,336,295 		JBrowse link
G Dolpp1 dolichyldiphosphatase 1 increases expression ISO chrysene results in increased expression of DOLPP1 mRNA CTD PMID:26377693 NCBI chr 3:34,063,825...34,072,133
Ensembl chr 3:34,063,825...34,072,132 		JBrowse link
G Dtl denticleless E3 ubiquitin protein ligase homolog multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of DTL mRNA CTD PMID:27858113 NCBI chr13:105,646,908...105,685,921
Ensembl chr13:105,646,908...105,686,174 		JBrowse link
G Dtx4 deltex E3 ubiquitin ligase 4 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of DTX4 mRNA CTD PMID:27858113 NCBI chr 1:218,882,391...218,969,837
Ensembl chr 1:218,832,284...218,917,130 		JBrowse link
G Dusp3 dual specificity phosphatase 3 decreases expression ISO chrysene results in decreased expression of DUSP3 mRNA CTD PMID:26377693 NCBI chr10:87,420,213...87,434,202
Ensembl chr10:87,419,494...87,434,063 		JBrowse link
G Dvl3 dishevelled segment polarity protein 3 decreases expression
multiple interactions 		ISO chrysene results in decreased expression of DVL3 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of DVL3 mRNA 		CTD PMID:26377693 PMID:27858113 NCBI chr11:93,869,834...93,887,013
Ensembl chr11:93,869,834...93,886,903 		JBrowse link
G Dzip1 DAZ interacting zinc finger protein 1 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of DZIP1 mRNA CTD PMID:27858113 NCBI chr15:102,363,392...102,417,085
Ensembl chr15:102,363,392...102,417,085 		JBrowse link
G Ecm1 extracellular matrix protein 1 increases expression
multiple interactions 		ISO chrysene results in increased expression of ECM1 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of ECM1 mRNA 		CTD PMID:26377693 PMID:27858113 NCBI chr 2:185,976,439...185,981,656
Ensembl chr 2:185,976,440...185,981,606 		JBrowse link
G Ednrb endothelin receptor type B multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of EDNRB mRNA CTD PMID:27858113 NCBI chr15:87,055,490...87,086,765
Ensembl chr15:87,057,691...87,086,765 		JBrowse link
G Efhd1 EF-hand domain family, member D1 increases expression ISO chrysene results in increased expression of EFHD1 mRNA CTD PMID:26377693 NCBI chr 9:95,386,155...95,432,800
Ensembl chr 9:95,386,169...95,432,798 		JBrowse link
G Efna1 ephrin A1 increases expression ISO chrysene results in increased expression of EFNA1 mRNA CTD PMID:26377693 NCBI chr 2:176,979,434...176,988,675
Ensembl chr 2:176,979,434...176,988,726 		JBrowse link
G Efnb1 ephrin B1 decreases expression
multiple interactions 		ISO chrysene results in decreased expression of EFNB1 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of EFNB1 mRNA 		CTD PMID:26377693 PMID:27858113 NCBI chr  X:68,297,529...68,310,335
Ensembl chr  X:68,297,492...68,349,546 		JBrowse link
G Efs embryonal Fyn-associated substrate increases expression ISO chrysene results in increased expression of EFS mRNA CTD PMID:26377693 NCBI chr15:32,362,401...32,374,490
Ensembl chr15:32,361,843...32,371,743 		JBrowse link
G Ehbp1 EH domain binding protein 1 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of EHBP1 mRNA CTD PMID:27858113 NCBI chr14:100,294,585...100,581,764
Ensembl chr14:100,294,585...100,546,579 		JBrowse link
G Ehd1 EH-domain containing 1 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of EHD1 mRNA CTD PMID:27858113 NCBI chr 1:213,009,113...213,031,488
Ensembl chr 1:213,008,049...213,031,485 		JBrowse link
G Ehd4 EH-domain containing 4 increases expression
multiple interactions 		ISO chrysene results in increased expression of EHD4 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of EHD4 mRNA 		CTD PMID:26377693 PMID:27858113 NCBI chr 3:127,511,973...127,575,856
Ensembl chr 3:127,511,954...127,576,072 		JBrowse link
G Eif1 eukaryotic translation initiation factor 1 increases expression ISO chrysene results in increased expression of EIF1 mRNA CTD PMID:26377693 NCBI chr10:85,747,064...85,749,447
Ensembl chr 5:25,895,968...25,896,654
Ensembl chr10:25,895,968...25,896,654 		JBrowse link
G Eif3d eukaryotic translation initiation factor 3, subunit D increases expression ISO chrysene results in increased expression of EIF3D mRNA CTD PMID:26377693 NCBI chr 7:111,420,351...111,432,761
Ensembl chr 7:111,420,351...111,432,740 		JBrowse link
G Eif4ebp3 eukaryotic translation initiation factor 4E binding protein 3 increases expression ISO chrysene results in increased expression of EIF4EBP3 mRNA CTD PMID:26377693 NCBI chr18:28,540,324...28,542,070
Ensembl chr18:28,540,058...28,542,061 		JBrowse link
G Eif4g1 eukaryotic translation initiation factor 4 gamma 1 increases expression ISO chrysene results in increased expression of EIF4G1 mRNA CTD PMID:26377693 NCBI chr11:93,726,322...93,746,387
Ensembl chr11:93,726,322...93,746,367 		JBrowse link
G Eif4g3 eukaryotic translation initiation factor 4 gamma, 3 increases expression ISO chrysene results in increased expression of EIF4G3 mRNA CTD PMID:26377693 NCBI chr 5:155,481,378...155,702,194
Ensembl chr 5:155,481,378...155,702,194 		JBrowse link
G Emcn endomucin multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of EMCN mRNA CTD PMID:27858113 NCBI chr 2:228,564,445...228,644,370
Ensembl chr 2:228,564,430...228,645,155 		JBrowse link
G Eml1 EMAP like 1 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of EML1 mRNA CTD PMID:27858113 NCBI chr 6:133,048,271...133,221,642
Ensembl chr 6:133,048,427...133,221,642 		JBrowse link
G Epb41 erythrocyte membrane protein band 4.1 decreases expression
multiple interactions 		ISO chrysene results in decreased expression of EPB41 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of EPB41 mRNA 		CTD PMID:26377693 PMID:27858113 NCBI chr 5:149,394,080...149,548,178
Ensembl chr 5:149,394,096...149,543,540 		JBrowse link
G Epha1 Eph receptor A1 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of EPHA1 mRNA CTD PMID:27858113 NCBI chr 4:72,213,022...72,227,543
Ensembl chr 4:72,213,037...72,227,474 		JBrowse link
G Ephx1 epoxide hydrolase 1 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of EPHX1 mRNA; EPHX1 protein promotes the reaction [CYP1A1 protein results in increased metabolism of chrysene]; EPHX1 protein promotes the reaction [CYP1A2 protein results in increased metabolism of chrysene] CTD PMID:8961944 PMID:27858113 NCBI chr13:95,246,079...95,275,852
Ensembl chr13:95,246,080...95,321,981 		JBrowse link
G Epor erythropoietin receptor multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of EPOR mRNA CTD PMID:27858113 NCBI chr 8:28,765,738...28,770,371
Ensembl chr 8:28,765,746...28,770,322 		JBrowse link
G Ermn ermin multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of ERMN mRNA CTD PMID:27858113 NCBI chr 3:63,037,001...63,042,657
Ensembl chr 3:63,035,150...63,042,585 		JBrowse link
G Esr1 estrogen receptor 1 multiple interactions
increases expression 		ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with chrysene] results in increased expression of ESR1 mRNA
chrysene results in increased expression of ESR1 mRNA 		CTD PMID:11922773 NCBI chr 1:43,511,685...43,904,454
Ensembl chr 1:43,644,392...43,900,354 		JBrowse link
G Ewsr1 EWS RNA-binding protein 1 decreases expression ISO chrysene results in decreased expression of EWSR1 mRNA CTD PMID:26377693 NCBI chr14:84,179,413...84,208,149
Ensembl chr14:84,179,618...84,208,095 		JBrowse link
G Exoc4 exocyst complex component 4 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of EXOC4 mRNA CTD PMID:27858113 NCBI chr 4:62,774,896...63,551,541
Ensembl chr 4:62,774,935...63,552,943 		JBrowse link
G Exoc6b exocyst complex component 6B increases expression ISO chrysene results in increased expression of EXOC6B mRNA CTD PMID:26377693 NCBI chr 4:118,652,279...119,107,725
Ensembl chr 4:118,652,279...119,107,683 		JBrowse link
G F13a1 coagulation factor XIII A1 chain increases expression ISO chrysene results in increased expression of F13A1 mRNA CTD PMID:26377693 NCBI chr17:28,021,197...28,197,960
Ensembl chr17:28,020,845...28,197,948 		JBrowse link
G F5 coagulation factor V increases expression ISO chrysene results in increased expression of F5 mRNA CTD PMID:26377693 NCBI chr13:79,046,657...79,116,247
Ensembl chr13:79,046,448...79,116,247 		JBrowse link
G Fam107a family with sequence similarity 107, member A multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of FAM107A mRNA CTD PMID:27858113 NCBI chr15:19,038,726...19,060,644
Ensembl chr15:19,038,616...19,065,219 		JBrowse link
G Fam110d family with sequence similarity 110, member D multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of FAM110D mRNA CTD PMID:27858113 NCBI chr 5:151,754,773...151,757,743
Ensembl chr 5:151,753,891...151,757,768 		JBrowse link
G Fam133b family with sequence similarity 133, member B multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of FAM133B mRNA CTD PMID:27858113 NCBI chr 4:31,544,458...31,571,056
Ensembl chr 4:31,544,458...31,570,780 		JBrowse link
G Fam13c family with sequence similarity 13, member C multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of FAM13C mRNA CTD PMID:27858113 NCBI chr20:18,064,706...18,186,888
Ensembl chr20:18,064,706...18,286,674 		JBrowse link
G Fam20b FAM20B, glycosaminoglycan xylosylkinase multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of FAM20B mRNA CTD PMID:27858113 NCBI chr13:71,351,834...71,390,192
Ensembl chr13:71,351,834...71,387,882 		JBrowse link
G Farp1 FERM, ARH/RhoGEF and pleckstrin domain protein 1 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of FARP1 mRNA CTD PMID:27858113 NCBI chr15:104,531,196...104,770,148
Ensembl chr15:104,531,813...104,770,147 		JBrowse link
G Fastk Fas-activated serine/threonine kinase multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of FASTK mRNA CTD PMID:27858113 NCBI chr 4:11,624,697...11,628,769
Ensembl chr 4:11,624,689...11,629,867 		JBrowse link
G Fat2 FAT atypical cadherin 2 increases expression ISO chrysene results in increased expression of FAT2 mRNA CTD PMID:26377693 NCBI chr10:39,864,765...39,957,027
Ensembl chr10:39,864,766...39,956,902 		JBrowse link
G Fbxo2 F-box protein 2 decreases expression ISO chrysene results in decreased expression of FBXO2 mRNA CTD PMID:26377693 NCBI chr 5:163,876,079...163,881,508
Ensembl chr 5:163,875,757...163,881,508 		JBrowse link
G Fcer2 Fc epsilon receptor II multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of FCER2A mRNA CTD PMID:27858113 NCBI chr12:6,540,697...6,552,364
Ensembl chr12:6,540,703...6,549,374 		JBrowse link
G Fdxacb1 ferredoxin-fold anticodon binding domain containing 1 increases expression ISO chrysene results in increased expression of FDXACB1 mRNA CTD PMID:26377693 NCBI chr 8:60,009,818...60,014,625 JBrowse link
G Fgf9 fibroblast growth factor 9 increases expression ISO chrysene results in increased expression of FGF9 mRNA CTD PMID:26377693 NCBI chr15:36,325,552...36,369,995
Ensembl chr15:36,325,599...36,367,926 		JBrowse link
G Fgfr1op2 FGFR1 oncogene partner 2 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of FGFR1OP2 mRNA CTD PMID:27858113 NCBI chr 4:181,222,298...181,243,318
Ensembl chr 4:181,222,323...181,243,322 		JBrowse link
G Fgfr3 fibroblast growth factor receptor 3 increases expression ISO chrysene results in increased expression of FGFR3 mRNA CTD PMID:26377693 NCBI chr14:81,211,800...81,227,215
Ensembl chr14:81,211,800...81,227,209 		JBrowse link
G Fhad1 forkhead associated phosphopeptide binding domain 1 increases expression ISO chrysene results in increased expression of FHAD1 mRNA CTD PMID:26377693 NCBI chr 5:159,474,111...159,593,455
Ensembl chr 5:159,474,158...159,593,367 		JBrowse link
G Fibin fin bud initiation factor homolog multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of FIBIN mRNA CTD PMID:27858113 NCBI chr 3:117,396,973...117,399,244
Ensembl chr 3:117,391,724...117,399,479 		JBrowse link
G Fig4 FIG4 phosphoinositide 5-phosphatase multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of FIG4 mRNA CTD PMID:27858113 NCBI chr20:46,183,225...46,306,686
Ensembl chr20:46,183,225...46,306,477 		JBrowse link
G Fignl1 fidgetin-like 1 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of FIGNL1 mRNA CTD PMID:27858113 NCBI chr14:90,573,090...90,595,342
Ensembl chr14:90,581,771...90,592,316 		JBrowse link
G Fkbp1a FKBP prolyl isomerase 1A decreases expression
multiple interactions 		ISO chrysene results in decreased expression of FKBP1A mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of FKBP1A mRNA 		CTD PMID:26377693 PMID:27858113 NCBI chr 3:160,500,748...160,520,492
Ensembl chr 3:160,500,726...160,524,233 		JBrowse link
G Fkbp3 FKBP prolyl isomerase 3 increases expression ISO chrysene results in increased expression of FKBP3 mRNA CTD PMID:26377693 NCBI chr 6:88,850,137...88,862,542
Ensembl chr 6:88,843,879...88,863,447 		JBrowse link
G Flii FLII, actin remodeling protein multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of FLII mRNA CTD PMID:27858113 NCBI chr10:45,893,566...45,907,547
Ensembl chr10:45,893,572...45,907,491 		JBrowse link
G Fmo1 flavin containing dimethylaniline monoxygenase 1 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of FMO1 mRNA CTD PMID:27858113 NCBI chr13:77,715,405...77,747,666
Ensembl chr13:77,715,402...77,747,874 		JBrowse link
G Fmr1 fragile X messenger ribonucleoprotein 1 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of FMR1 mRNA CTD PMID:27858113 NCBI chr  X:152,284,857...152,322,686
Ensembl chr  X:152,284,841...152,322,675 		JBrowse link
G Fndc1 fibronectin type III domain containing 1 increases expression
multiple interactions 		ISO chrysene results in increased expression of FNDC1 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of FNDC1 mRNA 		CTD PMID:26377693 PMID:27858113 NCBI chr 1:49,686,856...49,769,263
Ensembl chr 1:49,686,856...49,769,263 		JBrowse link
G Fos Fos proto-oncogene, AP-1 transcription factor subunit increases expression ISO chrysene results in increased expression of FOS mRNA CTD PMID:12799773 NCBI chr 6:110,852,188...110,855,054
Ensembl chr 6:110,852,190...110,855,598 		JBrowse link
G Foxf1 forkhead box F1 increases expression
multiple interactions 		ISO chrysene results in increased expression of FOXF1 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of FOXF1 mRNA 		CTD PMID:26377693 PMID:27858113 NCBI chr19:66,062,635...66,066,427
Ensembl chr19:66,062,369...66,066,428 		JBrowse link
G Foxs1 forkhead box S1 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of FOXS1 mRNA CTD PMID:27858113 NCBI chr 3:161,857,264...161,858,548
Ensembl chr 3:161,850,782...161,858,662 		JBrowse link
G Frg1 FSHD region gene 1 decreases expression
multiple interactions 		ISO chrysene results in decreased expression of FRG1 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of FRG1 mRNA 		CTD PMID:26377693 PMID:27858113 NCBI chr16:57,629,221...57,650,188
Ensembl chr16:57,629,315...57,650,188 		JBrowse link
G Frmd4b FERM domain containing 4B multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of FRMD4B mRNA CTD PMID:27858113 NCBI chr 4:131,452,361...131,778,734
Ensembl chr 4:131,452,365...131,640,287 		JBrowse link
G Fscn3 fascin actin-bundling protein 3 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of FSCN3 mRNA CTD PMID:27858113 NCBI chr 4:58,008,124...58,017,674
Ensembl chr 4:58,008,230...58,017,673 		JBrowse link
G Fxr2 FMR1 autosomal homolog 2 increases expression ISO chrysene results in increased expression of FXR2 mRNA CTD PMID:26377693 NCBI chr10:54,849,345...54,869,713
Ensembl chr10:54,849,267...54,869,713 		JBrowse link
G Fxyd3 FXYD domain-containing ion transport regulator 3 increases expression ISO chrysene results in increased expression of FXYD3 mRNA CTD PMID:26377693 NCBI chr 1:95,432,918...95,440,129
Ensembl chr 1:95,432,919...95,439,702 		JBrowse link
G Gabra3 gamma-aminobutyric acid type A receptor subunit alpha 3 increases expression ISO chrysene results in increased expression of GABRA3 mRNA CTD PMID:26377693 NCBI chr  X:155,301,979...155,543,870
Ensembl chr  X:155,303,928...155,543,863 		JBrowse link
G Gas6 growth arrest specific 6 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of GAS6 mRNA CTD PMID:27858113 NCBI chr16:82,747,676...82,778,090
Ensembl chr16:82,747,345...82,778,088 		JBrowse link
G Gask1b golgi associated kinase 1B multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of GASK1B mRNA CTD PMID:27858113 NCBI chr 2:167,345,738...167,410,606
Ensembl chr 2:167,345,809...167,410,603 		JBrowse link
G Gata2 GATA binding protein 2 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of GATA2 mRNA CTD PMID:27858113 NCBI chr 4:122,211,501...122,225,058
Ensembl chr 4:122,211,829...122,225,055 		JBrowse link
G Gatad2a GATA zinc finger domain containing 2A increases expression ISO chrysene results in increased expression of GATAD2A mRNA CTD PMID:26377693 NCBI chr16:19,463,500...19,553,497
Ensembl chr16:19,463,500...19,553,497 		JBrowse link
G Gcgr glucagon receptor multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of GCGR mRNA CTD PMID:27858113 NCBI chr10:106,306,803...106,314,970
Ensembl chr10:106,306,559...106,314,969 		JBrowse link
G Gch1 GTP cyclohydrolase 1 decreases expression ISO chrysene results in decreased expression of GCH1 mRNA CTD PMID:26377693 NCBI chr15:22,884,006...22,917,412
Ensembl chr15:22,884,006...22,917,412 		JBrowse link
G Gcm1 glial cells missing transcription factor 1 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of GCM1 mRNA CTD PMID:27858113 NCBI chr 8:87,805,993...87,819,229
Ensembl chr 8:87,805,993...87,819,229 		JBrowse link
G Gcn1 GCN1 activator of EIF2AK4 increases expression ISO chrysene results in increased expression of GCN1 mRNA CTD PMID:26377693 NCBI chr12:46,652,273...46,715,119
Ensembl chr12:46,652,273...46,713,488 		JBrowse link
G Gda guanine deaminase increases expression ISO chrysene results in increased expression of GDA mRNA CTD PMID:26377693 NCBI chr 1:228,333,401...228,408,901
Ensembl chr 1:228,333,364...228,409,348 		JBrowse link
G Gdf15 growth differentiation factor 15 decreases expression
multiple interactions 		ISO chrysene results in decreased expression of GDF15 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of GDF15 mRNA 		CTD PMID:26377693 PMID:27858113 NCBI chr16:18,838,436...18,842,022
Ensembl chr16:18,838,436...18,842,022 		JBrowse link
G Gfra4 GDNF family receptor alpha 4 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of GFRA4 mRNA CTD PMID:27858113 NCBI chr 3:138,707,970...138,715,279
Ensembl chr 3:138,703,114...138,711,561 		JBrowse link
G Gjb1 gap junction protein, beta 1 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of GJB1 mRNA CTD PMID:27858113 NCBI chr  X:70,541,845...70,549,776
Ensembl chr  X:70,541,862...70,549,843 		JBrowse link
G Glis2 GLIS family zinc finger 2 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of GLIS2 mRNA CTD PMID:27858113 NCBI chr10:11,457,594...11,484,948
Ensembl chr10:11,457,792...11,477,995 		JBrowse link
G Gmnn geminin, DNA replication inhibitor multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of GMNN mRNA CTD PMID:27858113 NCBI chr17:40,729,760...40,738,077
Ensembl chr17:40,729,824...40,738,068 		JBrowse link
G Gnai1 G protein subunit alpha i1 increases expression ISO chrysene results in increased expression of GNAI1 mRNA CTD PMID:26377693 NCBI chr 4:17,706,061...17,790,176
Ensembl chr 4:17,706,025...17,789,198 		JBrowse link
G Gpatch1 G patch domain containing 1 affects expression ISO chrysene affects the expression of GPATCH1 mRNA CTD PMID:26377693 NCBI chr 1:97,062,539...97,111,487
Ensembl chr 1:97,062,551...97,111,465 		JBrowse link
G Gpihbp1 glycosylphosphatidylinositol anchored high density lipoprotein binding protein 1 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of GPIHBP1 mRNA CTD PMID:27858113 NCBI chr 7:109,166,334...109,169,448
Ensembl chr 7:109,163,160...109,169,448 		JBrowse link
G Gpr4 G protein-coupled receptor 4 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of GPR4 mRNA CTD PMID:27858113 NCBI chr 1:87,993,398...88,004,568
Ensembl chr 1:87,993,430...88,006,254 		JBrowse link
G Gprin3 GPRIN family member 3 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of GPRIN3 mRNA CTD PMID:27858113 NCBI chr 4:89,902,198...89,987,496
Ensembl chr 4:89,892,867...89,987,565 		JBrowse link
G Grb10 growth factor receptor bound protein 10 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of GRB10 mRNA CTD PMID:27858113 NCBI chr14:90,708,653...90,816,399
Ensembl chr14:90,708,653...90,816,387 		JBrowse link
G Greb1 growth regulating estrogen receptor binding 1 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of GREB1 mRNA CTD PMID:27858113 NCBI chr 6:45,169,289...45,321,973
Ensembl chr 6:45,169,289...45,291,126 		JBrowse link
G Grifin galectin-related inter-fiber protein multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of GRIFIN mRNA CTD PMID:27858113 NCBI chr12:19,194,829...19,196,811
Ensembl chr12:19,186,641...19,196,815 		JBrowse link
G Gripap1 GRIP1 associated protein 1 increases expression ISO chrysene results in increased expression of GRIPAP1 mRNA CTD PMID:26377693 NCBI chr  X:17,350,817...17,380,626
Ensembl chr  X:17,350,819...17,380,588 		JBrowse link
G Grp gastrin releasing peptide multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of GRP mRNA CTD PMID:27858113 NCBI chr18:61,658,655...61,672,037
Ensembl chr18:61,658,250...61,672,037 		JBrowse link
G Gstm1 glutathione S-transferase mu 1 multiple interactions ISO GSTM1 protein affects the metabolism of [chrysene co-treated with Glutathione] CTD PMID:9403173 NCBI chr 2:198,338,005...198,346,007
Ensembl chr 2:198,338,008...198,343,569 		JBrowse link
G Gtf3c1 general transcription factor IIIC subunit 1 increases expression ISO chrysene results in increased expression of GTF3C1 mRNA CTD PMID:26377693 NCBI chr 1:189,634,645...189,700,848
Ensembl chr 1:189,634,645...189,700,995 		JBrowse link
G Gzma granzyme A multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of GZMA mRNA CTD PMID:27858113 NCBI chr 2:46,473,763...46,485,696
Ensembl chr 2:46,473,763...46,485,696 		JBrowse link
G H19 H19 imprinted maternally expressed transcript increases expression ISO chrysene results in increased expression of H19 mRNA CTD PMID:26377693 NCBI chr 1:207,160,175...207,162,851 JBrowse link
G H1f1 H1.1 linker histone, cluster member decreases expression ISO chrysene results in decreased expression of H1F1 mRNA CTD PMID:26377693 NCBI chr17:41,762,278...41,794,876 JBrowse link
G H1f2 H1.2 linker histone, cluster member multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of H1F2 mRNA CTD PMID:27858113 NCBI chr17:41,818,962...41,820,453
Ensembl chr17:41,779,051...41,822,317 		JBrowse link
G H1f4 H1.4 linker histone, cluster member decreases expression
multiple interactions 		ISO chrysene results in decreased expression of H1F4 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of H1F4 mRNA 		CTD PMID:26377693 PMID:27858113 NCBI chr17:41,914,425...41,915,206
Ensembl chr17:41,914,431...41,916,129 		JBrowse link
G H2bc14 H2B clustered histone 14 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of H2BC14 mRNA CTD PMID:27858113 NCBI chr17:47,488,627...47,489,008 JBrowse link
G Hagh hydroxyacyl glutathione hydrolase decreases expression ISO chrysene results in decreased expression of HAGH mRNA CTD PMID:26377693 NCBI chr10:14,379,400...14,394,046
Ensembl chr10:14,382,410...14,394,043 		JBrowse link
G Heatr1 HEAT repeat containing 1 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of HEATR1 mRNA CTD PMID:27858113 NCBI chr17:62,745,008...62,785,609
Ensembl chr17:62,745,008...62,785,186 		JBrowse link
G Herc4 HECT and RLD domain containing E3 ubiquitin protein ligase 4 increases expression ISO chrysene results in increased expression of HERC4 mRNA CTD PMID:26377693 NCBI chr20:25,329,005...25,403,443
Ensembl chr20:25,328,822...25,403,372 		JBrowse link
G Hic1 HIC ZBTB transcriptional repressor 1 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of HIC1 mRNA CTD PMID:27858113 NCBI chr10:60,512,855...60,517,812
Ensembl chr10:60,500,565...60,523,448 		JBrowse link
G Hilpda hypoxia inducible lipid droplet-associated multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of HILPDA mRNA CTD PMID:27858113 NCBI chr 4:58,836,463...58,839,423
Ensembl chr 4:58,836,463...58,839,423 		JBrowse link
G Hlf HLF transcription factor, PAR bZIP family member multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of HLF mRNA CTD PMID:27858113 NCBI chr10:75,651,320...75,708,979
Ensembl chr10:75,654,534...75,708,619 		JBrowse link
G Hm13 histocompatibility minor 13 decreases expression
multiple interactions 		ISO chrysene results in decreased expression of H13 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of H13 mRNA 		CTD PMID:26377693 PMID:27858113 NCBI chr 3:161,606,059...161,641,382
Ensembl chr 3:161,606,052...161,644,805 		JBrowse link
G Hmbox1 homeobox containing 1 decreases expression ISO chrysene results in decreased expression of HMBOX1 mRNA CTD PMID:26377693 NCBI chr15:43,243,503...43,376,011
Ensembl chr15:43,222,470...43,376,011 		JBrowse link
G Hmcn1 hemicentin 1 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of HMCN1 mRNA CTD PMID:27858113 NCBI chr13:65,165,532...65,634,681
Ensembl chr13:65,165,532...65,634,519 		JBrowse link
G Hmcn2 hemicentin 2 increases expression ISO chrysene results in increased expression of HMCN2 mRNA CTD PMID:26377693 NCBI chr 3:34,986,246...35,136,047
Ensembl chr 3:34,986,263...35,136,106 		JBrowse link
G Hmgb1 high mobility group box 1 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of HMGB1 mRNA CTD PMID:27858113 NCBI chr12:11,009,236...11,015,941
Ensembl chr16:39,039,050...39,041,327
Ensembl chr12:39,039,050...39,041,327 		JBrowse link
G Hmgn5 high mobility group nucleosome binding domain 5 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of HMGN5 mRNA CTD PMID:27858113 NCBI chr  X:78,161,439...78,170,613
Ensembl chr  X:78,161,442...78,169,924 		JBrowse link
G Hmmr hyaluronan-mediated motility receptor decreases expression ISO chrysene results in decreased expression of HMMR mRNA CTD PMID:26377693 NCBI chr10:25,635,249...25,665,389
Ensembl chr10:25,635,915...25,665,390 		JBrowse link
G Hnrnpab heterogeneous nuclear ribonucleoprotein A/B increases expression ISO chrysene results in increased expression of HNRNPAB mRNA CTD PMID:26377693 NCBI chr10:36,358,004...36,363,898
Ensembl chr10:36,358,006...36,364,307 		JBrowse link
G Hnrnpf heterogeneous nuclear ribonucleoprotein F increases expression
multiple interactions 		ISO chrysene results in increased expression of HNRNPF mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of HNRNPF mRNA 		CTD PMID:26377693 PMID:27858113 NCBI chr 4:152,755,668...152,776,867
Ensembl chr 4:152,722,617...152,815,769 		JBrowse link
G Hnrnph1 heterogeneous nuclear ribonucleoprotein H1 increases expression ISO chrysene results in increased expression of HNRNPH1 mRNA CTD PMID:26377693 NCBI chr10:35,187,412...35,203,909
Ensembl chr10:35,193,890...35,203,906 		JBrowse link
G Hps1 HPS1, biogenesis of lysosomal organelles complex 3 subunit 1 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of HPS1 mRNA CTD PMID:27858113 NCBI chr 1:251,500,427...251,526,529
Ensembl chr 1:251,500,427...251,526,739 		JBrowse link
G Hr HR, lysine demethylase and nuclear receptor corepressor increases expression ISO chrysene results in increased expression of HR mRNA CTD PMID:26377693 NCBI chr15:52,036,540...52,056,019
Ensembl chr15:52,036,540...52,056,015 		JBrowse link
G Hsd17b14 hydroxysteroid (17-beta) dehydrogenase 14 increases expression ISO chrysene results in increased expression of HSD17B14 mRNA CTD PMID:26377693 NCBI chr 1:105,165,695...105,176,045
Ensembl chr 1:105,165,695...105,176,510 		JBrowse link
G Hspa1a heat shock protein family A (Hsp70) member 1A multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of HSPA1A mRNA CTD PMID:27858113 NCBI chr20:3,875,411...3,877,866
Ensembl chr20:3,855,780...3,877,979 		JBrowse link
G Htatip2 HIV-1 Tat interactive protein 2 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of HTATIP2 mRNA CTD PMID:27858113 NCBI chr 1:108,609,424...108,624,810
Ensembl chr 1:108,605,811...108,624,815 		JBrowse link
G Htatsf1 HIV-1 Tat specific factor 1 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of HTATSF1 mRNA CTD PMID:27858113 NCBI chr  X:139,972,742...139,986,923
Ensembl chr  X:139,972,742...139,986,923 		JBrowse link
G Hunk hormonally upregulated Neu-associated kinase multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of HUNK mRNA CTD PMID:27858113 NCBI chr11:43,127,244...43,244,502
Ensembl chr11:43,127,244...43,244,502 		JBrowse link
G Ica1 islet cell autoantigen 1 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of ICA1 mRNA CTD PMID:27858113 NCBI chr 4:37,622,759...37,771,055
Ensembl chr 4:37,622,759...37,770,569 		JBrowse link
G Icam1 intercellular adhesion molecule 1 increases expression ISO chrysene results in increased expression of ICAM1 protein CTD PMID:22313677 NCBI chr 8:27,829,688...27,841,618
Ensembl chr 8:27,829,161...27,841,617 		JBrowse link
G Icoslg inducible T-cell co-stimulator ligand increases expression ISO chrysene results in increased expression of ICOSL mRNA CTD PMID:26377693 NCBI chr20:10,600,078...10,610,385
Ensembl chr20:10,600,078...10,610,365 		JBrowse link
G Id1 inhibitor of DNA binding 1 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of ID1 mRNA CTD PMID:27858113 NCBI chr 3:161,671,525...161,672,691
Ensembl chr 3:161,671,538...161,672,685 		JBrowse link
G Ier3 immediate early response 3 increases expression ISO chrysene results in increased expression of IER3 mRNA CTD PMID:22579512 NCBI chr20:2,933,173...2,934,377
Ensembl chr20:2,933,174...2,934,377 		JBrowse link
G Ier5 immediate early response 5 decreases expression
multiple interactions 		ISO chrysene results in decreased expression of IER5 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of IER5 mRNA 		CTD PMID:26377693 PMID:27858113 NCBI chr13:69,820,450...69,822,542
Ensembl chr13:69,820,451...69,822,543 		JBrowse link
G Igsf3 immunoglobulin superfamily, member 3 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of IGSF3 mRNA CTD PMID:27858113 NCBI chr 2:191,499,972...191,588,249
Ensembl chr 2:191,500,045...191,588,249 		JBrowse link
G Ik IK cytokine increases expression ISO chrysene results in increased expression of IK mRNA CTD PMID:26377693 NCBI chr18:28,632,025...28,646,829
Ensembl chr18:28,631,616...28,653,463 		JBrowse link
G Ikzf4 IKAROS family zinc finger 4 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of IKZF4 mRNA CTD PMID:27858113 NCBI chr 7:1,643,379...1,687,524
Ensembl chr 7:1,644,799...1,687,094 		JBrowse link
G Il10 interleukin 10 multiple interactions ISO [chrysene co-treated with Tobacco Smoke Pollution] results in decreased expression of IL10 mRNA; [chrysene co-treated with Tobacco Smoke Pollution] results in decreased expression of IL10 protein; chrysene promotes the reaction [Tobacco Smoke Pollution results in decreased expression of IL10 mRNA]; chrysene promotes the reaction [Tobacco Smoke Pollution results in decreased expression of IL10 protein] CTD PMID:33345606 NCBI chr13:45,024,921...45,029,586
Ensembl chr13:45,025,087...45,029,580 		JBrowse link
G Il17a interleukin 17A multiple interactions ISO [chrysene co-treated with Tobacco Smoke Pollution] results in increased expression of IL17A mRNA; [chrysene co-treated with Tobacco Smoke Pollution] results in increased expression of IL17A protein; chrysene promotes the reaction [Tobacco Smoke Pollution results in increased expression of IL17A mRNA]; chrysene promotes the reaction [Tobacco Smoke Pollution results in increased expression of IL17A protein] CTD PMID:33345606 NCBI chr 9:30,640,844...30,644,331
Ensembl chr 9:30,640,844...30,644,331 		JBrowse link
G Il17f interleukin 17F multiple interactions ISO [chrysene co-treated with Tobacco Smoke Pollution] results in increased expression of IL17F mRNA; [chrysene co-treated with Tobacco Smoke Pollution] results in increased expression of IL17F protein; chrysene promotes the reaction [Tobacco Smoke Pollution results in increased expression of IL17F mRNA]; chrysene promotes the reaction [Tobacco Smoke Pollution results in increased expression of IL17F protein] CTD PMID:33345606 NCBI chr 9:30,686,532...30,697,918
Ensembl chr 9:30,686,538...30,697,918 		JBrowse link
G Il18r1 interleukin 18 receptor 1 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of IL18R1 mRNA CTD PMID:27858113 NCBI chr 9:50,223,274...50,257,370
Ensembl chr 9:50,223,200...50,257,367 		JBrowse link
G Il1b interleukin 1 beta multiple interactions ISO [chrysene co-treated with Tobacco Smoke Pollution] results in increased expression of IL1B mRNA; [chrysene co-treated with Tobacco Smoke Pollution] results in increased expression of IL1B protein; chrysene promotes the reaction [Tobacco Smoke Pollution results in increased expression of IL1B mRNA]; chrysene promotes the reaction [Tobacco Smoke Pollution results in increased expression of IL1B protein] CTD PMID:33345606 NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:137,030,205...137,036,601 		JBrowse link
G Il6 interleukin 6 increases expression
multiple interactions 		ISO chrysene results in increased expression of IL6 mRNA
[chrysene co-treated with Tobacco Smoke Pollution] results in increased expression of IL6 mRNA; [chrysene co-treated with Tobacco Smoke Pollution] results in increased expression of IL6 protein; chrysene promotes the reaction [Tobacco Smoke Pollution results in increased expression of IL6 mRNA]; chrysene promotes the reaction [Tobacco Smoke Pollution results in increased expression of IL6 protein] 		CTD PMID:25433334 PMID:33345606 NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,889,999...5,894,610 		JBrowse link
G Ilf2 interleukin enhancer binding factor 2 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of ILF2 mRNA CTD PMID:27858113 NCBI chr 2:178,256,927...178,268,773
Ensembl chr 2:178,248,585...178,268,920 		JBrowse link
G Ilrun inflammation and lipid regulator with UBA-like and NBR1-like domains multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of ILRUN mRNA CTD PMID:27858113 NCBI chr20:5,811,721...5,878,082
Ensembl chr20:5,811,734...5,877,978 		JBrowse link
G Inka2 inka box actin regulator 2 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of INKA2 mRNA CTD PMID:27858113 NCBI chr 2:195,873,617...195,888,983
Ensembl chr 2:195,873,497...195,893,605 		JBrowse link
G Ino80b INO80 complex subunit B multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of INO80B mRNA CTD PMID:27858113 NCBI chr 4:117,185,427...117,188,930
Ensembl chr 4:117,185,620...117,189,168 		JBrowse link
G Iqsec1 IQ motif and Sec7 domain ArfGEF 1 decreases expression ISO chrysene results in decreased expression of IQSEC1 mRNA CTD PMID:26377693 NCBI chr 4:124,725,917...125,045,351
Ensembl chr 4:124,725,917...125,045,550 		JBrowse link
G Irag2 inositol 1,4,5-triphosphate receptor associated 2 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of IRAG2 mRNA CTD PMID:27858113 NCBI chr 4:179,819,526...179,874,408
Ensembl chr 4:179,820,188...179,874,406 		JBrowse link
G Irf2bpl interferon regulatory factor 2 binding protein-like multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of IRF2BPL mRNA CTD PMID:27858113 NCBI chr 6:112,258,149...112,262,264
Ensembl chr 6:112,258,188...112,263,280 		JBrowse link
G Itga1 integrin subunit alpha 1 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of ITGA1 mRNA CTD PMID:27858113 NCBI chr 2:48,379,181...48,545,336
Ensembl chr 2:48,386,249...48,545,284 		JBrowse link
G Itga7 integrin subunit alpha 7 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of ITGA7 mRNA CTD PMID:27858113 NCBI chr 7:1,944,447...1,973,347
Ensembl chr 7:1,944,460...1,973,339 		JBrowse link
G Itgax integrin subunit alpha X decreases expression ISO chrysene results in decreased expression of ITGAX mRNA CTD PMID:26377693 NCBI chr 1:192,140,089...192,171,151
Ensembl chr 1:192,149,905...192,171,151 		JBrowse link
G Itgb1 integrin subunit beta 1 decreases expression ISO chrysene results in decreased expression of ITGB1 mRNA CTD PMID:26377693 NCBI chr19:73,602,277...73,650,271
Ensembl chr19:73,602,126...73,650,269 		JBrowse link
G Itih5 inter-alpha-trypsin inhibitor heavy chain 5 increases expression ISO chrysene results in increased expression of ITIH5 mRNA CTD PMID:26377693 NCBI chr17:73,161,886...73,261,930
Ensembl chr17:73,161,611...73,262,496 		JBrowse link
G Itpr2 inositol 1,4,5-trisphosphate receptor, type 2 increases expression ISO chrysene results in increased expression of ITPR2 mRNA CTD PMID:26377693 NCBI chr 4:180,759,325...181,165,361
Ensembl chr 4:180,760,442...181,164,763 		JBrowse link
G Jun Jun proto-oncogene, AP-1 transcription factor subunit increases expression ISO chrysene results in increased expression of JUN mRNA CTD PMID:12799773 NCBI chr 5:115,009,900...115,012,993
Ensembl chr 5:114,973,151...115,013,285 		JBrowse link
G Junb JunB proto-oncogene, AP-1 transcription factor subunit increases expression ISO chrysene results in increased expression of JUNB mRNA CTD PMID:19000923 NCBI chr19:40,081,126...40,082,910
Ensembl chr19:40,073,541...40,085,218 		JBrowse link
G Kank4 KN motif and ankyrin repeat domains 4 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of KANK4 mRNA CTD PMID:27858113 NCBI chr 5:118,516,994...118,581,024
Ensembl chr 5:118,517,971...118,581,002 		JBrowse link
G Kat14 lysine acetyltransferase 14 increases expression ISO chrysene results in increased expression of KAT14 mRNA CTD PMID:26377693 NCBI chr 3:152,194,560...152,235,048
Ensembl chr 3:152,194,696...152,235,052 		JBrowse link
G Kcne3 potassium voltage-gated channel subfamily E regulatory subunit 3 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of KCNE3 mRNA CTD PMID:27858113 NCBI chr 1:163,936,035...163,942,998
Ensembl chr 1:163,935,991...163,950,162 		JBrowse link
G Kctd15 potassium channel tetramerization domain containing 15 increases expression ISO chrysene results in increased expression of KCTD15 mRNA CTD PMID:26377693 NCBI chr 1:96,395,794...96,411,502
Ensembl chr 1:96,395,794...96,410,631 		JBrowse link
G Kiaa0232 KIAA0232 homolog increases expression ISO chrysene results in increased expression of D5ERTD579E mRNA CTD PMID:26377693 NCBI chr14:78,318,660...78,384,012
Ensembl chr14:78,319,105...78,384,014 		JBrowse link
G Kif26b kinesin family member 26B multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of KIF26B mRNA CTD PMID:27858113 NCBI chr13:92,815,427...93,221,071
Ensembl chr13:92,815,427...93,215,453 		JBrowse link
G Kitlg KIT ligand decreases expression
multiple interactions 		ISO chrysene results in decreased expression of KITL mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of KITL mRNA 		CTD PMID:26377693 PMID:27858113 NCBI chr 7:36,782,621...36,863,796
Ensembl chr 7:36,782,638...36,863,793 		JBrowse link
G Klhl18 kelch-like family member 18 increases expression ISO chrysene results in increased expression of KLHL18 mRNA CTD PMID:26377693 NCBI chr 8:119,279,081...119,337,850
Ensembl chr 8:119,279,081...119,337,719 		JBrowse link
G Klhl29 kelch-like family member 29 increases expression ISO chrysene results in increased expression of KLHL29 mRNA CTD PMID:26377693 NCBI chr 6:33,805,922...34,110,055
Ensembl chr 6:33,805,922...34,110,055 		JBrowse link
G Klhl5 kelch-like family member 5 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of KLHL5 mRNA CTD PMID:27858113 NCBI chr14:43,497,915...43,565,833
Ensembl chr14:43,497,918...43,537,894 		JBrowse link
G Klhl6 kelch-like family member 6 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of KLHL6 mRNA CTD PMID:27858113 NCBI chr11:94,475,262...94,514,653
Ensembl chr11:94,475,262...94,514,623 		JBrowse link
G Klk1c10 kallikrein 1-related peptidase C10 multiple interactions ISO alpha-naphthoflavone inhibits the reaction [chrysene inhibits the reaction [Dihydrotestosterone results in increased expression of KLK3 mRNA]]; alpha-naphthoflavone inhibits the reaction [chrysene inhibits the reaction [Dihydrotestosterone results in increased expression of KLK3 protein]]; chrysene inhibits the reaction [Dihydrotestosterone results in increased expression of KLK3 mRNA]; chrysene inhibits the reaction [Dihydrotestosterone results in increased expression of KLK3 protein]; Proadifen promotes the reaction [chrysene inhibits the reaction [Dihydrotestosterone results in increased expression of KLK3 protein]] CTD PMID:12799773 NCBI chr 1:103,539,527...103,543,586
Ensembl chr 1:103,539,527...103,543,586 		JBrowse link
G Kmt2d lysine methyltransferase 2D multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of KMT2D mRNA CTD PMID:27858113 NCBI chr 7:131,859,696...131,901,032
Ensembl chr 7:131,859,696...131,900,072 		JBrowse link
G Kmt5b lysine methyltransferase 5B multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of KMT5B mRNA CTD PMID:27858113 NCBI chr 1:210,429,672...210,479,042
Ensembl chr 1:210,430,127...210,479,035 		JBrowse link
G Krt13 keratin 13 increases expression ISO chrysene results in increased expression of KRT13 mRNA CTD PMID:26377693 NCBI chr10:85,552,287...85,556,499
Ensembl chr10:85,552,287...85,556,499 		JBrowse link
G Krt15 keratin 15 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of KRT15 mRNA CTD PMID:27858113 NCBI chr10:85,567,197...85,571,014
Ensembl chr10:85,567,202...85,571,142 		JBrowse link
G Krt4 keratin 4 increases expression ISO chrysene results in increased expression of KRT4 mRNA CTD PMID:26377693 NCBI chr 7:134,924,753...134,931,050
Ensembl chr 7:134,924,753...134,930,713 		JBrowse link
G Krtcap2 keratinocyte associated protein 2 decreases expression ISO chrysene results in decreased expression of KRTCAP2 mRNA CTD PMID:26377693 NCBI chr 2:176,952,167...176,956,163
Ensembl chr 2:176,949,809...176,956,163 		JBrowse link
G Lama1 laminin subunit alpha 1 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of LAMA1 mRNA CTD PMID:27858113 NCBI chr 9:115,139,548...115,263,620
Ensembl chr 9:115,139,548...115,264,251 		JBrowse link
G Lama5 laminin subunit alpha 5 increases expression ISO chrysene results in increased expression of LAMA5 mRNA CTD PMID:26377693 NCBI chr 3:187,647,904...187,695,974
Ensembl chr 3:187,647,904...187,696,173 		JBrowse link
G Lamb1 laminin subunit beta 1 increases expression ISO chrysene results in increased expression of LAMB1 mRNA CTD PMID:26377693 NCBI chr 6:53,562,849...53,630,118
Ensembl chr 6:53,563,073...53,630,760 		JBrowse link
G Laptm4a lysosomal protein transmembrane 4 alpha decreases expression ISO chrysene results in decreased expression of LAPTM4A mRNA CTD PMID:26377693 NCBI chr 6:37,438,503...37,456,238
Ensembl chr 6:37,438,121...37,456,223 		JBrowse link
G Large2 LARGE xylosyl- and glucuronyltransferase 2 increases expression ISO chrysene results in increased expression of LARGE2 mRNA CTD PMID:26377693 NCBI chr 3:98,791,543...98,800,251
Ensembl chr 3:98,791,543...98,797,782 		JBrowse link
G Larp4b La ribonucleoprotein 4B increases expression ISO chrysene results in increased expression of LARP4B mRNA CTD PMID:26377693 NCBI chr17:65,813,125...65,908,920
Ensembl chr17:65,830,022...65,908,676 		JBrowse link
G Lasp1 LIM and SH3 protein 1 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of LASP1 mRNA CTD PMID:27858113 NCBI chr10:83,290,820...83,331,989
Ensembl chr10:83,290,865...83,331,988 		JBrowse link
G Lce3e late cornified envelope 3E increases expression ISO chrysene results in increased expression of LCE3B mRNA CTD PMID:26377693 NCBI chr 2:181,274,092...181,275,265
Ensembl chr 2:181,274,092...181,275,265 		JBrowse link
G Lcorl ligand dependent nuclear receptor corepressor-like multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of LCORL mRNA CTD PMID:27858113 NCBI chr14:69,482,919...69,620,269
Ensembl chr14:69,518,837...69,587,177 		JBrowse link
G Lefty1 left right determination factor 1 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of LEFTY1 mRNA CTD PMID:27858113 NCBI chr13:95,188,091...95,191,488
Ensembl chr13:95,188,091...95,191,488 		JBrowse link
G Lepr leptin receptor multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of LEPR mRNA CTD PMID:27858113 NCBI chr 5:121,409,735...121,593,201
Ensembl chr 5:121,474,099...121,591,215 		JBrowse link
G Lgals1 galectin 1 increases expression ISO chrysene results in increased expression of LGALS1 mRNA CTD PMID:22579512 NCBI chr 7:112,365,695...112,368,801
Ensembl chr 7:112,361,850...112,368,800 		JBrowse link
G Lhfpl3 LHFPL tetraspan subfamily member 3 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of LHFPL3 mRNA CTD PMID:27858113
G Lipa lipase A, lysosomal acid type decreases expression ISO chrysene results in decreased expression of LIPA mRNA CTD PMID:26377693 NCBI chr 1:241,437,524...241,470,936
Ensembl chr 1:241,437,524...241,470,740 		JBrowse link
G Loricrin loricrin cornified envelope precursor protein increases expression ISO chrysene results in increased expression of LORICRIN mRNA CTD PMID:26377693 NCBI chr 2:180,253,674...180,256,572
Ensembl chr 2:180,253,674...180,256,572 		JBrowse link
G Lpin1 lipin 1 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of LPIN1 mRNA CTD PMID:27858113 NCBI chr 6:45,039,110...45,145,845
Ensembl chr 6:45,041,522...45,145,991 		JBrowse link
G Lrrc45 leucine rich repeat containing 45 increases expression ISO chrysene results in increased expression of LRRC45 mRNA CTD PMID:26377693 NCBI chr10:106,492,846...106,500,751
Ensembl chr10:106,492,592...106,500,751 		JBrowse link
G Lrrc75b leucine rich repeat containing 75B multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of LRRC75B mRNA CTD PMID:27858113 NCBI chr20:13,099,741...13,105,942
Ensembl chr20:13,094,809...13,109,532 		JBrowse link
G Lrrc8b leucine rich repeat containing 8 VRAC subunit B decreases expression ISO chrysene results in decreased expression of LRRC8B mRNA CTD PMID:26377693 NCBI chr14:4,655,273...4,721,648
Ensembl chr14:4,655,273...4,721,076 		JBrowse link
G Lrrk1 leucine-rich repeat kinase 1 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of LRRK1 mRNA CTD PMID:27858113 NCBI chr 1:129,254,815...129,390,217
Ensembl chr 1:129,254,515...129,389,941 		JBrowse link
G Lrrn4 leucine rich repeat neuronal 4 increases expression ISO chrysene results in increased expression of LRRN4 mRNA CTD PMID:26377693 NCBI chr 3:140,592,303...140,603,986
Ensembl chr 3:140,592,076...140,605,574 		JBrowse link
G Lrtm2 leucine-rich repeats and transmembrane domains 2 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of LRTM2 mRNA CTD PMID:27858113 NCBI chr 4:154,158,165...154,180,389
Ensembl chr 4:154,158,168...154,167,641 		JBrowse link
G Lst1 leukocyte specific transcript 1 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of LST1 mRNA CTD PMID:27858113 NCBI chr20:3,639,353...3,644,399
Ensembl chr20:3,639,341...3,642,669 		JBrowse link
G Ltc4s leukotriene C4 synthase multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of LTC4S mRNA CTD PMID:27858113 NCBI chr10:35,060,002...35,066,466
Ensembl chr10:35,061,437...35,063,768 		JBrowse link
G Ltv1 LTV1 ribosome biogenesis factor increases expression ISO chrysene results in increased expression of LTV1 mRNA CTD PMID:26377693 NCBI chr 1:9,385,834...9,398,557
Ensembl chr 1:9,385,830...9,398,677 		JBrowse link
G Lum lumican multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of LUM mRNA CTD PMID:27858113 NCBI chr 7:34,245,323...34,252,510
Ensembl chr 7:34,245,360...34,252,508 		JBrowse link
G Ly6a lymphocyte antigen 6 family member A multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of LY6A mRNA CTD PMID:27858113 NCBI chr 7:109,064,222...109,067,757 JBrowse link
G Lyve1 lymphatic vessel endothelial hyaluronan receptor 1 increases expression
multiple interactions 		ISO chrysene results in increased expression of LYVE1 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of LYVE1 mRNA 		CTD PMID:26377693 PMID:27858113 NCBI chr 1:174,393,387...174,410,977 JBrowse link
G Lzts3 leucine zipper tumor suppressor family member 3 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of LZTS3 mRNA CTD PMID:27858113 NCBI chr 3:138,303,378...138,313,645
Ensembl chr 3:138,303,378...138,313,611 		JBrowse link
G Magi3 membrane associated guanylate kinase, WW and PDZ domain containing 3 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of MAGI3 mRNA CTD PMID:27858113 NCBI chr 2:194,206,587...194,405,468
Ensembl chr 2:194,206,934...194,405,157 		JBrowse link
G Magt1 magnesium transporter 1 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of MAGT1 mRNA CTD PMID:27858113 NCBI chr  X:75,104,040...75,145,247
Ensembl chr  X:75,106,172...75,145,365 		JBrowse link
G Maoa monoamine oxidase A multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of MAOA mRNA CTD PMID:27858113 NCBI chr  X:8,615,239...8,681,372
Ensembl chr  X:8,615,239...8,682,631 		JBrowse link
G Map4k4 mitogen-activated protein kinase kinase kinase kinase 4 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of MAP4K4 mRNA CTD PMID:27858113 NCBI chr 9:49,696,573...49,822,353
Ensembl chr 9:49,696,700...49,822,353 		JBrowse link
G Marco macrophage receptor with collagenous structure multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of MARCO mRNA CTD PMID:27858113 NCBI chr13:34,169,011...34,210,340
Ensembl chr13:34,169,011...34,201,255 		JBrowse link
G Marveld3 MARVEL domain containing 3 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of MARVELD3 mRNA CTD PMID:27858113 NCBI chr19:54,818,180...54,832,871
Ensembl chr19:54,818,180...54,832,871 		JBrowse link
G Mat1a methionine adenosyltransferase 1A multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of MAT1A mRNA CTD PMID:27858113 NCBI chr16:17,017,168...17,035,368
Ensembl chr16:17,016,030...17,035,367 		JBrowse link
G Mat2a methionine adenosyltransferase 2A increases expression ISO chrysene results in increased expression of MAT2A mRNA CTD PMID:26377693 NCBI chr 4:106,048,043...106,053,612
Ensembl chr 4:106,038,254...106,053,645 		JBrowse link
G Mboat2 membrane bound O-acyltransferase domain containing 2 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of MBOAT2 mRNA CTD PMID:27858113 NCBI chr 6:47,199,751...47,326,215
Ensembl chr 6:47,199,774...47,326,208 		JBrowse link
G Mcam melanoma cell adhesion molecule multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of MCAM mRNA CTD PMID:27858113 NCBI chr 8:53,376,225...53,384,407
Ensembl chr 8:53,376,197...53,384,406 		JBrowse link
G Mdm2 MDM2 proto-oncogene multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of MDM2 mRNA CTD PMID:27858113 NCBI chr 7:55,176,558...55,201,757
Ensembl chr 7:55,176,560...55,200,791 		JBrowse link
G Mdm4 MDM4 regulator of p53 decreases expression
multiple interactions 		ISO chrysene results in decreased expression of MDM4 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of MDM4 mRNA 		CTD PMID:26377693 PMID:27858113 NCBI chr13:46,922,236...47,068,241
Ensembl chr13:46,958,298...47,026,372 		JBrowse link
G Mdn1 midasin AAA ATPase 1 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of MDN1 mRNA CTD PMID:27858113 NCBI chr 5:51,851,785...51,982,688
Ensembl chr 5:51,851,809...51,982,688 		JBrowse link
G Med10 mediator complex subunit 10 decreases expression ISO chrysene results in decreased expression of MED10 mRNA CTD PMID:26377693 NCBI chr 1:35,298,494...35,310,163
Ensembl chr 1:35,298,495...35,304,154 		JBrowse link
G Med21 mediator complex subunit 21 decreases expression ISO chrysene results in decreased expression of MED21 mRNA CTD PMID:26377693 NCBI chr 4:181,291,191...181,314,504
Ensembl chr 4:181,291,271...181,298,234 		JBrowse link
G Med24 mediator complex subunit 24 increases expression ISO chrysene results in increased expression of MED24 mRNA CTD PMID:26377693 NCBI chr10:84,160,866...84,198,607
Ensembl chr10:84,160,866...84,186,379 		JBrowse link
G Med28 mediator complex subunit 28 decreases expression ISO chrysene results in decreased expression of MED28 mRNA CTD PMID:26377693 NCBI chr14:69,807,319...69,816,115
Ensembl chr14:69,807,319...69,816,115 		JBrowse link
G Med7 mediator complex subunit 7 decreases expression ISO chrysene results in decreased expression of MED7 mRNA CTD PMID:26377693 NCBI chr10:31,343,613...31,359,192
Ensembl chr10:31,343,361...31,361,017 		JBrowse link
G Mef2c myocyte enhancer factor 2C increases expression ISO chrysene results in increased expression of MEF2C mRNA CTD PMID:26377693 NCBI chr 2:15,708,732...15,871,639
Ensembl chr 2:15,708,924...15,871,640 		JBrowse link
G Meg3 maternally expressed 3 increases expression ISO chrysene results in increased expression of MEG3 mRNA CTD PMID:26377693 NCBI chr 6:134,274,056...134,306,249 JBrowse link
G Mfap2 microfibril associated protein 2 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of MFAP2 mRNA CTD PMID:27858113 NCBI chr 5:158,595,121...158,603,283
Ensembl chr 5:158,597,512...158,610,656 		JBrowse link
G Mfap4 microfibril associated protein 4 increases expression
multiple interactions 		ISO chrysene results in increased expression of MFAP4 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of MFAP4 mRNA 		CTD PMID:26377693 PMID:27858113 NCBI chr10:46,666,552...46,669,613
Ensembl chr10:46,655,722...46,669,740 		JBrowse link
G Mfsd2a MFSD2 lysolipid transporter A, lysophospholipid increases expression ISO chrysene results in increased expression of MFSD2A mRNA CTD PMID:26377693 NCBI chr 5:140,510,933...140,525,828
Ensembl chr 5:140,510,953...140,525,916 		JBrowse link
G Mgat2 alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of MGAT2 mRNA CTD PMID:27858113 NCBI chr 6:93,392,416...93,394,905
Ensembl chr 6:93,390,555...93,395,176 		JBrowse link
G Mgll monoglyceride lipase multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of MGLL mRNA CTD PMID:27858113 NCBI chr 4:122,749,436...122,851,440
Ensembl chr 4:122,749,436...122,851,440 		JBrowse link
G Mgmt O-6-methylguanine-DNA methyltransferase multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of MGMT mRNA CTD PMID:27858113 NCBI chr 1:201,140,832...201,367,481
Ensembl chr 1:201,140,661...201,367,482 		JBrowse link
G Mia MIA SH3 domain containing decreases expression ISO chrysene results in decreased expression of MIA mRNA CTD PMID:26377693 NCBI chr 1:91,601,326...91,603,019
Ensembl chr 1:91,601,327...91,603,019 		JBrowse link
G Micall1 MICAL-like 1 increases expression ISO chrysene results in increased expression of MICALL1 mRNA CTD PMID:26377693 NCBI chr 7:112,557,192...112,587,618
Ensembl chr 7:112,557,192...112,587,618 		JBrowse link
G Mideas mitotic deacetylase associated SANT domain protein multiple interactions
decreases expression 		ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of MIDEAS mRNA
chrysene results in decreased expression of MIDEAS mRNA 		CTD PMID:26377693 PMID:27858113 NCBI chr 6:109,519,011...109,585,631
Ensembl chr 6:109,519,011...109,560,312 		JBrowse link
G Mki67 marker of proliferation Ki-67 multiple interactions ISO [benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with Benzo(a)pyrene co-treated with chrysene] results in increased expression of MKI67 protein; [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of MKI67 mRNA CTD PMID:27858113 PMID:38237855 NCBI chr 1:199,926,150...199,952,847
Ensembl chr 1:199,926,150...199,952,593 		JBrowse link
G Mlst8 MTOR associated protein, LST8 homolog increases expression ISO chrysene results in increased expression of MLST8 mRNA CTD PMID:26377693 NCBI chr10:14,002,927...14,008,678
Ensembl chr10:14,002,938...14,008,678 		JBrowse link
G Mmgt1 membrane magnesium transporter 1 decreases expression ISO chrysene results in decreased expression of MMGT1 mRNA CTD PMID:26377693 NCBI chr  X:139,445,834...139,458,169
Ensembl chr  X:139,445,834...139,458,169 		JBrowse link
G Mmp14 matrix metallopeptidase 14 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of MMP14 mRNA CTD PMID:27858113 NCBI chr15:31,857,824...31,867,049
Ensembl chr15:31,857,546...31,869,893 		JBrowse link
G Mmp8 matrix metallopeptidase 8 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of MMP8 mRNA CTD PMID:27858113 NCBI chr 8:13,008,873...13,018,729
Ensembl chr 8:13,008,890...13,018,729 		JBrowse link
G Mmrn2 multimerin 2 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of MMRN2 mRNA CTD PMID:27858113 NCBI chr16:9,712,181...9,733,653
Ensembl chr16:9,711,953...9,733,653 		JBrowse link
G Mpdu1 mannose-P-dolichol utilization defect 1 decreases expression ISO chrysene results in decreased expression of MPDU1 mRNA CTD PMID:26377693 NCBI chr10:54,873,467...54,880,536
Ensembl chr10:54,873,473...54,879,195 		JBrowse link
G Mpeg1 macrophage expressed 1 decreases expression
multiple interactions 		ISO chrysene results in decreased expression of MPEG1 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of MPEG1 mRNA 		CTD PMID:26377693 PMID:27858113 NCBI chr 1:218,876,848...218,881,364
Ensembl chr 1:218,876,069...218,908,715 		JBrowse link
G Mpv17l2 MPV17 mitochondrial inner membrane protein like 2 decreases expression ISO chrysene results in decreased expression of MPV17L2 mRNA CTD PMID:26377693 NCBI chr16:18,713,690...18,718,191
Ensembl chr16:18,715,849...18,718,708 		JBrowse link
G Ms4a1 membrane spanning 4-domains A1 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of MS4A1 mRNA CTD PMID:27858113 NCBI chr 1:217,331,274...217,351,934
Ensembl chr 1:217,331,274...217,343,447 		JBrowse link
G Msln mesothelin multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of MSLN mRNA CTD PMID:27858113 NCBI chr10:15,276,489...15,285,921
Ensembl chr10:15,275,659...15,282,153 		JBrowse link
G Msr1 macrophage scavenger receptor 1 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of MSR1 mRNA CTD PMID:27858113 NCBI chr16:59,421,250...59,507,070
Ensembl chr16:59,421,057...59,507,070 		JBrowse link
G Mst1r macrophage stimulating 1 receptor increases expression ISO chrysene results in increased expression of MST1R mRNA CTD PMID:26377693 NCBI chr 8:117,471,928...117,491,059
Ensembl chr 8:117,475,968...117,490,515 		JBrowse link
G Mt-nd4l mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 4L multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of ND4L mRNA CTD PMID:27858113 NCBI chr MT:9,870...10,166
Ensembl chr MT:9,855...10,151 		JBrowse link
G Mt-nd6 mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 6 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of ND6 mRNA CTD PMID:27858113 NCBI chr MT:13,543...14,061
Ensembl chr MT:13,531...14,049 		JBrowse link
G Mt1a metallothionein 1A increases expression ISO chrysene results in increased expression of MT1 mRNA CTD PMID:26377693 NCBI chr19:10,831,959...10,832,975
Ensembl chr17:79,695,809...79,696,200
Ensembl chr  X:79,695,809...79,696,200
Ensembl chr19:79,695,809...79,696,200 		JBrowse link
G Mt2 metallothionein 2 increases expression ISO chrysene results in increased expression of MT2 mRNA CTD PMID:26377693 NCBI chr19:10,837,934...10,838,708
Ensembl chr19:10,837,927...10,838,709 		JBrowse link
G Mtfr1 mitochondrial fission regulator 1 decreases expression ISO chrysene results in decreased expression of MTFR1 mRNA CTD PMID:26377693 NCBI chr 2:103,594,458...103,629,697
Ensembl chr 2:103,594,497...103,629,690 		JBrowse link
G Mthfd1l methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1-like multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of MTHFD1L mRNA CTD PMID:27858113 NCBI chr 1:42,849,424...43,038,313
Ensembl chr 1:42,849,374...43,038,309 		JBrowse link
G Mtmr10 myotubularin related protein 10 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of MTMR10 mRNA CTD PMID:27858113 NCBI chr 1:127,271,139...127,322,621
Ensembl chr 1:127,270,870...127,322,621 		JBrowse link
G Muc16 mucin 16, cell surface associated increases expression ISO chrysene results in increased expression of MUC16 mRNA CTD PMID:26377693 NCBI chr 8:24,440,840...24,644,494 JBrowse link
G Myadm myeloid-associated differentiation marker multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of MYADM mRNA CTD PMID:27858113 NCBI chr 1:74,779,616...74,796,752
Ensembl chr 1:74,775,698...74,789,710 		JBrowse link
G Mybpc1 myosin binding protein C1 increases expression ISO chrysene results in increased expression of MYBPC1 mRNA CTD PMID:26377693 NCBI chr 7:24,817,770...24,903,681
Ensembl chr 7:24,817,561...24,903,544 		JBrowse link
G Myh1 myosin heavy chain 1 increases expression ISO chrysene results in increased expression of MYH1 mRNA CTD PMID:26377693 NCBI chr10:52,384,810...52,408,698
Ensembl chr10:52,384,908...52,409,047 		JBrowse link
G Myh4 myosin heavy chain 4 increases expression ISO chrysene results in increased expression of MYH4 mRNA CTD PMID:26377693 NCBI chr10:52,422,148...52,445,296
Ensembl chr10:52,421,951...52,445,294 		JBrowse link
G Myl6 myosin light chain 6 increases expression ISO chrysene results in increased expression of MYL6 mRNA CTD PMID:26377693 NCBI chr 7:1,495,301...1,498,512
Ensembl chr 7:1,495,747...1,498,344 		JBrowse link
G Mylk myosin light chain kinase increases expression ISO chrysene results in increased expression of MYLK mRNA CTD PMID:26377693 NCBI chr11:79,288,243...79,535,450
Ensembl chr11:79,288,243...79,535,659 		JBrowse link
G Myo1g myosin IG multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of MYO1G mRNA CTD PMID:27858113 NCBI chr14:85,600,619...85,615,760
Ensembl chr14:85,600,619...85,615,760 		JBrowse link
G Myom3 myomesin 3 increases expression ISO chrysene results in increased expression of MYOM3 mRNA CTD PMID:26377693 NCBI chr 5:153,276,306...153,326,847
Ensembl chr 5:153,276,261...153,326,839 		JBrowse link
G Myoz1 myozenin 1 increases expression ISO chrysene results in increased expression of MYOZ1 mRNA CTD PMID:26377693 NCBI chr15:3,693,576...3,700,831
Ensembl chr15:3,693,613...3,700,826 		JBrowse link
G Nat8 N-acetyltransferase 8 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of NAT8 mRNA CTD PMID:27858113 NCBI chr 4:119,836,986...119,837,764
Ensembl chr 4:119,835,645...119,843,159 		JBrowse link
G Nbeal1 neurobeachin-like 1 decreases expression ISO chrysene results in decreased expression of NBEAL1 mRNA CTD PMID:26377693 NCBI chr 9:69,069,326...69,237,932
Ensembl chr 9:69,070,247...69,231,307 		JBrowse link
G Ncaph non-SMC condensin I complex, subunit H multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of NCAPH mRNA CTD PMID:27858113 NCBI chr 3:134,825,271...134,852,502
Ensembl chr 3:134,825,271...134,852,502 		JBrowse link
G Ncbp2 nuclear cap binding protein subunit 2 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of NCBP2 mRNA CTD PMID:27858113 NCBI chr11:82,326,002...82,334,839
Ensembl chr11:82,322,716...82,335,116 		JBrowse link
G Ncbp3 nuclear cap binding subunit 3 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of NCBP3 mRNA CTD PMID:27858113 NCBI chr10:58,164,241...58,193,952
Ensembl chr10:58,164,234...58,193,964 		JBrowse link
G Ncoa3 nuclear receptor coactivator 3 increases expression ISO chrysene results in increased expression of NCOA3 mRNA CTD PMID:26377693 NCBI chr 3:175,157,824...175,237,831
Ensembl chr 3:175,157,821...175,240,631 		JBrowse link
G Ndc80 NDC80 kinetochore complex component decreases expression ISO chrysene results in decreased expression of NDC80 mRNA CTD PMID:22579512 NCBI chr 9:118,853,806...118,887,582
Ensembl chr 9:118,853,806...118,887,568 		JBrowse link
G Ndufb6 NADH:ubiquinone oxidoreductase subunit B6 decreases expression ISO chrysene results in decreased expression of NDUFB6 mRNA CTD PMID:26377693 NCBI chr 5:60,196,585...60,206,152
Ensembl chr 5:60,196,585...60,206,055 		JBrowse link
G Neat1 nuclear paraspeckle assembly transcript 1 increases expression ISO chrysene results in increased expression of NEAT1 mRNA CTD PMID:26377693 NCBI chr 1:212,507,512...212,568,055 JBrowse link
G Neb nebulin increases expression ISO chrysene results in increased expression of NEB mRNA CTD PMID:26377693 NCBI chr 3:57,022,822...57,220,752
Ensembl chr 3:57,022,822...57,220,709 		JBrowse link
G Nectin1 nectin cell adhesion molecule 1 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of PVRL1 mRNA CTD PMID:27858113 NCBI chr 8:52,998,662...53,061,745
Ensembl chr 8:52,998,662...53,086,664 		JBrowse link
G Neu2 neuraminidase 2 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of NEU2 mRNA CTD PMID:27858113 NCBI chr 9:95,666,338...95,715,209
Ensembl chr 9:95,696,507...95,715,208 		JBrowse link
G Nexn nexilin (F actin binding protein) increases expression ISO chrysene results in increased expression of NEXN mRNA CTD PMID:26377693 NCBI chr 2:243,846,736...243,878,268
Ensembl chr 2:243,846,433...243,887,114 		JBrowse link
G Nfatc1 nuclear factor of activated T-cells 1 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of NFATC1 mRNA CTD PMID:27858113 NCBI chr18:76,321,386...76,430,997
Ensembl chr18:76,321,386...76,430,990 		JBrowse link
G Nfe2 nuclear factor, erythroid 2 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of NFE2 mRNA CTD PMID:27858113 NCBI chr 7:136,261,234...136,273,850
Ensembl chr 7:136,261,236...136,268,585 		JBrowse link
G Nfil3 nuclear factor, interleukin 3 regulated multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of NFIL3 mRNA CTD PMID:27858113 NCBI chr17:12,432,376...12,447,605
Ensembl chr17:12,432,198...12,450,826 		JBrowse link
G Nfkbia NFKB inhibitor alpha decreases expression ISO chrysene results in decreased expression of NFKBIA mRNA CTD PMID:26377693 NCBI chr 6:78,593,844...78,597,307
Ensembl chr 6:78,593,847...78,597,072 		JBrowse link
G Ngfr nerve growth factor receptor multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of TNFRSF10B mRNA CTD PMID:27858113 NCBI chr10:81,012,077...81,030,305
Ensembl chr10:81,012,089...81,030,305 		JBrowse link
G Nhlrc2 NHL repeat containing 2 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of NHLRC2 mRNA CTD PMID:27858113 NCBI chr 1:265,594,915...265,655,647
Ensembl chr 1:265,594,915...265,676,143 		JBrowse link
G Nhsl1 NHS-like 1 increases expression ISO chrysene results in increased expression of NHSL1 mRNA CTD PMID:26377693 NCBI chr 1:14,775,874...15,008,327
Ensembl chr 1:14,705,839...15,008,327 		JBrowse link
G Nktr natural killer cell triggering receptor decreases expression
multiple interactions 		ISO chrysene results in decreased expression of NKTR mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of NKTR mRNA 		CTD PMID:26377693 PMID:27858113 NCBI chr 8:130,255,541...130,298,001
Ensembl chr 8:130,259,461...130,298,008 		JBrowse link
G Noc2l NOC2-like nucleolar associated transcriptional repressor increases expression ISO chrysene results in increased expression of NOC2L mRNA CTD PMID:26377693 NCBI chr 5:172,102,369...172,114,168
Ensembl chr 5:172,101,223...172,114,162 		JBrowse link
G Nono non-POU domain containing, octamer-binding increases expression ISO chrysene results in increased expression of NONO mRNA CTD PMID:26377693 NCBI chr  X:70,594,116...70,611,976
Ensembl chr  X:70,593,888...70,611,979 		JBrowse link
G Nop2 NOP2 nucleolar protein increases expression ISO chrysene results in increased expression of NOP2 mRNA CTD PMID:26377693 NCBI chr 4:159,618,894...159,630,697
Ensembl chr 4:159,618,966...159,630,697 		JBrowse link
G Notch1 notch receptor 1 decreases expression
multiple interactions 		ISO chrysene results in decreased expression of NOTCH1 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of NOTCH1 mRNA 		CTD PMID:26377693 PMID:27858113 NCBI chr 3:29,676,040...29,721,613
Ensembl chr 3:29,676,171...29,721,613 		JBrowse link
G Noxa1 NADPH oxidase activator 1 decreases expression ISO chrysene results in decreased expression of NOXA1 mRNA CTD PMID:26377693 NCBI chr 3:28,293,643...28,309,828
Ensembl chr 3:28,293,658...28,304,022 		JBrowse link
G Nphp1 nephrocystin 1 decreases expression
multiple interactions 		ISO chrysene results in decreased expression of NPHP1 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of NPHP1 mRNA 		CTD PMID:26377693 PMID:27858113 NCBI chr 3:135,413,927...135,469,505
Ensembl chr 3:135,413,927...135,469,505 		JBrowse link
G Npm1 nucleophosmin 1 increases expression ISO chrysene results in increased expression of NPM1 mRNA CTD PMID:26377693 NCBI chr10:18,245,739...18,255,913
Ensembl chr10:18,245,740...18,256,024
Ensembl chr  X:18,245,740...18,256,024 		JBrowse link
G Npr3 natriuretic peptide receptor 3 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of NPR3 mRNA CTD PMID:27858113 NCBI chr 2:62,592,557...62,660,497
Ensembl chr 2:62,597,668...62,660,066 		JBrowse link
G Npy1r neuropeptide Y receptor Y1 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of NPY1R mRNA CTD PMID:27858113 NCBI chr16:27,804,416...27,814,070
Ensembl chr16:27,804,416...27,813,387 		JBrowse link
G Nqo1 NAD(P)H quinone dehydrogenase 1 increases activity EXP chrysene results in increased activity of NQO1 protein CTD PMID:16906435 NCBI chr19:52,205,374...52,220,267
Ensembl chr19:52,205,314...52,220,260 		JBrowse link
G Nr1d1 nuclear receptor subfamily 1, group D, member 1 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of NR1D1 mRNA CTD PMID:27858113 NCBI chr10:84,224,599...84,231,812
Ensembl chr10:84,224,540...84,231,812 		JBrowse link
G Nr1d2 nuclear receptor subfamily 1, group D, member 2 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of NR1D2 mRNA CTD PMID:27858113 NCBI chr15:9,955,034...9,981,329
Ensembl chr15:9,954,906...9,981,330 		JBrowse link
G Nrbp2 nuclear receptor binding protein 2 increases expression ISO chrysene results in increased expression of NRBP2 mRNA CTD PMID:26377693 NCBI chr 7:109,679,330...109,685,656
Ensembl chr 7:109,679,330...109,685,588 		JBrowse link
G Nrcam neuronal cell adhesion molecule multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of NRCAM mRNA CTD PMID:27858113 NCBI chr 6:67,129,723...67,425,510
Ensembl chr 6:67,129,801...67,430,539 		JBrowse link
G Nsd1 nuclear receptor binding SET domain protein 1 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of NSD1 mRNA CTD PMID:27858113 NCBI chr17:9,317,085...9,431,528
Ensembl chr17:9,317,085...9,452,250 		JBrowse link
G Nsfl1c NSFL1 cofactor increases expression ISO chrysene results in increased expression of NSFL1C mRNA CTD PMID:26377693 NCBI chr 3:160,438,708...160,463,261
Ensembl chr 3:160,438,708...160,463,228 		JBrowse link
G Nt5dc2 5'-nucleotidase domain containing 2 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of NT5DC2 mRNA CTD PMID:27858113 NCBI chr16:6,328,925...6,336,978
Ensembl chr16:6,328,523...6,336,980 		JBrowse link
G Ntn1 netrin 1 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of NTN1 mRNA CTD PMID:27858113 NCBI chr10:53,398,852...53,597,595
Ensembl chr10:53,398,852...53,584,060 		JBrowse link
G Nufip2 nuclear FMR1 interacting protein 2 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of NUFIP2 mRNA CTD PMID:27858113 NCBI chr10:63,072,964...63,105,823
Ensembl chr10:63,073,397...63,105,823 		JBrowse link
G Nup85 nucleoporin 85 increases expression ISO chrysene results in increased expression of NUP85 mRNA CTD PMID:26377693 NCBI chr10:101,305,241...101,323,980
Ensembl chr10:101,305,390...101,324,641 		JBrowse link
G Nxf1 nuclear RNA export factor 1 increases expression ISO chrysene results in increased expression of NXF1 mRNA CTD PMID:26377693 NCBI chr 1:215,084,563...215,097,756
Ensembl chr 1:215,084,099...215,097,756 		JBrowse link
G Nxn nucleoredoxin increases expression ISO chrysene results in increased expression of NXN mRNA CTD PMID:26377693 NCBI chr10:61,607,557...61,745,807
Ensembl chr10:61,607,568...61,745,807 		JBrowse link
G Nxph3 neurexophilin 3 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of NXPH3 mRNA CTD PMID:27858113 NCBI chr10:80,953,080...80,956,746
Ensembl chr10:80,952,227...80,956,668 		JBrowse link
G Oga O-GlcNAcase multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of OGA mRNA CTD PMID:27858113 NCBI chr 1:254,547,311...254,589,596
Ensembl chr 1:254,547,311...254,582,855 		JBrowse link
G P2rx7 purinergic receptor P2X 7 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of P2RX7 mRNA CTD PMID:27858113 NCBI chr12:39,550,531...39,594,984
Ensembl chr12:39,540,567...39,595,193 		JBrowse link
G Pa2g4 proliferation-associated 2G4 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of PA2G4 mRNA CTD PMID:27858113 NCBI chr 7:1,569,326...1,576,794
Ensembl chr 7:1,569,327...1,576,802 		JBrowse link
G Pabpn1l PABPN1 like multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of PABPN1L mRNA CTD PMID:27858113 NCBI chr19:67,578,494...67,581,938
Ensembl chr19:67,578,496...67,581,895 		JBrowse link
G Paf1 PAF1 homolog, Paf1/RNA polymerase II complex component increases expression ISO chrysene results in increased expression of PAF1 mRNA CTD PMID:26377693 NCBI chr 1:92,811,197...92,816,775
Ensembl chr 1:92,798,237...92,816,779 		JBrowse link
G Pah phenylalanine hydroxylase decreases expression ISO chrysene results in decreased expression of PAH mRNA CTD PMID:22579512 NCBI chr 7:23,793,096...23,885,631
Ensembl chr 7:23,792,781...23,885,627 		JBrowse link
G Palmd palmdelphin multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of PALMD mRNA CTD PMID:27858113 NCBI chr 2:207,574,413...207,626,239
Ensembl chr 2:207,574,249...207,626,239 		JBrowse link
G Pan3 poly(A) specific ribonuclease subunit PAN3 increases expression ISO chrysene results in increased expression of PAN3 mRNA CTD PMID:26377693 NCBI chr12:12,512,835...12,637,066
Ensembl chr12:12,512,835...12,631,492 		JBrowse link
G Pank4 pantothenate kinase 4 increases expression ISO chrysene results in increased expression of PANK4 mRNA CTD PMID:26377693 NCBI chr 5:170,807,744...170,824,478
Ensembl chr 5:170,807,745...170,824,477 		JBrowse link
G Papola poly (A) polymerase alpha multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of PAPOLA mRNA CTD PMID:27858113 NCBI chr 6:130,446,236...130,499,371
Ensembl chr 6:130,446,797...130,499,336 		JBrowse link
G Parm1 prostate androgen-regulated mucin-like protein 1 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of PARM1 mRNA CTD PMID:27858113 NCBI chr14:16,752,541...16,861,570
Ensembl chr14:16,752,541...16,881,138 		JBrowse link
G Pbk PDZ binding kinase multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of PBK mRNA CTD PMID:27858113 NCBI chr15:44,198,506...44,209,572
Ensembl chr15:44,198,544...44,209,570 		JBrowse link
G Pbx1 PBX homeobox 1 decreases expression
multiple interactions 		ISO chrysene results in decreased expression of PBX1 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of PBX1 mRNA 		CTD PMID:26377693 PMID:27858113 NCBI chr13:82,811,664...83,121,447
Ensembl chr13:82,812,131...83,121,066 		JBrowse link
G Pcdh17 protocadherin 17 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of PCDH17 mRNA CTD PMID:27858113 NCBI chr15:66,631,549...66,725,007
Ensembl chr15:66,633,142...66,722,105 		JBrowse link
G Pcdhac2 protocadherin alpha subfamily C, 2 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of PCDHAC2 mRNA CTD PMID:27858113 Ensembl chr18:28,855,256...29,120,227 JBrowse link
G Pcdhga9 protocadherin gamma subfamily A, 9 decreases expression
multiple interactions 		ISO chrysene results in decreased expression of PCDHGA9 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of PCDHGA9 mRNA 		CTD PMID:26377693 PMID:27858113 NCBI chr18:29,815,845...29,919,095 JBrowse link
G Pcp2 Purkinje cell protein 2 increases expression ISO chrysene results in increased expression of PCP2 mRNA CTD PMID:26377693 NCBI chr12:6,479,554...6,481,550
Ensembl chr12:6,479,554...6,485,159 		JBrowse link
G Pdap1 PDGFA associated protein 1 increases expression ISO chrysene results in increased expression of PDAP1 mRNA CTD PMID:26377693 NCBI chr12:14,584,414...14,594,641
Ensembl chr12:14,584,398...14,594,641 		JBrowse link
G Pde4a phosphodiesterase 4A multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of PDE4A mRNA CTD PMID:27858113 NCBI chr 8:27,966,978...28,029,721
Ensembl chr 8:27,966,996...28,046,924 		JBrowse link
G Pdk2 pyruvate dehydrogenase kinase 2 increases expression ISO chrysene results in increased expression of PDK2 mRNA CTD PMID:26377693 NCBI chr10:80,469,388...80,483,988
Ensembl chr10:80,469,389...80,484,355 		JBrowse link
G Pdxk pyridoxal kinase decreases expression ISO chrysene results in decreased expression of PDXK mRNA CTD PMID:26377693 NCBI chr20:10,209,975...10,232,012
Ensembl chr20:10,209,832...10,233,780 		JBrowse link
G Pebp1 phosphatidylethanolamine binding protein 1 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of PEBP1 mRNA CTD PMID:27858113 NCBI chr12:44,946,307...44,967,890
Ensembl chr12:44,963,675...44,971,780 		JBrowse link
G Pecam1 platelet and endothelial cell adhesion molecule 1 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of PECAM1 mRNA CTD PMID:27858113 NCBI chr10:92,090,263...92,152,002
Ensembl chr10:92,090,235...92,151,839 		JBrowse link
G Per1 period circadian regulator 1 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of PER1 mRNA CTD PMID:27858113 NCBI chr10:54,299,002...54,313,804
Ensembl chr10:54,302,641...54,314,211 		JBrowse link
G Per2 period circadian regulator 2 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of PER2 mRNA CTD PMID:27858113 NCBI chr 9:99,454,828...99,497,069
Ensembl chr 9:99,454,830...99,496,993 		JBrowse link
G Per3 period circadian regulator 3 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of PER3 mRNA CTD PMID:27858113 NCBI chr 5:166,740,914...166,778,243
Ensembl chr 5:166,743,050...166,777,999 		JBrowse link
G Pfkfb3 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of PFKFB3 mRNA CTD PMID:27858113 NCBI chr17:71,893,320...71,974,526
Ensembl chr17:71,893,416...71,975,052 		JBrowse link
G Pgap2 post-GPI attachment to proteins 2 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of PGAP2 mRNA CTD PMID:27858113 NCBI chr 1:166,003,593...166,030,088
Ensembl chr 1:166,003,523...166,030,088 		JBrowse link
G Phf19 PHD finger protein 19 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of PHF19 mRNA CTD PMID:27858113 NCBI chr 3:38,572,766...38,604,950
Ensembl chr 3:38,572,766...38,593,854 		JBrowse link
G Phf20l1 PHD finger protein 20-like 1 decreases expression ISO chrysene results in decreased expression of PHF20L1 mRNA CTD PMID:26377693 NCBI chr 7:100,219,598...100,285,580
Ensembl chr 7:100,219,639...100,285,580 		JBrowse link
G Phf21a PHD finger protein 21A multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of PHF21A mRNA CTD PMID:27858113 NCBI chr 3:98,600,933...98,791,132
Ensembl chr 3:98,613,844...98,787,350 		JBrowse link
G Phlda3 pleckstrin homology-like domain, family A, member 3 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of PHLDA3 mRNA CTD PMID:27858113 NCBI chr13:49,745,003...49,748,088
Ensembl chr13:49,742,591...49,749,621 		JBrowse link
G Phlpp1 PH domain and leucine rich repeat protein phosphatase 1 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of PHLPP1 mRNA CTD PMID:27858113 NCBI chr13:22,823,132...23,045,619
Ensembl chr13:22,823,132...23,045,619 		JBrowse link
G Phyhip phytanoyl-CoA 2-hydroxylase interacting protein increases expression ISO chrysene results in increased expression of PHYHIP mRNA CTD PMID:26377693 NCBI chr15:51,943,670...51,954,921
Ensembl chr15:51,943,378...51,954,920 		JBrowse link
G Piezo1 piezo-type mechanosensitive ion channel component 1 increases expression ISO chrysene results in increased expression of PIEZO1 mRNA CTD PMID:26377693 NCBI chr19:67,453,120...67,515,347
Ensembl chr19:67,453,122...67,515,037 		JBrowse link
G Pigr polymeric immunoglobulin receptor multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of PIGR mRNA CTD PMID:27858113 NCBI chr13:44,851,001...44,879,143
Ensembl chr13:44,851,182...44,879,141 		JBrowse link
G Pim1 Pim-1 proto-oncogene, serine/threonine kinase multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of PIM1 mRNA CTD PMID:27858113 NCBI chr20:7,556,496...7,560,747
Ensembl chr20:7,556,113...7,561,764 		JBrowse link
G Pimreg PICALM interacting mitotic regulator multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of PIMREG mRNA CTD PMID:27858113 NCBI chr10:57,168,136...57,173,713
Ensembl chr10:57,167,797...57,173,063 		JBrowse link
G Pinx1 PIN2/TERF1 interacting, telomerase inhibitor 1 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of PINX1 mRNA CTD PMID:27858113 NCBI chr15:42,273,805...42,333,047
Ensembl chr15:42,273,799...42,333,047 		JBrowse link
G Pip4p1 phosphatidylinositol-4,5-bisphosphate 4-phosphatase 1 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of PIP4P1 mRNA CTD PMID:27858113 NCBI chr15:26,620,399...26,624,369
Ensembl chr15:26,620,401...26,624,246 		JBrowse link
G Pkia cAMP-dependent protein kinase inhibitor alpha increases expression ISO chrysene results in increased expression of PKIA mRNA CTD PMID:26377693 NCBI chr 2:96,306,181...96,380,959
Ensembl chr 2:96,306,184...96,321,262 		JBrowse link
G Pkig cAMP-dependent protein kinase inhibitor gamma multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of PKIG mRNA CTD PMID:27858113 NCBI chr 3:172,749,871...172,817,514
Ensembl chr 3:172,749,928...172,817,519 		JBrowse link
G Pkn3 protein kinase N3 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of PKN3 mRNA CTD PMID:27858113 NCBI chr 3:33,747,610...33,761,405
Ensembl chr 3:33,747,867...33,761,405 		JBrowse link
G Plac8 placenta associated 8 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of PLAC8 mRNA CTD PMID:27858113 NCBI chr14:9,356,950...9,378,586
Ensembl chr14:9,356,972...9,378,572 		JBrowse link
G Plagl2 PLAG1 like zinc finger 2 increases expression ISO chrysene results in increased expression of PLAGL2 mRNA CTD PMID:26377693 NCBI chr 3:162,155,554...162,168,748
Ensembl chr 3:162,155,554...162,168,748 		JBrowse link
G Plat plasminogen activator, tissue type multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of PLAT mRNA CTD PMID:27858113 NCBI chr16:75,943,061...76,022,037
Ensembl chr16:75,943,064...75,967,696 		JBrowse link
G Plcb1 phospholipase C beta 1 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of PLCB1 mRNA CTD PMID:27858113 NCBI chr 3:142,512,765...143,224,042
Ensembl chr 3:142,513,033...143,225,646 		JBrowse link
G Plcd1 phospholipase C, delta 1 increases expression ISO chrysene results in increased expression of PLCD1 mRNA CTD PMID:26377693 NCBI chr 8:127,672,955...127,695,939
Ensembl chr 8:127,672,980...127,695,939 		JBrowse link
G Plcd4 phospholipase C, delta 4 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of PLCD4 mRNA CTD PMID:27858113 NCBI chr 9:83,564,616...83,613,742
Ensembl chr 9:83,564,606...83,606,454 		JBrowse link
G Plch2 phospholipase C, eta 2 increases expression ISO chrysene results in increased expression of PLCH2 mRNA CTD PMID:26377693 NCBI chr 5:170,826,543...170,885,012
Ensembl chr 5:170,826,543...170,885,152 		JBrowse link
G Plekhg6 pleckstrin homology and RhoGEF domain containing G6 increases expression ISO chrysene results in increased expression of PLEKHG6 mRNA CTD PMID:26377693 NCBI chr 4:159,849,987...159,885,730
Ensembl chr 4:159,849,364...159,868,122 		JBrowse link
G Plekhh3 pleckstrin homology, MyTH4 and FERM domain containing H3 increases expression ISO chrysene results in increased expression of PLEKHH3 mRNA CTD PMID:26377693 NCBI chr10:86,598,749...86,607,482
Ensembl chr10:86,598,754...86,607,165 		JBrowse link
G Plk2 polo-like kinase 2 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of PLK2 mRNA CTD PMID:27858113 NCBI chr 2:43,702,536...43,708,305
Ensembl chr 2:43,701,865...43,708,296 		JBrowse link
G Plk5 polo-like kinase 5 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of PLK5 mRNA CTD PMID:27858113 NCBI chr 7:9,997,453...10,006,959
Ensembl chr 7:9,997,453...10,019,340 		JBrowse link
G Plpp1 phospholipid phosphatase 1 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of PPAP2A mRNA CTD PMID:27858113 NCBI chr 2:46,172,202...46,233,632
Ensembl chr 2:46,172,197...46,234,676 		JBrowse link
G Pmaip1 phorbol-12-myristate-13-acetate-induced protein 1 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of PMAIP1 mRNA CTD PMID:27858113 NCBI chr18:62,255,970...62,262,384
Ensembl chr18:62,255,598...62,262,382 		JBrowse link
G Pmp22 peripheral myelin protein 22 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of PMP22 mRNA CTD PMID:27858113 NCBI chr10:48,294,932...48,324,941
Ensembl chr10:48,297,437...48,324,940 		JBrowse link
G Pnck pregnancy up-regulated nonubiquitous CaM kinase increases expression ISO chrysene results in increased expression of PNCK mRNA CTD PMID:26377693 NCBI chr  X:156,520,751...156,524,828
Ensembl chr  X:156,520,753...156,525,352 		JBrowse link
G Pnma2 PNMA family member 2 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of PNMA2 mRNA CTD PMID:27858113 NCBI chr15:45,287,445...45,296,340
Ensembl chr15:45,286,304...45,298,080 		JBrowse link
G Poldip3 DNA polymerase delta interacting protein 3 increases expression ISO chrysene results in increased expression of POLDIP3 mRNA CTD PMID:26377693 NCBI chr 7:116,154,892...116,183,319
Ensembl chr 7:116,154,892...116,183,300 		JBrowse link
G Polk DNA polymerase kappa multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of POLK mRNA CTD PMID:27858113 NCBI chr 2:29,556,831...29,616,960
Ensembl chr 2:29,557,336...29,616,960 		JBrowse link
G Pomp proteasome maturation protein decreases expression ISO chrysene results in decreased expression of POMP mRNA CTD PMID:26377693 NCBI chr12:12,198,262...12,212,132
Ensembl chr12:12,198,263...12,210,880 		JBrowse link
G Pon2 paraoxonase 2 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of PON2 mRNA CTD PMID:27858113 NCBI chr 4:34,356,270...34,391,684
Ensembl chr 4:34,356,274...34,391,996 		JBrowse link
G Pou2af1 POU class 2 homeobox associating factor 1 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of POU2AF1 mRNA CTD PMID:27858113 NCBI chr 8:60,418,173...60,445,176
Ensembl chr 8:60,436,844...60,445,176 		JBrowse link
G Ppfia3 PTPRF interacting protein alpha 3 increases expression ISO chrysene results in increased expression of PPFIA3 mRNA CTD PMID:26377693 NCBI chr 1:104,953,598...104,982,373
Ensembl chr 1:104,953,598...104,982,278 		JBrowse link
G Ppig peptidylprolyl isomerase G multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of PPIG mRNA CTD PMID:27858113 NCBI chr 3:74,891,846...74,923,010
Ensembl chr 3:74,891,846...74,920,750 		JBrowse link
G Ppm1a protein phosphatase, Mg2+/Mn2+ dependent, 1A decreases expression ISO chrysene results in decreased expression of PPM1A mRNA CTD PMID:26377693 NCBI chr 6:97,174,955...97,216,585
Ensembl chr 6:97,174,916...97,216,574 		JBrowse link
G Prickle3 prickle planar cell polarity protein 3 increases expression ISO chrysene results in increased expression of PRICKLE3 mRNA CTD PMID:26377693 NCBI chr  X:17,509,551...17,520,157
Ensembl chr  X:17,509,554...17,520,122 		JBrowse link
G Prkag3 protein kinase AMP-activated non-catalytic subunit gamma 3 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of PRKAG3 mRNA CTD PMID:27858113 NCBI chr 9:83,744,385...83,753,629
Ensembl chr 9:83,744,385...83,753,729 		JBrowse link
G Prkce protein kinase C, epsilon multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of PRKCE mRNA CTD PMID:27858113 NCBI chr 6:13,718,050...14,204,931
Ensembl chr 6:13,718,050...14,204,288 		JBrowse link
G Prkci protein kinase C, iota increases expression ISO chrysene results in increased expression of PRKCI mRNA CTD PMID:26377693 NCBI chr 2:114,250,398...114,310,784
Ensembl chr 2:114,250,398...114,310,784 		JBrowse link
G Proser2 proline and serine rich 2 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of PROSER2 mRNA CTD PMID:27858113 NCBI chr17:77,061,371...77,096,788
Ensembl chr17:77,077,727...77,095,194 		JBrowse link
G Prpf38b pre-mRNA processing factor 38B multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of PRPF38B mRNA CTD PMID:27858113 NCBI chr 2:199,241,312...199,250,342
Ensembl chr 2:199,241,313...199,250,338 		JBrowse link
G Prpf4b pre-mRNA processing factor 4B multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of PRPF4B mRNA CTD PMID:27858113 NCBI chr17:30,190,721...30,230,153
Ensembl chr17:30,193,907...30,225,420 		JBrowse link
G Prr7 proline rich 7 (synaptic) multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of PRR7 mRNA CTD PMID:27858113 NCBI chr17:9,170,405...9,178,814
Ensembl chr17:9,170,411...9,179,361 		JBrowse link
G Prrg3 proline rich and Gla domain 3 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of PRRG3 mRNA CTD PMID:27858113 NCBI chr  X:154,711,246...154,731,359
Ensembl chr  X:154,712,625...154,722,831 		JBrowse link
G Prss12 serine protease 12 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of PRSS12 mRNA CTD PMID:27858113 NCBI chr 2:214,308,695...214,368,679
Ensembl chr 2:214,308,774...214,369,941 		JBrowse link
G Prss23 serine protease 23 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of PRSS23 mRNA CTD PMID:27858113 NCBI chr 1:152,815,301...152,835,005
Ensembl chr 1:152,813,670...152,947,871 		JBrowse link
G Psmd3 proteasome 26S subunit, non-ATPase 3 increases expression ISO chrysene results in increased expression of PSMD3 mRNA CTD PMID:26377693 NCBI chr10:84,139,249...84,151,879
Ensembl chr10:84,139,677...84,151,878 		JBrowse link
G Psrc1 proline and serine rich coiled-coil 1 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of PSRC1 mRNA CTD PMID:27858113 NCBI chr 2:198,710,427...198,715,001
Ensembl chr 2:198,705,839...198,714,997 		JBrowse link
G Ptbp1 polypyrimidine tract binding protein 1 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of PTBP1 mRNA CTD PMID:27858113 NCBI chr 7:10,493,199...10,502,957
Ensembl chr 7:10,493,200...10,502,957 		JBrowse link
G Ptma prothymosin alpha increases expression
multiple interactions 		ISO chrysene results in increased expression of PTMA mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of PTMA mRNA 		CTD PMID:26377693 PMID:27858113 NCBI chr 9:94,624,194...94,628,276
Ensembl chr 9:94,624,196...94,628,276 		JBrowse link
G Ptpn5 protein tyrosine phosphatase, non-receptor type 5 decreases expression ISO chrysene results in decreased expression of PTPN5 mRNA CTD PMID:26377693 NCBI chr 1:106,756,896...106,817,369
Ensembl chr 1:106,756,896...106,816,828 		JBrowse link
G Ptprb protein tyrosine phosphatase, receptor type, B multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of PTPRB mRNA CTD PMID:27858113 NCBI chr 7:53,816,197...53,920,760
Ensembl chr 7:53,816,097...53,920,760 		JBrowse link
G Ptprg protein tyrosine phosphatase, receptor type, G multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of PTPRG mRNA CTD PMID:27858113 NCBI chr15:15,298,669...15,982,581
Ensembl chr15:15,302,133...15,982,668 		JBrowse link
G Ptprz1 protein tyrosine phosphatase, receptor type Z1 increases expression ISO chrysene results in increased expression of PTPRZ1 mRNA CTD PMID:26377693 NCBI chr 4:52,363,006...52,560,905
Ensembl chr 4:52,363,295...52,560,903 		JBrowse link
G Rab11fip1 RAB11 family interacting protein 1 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of RAB11FIP1 mRNA CTD PMID:27858113 NCBI chr16:71,589,753...71,620,341
Ensembl chr16:71,589,753...71,620,341 		JBrowse link
G Rab44 RAB44, member RAS oncogene family increases expression ISO chrysene results in increased expression of RAB44 mRNA CTD PMID:26377693 NCBI chr20:7,166,219...7,200,114
Ensembl chr20:7,166,371...7,200,111 		JBrowse link
G Rabac1 Rab acceptor 1 decreases expression ISO chrysene results in decreased expression of RABAC1 mRNA CTD PMID:26377693 NCBI chr 1:89,691,884...89,695,017
Ensembl chr 1:89,691,884...89,695,017 		JBrowse link
G Rabggtb Rab geranylgeranyltransferase subunit beta decreases expression ISO chrysene results in decreased expression of RABGGTB mRNA CTD PMID:26377693 NCBI chr 2:245,504,586...245,510,878
Ensembl chr 2:245,504,586...245,510,774 		JBrowse link
G Rad51 RAD51 recombinase multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of RAD51 mRNA CTD PMID:27858113 NCBI chr 3:126,554,210...126,578,888
Ensembl chr 3:126,554,190...126,579,469 		JBrowse link
G Rai2 retinoic acid induced 2 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of RAI2 mRNA CTD PMID:27858113 NCBI chr  X:36,580,406...36,642,943
Ensembl chr  X:36,573,917...36,643,240 		JBrowse link
G Ramp3 receptor activity modifying protein 3 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of RAMP3 mRNA CTD PMID:27858113 NCBI chr14:85,741,314...85,758,813
Ensembl chr14:85,755,211...85,758,818 		JBrowse link
G Rasd2 RASD family, member 2 increases expression
multiple interactions 		ISO chrysene results in increased expression of RASD2 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of RASD2 mRNA 		CTD PMID:26377693 PMID:27858113 NCBI chr19:13,600,028...13,610,753
Ensembl chr19:13,599,986...13,610,753 		JBrowse link
G Rasgef1c RasGEF domain family, member 1C multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of RASGEF1C mRNA CTD PMID:27858113 NCBI chr10:34,728,573...34,794,763
Ensembl chr10:34,728,573...34,794,763 		JBrowse link
G Rasgrp3 RAS guanyl releasing protein 3 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of RASGRP3 mRNA CTD PMID:27858113 NCBI chr 6:25,647,386...25,745,952
Ensembl chr 6:25,647,386...25,710,591 		JBrowse link
G Rasl11a RAS-like family 11 member A multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of RASL11A mRNA CTD PMID:27858113 NCBI chr12:13,372,023...13,374,784
Ensembl chr12:13,372,023...13,376,451 		JBrowse link
G Rassf1 Ras association domain family member 1 increases expression ISO chrysene results in increased expression of RASSF1 mRNA CTD PMID:26377693 NCBI chr 8:117,103,665...117,114,805
Ensembl chr 8:117,103,362...117,114,805 		JBrowse link
G Rassf8 Ras association domain family member 8 decreases expression ISO chrysene results in decreased expression of RASSF8 mRNA CTD PMID:26377693 NCBI chr 4:180,447,050...180,528,792
Ensembl chr 4:180,446,846...180,528,790 		JBrowse link
G Rbm25 RNA binding motif protein 25 increases expression ISO chrysene results in increased expression of RBM25 mRNA CTD PMID:26377693 NCBI chr 6:108,993,119...109,050,159
Ensembl chr 6:109,002,869...109,050,159 		JBrowse link
G Rbm39 RNA binding motif protein 39 increases expression ISO chrysene results in increased expression of RBM39 mRNA CTD PMID:26377693 NCBI chr 3:165,123,087...165,156,453
Ensembl chr 3:165,123,095...165,149,397 		JBrowse link
G Rbm6 RNA binding motif protein 6 increases expression ISO chrysene results in increased expression of RBM6 mRNA CTD PMID:26377693 NCBI chr 8:117,327,607...117,431,397
Ensembl chr 8:117,331,325...117,431,397 		JBrowse link
G Rbp1 retinol binding protein 1 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of RBP1 mRNA CTD PMID:27858113 NCBI chr 8:107,904,589...107,926,109
Ensembl chr 8:107,887,417...107,983,847 		JBrowse link
G Reep1 receptor accessory protein 1 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of REEP1 mRNA CTD PMID:27858113 NCBI chr 4:105,303,974...105,420,611
Ensembl chr 4:105,303,969...105,420,602 		JBrowse link
G Reep2 receptor accessory protein 2 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of REEP2 mRNA CTD PMID:27858113 NCBI chr18:26,712,236...26,721,275
Ensembl chr18:26,712,426...26,721,278 		JBrowse link
G Rev1 REV1, DNA directed polymerase multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of REV1 mRNA CTD PMID:27858113 NCBI chr 9:47,773,907...47,847,554
Ensembl chr 9:47,773,907...47,847,332 		JBrowse link
G Rexo4 REX4 homolog, 3'-5' exonuclease increases expression ISO chrysene results in increased expression of REXO4 mRNA CTD PMID:26377693 NCBI chr 3:30,678,729...30,692,376
Ensembl chr 3:30,678,740...30,689,059 		JBrowse link
G Rgs12 regulator of G-protein signaling 12 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of RGS12 mRNA CTD PMID:27858113 NCBI chr14:79,940,561...80,048,637
Ensembl chr14:79,940,565...80,034,859 		JBrowse link
G Rgs7bp regulator of G-protein signaling 7 binding protein multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of RGS7BP mRNA CTD PMID:27858113 NCBI chr 2:37,867,698...37,965,587
Ensembl chr 2:37,872,949...37,965,253 		JBrowse link
G Rhob ras homolog family member B decreases expression
multiple interactions 		ISO chrysene results in decreased expression of RHOB mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of RHOB mRNA 		CTD PMID:26377693 PMID:27858113 NCBI chr 6:37,083,030...37,085,204
Ensembl chr 6:37,075,015...37,112,772 		JBrowse link
G Rhoc ras homolog family member C increases expression ISO chrysene results in increased expression of RHOC mRNA CTD PMID:22579512 NCBI chr 2:194,975,586...194,981,637
Ensembl chr 2:194,975,242...194,983,745 		JBrowse link
G Rhot2 ras homolog family member T2 increases expression ISO chrysene results in increased expression of RHOT2 mRNA CTD PMID:26377693 NCBI chr10:15,363,467...15,369,263
Ensembl chr10:15,361,726...15,369,006 		JBrowse link
G Rhoxf8 Rhox homeobox family member 8 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of RHOX8 mRNA CTD PMID:27858113 NCBI chr  X:121,450,408...121,454,031
Ensembl chr  X:121,450,332...121,454,027 		JBrowse link
G Ripply3 ripply transcriptional repressor 3 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of RIPPLY3 mRNA CTD PMID:27858113 NCBI chr11:47,118,147...47,126,244
Ensembl chr11:47,118,147...47,131,954 		JBrowse link
G Rnase10 ribonuclease A family member 10 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of RNASE10 mRNA CTD PMID:27858113 NCBI chr15:26,700,219...26,702,681
Ensembl chr15:26,688,102...26,706,105 		JBrowse link
G Rnaseh2b ribonuclease H2, subunit B multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of RNASEH2B mRNA CTD PMID:27858113 NCBI chr15:40,717,252...40,770,826
Ensembl chr15:40,717,232...40,770,825 		JBrowse link
G Rnf144a ring finger protein 144A multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of RNF144A mRNA CTD PMID:27858113 NCBI chr 6:48,628,241...48,748,241
Ensembl chr 6:48,631,648...48,748,179 		JBrowse link
G Rnf169 ring finger protein 169 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of RNF169 mRNA CTD PMID:27858113 NCBI chr 1:163,662,582...163,724,154
Ensembl chr 1:163,666,592...163,723,897 		JBrowse link
G Rnf20 ring finger protein 20 increases expression ISO chrysene results in increased expression of RNF20 mRNA CTD PMID:26377693 NCBI chr 5:68,771,507...68,797,240
Ensembl chr 5:68,771,535...68,797,240 		JBrowse link
G Rnf43 ring finger protein 43 increases expression ISO chrysene results in increased expression of RNF43 mRNA CTD PMID:26377693 NCBI chr10:72,958,744...73,034,540
Ensembl chr10:72,961,641...73,034,551 		JBrowse link
G Robo1 roundabout guidance receptor 1 decreases expression ISO chrysene results in decreased expression of ROBO1 mRNA CTD PMID:26377693 NCBI chr11:24,067,869...25,108,694
Ensembl chr11:24,067,878...25,108,694 		JBrowse link
G Rock2 Rho-associated coiled-coil containing protein kinase 2 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of ROCK2 mRNA CTD PMID:27858113 NCBI chr 6:45,407,823...45,502,773
Ensembl chr 6:45,407,965...45,502,771 		JBrowse link
G Rorc RAR-related orphan receptor C multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of RORC mRNA CTD PMID:27858113 NCBI chr 2:184,698,779...184,723,942
Ensembl chr 2:184,698,818...184,724,566 		JBrowse link
G Rpap2 RNA polymerase II associated protein 2 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of RPAP2 mRNA CTD PMID:27858113 NCBI chr14:2,253,966...2,332,251
Ensembl chr14:2,253,968...2,332,356 		JBrowse link
G Rps27l ribosomal protein S27-like multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of RPS27L mRNA CTD PMID:27858113 NCBI chr 8:76,443,658...76,448,593
Ensembl chr12:33,713,661...33,714,130
Ensembl chr 8:33,713,661...33,714,130 		JBrowse link
G Rrm1 ribonucleotide reductase catalytic subunit M1 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of RRM1 mRNA CTD PMID:27858113 NCBI chr 1:166,235,904...166,260,206
Ensembl chr 1:166,235,900...166,260,944 		JBrowse link
G Rrm2 ribonucleotide reductase regulatory subunit M2 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of RRM2 mRNA CTD PMID:27858113 NCBI chr 6:47,044,755...47,075,370
Ensembl chr 6:47,067,690...47,075,370 		JBrowse link
G Rrp1 ribosomal RNA processing 1 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of RRP1 mRNA CTD PMID:27858113 NCBI chr20:10,260,580...10,271,829
Ensembl chr20:10,260,592...10,275,076 		JBrowse link
G Rs1 retinoschisin 1 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of RS1 mRNA CTD PMID:27858113 NCBI chr  X:37,771,135...37,800,894
Ensembl chr  X:37,771,135...37,800,894 		JBrowse link
G Rsrp1 arginine and serine rich protein 1 increases expression ISO chrysene results in increased expression of RSRP1 mRNA CTD PMID:26377693 NCBI chr 5:152,431,448...152,435,202
Ensembl chr 5:152,431,478...152,435,126 		JBrowse link
G RT1-DOa RT1 class II, locus DOa multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of H2-OA mRNA CTD PMID:27858113 NCBI chr20:4,755,287...4,758,491
Ensembl chr20:4,755,499...4,758,478 		JBrowse link
G RT1-DOb RT1 class II, locus DOb multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of H2-OB mRNA CTD PMID:27858113 NCBI chr20:4,621,336...4,627,537
Ensembl chr20:4,619,694...4,627,523 		JBrowse link
G Rtn3 reticulon 3 decreases expression ISO chrysene results in decreased expression of RTN3 mRNA CTD PMID:26377693 NCBI chr 1:214,041,838...214,098,644
Ensembl chr 1:214,041,838...214,109,638 		JBrowse link
G Rtp3 receptor (chemosensory) transporter protein 3 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of RTP3 mRNA CTD PMID:27858113 NCBI chr 8:119,847,947...119,853,549
Ensembl chr 8:119,848,556...119,853,095 		JBrowse link
G Rtp4 receptor (chemosensory) transporter protein 4 decreases expression ISO chrysene results in decreased expression of RTP4 mRNA CTD PMID:26377693 NCBI chr11:90,741,992...90,840,061
Ensembl chr11:90,741,992...90,753,851 		JBrowse link
G Rufy2 RUN and FYVE domain containing 2 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of RUFY2 mRNA CTD PMID:27858113 NCBI chr20:25,566,950...25,657,937
Ensembl chr20:25,621,646...25,656,844 		JBrowse link
G Ryr1 ryanodine receptor 1 increases expression ISO chrysene results in increased expression of RYR1 mRNA CTD PMID:26377693 NCBI chr 1:93,420,078...93,551,305
Ensembl chr 1:93,420,078...93,551,305 		JBrowse link
G S100a14 S100 calcium binding protein A14 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of S100A14 mRNA CTD PMID:27858113 NCBI chr 2:178,305,976...178,308,004
Ensembl chr 2:178,306,025...178,307,999 		JBrowse link
G S100a6 S100 calcium binding protein A6 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of S100A6 mRNA CTD PMID:27858113 NCBI chr 2:178,398,189...178,399,763
Ensembl chr 2:178,398,481...178,399,762 		JBrowse link
G S1pr1 sphingosine-1-phosphate receptor 1 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of S1PR1 mRNA CTD PMID:27858113 NCBI chr 2:206,309,715...206,314,070
Ensembl chr 2:205,900,836...206,328,689 		JBrowse link
G Sac3d1 SAC3 domain containing 1 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of SAC3D1 mRNA CTD PMID:27858113 NCBI chr 1:212,843,463...212,845,842
Ensembl chr 1:212,843,463...212,845,883 		JBrowse link
G Safb2 scaffold attachment factor B2 increases expression ISO chrysene results in increased expression of SAFB2 mRNA CTD PMID:26377693 NCBI chr 9:1,482,985...1,504,142
Ensembl chr 9:1,479,061...1,504,142 		JBrowse link
G Sbsn suprabasin increases expression ISO chrysene results in increased expression of SBSN mRNA CTD PMID:26377693 NCBI chr 1:95,106,390...95,133,448
Ensembl chr 1:95,120,927...95,134,220 		JBrowse link
G Scd stearoyl-CoA desaturase multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of SCD1 mRNA CTD PMID:27858113 NCBI chr 1:253,218,968...253,232,101
Ensembl chr 1:253,218,970...253,231,785 		JBrowse link
G Scn3b sodium voltage-gated channel beta subunit 3 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of SCN3B mRNA CTD PMID:27858113 NCBI chr 8:49,527,529...49,550,019
Ensembl chr 8:49,527,577...49,550,018 		JBrowse link
G Scyl1 SCY1 like pseudokinase 1 increases expression ISO chrysene results in increased expression of SCYL1 mRNA CTD PMID:26377693 NCBI chr 1:212,475,198...212,489,285
Ensembl chr 1:212,475,068...212,501,129 		JBrowse link
G Sdf4 stromal cell derived factor 4 decreases expression
multiple interactions 		ISO chrysene results in decreased expression of SDF4 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of SDF4 mRNA 		CTD PMID:26377693 PMID:27858113 NCBI chr 5:171,868,591...171,885,827
Ensembl chr 5:171,868,563...171,888,884 		JBrowse link
G Sec61b SEC61 translocon subunit beta decreases expression ISO chrysene results in decreased expression of SEC61B mRNA CTD PMID:26377693 NCBI chr 5:66,569,184...66,577,394
Ensembl chr 5:66,569,196...66,580,028 		JBrowse link
G Selenos selenoprotein S decreases expression ISO chrysene results in decreased expression of SELENOS mRNA CTD PMID:26377693 NCBI chr 1:129,070,240...129,080,007
Ensembl chr 1:129,070,230...129,077,991 		JBrowse link
G Sell selectin L multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of SELL mRNA CTD PMID:27858113 NCBI chr13:78,950,100...78,969,604
Ensembl chr13:78,950,015...78,969,600 		JBrowse link
G Sema3c semaphorin 3C multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of SEMA3C mRNA CTD PMID:27858113 NCBI chr 4:18,538,452...18,702,453
Ensembl chr 4:18,538,454...18,701,740 		JBrowse link
G Septin11 septin 11 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of SEPTIN11 mRNA CTD PMID:27858113 NCBI chr14:15,119,760...15,275,222
Ensembl chr14:15,128,951...15,275,200 		JBrowse link
G Septin3 septin 3 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of SEPTIN3 mRNA CTD PMID:27858113 NCBI chr 7:115,659,414...115,691,173
Ensembl chr 7:115,663,234...115,691,171 		JBrowse link
G Serp2 stress-associated endoplasmic reticulum protein family member 2 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of SERP2 mRNA CTD PMID:27858113 NCBI chr15:58,289,148...58,313,224
Ensembl chr15:58,289,148...58,313,430 		JBrowse link
G Serpinb10 serpin family B member 10 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of SERPINB10 mRNA CTD PMID:27858113 NCBI chr13:24,067,971...24,085,814
Ensembl chr13:24,068,040...24,085,802 		JBrowse link
G Serpinb1a serpin family B member 1A multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of SERPINB1A mRNA CTD PMID:27858113 NCBI chr17:31,799,446...31,807,853
Ensembl chr17:31,799,415...31,808,166 		JBrowse link
G Serpinb5 serpin family B member 5 increases expression ISO chrysene results in increased expression of SERPINB5 mRNA CTD PMID:26377693 NCBI chr13:23,500,203...23,520,401
Ensembl chr13:23,500,198...23,520,400 		JBrowse link
G Serpine1 serpin family E member 1 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of SERPINE1 mRNA CTD PMID:27858113 NCBI chr12:25,237,977...25,248,356
Ensembl chr12:25,237,952...25,248,357 		JBrowse link
G Sertad2 SERTA domain containing 2 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of SERTAD2 mRNA CTD PMID:27858113 NCBI chr14:98,935,428...99,039,536
Ensembl chr14:98,934,769...99,041,468 		JBrowse link
G Sesn2 sestrin 2 decreases expression
multiple interactions 		ISO chrysene results in decreased expression of SESN2 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of SESN2 mRNA 		CTD PMID:26377693 PMID:27858113 NCBI chr 5:149,986,304...150,005,255
Ensembl chr 5:149,986,317...150,005,255 		JBrowse link
G Setd1b SET domain containing 1B, histone lysine methyltransferase multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of SETD1B mRNA CTD PMID:27858113 NCBI chr12:39,056,809...39,082,399
Ensembl chr12:39,058,262...39,082,566 		JBrowse link
G Setd6 SET domain containing 6, protein lysine methyltransferase increases expression ISO chrysene results in increased expression of SETD6 mRNA CTD PMID:26377693 NCBI chr19:9,349,011...9,356,515
Ensembl chr19:9,353,520...9,356,515 		JBrowse link
G Sfi1 SFI1 centrin binding protein multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of SFI1 mRNA CTD PMID:27858113 NCBI chr14:82,215,423...82,272,811
Ensembl chr14:82,214,608...82,272,711 		JBrowse link
G Sfr1 SWI5-dependent homologous recombination repair protein 1 increases expression ISO chrysene results in increased expression of SFR1 mRNA CTD PMID:26377693 NCBI chr 1:256,560,533...256,564,547
Ensembl chr 1:256,560,469...256,567,252 		JBrowse link
G Sfrp2 secreted frizzled-related protein 2 increases expression ISO chrysene results in increased expression of SFRP2 mRNA CTD PMID:26377693 NCBI chr 2:171,387,536...171,395,081
Ensembl chr 2:171,387,385...171,395,079 		JBrowse link
G Sfxn2 sideroflexin 2 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of SFXN2 mRNA CTD PMID:27858113 NCBI chr 1:255,388,428...255,400,724
Ensembl chr 1:255,388,429...255,409,780 		JBrowse link
G Sgms1 sphingomyelin synthase 1 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of SGMS1 mRNA CTD PMID:27858113 NCBI chr 1:239,409,991...239,681,195
Ensembl chr 1:239,409,991...239,505,774 		JBrowse link
G Sh3bgr SH3 domain binding glutamate-rich protein increases expression ISO chrysene results in increased expression of SH3BGR mRNA CTD PMID:26377693 NCBI chr11:48,973,033...48,997,328
Ensembl chr11:48,973,097...48,997,326 		JBrowse link
G Sh3bp1 SH3-domain binding protein 1 increases expression ISO chrysene results in increased expression of SH3BP1 mRNA CTD PMID:26377693 NCBI chr 7:112,338,087...112,350,659
Ensembl chr 7:112,338,107...112,350,659 		JBrowse link
G Sh3d19 SH3 domain containing 19 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of SH3D19 mRNA CTD PMID:27858113 NCBI chr 2:173,654,234...173,814,030
Ensembl chr 2:173,654,420...173,814,025 		JBrowse link
G Sh3pxd2a SH3 and PX domains 2A multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of SH3PXD2A mRNA CTD PMID:27858113 NCBI chr 1:256,094,991...256,301,120
Ensembl chr 1:256,094,991...256,300,967 		JBrowse link
G Shc4 SHC adaptor protein 4 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of SHC4 mRNA CTD PMID:27858113 NCBI chr 3:133,334,026...133,428,404
Ensembl chr 3:133,334,034...133,427,826 		JBrowse link
G Shisa2 shisa family member 2 increases expression ISO chrysene results in increased expression of SHISA2 mRNA CTD PMID:26377693 NCBI chr15:37,982,913...37,987,211
Ensembl chr15:37,982,169...37,988,535 		JBrowse link
G Slc19a2 solute carrier family 19 member 2 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of SLC19A2 mRNA CTD PMID:27858113 NCBI chr13:79,135,118...79,149,316
Ensembl chr13:79,135,059...79,149,315 		JBrowse link
G Slc25a33 solute carrier family 25 member 33 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of SLC25A33 mRNA CTD PMID:27858113 NCBI chr 5:165,478,070...165,518,186
Ensembl chr 5:165,478,072...165,502,973 		JBrowse link
G Slc26a10 solute carrier family 26, member 10 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of SLC26A10 mRNA CTD PMID:27858113 NCBI chr 7:64,880,694...64,890,340
Ensembl chr 7:64,880,699...64,889,409 		JBrowse link
G Slc26a4 solute carrier family 26 member 4 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of SLC26A4 mRNA CTD PMID:27858113 NCBI chr 6:53,835,102...53,873,968
Ensembl chr 6:53,835,110...53,873,216 		JBrowse link
G Slc2a6 solute carrier family 2 member 6 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of SLC2A6 mRNA CTD PMID:27858113 NCBI chr 3:30,746,472...30,753,287
Ensembl chr 3:30,745,995...30,753,287 		JBrowse link
G Slc2a9 solute carrier family 2 member 9 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of SLC2A9 mRNA CTD PMID:27858113 NCBI chr14:76,540,649...76,674,277
Ensembl chr14:76,540,571...76,674,277 		JBrowse link
G Slc30a1 solute carrier family 30 member 1 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of SLC30A1 mRNA CTD PMID:27858113 NCBI chr13:106,022,019...106,025,892
Ensembl chr13:106,022,019...106,025,892 		JBrowse link
G Slc35g2 solute carrier family 35, member G2 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of SLC35G2 mRNA CTD PMID:27858113 NCBI chr 8:109,964,589...109,992,347
Ensembl chr 8:109,964,378...109,992,412 		JBrowse link
G Slc3a2 solute carrier family 3 member 2 increases expression ISO chrysene results in increased expression of SLC3A2 mRNA CTD PMID:26621329 NCBI chr 1:215,033,601...215,048,064
Ensembl chr 1:215,033,601...215,048,064 		JBrowse link
G Slc45a4 solute carrier family 45, member 4 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of SLC45A4 mRNA CTD PMID:27858113 NCBI chr 7:107,370,826...107,459,163
Ensembl chr 7:107,371,273...107,398,284 		JBrowse link
G Slc46a3 solute carrier family 46, member 3 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of SLC46A3 mRNA CTD PMID:27858113 NCBI chr12:12,176,776...12,193,256
Ensembl chr12:12,176,807...12,193,255 		JBrowse link
G Slc5a12 solute carrier family 5 member 12 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of SLC5A12 mRNA CTD PMID:27858113 NCBI chr 3:117,633,885...117,683,966
Ensembl chr 3:117,633,887...117,682,963 		JBrowse link
G Slc5a3 solute carrier family 5 member 3 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of SLC5A3 mRNA CTD PMID:27858113 NCBI chr11:44,799,787...44,802,233
Ensembl chr11:44,790,297...44,818,157 		JBrowse link
G Slc66a3 solute carrier family 66 member 3 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of SLC66A3 mRNA CTD PMID:27858113 NCBI chr 6:45,503,541...45,515,293
Ensembl chr 6:45,503,545...45,515,117 		JBrowse link
G Slc7a5 solute carrier family 7 member 5 increases expression ISO chrysene results in increased expression of SLC7A5 mRNA CTD PMID:26621329 NCBI chr19:66,843,808...66,872,412
Ensembl chr19:66,843,808...66,872,412 		JBrowse link
G Slc8a1 solute carrier family 8 member A1 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of SLC8A1 mRNA CTD PMID:27858113 NCBI chr 6:18,975,498...19,299,704
Ensembl chr 6:18,946,798...19,287,964 		JBrowse link
G Slmap sarcolemma associated protein increases expression ISO chrysene results in increased expression of SLMAP mRNA CTD PMID:26377693 NCBI chr16:1,673,964...1,791,902
Ensembl chr16:1,673,964...1,791,902 		JBrowse link
G Smc1a structural maintenance of chromosomes 1A increases expression ISO chrysene results in increased expression of SMC1A mRNA CTD PMID:26377693 NCBI chr  X:24,582,732...24,627,462
Ensembl chr  X:24,582,690...24,627,462 		JBrowse link
G Smoc2 SPARC related modular calcium binding 2 increases expression ISO chrysene results in increased expression of SMOC2 mRNA CTD PMID:26377693 NCBI chr 1:63,935,627...64,064,952
Ensembl chr 1:63,935,647...64,064,955 		JBrowse link
G Smpd2 sphingomyelin phosphodiesterase 2 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of SMPD2 mRNA CTD PMID:27858113 NCBI chr20:46,568,627...46,571,741
Ensembl chr20:46,568,629...46,571,741 		JBrowse link
G Smpd3 sphingomyelin phosphodiesterase 3 increases expression ISO chrysene results in increased expression of SMPD3 mRNA CTD PMID:26377693 NCBI chr19:51,072,209...51,155,639
Ensembl chr19:51,072,209...51,085,936 		JBrowse link
G Smtnl1 smoothelin-like 1 increases expression ISO chrysene results in increased expression of SMTNL1 mRNA CTD PMID:26377693 NCBI chr 3:90,295,682...90,307,769
Ensembl chr 3:90,295,682...90,307,752 		JBrowse link
G Snai2 snail family transcriptional repressor 2 increases expression ISO chrysene results in increased expression of SNAI2 mRNA CTD PMID:26377693 NCBI chr11:99,686,934...99,690,349
Ensembl chr11:99,686,934...99,690,349 		JBrowse link
G Snap23 synaptosome associated protein 23 decreases expression
multiple interactions 		ISO chrysene results in decreased expression of SNAP23 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of SNAP23 mRNA 		CTD PMID:26377693 PMID:27858113 NCBI chr 3:127,966,184...127,999,929
Ensembl chr 3:127,967,886...127,998,067 		JBrowse link
G Snap47 synaptosome associated protein 47 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of SNAP47 mRNA CTD PMID:27858113 NCBI chr10:44,692,430...44,733,986
Ensembl chr10:44,692,354...44,733,949 		JBrowse link
G Snord123 small nucleolar RNA, C/D box 123 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of SNORD123 mRNA CTD PMID:27858113 NCBI chr 2:85,017,799...85,017,868
Ensembl chr 2:85,017,799...85,017,868 		JBrowse link
G Snrnp70 small nuclear ribonucleoprotein U1 subunit 70 increases expression ISO chrysene results in increased expression of SNRNP70 mRNA CTD PMID:26377693 NCBI chr 1:104,992,518...105,012,851
Ensembl chr 1:104,992,442...105,012,851 		JBrowse link
G Sntb1 syntrophin, beta 1 decreases expression
multiple interactions 		ISO chrysene results in decreased expression of SNTB1 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of SNTB1 mRNA 		CTD PMID:26377693 PMID:27858113 NCBI chr 7:88,950,642...89,219,017
Ensembl chr 7:88,950,642...89,219,017 		JBrowse link
G Sorbs1 sorbin and SH3 domain containing 1 increases expression ISO chrysene results in increased expression of SORBS1 mRNA CTD PMID:26377693 NCBI chr 1:249,057,324...249,279,703
Ensembl chr 1:249,057,324...249,279,608 		JBrowse link
G Sord sorbitol dehydrogenase multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of SORD mRNA CTD PMID:27858113 NCBI chr 3:129,638,282...129,669,727
Ensembl chr 3:129,638,302...129,686,100 		JBrowse link
G Sox17 SRY-box transcription factor 17 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of SOX17 mRNA CTD PMID:27858113 NCBI chr 5:19,814,345...19,819,859
Ensembl chr 5:19,814,360...19,819,854 		JBrowse link
G Sox2 SRY-box transcription factor 2 increases expression ISO chrysene results in increased expression of SOX2 mRNA CTD PMID:26377693 NCBI chr 2:119,465,131...119,467,542
Ensembl chr 2:119,454,541...119,496,350 		JBrowse link
G Sox4 SRY-box transcription factor 4 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of SOX4 mRNA CTD PMID:27858113 NCBI chr17:35,876,298...35,881,004
Ensembl chr17:35,875,756...35,884,024 		JBrowse link
G Sparcl1 SPARC like 1 increases expression ISO chrysene results in increased expression of SPARCL1 mRNA CTD PMID:26377693 NCBI chr14:5,937,484...5,968,532
Ensembl chr14:5,914,535...5,969,120 		JBrowse link
G Spc25 SPC25 component of NDC80 kinetochore complex multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of SPC25 mRNA CTD PMID:27858113 NCBI chr 3:74,337,872...74,396,825
Ensembl chr 3:74,383,548...74,396,718 		JBrowse link
G Spcs2 signal peptidase complex subunit 2 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of SPCS2 mRNA CTD PMID:27858113 NCBI chr 1:163,575,842...163,595,269
Ensembl chr 1:163,575,842...163,595,271 		JBrowse link
G Spib Spi-B transcription factor increases expression ISO chrysene results in increased expression of SPIB mRNA CTD PMID:26377693 NCBI chr 1:104,155,456...104,161,311
Ensembl chr 1:104,155,464...104,161,517 		JBrowse link
G Spin1 spindlin 1 decreases expression
multiple interactions 		ISO chrysene results in decreased expression of SPIN1 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of SPIN1 mRNA 		CTD PMID:26377693 PMID:27858113 NCBI chr17:14,207,384...14,257,330
Ensembl chr17:14,207,384...14,257,190 		JBrowse link
G Spink1 serine peptidase inhibitor, Kazal type 1 increases expression ISO chrysene results in increased expression of SPINK1 mRNA CTD PMID:26377693 NCBI chr18:36,121,626...36,133,596
Ensembl chr18:36,076,399...36,133,545 		JBrowse link
G Spon2 spondin 2 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of SPON2 mRNA CTD PMID:27858113 NCBI chr14:81,713,070...81,742,510
Ensembl chr14:81,731,188...81,742,609 		JBrowse link
G Spp1 secreted phosphoprotein 1 decreases expression ISO chrysene results in decreased expression of SPP1 mRNA CTD PMID:26377693 NCBI chr14:5,613,569...5,620,695
Ensembl chr14:5,613,576...5,619,820 		JBrowse link
G Sptbn1 spectrin, beta, non-erythrocytic 1 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of SPTBN1 mRNA CTD PMID:27858113 NCBI chr14:108,042,629...108,217,884
Ensembl chr14:108,042,629...108,217,836 		JBrowse link
G Srcin1 SRC kinase signaling inhibitor 1 increases expression ISO chrysene results in increased expression of SRCIN1 mRNA CTD PMID:26377693 NCBI chr10:82,999,295...83,066,359
Ensembl chr10:82,991,033...83,067,419 		JBrowse link
G Srgn serglycin multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of SRGN mRNA CTD PMID:27858113 NCBI chr20:30,985,508...31,022,296
Ensembl chr20:30,985,508...31,000,327 		JBrowse link
G Srp9 signal recognition particle 9 decreases expression ISO chrysene results in decreased expression of SRP9 mRNA CTD PMID:26377693 NCBI chr13:96,364,253...96,372,393
Ensembl chr13:96,364,298...96,373,257 		JBrowse link
G Srpk3 SRSF protein kinase 3 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of SRPK3 mRNA CTD PMID:27858113 NCBI chr  X:156,661,888...156,666,537
Ensembl chr  X:156,661,875...156,666,531 		JBrowse link
G Srrm2 serine/arginine repetitive matrix 2 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of SRRM2 mRNA CTD PMID:27858113 NCBI chr10:13,320,059...13,353,337
Ensembl chr10:13,320,059...13,353,337 		JBrowse link
G Srsf5 serine and arginine rich splicing factor 5 increases expression ISO chrysene results in increased expression of SRSF5 mRNA CTD PMID:26377693 NCBI chr 6:106,333,998...106,341,467
Ensembl chr 6:106,336,756...106,341,931 		JBrowse link
G Ssb small RNA binding exonuclease protection factor La multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of SSB mRNA CTD PMID:27858113 NCBI chr 3:75,024,385...75,034,016
Ensembl chr 3:75,024,474...75,034,031 		JBrowse link
G Ssh3 slingshot protein phosphatase 3 increases expression ISO chrysene results in increased expression of SSH3 mRNA CTD PMID:26377693 NCBI chr 1:210,986,604...210,994,975
Ensembl chr 1:210,986,606...210,994,284 		JBrowse link
G Sspn sarcospan increases expression
multiple interactions 		ISO chrysene results in increased expression of SSPN mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of SSPN mRNA 		CTD PMID:26377693 PMID:27858113 NCBI chr 4:180,620,762...180,666,893
Ensembl chr 4:180,627,848...180,662,284 		JBrowse link
G Ssr2 signal sequence receptor subunit 2 decreases expression ISO chrysene results in decreased expression of SSR2 mRNA CTD PMID:26377693 NCBI chr 2:176,346,117...176,354,868
Ensembl chr 2:176,346,404...176,355,781 		JBrowse link
G Ssr3 signal sequence receptor subunit 3 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of SSR3 mRNA CTD PMID:27858113 NCBI chr 2:151,915,101...151,935,162
Ensembl chr 2:151,906,149...151,935,170 		JBrowse link
G St6galnac1 ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 1 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of ST6GALNAC1 mRNA CTD PMID:27858113 NCBI chr10:102,471,481...102,481,876
Ensembl chr10:102,471,493...102,481,876 		JBrowse link
G St8sia4 ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 4 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of ST8SIA4 mRNA CTD PMID:27858113 NCBI chr 9:103,437,479...103,532,008
Ensembl chr 9:103,437,479...103,532,008 		JBrowse link
G Stau2 staufen double-stranded RNA binding protein 2 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of STAU2 mRNA CTD PMID:27858113 NCBI chr 5:7,623,528...7,868,206
Ensembl chr 5:7,624,019...7,868,204 		JBrowse link
G Stbd1 starch binding domain 1 increases expression ISO chrysene results in increased expression of STBD1 mRNA CTD PMID:26377693 NCBI chr14:15,754,769...15,758,174
Ensembl chr14:15,754,644...15,761,659 		JBrowse link
G Sulf1 sulfatase 1 increases expression ISO chrysene results in increased expression of SULF1 mRNA CTD PMID:26377693 NCBI chr 5:11,145,950...11,308,622
Ensembl chr 5:11,145,950...11,308,643 		JBrowse link
G Sumo2 small ubiquitin-like modifier 2 decreases expression ISO chrysene results in decreased expression of SUMO2 mRNA CTD PMID:26377693 NCBI chr10:101,270,899...101,283,458
Ensembl chr10:101,270,900...101,283,938
Ensembl chr 5:101,270,900...101,283,938 		JBrowse link
G Syne2 spectrin repeat containing nuclear envelope protein 2 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of SYNE2 mRNA CTD PMID:27858113 NCBI chr 6:100,272,729...100,586,364
Ensembl chr 6:100,272,729...100,583,723 		JBrowse link
G Sys1 Sys1 golgi trafficking protein decreases expression ISO chrysene results in decreased expression of SYS1 mRNA CTD PMID:26377693 NCBI chr 3:173,610,332...173,637,624
Ensembl chr 3:173,610,710...173,614,814 		JBrowse link
G Syt10 synaptotagmin 10 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of SYT10 mRNA CTD PMID:27858113 NCBI chr 7:122,737,301...122,800,462
Ensembl chr 7:122,648,419...122,800,462 		JBrowse link
G Syt15 synaptotagmin 15 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of SYT15 mRNA CTD PMID:27858113 NCBI chr16:9,538,740...9,549,548
Ensembl chr16:9,538,748...9,549,558 		JBrowse link
G Tab2 TGF-beta activated kinase 1/MAP3K7 binding protein 2 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of TAB2 mRNA CTD PMID:27858113 NCBI chr 1:4,195,400...4,245,485
Ensembl chr 1:4,195,400...4,245,485 		JBrowse link
G Tacc2 transforming, acidic coiled-coil containing protein 2 increases expression ISO chrysene results in increased expression of TACC2 mRNA CTD PMID:26377693 NCBI chr 1:194,546,428...194,758,152
Ensembl chr 1:194,569,650...194,758,152 		JBrowse link
G Tada2a transcriptional adaptor 2A increases expression ISO chrysene results in increased expression of TADA2A mRNA CTD PMID:26377693 NCBI chr10:69,463,966...69,511,612
Ensembl chr10:69,463,968...69,511,607 		JBrowse link
G Taf1 TATA-box binding protein associated factor 1 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of TAF1 mRNA CTD PMID:27858113 NCBI chr  X:70,680,901...70,756,535
Ensembl chr  X:70,680,906...70,756,735 		JBrowse link
G Tap1 transporter 1, ATP binding cassette subfamily B member multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of TAP1 mRNA CTD PMID:27858113 NCBI chr20:4,658,171...4,668,543
Ensembl chr20:4,658,172...4,668,810 		JBrowse link
G Tardbp TAR DNA binding protein increases expression ISO chrysene results in increased expression of TARDBP mRNA CTD PMID:26377693 NCBI chr 5:164,330,452...164,348,435
Ensembl chr 5:164,334,924...164,345,204 		JBrowse link
G Tbx21 T-box transcription factor 21 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of TBX21 mRNA CTD PMID:27858113 NCBI chr10:82,578,751...82,595,253
Ensembl chr10:82,578,751...82,595,253 		JBrowse link
G Tcea3 transcription elongation factor A3 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of TCEA3 mRNA CTD PMID:27858113 NCBI chr 5:153,760,401...153,792,934
Ensembl chr 5:153,760,407...153,792,930 		JBrowse link
G Tcf19 transcription factor 19 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of TCF19 mRNA CTD PMID:27858113 NCBI chr20:3,223,464...3,227,569
Ensembl chr20:3,223,324...3,230,060 		JBrowse link
G Tcf7l2 transcription factor 7 like 2 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of TCF7L2 mRNA CTD PMID:27858113 NCBI chr 1:264,791,335...264,984,225
Ensembl chr 1:264,791,335...264,984,225 		JBrowse link
G Tcof1 treacle ribosome biogenesis factor 1 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of TCOF1 mRNA CTD PMID:27858113 NCBI chr18:56,537,437...56,570,727
Ensembl chr18:56,537,437...56,570,727 		JBrowse link
G Tdrd3 tudor domain containing 3 increases expression ISO chrysene results in increased expression of TDRD3 mRNA CTD PMID:26377693 NCBI chr15:69,748,754...69,911,605
Ensembl chr15:69,749,217...69,884,656 		JBrowse link
G Tdrp testis development related protein multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of TDRP mRNA CTD PMID:27858113 NCBI chr16:82,326,837...82,354,861
Ensembl chr16:82,314,220...82,354,861 		JBrowse link
G Tec tec protein tyrosine kinase multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of TEC mRNA CTD PMID:27858113 NCBI chr14:35,706,557...35,815,563
Ensembl chr14:35,691,741...35,815,585 		JBrowse link
G Tecpr1 tectonin beta-propeller repeat containing 1 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of TECPR1 mRNA CTD PMID:27858113 NCBI chr12:15,504,456...15,534,541
Ensembl chr12:15,505,343...15,534,116 		JBrowse link
G Teddm3 transmembrane epididymal family member 3 increases expression ISO chrysene results in increased expression of TEDDM3 mRNA CTD PMID:26377693 NCBI chr11:93,493,233...93,494,572
Ensembl chr11:93,493,500...93,494,384 		JBrowse link
G Tef TEF transcription factor, PAR bZIP family member increases expression
multiple interactions 		ISO chrysene results in increased expression of TEF mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of TEF mRNA 		CTD PMID:26377693 PMID:27858113 NCBI chr 7:115,197,180...115,221,930
Ensembl chr 7:115,193,282...115,221,928 		JBrowse link
G Tenm2 teneurin transmembrane protein 2 increases expression ISO chrysene results in increased expression of TENM2 mRNA CTD PMID:26377693 NCBI chr10:20,984,710...22,121,001
Ensembl chr10:20,985,902...22,447,611 		JBrowse link
G Tenm4 teneurin transmembrane protein 4 increases expression ISO chrysene results in increased expression of TENM4 mRNA CTD PMID:26377693 NCBI chr 1:157,699,611...160,674,549
Ensembl chr 1:159,974,017...160,674,549 		JBrowse link
G Tepsin TEPSIN, adaptor related protein complex 4 accessory protein increases expression ISO chrysene results in increased expression of TEPSIN mRNA CTD PMID:26377693 NCBI chr10:105,872,363...105,879,731
Ensembl chr10:105,872,366...105,880,209 		JBrowse link
G Tex11 testis expressed 11 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of TEX11 mRNA CTD PMID:27858113 NCBI chr  X:69,973,012...70,236,544
Ensembl chr  X:69,972,723...70,236,011 		JBrowse link
G Tfcp2l1 transcription factor CP2-like 1 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of TFCP2L1 mRNA CTD PMID:27858113 NCBI chr13:32,286,643...32,346,671
Ensembl chr13:32,286,643...32,346,671 		JBrowse link
G Thbs1 thrombospondin 1 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of THBS1 mRNA CTD PMID:27858113 NCBI chr 3:125,510,250...125,525,402
Ensembl chr 3:125,510,250...125,525,402 		JBrowse link
G Thrap3 thyroid hormone receptor associated protein 3 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of THRAP3 mRNA CTD PMID:27858113 NCBI chr 5:143,729,821...143,772,105
Ensembl chr 5:143,730,596...143,771,983 		JBrowse link
G Thsd4 thrombospondin type 1 domain containing 4 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of THSD4 mRNA CTD PMID:27858113 NCBI chr 8:69,280,397...69,880,144
Ensembl chr 8:69,284,646...69,917,342 		JBrowse link
G Thsd7a thrombospondin type 1 domain containing 7A decreases expression
multiple interactions 		ISO chrysene results in decreased expression of THSD7A mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of THSD7A mRNA 		CTD PMID:26377693 PMID:27858113 NCBI chr 4:41,427,276...41,865,524
Ensembl chr 4:41,426,275...41,865,723 		JBrowse link
G Thyn1 thymocyte nuclear protein 1 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of THYN1 mRNA CTD PMID:27858113 NCBI chr 8:33,665,614...33,674,593
Ensembl chr 8:33,665,650...33,675,414 		JBrowse link
G Timp1 TIMP metallopeptidase inhibitor 1 increases expression ISO chrysene results in increased expression of TIMP1 mRNA CTD PMID:22579512 NCBI chr  X:3,766,509...3,772,578
Ensembl chr  X:3,766,510...3,771,135 		JBrowse link
G Tlcd3b TLC domain containing 3B multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of TLCD3B mRNA CTD PMID:27858113 NCBI chr 1:190,851,582...190,870,278
Ensembl chr 1:190,835,208...190,870,277 		JBrowse link
G Tln1 talin 1 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of TLN1 mRNA CTD PMID:27858113 NCBI chr 5:62,583,730...62,613,687
Ensembl chr 5:62,583,731...62,613,687 		JBrowse link
G Tm2d2 TM2 domain containing 2 decreases expression ISO chrysene results in decreased expression of TM2D2 mRNA CTD PMID:26377693 NCBI chr16:73,719,331...73,724,853
Ensembl chr16:73,719,332...73,724,981 		JBrowse link
G Tmed9 transmembrane p24 trafficking protein 9 decreases expression ISO chrysene results in decreased expression of TMED9 mRNA CTD PMID:26377693 NCBI chr17:9,034,797...9,039,311
Ensembl chr17:9,034,823...9,039,319 		JBrowse link
G Tmeff2 transmembrane protein with EGF-like and two follistatin-like domains 2 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of TMEFF2 mRNA CTD PMID:27858113 NCBI chr 9:57,937,873...58,225,372
Ensembl chr 9:57,937,873...58,225,372 		JBrowse link
G Tmem171 transmembrane protein 171 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of TMEM171 mRNA CTD PMID:27858113 NCBI chr 2:31,769,486...31,779,358
Ensembl chr 2:31,769,486...31,780,134 		JBrowse link
G Tmem219 transmembrane protein 219 decreases expression ISO chrysene results in decreased expression of TMEM219 mRNA CTD PMID:26377693 NCBI chr 1:190,926,722...190,965,044
Ensembl chr 1:190,926,722...190,958,912 		JBrowse link
G Tmem242 transmembrane protein 242 decreases expression ISO chrysene results in decreased expression of TMEM242 mRNA CTD PMID:26377693 NCBI chr 1:48,397,865...48,424,639
Ensembl chr 1:48,397,865...48,424,633 		JBrowse link
G Tmem245 transmembrane protein 245 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of TMEM245 mRNA CTD PMID:27858113 NCBI chr 5:76,366,157...76,443,108
Ensembl chr 5:76,366,157...76,442,888 		JBrowse link
G Tmem258 transmembrane protein 258 decreases expression ISO chrysene results in decreased expression of TMEM258 mRNA CTD PMID:26377693 NCBI chr 1:216,274,607...216,278,505 JBrowse link
G Tmem37 transmembrane protein 37 decreases expression ISO chrysene results in decreased expression of TMEM37 mRNA CTD PMID:26377693 NCBI chr13:33,737,096...33,743,602
Ensembl chr13:33,736,308...33,743,747 		JBrowse link
G Tmem42 transmembrane protein 42 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of TMEM42 mRNA CTD PMID:27858113 NCBI chr 8:131,551,616...131,554,749
Ensembl chr 8:131,552,257...131,555,765 		JBrowse link
G Tmem91 transmembrane protein 91 increases expression ISO chrysene results in increased expression of TMEM91 mRNA CTD PMID:26377693 NCBI chr 1:90,307,264...90,314,796
Ensembl chr 1:90,306,289...90,313,320 		JBrowse link
G Tnc tenascin C multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of TNC mRNA CTD PMID:27858113 NCBI chr 5:82,391,340...82,476,197
Ensembl chr 5:82,391,340...82,476,131 		JBrowse link
G Tnf tumor necrosis factor increases expression
multiple interactions 		ISO chrysene results in increased expression of TNF mRNA
[chrysene co-treated with Tobacco Smoke Pollution] results in increased expression of TNF mRNA; [chrysene co-treated with Tobacco Smoke Pollution] results in increased expression of TNF protein; chrysene promotes the reaction [Tobacco Smoke Pollution results in increased expression of TNF mRNA]; chrysene promotes the reaction [Tobacco Smoke Pollution results in increased expression of TNF protein] 		CTD PMID:25433334 PMID:33345606 NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,626,532...3,629,303 		JBrowse link
G Tnfsf10 TNF superfamily member 10 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of TNFSF10 mRNA CTD PMID:27858113 NCBI chr 2:112,136,550...112,155,903 JBrowse link
G Tnip1 TNFAIP3 interacting protein 1 increases expression ISO chrysene results in increased expression of TNIP1 mRNA CTD PMID:26377693 NCBI chr10:39,537,759...39,585,038
Ensembl chr10:39,537,437...39,585,158 		JBrowse link
G Tnnc2 troponin C2, fast skeletal type increases expression ISO chrysene results in increased expression of TNNC2 mRNA CTD PMID:26377693 NCBI chr 3:173,932,611...173,935,339
Ensembl chr 3:173,932,611...173,935,339 		JBrowse link
G Tnnt3 troponin T3, fast skeletal type increases expression ISO chrysene results in increased expression of TNNT3 mRNA CTD PMID:26377693 NCBI chr 1:207,082,014...207,099,014
Ensembl chr 1:207,081,812...207,099,423 		JBrowse link
G Tnpo3 transportin 3 increases expression ISO chrysene results in increased expression of TNPO3 mRNA CTD PMID:26377693 NCBI chr 4:59,108,278...59,197,012
Ensembl chr 4:59,108,348...59,197,276 		JBrowse link
G Tnxb tenascin XB increases expression ISO chrysene results in increased expression of TNXB mRNA CTD PMID:26377693 Ensembl chr20:4,031,082...4,090,128 JBrowse link
G Tox4 TOX high mobility group box family member 4 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of TOX4 mRNA CTD PMID:27858113 NCBI chr15:27,462,735...27,476,320
Ensembl chr15:27,462,727...27,477,617 		JBrowse link
G Tp53 tumor protein p53 multiple interactions
increases expression 		ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of TRP53 mRNA; chrysene promotes the reaction [Benzo(a)pyrene results in increased expression of TRP53 protein]
chrysene results in increased expression of TRP53 protein 		CTD PMID:22120587 PMID:27858113 NCBI chr10:54,798,871...54,810,300
Ensembl chr10:54,798,851...54,810,299 		JBrowse link
G Tp53inp1 tumor protein p53 inducible nuclear protein 1 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of TRP53INP1 mRNA CTD PMID:27858113 NCBI chr 5:29,051,267...29,069,486
Ensembl chr 5:29,051,264...29,069,484 		JBrowse link
G Tpk1 thiamin pyrophosphokinase 1 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of TPK1 mRNA CTD PMID:27858113 NCBI chr 4:73,170,125...73,557,683
Ensembl chr 4:73,170,125...73,557,783 		JBrowse link
G Tpsb2 tryptase beta 2 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of TPSB2 mRNA CTD PMID:27858113 NCBI chr10:14,886,310...14,888,102
Ensembl chr10:14,886,360...14,888,100 		JBrowse link
G Traf3ip3 TRAF3 interacting protein 3 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of TRAF3IP3 mRNA CTD PMID:27858113 NCBI chr13:107,223,499...107,248,358
Ensembl chr13:107,223,502...107,248,155 		JBrowse link
G Trib2 tribbles pseudokinase 2 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of TRIB2 mRNA CTD PMID:27858113 NCBI chr 6:44,274,762...44,299,139
Ensembl chr 6:44,274,762...44,299,094 		JBrowse link
G Trim35 tripartite motif-containing 35 decreases expression
multiple interactions 		ISO chrysene results in decreased expression of TRIM35 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of TRIM35 mRNA 		CTD PMID:26377693 PMID:27858113 NCBI chr15:44,669,222...44,685,766
Ensembl chr15:44,656,322...44,685,765 		JBrowse link
G Trpv1 transient receptor potential cation channel, subfamily V, member 1 multiple interactions ISO [chrysene co-treated with Tobacco Smoke Pollution] results in increased expression of TRPV1 mRNA; [chrysene co-treated with Tobacco Smoke Pollution] results in increased expression of TRPV1 protein; chrysene promotes the reaction [Tobacco Smoke Pollution results in increased expression of TRPV1 mRNA]; chrysene promotes the reaction [Tobacco Smoke Pollution results in increased expression of TRPV1 protein] CTD PMID:33345606 NCBI chr10:58,349,936...58,375,021
Ensembl chr10:58,340,223...58,375,021 		JBrowse link
G Trpv4 transient receptor potential cation channel, subfamily V, member 4 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of TRPV4 mRNA CTD PMID:27858113 NCBI chr12:47,599,161...47,638,143
Ensembl chr12:47,599,035...47,638,143 		JBrowse link
G Trub2 TruB pseudouridine synthase family member 2 increases expression ISO chrysene results in increased expression of TRUB2 mRNA CTD PMID:26377693 NCBI chr 3:33,447,101...33,457,712
Ensembl chr 3:33,431,628...33,457,726 		JBrowse link
G Tsc22d1 TSC22 domain family, member 1 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of TSC22D1 mRNA CTD PMID:27858113 NCBI chr15:58,159,612...58,260,244
Ensembl chr15:58,159,952...58,183,322 		JBrowse link
G Tspan17 tetraspanin 17 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of TSPAN17 mRNA CTD PMID:27858113 NCBI chr17:9,824,353...9,831,985
Ensembl chr17:9,823,990...9,831,974 		JBrowse link
G Tspan18 tetraspanin 18 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of TSPAN18 mRNA CTD PMID:27858113 NCBI chr 3:99,615,465...99,755,270
Ensembl chr 3:99,615,466...99,755,270 		JBrowse link
G Tspan4 tetraspanin 4 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of TSPAN4 mRNA CTD PMID:27858113 NCBI chr 1:206,001,731...206,021,414
Ensembl chr 1:206,001,731...206,021,413 		JBrowse link
G Ttc7a tetratricopeptide repeat domain 7A multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of TTC7 mRNA CTD PMID:27858113 NCBI chr 6:12,912,822...13,015,374
Ensembl chr 6:12,905,527...13,015,374 		JBrowse link
G Ttl tubulin tyrosine ligase multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of TTL mRNA CTD PMID:27858113 NCBI chr 3:136,752,025...136,781,758
Ensembl chr 3:136,752,000...136,781,758 		JBrowse link
G Ttll7 tubulin tyrosine ligase like 7 increases expression ISO chrysene results in increased expression of TTLL7 mRNA CTD PMID:26377693 NCBI chr 2:238,425,786...238,549,296
Ensembl chr 2:238,426,076...238,545,960 		JBrowse link
G Tug1 taurine up-regulated 1 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of TUG1 mRNA CTD PMID:27858113 NCBI chr14:82,743,501...82,750,534
Ensembl chr14:82,746,113...82,750,534 		JBrowse link
G Tulp4 TUB like protein 4 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of TULP4 mRNA CTD PMID:27858113 NCBI chr 1:49,082,492...49,218,262
Ensembl chr 1:49,087,886...49,218,250 		JBrowse link
G Tusc3 tumor suppressor candidate 3 decreases expression ISO chrysene results in decreased expression of TUSC3 mRNA CTD PMID:26377693 NCBI chr16:59,899,642...60,048,813
Ensembl chr16:59,899,091...60,048,215 		JBrowse link
G Txlna taxilin alpha decreases expression
multiple interactions 		ISO chrysene results in decreased expression of TXLNA mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of TXLNA mRNA 		CTD PMID:26377693 PMID:27858113 NCBI chr 5:147,253,694...147,269,410
Ensembl chr 5:147,255,649...147,269,273 		JBrowse link
G Uaca uveal autoantigen with coiled-coil domains and ankyrin repeats increases expression ISO chrysene results in increased expression of UACA mRNA CTD PMID:26377693 NCBI chr 8:70,155,059...70,243,416
Ensembl chr 8:70,155,047...70,243,415 		JBrowse link
G Ube2b ubiquitin-conjugating enzyme E2B decreases expression ISO chrysene results in decreased expression of UBE2B mRNA CTD PMID:26377693 NCBI chr10:36,749,365...36,764,335
Ensembl chr10:36,749,369...36,765,587 		JBrowse link
G Ubr5 ubiquitin protein ligase E3 component n-recognin 5 increases expression ISO chrysene results in increased expression of UBR5 mRNA CTD PMID:26377693 NCBI chr 7:71,000,197...71,109,841
Ensembl chr 7:71,000,197...71,109,813 		JBrowse link
G Ucp1 uncoupling protein 1 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of UCP1 mRNA CTD PMID:27858113 NCBI chr19:41,713,350...41,721,421
Ensembl chr19:41,713,351...41,721,420 		JBrowse link
G Ugt1a6a UDP glucuronosyltransferase family 1 member A6a increases expression ISO chrysene results in increased expression of UGT1A6 mRNA CTD PMID:15566942 NCBI chr 9:96,195,018...96,256,264
Ensembl chr 9:96,144,786...96,256,264 		JBrowse link
G Unc45a unc-45 myosin chaperone A increases expression ISO chrysene results in increased expression of UNC45A mRNA CTD PMID:26377693 NCBI chr 1:143,691,183...143,705,944
Ensembl chr 1:143,691,186...143,707,312 		JBrowse link
G Upk1a uroplakin 1A multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of UPK1A mRNA CTD PMID:27858113 NCBI chr 1:94,987,110...94,998,083
Ensembl chr 1:94,987,108...94,997,787 		JBrowse link
G Upk3a uroplakin 3A multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of UPK3A mRNA CTD PMID:27858113 NCBI chr 7:118,008,898...118,019,865
Ensembl chr 7:118,014,108...118,019,870 		JBrowse link
G Uqcrq ubiquinol-cytochrome c reductase, complex III subunit VII decreases expression ISO chrysene results in decreased expression of UQCRQ mRNA CTD PMID:26377693 NCBI chr10:38,086,691...38,093,871
Ensembl chr10:38,087,715...38,089,996 		JBrowse link
G Usp2 ubiquitin specific peptidase 2 increases expression
multiple interactions 		ISO chrysene results in increased expression of USP2 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of USP2 mRNA 		CTD PMID:26377693 PMID:27858113 NCBI chr 8:53,308,264...53,336,800
Ensembl chr 8:53,308,303...53,336,794 		JBrowse link
G Utp14a UTP14A small subunit processome component multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of UTP14A mRNA CTD PMID:27858113 NCBI chr  X:132,317,163...132,342,524
Ensembl chr  X:132,317,159...132,342,523 		JBrowse link
G Utrn utrophin multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of UTRN mRNA CTD PMID:27858113 NCBI chr 1:8,541,061...9,044,487
Ensembl chr 1:8,542,798...9,044,487 		JBrowse link
G Vash1 vasohibin 1 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of VASH1 mRNA CTD PMID:27858113 NCBI chr 6:112,060,086...112,076,689
Ensembl chr 6:112,060,086...112,076,689 		JBrowse link
G Vcam1 vascular cell adhesion molecule 1 decreases expression ISO chrysene results in decreased expression of VCAM1 mRNA CTD PMID:26377693 NCBI chr 2:206,723,050...206,742,783
Ensembl chr 2:206,723,044...206,742,801 		JBrowse link
G Vps16 VPS16 core subunit of CORVET and HOPS complexes multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of VPS16 mRNA CTD PMID:27858113 NCBI chr 3:138,075,649...138,097,154
Ensembl chr 3:138,075,660...138,110,632 		JBrowse link
G Vps39 VPS39 subunit of HOPS complex multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of VPS39 mRNA CTD PMID:27858113 NCBI chr 3:127,721,076...127,758,658
Ensembl chr 3:127,721,076...127,758,768 		JBrowse link
G Vrk2 VRK serine/threonine kinase 2 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of VRK2 mRNA CTD PMID:27858113 NCBI chr14:104,514,815...104,635,549
Ensembl chr14:104,514,100...104,720,933 		JBrowse link
G Vsir V-set immunoregulatory receptor multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of VSIR mRNA CTD PMID:27858113 NCBI chr20:28,824,493...28,850,175
Ensembl chr20:28,823,945...28,850,175 		JBrowse link
G Wasl WASP like actin nucleation promoting factor multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of WASL mRNA CTD PMID:27858113 NCBI chr 4:54,049,081...54,097,653
Ensembl chr 4:54,049,082...54,097,570 		JBrowse link
G Wee1 WEE1 G2 checkpoint kinase multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of WEE1 mRNA CTD PMID:27858113 NCBI chr 1:173,605,609...173,632,450
Ensembl chr 1:173,608,949...173,632,449 		JBrowse link
G Wfdc12 WAP four-disulfide core domain 12 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of WFDC12 mRNA CTD PMID:27858113 NCBI chr 3:173,280,844...173,282,167
Ensembl chr 3:173,280,844...173,282,167 		JBrowse link
G Wnk4 WNK lysine deficient protein kinase 4 increases expression ISO chrysene results in increased expression of WNK4 mRNA CTD PMID:26377693 NCBI chr10:86,702,828...86,719,917
Ensembl chr10:86,702,865...86,720,198 		JBrowse link
G Wscd2 WSC domain containing 2 increases expression ISO chrysene results in increased expression of WSCD2 mRNA CTD PMID:26377693 NCBI chr12:48,707,056...48,801,443
Ensembl chr12:48,707,056...48,801,319 		JBrowse link
G Wt1 WT1 transcription factor increases expression ISO chrysene results in increased expression of WT1 mRNA CTD PMID:26377693 NCBI chr 3:112,019,721...112,068,454
Ensembl chr 3:112,021,641...112,068,444 		JBrowse link
G Xbp1 X-box binding protein 1 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of XBP1 mRNA CTD PMID:27858113 NCBI chr14:84,604,623...84,609,707
Ensembl chr14:84,604,107...84,609,706 		JBrowse link
G Xpnpep2 X-prolyl aminopeptidase 2 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of XPNPEP2 mRNA CTD PMID:27858113 NCBI chr  X:132,165,696...132,194,937
Ensembl chr  X:132,165,701...132,195,126 		JBrowse link
G Yap1 Yes1 associated transcriptional regulator increases expression ISO chrysene results in increased expression of YAP1 mRNA CTD PMID:26377693 NCBI chr 8:13,380,551...13,451,640
Ensembl chr 8:13,380,551...13,451,437 		JBrowse link
G Ybx1 Y box binding protein 1 increases expression ISO chrysene results in increased expression of YBX1 mRNA CTD PMID:26377693 NCBI chr 5:138,167,444...138,188,155
Ensembl chr 5:138,167,444...138,184,188 		JBrowse link
G Ypel5 yippee-like 5 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of YPEL5 mRNA CTD PMID:27858113 NCBI chr 6:28,408,079...28,423,536
Ensembl chr 6:28,408,080...28,412,385 		JBrowse link
G Ythdc1 YTH N6-methyladenosine RNA binding protein C1 increases expression ISO chrysene results in increased expression of YTHDC1 mRNA CTD PMID:26377693 NCBI chr14:21,540,276...21,570,724
Ensembl chr14:21,540,278...21,570,769 		JBrowse link
G Ywhaz tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of YWHAZ mRNA CTD PMID:27858113 NCBI chr 7:69,826,404...69,848,702
Ensembl chr 7:69,826,404...69,849,007 		JBrowse link
G Zc3h7a zinc finger CCCH type containing 7 A increases expression ISO chrysene results in increased expression of ZC3H7A mRNA CTD PMID:26377693 NCBI chr10:4,980,147...5,019,637
Ensembl chr10:4,980,161...5,019,636 		JBrowse link
G Zcchc7 zinc finger CCHC-type containing 7 increases expression ISO chrysene results in increased expression of ZCCHC7 mRNA CTD PMID:26377693 NCBI chr 5:63,787,292...63,968,960
Ensembl chr 5:63,788,217...63,968,549 		JBrowse link
G Zdhhc22 zinc finger DHHC-type palmitoyltransferase 22 decreases expression ISO chrysene results in decreased expression of ZDHHC22 mRNA CTD PMID:26377693 NCBI chr 6:112,360,051...112,377,950
Ensembl chr 6:112,360,051...112,369,833 		JBrowse link
G Zfp185 zinc finger protein 185 increases expression ISO chrysene results in increased expression of ZFP185 mRNA CTD PMID:26377693 NCBI chr  X:155,874,138...155,919,921
Ensembl chr  X:155,874,127...155,917,077 		JBrowse link
G Zfp280d zinc finger protein 280D multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of ZFP280D mRNA CTD PMID:27858113 NCBI chr 8:81,872,108...81,961,194
Ensembl chr 8:81,873,335...81,961,201 		JBrowse link
G Zfp346 zinc finger protein 346 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of ZFP346 mRNA CTD PMID:27858113 NCBI chr17:9,498,933...9,528,824
Ensembl chr17:9,498,933...9,528,783 		JBrowse link
G Zfp365 zinc finger protein 365 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of ZFP365 mRNA CTD PMID:27858113 NCBI chr20:20,665,122...20,688,607
Ensembl chr20:20,665,046...20,690,114 		JBrowse link
G Zfp367 zinc finger protein 367 decreases expression
multiple interactions 		ISO chrysene results in decreased expression of ZFP367 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of ZFP367 mRNA 		CTD PMID:26377693 PMID:27858113 NCBI chr17:970,896...990,025
Ensembl chr17:970,741...990,029 		JBrowse link
G Zfp423 zinc finger protein 423 increases expression ISO chrysene results in increased expression of ZFP423 mRNA CTD PMID:26377693 NCBI chr19:35,282,149...35,580,775
Ensembl chr19:35,282,110...35,580,773 		JBrowse link
G Zfp62 zinc finger protein 62 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of ZFP62 mRNA CTD PMID:27858113 NCBI chr10:34,019,367...34,040,564
Ensembl chr10:33,971,943...34,054,637 		JBrowse link
G Zfp628 zinc finger protein 628 decreases expression
multiple interactions 		ISO chrysene results in decreased expression of ZFP628 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of ZFP628 mRNA 		CTD PMID:26377693 PMID:27858113 NCBI chr 1:77,942,431...77,950,013
Ensembl chr 1:77,941,082...77,951,838 		JBrowse link
G Zfp664 zinc finger protein 664 decreases expression ISO chrysene results in decreased expression of ZFP664 mRNA CTD PMID:26377693 NCBI chr12:37,428,787...37,456,907
Ensembl chr12:37,424,753...37,458,256 		JBrowse link
G Zfp710 zinc finger protein 710 increases expression ISO chrysene results in increased expression of ZFP710 mRNA CTD PMID:26377693 NCBI chr 1:143,375,524...143,445,874
Ensembl chr 1:143,375,271...143,445,874 		JBrowse link
G Zmat3 zinc finger, matrin type 3 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of ZMAT3 mRNA CTD PMID:27858113 NCBI chr 2:117,034,517...117,066,141
Ensembl chr 2:117,034,517...117,065,294 		JBrowse link
G Zmynd15 zinc finger, MYND-type containing 15 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of ZMYND15 mRNA CTD PMID:27858113 NCBI chr10:55,669,832...55,676,446
Ensembl chr10:55,669,752...55,676,434 		JBrowse link
G Zmynd8 zinc finger, MYND-type containing 8 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of ZMYND8 mRNA CTD PMID:27858113 NCBI chr 3:174,948,162...175,061,382
Ensembl chr 3:174,948,537...175,061,571 		JBrowse link
dibenz[a,h]anthracene term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G A2m alpha-2-macroglobulin multiple interactions ISO [Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of A2M mRNA CTD PMID:17690111 NCBI chr 4:156,570,163...156,619,870
Ensembl chr 4:156,569,860...156,619,868 		JBrowse link
G Aard alanine and arginine rich domain containing protein increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of AARD mRNA CTD PMID:26377693 NCBI chr 7:85,254,322...85,259,163
Ensembl chr 7:85,253,992...85,259,163 		JBrowse link
G Abca1 ATP binding cassette subfamily A member 1 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of ABCA1 mRNA CTD PMID:26377693 NCBI chr 5:72,473,676...72,596,563
Ensembl chr 5:72,473,676...72,596,473 		JBrowse link
G Abcb1a ATP binding cassette subfamily B member 1A increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of ABCB1A mRNA CTD PMID:26377693 NCBI chr 4:26,312,403...26,488,456
Ensembl chr 4:26,312,409...26,397,135 		JBrowse link
G Abcb1b ATP-binding cassette, sub-family B member 1B increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of ABCB1B mRNA CTD PMID:26377693 NCBI chr 4:26,197,706...26,280,156
Ensembl chr 4:26,106,903...26,279,567 		JBrowse link
G Abcb4 ATP binding cassette subfamily B member 4 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of ABCB4 mRNA CTD PMID:26377693 NCBI chr 4:26,106,895...26,164,440 JBrowse link
G Abcc3 ATP binding cassette subfamily C member 3 decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of ABCC3 mRNA CTD PMID:26377693 NCBI chr10:79,793,571...79,839,528
Ensembl chr10:79,793,583...79,839,494 		JBrowse link
G Abcd3 ATP binding cassette subfamily D member 3 multiple interactions EXP [1,2,5,6-dibenzanthracene co-treated with dibenzo(a,l)pyrene] affects the expression of ABCD3 mRNA; [1,2,5,6-dibenzanthracene co-treated with fluoranthene] affects the expression of ABCD3 mRNA CTD PMID:18711122 NCBI chr 2:212,536,791...212,590,379
Ensembl chr 2:212,536,791...212,590,504 		JBrowse link
G Abcg5 ATP binding cassette subfamily G member 5 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of ABCG5 mRNA CTD PMID:26377693 NCBI chr 6:15,717,936...15,743,376
Ensembl chr 6:15,717,936...15,743,376 		JBrowse link
G Abhd15 abhydrolase domain containing 15 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of ABHD15 mRNA CTD PMID:26377693 NCBI chr10:62,861,335...62,866,726
Ensembl chr10:62,861,317...62,868,540 		JBrowse link
G Abhd5 abhydrolase domain containing 5, lysophosphatidic acid acyltransferase increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of ABHD5 mRNA CTD PMID:26377693 NCBI chr 8:130,877,834...130,903,947
Ensembl chr 8:130,877,703...130,903,947 		JBrowse link
G Abi3 ABI family, member 3 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of ABI3 mRNA CTD PMID:26377693 NCBI chr10:81,266,571...81,277,561
Ensembl chr10:81,266,571...81,277,561 		JBrowse link
G Abi3bp ABI family member 3 binding protein decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of ABI3BP mRNA CTD PMID:26377693 NCBI chr11:57,381,282...57,597,989
Ensembl chr11:57,381,422...57,598,120 		JBrowse link
G Ablim1 actin-binding LIM protein 1 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of ABLIM1 mRNA CTD PMID:26377693 NCBI chr 1:266,088,868...266,377,169
Ensembl chr 1:266,088,870...266,377,098 		JBrowse link
G Ackr3 atypical chemokine receptor 3 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of CXCR7 mRNA CTD PMID:26377693 NCBI chr 9:98,247,300...98,258,877
Ensembl chr 9:98,246,605...98,260,214 		JBrowse link
G Ackr4 atypical chemokine receptor 4 decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of ACKR4 mRNA CTD PMID:26377693 NCBI chr 8:113,595,325...113,599,762
Ensembl chr 8:113,595,293...113,602,372 		JBrowse link
G Acot1 acyl-CoA thioesterase 1 decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of ACOT1 mRNA CTD PMID:26377693 NCBI chr 6:109,367,274...109,375,268
Ensembl chr 6:109,367,268...109,380,749 		JBrowse link
G Acox2 acyl-CoA oxidase 2 multiple interactions EXP [1,2,5,6-dibenzanthracene co-treated with dibenzo(a,l)pyrene] affects the expression of ACOX2 mRNA; [1,2,5,6-dibenzanthracene co-treated with fluoranthene] affects the expression of ACOX2 mRNA; [Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of ACOX2 mRNA CTD PMID:18711122 NCBI chr15:19,090,820...19,122,392
Ensembl chr15:19,090,926...19,122,392 		JBrowse link
G Acoxl acyl-CoA oxidase-like decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of ACOXL mRNA CTD PMID:26377693 NCBI chr 3:135,514,340...135,820,291
Ensembl chr 3:135,514,275...135,820,291 		JBrowse link
G Acvr2b activin A receptor type 2B increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of ACVR2B mRNA CTD PMID:26377693 NCBI chr 8:128,016,589...128,056,193
Ensembl chr 8:128,016,526...128,048,171 		JBrowse link
G Adam15 ADAM metallopeptidase domain 15 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of ADAM15 mRNA CTD PMID:26377693 NCBI chr 2:177,052,363...177,062,879
Ensembl chr 2:177,052,363...177,062,849 		JBrowse link
G Adamdec1 ADAM-like, decysin 1 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of ADAMDEC1 mRNA CTD PMID:26377693 NCBI chr15:47,076,011...47,097,065
Ensembl chr15:47,076,019...47,097,065 		JBrowse link
G Adamtsl2 ADAMTS-like 2 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of ADAMTSL2 mRNA CTD PMID:26377693 NCBI chr 3:30,795,882...30,832,635
Ensembl chr 3:30,802,700...30,832,635 		JBrowse link
G Adat3 adenosine deaminase, tRNA-specific 3 decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of ADAT3 mRNA CTD PMID:26377693 NCBI chr 7:9,759,758...9,761,127
Ensembl chr 7:9,758,671...9,764,582 		JBrowse link
G Adgrl4 adhesion G protein-coupled receptor L4 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of ADGRL4 mRNA CTD PMID:26377693 NCBI chr 2:243,014,927...243,117,226
Ensembl chr 2:243,014,796...243,117,222 		JBrowse link
G Adm adrenomedullin decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of ADM mRNA CTD PMID:26377693 NCBI chr 1:174,164,178...174,182,372
Ensembl chr 1:174,178,773...174,182,371 		JBrowse link
G Adprh ADP-ribosylarginine hydrolase decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of ADPRH mRNA CTD PMID:26377693 NCBI chr11:75,805,347...75,811,686
Ensembl chr11:75,805,310...75,812,452 		JBrowse link
G Adrb1 adrenoceptor beta 1 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of ADRB1 mRNA CTD PMID:26377693 NCBI chr 1:265,777,103...265,780,114
Ensembl chr 1:265,766,079...265,849,237 		JBrowse link
G Adrb2 adrenoceptor beta 2 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of ADRB2 mRNA CTD PMID:26377693 NCBI chr18:57,912,760...57,914,802
Ensembl chr18:57,911,348...57,914,803 		JBrowse link
G Aen apoptosis enhancing nuclease increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of AEN mRNA CTD PMID:26377693 NCBI chr 1:142,224,499...142,233,902
Ensembl chr 1:142,224,493...142,233,898 		JBrowse link
G Afg1l AFG1 like ATPase increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of AFG1L mRNA CTD PMID:26377693 NCBI chr20:47,380,582...47,550,307
Ensembl chr20:47,380,583...47,550,126 		JBrowse link
G Agtr1a angiotensin II receptor, type 1a increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of AGTR1A mRNA CTD PMID:26377693 NCBI chr17:34,383,397...34,435,523
Ensembl chr17:34,381,467...34,435,660 		JBrowse link
G Ahcyl2 adenosylhomocysteinase-like 2 decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of AHCYL2 mRNA CTD PMID:26377693 NCBI chr 4:59,348,747...59,498,503
Ensembl chr 4:59,348,217...59,498,502 		JBrowse link
G Ahr aryl hydrocarbon receptor affects response to substance
increases activity
multiple interactions
affects binding
affects localization 		ISO
EXP 		AHR affects the susceptibility to 1,2,5,6-dibenzanthracene
1,2,5,6-dibenzanthracene results in increased activity of AHR protein
1,2,5,6-dibenzanthracene inhibits the reaction [Tetrachlorodibenzodioxin binds to AHR protein]
1,2,5,6-dibenzanthracene binds to and results in increased activity of AHR protein; 1,2,5,6-dibenzanthracene inhibits the reaction [Tetrachlorodibenzodioxin binds to AHR protein]; 1,2,5,6-dibenzanthracene promotes the reaction [AHR protein results in increased expression of CYP1A1 mRNA]; [acenaphthene co-treated with anthracene co-treated with 1,12-benzoperylene co-treated with 1,2,5,6-dibenzanthracene co-treated with fluorene co-treated with naphthalene co-treated with phenanthrene] results in increased activity of AHR protein; [benz(a)anthracene co-treated with Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene co-treated with pyrene] results in increased activity of AHR protein; sulforaphane inhibits the reaction [1,2,5,6-dibenzanthracene affects the localization of AHR protein]
1,2,5,6-dibenzanthracene binds to AHR protein
1,2,5,6-dibenzanthracene affects the reaction [Benzo(a)pyrene binds to AHR protein]; 1,2,5,6-dibenzanthracene binds to and results in increased activity of AHR protein; 1,2,5,6-dibenzanthracene inhibits the reaction [Tetrachlorodibenzodioxin binds to AHR protein] 		CTD PMID:3005314 PMID:3011254 PMID:3024361 PMID:6322977 PMID:11525907 More... NCBI chr 6:57,961,423...57,998,901
Ensembl chr 6:57,961,423...57,998,901 		JBrowse link
G Ahrr aryl-hydrocarbon receptor repressor increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of AHRR mRNA CTD PMID:26377693 NCBI chr 1:30,822,219...30,917,251
Ensembl chr 1:30,810,866...30,952,866 		JBrowse link
G Aifm2 AIF family member 2 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of AIFM2 mRNA CTD PMID:26377693 NCBI chr20:30,195,781...30,222,014
Ensembl chr20:30,193,829...30,220,957 		JBrowse link
G Ak1 adenylate kinase 1 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of AK1 mRNA CTD PMID:26377693 NCBI chr 3:36,310,113...36,320,760
Ensembl chr 3:36,310,197...36,320,757 		JBrowse link
G Ak4 adenylate kinase 4 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of AK4 mRNA CTD PMID:26377693 NCBI chr 5:121,154,565...121,214,403
Ensembl chr 5:121,154,572...121,214,401 		JBrowse link
G Akr1b1 aldo-keto reductase family 1 member B1 multiple interactions ISO
EXP 		[Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of AKR1B1 mRNA
[1,2,5,6-dibenzanthracene co-treated with dibenzo(a,l)pyrene] affects the expression of AKR1B1 mRNA; [1,2,5,6-dibenzanthracene co-treated with fluoranthene] affects the expression of AKR1B1 mRNA; [Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of AKR1B1 mRNA 		CTD PMID:17690111 PMID:18711122 NCBI chr 4:63,899,222...63,913,315
Ensembl chr 4:63,899,222...63,913,315 		JBrowse link
G Akr1c1 aldo-keto reductase family 1, member C1 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of AKR1C1 mRNA CTD PMID:17253728 NCBI chr17:70,720,397...70,747,285
Ensembl chr17:70,720,398...70,747,247 		JBrowse link
G Aldob aldolase, fructose-bisphosphate B multiple interactions ISO [Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of ALDOB mRNA CTD PMID:17690111 NCBI chr 5:68,684,541...68,697,582
Ensembl chr 5:68,684,542...68,716,740 		JBrowse link
G Alpl alkaline phosphatase, biomineralization associated increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of ALPL mRNA CTD PMID:26377693 NCBI chr 5:155,234,770...155,289,785
Ensembl chr 5:155,234,775...155,254,167 		JBrowse link
G Als2 alsin Rho guanine nucleotide exchange factor ALS2 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of ALS2 mRNA CTD PMID:26377693 NCBI chr 9:68,107,310...68,180,192
Ensembl chr 9:68,107,528...68,179,660 		JBrowse link
G Amacr alpha-methylacyl-CoA racemase multiple interactions ISO [Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of AMACR mRNA CTD PMID:17690111 NCBI chr 2:61,673,291...61,685,381
Ensembl chr 2:61,670,475...61,685,379 		JBrowse link
G Anln anillin, actin binding protein increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of ANLN mRNA CTD PMID:26377693 NCBI chr 8:29,134,222...29,197,513
Ensembl chr 8:29,134,222...29,197,513 		JBrowse link
G Anxa8 annexin A8 decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of ANXA8 mRNA CTD PMID:26377693 NCBI chr16:9,403,267...9,418,317
Ensembl chr16:9,403,353...9,418,310 		JBrowse link
G Apoc3 apolipoprotein C3 multiple interactions ISO [Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of APOC3 mRNA CTD PMID:17690111 NCBI chr 8:55,428,172...55,430,352
Ensembl chr 8:55,428,024...55,458,679 		JBrowse link
G Apod apolipoprotein D increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of APOD mRNA CTD PMID:26377693 NCBI chr11:82,936,216...82,957,264
Ensembl chr11:82,936,038...82,957,263 		JBrowse link
G Appl1 adaptor protein, phosphotyrosine interacting with PH domain and leucine zipper 1 decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of APPL1 mRNA CTD PMID:26377693 NCBI chr16:2,125,234...2,173,457
Ensembl chr16:2,125,234...2,173,421 		JBrowse link
G Aqp1 aquaporin 1 decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of AQP1 mRNA CTD PMID:26377693 NCBI chr 4:85,812,784...85,824,964
Ensembl chr 4:85,812,784...85,830,504 		JBrowse link
G Ar androgen receptor increases activity
multiple interactions 		EXP
ISO 		1,2,5,6-dibenzanthracene results in increased activity of AR protein
1,2,5,6-dibenzanthracene affects the reaction [Androgens results in increased activity of AR protein]; 1,2,5,6-dibenzanthracene binds to and results in increased activity of AR protein 		CTD PMID:10771140 PMID:28377212 PMID:28803809 NCBI chr  X:67,135,317...67,304,476
Ensembl chr  X:67,135,317...67,304,467 		JBrowse link
G Arglu1 arginine and glutamate rich 1 decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of ARGLU1 mRNA CTD PMID:26377693 NCBI chr16:87,455,097...87,479,148
Ensembl chr16:87,455,113...87,479,148 		JBrowse link
G Arhgap26 Rho GTPase activating protein 26 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of ARHGAP26 mRNA CTD PMID:26377693 NCBI chr18:30,702,602...31,489,047
Ensembl chr18:31,089,787...31,489,047 		JBrowse link
G Arhgef26 Rho guanine nucleotide exchange factor 26 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of ARHGEF26 mRNA CTD PMID:26377693 NCBI chr 2:148,889,405...149,000,538
Ensembl chr 2:148,889,423...149,000,538 		JBrowse link
G Arl4a ARF like GTPase 4A decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of ARL4A mRNA CTD PMID:26377693 NCBI chr 6:62,809,287...62,811,297
Ensembl chr 6:62,804,548...62,820,760 		JBrowse link
G Arl4d ARF like GTPase 4D decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of ARL4D mRNA CTD PMID:26377693 NCBI chr10:87,092,276...87,103,079
Ensembl chr10:87,077,523...87,106,199 		JBrowse link
G Armcx4 armadillo repeat containing, X-linked 4 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of ARMCX4 mRNA CTD PMID:26377693 NCBI chr  X:102,153,743...102,164,173
Ensembl chr  X:102,153,800...102,164,633 		JBrowse link
G Arrdc4 arrestin domain containing 4 decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of ARRDC4 mRNA CTD PMID:26377693 NCBI chr 1:131,779,436...131,793,438
Ensembl chr 1:131,779,437...131,793,565 		JBrowse link
G Arsg arylsulfatase G decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of ARSG mRNA CTD PMID:26377693 NCBI chr10:94,912,094...95,063,021
Ensembl chr10:94,913,152...95,042,447 		JBrowse link
G Art3 ADP-ribosyltransferase 3 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of ART3 mRNA CTD PMID:26377693 NCBI chr14:15,921,540...16,003,764
Ensembl chr14:15,921,395...15,949,806 		JBrowse link
G Art4 ADP-ribosyltransferase 4 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of ART4 mRNA CTD PMID:26377693 NCBI chr 4:171,468,415...171,482,435
Ensembl chr 4:171,471,534...171,481,868 		JBrowse link
G Asap2 ArfGAP with SH3 domain, ankyrin repeat and PH domain 2 decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of ASAP2 mRNA CTD PMID:26377693 NCBI chr 6:46,386,605...46,549,669
Ensembl chr 6:46,386,605...46,549,669 		JBrowse link
G Asf1b anti-silencing function 1B histone chaperone increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of ASF1B mRNA CTD PMID:26377693 NCBI chr19:41,085,786...41,100,352
Ensembl chr19:41,086,114...41,100,352 		JBrowse link
G Asgr1 asialoglycoprotein receptor 1 decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of ASGR1 mRNA CTD PMID:26377693 NCBI chr10:55,274,299...55,278,323
Ensembl chr10:55,274,706...55,278,322 		JBrowse link
G Asns asparagine synthetase (glutamine-hydrolyzing) decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of ASNS mRNA CTD PMID:26377693 NCBI chr 4:36,752,061...36,769,970
Ensembl chr 4:36,751,802...36,776,050 		JBrowse link
G Aspa aspartoacylase increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of ASPA mRNA CTD PMID:26377693 NCBI chr10:58,390,204...58,443,790
Ensembl chr10:58,379,410...58,443,769 		JBrowse link
G Aspm assembly factor for spindle microtubules increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of ASPM mRNA CTD PMID:26377693 NCBI chr13:53,625,584...53,674,489
Ensembl chr13:53,625,584...53,674,489 		JBrowse link
G Atf3 activating transcription factor 3 multiple interactions ISO [Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of ATF3 mRNA CTD PMID:17690111 NCBI chr13:105,274,103...105,331,653
Ensembl chr13:105,282,440...105,295,750 		JBrowse link
G Atf5 activating transcription factor 5 decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of ATF5 mRNA CTD PMID:26377693 NCBI chr 1:104,432,094...104,437,611
Ensembl chr 1:104,432,094...104,436,183 		JBrowse link
G Atg4c autophagy related 4C, cysteine peptidase increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of ATG4C mRNA CTD PMID:16269432 NCBI chr 5:118,977,594...119,050,894
Ensembl chr 5:118,982,918...119,052,695 		JBrowse link
G Atp1a2 ATPase Na+/K+ transporting subunit alpha 2 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of ATP1A2 mRNA CTD PMID:26377693 NCBI chr13:87,261,964...87,286,911
Ensembl chr13:87,261,968...87,286,911 		JBrowse link
G Atp8b5 ATPase, class I, type 8B, member 5 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of ATP8B5 mRNA CTD PMID:26377693 NCBI chr 5:62,302,213...62,415,843
Ensembl chr 5:62,302,275...62,415,834 		JBrowse link
G Aurka aurora kinase A increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of AURKA mRNA CTD PMID:26377693 NCBI chr 3:181,546,742...181,562,890
Ensembl chr 3:181,546,742...181,562,771 		JBrowse link
G Avpr1a arginine vasopressin receptor 1A decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of AVPR1A mRNA CTD PMID:26377693 NCBI chr 7:59,999,743...60,003,667
Ensembl chr 7:59,999,738...60,003,837 		JBrowse link
G Bace2 beta-secretase 2 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of BACE2 mRNA CTD PMID:26377693 NCBI chr11:50,176,852...50,258,948
Ensembl chr11:50,176,621...50,259,008 		JBrowse link
G Bag3 BAG cochaperone 3 decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of BAG3 mRNA CTD PMID:26377693 NCBI chr 1:192,533,460...192,557,281
Ensembl chr 1:192,475,828...192,557,280 		JBrowse link
G Baiap2 BAR/IMD domain containing adaptor protein 2 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of BAIAP2 mRNA CTD PMID:26377693 NCBI chr10:105,721,371...105,788,549
Ensembl chr10:105,721,417...105,788,549 		JBrowse link
G Batf basic leucine zipper ATF-like transcription factor decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of BATF mRNA CTD PMID:26377693 NCBI chr 6:111,084,717...111,107,052
Ensembl chr 6:111,084,717...111,107,052 		JBrowse link
G Bax BCL2 associated X, apoptosis regulator increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of BAX mRNA CTD PMID:26377693 NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:105,076,473...105,086,429 		JBrowse link
G Bbc3 Bcl-2 binding component 3 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of BBC3 mRNA CTD PMID:26377693 NCBI chr 1:86,141,450...86,150,666
Ensembl chr 1:86,141,603...86,150,666 		JBrowse link
G Bcan brevican increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of BCAN mRNA CTD PMID:26377693 NCBI chr 2:175,752,333...175,765,766
Ensembl chr 2:175,752,336...175,765,314 		JBrowse link
G Bcl2l1 Bcl2-like 1 decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of BCL2L1 mRNA CTD PMID:16269432 NCBI chr 3:161,713,777...161,764,844
Ensembl chr 3:161,745,540...161,764,907
Ensembl chr 1:161,745,540...161,764,907 		JBrowse link
G Bcl3 BCL3, transcription coactivator increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of BCL3 mRNA CTD PMID:16269432 NCBI chr 1:88,599,321...88,613,555
Ensembl chr 1:88,599,321...88,614,368 		JBrowse link
G Bcl6 BCL6, transcription repressor decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of BCL6 mRNA CTD PMID:26377693 NCBI chr11:90,358,753...90,382,049
Ensembl chr11:90,358,753...90,382,047 		JBrowse link
G Bcl6b BCL6B, transcription repressor increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of BCL6B mRNA CTD PMID:26377693 NCBI chr10:55,439,566...55,444,631
Ensembl chr10:55,432,382...55,444,631 		JBrowse link
G Bcl7c BAF chromatin remodeling complex subunit BCL7C decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of BCL7C mRNA CTD PMID:26377693 NCBI chr 1:191,703,432...191,754,751
Ensembl chr 1:191,691,089...191,754,641 		JBrowse link
G Bean1 brain expressed, associated with NEDD4, 1 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of BEAN1 mRNA CTD PMID:26377693 NCBI chr19:745,993...792,853
Ensembl chr19:745,993...793,039 		JBrowse link
G Bhlhe40 basic helix-loop-helix family, member e40 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of BHLHE40 mRNA CTD PMID:26377693 NCBI chr 4:143,174,450...143,180,150
Ensembl chr 4:143,174,048...143,180,783 		JBrowse link
G Bin2 bridging integrator 2 decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of BIN2 mRNA CTD PMID:26377693 NCBI chr 7:133,620,782...133,647,019
Ensembl chr 7:133,620,140...133,647,218 		JBrowse link
G Birc5 baculoviral IAP repeat-containing 5 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of BIRC5 mRNA CTD PMID:26377693 NCBI chr10:103,567,369...103,580,069
Ensembl chr10:103,572,080...103,582,155 		JBrowse link
G Bmal1 basic helix-loop-helix ARNT like 1 decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of BMAL1 mRNA CTD PMID:26377693 NCBI chr 1:176,766,222...176,864,741
Ensembl chr 1:176,829,305...176,864,739 		JBrowse link
G Bmpr1b bone morphogenetic protein receptor type 1B decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of BMPR1B mRNA CTD PMID:26377693 NCBI chr 2:233,211,525...233,544,344
Ensembl chr 2:233,211,525...233,544,311 		JBrowse link
G Bnip3 BCL2 interacting protein 3 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of BNIP3 mRNA CTD PMID:26377693 NCBI chr 1:203,137,778...203,154,962
Ensembl chr 1:203,137,778...203,154,962 		JBrowse link
G Bok BCL2 family apoptosis regulator BOK decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of BOK mRNA CTD PMID:26377693 NCBI chr 9:101,670,729...101,681,834
Ensembl chr 9:101,670,625...101,681,833 		JBrowse link
G Bst2 bone marrow stromal cell antigen 2 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of BST2 mRNA CTD PMID:26377693 NCBI chr16:18,250,593...18,254,967
Ensembl chr16:18,251,847...18,254,967 		JBrowse link
G Btg1 BTG anti-proliferation factor 1 decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of BTG1 mRNA CTD PMID:26377693 NCBI chr 7:33,228,149...33,230,406
Ensembl chr 7:33,227,833...33,230,406 		JBrowse link
G C1qb complement C1q B chain decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of C1QB mRNA CTD PMID:26377693 NCBI chr 5:154,402,276...154,407,827
Ensembl chr 5:154,402,279...154,407,840 		JBrowse link
G C1qtnf2 C1q and TNF related 2 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of C1QTNF2 mRNA CTD PMID:26377693 NCBI chr10:28,443,326...28,460,400
Ensembl chr10:28,443,425...28,460,395 		JBrowse link
G C1qtnf5 C1q and TNF related 5 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of C1QTNF5 mRNA CTD PMID:26377693 NCBI chr 8:53,347,754...53,349,912
Ensembl chr 8:53,347,711...53,349,912 		JBrowse link
G C1qtnf7 C1q and TNF related 7 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of C1QTNF7 mRNA CTD PMID:26377693 NCBI chr14:71,680,415...71,792,931
Ensembl chr14:71,680,479...71,792,865 		JBrowse link
G C5 complement C5 decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of HC mRNA CTD PMID:26377693 NCBI chr 3:38,668,174...38,759,468
Ensembl chr 3:38,668,174...38,759,468 		JBrowse link
G Ca3 carbonic anhydrase 3 multiple interactions
decreases expression 		ISO [Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of CA3 mRNA
1,2,5,6-dibenzanthracene results in decreased expression of CAR3 mRNA 		CTD PMID:17690111 PMID:26377693 NCBI chr 2:88,491,666...88,501,299
Ensembl chr 2:88,491,670...88,500,524 		JBrowse link
G Ca8 carbonic anhydrase 8 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of CAR8 mRNA CTD PMID:26377693 NCBI chr 5:26,102,767...26,199,819
Ensembl chr 5:26,102,813...26,199,796 		JBrowse link
G Cad carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of CAD mRNA CTD PMID:26377693 NCBI chr 6:31,012,091...31,035,098
Ensembl chr 6:31,012,091...31,035,297 		JBrowse link
G Calcr calcitonin receptor increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of CALCR mRNA CTD PMID:26377693 NCBI chr 4:32,615,955...32,691,075
Ensembl chr 4:32,615,958...32,691,075 		JBrowse link
G Capn8 calpain 8 decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of CAPN8 mRNA CTD PMID:26377693 NCBI chr13:96,783,640...96,847,825
Ensembl chr13:96,783,667...96,847,820 		JBrowse link
G Caprin1 cell cycle associated protein 1 decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of CAPRIN1 mRNA CTD PMID:26377693 NCBI chr 3:110,606,489...110,685,408
Ensembl chr 3:110,606,489...110,685,562 		JBrowse link
G Carhsp1 calcium regulated heat stable protein 1 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of CARHSP1 mRNA CTD PMID:26377693 NCBI chr10:7,453,602...7,467,218
Ensembl chr10:7,452,978...7,467,770 		JBrowse link
G Casp3 caspase 3 increases activity EXP 1,2,5,6-dibenzanthracene results in increased activity of CASP3 protein CTD PMID:31368503 NCBI chr16:52,395,539...52,413,794
Ensembl chr16:52,395,540...52,413,732 		JBrowse link
G Casp7 caspase 7 increases activity EXP 1,2,5,6-dibenzanthracene results in increased activity of CASP7 protein CTD PMID:31368503 NCBI chr 1:265,442,647...265,481,938
Ensembl chr 1:265,442,676...265,482,512 		JBrowse link
G Ccdc162 coiled-coil domain containing 162 decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of CCDC162 mRNA CTD PMID:26377693 NCBI chr20:46,627,277...46,820,216
Ensembl chr20:46,627,277...46,818,249 		JBrowse link
G Ccdc184 coiled-coil domain containing 184 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of CCDC184 mRNA CTD PMID:26377693 NCBI chr 7:131,178,732...131,180,136
Ensembl chr 7:131,176,373...131,183,680 		JBrowse link
G Ccl19 C-C motif chemokine ligand 19 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of CCL19 mRNA CTD PMID:26377693 NCBI chr 5:61,759,220...61,761,164
Ensembl chr 5:61,759,220...61,772,022 		JBrowse link
G Ccm2l CCM2 like scaffold protein increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of CCM2L mRNA CTD PMID:26377693 NCBI chr 3:161,993,717...162,009,372
Ensembl chr 3:161,859,312...162,009,371 		JBrowse link
G Ccn1 cellular communication network factor 1 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of CCN1 mRNA CTD PMID:26377693 NCBI chr 2:237,222,730...237,225,689
Ensembl chr 2:237,222,432...237,225,883 		JBrowse link
G Ccn2 cellular communication network factor 2 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of CCN2 mRNA CTD PMID:26377693 NCBI chr 1:22,621,498...22,624,614
Ensembl chr 1:22,621,501...22,624,976 		JBrowse link
G Ccn4 cellular communication network factor 4 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of CCN4 mRNA CTD PMID:26377693 NCBI chr 7:100,534,578...100,566,287
Ensembl chr 7:100,534,505...100,563,094 		JBrowse link
G Ccn5 cellular communication network factor 5 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of CCN5 mRNA CTD PMID:26377693 NCBI chr 3:172,910,670...172,922,064
Ensembl chr 3:172,910,681...172,922,062 		JBrowse link
G Ccna2 cyclin A2 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of CCNA2 mRNA CTD PMID:26377693 NCBI chr 2:121,355,363...121,361,762
Ensembl chr 2:121,355,363...121,361,701 		JBrowse link
G Ccnb1 cyclin B1 decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of CCNB1 mRNA CTD PMID:26377693 NCBI chr 2:33,646,252...33,655,225
Ensembl chr 2:33,646,252...33,655,225 		JBrowse link
G Ccnb2 cyclin B2 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of CCNB2 mRNA CTD PMID:26377693 NCBI chr 8:79,968,459...79,981,717
Ensembl chr 8:79,968,465...79,981,682 		JBrowse link
G Ccnd1 cyclin D1 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of CCND1 mRNA CTD PMID:26377693 NCBI chr 1:209,518,288...209,527,986
Ensembl chr 1:209,518,288...209,527,810 		JBrowse link
G Ccnf cyclin F increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of CCNF mRNA CTD PMID:26377693 NCBI chr10:13,757,884...13,783,669
Ensembl chr10:13,758,421...13,783,837 		JBrowse link
G Ccng1 cyclin G1 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of CCNG1 mRNA CTD PMID:26377693 NCBI chr10:25,678,503...25,684,876
Ensembl chr10:25,677,885...25,683,766 		JBrowse link
G Ccnjl cyclin J-like decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of CCNJL mRNA CTD PMID:26377693 NCBI chr10:28,497,144...28,554,877
Ensembl chr10:28,496,990...28,554,877 		JBrowse link
G Ccr2 C-C motif chemokine receptor 2 multiple interactions EXP [Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of CCR2 mRNA CTD PMID:18711122 NCBI chr 8:132,611,883...132,619,106
Ensembl chr 8:132,611,410...132,620,059 		JBrowse link
G Cd151 CD151 molecule (Raph blood group) increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of CD151 mRNA CTD PMID:26377693 NCBI chr 1:205,994,300...205,998,307
Ensembl chr 1:205,994,738...205,998,784 		JBrowse link
G Cd1d1 CD1d1 molecule decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of CD1D1 mRNA CTD PMID:26377693 NCBI chr 2:174,721,522...174,725,029
Ensembl chr 2:174,721,522...174,725,029 		JBrowse link
G Cd200 Cd200 molecule increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of CD200 mRNA CTD PMID:26377693 NCBI chr11:68,916,200...68,943,570
Ensembl chr11:68,916,224...68,943,569 		JBrowse link
G Cd24 CD24 molecule decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of CD24A mRNA CTD PMID:26377693 NCBI chr20:48,655,549...48,661,786
Ensembl chr20:48,655,805...48,661,785 		JBrowse link
G Cd34 CD34 molecule increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of CD34 mRNA CTD PMID:26377693 NCBI chr13:109,008,786...109,029,317
Ensembl chr13:109,008,623...109,029,315 		JBrowse link
G Cd38 CD38 molecule increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of CD38 mRNA CTD PMID:26377693 NCBI chr14:71,384,532...71,424,794
Ensembl chr14:71,384,532...71,424,505 		JBrowse link
G Cd63 Cd63 molecule decreases expression EXP 1,2,5,6-dibenzanthracene results in decreased expression of CD63 protein CTD PMID:31368503 NCBI chr 7:1,909,538...1,924,937
Ensembl chr 7:1,922,169...1,924,938 		JBrowse link
G Cd81 Cd81 molecule decreases expression EXP 1,2,5,6-dibenzanthracene results in decreased expression of CD81 protein CTD PMID:31368503 NCBI chr 1:207,665,274...207,681,094
Ensembl chr 1:207,664,885...207,681,092 		JBrowse link
G Cdc20 cell division cycle 20 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of CDC20 mRNA CTD PMID:26377693 NCBI chr 5:137,251,596...137,255,799
Ensembl chr 5:137,251,596...137,255,799 		JBrowse link
G Cdca5 cell division cycle associated 5 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of CDCA5 mRNA CTD PMID:26377693 NCBI chr 1:212,807,863...212,821,313
Ensembl chr 1:212,804,014...212,821,309 		JBrowse link
G Cdca8 cell division cycle associated 8 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of CDCA8 mRNA CTD PMID:26377693 NCBI chr 5:142,461,082...142,483,336
Ensembl chr 5:142,461,084...142,483,283 		JBrowse link
G Cdh1 cadherin 1 decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of CDH1 mRNA CTD PMID:26377693 NCBI chr19:51,402,178...51,471,572
Ensembl chr19:51,402,034...51,471,565 		JBrowse link
G Cdh17 cadherin 17 multiple interactions EXP [1,2,5,6-dibenzanthracene co-treated with dibenzo(a,l)pyrene] affects the expression of CDH17 mRNA; [1,2,5,6-dibenzanthracene co-treated with fluoranthene] affects the expression of CDH17 mRNA CTD PMID:18711122 NCBI chr 5:30,024,544...30,112,226
Ensembl chr 5:30,060,090...30,112,226 		JBrowse link
G Cdk1 cyclin-dependent kinase 1 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of CDK1 mRNA CTD PMID:26377693 NCBI chr20:19,265,252...19,280,456
Ensembl chr20:19,265,289...19,280,455 		JBrowse link
G Cdkn1a cyclin-dependent kinase inhibitor 1A increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of CDKN1A mRNA CTD PMID:26377693 NCBI chr20:7,150,820...7,161,373
Ensembl chr20:7,153,958...7,164,969 		JBrowse link
G Cdkn3 cyclin-dependent kinase inhibitor 3 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of CDKN3 mRNA CTD PMID:26377693 NCBI chr15:22,502,299...22,513,725
Ensembl chr15:22,502,382...22,513,722 		JBrowse link
G Cdt1 chromatin licensing and DNA replication factor 1 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of CDT1 mRNA CTD PMID:26377693 NCBI chr19:67,529,249...67,534,195
Ensembl chr19:67,529,201...67,534,194 		JBrowse link
G Cebpb CCAAT/enhancer binding protein beta decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of CEBPB mRNA CTD PMID:26377693 NCBI chr 3:176,817,005...176,818,436
Ensembl chr 3:176,816,859...176,838,072 		JBrowse link
G Celf5 CUGBP, Elav-like family member 5 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of CELF5 mRNA CTD PMID:26377693 NCBI chr 7:8,876,551...8,901,078
Ensembl chr 7:8,876,564...8,901,069 		JBrowse link
G Cemip2 cell migration inducing hyaluronidase 2 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of CEMIP2 mRNA CTD PMID:26377693 NCBI chr 1:228,756,826...228,834,313
Ensembl chr 1:228,757,466...228,832,906 		JBrowse link
G Cenpe centromere protein E increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of CENPE mRNA CTD PMID:26377693 NCBI chr 2:226,310,970...226,369,636
Ensembl chr 2:226,300,798...226,369,636 		JBrowse link
G Cenpk centromere protein K increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of CENPK mRNA CTD PMID:26377693 NCBI chr 2:37,094,163...37,155,158
Ensembl chr 2:37,094,248...37,119,488 		JBrowse link
G Ces2e carboxylesterase 2E increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of CES2E mRNA CTD PMID:26377693 NCBI chr19:163,899...179,274
Ensembl chr19:163,859...179,308 		JBrowse link
G Ces2h carboxylesterase 2H increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of CES2 mRNA CTD PMID:26377693 NCBI chr19:49,884,164...49,898,764
Ensembl chr19:49,884,164...49,898,752 		JBrowse link
G Cfap69 cilia and flagella associated protein 69 decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of CFAP69 mRNA CTD PMID:26377693 NCBI chr 4:29,334,624...29,405,513
Ensembl chr 4:29,334,415...29,408,727 		JBrowse link
G Cfd complement factor D decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of CFD mRNA CTD PMID:26377693 NCBI chr 7:10,463,773...10,465,496
Ensembl chr 7:10,463,775...10,465,572 		JBrowse link
G Cflar CASP8 and FADD-like apoptosis regulator decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of CFLAR mRNA CTD PMID:26377693 NCBI chr 9:67,679,502...67,747,226
Ensembl chr 9:67,679,559...67,726,434 		JBrowse link
G Cgref1 cell growth regulator with EF hand domain 1 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of CGREF1 mRNA CTD PMID:26377693 NCBI chr 6:31,151,795...31,163,801
Ensembl chr 6:31,151,795...31,163,800 		JBrowse link
G Chaf1b chromatin assembly factor 1 subunit B increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of CHAF1B mRNA CTD PMID:26377693 NCBI chr11:46,670,560...46,690,739
Ensembl chr11:46,670,630...46,690,733 		JBrowse link
G Chd2 chromodomain helicase DNA binding protein 2 decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of CHD2 mRNA CTD PMID:26377693 NCBI chr 1:136,597,993...136,726,874
Ensembl chr 1:136,599,900...136,710,335 		JBrowse link
G Chka choline kinase alpha decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of CHKA mRNA CTD PMID:26377693 NCBI chr 1:210,506,069...210,554,753
Ensembl chr 1:210,506,056...210,554,752 		JBrowse link
G Chn2 chimerin 2 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of CHN2 mRNA CTD PMID:26377693 NCBI chr 4:84,478,989...84,738,068
Ensembl chr 4:84,704,862...84,738,068 		JBrowse link
G Chordc1 cysteine and histidine rich domain containing 1 decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of CHORDC1 mRNA CTD PMID:26377693 NCBI chr 8:23,650,721...23,674,786
Ensembl chr 8:23,650,865...23,677,696 		JBrowse link
G Chst6 carbohydrate sulfotransferase 6 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of CHST5 mRNA CTD PMID:26377693 NCBI chr19:56,769,991...56,790,276
Ensembl chr19:56,769,967...56,790,306 		JBrowse link
G Cimap1b ciliary microtubule associated protein 1B decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of CIMAP1B mRNA CTD PMID:26377693 NCBI chr 7:122,323,860...122,326,921
Ensembl chr 7:122,323,860...122,326,876 		JBrowse link
G Cimip2b ciliary microtubule inner protein 2B decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of CIMIP2B mRNA CTD PMID:26377693 NCBI chr 5:62,471,246...62,477,812
Ensembl chr 5:62,470,367...62,478,198 		JBrowse link
G Cish cytokine inducible SH2-containing protein increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of CISH mRNA CTD PMID:26377693 NCBI chr 8:116,850,969...116,855,917
Ensembl chr 8:116,850,773...116,855,986 		JBrowse link
G Ckap2 cytoskeleton associated protein 2 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of CKAP2 mRNA CTD PMID:26377693 NCBI chr16:76,542,114...76,567,297
Ensembl chr16:76,542,104...76,567,352 		JBrowse link
G Cks1b CDC28 protein kinase regulatory subunit 1B affects expression ISO 1,2,5,6-dibenzanthracene affects the expression of CKS1B mRNA CTD PMID:26377693 NCBI chr 2:177,130,751...177,135,333
Ensembl chr 2:177,130,777...177,135,365 		JBrowse link
G Clcn2 chloride voltage-gated channel 2 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of CLCN2 mRNA CTD PMID:26377693 NCBI chr11:93,702,382...93,716,059
Ensembl chr11:93,702,360...93,716,059 		JBrowse link
G Cldn7 claudin 7 multiple interactions EXP [1,2,5,6-dibenzanthracene co-treated with dibenzo(a,l)pyrene] affects the expression of CLDN7 mRNA; [1,2,5,6-dibenzanthracene co-treated with fluoranthene] affects the expression of CLDN7 mRNA; [Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of CLDN7 mRNA CTD PMID:18711122 NCBI chr10:55,188,670...55,190,871
Ensembl chr10:55,188,684...55,190,905 		JBrowse link
G Cldnd1 claudin domain containing 1 decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of CLDND1 mRNA CTD PMID:26377693 NCBI chr11:55,352,321...55,358,779
Ensembl chr11:55,352,321...55,358,907 		JBrowse link
G Clec1a C-type lectin domain family 1, member A increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of CLEC1A mRNA CTD PMID:26377693 NCBI chr 4:164,561,385...164,588,593
Ensembl chr 4:164,563,374...164,587,269 		JBrowse link
G Clec1b C-type lectin domain family 1, member B decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of CLEC1B mRNA CTD PMID:26377693 NCBI chr 4:164,533,987...164,542,320
Ensembl chr 4:164,534,055...164,542,867 		JBrowse link
G Clec4d C-type lectin domain family 4, member D decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of CLEC4D mRNA CTD PMID:26377693 NCBI chr 4:158,275,287...158,286,978
Ensembl chr 4:158,275,341...158,287,055 		JBrowse link
G Clmn calmin increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of CLMN mRNA CTD PMID:26377693 NCBI chr 6:129,470,613...129,572,079
Ensembl chr 6:129,478,149...129,572,027 		JBrowse link
G Clock clock circadian regulator decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of CLOCK mRNA CTD PMID:26377693 NCBI chr14:32,262,747...32,346,872
Ensembl chr14:32,262,750...32,346,872 		JBrowse link
G Clpx caseinolytic mitochondrial matrix peptidase chaperone subunit X decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of CLPX mRNA CTD PMID:26377693 NCBI chr 8:74,700,602...74,740,244
Ensembl chr 8:74,700,662...74,744,762 		JBrowse link
G Clstn3 calsyntenin 3 decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of CLSTN3 mRNA CTD PMID:26377693 NCBI chr 4:159,017,795...159,051,069
Ensembl chr 4:159,017,795...159,051,069 		JBrowse link
G Cmtm4 CKLF-like MARVEL transmembrane domain containing 4 decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of CMTM4 mRNA CTD PMID:26377693 NCBI chr19:582,642...622,546
Ensembl chr19:582,621...677,816 		JBrowse link
G Col4a1 collagen type IV alpha 1 chain increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of COL4A1 mRNA CTD PMID:26377693 NCBI chr16:84,885,597...84,996,482
Ensembl chr16:84,885,597...84,996,482 		JBrowse link
G Col4a2 collagen type IV alpha 2 chain increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of COL4A2 mRNA CTD PMID:26377693 NCBI chr16:84,749,672...84,885,520
Ensembl chr16:84,749,672...84,885,520 		JBrowse link
G Col5a3 collagen type V alpha 3 chain decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of COL5A3 mRNA CTD PMID:26377693 NCBI chr 8:27,580,768...27,626,002
Ensembl chr 8:27,580,768...27,626,122 		JBrowse link
G Colq collagen like tail subunit of asymmetric acetylcholinesterase decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of COLQ mRNA CTD PMID:26377693 NCBI chr16:6,738,251...6,830,492
Ensembl chr16:6,738,251...6,793,501 		JBrowse link
G Commd3 COMM domain containing 3 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of COMMD3 mRNA CTD PMID:26377693 NCBI chr17:86,235,863...86,239,610
Ensembl chr17:86,235,863...86,239,610 		JBrowse link
G Coq10b coenzyme Q10B increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of COQ10B mRNA CTD PMID:26377693 NCBI chr 9:64,048,168...64,068,082
Ensembl chr 9:64,048,103...64,068,322 		JBrowse link
G Cp ceruloplasmin increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of CP mRNA CTD PMID:16269432 NCBI chr 2:104,368,336...104,427,119
Ensembl chr 2:104,368,456...104,427,087 		JBrowse link
G Cpe carboxypeptidase E increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of CPE mRNA CTD PMID:26377693 NCBI chr16:29,796,707...29,908,647
Ensembl chr16:29,796,689...29,909,524 		JBrowse link
G Cpped1 calcineurin-like phosphoesterase domain containing 1 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of CPPED1 mRNA CTD PMID:26377693 NCBI chr10:4,135,601...4,328,039
Ensembl chr10:4,208,463...4,231,065 		JBrowse link
G Cptp ceramide-1-phosphate transfer protein increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of CPTP mRNA CTD PMID:26377693 NCBI chr 5:171,757,181...171,761,271
Ensembl chr 5:171,757,181...171,761,266 		JBrowse link
G Crabp2 cellular retinoic acid binding protein 2 decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of CRABP2 mRNA CTD PMID:16269432 NCBI chr 2:175,714,862...175,719,208
Ensembl chr 2:175,707,312...175,728,385 		JBrowse link
G Crebl2 cAMP responsive element binding protein-like 2 decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of CREBL2 mRNA CTD PMID:26377693 NCBI chr 4:169,404,630...169,430,618
Ensembl chr 4:169,376,495...169,430,611 		JBrowse link
G Crebzf CREB/ATF bZIP transcription factor decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of CREBZF mRNA CTD PMID:26377693 NCBI chr 1:153,829,544...153,836,073
Ensembl chr 1:153,829,448...153,845,122 		JBrowse link
G Crlf2 cytokine receptor-like factor 2 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of CRLF2 mRNA CTD PMID:26377693 NCBI chr14:118,932...123,632
Ensembl chr14:115,497...123,631 		JBrowse link
G Crot carnitine O-octanoyltransferase decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of CROT mRNA CTD PMID:26377693 NCBI chr 4:26,031,729...26,088,057
Ensembl chr 4:26,052,516...26,088,064 		JBrowse link
G Cry2 cryptochrome circadian regulator 2 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of CRY2 mRNA CTD PMID:26377693 NCBI chr 3:98,830,479...98,860,437
Ensembl chr 3:98,830,483...98,860,447 		JBrowse link
G Crym crystallin, mu increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of CRYM mRNA CTD PMID:26377693 NCBI chr 1:183,991,752...184,006,923
Ensembl chr 1:183,991,745...184,006,962 		JBrowse link
G Csf1 colony stimulating factor 1 decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of CSF1 mRNA CTD PMID:26377693 NCBI chr 2:198,065,400...198,084,774
Ensembl chr 2:198,065,405...198,084,468 		JBrowse link
G Ctnnd2 catenin delta 2 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of CTNND2 mRNA CTD PMID:26377693 NCBI chr 2:82,879,469...83,727,409
Ensembl chr 2:82,879,469...83,727,409 		JBrowse link
G Cx3cl1 C-X3-C motif chemokine ligand 1 decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of CX3CL1 mRNA CTD PMID:26377693 NCBI chr19:10,233,326...10,244,856
Ensembl chr19:10,233,329...10,242,999 		JBrowse link
G Cxcl12 C-X-C motif chemokine ligand 12 decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of CXCL12 mRNA CTD PMID:26377693 NCBI chr 4:152,060,781...152,073,628
Ensembl chr 4:152,060,780...152,073,627 		JBrowse link
G Cyb5a cytochrome b5 type A increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of CYB5A mRNA CTD PMID:16269432 NCBI chr18:80,487,923...80,520,544
Ensembl chr18:14,453,966...14,455,094
Ensembl chr18:14,453,966...14,455,094 		JBrowse link
G Cyp1a1 cytochrome P450, family 1, subfamily a, polypeptide 1 multiple interactions
increases expression
affects expression
decreases expression
increases activity 		ISO
EXP 		1,2,5,6-dibenzanthracene promotes the reaction [AHR protein results in increased expression of CYP1A1 mRNA]; 2-oxohexyl isothiocyanate inhibits the reaction [1,2,5,6-dibenzanthracene results in increased activity of CYP1A1 protein]; [Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of CYP1A1 mRNA; [CYP1A1 protein co-treated with Trichloroepoxypropane] results in increased metabolism of 1,2,5,6-dibenzanthracene; alyssin inhibits the reaction [1,2,5,6-dibenzanthracene results in increased activity of CYP1A1 protein]; Cadmium Chloride inhibits the reaction [1,2,5,6-dibenzanthracene results in increased activity of CYP1A1 protein]; EPHX1 protein promotes the reaction [CYP1A1 protein results in increased metabolism of 1,2,5,6-dibenzanthracene]; lead nitrate inhibits the reaction [1,2,5,6-dibenzanthracene results in increased activity of CYP1A1 protein]; sodium arsenite inhibits the reaction [1,2,5,6-dibenzanthracene results in increased activity of CYP1A1 protein]; TP53 protein affects the reaction [1,2,5,6-dibenzanthracene results in increased expression of CYP1A1 protein]
1,2,5,6-dibenzanthracene results in increased expression of CYP1A1 mRNA; 1,2,5,6-dibenzanthracene results in increased expression of CYP1A1 protein
1,2,5,6-dibenzanthracene affects the expression of CYP1A1 mRNA
1,2,5,6-dibenzanthracene results in decreased expression of CYP1A1 mRNA
1,2,5,6-dibenzanthracene affects the reaction [Benzo(a)pyrene affects the expression of CYP1A1 mRNA]; 1,2,5,6-dibenzanthracene promotes the reaction [Benzo(a)pyrene results in increased expression of CYP1A1 mRNA]; 1,2,5,6-dibenzanthracene promotes the reaction [dibenzo(a,l)pyrene results in increased expression of CYP1A1 mRNA]; 1,2,5,6-dibenzanthracene promotes the reaction [fluoranthene results in increased expression of CYP1A1 mRNA]; Benzo(a)pyrene promotes the reaction [1,2,5,6-dibenzanthracene results in increased expression of CYP1A1 mRNA]; dibenzo(a,l)pyrene promotes the reaction [1,2,5,6-dibenzanthracene results in increased expression of CYP1A1 mRNA]; fluoranthene promotes the reaction [1,2,5,6-dibenzanthracene results in increased expression of CYP1A1 mRNA]
CYP1A1 protein results in increased activity of 1,2,5,6-dibenzanthracene
[CYP1A1 protein co-treated with Trichloroepoxypropane] results in increased metabolism of 1,2,5,6-dibenzanthracene; EPHX1 protein promotes the reaction [CYP1A1 protein results in increased metabolism of 1,2,5,6-dibenzanthracene] 		CTD PMID:8961944 PMID:10190573 PMID:11162773 PMID:11408366 PMID:11955671 More... NCBI chr 8:66,991,940...66,998,014
Ensembl chr 8:66,991,970...66,998,012 		JBrowse link
G Cyp1a2 cytochrome P450, family 1, subfamily a, polypeptide 2 multiple interactions
increases expression
decreases activity
increases metabolic processing
increases activity 		ISO
EXP 		[Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of CYP1A2 mRNA; [CYP1A2 protein co-treated with Trichloroepoxypropane] results in increased metabolism of 1,2,5,6-dibenzanthracene; [CYP1A2 protein results in increased metabolism of 1,2,5,6-dibenzanthracene] which results in increased chemical synthesis of dibenzoanthracene-1,2-dihydrodiol; [CYP1A2 protein results in increased metabolism of 1,2,5,6-dibenzanthracene] which results in increased chemical synthesis of dibenzoanthracene-3,4-dihydrodiol; alyssin inhibits the reaction [1,2,5,6-dibenzanthracene results in increased activity of CYP1A2 protein]; EPHX1 protein promotes the reaction [CYP1A2 protein results in increased metabolism of 1,2,5,6-dibenzanthracene]; sulforaphane inhibits the reaction [1,2,5,6-dibenzanthracene results in increased activity of CYP1A2 protein]
[1,2,5,6-dibenzanthracene co-treated with dibenzo(a,l)pyrene] affects the expression of CYP1A2 mRNA; [1,2,5,6-dibenzanthracene co-treated with fluoranthene] affects the expression of CYP1A2 mRNA; [Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of CYP1A2 mRNA
1,2,5,6-dibenzanthracene results in increased expression of CYP1A2 mRNA
1,2,5,6-dibenzanthracene results in decreased activity of CYP1A2 protein
[CYP1A2 protein co-treated with Trichloroepoxypropane] results in increased metabolism of 1,2,5,6-dibenzanthracene; EPHX1 protein promotes the reaction [CYP1A2 protein results in increased metabolism of 1,2,5,6-dibenzanthracene] 		CTD PMID:8638931 PMID:8961944 PMID:11162773 PMID:16269432 PMID:17253728 More... NCBI chr 8:66,971,261...66,978,149
Ensembl chr 8:66,971,261...66,978,149 		JBrowse link
G Cyp1b1 cytochrome P450, family 1, subfamily b, polypeptide 1 increases expression
increases expression
multiple interactions
affects expression 		EXP
ISO 		1,2,5,6-dibenzanthracene results in increased expression of CYP1B1 mRNA
dibenz[a,h]anthracene increases expression of CYP1B1 mRNA in lung epithelial cell
1,2,5,6-dibenzanthracene results in increased expression of CYP1B1 mRNA; 1,2,5,6-dibenzanthracene results in increased expression of CYP1B1 protein
1,2,5,6-dibenzanthracene affects the reaction [Benzo(a)pyrene affects the expression of CYP1B1 mRNA]
1,2,5,6-dibenzanthracene affects the expression of CYP1B1 mRNA 		CTD
RGD		 PMID:11955671 PMID:12117779 PMID:17253728 PMID:17961608 PMID:19358281 More... RGD:152177688 NCBI chr 6:21,093,927...21,103,091
Ensembl chr 6:21,078,146...21,103,142 		JBrowse link
G Cyp26b1 cytochrome P450, family 26, subfamily b, polypeptide 1 decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of CYP26B1 mRNA CTD PMID:26377693 NCBI chr 4:118,599,356...118,616,176
Ensembl chr 4:118,599,356...118,616,176 		JBrowse link
G Cyp2b3 cytochrome P450, family 2, subfamily b, polypeptide 3 increases metabolic processing
multiple interactions 		ISO CYP2B6 protein results in increased metabolism of 1,2,5,6-dibenzanthracene
[Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of CYP2B6 mRNA; [CYP2B6 protein results in increased metabolism of 1,2,5,6-dibenzanthracene] which results in increased chemical synthesis of dibenzoanthracene-3,4-dihydrodiol 		CTD PMID:8638931 PMID:17690111 NCBI chr 1:90,780,468...90,859,852 JBrowse link
G Cyp2d4 cytochrome P450, family 2, subfamily d, polypeptide 4 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of CYP2D6 mRNA CTD PMID:16269432 NCBI chr 7:115,762,662...115,771,832
Ensembl chr 7:115,761,696...115,771,837 		JBrowse link
G Cyp2e1 cytochrome P450, family 2, subfamily e, polypeptide 1 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of CYP2E1 mRNA CTD PMID:16269432 NCBI chr 1:205,269,967...205,280,365
Ensembl chr 1:205,267,505...205,293,495 		JBrowse link
G Cyp2s1 cytochrome P450, family 2, subfamily s, polypeptide 1 decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of CYP2S1 mRNA CTD PMID:26377693 NCBI chr 1:90,437,741...90,453,073
Ensembl chr 1:90,438,224...90,453,073 		JBrowse link
G Cyp7b1 cytochrome P450 family 7 subfamily B member 1 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of CYP7B1 mRNA CTD PMID:26377693 NCBI chr 2:102,419,011...102,586,047
Ensembl chr 2:102,419,011...102,451,804 		JBrowse link
G Cys1 cystin 1 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of CYS1 mRNA CTD PMID:26377693 NCBI chr 6:47,029,440...47,046,671
Ensembl chr 6:47,028,461...47,046,671 		JBrowse link
G Cyyr1 cysteine and tyrosine rich 1 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of CYYR1 mRNA CTD PMID:26377693 NCBI chr11:38,044,003...38,150,391
Ensembl chr11:38,001,699...38,164,473 		JBrowse link
G Dach1 dachshund family transcription factor 1 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of DACH1 mRNA CTD PMID:26377693 NCBI chr15:80,936,063...81,317,746
Ensembl chr15:80,936,063...81,317,627 		JBrowse link
G Dbi diazepam binding inhibitor decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of DBI mRNA CTD PMID:16269432 NCBI chr13:33,794,231...33,802,632
Ensembl chr13:33,759,845...33,821,450 		JBrowse link
G Dbp D-box binding PAR bZIP transcription factor increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of DBP mRNA CTD PMID:26377693 NCBI chr 1:105,312,256...105,317,205
Ensembl chr 1:105,312,108...105,317,205 		JBrowse link
G Dcaf4 DDB1 and CUL4 associated factor 4 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of DCAF4 mRNA CTD PMID:26377693 NCBI chr 6:108,885,970...108,912,116
Ensembl chr 6:108,885,932...108,912,110 		JBrowse link
G Dchs1 dachsous cadherin-related 1 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of DCHS1 mRNA CTD PMID:26377693 NCBI chr 1:169,516,758...169,550,789
Ensembl chr 1:169,516,762...169,536,639 		JBrowse link
G Dclre1a DNA cross-link repair 1A increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of DCLRE1A mRNA CTD PMID:26377693 NCBI chr 1:265,575,087...265,594,987
Ensembl chr 1:265,575,087...265,593,899 		JBrowse link
G Ddah1 dimethylarginine dimethylaminohydrolase 1 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of DDAH1 mRNA CTD PMID:26377693 NCBI chr 2:237,327,812...237,460,624
Ensembl chr 2:237,327,766...237,460,626 		JBrowse link
G Ddias DNA damage-induced apoptosis suppressor increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of DDIAS mRNA CTD PMID:26377693 NCBI chr 1:156,318,559...156,342,869
Ensembl chr 1:156,318,563...156,342,869 		JBrowse link
G Ddit3 DNA-damage inducible transcript 3 decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of DDIT3 mRNA CTD PMID:26377693 NCBI chr 7:65,001,695...65,006,517
Ensembl chr 7:65,005,501...65,006,509 		JBrowse link
G Ddit4l DNA-damage-inducible transcript 4-like increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of DDIT4L mRNA CTD PMID:26377693 NCBI chr 2:228,800,831...228,804,478
Ensembl chr 2:228,801,705...228,806,225 		JBrowse link
G Ddo D-aspartate oxidase increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of DDO mRNA CTD PMID:26377693 NCBI chr20:45,673,486...45,693,056
Ensembl chr20:45,675,532...45,715,758 		JBrowse link
G Dedd2 death effector domain containing 2 decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of DEDD2 mRNA CTD PMID:26377693 NCBI chr 1:89,916,906...89,934,663
Ensembl chr 1:89,919,524...89,936,804 		JBrowse link
G Dennd2b DENN domain containing 2B decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of DENND2B mRNA CTD PMID:26377693 NCBI chr 1:172,978,895...173,129,623
Ensembl chr 1:172,978,895...173,129,810 		JBrowse link
G Desi2 desumoylating isopeptidase 2 decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of DESI2 mRNA CTD PMID:26377693 NCBI chr13:92,493,765...92,543,307
Ensembl chr13:92,493,989...92,564,981 		JBrowse link
G Dhh desert hedgehog signaling molecule increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of DHH mRNA CTD PMID:26377693 NCBI chr 7:131,929,857...131,935,352
Ensembl chr 7:131,929,857...131,935,352 		JBrowse link
G Disp2 dispatched RND transporter family member 2 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of DISP2 mRNA CTD PMID:26377693 NCBI chr 3:126,216,194...126,231,724
Ensembl chr 3:126,216,218...126,231,711 		JBrowse link
G Dnai1 dynein, axonemal, intermediate chain 1 decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of DNAI1 mRNA CTD PMID:26377693 NCBI chr 5:61,526,079...61,596,806
Ensembl chr 5:61,525,999...61,596,810 		JBrowse link
G Dnai4 dynein axonemal intermediate chain 4 decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of DNAI4 mRNA CTD PMID:26377693 NCBI chr 5:123,016,480...123,105,283
Ensembl chr 5:123,016,480...123,105,283 		JBrowse link
G Dnaja1 DnaJ heat shock protein family (Hsp40) member A1 decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of DNAJA1 mRNA CTD PMID:26377693 NCBI chr 5:60,638,404...60,649,315
Ensembl chr 5:60,638,410...60,650,160 		JBrowse link
G Dnajb1 DnaJ heat shock protein family (Hsp40) member B1 decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of DNAJB1 mRNA CTD PMID:26377693 NCBI chr19:41,427,453...41,431,141
Ensembl chr19:41,427,453...41,431,416 		JBrowse link
G Dnmt3b DNA methyltransferase 3 beta decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of DNMT3B mRNA CTD PMID:26377693 NCBI chr 3:162,590,777...162,629,313
Ensembl chr 3:162,604,037...162,629,313 		JBrowse link
G Dnttip1 deoxynucleotidyltransferase, terminal, interacting protein 1 decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of DNTTIP1 mRNA CTD PMID:26377693 NCBI chr 3:173,901,070...173,924,742
Ensembl chr 3:173,900,945...173,925,098 		JBrowse link
G Dsp desmoplakin increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of DSP mRNA CTD PMID:26377693 NCBI chr17:26,829,153...26,877,419
Ensembl chr17:26,829,153...26,877,121 		JBrowse link
G Dtx4 deltex E3 ubiquitin ligase 4 decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of DTX4 mRNA CTD PMID:26377693 NCBI chr 1:218,882,391...218,969,837
Ensembl chr 1:218,832,284...218,917,130 		JBrowse link
G Dusp1 dual specificity phosphatase 1 multiple interactions EXP [1,2,5,6-dibenzanthracene co-treated with dibenzo(a,l)pyrene] affects the expression of DUSP1 mRNA; [1,2,5,6-dibenzanthracene co-treated with fluoranthene] affects the expression of DUSP1 mRNA; [Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of DUSP1 mRNA CTD PMID:18711122 NCBI chr10:17,184,853...17,187,646
Ensembl chr10:17,184,823...17,187,644 		JBrowse link
G Dyrk3 dual specificity tyrosine phosphorylation regulated kinase 3 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of DYRK3 mRNA CTD PMID:26377693 NCBI chr13:45,146,383...45,157,082
Ensembl chr13:45,146,384...45,157,249 		JBrowse link
G Dysf dysferlin increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of DYSF mRNA CTD PMID:26377693 NCBI chr 4:118,048,460...118,248,273
Ensembl chr 4:118,047,989...118,248,273 		JBrowse link
G E2f7 E2F transcription factor 7 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of E2F7 mRNA CTD PMID:26377693 NCBI chr 7:48,036,881...48,079,055
Ensembl chr 7:48,037,749...48,079,055 		JBrowse link
G E2f8 E2F transcription factor 8 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of E2F8 mRNA CTD PMID:26377693 NCBI chr 1:107,701,985...107,720,538
Ensembl chr 1:107,701,985...107,720,009 		JBrowse link
G Ece1 endothelin converting enzyme 1 multiple interactions ISO [Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of ECE1 mRNA CTD PMID:17690111 NCBI chr 5:155,361,031...155,462,723
Ensembl chr 5:155,360,639...155,462,719 		JBrowse link
G Ecm1 extracellular matrix protein 1 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of ECM1 mRNA CTD PMID:26377693 NCBI chr 2:185,976,439...185,981,656
Ensembl chr 2:185,976,440...185,981,606 		JBrowse link
G Ednrb endothelin receptor type B decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of EDNRB mRNA CTD PMID:26377693 NCBI chr15:87,055,490...87,086,765
Ensembl chr15:87,057,691...87,086,765 		JBrowse link
G Efna1 ephrin A1 decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of EFNA1 mRNA CTD PMID:26377693 NCBI chr 2:176,979,434...176,988,675
Ensembl chr 2:176,979,434...176,988,726 		JBrowse link
G Efnb2 ephrin B2 decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of EFNB2 mRNA CTD PMID:26377693 NCBI chr16:87,485,215...87,529,224
Ensembl chr16:87,485,198...87,529,208 		JBrowse link
G Egr1 early growth response 1 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of EGR1 mRNA CTD PMID:26377693 NCBI chr18:26,737,078...26,740,877
Ensembl chr18:26,736,838...26,740,843 		JBrowse link
G Ehhadh enoyl-CoA hydratase and 3-hydroxyacyl CoA dehydrogenase multiple interactions EXP [1,2,5,6-dibenzanthracene co-treated with dibenzo(a,l)pyrene] affects the expression of EHHADH mRNA; [1,2,5,6-dibenzanthracene co-treated with fluoranthene] affects the expression of EHHADH mRNA; [Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of EHHADH mRNA CTD PMID:18711122 NCBI chr11:92,746,409...92,779,647
Ensembl chr11:92,746,420...92,779,662 		JBrowse link
G Ei24 EI24, autophagy associated transmembrane protein increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of EI24 mRNA CTD PMID:26377693 NCBI chr 8:44,683,138...44,699,502
Ensembl chr 8:44,683,144...44,695,214 		JBrowse link
G Emcn endomucin increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of EMCN mRNA CTD PMID:26377693 NCBI chr 2:228,564,445...228,644,370
Ensembl chr 2:228,564,430...228,645,155 		JBrowse link
G Emid1 EMI domain containing 1 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of EMID1 mRNA CTD PMID:26377693 NCBI chr14:84,214,530...84,257,628
Ensembl chr14:84,214,530...84,257,579 		JBrowse link
G Emp1 epithelial membrane protein 1 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of EMP1 mRNA CTD PMID:26377693 NCBI chr 4:169,931,537...169,964,366
Ensembl chr 4:169,931,440...169,964,365 		JBrowse link
G Enkur enkurin, TRPC channel interacting protein decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of ENKUR mRNA CTD PMID:26377693 NCBI chr17:88,599,057...88,622,668
Ensembl chr17:88,599,057...88,622,668 		JBrowse link
G Epb41l5 erythrocyte membrane protein band 4.1 like 5 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of EPB41L5 mRNA CTD PMID:26377693 NCBI chr13:33,221,705...33,321,400
Ensembl chr13:33,223,589...33,321,133 		JBrowse link
G Epha4 Eph receptor A4 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of EPHA4 mRNA CTD PMID:26377693 NCBI chr 9:86,263,982...86,406,744
Ensembl chr 9:86,263,982...86,406,755 		JBrowse link
G Ephb6 Eph receptor B6 decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of EPHB6 mRNA CTD PMID:26377693 NCBI chr 4:71,458,632...71,473,889
Ensembl chr 4:71,458,971...71,476,659 		JBrowse link
G Ephx1 epoxide hydrolase 1 multiple interactions
increases expression 		ISO EPHX1 protein promotes the reaction [CYP1A1 protein results in increased metabolism of 1,2,5,6-dibenzanthracene]; EPHX1 protein promotes the reaction [CYP1A2 protein results in increased metabolism of 1,2,5,6-dibenzanthracene]
1,2,5,6-dibenzanthracene results in increased expression of EPHX1 mRNA 		CTD PMID:8961944 PMID:26377693 NCBI chr13:95,246,079...95,275,852
Ensembl chr13:95,246,080...95,321,981 		JBrowse link
G Erbb2 erb-b2 receptor tyrosine kinase 2 decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of ERBB2 mRNA CTD PMID:16269432 NCBI chr10:83,907,491...83,931,365
Ensembl chr10:83,907,460...83,931,481 		JBrowse link
G Erich3 glutamate-rich 3 decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of ERICH3 mRNA CTD PMID:26377693 NCBI chr 2:246,275,438...246,377,673
Ensembl chr 2:246,275,757...246,375,695 		JBrowse link
G Esm1 endothelial cell-specific molecule 1 decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of ESM1 mRNA CTD PMID:26377693 NCBI chr 2:46,609,253...46,617,991
Ensembl chr 2:46,609,204...46,617,990 		JBrowse link
G Esrra estrogen related receptor, alpha increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of ESRRA mRNA CTD PMID:26377693 NCBI chr 1:213,533,309...213,543,432
Ensembl chr 1:213,533,310...213,543,811 		JBrowse link
G Ethe1 ETHE1, persulfide dioxygenase decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of ETHE1 mRNA CTD PMID:26377693 NCBI chr 1:89,311,948...89,327,000
Ensembl chr 1:89,311,934...89,326,998 		JBrowse link
G Eva1a eva-1 homolog A, regulator of programmed cell death increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of EVA1A mRNA CTD PMID:26377693 NCBI chr 4:116,151,595...116,200,827
Ensembl chr 4:116,151,173...116,200,827 		JBrowse link
G Exoc3l2 exocyst complex component 3-like 2 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of EXOC3L2 mRNA CTD PMID:26377693 NCBI chr 1:88,241,784...88,273,352
Ensembl chr 1:88,240,477...88,276,847 		JBrowse link
G Exoc4 exocyst complex component 4 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of EXOC4 mRNA CTD PMID:26377693 NCBI chr 4:62,774,896...63,551,541
Ensembl chr 4:62,774,935...63,552,943 		JBrowse link
G F3 coagulation factor III, tissue factor increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of F3 mRNA CTD PMID:26377693 NCBI chr 2:212,511,675...212,523,375
Ensembl chr 2:212,511,680...212,523,369 		JBrowse link
G Fabp1 fatty acid binding protein 1 multiple interactions ISO [Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of FABP1 mRNA CTD PMID:17690111 NCBI chr 4:104,744,302...104,753,119
Ensembl chr 4:104,744,309...104,753,113 		JBrowse link
G Fam107a family with sequence similarity 107, member A increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of FAM107A mRNA CTD PMID:26377693 NCBI chr15:19,038,726...19,060,644
Ensembl chr15:19,038,616...19,065,219 		JBrowse link
G Fam169b family with sequence similarity 169, member B increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of FAM169B mRNA CTD PMID:26377693 NCBI chr 1:131,288,780...131,378,548
Ensembl chr 1:131,288,799...131,370,145 		JBrowse link
G Fam181b family with sequence similarity 181, member B increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of FAM181B mRNA CTD PMID:26377693 NCBI chr 1:156,578,821...156,580,318
Ensembl chr 1:156,491,094...156,595,845 		JBrowse link
G Fam53b family with sequence similarity 53, member B increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of FAM53B mRNA CTD PMID:26377693 NCBI chr 1:196,930,170...197,021,290
Ensembl chr 1:196,930,175...197,021,290 		JBrowse link
G Fam76a family with sequence similarity 76, member A increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of FAM76A mRNA CTD PMID:26377693 NCBI chr 5:150,391,460...150,419,526
Ensembl chr 5:150,391,463...150,419,807 		JBrowse link
G Fasn fatty acid synthase multiple interactions ISO [Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of FASN mRNA CTD PMID:17690111 NCBI chr10:106,570,415...106,588,581
Ensembl chr10:106,570,413...106,588,583 		JBrowse link
G Fbln1 fibulin 1 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of FBLN1 mRNA CTD PMID:26377693 NCBI chr 7:118,190,347...118,269,965
Ensembl chr 7:118,190,478...118,269,965 		JBrowse link
G Fbxo5 F-box protein 5 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of FBXO5 mRNA CTD PMID:26377693 NCBI chr 1:44,601,412...44,607,781
Ensembl chr 1:44,601,412...44,607,781 		JBrowse link
G Fen1 flap structure-specific endonuclease 1 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of FEN1 mRNA CTD PMID:26377693 NCBI chr 1:216,270,016...216,274,873
Ensembl chr 1:216,269,163...216,275,016 		JBrowse link
G Fga fibrinogen alpha chain multiple interactions ISO [Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of FGA mRNA CTD PMID:17690111 NCBI chr 2:170,672,169...170,679,572
Ensembl chr 2:170,672,012...170,679,577 		JBrowse link
G Fgf1 fibroblast growth factor 1 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of FGF1 mRNA CTD PMID:26377693 NCBI chr18:30,937,670...31,023,786
Ensembl chr18:30,939,870...30,961,393 		JBrowse link
G Fgf9 fibroblast growth factor 9 increases expression
increases expression 		ISO 1,2,5,6-dibenzanthracene results in increased expression of FGF9 mRNA
dibenz[a,h]anthracene increases expression of FGF9 mRNA in lung epithelial cell 		CTD
RGD		 PMID:19358281 PMID:19358281 RGD:152177688 NCBI chr15:36,325,552...36,369,995
Ensembl chr15:36,325,599...36,367,926 		JBrowse link
G Fgfr3 fibroblast growth factor receptor 3 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of FGFR3 mRNA CTD PMID:26377693 NCBI chr14:81,211,800...81,227,215
Ensembl chr14:81,211,800...81,227,209 		JBrowse link
G Fgg fibrinogen gamma chain multiple interactions ISO [Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of FGG mRNA CTD PMID:17690111 NCBI chr 2:170,652,929...170,660,372
Ensembl chr 2:170,652,234...170,661,170 		JBrowse link
G Fgl2 fibrinogen-like 2 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of FGL2 mRNA CTD PMID:26377693 NCBI chr 4:14,602,762...14,608,405
Ensembl chr 4:14,602,771...14,608,405 		JBrowse link
G Fhl1 four and a half LIM domains 1 decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of FHL1 mRNA CTD PMID:26377693 NCBI chr  X:139,592,794...139,652,290
Ensembl chr  X:139,592,604...139,652,282 		JBrowse link
G Fibin fin bud initiation factor homolog decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of FIBIN mRNA CTD PMID:26377693 NCBI chr 3:117,396,973...117,399,244
Ensembl chr 3:117,391,724...117,399,479 		JBrowse link
G Fignl1 fidgetin-like 1 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of FIGNL1 mRNA CTD PMID:26377693 NCBI chr14:90,573,090...90,595,342
Ensembl chr14:90,581,771...90,592,316 		JBrowse link
G Flnb filamin B increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of FLNB mRNA CTD PMID:26377693 NCBI chr15:19,392,212...19,525,278
Ensembl chr15:19,392,216...19,525,209 		JBrowse link
G Fmo1 flavin containing dimethylaniline monoxygenase 1 affects expression ISO 1,2,5,6-dibenzanthracene affects the expression of FMO1 mRNA CTD PMID:26377693 NCBI chr13:77,715,405...77,747,666
Ensembl chr13:77,715,402...77,747,874 		JBrowse link
G Fmo2 flavin containing dimethylaniline monoxygenase 2 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of FMO2 mRNA CTD PMID:26377693 NCBI chr13:77,755,131...77,777,597
Ensembl chr13:77,757,629...77,777,534 		JBrowse link
G Fmo3 flavin containing dimethylaniline monoxygenase 3 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of FMO3 mRNA CTD PMID:26377693 NCBI chr13:77,838,899...77,868,869
Ensembl chr13:77,842,602...77,861,256 		JBrowse link
G Fmo5 flavin containing dimethylaniline monoxygenase 5 multiple interactions ISO [Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of FMO5 mRNA CTD PMID:17690111 NCBI chr 2:187,885,741...187,938,468
Ensembl chr 2:187,910,964...187,938,464 		JBrowse link
G Fn1 fibronectin 1 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of FN1 mRNA CTD PMID:26377693 NCBI chr 9:80,645,507...80,714,200
Ensembl chr 9:80,645,507...80,714,137 		JBrowse link
G Foxa2 forkhead box A2 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of FOXA2 mRNA CTD PMID:26377693 NCBI chr 3:155,923,305...155,927,508
Ensembl chr 3:155,923,307...155,928,757 		JBrowse link
G Foxf2 forkhead box F2 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of FOXF2 mRNA CTD PMID:27322209 NCBI chr17:33,044,446...33,051,259
Ensembl chr17:32,846,603...33,051,259 		JBrowse link
G Frrs1 ferric-chelate reductase 1 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of FRRS1 mRNA CTD PMID:26377693 NCBI chr 2:207,505,786...207,566,376
Ensembl chr 2:207,507,910...207,566,376 		JBrowse link
G Fzd6 frizzled class receptor 6 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of FZD6 mRNA CTD PMID:26377693 NCBI chr 7:71,939,916...71,971,685
Ensembl chr 7:71,939,973...71,971,680 		JBrowse link
G G6pd glucose-6-phosphate dehydrogenase multiple interactions ISO [Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of G6PD mRNA CTD PMID:17690111 NCBI chr  X:157,352,364...157,372,144
Ensembl chr  X:157,352,373...157,372,144 		JBrowse link
G Gadd45a growth arrest and DNA-damage-inducible, alpha increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of GADD45A mRNA CTD PMID:26377693 NCBI chr 4:97,484,497...97,486,799
Ensembl chr 4:97,484,502...97,486,807 		JBrowse link
G Galnt12 polypeptide N-acetylgalactosaminyltransferase 12 decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of GALNT12 mRNA CTD PMID:26377693 NCBI chr 5:66,180,171...66,208,931
Ensembl chr 5:66,180,164...66,208,938 		JBrowse link
G Gap43 growth associated protein 43 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of GAP43 mRNA CTD PMID:26377693 NCBI chr11:71,882,131...71,975,799
Ensembl chr11:71,882,131...71,975,797 		JBrowse link
G Garin1a golgi associated RAB2 interactor 1A decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of GARIN1A mRNA CTD PMID:26377693 NCBI chr 4:58,845,394...58,856,199
Ensembl chr 4:58,845,354...58,856,195 		JBrowse link
G Gask1b golgi associated kinase 1B increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of GASK1B mRNA CTD PMID:26377693 NCBI chr 2:167,345,738...167,410,606
Ensembl chr 2:167,345,809...167,410,603 		JBrowse link
G Gata2 GATA binding protein 2 decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of GATA2 mRNA CTD PMID:26377693 NCBI chr 4:122,211,501...122,225,058
Ensembl chr 4:122,211,829...122,225,055 		JBrowse link
G Gbp4 guanylate binding protein 4 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of GBP4 mRNA CTD PMID:26377693 NCBI chr 2:233,978,163...233,992,124
Ensembl chr 2:233,978,486...233,992,120 		JBrowse link
G Gbp5 guanylate binding protein 5 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of GBP5 mRNA CTD PMID:26377693 NCBI chr 2:233,910,999...233,930,320
Ensembl chr 2:233,902,113...233,930,826 		JBrowse link
G Gbp6 guanylate binding protein family member 6 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of GBP6 mRNA CTD PMID:26377693 NCBI chr14:5,034,999...5,062,023
Ensembl chr14:4,968,325...4,983,692
Ensembl chr14:4,968,325...4,983,692 		JBrowse link
G Gck glucokinase multiple interactions ISO [Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of GCK mRNA CTD PMID:17690111 NCBI chr14:84,999,019...85,041,098
Ensembl chr14:84,999,020...85,040,949 		JBrowse link
G Gdf1 growth differentiation factor 1 decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of GDF1 mRNA CTD PMID:26377693 NCBI chr16:19,131,271...19,146,480
Ensembl chr16:19,131,276...19,146,480 		JBrowse link
G Gdf15 growth differentiation factor 15 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of GDF15 mRNA CTD PMID:26377693 NCBI chr16:18,838,436...18,842,022
Ensembl chr16:18,838,436...18,842,022 		JBrowse link
G Gdpd5 glycerophosphodiester phosphodiesterase domain containing 5 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of GDPD5 mRNA CTD PMID:26377693 NCBI chr 1:163,091,844...163,173,559
Ensembl chr 1:163,091,833...163,173,559 		JBrowse link
G Gldn gliomedin decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of GLDN mRNA CTD PMID:26377693 NCBI chr 8:63,575,270...63,619,346
Ensembl chr 8:63,575,270...63,619,346 		JBrowse link
G Glis2 GLIS family zinc finger 2 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of GLIS2 mRNA CTD PMID:26377693 NCBI chr10:11,457,594...11,484,948
Ensembl chr10:11,457,792...11,477,995 		JBrowse link
G Gna14 G protein subunit alpha 14 decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of GNA14 mRNA CTD PMID:26377693 NCBI chr 1:223,141,802...223,324,210
Ensembl chr 1:223,141,802...223,324,210 		JBrowse link
G Gnat1 G protein subunit alpha transducin 1 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of GNAT1 mRNA CTD PMID:26377693 NCBI chr 8:117,229,575...117,234,311
Ensembl chr 8:117,229,575...117,234,311 		JBrowse link
G Golph3l golgi phosphoprotein 3-like decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of GOLPH3L mRNA CTD PMID:26377693 NCBI chr 2:185,840,879...185,872,037
Ensembl chr 2:185,840,958...185,872,043 		JBrowse link
G Gpihbp1 glycosylphosphatidylinositol anchored high density lipoprotein binding protein 1 decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of GPIHBP1 mRNA CTD PMID:26377693 NCBI chr 7:109,166,334...109,169,448
Ensembl chr 7:109,163,160...109,169,448 		JBrowse link
G Gpr146 G protein-coupled receptor 146 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of GPR146 mRNA CTD PMID:26377693 NCBI chr12:20,365,790...20,381,122
Ensembl chr12:20,364,269...20,381,345 		JBrowse link
G Gpr162 G protein-coupled receptor 162 decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of GPR162 mRNA CTD PMID:26377693 NCBI chr 4:159,348,465...159,354,577
Ensembl chr 4:159,348,303...159,354,390 		JBrowse link
G Gprc5b G protein-coupled receptor, class C, group 5, member B increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of GPRC5B mRNA CTD PMID:26377693 NCBI chr 1:182,748,247...182,772,711
Ensembl chr 1:182,748,247...182,772,757 		JBrowse link
G Gprin3 GPRIN family member 3 decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of GPRIN3 mRNA CTD PMID:26377693 NCBI chr 4:89,902,198...89,987,496
Ensembl chr 4:89,892,867...89,987,565 		JBrowse link
G Gpx7 glutathione peroxidase 7 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of GPX7 mRNA CTD PMID:26377693 NCBI chr 5:128,373,881...128,381,866
Ensembl chr 5:128,372,875...128,381,725 		JBrowse link
G Greb1 growth regulating estrogen receptor binding 1 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of GREB1 mRNA CTD PMID:26377693 NCBI chr 6:45,169,289...45,321,973
Ensembl chr 6:45,169,289...45,291,126 		JBrowse link
G Grem2 gremlin 2, DAN family BMP antagonist increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of GREM2 mRNA CTD PMID:26377693 NCBI chr13:89,310,897...89,403,856
Ensembl chr13:89,310,662...89,404,312 		JBrowse link
G Grp gastrin releasing peptide decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of GRP mRNA CTD PMID:26377693 NCBI chr18:61,658,655...61,672,037
Ensembl chr18:61,658,250...61,672,037 		JBrowse link
G Gsta1 glutathione S-transferase alpha 1 multiple interactions ISO GSTA1 protein affects the metabolism of and results in decreased susceptibility to 1,2,5,6-dibenzanthracene CTD PMID:11673082 NCBI chr 9:31,199,887...31,216,606
Ensembl chr 9:31,199,888...31,211,528 		JBrowse link
G Gstm1 glutathione S-transferase mu 1 multiple interactions ISO GSTM1 protein affects the metabolism of [1,2,5,6-dibenzanthracene co-treated with Glutathione] CTD PMID:9403173 NCBI chr 2:198,338,005...198,346,007
Ensembl chr 2:198,338,008...198,343,569 		JBrowse link
G Gstp1 glutathione S-transferase pi 1 decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of GSTP1 mRNA CTD PMID:26377693 NCBI chr 1:210,767,237...210,770,242
Ensembl chr 1:210,767,237...210,769,705 		JBrowse link
G Gtse1 G-2 and S-phase expressed 1 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of GTSE1 mRNA CTD PMID:26377693 NCBI chr 7:118,829,793...118,846,662
Ensembl chr 7:118,829,903...118,846,661 		JBrowse link
G Gucy1a2 guanylate cyclase 1 soluble subunit alpha 2 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of GUCY1A2 mRNA CTD PMID:26377693 NCBI chr 8:8,785,212...9,174,322
Ensembl chr 8:8,785,121...9,174,272 		JBrowse link
G H1f2 H1.2 linker histone, cluster member increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of H1F2 mRNA CTD PMID:26377693 NCBI chr17:41,818,962...41,820,453
Ensembl chr17:41,779,051...41,822,317 		JBrowse link
G H1f5 H1.5 linker histone, cluster member increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of H1F5 mRNA CTD PMID:26377693 NCBI chr17:47,421,875...47,422,905
Ensembl chr17:47,421,843...47,477,387 		JBrowse link
G H2ac10 H2A clustered histone 10 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of H2AC10 mRNA CTD PMID:26377693 NCBI chr17:41,998,567...41,999,055
Ensembl chr17:41,998,622...41,999,025 		JBrowse link
G H2ac12 H2A clustered histone 12 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of H2AC12 mRNA CTD PMID:26377693 NCBI chr17:47,182,193...47,182,658 JBrowse link
G H2ac20 H2A clustered histone 20 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of H2AC20 mRNA CTD PMID:26377693 NCBI chr 2:186,468,748...186,469,226 JBrowse link
G H2ac22 H2A clustered histone 22 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of H2AC11 mRNA; 1,2,5,6-dibenzanthracene results in increased expression of H2AC22 mRNA CTD PMID:26377693 NCBI chr17:41,812,378...41,812,875
Ensembl chr17:41,797,862...41,812,946 		JBrowse link
G H2ac4 H2A clustered histone 4 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of H2AC4 mRNA CTD PMID:26377693 NCBI chr17:47,495,624...47,496,127
Ensembl chr17:47,495,546...47,496,173 		JBrowse link
G H2ax H2A.X variant histone increases expression ISO 1,2,5,6-dibenzanthracene metabolite results in increased expression of H2AX protein CTD PMID:31051210 NCBI chr 8:53,568,718...53,570,072
Ensembl chr 8:53,568,281...53,573,079 		JBrowse link
G H2bc14 H2B clustered histone 14 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of H2BC14 mRNA CTD PMID:26377693 NCBI chr17:47,488,627...47,489,008 JBrowse link
G Hamp hepcidin antimicrobial peptide increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of HAMP mRNA CTD PMID:16269432 NCBI chr 1:95,298,332...95,300,271
Ensembl chr 1:95,298,307...95,300,297 		JBrowse link
G Hapln1 hyaluronan and proteoglycan link protein 1 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of HAPLN1 mRNA CTD PMID:26377693 NCBI chr 2:22,366,967...22,431,709
Ensembl chr 2:22,366,967...22,429,098 		JBrowse link
G Hdac1 histone deacetylase 1 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of HDAC1 mRNA CTD PMID:26377693 NCBI chr 5:147,138,328...147,165,387
Ensembl chr 5:147,138,156...147,165,387 		JBrowse link
G Heatr1 HEAT repeat containing 1 decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of HEATR1 mRNA CTD PMID:26377693 NCBI chr17:62,745,008...62,785,609
Ensembl chr17:62,745,008...62,785,186 		JBrowse link
G Heph hephaestin increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of HEPH mRNA CTD PMID:26377693 NCBI chr  X:65,160,628...65,412,457
Ensembl chr  X:65,305,773...65,412,453 		JBrowse link
G Herc6 HECT and RLD domain containing E3 ubiquitin protein ligase family member 6 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of HERC6 mRNA CTD PMID:26377693 NCBI chr 4:88,854,612...88,897,043
Ensembl chr 4:88,854,640...88,896,993 		JBrowse link
G Heyl hes-related family bHLH transcription factor with YRPW motif-like increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of HEYL mRNA CTD PMID:26377693 NCBI chr 5:140,793,271...140,810,262
Ensembl chr 5:140,793,271...140,810,262 		JBrowse link
G Hhip Hedgehog-interacting protein increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of HHIP mRNA CTD PMID:26377693 NCBI chr19:44,768,038...44,856,878
Ensembl chr19:44,767,536...44,862,795 		JBrowse link
G Hic1 HIC ZBTB transcriptional repressor 1 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of HIC1 mRNA CTD PMID:26377693 NCBI chr10:60,512,855...60,517,812
Ensembl chr10:60,500,565...60,523,448 		JBrowse link
G Hif1a hypoxia inducible factor 1 subunit alpha increases activity
multiple interactions 		ISO 1,2,5,6-dibenzanthracene results in increased activity of HIF1A protein
[Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of HIF1A mRNA 		CTD PMID:17690111 PMID:19502547 NCBI chr 6:98,357,788...98,405,068
Ensembl chr 6:98,359,910...98,405,323 		JBrowse link
G Hilpda hypoxia inducible lipid droplet-associated decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of HILPDA mRNA CTD PMID:26377693 NCBI chr 4:58,836,463...58,839,423
Ensembl chr 4:58,836,463...58,839,423 		JBrowse link
G Hk1 hexokinase 1 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of HK1 mRNA CTD PMID:26377693 NCBI chr20:30,773,222...30,874,814
Ensembl chr20:30,773,220...30,874,814 		JBrowse link
G Hkdc1 hexokinase domain containing 1 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of HKDC1 mRNA CTD PMID:26377693 NCBI chr20:30,878,037...30,917,044
Ensembl chr20:30,878,319...30,916,704 		JBrowse link
G Hlf HLF transcription factor, PAR bZIP family member increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of HLF mRNA CTD PMID:26377693 NCBI chr10:75,651,320...75,708,979
Ensembl chr10:75,654,534...75,708,619 		JBrowse link
G Hmgb2 high mobility group box 2 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of HMGB2 mRNA CTD PMID:26377693 NCBI chr16:37,721,374...37,723,950
Ensembl chr16:37,721,379...37,723,860 		JBrowse link
G Hmgb3 high mobility group box 3 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of HMGB3 mRNA CTD PMID:26377693 NCBI chr  X:154,341,106...154,346,087
Ensembl chr  X:154,340,935...154,346,097 		JBrowse link
G Hmgcr 3-hydroxy-3-methylglutaryl-CoA reductase decreases expression
multiple interactions 		ISO 1,2,5,6-dibenzanthracene results in decreased expression of HMGCR mRNA
[Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of HMGCR mRNA 		CTD PMID:16269432 PMID:17690111 NCBI chr 2:29,732,163...29,754,276
Ensembl chr 2:29,720,553...29,754,533 		JBrowse link
G Hmgn2 high mobility group nucleosomal binding domain 2 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of HMGN2 mRNA CTD PMID:26377693 NCBI chr 5:151,475,907...151,479,361
Ensembl chr 5:151,475,909...151,479,397 		JBrowse link
G Hnmt histamine N-methyltransferase increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of HNMT mRNA CTD PMID:26377693 NCBI chr 3:26,978,274...27,010,291
Ensembl chr 3:26,977,933...27,010,482 		JBrowse link
G Homer2 homer scaffold protein 2 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of HOMER2 mRNA CTD PMID:26377693 NCBI chr 1:144,968,207...145,069,022
Ensembl chr 1:144,976,436...145,068,997 		JBrowse link
G Hook2 hook microtubule-tethering protein 2 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of HOOK2 mRNA CTD PMID:26377693 NCBI chr19:40,056,732...40,075,027
Ensembl chr19:40,056,732...40,081,270 		JBrowse link
G Hpgd 15-hydroxyprostaglandin dehydrogenase increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of HPGD mRNA CTD PMID:26377693 NCBI chr16:38,996,876...39,034,831
Ensembl chr16:38,996,876...39,034,831 		JBrowse link
G Hsd11b1 hydroxysteroid 11-beta dehydrogenase 1 multiple interactions EXP [1,2,5,6-dibenzanthracene co-treated with dibenzo(a,l)pyrene] affects the expression of HSD11B1 mRNA; [1,2,5,6-dibenzanthracene co-treated with fluoranthene] affects the expression of HSD11B1 mRNA; [Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of HSD11B1 mRNA CTD PMID:18711122 NCBI chr13:107,277,526...107,327,462
Ensembl chr13:107,257,239...107,327,432 		JBrowse link
G Hspa1a heat shock protein family A (Hsp70) member 1A decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of HSPA1A mRNA CTD PMID:26377693 NCBI chr20:3,875,411...3,877,866
Ensembl chr20:3,855,780...3,877,979 		JBrowse link
G Hspa4l heat shock protein family A (Hsp70) member 4 like decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of HSPA4L mRNA CTD PMID:26377693 NCBI chr 2:125,668,346...125,726,404
Ensembl chr 2:125,668,236...125,720,986 		JBrowse link
G Hsph1 heat shock protein family H (Hsp110) member 1 decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of HSPH1 mRNA CTD PMID:26377693 NCBI chr12:10,427,368...10,446,602
Ensembl chr12:10,427,297...10,446,891 		JBrowse link
G Hunk hormonally upregulated Neu-associated kinase increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of HUNK mRNA CTD PMID:26377693 NCBI chr11:43,127,244...43,244,502
Ensembl chr11:43,127,244...43,244,502 		JBrowse link
G Hydin Hydin, axonemal central pair apparatus protein decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of HYDIN mRNA CTD PMID:26377693 NCBI chr19:55,146,382...55,492,660
Ensembl chr19:55,146,466...55,492,660 		JBrowse link
G Id1 inhibitor of DNA binding 1 multiple interactions
increases expression 		EXP
ISO 		[1,2,5,6-dibenzanthracene co-treated with fluoranthene] affects the expression of ID1 mRNA; [Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of ID1 mRNA
1,2,5,6-dibenzanthracene results in increased expression of ID1 mRNA 		CTD PMID:18711122 PMID:26377693 NCBI chr 3:161,671,525...161,672,691
Ensembl chr 3:161,671,538...161,672,685 		JBrowse link
G Id2 inhibitor of DNA binding 2 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of ID2 mRNA CTD PMID:16269432 NCBI chr 6:47,469,162...47,470,995
Ensembl chr 6:47,457,554...47,472,961 		JBrowse link
G Ier3 immediate early response 3 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of IER3 mRNA CTD PMID:22579512 NCBI chr20:2,933,173...2,934,377
Ensembl chr20:2,933,174...2,934,377 		JBrowse link
G Ier5 immediate early response 5 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of IER5 mRNA CTD PMID:26377693 NCBI chr13:69,820,450...69,822,542
Ensembl chr13:69,820,451...69,822,543 		JBrowse link
G Ifi27l2a interferon, alpha-inducible protein 27 like 2A increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of IFI27L2A mRNA CTD PMID:26377693 NCBI chr 6:128,363,658...128,365,144
Ensembl chr 6:128,363,658...128,365,146 		JBrowse link
G Igf1 insulin-like growth factor 1 increases expression
multiple interactions 		ISO 1,2,5,6-dibenzanthracene results in increased expression of IGF1 mRNA
[Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of IGF1 mRNA 		CTD PMID:16269432 PMID:17690111 NCBI chr 7:24,169,608...24,249,446
Ensembl chr 7:24,130,137...24,246,764 		JBrowse link
G Igf1r insulin-like growth factor 1 receptor decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of IGF1R mRNA CTD PMID:26377693 NCBI chr 1:130,959,787...131,248,664
Ensembl chr 1:130,959,997...131,248,664 		JBrowse link
G Igf2 insulin-like growth factor 2 multiple interactions ISO [Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of IGF2 mRNA CTD PMID:17690111 NCBI chr 1:207,243,873...207,261,263
Ensembl chr 1:207,243,873...207,260,667 		JBrowse link
G Igfbp1 insulin-like growth factor binding protein 1 increases expression
decreases expression
multiple interactions 		ISO 1,2,5,6-dibenzanthracene results in increased expression of IGFBP1 mRNA
1,2,5,6-dibenzanthracene results in decreased expression of IGFBP1 mRNA
[Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of IGFBP1 mRNA 		CTD PMID:16269432 PMID:17690111 PMID:26377693 NCBI chr14:86,261,277...86,266,344
Ensembl chr14:86,261,277...86,266,344 		JBrowse link
G Igfbp2 insulin-like growth factor binding protein 2 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of IGFBP2 mRNA CTD PMID:26377693 NCBI chr 9:81,864,811...81,892,179
Ensembl chr 9:81,864,783...81,892,171 		JBrowse link
G Igfbp5 insulin-like growth factor binding protein 5 decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of IGFBP5 mRNA CTD PMID:26377693 NCBI chr 9:81,901,605...81,914,187
Ensembl chr 9:81,897,616...81,914,390 		JBrowse link
G Igfbp6 insulin-like growth factor binding protein 6 decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of IGFBP6 mRNA CTD PMID:26377693 NCBI chr 7:135,154,919...135,159,550
Ensembl chr 7:135,154,685...135,159,795 		JBrowse link
G Ikzf4 IKAROS family zinc finger 4 affects expression ISO 1,2,5,6-dibenzanthracene affects the expression of IKZF4 mRNA CTD PMID:26377693 NCBI chr 7:1,643,379...1,687,524
Ensembl chr 7:1,644,799...1,687,094 		JBrowse link
G Il18r1 interleukin 18 receptor 1 decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of IL18R1 mRNA CTD PMID:26377693 NCBI chr 9:50,223,274...50,257,370
Ensembl chr 9:50,223,200...50,257,367 		JBrowse link
G Il4r interleukin 4 receptor affects expression ISO 1,2,5,6-dibenzanthracene affects the expression of IL4RA mRNA CTD PMID:26377693 NCBI chr 1:189,545,739...189,570,639
Ensembl chr 1:189,544,988...189,570,636 		JBrowse link
G Inf2 inverted formin 2 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of INF2 mRNA CTD PMID:26377693 NCBI chr 6:137,470,259...137,497,039
Ensembl chr 6:137,470,286...137,497,039 		JBrowse link
G Inhbb inhibin subunit beta B decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of INHBB mRNA CTD PMID:26377693 NCBI chr13:33,083,671...33,089,373
Ensembl chr13:33,083,671...33,089,609 		JBrowse link
G Inka2 inka box actin regulator 2 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of INKA2 mRNA CTD PMID:26377693 NCBI chr 2:195,873,617...195,888,983
Ensembl chr 2:195,873,497...195,893,605 		JBrowse link
G Insig2 insulin induced gene 2 decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of INSIG2 mRNA CTD PMID:26377693 NCBI chr13:35,025,160...35,052,937
Ensembl chr13:35,025,164...35,047,658 		JBrowse link
G Iqgap3 IQ motif containing GTPase activating protein 3 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of IQGAP3 mRNA CTD PMID:26377693 NCBI chr 2:175,840,001...175,881,799
Ensembl chr 2:175,839,949...175,881,797 		JBrowse link
G Irs1 insulin receptor substrate 1 decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of IRS1 mRNA CTD PMID:26377693 NCBI chr 9:91,001,137...91,053,959
Ensembl chr 9:90,993,519...91,054,538 		JBrowse link
G Irx2 iroquois homeobox 2 decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of IRX2 mRNA CTD PMID:26377693 NCBI chr 1:32,489,512...32,494,930
Ensembl chr 1:32,489,512...32,494,930 		JBrowse link
G Itgb4 integrin subunit beta 4 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of ITGB4 mRNA CTD PMID:26377693 NCBI chr10:101,705,592...101,741,933
Ensembl chr10:101,705,587...101,741,932 		JBrowse link
G Itm2a integral membrane protein 2A increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of ITM2A mRNA CTD PMID:26377693 NCBI chr  X:76,559,183...76,565,144
Ensembl chr  X:76,559,181...76,565,437 		JBrowse link
G Itpka inositol-trisphosphate 3-kinase A decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of ITPKA mRNA CTD PMID:26377693 NCBI chr 3:127,179,841...127,188,405
Ensembl chr 3:127,179,808...127,188,414 		JBrowse link
G Jag2 jagged canonical Notch ligand 2 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of JAG2 mRNA CTD PMID:26377693 NCBI chr 6:137,804,133...137,826,738
Ensembl chr 6:137,804,133...137,826,738 		JBrowse link
G Jam2 junctional adhesion molecule 2 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of JAM2 mRNA CTD PMID:26377693 NCBI chr11:37,316,287...37,366,517
Ensembl chr11:37,317,511...37,367,510 		JBrowse link
G Jchain joining chain of multimeric IgA and IgM decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of JCHAIN mRNA CTD PMID:26377693 NCBI chr14:19,822,976...19,831,072
Ensembl chr14:19,822,976...19,838,307 		JBrowse link
G Kank4 KN motif and ankyrin repeat domains 4 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of KANK4 mRNA CTD PMID:26377693 NCBI chr 5:118,516,994...118,581,024
Ensembl chr 5:118,517,971...118,581,002 		JBrowse link
G Kazn kazrin, periplakin interacting protein increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of KAZN mRNA CTD PMID:26377693 NCBI chr 5:159,675,803...160,666,084
Ensembl chr 5:159,675,803...160,664,154 		JBrowse link
G Kcnb1 potassium voltage-gated channel subfamily B member 1 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of KCNB1 mRNA CTD PMID:26377693 NCBI chr 3:176,239,285...176,332,408
Ensembl chr 3:176,242,589...176,332,408 		JBrowse link
G Kcne3 potassium voltage-gated channel subfamily E regulatory subunit 3 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of KCNE3 mRNA CTD PMID:26377693 NCBI chr 1:163,936,035...163,942,998
Ensembl chr 1:163,935,991...163,950,162 		JBrowse link
G Kcnn2 potassium calcium-activated channel subfamily N member 2 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of KCNN2 mRNA CTD PMID:26377693 NCBI chr18:40,004,693...40,445,043
Ensembl chr18:40,155,939...40,445,045 		JBrowse link
G Kcns3 potassium voltage-gated channel, modifier subfamily S, member 3 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of KCNS3 mRNA CTD PMID:26377693 NCBI chr 6:39,527,410...39,584,105
Ensembl chr 6:39,523,777...39,618,848 		JBrowse link
G Kctd12 potassium channel tetramerization domain containing 12 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of KCTD12 mRNA CTD PMID:26377693 NCBI chr15:86,214,786...86,220,725
Ensembl chr15:86,214,840...86,224,539 		JBrowse link
G Kif20a kinesin family member 20A increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of KIF20A mRNA CTD PMID:26377693 NCBI chr18:26,504,422...26,512,908
Ensembl chr18:26,504,072...26,512,909 		JBrowse link
G Kif20b kinesin family member 20B increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of KIF20B mRNA CTD PMID:26377693 NCBI chr 1:241,840,898...241,896,451
Ensembl chr 1:241,840,987...241,896,451 		JBrowse link
G Kif22 kinesin family member 22 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of KIF22 mRNA CTD PMID:26377693 NCBI chr 1:191,065,875...191,080,955
Ensembl chr 1:191,065,875...191,080,878 		JBrowse link
G Kif26b kinesin family member 26B decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of KIF26B mRNA CTD PMID:26377693 NCBI chr13:92,815,427...93,221,071
Ensembl chr13:92,815,427...93,215,453 		JBrowse link
G Kifc1 kinesin family member C1 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of KIFC1 mRNA CTD PMID:26377693 NCBI chr20:5,000,929...5,018,967
Ensembl chr20:5,000,648...5,018,988 		JBrowse link
G Kit KIT proto-oncogene receptor tyrosine kinase decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of KIT mRNA CTD PMID:26377693 NCBI chr14:32,901,615...32,978,895
Ensembl chr14:32,903,033...32,978,812 		JBrowse link
G Klf13 KLF transcription factor 13 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of KLF13 mRNA CTD PMID:26377693 NCBI chr 1:126,917,671...126,948,436
Ensembl chr 1:126,916,781...126,961,056 		JBrowse link
G Klhl5 kelch-like family member 5 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of KLHL5 mRNA CTD PMID:26377693 NCBI chr14:43,497,915...43,565,833
Ensembl chr14:43,497,918...43,537,894 		JBrowse link
G Klk8 kallikrein related-peptidase 8 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of KLK8 mRNA CTD PMID:26377693 NCBI chr 1:103,388,352...103,395,195
Ensembl chr 1:103,388,352...103,395,195 		JBrowse link
G Knstrn kinetochore-localized astrin/SPAG5 binding protein affects expression ISO 1,2,5,6-dibenzanthracene affects the expression of KNSTRN mRNA CTD PMID:26377693 NCBI chr 3:126,254,633...126,274,412
Ensembl chr 3:126,254,663...126,274,418 		JBrowse link
G Krt8 keratin 8 decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of KRT8 mRNA CTD PMID:26377693 NCBI chr 7:135,002,886...135,010,339
Ensembl chr 7:135,002,894...135,010,403 		JBrowse link
G Lag3 lymphocyte activating 3 decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of LAG3 mRNA CTD PMID:26377693 NCBI chr 4:159,398,930...159,407,001
Ensembl chr 4:159,398,932...159,406,669 		JBrowse link
G Lama1 laminin subunit alpha 1 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of LAMA1 mRNA CTD PMID:26377693 NCBI chr 9:115,139,548...115,263,620
Ensembl chr 9:115,139,548...115,264,251 		JBrowse link
G Lama2 laminin subunit alpha 2 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of LAMA2 mRNA CTD PMID:26377693 NCBI chr 1:19,492,126...20,140,056
Ensembl chr 1:19,244,599...20,140,056 		JBrowse link
G Lama4 laminin subunit alpha 4 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of LAMA4 mRNA CTD PMID:26377693 NCBI chr20:43,946,898...44,087,972
Ensembl chr20:43,946,898...44,087,972 		JBrowse link
G Lbp lipopolysaccharide binding protein multiple interactions EXP [1,2,5,6-dibenzanthracene co-treated with dibenzo(a,l)pyrene] affects the expression of LBP mRNA; [1,2,5,6-dibenzanthracene co-treated with fluoranthene] affects the expression of LBP mRNA; [Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of LBP mRNA CTD PMID:18711122 NCBI chr 3:167,373,786...167,400,941
Ensembl chr 3:167,373,924...167,401,518 		JBrowse link
G Lefty1 left right determination factor 1 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of LEFTY1 mRNA CTD PMID:26377693 NCBI chr13:95,188,091...95,191,488
Ensembl chr13:95,188,091...95,191,488 		JBrowse link
G Lepr leptin receptor increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of LEPR mRNA CTD PMID:26377693 NCBI chr 5:121,409,735...121,593,201
Ensembl chr 5:121,474,099...121,591,215 		JBrowse link
G Lgals1 galectin 1 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of LGALS1 mRNA CTD PMID:22579512 NCBI chr 7:112,365,695...112,368,801
Ensembl chr 7:112,361,850...112,368,800 		JBrowse link
G Lgals3 galectin 3 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of LGALS3 mRNA CTD PMID:16269432 NCBI chr15:23,099,795...23,111,731
Ensembl chr15:23,086,841...23,111,737 		JBrowse link
G Lgals9 galectin 9 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of LGALS9 mRNA CTD PMID:26377693 NCBI chr10:64,405,044...64,428,249
Ensembl chr10:64,405,044...64,428,070 		JBrowse link
G Lgalsl galectin-like decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of LGALSL mRNA CTD PMID:26377693 NCBI chr14:99,198,340...99,205,846
Ensembl chr14:99,198,339...99,206,487 		JBrowse link
G Lgi2 leucine-rich repeat LGI family, member 2 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of LGI2 mRNA CTD PMID:26377693 NCBI chr14:62,628,746...62,656,231
Ensembl chr14:62,596,150...62,656,188 		JBrowse link
G Lifr LIF receptor subunit alpha decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of LIFR mRNA CTD PMID:26377693 NCBI chr 2:57,951,787...58,020,357
Ensembl chr 2:57,952,975...58,020,364 		JBrowse link
G Lmo2 LIM domain only 2 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of LMO2 mRNA CTD PMID:26377693 NCBI chr 3:110,810,162...110,832,895
Ensembl chr 3:110,809,912...110,833,075 		JBrowse link
G Lnx2 ligand of numb-protein X 2 decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of LNX2 mRNA CTD PMID:26377693 NCBI chr12:13,119,139...13,184,401
Ensembl chr12:13,119,139...13,184,401 		JBrowse link
G Loxl4 lysyl oxidase-like 4 decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of LOXL4 mRNA CTD PMID:26377693 NCBI chr 1:251,345,445...251,365,640
Ensembl chr 1:251,347,238...251,365,577 		JBrowse link
G Lpin1 lipin 1 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of LPIN1 mRNA CTD PMID:26377693 NCBI chr 6:45,039,110...45,145,845
Ensembl chr 6:45,041,522...45,145,991 		JBrowse link
G Lpl lipoprotein lipase decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of LPL mRNA CTD PMID:26377693 NCBI chr16:25,596,205...25,621,928
Ensembl chr16:25,596,211...25,622,107 		JBrowse link
G Lrat lecithin retinol acyltransferase increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of LRAT mRNA CTD PMID:26377693 NCBI chr 2:170,562,148...170,571,212
Ensembl chr 2:170,565,543...170,571,148 		JBrowse link
G Lrfn3 leucine rich repeat and fibronectin type III domain containing 3 decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of LRFN3 mRNA CTD PMID:26377693 NCBI chr 1:94,744,315...94,751,001
Ensembl chr 1:94,744,321...94,751,178 		JBrowse link
G Lrrc36 leucine rich repeat containing 36 decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of LRRC36 mRNA CTD PMID:26377693 NCBI chr19:50,201,944...50,252,338
Ensembl chr19:50,201,987...50,252,338 		JBrowse link
G Lrrc75b leucine rich repeat containing 75B increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of LRRC75B mRNA CTD PMID:26377693 NCBI chr20:13,099,741...13,105,942
Ensembl chr20:13,094,809...13,109,532 		JBrowse link
G Ltb4r leukotriene B4 receptor increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of LTB4R1 mRNA CTD PMID:26377693 NCBI chr15:33,233,120...33,235,636
Ensembl chr15:33,232,820...33,235,637 		JBrowse link
G Ltbp2 latent transforming growth factor beta binding protein 2 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of LTBP2 mRNA CTD PMID:26377693 NCBI chr 6:110,161,029...110,261,586
Ensembl chr 6:110,161,029...110,257,298 		JBrowse link
G Ltc4s leukotriene C4 synthase increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of LTC4S mRNA CTD PMID:26377693 NCBI chr10:35,060,002...35,066,466
Ensembl chr10:35,061,437...35,063,768 		JBrowse link
G Lxn latexin increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of LXN mRNA CTD PMID:26377693 NCBI chr 2:154,037,604...154,043,473
Ensembl chr 2:154,037,292...154,043,488 		JBrowse link
G Ly6a lymphocyte antigen 6 family member A increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of LY6A mRNA CTD PMID:26377693 NCBI chr 7:109,064,222...109,067,757 JBrowse link
G Lysmd2 LysM domain containing 2 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of LYSMD2 mRNA CTD PMID:26377693 NCBI chr 8:85,259,443...85,274,876
Ensembl chr 8:85,259,410...85,275,241 		JBrowse link
G Lysmd3 LysM domain containing 3 decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of LYSMD3 mRNA CTD PMID:26377693 NCBI chr 2:13,669,465...13,675,622
Ensembl chr 2:13,669,429...13,678,643 		JBrowse link
G Lyve1 lymphatic vessel endothelial hyaluronan receptor 1 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of LYVE1 mRNA CTD PMID:26377693 NCBI chr 1:174,393,387...174,410,977 JBrowse link
G Mad2l1 mitotic arrest deficient 2 like 1 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of MAD2L1 mRNA CTD PMID:26377693 NCBI chr 4:97,236,419...97,247,603
Ensembl chr 4:97,236,503...97,243,222 		JBrowse link
G Mad2l2 mitotic arrest deficient 2 like 2 decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of MAD2L2 mRNA CTD PMID:26377693 NCBI chr 5:163,846,678...163,859,851
Ensembl chr 5:163,846,687...163,859,851 		JBrowse link
G Mafb MAF bZIP transcription factor B increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of MAFB mRNA CTD PMID:26377693 NCBI chr 3:169,417,890...169,419,810
Ensembl chr 3:169,416,945...169,419,975 		JBrowse link
G Maff MAF bZIP transcription factor F increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of MAFF mRNA CTD PMID:26377693 NCBI chr 7:112,792,787...112,804,139
Ensembl chr 7:112,791,416...112,804,147 		JBrowse link
G Map2k6 mitogen-activated protein kinase kinase 6 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of MAP2K6 mRNA CTD PMID:26377693 NCBI chr10:95,872,747...95,987,747
Ensembl chr10:95,872,546...95,987,721 		JBrowse link
G Map3k6 mitogen-activated protein kinase kinase kinase 6 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of MAP3K6 mRNA CTD PMID:26377693 NCBI chr 5:150,724,029...150,736,113
Ensembl chr 5:150,724,216...150,736,111 		JBrowse link
G Map4k4 mitogen-activated protein kinase kinase kinase kinase 4 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of MAP4K4 mRNA CTD PMID:26377693 NCBI chr 9:49,696,573...49,822,353
Ensembl chr 9:49,696,700...49,822,353 		JBrowse link
G Mapt microtubule-associated protein tau increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of MAPT mRNA CTD PMID:16269432 NCBI chr10:89,638,618...89,736,108
Ensembl chr10:89,638,599...89,736,108 		JBrowse link
G Marcks myristoylated alanine rich protein kinase C substrate increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of MARCKS mRNA CTD PMID:26377693 NCBI chr20:42,240,185...42,245,882
Ensembl chr20:42,240,185...42,245,882 		JBrowse link
G Marveld1 MARVEL domain containing 1 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of MARVELD1 mRNA CTD PMID:26377693 NCBI chr 1:250,903,342...250,907,393
Ensembl chr 1:250,903,342...250,907,393 		JBrowse link
G Mboat1 membrane bound O-acyltransferase domain containing 1 decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of MBOAT1 mRNA CTD PMID:26377693 NCBI chr17:34,540,032...34,653,705
Ensembl chr17:34,540,041...34,653,698 		JBrowse link
G Mboat2 membrane bound O-acyltransferase domain containing 2 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of MBOAT2 mRNA CTD PMID:26377693 NCBI chr 6:47,199,751...47,326,215
Ensembl chr 6:47,199,774...47,326,208 		JBrowse link
G Mcl1 MCL1 apoptosis regulator, BCL2 family member multiple interactions ISO [Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of MCL1 mRNA CTD PMID:17690111 NCBI chr 2:185,884,840...185,912,532
Ensembl chr 2:185,908,168...185,938,782 		JBrowse link
G Mcm2 minichromosome maintenance complex component 2 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of MCM2 mRNA CTD PMID:26377693 NCBI chr 4:122,903,679...122,918,205
Ensembl chr 4:122,903,682...122,918,094 		JBrowse link
G Mcm3 minichromosome maintenance complex component 3 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of MCM3 mRNA CTD PMID:26377693 NCBI chr 9:30,715,602...30,733,746
Ensembl chr 9:30,715,602...30,733,746 		JBrowse link
G Mcm6 minichromosome maintenance complex component 6 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of MCM6 mRNA CTD PMID:26377693 NCBI chr13:42,379,161...42,404,352
Ensembl chr13:42,379,162...42,465,467 		JBrowse link
G Mdm2 MDM2 proto-oncogene increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of MDM2 mRNA CTD PMID:26377693 NCBI chr 7:55,176,558...55,201,757
Ensembl chr 7:55,176,560...55,200,791 		JBrowse link
G Me1 malic enzyme 1 multiple interactions EXP [Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of ME1 mRNA CTD PMID:18711122 NCBI chr 8:96,429,057...96,540,244
Ensembl chr 8:96,429,057...96,540,275 		JBrowse link
G Me3 malic enzyme 3 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of ME3 mRNA CTD PMID:26377693 NCBI chr 1:152,946,595...153,148,026
Ensembl chr 1:152,946,628...153,148,026 		JBrowse link
G Megf6 multiple EGF-like-domains 6 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of MEGF6 mRNA CTD PMID:26377693 NCBI chr 5:170,020,699...170,121,557
Ensembl chr 5:170,020,778...170,121,554 		JBrowse link
G Mgmt O-6-methylguanine-DNA methyltransferase increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of MGMT mRNA CTD PMID:26377693 NCBI chr 1:201,140,832...201,367,481
Ensembl chr 1:201,140,661...201,367,482 		JBrowse link
G Mgp matrix Gla protein increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of MGP mRNA CTD PMID:26377693 NCBI chr 4:171,497,472...171,500,888
Ensembl chr 4:171,497,471...171,500,859 		JBrowse link
G Mki67 marker of proliferation Ki-67 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of MKI67 mRNA CTD PMID:26377693 NCBI chr 1:199,926,150...199,952,847
Ensembl chr 1:199,926,150...199,952,593 		JBrowse link
G Mknk2 MAPK interacting serine/threonine kinase 2 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of MKNK2 mRNA CTD PMID:26377693 NCBI chr 7:9,690,385...9,701,527
Ensembl chr 7:9,690,421...9,701,529 		JBrowse link
G Mlana melan-A increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of MLANA mRNA CTD PMID:26377693 NCBI chr 1:236,883,075...236,897,693
Ensembl chr 1:236,883,075...236,896,880 		JBrowse link
G Mmd2 monocyte to macrophage differentiation-associated 2 decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of MMD2 mRNA CTD PMID:26377693 NCBI chr12:17,075,870...17,123,255
Ensembl chr12:17,076,260...17,123,904 		JBrowse link
G Mmp8 matrix metallopeptidase 8 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of MMP8 mRNA CTD PMID:26377693 NCBI chr 8:13,008,873...13,018,729
Ensembl chr 8:13,008,890...13,018,729 		JBrowse link
G Mmrn2 multimerin 2 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of MMRN2 mRNA CTD PMID:26377693 NCBI chr16:9,712,181...9,733,653
Ensembl chr16:9,711,953...9,733,653 		JBrowse link
G Mnd1 meiotic nuclear divisions 1 decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of MND1 mRNA CTD PMID:26377693 NCBI chr 2:171,731,523...171,794,124
Ensembl chr 2:171,731,523...171,794,095 		JBrowse link
G Morc3 MORC family CW-type zinc finger 3 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of MORC3 mRNA CTD PMID:26377693 NCBI chr11:46,621,575...46,664,315
Ensembl chr11:46,621,548...46,664,309 		JBrowse link
G Mpp4 MAGUK p55 scaffold protein 4 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of MPP4 mRNA CTD PMID:26377693 NCBI chr 9:68,063,867...68,103,050
Ensembl chr 9:68,063,867...68,106,128 		JBrowse link
G Mpv17l MPV17 mitochondrial inner membrane protein like increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of MPV17L mRNA CTD PMID:26377693 NCBI chr10:2,495,605...2,532,448
Ensembl chr10:2,495,607...2,532,448 		JBrowse link
G Mpzl1 myelin protein zero-like 1 decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of MPZL1 mRNA CTD PMID:26377693 NCBI chr13:80,385,454...80,422,315
Ensembl chr13:80,385,456...80,422,390 		JBrowse link
G Mrgpre MAS related GPR family member E decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of MRGPRE mRNA CTD PMID:26377693 NCBI chr 1:208,393,141...208,401,252
Ensembl chr 1:208,392,642...208,399,408 		JBrowse link
G Mrln myoregulin decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of MRLN mRNA CTD PMID:26377693 NCBI chr20:18,405,858...18,422,874
Ensembl chr20:18,405,858...18,420,878 		JBrowse link
G Msh3 mutS homolog 3 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of MSH3 mRNA CTD PMID:26377693 NCBI chr 2:25,179,400...25,320,857
Ensembl chr 2:25,179,400...25,321,102 		JBrowse link
G Msi2 musashi RNA-binding protein 2 decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of MSI2 mRNA CTD PMID:26377693 NCBI chr10:73,640,960...74,007,497
Ensembl chr10:73,646,139...74,007,552 		JBrowse link
G Msr1 macrophage scavenger receptor 1 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of MSR1 mRNA CTD PMID:26377693 NCBI chr16:59,421,250...59,507,070
Ensembl chr16:59,421,057...59,507,070 		JBrowse link
G Mt1-ps3 metallothionein 1, pseudogene 3 multiple interactions ISO [Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of MT1E mRNA CTD PMID:17690111 NCBI chr17:79,695,812...79,696,200
Ensembl chr17:79,695,809...79,696,200 		JBrowse link
G Mthfr methylenetetrahydrofolate reductase decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of MTHFR mRNA CTD PMID:26377693 NCBI chr 5:163,748,346...163,768,141
Ensembl chr 5:163,748,321...163,768,105 		JBrowse link
G Mtmr10 myotubularin related protein 10 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of MTMR10 mRNA CTD PMID:26377693 NCBI chr 1:127,271,139...127,322,621
Ensembl chr 1:127,270,870...127,322,621 		JBrowse link
G Mtnr1a melatonin receptor 1A decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of MTNR1A mRNA CTD PMID:26377693 NCBI chr16:53,876,964...53,896,421
Ensembl chr16:53,876,964...53,896,421 		JBrowse link
G Mtss1 MTSS I-BAR domain containing 1 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of MTSS1 mRNA CTD PMID:26377693 NCBI chr 7:92,378,228...92,517,444
Ensembl chr 7:92,378,238...92,517,303 		JBrowse link
G Mustn1 musculoskeletal, embryonic nuclear protein 1 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of MUSTN1 mRNA CTD PMID:26377693 NCBI chr16:6,079,355...6,081,608
Ensembl chr16:6,079,277...6,081,586 		JBrowse link
G Mycn MYCN proto-oncogene, bHLH transcription factor increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of MYCN mRNA CTD PMID:26377693 NCBI chr 6:41,446,683...41,452,584
Ensembl chr 6:41,446,684...41,452,508 		JBrowse link
G Nampt nicotinamide phosphoribosyltransferase increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of NAMPT mRNA CTD PMID:26377693 NCBI chr 6:55,152,756...55,189,547
Ensembl chr 6:55,151,926...55,189,544 		JBrowse link
G Narf nuclear prelamin A recognition factor increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of NARF mRNA CTD PMID:26377693 NCBI chr10:107,017,344...107,035,777
Ensembl chr10:107,016,510...107,037,283 		JBrowse link
G Nat8f5 N-acetyltransferase 8 (GCN5-related) family member 5 decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of NAT8F5 mRNA CTD PMID:26377693 NCBI chr 4:119,817,788...119,842,503
Ensembl chr 4:119,816,735...119,863,953 		JBrowse link
G Ncapd2 non-SMC condensin I complex, subunit D2 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of NCAPD2 mRNA CTD PMID:26377693 NCBI chr 4:159,655,051...159,677,938
Ensembl chr 4:159,655,051...159,677,938 		JBrowse link
G Ncaph non-SMC condensin I complex, subunit H increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of NCAPH mRNA CTD PMID:26377693 NCBI chr 3:134,825,271...134,852,502
Ensembl chr 3:134,825,271...134,852,502 		JBrowse link
G Nceh1 neutral cholesterol ester hydrolase 1 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of NCEH1 mRNA CTD PMID:26377693 NCBI chr 2:112,003,677...112,064,274
Ensembl chr 2:112,003,502...112,064,272 		JBrowse link
G Ndc80 NDC80 kinetochore complex component decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of NDC80 mRNA CTD PMID:22579512 NCBI chr 9:118,853,806...118,887,582
Ensembl chr 9:118,853,806...118,887,568 		JBrowse link
G Ndrg1 N-myc downstream regulated 1 decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of NDRG1 mRNA CTD PMID:26377693 NCBI chr 7:100,573,526...100,614,902
Ensembl chr 7:100,573,523...100,614,913 		JBrowse link
G Neat1 nuclear paraspeckle assembly transcript 1 decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of NEAT1 mRNA CTD PMID:26377693 NCBI chr 1:212,507,512...212,568,055 JBrowse link
G Nectin3 nectin cell adhesion molecule 3 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of NECTIN3 mRNA CTD PMID:26377693 NCBI chr11:67,825,296...67,931,999
Ensembl chr11:67,827,137...67,871,383 		JBrowse link
G Nes nestin increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of NES mRNA CTD PMID:26377693 NCBI chr 2:175,735,715...175,745,631
Ensembl chr 2:175,736,551...175,746,228 		JBrowse link
G Net1 neuroepithelial cell transforming 1 decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of NET1 mRNA CTD PMID:26377693 NCBI chr17:71,251,145...71,280,345
Ensembl chr17:71,251,149...71,289,270 		JBrowse link
G Nfil3 nuclear factor, interleukin 3 regulated decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of NFIL3 mRNA CTD PMID:26377693 NCBI chr17:12,432,376...12,447,605
Ensembl chr17:12,432,198...12,450,826 		JBrowse link
G Nfkbia NFKB inhibitor alpha increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of NFKBIA mRNA CTD PMID:16269432 NCBI chr 6:78,593,844...78,597,307
Ensembl chr 6:78,593,847...78,597,072 		JBrowse link
G Ngef neuronal guanine nucleotide exchange factor increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of NGEF mRNA CTD PMID:26377693 NCBI chr 9:95,594,823...95,692,381
Ensembl chr 9:95,594,823...95,692,251 		JBrowse link
G Ngfr nerve growth factor receptor decreases expression
increases expression 		ISO 1,2,5,6-dibenzanthracene results in decreased expression of NGFR mRNA
1,2,5,6-dibenzanthracene results in increased expression of TNFRSF10B mRNA 		CTD PMID:16269432 PMID:26377693 NCBI chr10:81,012,077...81,030,305
Ensembl chr10:81,012,089...81,030,305 		JBrowse link
G Nhlrc2 NHL repeat containing 2 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of NHLRC2 mRNA CTD PMID:26377693 NCBI chr 1:265,594,915...265,655,647
Ensembl chr 1:265,594,915...265,676,143 		JBrowse link
G Nkd1 NKD inhibitor of WNT signaling pathway 1 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of NKD1 mRNA CTD PMID:26377693 NCBI chr19:34,649,803...34,722,846 JBrowse link
G Nmrk1 nicotinamide riboside kinase 1 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of NMRK1 mRNA CTD PMID:26377693 NCBI chr 1:225,475,975...225,503,414
Ensembl chr 1:225,475,830...225,503,602 		JBrowse link
G Nos3 nitric oxide synthase 3 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of NOS3 mRNA CTD PMID:26377693 NCBI chr 4:11,686,088...11,706,604
Ensembl chr 4:11,686,268...11,706,664 		JBrowse link
G Nox4 NADPH oxidase 4 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of NOX4 mRNA CTD PMID:26377693 NCBI chr 1:150,313,736...150,491,480
Ensembl chr 1:150,313,728...150,491,483 		JBrowse link
G Npy1r neuropeptide Y receptor Y1 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of NPY1R mRNA CTD PMID:26377693 NCBI chr16:27,804,416...27,814,070
Ensembl chr16:27,804,416...27,813,387 		JBrowse link
G Nqo1 NAD(P)H quinone dehydrogenase 1 increases expression
multiple interactions 		ISO
EXP 		1,2,5,6-dibenzanthracene results in increased expression of NQO1 mRNA
[1,2,5,6-dibenzanthracene co-treated with dibenzo(a,l)pyrene] affects the expression of NQO1 mRNA; [1,2,5,6-dibenzanthracene co-treated with fluoranthene] affects the expression of NQO1 mRNA; [Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of NQO1 mRNA 		CTD PMID:17253728 PMID:18711122 NCBI chr19:52,205,374...52,220,267
Ensembl chr19:52,205,314...52,220,260 		JBrowse link
G Nr1d2 nuclear receptor subfamily 1, group D, member 2 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of NR1D2 mRNA CTD PMID:26377693 NCBI chr15:9,955,034...9,981,329
Ensembl chr15:9,954,906...9,981,330 		JBrowse link
G Nr5a2 nuclear receptor subfamily 5, group A, member 2 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of NR5A2 mRNA CTD PMID:26377693 NCBI chr13:50,865,253...50,985,107
Ensembl chr13:50,867,920...50,984,938 		JBrowse link
G Nrarp Notch-regulated ankyrin repeat protein increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of NRARP mRNA CTD PMID:26377693 NCBI chr 3:28,390,745...28,393,299
Ensembl chr 3:28,390,733...28,393,453 		JBrowse link
G Nrep neuronal regeneration related protein increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of NREP mRNA CTD PMID:26377693 NCBI chr18:25,291,219...25,320,742
Ensembl chr18:25,291,219...25,320,742 		JBrowse link
G Nrg4 neuregulin 4 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of NRG4 mRNA CTD PMID:26377693 NCBI chr 8:64,483,559...64,555,671
Ensembl chr 8:64,488,722...64,573,439 		JBrowse link
G Nrxn1 neurexin 1 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of NRXN1 mRNA CTD PMID:26377693 NCBI chr 6:8,931,360...10,077,381
Ensembl chr 6:8,935,523...10,077,374 		JBrowse link
G Nsl1 NSL1 component of MIS12 kinetochore complex increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of NSL1 mRNA CTD PMID:26377693 NCBI chr13:105,176,163...105,205,179
Ensembl chr13:105,180,183...105,196,117 		JBrowse link
G Nuak2 NUAK family kinase 2 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of NUAK2 mRNA CTD PMID:26377693 NCBI chr13:46,305,744...46,322,755
Ensembl chr13:46,305,975...46,322,748 		JBrowse link
G Nup58 nucleoporin 58 multiple interactions EXP [1,2,5,6-dibenzanthracene co-treated with dibenzo(a,l)pyrene] affects the expression of NUP58 mRNA; [1,2,5,6-dibenzanthracene co-treated with fluoranthene] affects the expression of NUP58 mRNA; [Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of NUP58 mRNA CTD PMID:18711122 NCBI chr15:38,534,340...38,583,959
Ensembl chr15:38,533,614...38,583,178 		JBrowse link
G Nupr1 nuclear protein 1, transcriptional regulator multiple interactions EXP [1,2,5,6-dibenzanthracene co-treated with dibenzo(a,l)pyrene] affects the expression of NUPR1 mRNA; [1,2,5,6-dibenzanthracene co-treated with fluoranthene] affects the expression of NUPR1 mRNA; [Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of NUPR1 mRNA CTD PMID:18711122 NCBI chr 1:190,643,866...190,645,901
Ensembl chr 1:190,643,867...190,645,901 		JBrowse link
G Nusap1 nucleolar and spindle associated protein 1 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of NUSAP1 mRNA CTD PMID:26377693 NCBI chr 3:127,057,220...127,092,779
Ensembl chr 3:127,057,265...127,087,237 		JBrowse link
G Odc1 ornithine decarboxylase 1 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of ODC1 mRNA CTD PMID:26377693 NCBI chr 6:46,058,439...46,065,148
Ensembl chr 6:46,058,463...46,065,146 		JBrowse link
G Olfml1 olfactomedin-like 1 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of OLFML1 mRNA CTD PMID:26377693 NCBI chr 1:170,889,912...170,914,300
Ensembl chr 1:170,889,980...170,915,762 		JBrowse link
G Onecut1 one cut homeobox 1 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of ONECUT1 mRNA CTD PMID:26377693 NCBI chr 8:84,480,066...84,507,848
Ensembl chr 8:84,480,305...84,508,124 		JBrowse link
G Osbpl5 oxysterol binding protein-like 5 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of OSBPL5 mRNA CTD PMID:26377693 NCBI chr 1:208,291,441...208,362,086
Ensembl chr 1:208,291,441...208,362,169 		JBrowse link
G Otop1 otopetrin 1 decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of OTOP1 mRNA CTD PMID:26377693 NCBI chr14:76,717,330...76,744,785
Ensembl chr14:76,716,329...76,744,785 		JBrowse link
G P2rx7 purinergic receptor P2X 7 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of P2RX7 mRNA CTD PMID:26377693 NCBI chr12:39,550,531...39,594,984
Ensembl chr12:39,540,567...39,595,193 		JBrowse link
G P2ry1 purinergic receptor P2Y1 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of P2RY1 mRNA CTD PMID:26377693 NCBI chr 2:147,391,661...147,397,870
Ensembl chr 2:147,390,681...147,398,027 		JBrowse link
G P2ry2 purinergic receptor P2Y2 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of P2RY2 mRNA CTD PMID:26377693 NCBI chr 1:164,764,119...164,779,578
Ensembl chr 1:164,759,213...164,781,852 		JBrowse link
G Pah phenylalanine hydroxylase decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of PAH mRNA CTD PMID:22579512 NCBI chr 7:23,793,096...23,885,631
Ensembl chr 7:23,792,781...23,885,627 		JBrowse link
G Pak3 p21 (RAC1) activated kinase 3 decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of PAK3 mRNA CTD PMID:26377693 NCBI chr  X:111,912,967...112,171,037
Ensembl chr  X:111,913,059...112,165,035 		JBrowse link
G Palmd palmdelphin increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of PALMD mRNA CTD PMID:26377693 NCBI chr 2:207,574,413...207,626,239
Ensembl chr 2:207,574,249...207,626,239 		JBrowse link
G Pbk PDZ binding kinase increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of PBK mRNA CTD PMID:26377693 NCBI chr15:44,198,506...44,209,572
Ensembl chr15:44,198,544...44,209,570 		JBrowse link
G Pcdh17 protocadherin 17 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of PCDH17 mRNA CTD PMID:26377693 NCBI chr15:66,631,549...66,725,007
Ensembl chr15:66,633,142...66,722,105 		JBrowse link
G Pcdhac2 protocadherin alpha subfamily C, 2 decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of PCDHAC2 mRNA CTD PMID:26377693 Ensembl chr18:28,855,256...29,120,227 JBrowse link
G Pcdhb1 protocadherin beta 1 decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of PCDHB1 mRNA CTD PMID:26377693 NCBI chr18:29,187,848...29,190,759
Ensembl chr18:29,187,848...29,190,759 		JBrowse link
G Pcdhb15 protocadherin beta 15 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of PCDHB7 mRNA CTD PMID:26377693 NCBI chr18:29,454,334...29,457,872 JBrowse link
G Pcna proliferating cell nuclear antigen increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of PCNA mRNA CTD PMID:16269432 NCBI chr 3:139,951,948...139,955,820
Ensembl chr 3:139,951,941...139,955,901 		JBrowse link
G Pcp4l1 Purkinje cell protein 4-like 1 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of PCP4L1 mRNA CTD PMID:26377693 NCBI chr13:86,121,463...86,145,097
Ensembl chr13:86,121,464...86,144,899 		JBrowse link
G Pcsk4 proprotein convertase subtilisin/kexin type 4 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of PCSK4 mRNA CTD PMID:26377693 NCBI chr 7:10,032,040...10,040,263
Ensembl chr 7:10,031,988...10,040,255 		JBrowse link
G Pdcd6ip programmed cell death 6 interacting protein increases expression EXP 1,2,5,6-dibenzanthracene results in increased expression of PDCD6IP protein CTD PMID:31368503 NCBI chr 8:122,469,223...122,524,993
Ensembl chr 8:122,469,223...122,524,993 		JBrowse link
G Pde8b phosphodiesterase 8B decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of PDE8B mRNA CTD PMID:26377693 NCBI chr 2:28,009,841...28,244,050
Ensembl chr 2:28,011,359...28,244,327 		JBrowse link
G Pde9a phosphodiesterase 9A increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of PDE9A mRNA CTD PMID:26377693 NCBI chr20:9,471,136...9,564,286
Ensembl chr20:9,471,167...9,564,286 		JBrowse link
G Pdgfc platelet derived growth factor C decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of PDGFC mRNA CTD PMID:26377693 NCBI chr 2:168,613,409...168,791,575
Ensembl chr 2:168,614,353...168,791,573 		JBrowse link
G Pdgfd platelet derived growth factor D increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of PDGFD mRNA CTD PMID:26377693 NCBI chr 8:11,773,335...12,007,277
Ensembl chr 8:11,773,475...12,007,271 		JBrowse link
G Pdk4 pyruvate dehydrogenase kinase 4 decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of PDK4 mRNA CTD PMID:26377693 NCBI chr 4:34,558,327...34,568,329
Ensembl chr 4:34,556,330...34,568,381 		JBrowse link
G Pecam1 platelet and endothelial cell adhesion molecule 1 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of PECAM1 mRNA CTD PMID:26377693 NCBI chr10:92,090,263...92,152,002
Ensembl chr10:92,090,235...92,151,839 		JBrowse link
G Per1 period circadian regulator 1 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of PER1 mRNA CTD PMID:26377693 NCBI chr10:54,299,002...54,313,804
Ensembl chr10:54,302,641...54,314,211 		JBrowse link
G Per2 period circadian regulator 2 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of PER2 mRNA CTD PMID:26377693 NCBI chr 9:99,454,828...99,497,069
Ensembl chr 9:99,454,830...99,496,993 		JBrowse link
G Per3 period circadian regulator 3 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of PER3 mRNA CTD PMID:26377693 NCBI chr 5:166,740,914...166,778,243
Ensembl chr 5:166,743,050...166,777,999 		JBrowse link
G Pex26 peroxisomal biogenesis factor 26 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of PEX26 mRNA CTD PMID:26377693 NCBI chr 4:156,085,967...156,099,096
Ensembl chr 4:156,086,960...156,099,093 		JBrowse link
G Pfkfb1 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 1 multiple interactions EXP [Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of PFKFB1 mRNA CTD PMID:18711122 NCBI chr  X:22,936,038...22,989,691
Ensembl chr  X:22,937,494...22,989,704 		JBrowse link
G Pfkfb3 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of PFKFB3 mRNA CTD PMID:26377693 NCBI chr17:71,893,320...71,974,526
Ensembl chr17:71,893,416...71,975,052 		JBrowse link
G Pgpep1 pyroglutamyl-peptidase I increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of PGPEP1 mRNA CTD PMID:26377693 NCBI chr16:18,804,408...18,817,466
Ensembl chr16:18,805,009...18,817,462 		JBrowse link
G Phlda3 pleckstrin homology-like domain, family A, member 3 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of PHLDA3 mRNA CTD PMID:26377693 NCBI chr13:49,745,003...49,748,088
Ensembl chr13:49,742,591...49,749,621 		JBrowse link
G Pid1 phosphotyrosine interaction domain containing 1 decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of PID1 mRNA CTD PMID:26377693 NCBI chr 9:92,732,471...92,951,168
Ensembl chr 9:92,734,214...92,750,070 		JBrowse link
G Piezo2 piezo-type mechanosensitive ion channel component 2 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of PIEZO2 mRNA CTD PMID:26377693 NCBI chr18:58,738,734...59,115,252
Ensembl chr18:58,738,740...59,115,215 		JBrowse link
G Pik3r1 phosphoinositide-3-kinase regulatory subunit 1 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of PIK3R1 mRNA CTD PMID:26377693 NCBI chr 2:34,612,946...34,697,660
Ensembl chr 2:34,612,946...34,626,347 		JBrowse link
G Pim1 Pim-1 proto-oncogene, serine/threonine kinase increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of PIM1 mRNA CTD PMID:16269432 NCBI chr20:7,556,496...7,560,747
Ensembl chr20:7,556,113...7,561,764 		JBrowse link
G Pimreg PICALM interacting mitotic regulator increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of PIMREG mRNA CTD PMID:26377693 NCBI chr10:57,168,136...57,173,713
Ensembl chr10:57,167,797...57,173,063 		JBrowse link
G Pitpnc1 phosphatidylinositol transfer protein, cytoplasmic 1 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of PITPNC1 mRNA CTD PMID:26377693 NCBI chr10:92,663,260...92,928,616
Ensembl chr10:92,663,260...92,928,344 		JBrowse link
G Pkig cAMP-dependent protein kinase inhibitor gamma increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of PKIG mRNA CTD PMID:26377693 NCBI chr 3:172,749,871...172,817,514
Ensembl chr 3:172,749,928...172,817,519 		JBrowse link
G Pklr pyruvate kinase L/R increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of PKLR mRNA CTD PMID:26377693 NCBI chr 2:176,840,779...176,849,637
Ensembl chr 2:176,840,764...176,849,644 		JBrowse link
G Pkn3 protein kinase N3 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of PKN3 mRNA CTD PMID:26377693 NCBI chr 3:33,747,610...33,761,405
Ensembl chr 3:33,747,867...33,761,405 		JBrowse link
G Plcd4 phospholipase C, delta 4 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of PLCD4 mRNA CTD PMID:26377693 NCBI chr 9:83,564,616...83,613,742
Ensembl chr 9:83,564,606...83,606,454 		JBrowse link
G Plcg1 phospholipase C, gamma 1 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of PLCG1 mRNA CTD PMID:26377693 NCBI chr 3:169,805,299...169,836,040
Ensembl chr 3:169,804,846...169,836,050 		JBrowse link
G Pld6 phospholipase D family, member 6 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of PLD6 mRNA CTD PMID:26377693 NCBI chr10:45,078,081...45,080,732
Ensembl chr10:45,077,080...45,087,160 		JBrowse link
G Plekha7 pleckstrin homology domain containing A7 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of PLEKHA7 mRNA CTD PMID:26377693 NCBI chr 1:179,798,856...179,982,155
Ensembl chr 1:179,799,040...179,982,281 		JBrowse link
G Plekhg6 pleckstrin homology and RhoGEF domain containing G6 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of PLEKHG6 mRNA CTD PMID:26377693 NCBI chr 4:159,849,987...159,885,730
Ensembl chr 4:159,849,364...159,868,122 		JBrowse link
G Plin2 perilipin 2 decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of PLIN2 mRNA CTD PMID:26377693 NCBI chr 5:106,202,634...106,258,748
Ensembl chr 5:106,202,634...106,258,878 		JBrowse link
G Plk1 polo-like kinase 1 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of PLK1 mRNA CTD PMID:26377693 NCBI chr 1:186,147,658...186,157,637
Ensembl chr 1:186,147,658...186,157,637 		JBrowse link
G Plk2 polo-like kinase 2 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of PLK2 mRNA CTD PMID:26377693 NCBI chr 2:43,702,536...43,708,305
Ensembl chr 2:43,701,865...43,708,296 		JBrowse link
G Plk5 polo-like kinase 5 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of PLK5 mRNA CTD PMID:26377693 NCBI chr 7:9,997,453...10,006,959
Ensembl chr 7:9,997,453...10,019,340 		JBrowse link
G Plpp1 phospholipid phosphatase 1 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of PPAP2A mRNA CTD PMID:26377693 NCBI chr 2:46,172,202...46,233,632
Ensembl chr 2:46,172,197...46,234,676 		JBrowse link
G Plpp6 phospholipid phosphatase 6 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of PLPP6 mRNA CTD PMID:26377693 NCBI chr 1:236,092,642...236,095,494
Ensembl chr 1:236,090,364...236,101,554 		JBrowse link
G Pmaip1 phorbol-12-myristate-13-acetate-induced protein 1 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of PMAIP1 mRNA CTD PMID:26377693 NCBI chr18:62,255,970...62,262,384
Ensembl chr18:62,255,598...62,262,382 		JBrowse link
G Pnpla1 patatin-like phospholipase domain containing 1 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of PNPLA1 mRNA CTD PMID:26377693 NCBI chr20:6,919,689...6,953,850
Ensembl chr20:6,919,115...6,955,143 		JBrowse link
G Pnrc1 proline-rich nuclear receptor coactivator 1 decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of PNRC1 mRNA CTD PMID:26377693 NCBI chr 5:52,443,400...52,489,303
Ensembl chr 5:52,443,400...52,446,491 		JBrowse link
G Poc1a POC1 centriolar protein A decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of POC1A mRNA CTD PMID:26377693 NCBI chr 8:115,801,335...115,869,812
Ensembl chr 8:115,801,396...115,870,392 		JBrowse link
G Podxl podocalyxin-like increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of PODXL mRNA CTD PMID:26377693 NCBI chr 4:61,102,434...61,149,131
Ensembl chr 4:61,102,419...61,149,789 		JBrowse link
G Pole DNA polymerase epsilon, catalytic subunit increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of POLE mRNA CTD PMID:26377693 NCBI chr12:52,005,155...52,053,761
Ensembl chr12:52,005,155...52,053,662 		JBrowse link
G Polk DNA polymerase kappa increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of POLK mRNA CTD PMID:26377693 NCBI chr 2:29,556,831...29,616,960
Ensembl chr 2:29,557,336...29,616,960 		JBrowse link
G Por cytochrome p450 oxidoreductase increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of POR mRNA CTD PMID:26377693 NCBI chr12:26,587,674...26,655,612
Ensembl chr12:26,587,674...26,635,809 		JBrowse link
G Ppard peroxisome proliferator-activated receptor delta decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of PPARD mRNA CTD PMID:26377693 NCBI chr20:6,300,527...6,365,707
Ensembl chr20:6,352,183...6,365,707 		JBrowse link
G Ppat phosphoribosyl pyrophosphate amidotransferase increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of PPAT mRNA CTD PMID:26377693 NCBI chr14:31,570,010...31,604,410
Ensembl chr14:31,551,388...31,604,405 		JBrowse link
G Ppbp pro-platelet basic protein decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of PPBP mRNA CTD PMID:26377693 NCBI chr14:17,586,495...17,587,299
Ensembl chr14:17,586,495...17,587,299 		JBrowse link
G Ppl periplakin increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of PPL mRNA CTD PMID:26377693 NCBI chr10:10,957,388...11,003,035
Ensembl chr10:10,957,341...11,003,658 		JBrowse link
G Ppm1f protein phosphatase, Mg2+/Mn2+ dependent, 1F increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of PPM1F mRNA CTD PMID:26377693 NCBI chr11:97,568,627...97,598,613
Ensembl chr11:97,568,625...97,598,545 		JBrowse link
G Ppp1r2 protein phosphatase 1, regulatory (inhibitor) subunit 2 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of PPP1R2 mRNA CTD PMID:26377693 NCBI chr11:82,977,634...82,999,426
Ensembl chr11:82,977,515...83,001,083 		JBrowse link
G Ppp1r3c protein phosphatase 1, regulatory subunit 3C decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of PPP1R3C mRNA CTD PMID:26377693 NCBI chr 1:243,873,524...243,878,527
Ensembl chr 1:243,871,704...243,878,835 		JBrowse link
G Prc1 protein regulator of cytokinesis 1 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of PRC1 mRNA CTD PMID:26377693 NCBI chr 1:143,659,312...143,681,019
Ensembl chr 1:143,659,481...143,681,012 		JBrowse link
G Prcp prolylcarboxypeptidase increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of PRCP mRNA CTD PMID:26377693 NCBI chr 1:156,343,894...156,396,295
Ensembl chr 1:156,343,896...156,396,939 		JBrowse link
G Procr protein C receptor increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of PROCR mRNA CTD PMID:26377693 NCBI chr 3:164,714,727...164,718,994
Ensembl chr 3:164,711,636...164,718,989 		JBrowse link
G Pros1 protein S increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of PROS1 mRNA CTD PMID:26377693 NCBI chr11:13,676,310...13,757,858
Ensembl chr11:13,676,769...13,757,852 		JBrowse link
G Prr36 proline rich 36 decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of PRR36 mRNA CTD PMID:26377693 NCBI chr12:7,358,385...7,365,616
Ensembl chr12:7,358,277...7,365,614 		JBrowse link
G Prrg3 proline rich and Gla domain 3 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of PRRG3 mRNA CTD PMID:26377693 NCBI chr  X:154,711,246...154,731,359
Ensembl chr  X:154,712,625...154,722,831 		JBrowse link
G Prss23 serine protease 23 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of PRSS23 mRNA CTD PMID:26377693 NCBI chr 1:152,815,301...152,835,005
Ensembl chr 1:152,813,670...152,947,871 		JBrowse link
G Prss44 serine protease 44 decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of PRSS44 mRNA CTD PMID:26377693 NCBI chr 8:119,670,088...119,683,717
Ensembl chr 8:119,670,112...119,683,717 		JBrowse link
G Ptgis prostaglandin I2 synthase increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of PTGIS mRNA CTD PMID:26377693 NCBI chr 3:176,347,589...176,383,251
Ensembl chr 3:176,335,437...176,407,650 		JBrowse link
G Ptgr1 prostaglandin reductase 1 multiple interactions EXP [1,2,5,6-dibenzanthracene co-treated with dibenzo(a,l)pyrene] affects the expression of PTGR1 mRNA; [1,2,5,6-dibenzanthracene co-treated with fluoranthene] affects the expression of PTGR1 mRNA; [Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of PTGR1 mRNA CTD PMID:18711122 NCBI chr 5:78,579,060...78,597,671
Ensembl chr 5:78,579,057...78,597,811 		JBrowse link
G Ptp4a1 protein tyrosine phosphatase 4A1 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of PTP4A1 mRNA CTD PMID:26377693 NCBI chr 9:40,710,250...40,718,176
Ensembl chr 9:40,710,250...40,718,176 		JBrowse link
G Ptpn9 protein tyrosine phosphatase, non-receptor type 9 decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of PTPN9 mRNA CTD PMID:26377693 NCBI chr 8:66,286,771...66,368,306
Ensembl chr 8:66,287,284...66,368,294 		JBrowse link
G Ptprg protein tyrosine phosphatase, receptor type, G increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of PTPRG mRNA CTD PMID:26377693 NCBI chr15:15,298,669...15,982,581
Ensembl chr15:15,302,133...15,982,668 		JBrowse link
G Ptprr protein tyrosine phosphatase, receptor type, R increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of PTPRR mRNA CTD PMID:26377693 NCBI chr 7:53,548,611...53,815,632
Ensembl chr 7:53,548,629...53,815,629 		JBrowse link
G Ptx3 pentraxin 3 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of PTX3 mRNA CTD PMID:26377693 NCBI chr 2:152,797,563...152,803,372
Ensembl chr 2:152,781,955...152,803,372 		JBrowse link
G Pxmp4 peroxisomal membrane protein 4 decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of PXMP4 mRNA CTD PMID:26377693 NCBI chr 3:163,553,582...163,570,829
Ensembl chr 3:163,553,599...163,570,829 		JBrowse link
G Rab38 RAB38, member RAS oncogene family decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of RAB38 mRNA CTD PMID:26377693 NCBI chr 1:151,595,153...151,675,492
Ensembl chr 1:151,595,078...151,675,493 		JBrowse link
G Racgap1 Rac GTPase-activating protein 1 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of RACGAP1 mRNA CTD PMID:26377693 NCBI chr 7:132,629,789...132,659,738
Ensembl chr 7:132,620,595...132,659,738 		JBrowse link
G Rad51 RAD51 recombinase increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of RAD51 mRNA CTD PMID:26377693 NCBI chr 3:126,554,210...126,578,888
Ensembl chr 3:126,554,190...126,579,469 		JBrowse link
G Rad52 RAD52 homolog, DNA repair protein increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of RAD52 mRNA CTD PMID:16269432 NCBI chr 4:154,778,320...154,802,002
Ensembl chr 4:154,778,320...154,800,021 		JBrowse link
G Raet1e retinoic acid early transcript 1E decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of RAET1E mRNA CTD PMID:26377693 NCBI chr 1:3,474,487...3,476,431 JBrowse link
G Rai2 retinoic acid induced 2 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of RAI2 mRNA CTD PMID:26377693 NCBI chr  X:36,580,406...36,642,943
Ensembl chr  X:36,573,917...36,643,240 		JBrowse link
G Ramp3 receptor activity modifying protein 3 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of RAMP3 mRNA CTD PMID:26377693 NCBI chr14:85,741,314...85,758,813
Ensembl chr14:85,755,211...85,758,818 		JBrowse link
G Rapgef4 Rap guanine nucleotide exchange factor 4 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of RAPGEF4 mRNA CTD PMID:26377693 NCBI chr 3:77,217,024...77,509,933
Ensembl chr 3:77,217,039...77,509,978 		JBrowse link
G Rasd2 RASD family, member 2 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of RASD2 mRNA CTD PMID:26377693 NCBI chr19:13,600,028...13,610,753
Ensembl chr19:13,599,986...13,610,753 		JBrowse link
G Rasgef1b RasGEF domain family, member 1B decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of RASGEF1B mRNA CTD PMID:26377693 NCBI chr14:10,164,366...10,684,184
Ensembl chr14:10,644,521...10,697,296 		JBrowse link
G Rasgrf2 RAS protein-specific guanine nucleotide-releasing factor 2 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of RASGRF2 mRNA CTD PMID:26377693 NCBI chr 2:24,848,699...25,096,773
Ensembl chr 2:24,848,699...25,147,558 		JBrowse link
G Rasgrp3 RAS guanyl releasing protein 3 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of RASGRP3 mRNA CTD PMID:26377693 NCBI chr 6:25,647,386...25,745,952
Ensembl chr 6:25,647,386...25,710,591 		JBrowse link
G Rbm47 RNA binding motif protein 47 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of RBM47 mRNA CTD PMID:26377693 NCBI chr14:42,407,226...42,545,304
Ensembl chr14:42,466,335...42,543,163 		JBrowse link
G Rcan1 regulator of calcineurin 1 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of RCAN1 mRNA CTD PMID:26377693 NCBI chr11:45,108,123...45,188,065
Ensembl chr11:45,108,124...45,118,236 		JBrowse link
G Rcsd1 RCSD domain containing 1 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of RCSD1 mRNA CTD PMID:26377693 NCBI chr13:80,434,878...80,497,312
Ensembl chr13:80,434,878...80,498,931 		JBrowse link
G Recql RecQ like helicase increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of RECQL mRNA CTD PMID:16269432 NCBI chr 4:177,039,351...177,063,968
Ensembl chr 4:177,035,128...177,063,838 		JBrowse link
G Reep1 receptor accessory protein 1 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of REEP1 mRNA CTD PMID:26377693 NCBI chr 4:105,303,974...105,420,611
Ensembl chr 4:105,303,969...105,420,602 		JBrowse link
G Rflnb refilin B increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of RFLNB mRNA CTD PMID:26377693 NCBI chr10:61,391,947...61,398,224
Ensembl chr10:61,390,659...61,398,224 		JBrowse link
G Rgcc regulator of cell cycle increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of RGCC mRNA CTD PMID:26377693 NCBI chr15:61,071,574...61,084,408
Ensembl chr15:61,071,574...61,084,408 		JBrowse link
G Rgs12 regulator of G-protein signaling 12 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of RGS12 mRNA CTD PMID:26377693 NCBI chr14:79,940,561...80,048,637
Ensembl chr14:79,940,565...80,034,859 		JBrowse link
G Rgs3 regulator of G-protein signaling 3 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of RGS3 mRNA CTD PMID:26377693 NCBI chr 5:81,037,588...81,177,446
Ensembl chr 5:81,056,068...81,177,445 		JBrowse link
G Rgs5 regulator of G-protein signaling 5 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of RGS5 mRNA CTD PMID:26377693 NCBI chr13:84,381,077...84,417,875
Ensembl chr13:84,380,910...84,421,352 		JBrowse link
G Rhob ras homolog family member B increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of RHOB mRNA CTD PMID:26377693 NCBI chr 6:37,083,030...37,085,204
Ensembl chr 6:37,075,015...37,112,772 		JBrowse link
G Rhoc ras homolog family member C increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of RHOC mRNA CTD PMID:22579512 PMID:26377693 NCBI chr 2:194,975,586...194,981,637
Ensembl chr 2:194,975,242...194,983,745 		JBrowse link
G Rhou ras homolog family member U decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of RHOU mRNA CTD PMID:26377693 NCBI chr19:68,538,960...68,548,733
Ensembl chr19:68,538,960...68,548,733 		JBrowse link
G Rnase2 ribonuclease A family member 2 decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of RNASE2A mRNA CTD PMID:26377693 NCBI chr15:26,923,125...26,923,934
Ensembl chr15:26,923,134...26,923,955 		JBrowse link
G Rnaseh2b ribonuclease H2, subunit B increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of RNASEH2B mRNA CTD PMID:26377693 NCBI chr15:40,717,252...40,770,826
Ensembl chr15:40,717,232...40,770,825 		JBrowse link
G Rnd1 Rho family GTPase 1 decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of RND1 mRNA CTD PMID:26377693 NCBI chr 7:131,700,321...131,707,392
Ensembl chr 7:131,700,321...131,707,392 		JBrowse link
G Rnf125 ring finger protein 125 decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of RNF125 mRNA CTD PMID:26377693 NCBI chr18:12,528,995...12,550,646
Ensembl chr18:12,528,838...12,554,430 		JBrowse link
G Rnf128 ring finger protein 128 decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of RNF128 mRNA CTD PMID:26377693 NCBI chr  X:107,968,973...108,087,037
Ensembl chr  X:107,972,348...108,087,288 		JBrowse link
G Rnf144a ring finger protein 144A decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of RNF144A mRNA CTD PMID:26377693 NCBI chr 6:48,628,241...48,748,241
Ensembl chr 6:48,631,648...48,748,179 		JBrowse link
G Rnf167 ring finger protein 167 decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of RNF167 mRNA CTD PMID:26377693 NCBI chr10:55,859,254...55,863,546
Ensembl chr10:55,859,297...55,863,905 		JBrowse link
G Rnf169 ring finger protein 169 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of RNF169 mRNA CTD PMID:26377693 NCBI chr 1:163,662,582...163,724,154
Ensembl chr 1:163,666,592...163,723,897 		JBrowse link
G Rnf186 ring finger protein 186 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of RNF186 mRNA CTD PMID:26377693 NCBI chr 5:156,493,750...156,494,974
Ensembl chr 5:156,493,752...156,494,978 		JBrowse link
G Robo2 roundabout guidance receptor 2 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of ROBO2 mRNA CTD PMID:26377693 NCBI chr11:26,015,919...27,583,750
Ensembl chr11:26,015,919...26,876,185 		JBrowse link
G Rpl39l1 ribosomal protein L39 like 1 decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of RPL39L mRNA CTD PMID:26377693 NCBI chr10:5,962,506...5,966,621
Ensembl chr10:5,962,515...5,966,621 		JBrowse link
G Rps27l ribosomal protein S27-like increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of RPS27L mRNA CTD PMID:26377693 NCBI chr 8:76,443,658...76,448,593
Ensembl chr12:33,713,661...33,714,130
Ensembl chr 8:33,713,661...33,714,130 		JBrowse link
G Rrad RRAD, Ras related glycolysis inhibitor and calcium channel regulator multiple interactions EXP [1,2,5,6-dibenzanthracene co-treated with dibenzo(a,l)pyrene] affects the expression of RRAD mRNA; [1,2,5,6-dibenzanthracene co-treated with fluoranthene] affects the expression of RRAD mRNA; [Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of RRAD mRNA CTD PMID:18711122 NCBI chr19:360,581...363,874
Ensembl chr19:360,973...363,871 		JBrowse link
G Rrm1 ribonucleotide reductase catalytic subunit M1 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of RRM1 mRNA CTD PMID:26377693 NCBI chr 1:166,235,904...166,260,206
Ensembl chr 1:166,235,900...166,260,944 		JBrowse link
G Rrm2 ribonucleotide reductase regulatory subunit M2 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of RRM2 mRNA CTD PMID:26377693 NCBI chr 6:47,044,755...47,075,370
Ensembl chr 6:47,067,690...47,075,370 		JBrowse link
G Rrn3 RRN3 homolog, RNA polymerase I transcription factor increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of RRN3 mRNA CTD PMID:26377693 NCBI chr10:2,637,016...2,672,338
Ensembl chr10:2,637,016...2,672,330 		JBrowse link
G Rsrp1 arginine and serine rich protein 1 decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of RSRP1 mRNA CTD PMID:26377693 NCBI chr 5:152,431,448...152,435,202
Ensembl chr 5:152,431,478...152,435,126 		JBrowse link
G Rtl6 retrotransposon Gag like 6 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of RTL6 mRNA CTD PMID:26377693 NCBI chr 7:117,564,780...117,569,865
Ensembl chr 7:117,563,239...117,570,129 		JBrowse link
G Rtl8a retrotransposon Gag like 8A increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of RTL8A mRNA; 1,2,5,6-dibenzanthracene results in increased expression of RTL8C mRNA CTD PMID:26377693 NCBI chr  X:138,436,824...138,438,037
Ensembl chr  X:138,436,605...138,470,972 		JBrowse link
G Rufy3 RUN and FYVE domain containing 3 decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of RUFY3 mRNA CTD PMID:26377693 NCBI chr14:19,715,593...19,790,530
Ensembl chr14:19,715,593...19,790,608 		JBrowse link
G S100a10 S100 calcium binding protein A10 decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of S100A10 mRNA CTD PMID:26377693 NCBI chr 2:181,904,454...181,913,101
Ensembl chr 2:181,904,261...181,913,103 		JBrowse link
G S100a14 S100 calcium binding protein A14 decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of S100A14 mRNA CTD PMID:26377693 NCBI chr 2:178,305,976...178,308,004
Ensembl chr 2:178,306,025...178,307,999 		JBrowse link
G Sac3d1 SAC3 domain containing 1 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of SAC3D1 mRNA CTD PMID:26377693 NCBI chr 1:212,843,463...212,845,842
Ensembl chr 1:212,843,463...212,845,883 		JBrowse link
G Samd5 sterile alpha motif domain containing 5 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of SAMD5 mRNA CTD PMID:26377693 NCBI chr 1:5,861,793...5,911,153
Ensembl chr 1:5,497,567...5,911,064 		JBrowse link
G Sat1 spermidine/spermine N1-acetyl transferase 1 multiple interactions ISO [Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of SAT1 mRNA CTD PMID:17690111 NCBI chr  X:44,008,089...44,011,376
Ensembl chr  X:44,006,781...44,011,374 		JBrowse link
G Scd stearoyl-CoA desaturase multiple interactions ISO [Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of SCD mRNA CTD PMID:17690111 NCBI chr 1:253,218,968...253,232,101
Ensembl chr 1:253,218,970...253,231,785 		JBrowse link
G Scgb3a1 secretoglobin, family 3A, member 1 decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of SCGB3A1 mRNA CTD PMID:26377693 NCBI chr10:34,469,166...34,470,473
Ensembl chr10:34,468,002...34,470,583 		JBrowse link
G Scn1b sodium voltage-gated channel beta subunit 1 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of SCN1B mRNA CTD PMID:26377693 NCBI chr 1:95,481,298...95,491,211
Ensembl chr 1:95,481,298...95,491,197 		JBrowse link
G Scn3b sodium voltage-gated channel beta subunit 3 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of SCN3B mRNA CTD PMID:26377693 NCBI chr 8:49,527,529...49,550,019
Ensembl chr 8:49,527,577...49,550,018 		JBrowse link
G Scube3 signal peptide, CUB domain and EGF like domain containing 3 decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of SCUBE3 mRNA CTD PMID:26377693 NCBI chr20:6,200,891...6,232,848
Ensembl chr20:6,200,178...6,233,051 		JBrowse link
G Selenoi selenoprotein I decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of SELENOI mRNA CTD PMID:26377693 NCBI chr 6:31,792,972...31,831,170
Ensembl chr 6:31,792,973...31,831,523 		JBrowse link
G Sema3c semaphorin 3C increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of SEMA3C mRNA CTD PMID:26377693 NCBI chr 4:18,538,452...18,702,453
Ensembl chr 4:18,538,454...18,701,740 		JBrowse link
G Sema3g semaphorin 3G decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of SEMA3G mRNA CTD PMID:26377693 NCBI chr16:6,420,025...6,431,655
Ensembl chr16:6,420,012...6,432,553 		JBrowse link
G Serp2 stress-associated endoplasmic reticulum protein family member 2 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of SERP2 mRNA CTD PMID:26377693 NCBI chr15:58,289,148...58,313,224
Ensembl chr15:58,289,148...58,313,430 		JBrowse link
G Serpina3n serpin family A member 3N multiple interactions ISO [Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of SERPINA3 mRNA CTD PMID:17690111 NCBI chr 6:129,088,392...129,095,950
Ensembl chr 6:129,088,398...129,097,415 		JBrowse link
G Serpinb1a serpin family B member 1A increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of SERPINB1A mRNA CTD PMID:26377693 NCBI chr17:31,799,446...31,807,853
Ensembl chr17:31,799,415...31,808,166 		JBrowse link
G Serpind1 serpin family D member 1 multiple interactions EXP [1,2,5,6-dibenzanthracene co-treated with dibenzo(a,l)pyrene] affects the expression of SERPIND1 mRNA; [1,2,5,6-dibenzanthracene co-treated with fluoranthene] affects the expression of SERPIND1 mRNA; [Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of SERPIND1 mRNA CTD PMID:18711122 NCBI chr11:97,168,753...97,179,830
Ensembl chr11:97,168,754...97,179,755 		JBrowse link
G Serpine1 serpin family E member 1 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of SERPINE1 mRNA CTD PMID:26377693 NCBI chr12:25,237,977...25,248,356
Ensembl chr12:25,237,952...25,248,357 		JBrowse link
G Serpine2 serpin family E member 2 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of SERPINE2 mRNA CTD PMID:26377693 NCBI chr 9:88,573,138...88,637,252
Ensembl chr 9:88,573,149...88,637,202 		JBrowse link
G Sesn2 sestrin 2 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of SESN2 mRNA CTD PMID:26377693 NCBI chr 5:149,986,304...150,005,255
Ensembl chr 5:149,986,317...150,005,255 		JBrowse link
G Sgo1 shugoshin 1 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of SGO1 mRNA CTD PMID:26377693 NCBI chr 9:6,908,661...6,943,483
Ensembl chr 9:6,908,661...6,924,415 		JBrowse link
G Sh3gl3 SH3 domain containing GRB2 like 3, endophilin A3 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of SH3GL3 mRNA CTD PMID:26377693 NCBI chr 1:145,533,728...145,664,881
Ensembl chr 1:145,533,728...145,664,881 		JBrowse link
G Shcbp1 SHC binding and spindle associated 1 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of SHCBP1 mRNA CTD PMID:26377693 NCBI chr16:91,373,843...91,405,409
Ensembl chr16:91,373,871...91,405,409 		JBrowse link
G Siah2 siah E3 ubiquitin protein ligase 2 decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of SIAH2 mRNA CTD PMID:26377693 NCBI chr 2:145,063,847...145,081,675
Ensembl chr 2:145,063,857...145,081,873 		JBrowse link
G Six1 SIX homeobox 1 decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of SIX1 mRNA CTD PMID:26377693 NCBI chr 6:97,482,617...97,487,853
Ensembl chr 6:97,482,617...97,487,853 		JBrowse link
G Ska1 spindle and kinetochore associated complex subunit 1 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of SKA1 mRNA CTD PMID:26377693 NCBI chr18:70,069,957...70,080,303
Ensembl chr18:70,069,957...70,080,398 		JBrowse link
G Slc10a2 solute carrier family 10 member 2 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of SLC10A2 mRNA CTD PMID:26377693 NCBI chr16:91,088,089...91,111,025
Ensembl chr16:91,076,423...91,111,025 		JBrowse link
G Slc13a2 solute carrier family 13 member 2 decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of SLC13A2 mRNA CTD PMID:26377693 NCBI chr10:63,789,874...63,817,441
Ensembl chr10:63,789,876...63,817,184 		JBrowse link
G Slc13a4 solute carrier family 13 member 4 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of SLC13A4 mRNA CTD PMID:26377693 NCBI chr 4:64,910,505...64,955,986
Ensembl chr 4:64,910,507...64,955,986 		JBrowse link
G Slc16a1 solute carrier family 16 member 1 multiple interactions EXP [1,2,5,6-dibenzanthracene co-treated with dibenzo(a,l)pyrene] affects the expression of SLC16A1 mRNA; [1,2,5,6-dibenzanthracene co-treated with fluoranthene] affects the expression of SLC16A1 mRNA; [Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of SLC16A1 mRNA CTD PMID:18711122 NCBI chr 2:194,805,556...194,832,966
Ensembl chr 2:194,812,502...194,832,977 		JBrowse link
G Slc16a5 solute carrier family 16 member 5 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of SLC16A5 mRNA CTD PMID:26377693 NCBI chr10:101,206,371...101,220,300
Ensembl chr10:101,206,398...101,220,300 		JBrowse link
G Slc16a7 solute carrier family 16 member 7 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of SLC16A7 mRNA CTD PMID:26377693 NCBI chr 7:62,929,067...63,096,995
Ensembl chr 7:62,936,567...63,040,386 		JBrowse link
G Slc17a2 solute carrier family 17, member 2 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of SLC17A2 mRNA CTD PMID:26377693 NCBI chr17:41,748,195...41,767,601
Ensembl chr17:41,748,195...41,764,180 		JBrowse link
G Slc19a2 solute carrier family 19 member 2 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of SLC19A2 mRNA CTD PMID:26377693 NCBI chr13:79,135,118...79,149,316
Ensembl chr13:79,135,059...79,149,315 		JBrowse link
G Slc25a33 solute carrier family 25 member 33 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of SLC25A33 mRNA CTD PMID:26377693 NCBI chr 5:165,478,070...165,518,186
Ensembl chr 5:165,478,072...165,502,973 		JBrowse link
G Slc25a34 solute carrier family 25, member 34 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of SLC25A34 mRNA CTD PMID:26377693 NCBI chr 5:159,215,120...159,219,892
Ensembl chr 5:159,215,120...159,219,892 		JBrowse link
G Slc25a37 solute carrier family 25 member 37 decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of SLC25A37 mRNA CTD PMID:26377693 NCBI chr15:50,944,085...50,986,506
Ensembl chr15:50,946,236...50,986,808 		JBrowse link
G Slc29a4 solute carrier family 29 member 4 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of SLC29A4 mRNA CTD PMID:26377693 NCBI chr12:16,967,047...16,998,276
Ensembl chr12:16,967,047...16,988,338 		JBrowse link
G Slc2a1 solute carrier family 2 member 1 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of SLC2A1 mRNA CTD PMID:16269432 NCBI chr 5:138,002,522...138,030,742
Ensembl chr 5:138,002,522...138,030,742 		JBrowse link
G Slc2a9 solute carrier family 2 member 9 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of SLC2A9 mRNA CTD PMID:26377693 NCBI chr14:76,540,649...76,674,277
Ensembl chr14:76,540,571...76,674,277 		JBrowse link
G Slc30a1 solute carrier family 30 member 1 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of SLC30A1 mRNA CTD PMID:26377693 NCBI chr13:106,022,019...106,025,892
Ensembl chr13:106,022,019...106,025,892 		JBrowse link
G Slc30a10 solute carrier family 30, member 10 decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of SLC30A10 mRNA CTD PMID:26377693 NCBI chr13:99,529,664...99,584,442
Ensembl chr13:99,529,790...99,544,213 		JBrowse link
G Slc36a2 solute carrier family 36 member 2 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of SLC36A2 mRNA CTD PMID:26377693 NCBI chr10:39,778,667...39,806,781
Ensembl chr10:39,778,693...39,806,773 		JBrowse link
G Slc39a14 solute carrier family 39 member 14 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of SLC39A14 mRNA CTD PMID:26377693 NCBI chr15:51,786,517...51,833,260
Ensembl chr15:51,786,623...51,833,229 		JBrowse link
G Slc43a1 solute carrier family 43 member 1 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of SLC43A1 mRNA CTD PMID:26377693 NCBI chr 3:90,327,250...90,353,438
Ensembl chr 3:90,327,149...90,353,438 		JBrowse link
G Slc4a1 solute carrier family 4 member 1 (Diego blood group) decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of SLC4A1 mRNA CTD PMID:26377693 NCBI chr10:87,807,010...87,823,274
Ensembl chr10:87,807,013...87,823,258 		JBrowse link
G Slc5a12 solute carrier family 5 member 12 decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of SLC5A12 mRNA CTD PMID:26377693 NCBI chr 3:117,633,885...117,683,966
Ensembl chr 3:117,633,887...117,682,963 		JBrowse link
G Slc5a6 solute carrier family 5 member 6 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of SLC5A6 mRNA CTD PMID:26377693 NCBI chr 6:31,039,865...31,051,671
Ensembl chr 6:31,040,017...31,051,670 		JBrowse link
G Slc6a14 solute carrier family 6 member 14 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of SLC6A14 mRNA CTD PMID:26377693 NCBI chr  X:117,109,063...117,169,522
Ensembl chr  X:117,108,947...117,169,828 		JBrowse link
G Slco2b1 solute carrier organic anion transporter family, member 2b1 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of SLCO2B1 mRNA CTD PMID:26377693 NCBI chr 1:163,371,410...163,419,412
Ensembl chr 1:163,371,410...163,419,279 		JBrowse link
G Smad3 SMAD family member 3 multiple interactions EXP [Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of SMAD3 mRNA CTD PMID:18711122 NCBI chr 8:73,022,204...73,132,324
Ensembl chr 8:73,024,760...73,132,324 		JBrowse link
G Smagp small cell adhesion glycoprotein decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of SMAGP mRNA CTD PMID:26377693 NCBI chr 7:133,599,043...133,617,492
Ensembl chr 7:133,599,043...133,616,642 		JBrowse link
G Smarca2 SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of SMARCA2 mRNA CTD PMID:26377693 NCBI chr 1:233,617,277...233,784,908
Ensembl chr 1:233,617,366...233,784,869 		JBrowse link
G Snca synuclein alpha decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of SNCA mRNA CTD PMID:26377693 NCBI chr 4:91,026,474...91,127,444
Ensembl chr 4:91,026,474...91,126,315 		JBrowse link
G Sncg synuclein, gamma increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of SNCG mRNA CTD PMID:26377693 NCBI chr16:9,706,765...9,712,072
Ensembl chr16:9,706,753...9,712,076 		JBrowse link
G Socs2 suppressor of cytokine signaling 2 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of SOCS2 mRNA CTD PMID:26377693 NCBI chr 7:31,890,564...31,932,092
Ensembl chr 7:31,874,463...31,930,423 		JBrowse link
G Sorbs3 sorbin and SH3 domain containing 3 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of SORBS3 mRNA CTD PMID:26377693 NCBI chr15:51,662,639...51,699,161
Ensembl chr15:51,663,095...51,694,522 		JBrowse link
G Sox9 SRY-box transcription factor 9 decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of SOX9 mRNA CTD PMID:26377693 NCBI chr10:98,305,744...98,311,250
Ensembl chr10:98,305,744...98,311,250 		JBrowse link
G Sp8 Sp8 transcription factor increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of SP8 mRNA CTD PMID:26377693 NCBI chr 6:145,959,219...145,961,824
Ensembl chr 6:145,959,097...145,964,845 		JBrowse link
G Spc25 SPC25 component of NDC80 kinetochore complex increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of SPC25 mRNA CTD PMID:26377693 NCBI chr 3:74,337,872...74,396,825
Ensembl chr 3:74,383,548...74,396,718 		JBrowse link
G Spint1 serine peptidase inhibitor, Kunitz type 1 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of SPINT1 mRNA CTD PMID:26377693 NCBI chr 3:126,685,017...126,697,957
Ensembl chr 3:126,685,422...126,697,956 		JBrowse link
G Spon1 spondin 1 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of SPON1 mRNA CTD PMID:26377693 NCBI chr 1:177,363,526...177,662,689
Ensembl chr 1:177,363,197...177,662,676 		JBrowse link
G Spon2 spondin 2 decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of SPON2 mRNA CTD PMID:26377693 NCBI chr14:81,713,070...81,742,510
Ensembl chr14:81,731,188...81,742,609 		JBrowse link
G Spp1 secreted phosphoprotein 1 multiple interactions EXP
ISO 		[Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of SPP1 mRNA CTD PMID:17690111 PMID:18711122 NCBI chr14:5,613,569...5,620,695
Ensembl chr14:5,613,576...5,619,820 		JBrowse link
G Spsb1 splA/ryanodine receptor domain and SOCS box containing 1 decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of SPSB1 mRNA CTD PMID:26377693 NCBI chr 5:165,641,255...165,701,482
Ensembl chr 5:165,642,851...165,654,225 		JBrowse link
G Sptbn2 spectrin, beta, non-erythrocytic 2 multiple interactions EXP [Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of SPTBN2 mRNA CTD PMID:18711122 NCBI chr 1:211,432,373...211,473,016
Ensembl chr 1:211,432,373...211,473,306 		JBrowse link
G Srgap3 SLIT-ROBO Rho GTPase activating protein 3 decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of SRGAP3 mRNA CTD PMID:26377693 NCBI chr 4:147,391,082...147,626,407
Ensembl chr 4:147,395,880...147,625,713 		JBrowse link
G Srgn serglycin increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of SRGN mRNA CTD PMID:26377693 NCBI chr20:30,985,508...31,022,296
Ensembl chr20:30,985,508...31,000,327 		JBrowse link
G Sspn sarcospan increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of SSPN mRNA CTD PMID:26377693 NCBI chr 4:180,620,762...180,666,893
Ensembl chr 4:180,627,848...180,662,284 		JBrowse link
G St3gal5 ST3 beta-galactoside alpha-2,3-sialyltransferase 5 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of ST3GAL5 mRNA CTD PMID:26377693 NCBI chr 4:105,692,840...105,750,774
Ensembl chr 4:105,692,840...105,750,775 		JBrowse link
G St6galnac4 ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 4 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of ST6GALNAC4 mRNA CTD PMID:26377693 NCBI chr 3:36,269,834...36,282,971
Ensembl chr 3:36,269,878...36,282,971 		JBrowse link
G St8sia4 ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 4 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of ST8SIA4 mRNA CTD PMID:26377693 NCBI chr 9:103,437,479...103,532,008
Ensembl chr 9:103,437,479...103,532,008 		JBrowse link
G Stab2 stabilin 2 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of STAB2 mRNA CTD PMID:26377693 NCBI chr 7:23,136,938...23,342,633
Ensembl chr 7:23,136,941...23,320,562 		JBrowse link
G Stard13 StAR-related lipid transfer domain containing 13 decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of STARD13 mRNA CTD PMID:26377693 NCBI chr12:5,401,878...5,797,937
Ensembl chr12:5,401,995...5,794,967 		JBrowse link
G Stk35 serine/threonine kinase 35 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of STK35 mRNA CTD PMID:26377693 NCBI chr 3:137,465,884...137,498,554
Ensembl chr 3:137,470,110...137,498,940 		JBrowse link
G Stmn1 stathmin 1 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of STMN1 mRNA CTD PMID:26377693 NCBI chr 5:151,964,308...151,970,843
Ensembl chr 5:151,964,351...151,970,842 		JBrowse link
G Stmnd1 stathmin domain containing 1 decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of STMND1 mRNA CTD PMID:26377693 NCBI chr17:18,600,537...18,626,807
Ensembl chr17:18,599,971...18,643,590 		JBrowse link
G Sulf2 sulfatase 2 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of SULF2 mRNA CTD PMID:26377693 NCBI chr 3:175,241,322...175,323,808
Ensembl chr 3:175,241,322...175,323,651 		JBrowse link
G Sun3 Sad1 and UNC84 domain containing 3 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of SUN3 mRNA CTD PMID:26377693 NCBI chr14:87,923,891...87,962,699
Ensembl chr14:87,923,074...87,962,867 		JBrowse link
G Syt15 synaptotagmin 15 decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of SYT15 mRNA CTD PMID:26377693 NCBI chr16:9,538,740...9,549,548
Ensembl chr16:9,538,748...9,549,558 		JBrowse link
G Tab2 TGF-beta activated kinase 1/MAP3K7 binding protein 2 decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of TAB2 mRNA CTD PMID:26377693 NCBI chr 1:4,195,400...4,245,485
Ensembl chr 1:4,195,400...4,245,485 		JBrowse link
G Tacc3 transforming, acidic coiled-coil containing protein 3 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of TACC3 mRNA CTD PMID:26377693 NCBI chr14:81,275,755...81,289,894
Ensembl chr14:81,275,755...81,289,698 		JBrowse link
G Tap1 transporter 1, ATP binding cassette subfamily B member increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of TAP1 mRNA CTD PMID:26377693 NCBI chr20:4,658,171...4,668,543
Ensembl chr20:4,658,172...4,668,810 		JBrowse link
G Tars1 threonyl-tRNA synthetase 1 decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of TARS1 mRNA CTD PMID:26377693 NCBI chr 2:62,095,978...62,114,802
Ensembl chr 2:62,087,763...62,114,802 		JBrowse link
G Tbc1d30 TBC1 domain family, member 30 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of TBC1D30 mRNA CTD PMID:26377693 NCBI chr 7:58,665,054...58,754,427
Ensembl chr 7:58,665,054...58,754,614 		JBrowse link
G Tbkbp1 TBK1 binding protein 1 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of TBKBP1 mRNA CTD PMID:26377693 NCBI chr10:82,616,978...82,632,169
Ensembl chr10:82,616,984...82,631,153 		JBrowse link
G Tbx4 T-box transcription factor 4 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of TBX4 mRNA CTD PMID:26377693 NCBI chr10:71,228,145...71,258,222
Ensembl chr10:71,197,727...71,258,218 		JBrowse link
G Tbxa2r thromboxane A2 receptor increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of TBXA2R mRNA CTD PMID:26377693 NCBI chr 7:9,034,077...9,041,489
Ensembl chr 7:9,034,108...9,038,905 		JBrowse link
G Tcap titin-cap increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of TCAP mRNA CTD PMID:26377693 NCBI chr10:83,878,006...83,879,174
Ensembl chr10:83,876,939...83,879,483 		JBrowse link
G Tchh trichohyalin increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of TCHH mRNA CTD PMID:26377693 NCBI chr 2:181,787,109...181,795,463
Ensembl chr 2:181,787,109...181,795,463 		JBrowse link
G Tef TEF transcription factor, PAR bZIP family member increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of TEF mRNA CTD PMID:26377693 NCBI chr 7:115,197,180...115,221,930
Ensembl chr 7:115,193,282...115,221,928 		JBrowse link
G Tent5c terminal nucleotidyltransferase 5C decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of TENT5C mRNA CTD PMID:26377693 NCBI chr 2:190,541,668...190,563,902
Ensembl chr 2:190,540,650...190,565,995 		JBrowse link
G Tet2 tet methylcytosine dioxygenase 2 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of TET2 mRNA CTD PMID:26377693 NCBI chr 2:224,662,654...224,746,819
Ensembl chr 2:224,662,654...224,746,186 		JBrowse link
G Tfcp2 transcription factor CP2 decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of TFCP2 mRNA CTD PMID:26377693 NCBI chr 7:133,495,577...133,537,799
Ensembl chr 7:133,495,577...133,537,531 		JBrowse link
G Tfcp2l1 transcription factor CP2-like 1 decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of TFCP2L1 mRNA CTD PMID:26377693 NCBI chr13:32,286,643...32,346,671
Ensembl chr13:32,286,643...32,346,671 		JBrowse link
G Tff3 trefoil factor 3 decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of TFF3 mRNA CTD PMID:26377693 NCBI chr20:9,194,623...9,199,333
Ensembl chr20:9,194,626...9,199,333 		JBrowse link
G Tfpi tissue factor pathway inhibitor increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of TFPI mRNA CTD PMID:26377693 NCBI chr 3:89,939,862...89,989,253
Ensembl chr 3:89,939,868...89,980,742 		JBrowse link
G Tgm1 transglutaminase 1 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of TGM1 mRNA CTD PMID:26377693 NCBI chr15:33,160,985...33,175,632
Ensembl chr15:33,160,987...33,174,463 		JBrowse link
G Tgm2 transglutaminase 2 decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of TGM2 mRNA CTD PMID:16269432 NCBI chr 3:167,192,612...167,221,845
Ensembl chr 3:167,192,612...167,304,240 		JBrowse link
G Thbs1 thrombospondin 1 decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of THBS1 mRNA CTD PMID:26377693 NCBI chr 3:125,510,250...125,525,402
Ensembl chr 3:125,510,250...125,525,402 		JBrowse link
G Thbs3 thrombospondin 3 decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of THBS3 mRNA CTD PMID:26377693 NCBI chr 2:176,919,549...176,931,357
Ensembl chr 2:176,919,230...176,931,357 		JBrowse link
G Thra thyroid hormone receptor alpha decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of THRA mRNA CTD PMID:26377693 NCBI chr10:84,198,141...84,225,659
Ensembl chr10:84,197,011...84,225,657 		JBrowse link
G Thrsp thyroid hormone responsive increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of THRSP mRNA CTD PMID:26377693 NCBI chr 1:161,134,640...161,138,964
Ensembl chr 1:161,133,453...161,139,827 		JBrowse link
G Thsd1 thrombospondin type 1 domain containing 1 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of THSD1 mRNA CTD PMID:26377693 NCBI chr16:76,473,026...76,507,404
Ensembl chr16:76,473,859...76,503,951 		JBrowse link
G Thyn1 thymocyte nuclear protein 1 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of THYN1 mRNA CTD PMID:26377693 NCBI chr 8:33,665,614...33,674,593
Ensembl chr 8:33,665,650...33,675,414 		JBrowse link
G Timp1 TIMP metallopeptidase inhibitor 1 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of TIMP1 mRNA CTD PMID:22579512 NCBI chr  X:3,766,509...3,772,578
Ensembl chr  X:3,766,510...3,771,135 		JBrowse link
G Tinagl1 tubulointerstitial nephritis antigen-like 1 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of TINAGL1 mRNA CTD PMID:26377693 NCBI chr 5:147,797,884...147,807,925
Ensembl chr 5:147,797,892...147,807,871 		JBrowse link
G Tipin timeless interacting protein increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of TIPIN mRNA CTD PMID:26377693 NCBI chr 8:73,676,020...73,696,620
Ensembl chr 8:73,676,091...73,696,620 		JBrowse link
G Tk1 thymidine kinase 1 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of TK1 mRNA CTD PMID:26377693 NCBI chr10:103,533,449...103,544,818
Ensembl chr10:103,533,449...103,556,228 		JBrowse link
G Tlcd3b TLC domain containing 3B increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of TLCD3B mRNA CTD PMID:26377693 NCBI chr 1:190,851,582...190,870,278
Ensembl chr 1:190,835,208...190,870,277 		JBrowse link
G Tlcd5 TLC domain containing 5 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of TLCD5 mRNA CTD PMID:26377693 NCBI chr 8:52,378,360...52,383,258
Ensembl chr 8:52,375,988...52,383,260 		JBrowse link
G Tm6sf1 transmembrane 6 superfamily member 1 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of TM6SF1 mRNA CTD PMID:26377693 NCBI chr 1:145,209,052...145,237,725
Ensembl chr 1:145,209,585...145,237,715 		JBrowse link
G Tmeff2 transmembrane protein with EGF-like and two follistatin-like domains 2 decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of TMEFF2 mRNA CTD PMID:26377693 NCBI chr 9:57,937,873...58,225,372
Ensembl chr 9:57,937,873...58,225,372 		JBrowse link
G Tmem171 transmembrane protein 171 decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of TMEM171 mRNA CTD PMID:26377693 NCBI chr 2:31,769,486...31,779,358
Ensembl chr 2:31,769,486...31,780,134 		JBrowse link
G Tmem39a transmembrane protein 39a decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of TMEM39A mRNA CTD PMID:26377693 NCBI chr11:75,666,154...75,695,486
Ensembl chr11:75,666,154...75,695,486 		JBrowse link
G Tmem41b transmembrane protein 41B decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of TMEM41B mRNA CTD PMID:26377693 NCBI chr 1:173,447,362...173,461,760
Ensembl chr 1:173,447,367...173,461,597 		JBrowse link
G Tmem88 transmembrane protein 88 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of TMEM88 mRNA CTD PMID:26377693 NCBI chr10:54,617,554...54,619,309
Ensembl chr10:54,617,630...54,619,438 		JBrowse link
G Tmod2 tropomodulin 2 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of TMOD2 mRNA CTD PMID:26377693 NCBI chr 8:85,197,222...85,250,627
Ensembl chr 8:85,196,226...85,246,371 		JBrowse link
G Tmtc1 transmembrane O-mannosyltransferase targeting cadherins 1 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of TMTC1 mRNA CTD PMID:26377693 NCBI chr 4:182,874,350...183,089,408
Ensembl chr 4:182,878,802...183,102,532 		JBrowse link
G Tmtc2 transmembrane O-mannosyltransferase targeting cadherins 2 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of TMTC2 mRNA CTD PMID:26377693 NCBI chr 7:42,280,746...42,695,651
Ensembl chr 7:42,280,746...42,693,350 		JBrowse link
G Tnfaip8l1 TNF alpha induced protein 8 like 1 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of TNFAIP8L1 mRNA CTD PMID:26377693 NCBI chr 9:1,075,724...1,088,256
Ensembl chr 9:1,055,801...1,092,803 		JBrowse link
G Tnfsf10 TNF superfamily member 10 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of TNFSF10 mRNA CTD PMID:26377693 NCBI chr 2:112,136,550...112,155,903 JBrowse link
G Tnks1bp1 tankyrase 1 binding protein 1 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of TNKS1BP1 mRNA CTD PMID:26377693 NCBI chr 3:90,542,006...90,566,720
Ensembl chr 3:90,542,033...90,566,713 		JBrowse link
G Tp53 tumor protein p53 multiple interactions
increases response to substance 		ISO TP53 protein affects the reaction [1,2,5,6-dibenzanthracene results in increased expression of CYP1A1 protein]
TP53 protein results in increased susceptibility to 1,2,5,6-dibenzanthracene 		CTD PMID:25398514 NCBI chr10:54,798,871...54,810,300
Ensembl chr10:54,798,851...54,810,299 		JBrowse link
G Tp53inp1 tumor protein p53 inducible nuclear protein 1 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of TRP53INP1 mRNA CTD PMID:26377693 NCBI chr 5:29,051,267...29,069,486
Ensembl chr 5:29,051,264...29,069,484 		JBrowse link
G Tpo thyroid peroxidase increases activity ISO 1,2,5,6-dibenzanthracene results in increased activity of TPO protein CTD PMID:21809831 NCBI chr 6:52,425,998...52,495,793
Ensembl chr 6:52,426,010...52,495,793 		JBrowse link
G Tpx2 TPX2, microtubule nucleation factor increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of TPX2 mRNA CTD PMID:26377693 NCBI chr 3:161,778,709...161,820,941
Ensembl chr 3:161,778,742...161,820,724 		JBrowse link
G Treml1 triggering receptor expressed on myeloid cells-like 1 decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of TREML1 mRNA CTD PMID:26377693 NCBI chr 9:20,133,193...20,139,933
Ensembl chr 9:20,133,199...20,139,956 		JBrowse link
G Trib1 tribbles pseudokinase 1 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of TRIB1 mRNA CTD PMID:26377693 NCBI chr 7:93,096,001...93,102,547
Ensembl chr 7:93,095,973...93,117,480 		JBrowse link
G Trib2 tribbles pseudokinase 2 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of TRIB2 mRNA CTD PMID:26377693 NCBI chr 6:44,274,762...44,299,139
Ensembl chr 6:44,274,762...44,299,094 		JBrowse link
G Trim16 tripartite motif-containing 16 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of TRIM16 mRNA CTD PMID:26377693 NCBI chr10:47,985,235...48,008,242
Ensembl chr10:47,958,677...48,051,136 		JBrowse link
G Trim2 tripartite motif-containing 2 decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of TRIM2 mRNA CTD PMID:26377693 NCBI chr 2:171,798,654...171,950,193
Ensembl chr 2:171,798,660...171,913,468 		JBrowse link
G Trim24 tripartite motif-containing 24 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of TRIM24 mRNA CTD PMID:26377693 NCBI chr 4:67,534,240...67,659,014
Ensembl chr 4:67,534,335...67,684,226 		JBrowse link
G Trpv4 transient receptor potential cation channel, subfamily V, member 4 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of TRPV4 mRNA CTD PMID:26377693 NCBI chr12:47,599,161...47,638,143
Ensembl chr12:47,599,035...47,638,143 		JBrowse link
G Tsc22d1 TSC22 domain family, member 1 affects expression ISO 1,2,5,6-dibenzanthracene affects the expression of TSC22D1 mRNA CTD PMID:26377693 NCBI chr15:58,159,612...58,260,244
Ensembl chr15:58,159,952...58,183,322 		JBrowse link
G Tsc22d3 TSC22 domain family, member 3 multiple interactions EXP [1,2,5,6-dibenzanthracene co-treated with dibenzo(a,l)pyrene] affects the expression of TSC22D3 mRNA; [1,2,5,6-dibenzanthracene co-treated with fluoranthene] affects the expression of TSC22D3 mRNA; [Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of TSC22D3 mRNA CTD PMID:18711122 NCBI chr  X:109,006,410...109,066,389
Ensembl chr  X:109,006,420...109,015,519 		JBrowse link
G Tsg101 tumor susceptibility 101 increases expression EXP 1,2,5,6-dibenzanthracene results in increased expression of TSG101 protein CTD PMID:31368503 NCBI chr 1:106,549,035...106,578,859
Ensembl chr 1:106,535,021...106,578,775 		JBrowse link
G Tsku tsukushi, small leucine rich proteoglycan increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of TSKU mRNA CTD PMID:26377693 NCBI chr 1:162,071,459...162,082,972
Ensembl chr 1:162,064,126...162,089,272 		JBrowse link
G Tspan13 tetraspanin 13 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of TSPAN13 mRNA CTD PMID:26377693 NCBI chr 6:58,466,051...58,492,804
Ensembl chr 6:58,465,684...58,492,819 		JBrowse link
G Tspan18 tetraspanin 18 decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of TSPAN18 mRNA CTD PMID:26377693 NCBI chr 3:99,615,465...99,755,270
Ensembl chr 3:99,615,466...99,755,270 		JBrowse link
G Tspan4 tetraspanin 4 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of TSPAN4 mRNA CTD PMID:26377693 NCBI chr 1:206,001,731...206,021,414
Ensembl chr 1:206,001,731...206,021,413 		JBrowse link
G Tspyl4 TSPY-like 4 decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of TSPYL4 mRNA CTD PMID:26377693 NCBI chr20:39,653,788...39,655,784
Ensembl chr20:39,653,604...39,664,566 		JBrowse link
G Ttll3 tubulin tyrosine ligase like 3 decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of TTLL3 mRNA CTD PMID:26377693 NCBI chr 4:148,088,575...148,113,526
Ensembl chr 4:148,089,575...148,113,499 		JBrowse link
G Tubb2a tubulin, beta 2A class IIa decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of TUBB2A mRNA CTD PMID:26377693 NCBI chr17:31,002,186...31,006,057
Ensembl chr17:30,983,387...31,006,838 		JBrowse link
G Tubb5 tubulin, beta 5 class I multiple interactions EXP [1,2,5,6-dibenzanthracene co-treated with dibenzo(a,l)pyrene] affects the expression of TUBB5 mRNA; [1,2,5,6-dibenzanthracene co-treated with fluoranthene] affects the expression of TUBB5 mRNA; [Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of TUBB5 mRNA CTD PMID:18711122 NCBI chr20:2,917,577...2,921,726
Ensembl chr20:2,917,539...2,921,726 		JBrowse link
G Tulp4 TUB like protein 4 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of TULP4 mRNA CTD PMID:26377693 NCBI chr 1:49,082,492...49,218,262
Ensembl chr 1:49,087,886...49,218,250 		JBrowse link
G Txlng taxilin gamma increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of TXLNG mRNA CTD PMID:26377693 NCBI chr  X:35,495,822...35,544,716
Ensembl chr  X:35,495,893...35,544,716 		JBrowse link
G Tymp thymidine phosphorylase decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of TYMP mRNA CTD PMID:26377693 NCBI chr 7:122,318,396...122,323,716
Ensembl chr 7:122,316,520...122,324,003 		JBrowse link
G Tyrobp transmembrane immune signaling adaptor Tyrobp multiple interactions ISO [Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of TYROBP mRNA CTD PMID:17690111 NCBI chr 1:94,800,372...94,804,307
Ensembl chr 1:94,800,117...94,804,299 		JBrowse link
G Ubd ubiquitin D increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of UBD mRNA CTD PMID:16269432 NCBI chr20:1,390,734...1,392,685
Ensembl chr20:1,390,600...1,413,965 		JBrowse link
G Ube2a ubiquitin-conjugating enzyme E2A multiple interactions ISO [Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of UBE2A mRNA CTD PMID:17690111 NCBI chr  X:120,979,993...120,990,773
Ensembl chr  X:120,978,790...120,990,750 		JBrowse link
G Ube2c ubiquitin-conjugating enzyme E2C increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of UBE2C mRNA CTD PMID:26377693 NCBI chr 3:173,925,975...173,928,375
Ensembl chr 3:173,925,934...173,932,678 		JBrowse link
G Ubl3 ubiquitin-like 3 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of UBL3 mRNA CTD PMID:26377693 NCBI chr12:11,509,912...11,554,548
Ensembl chr12:11,509,848...11,554,547 		JBrowse link
G Ubxn1 UBX domain protein 1 decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of UBXN1 mRNA CTD PMID:26377693 NCBI chr 1:215,194,418...215,198,343
Ensembl chr 1:215,174,216...215,198,343 		JBrowse link
G Ubxn11 UBX domain protein 11 decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of UBXN11 mRNA CTD PMID:26377693 NCBI chr 5:151,613,411...151,637,274
Ensembl chr 5:151,613,565...151,637,272 		JBrowse link
G Ugcg UDP-glucose ceramide glucosyltransferase multiple interactions EXP [1,2,5,6-dibenzanthracene co-treated with dibenzo(a,l)pyrene] affects the expression of UGCG mRNA; [1,2,5,6-dibenzanthracene co-treated with fluoranthene] affects the expression of UGCG mRNA; [Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of UGCG mRNA CTD PMID:18711122 NCBI chr 5:78,828,006...78,860,725
Ensembl chr 5:78,828,006...78,860,417 		JBrowse link
G Uhrf1 ubiquitin-like with PHD and ring finger domains 1 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of UHRF1 mRNA CTD PMID:26377693 NCBI chr 9:1,220,162...1,241,792
Ensembl chr 9:1,222,063...1,241,792 		JBrowse link
G Unc5a unc-5 netrin receptor A increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of UNC5A mRNA CTD PMID:26377693 NCBI chr17:9,620,005...9,675,794
Ensembl chr17:9,620,005...9,676,140 		JBrowse link
G Upk1a uroplakin 1A decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of UPK1A mRNA CTD PMID:26377693 NCBI chr 1:94,987,110...94,998,083
Ensembl chr 1:94,987,108...94,997,787 		JBrowse link
G Upk3a uroplakin 3A decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of UPK3A mRNA CTD PMID:26377693 NCBI chr 7:118,008,898...118,019,865
Ensembl chr 7:118,014,108...118,019,870 		JBrowse link
G Upp2 uridine phosphorylase 2 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of UPP2 mRNA CTD PMID:26377693 NCBI chr 3:63,681,671...63,726,194
Ensembl chr 3:63,681,826...63,726,191 		JBrowse link
G Uqcrb ubiquinol-cytochrome c reductase binding protein decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of UQCRB mRNA CTD PMID:16269432 NCBI chr 7:65,700,016...65,705,382
Ensembl chr 7:65,700,029...65,705,558 		JBrowse link
G Usp2 ubiquitin specific peptidase 2 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of USP2 mRNA CTD PMID:26377693 NCBI chr 8:53,308,264...53,336,800
Ensembl chr 8:53,308,303...53,336,794 		JBrowse link
G Utrn utrophin decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of UTRN mRNA CTD PMID:26377693 NCBI chr 1:8,541,061...9,044,487
Ensembl chr 1:8,542,798...9,044,487 		JBrowse link
G Vasn vasorin decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of VASN mRNA CTD PMID:26377693 NCBI chr10:11,424,174...11,434,681
Ensembl chr10:11,417,327...11,450,704 		JBrowse link
G Vat1 vesicle amine transport 1 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of VAT1 mRNA CTD PMID:16269432 NCBI chr10:86,889,793...86,897,411
Ensembl chr10:86,889,793...86,897,411 		JBrowse link
G Vegfc vascular endothelial growth factor C increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of VEGFC mRNA CTD PMID:26377693 NCBI chr16:44,445,293...44,560,887
Ensembl chr16:44,445,293...44,560,887 		JBrowse link
G Vim vimentin increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of VIM mRNA CTD PMID:26377693 NCBI chr17:81,577,261...81,585,746
Ensembl chr17:81,568,272...81,585,746 		JBrowse link
G Vmp1 vacuole membrane protein 1 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of VMP1 mRNA CTD PMID:16269432 NCBI chr10:71,903,223...72,002,337
Ensembl chr10:71,903,227...72,002,319 		JBrowse link
G Vps13a vacuolar protein sorting 13 homolog A increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of VPS13A mRNA CTD PMID:26377693 NCBI chr 1:223,328,784...223,555,500
Ensembl chr 1:223,328,784...223,555,331 		JBrowse link
G Vps16 VPS16 core subunit of CORVET and HOPS complexes decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of VPS16 mRNA CTD PMID:26377693 NCBI chr 3:138,075,649...138,097,154
Ensembl chr 3:138,075,660...138,110,632 		JBrowse link
G Vwf von Willebrand factor increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of VWF mRNA CTD PMID:26377693 NCBI chr 4:160,042,900...160,177,757
Ensembl chr 4:160,047,982...160,177,757 		JBrowse link
G Wdr45 WD repeat domain 45 decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of WDR45 mRNA CTD PMID:26377693 NCBI chr  X:17,448,195...17,454,117
Ensembl chr  X:17,448,207...17,454,117 		JBrowse link
G Wdr62 WD repeat domain 62 decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of WDR62 mRNA CTD PMID:26377693 NCBI chr 1:94,618,992...94,658,097
Ensembl chr 1:94,618,992...94,658,223 		JBrowse link
G Wdr86 WD repeat domain 86 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of WDR86 mRNA CTD PMID:26377693 NCBI chr 4:11,315,826...11,335,932
Ensembl chr 4:11,316,534...11,335,932 		JBrowse link
G Wee1 WEE1 G2 checkpoint kinase increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of WEE1 mRNA CTD PMID:26377693 NCBI chr 1:173,605,609...173,632,450
Ensembl chr 1:173,608,949...173,632,449 		JBrowse link
G Wfdc12 WAP four-disulfide core domain 12 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of WFDC12 mRNA CTD PMID:26377693 NCBI chr 3:173,280,844...173,282,167
Ensembl chr 3:173,280,844...173,282,167 		JBrowse link
G Wipf3 WAS/WASL interacting protein family, member 3 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of WIPF3 mRNA CTD PMID:26377693 NCBI chr 4:84,880,403...84,960,250
Ensembl chr 4:84,880,740...84,961,524 		JBrowse link
G Wnt1 Wnt family member 1 decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of WNT1 mRNA CTD PMID:26377693 NCBI chr 7:131,817,558...131,821,605
Ensembl chr 7:131,817,558...131,821,605 		JBrowse link
G Xbp1 X-box binding protein 1 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of XBP1 mRNA CTD PMID:26377693 NCBI chr14:84,604,623...84,609,707
Ensembl chr14:84,604,107...84,609,706 		JBrowse link
G Xpnpep2 X-prolyl aminopeptidase 2 decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of XPNPEP2 mRNA CTD PMID:26377693 NCBI chr  X:132,165,696...132,194,937
Ensembl chr  X:132,165,701...132,195,126 		JBrowse link
G Zbp1 Z-DNA binding protein 1 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of ZBP1 mRNA CTD PMID:26377693 NCBI chr 3:182,411,665...182,427,604
Ensembl chr 3:182,411,665...182,422,839 		JBrowse link
G Zbtb16 zinc finger and BTB domain containing 16 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of ZBTB16 mRNA CTD PMID:26377693 NCBI chr 8:57,885,886...58,073,507
Ensembl chr 8:57,891,081...58,073,507 		JBrowse link
G Zbtb5 zinc finger and BTB domain containing 5 decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of ZBTB5 mRNA CTD PMID:26377693 NCBI chr 5:64,039,805...64,062,451
Ensembl chr 5:64,035,080...64,074,912 		JBrowse link
G Zcchc2 zinc finger CCHC-type containing 2 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of ZCCHC2 mRNA CTD PMID:26377693 NCBI chr13:22,621,275...22,708,232
Ensembl chr13:22,634,171...22,708,464 		JBrowse link
G Zdhhc2 zinc finger DHHC-type palmitoyltransferase 2 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of ZDHHC2 mRNA CTD PMID:26377693 NCBI chr16:58,511,931...58,581,530
Ensembl chr16:58,511,934...58,581,516 		JBrowse link
G Zdhhc22 zinc finger DHHC-type palmitoyltransferase 22 decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of ZDHHC22 mRNA CTD PMID:26377693 NCBI chr 6:112,360,051...112,377,950
Ensembl chr 6:112,360,051...112,369,833 		JBrowse link
G Zfp365 zinc finger protein 365 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of ZFP365 mRNA CTD PMID:26377693 NCBI chr20:20,665,122...20,688,607
Ensembl chr20:20,665,046...20,690,114 		JBrowse link
G Zfp385b zinc finger protein 385B increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of ZFP385B mRNA CTD PMID:26377693 NCBI chr 3:82,762,387...83,140,856
Ensembl chr 3:82,762,387...83,084,615 		JBrowse link
G Zfp423 zinc finger protein 423 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of ZFP423 mRNA CTD PMID:26377693 NCBI chr19:35,282,149...35,580,775
Ensembl chr19:35,282,110...35,580,773 		JBrowse link
G Zfp445 zinc finger protein 445 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of ZFP445 mRNA CTD PMID:26377693 NCBI chr 8:131,331,795...131,350,749
Ensembl chr 8:131,331,795...131,350,749 		JBrowse link
G Zfp503 zinc finger protein 503 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of ZFP503 mRNA CTD PMID:26377693 NCBI chr15:2,362,450...2,366,238
Ensembl chr15:2,362,427...2,366,238 		JBrowse link
G Zfp521 zinc finger protein 521 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of ZFP521 mRNA CTD PMID:26377693 NCBI chr18:5,050,297...5,343,188
Ensembl chr18:5,056,236...5,343,054 		JBrowse link
G Zfp536 zinc finger protein 536 decreases expression ISO 1,2,5,6-dibenzanthracene results in decreased expression of ZFP536 mRNA CTD PMID:26377693 NCBI chr 1:99,137,133...99,600,379
Ensembl chr 1:99,137,133...99,599,043 		JBrowse link
G Zfp612 zinc finger protein 612 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of ZFP612 mRNA CTD PMID:26377693 NCBI chr19:54,963,400...54,976,888
Ensembl chr19:54,963,379...54,977,075 		JBrowse link
G Zmat3 zinc finger, matrin type 3 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of ZMAT3 mRNA CTD PMID:26377693 NCBI chr 2:117,034,517...117,066,141
Ensembl chr 2:117,034,517...117,065,294 		JBrowse link
G Zmynd15 zinc finger, MYND-type containing 15 increases expression ISO 1,2,5,6-dibenzanthracene results in increased expression of ZMYND15 mRNA CTD PMID:26377693 NCBI chr10:55,669,832...55,676,446
Ensembl chr10:55,669,752...55,676,434 		JBrowse link
fluorene term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Ahr aryl hydrocarbon receptor multiple interactions
increases activity 		ISO [acenaphthene co-treated with anthracene co-treated with 1,12-benzoperylene co-treated with 1,2,5,6-dibenzanthracene co-treated with fluorene co-treated with naphthalene co-treated with phenanthrene] results in increased activity of AHR protein
fluorene results in increased activity of AHR protein 		CTD PMID:17665671 NCBI chr 6:57,961,423...57,998,901
Ensembl chr 6:57,961,423...57,998,901 		JBrowse link
G Ahrr aryl-hydrocarbon receptor repressor decreases methylation ISO fluorene metabolite results in decreased methylation of AHRR gene CTD PMID:32385190 NCBI chr 1:30,822,219...30,917,251
Ensembl chr 1:30,810,866...30,952,866 		JBrowse link
G Cat catalase increases activity
multiple interactions 		ISO fluorene results in increased activity of CAT protein
[phenanthrene co-treated with fluorene] results in increased activity of CAT protein 		CTD PMID:32856796 NCBI chr 3:110,297,340...110,329,526
Ensembl chr 3:110,297,342...110,329,526 		JBrowse link
G Cyp1a1 cytochrome P450, family 1, subfamily a, polypeptide 1 increases expression EXP fluorene results in increased expression of CYP1A1 protein CTD PMID:10445401 NCBI chr 8:66,991,940...66,998,014
Ensembl chr 8:66,991,970...66,998,012 		JBrowse link
G Cyp1a2 cytochrome P450, family 1, subfamily a, polypeptide 2 increases activity
multiple interactions 		ISO fluorene results in increased activity of CYP1A2 protein
[acenaphthylene co-treated with acenaphthene co-treated with dibenzofuran co-treated with fluorene co-treated with phenanthrene co-treated with anthracene] results in increased expression of CYP1A2 mRNA 		CTD PMID:7750161 PMID:8001243 NCBI chr 8:66,971,261...66,978,149
Ensembl chr 8:66,971,261...66,978,149 		JBrowse link
G Cyp2b1 cytochrome P450, family 2, subfamily b, polypeptide 1 increases expression EXP fluorene results in increased expression of CYP2B1 protein CTD PMID:10445401 NCBI chr 1:90,646,098...90,669,762 JBrowse link
G Cyp3a2 cytochrome P450, family 3, subfamily a, polypeptide 2 increases expression EXP fluorene results in increased expression of CYP3A2 protein CTD PMID:10445401 NCBI chr12:14,321,771...14,343,886
Ensembl chr12:14,321,771...14,343,857 		JBrowse link
G F2rl3 F2R like thrombin or trypsin receptor 3 decreases methylation ISO fluorene metabolite results in decreased methylation of F2RL3 gene CTD PMID:32385190 NCBI chr16:17,151,516...17,153,509
Ensembl chr16:17,151,516...17,153,823 		JBrowse link
G Gja1 gap junction protein, alpha 1 decreases expression
decreases localization 		ISO fluorene results in decreased expression of GJA1 protein
fluorene results in decreased localization of GJA1 protein 		CTD PMID:30668803 NCBI chr20:36,302,490...36,315,010
Ensembl chr20:36,302,352...36,319,689 		JBrowse link
G Il6 interleukin 6 increases expression
multiple interactions 		ISO fluorene results in increased expression of IL6 mRNA; fluorene results in increased expression of IL6 protein
[fluorene co-treated with phenanthrene] results in increased expression of IL6 mRNA; [fluorene co-treated with phenanthrene] results in increased expression of IL6 protein 		CTD PMID:32856796 NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,889,999...5,894,610 		JBrowse link
G Nos3 nitric oxide synthase 3 multiple interactions
increases expression 		ISO 1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [fluorene results in increased expression of NOS3 mRNA]; 1-(2-(3-(4-methoxyphenyl)propoxy)-4-methoxyphenylethyl)-1H-imidazole inhibits the reaction [fluorene results in increased expression of NOS3 protein]; nickel chloride inhibits the reaction [fluorene results in increased expression of NOS3 protein]; Proadifen inhibits the reaction [fluorene results in increased expression of NOS3 protein]
fluorene results in increased expression of NOS3 mRNA; fluorene results in increased expression of NOS3 protein 		CTD PMID:15183461 NCBI chr 4:11,686,088...11,706,604
Ensembl chr 4:11,686,268...11,706,664 		JBrowse link
G Nr1i3 nuclear receptor subfamily 1, group I, member 3 increases activity ISO fluorene results in increased activity of NR1I3 protein CTD PMID:28927721 NCBI chr13:86,165,327...86,170,362
Ensembl chr13:86,165,349...86,170,370 		JBrowse link
G Tgfb1 transforming growth factor, beta 1 decreases expression ISO fluorene results in decreased expression of TGFB1 mRNA CTD PMID:32856796 NCBI chr 1:90,324,312...90,340,627
Ensembl chr 1:90,324,046...90,340,899 		JBrowse link
G Tnf tumor necrosis factor multiple interactions
increases expression 		ISO [fluorene co-treated with phenanthrene] results in increased expression of TNF mRNA; [fluorene co-treated with phenanthrene] results in increased expression of TNF protein
fluorene results in increased expression of TNF mRNA; fluorene results in increased expression of TNF protein 		CTD PMID:32856796 NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,626,532...3,629,303 		JBrowse link
naphthalene term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G A2m alpha-2-macroglobulin affects binding
increases expression 		ISO
EXP 		naphthalene metabolite binds to A2M protein
naphthalene analog results in increased expression of A2M mRNA 		CTD PMID:15892573 PMID:24976557 NCBI chr 4:156,570,163...156,619,870
Ensembl chr 4:156,569,860...156,619,868 		JBrowse link
G Abcb1a ATP binding cassette subfamily B member 1A decreases activity ISO naphthalene results in decreased activity of ABCB1 protein CTD PMID:19135510 NCBI chr 4:26,312,403...26,488,456
Ensembl chr 4:26,312,409...26,397,135 		JBrowse link
G Ackr4 atypical chemokine receptor 4 decreases expression ISO naphthalene results in decreased expression of ACKR4 mRNA CTD PMID:18757308 NCBI chr 8:113,595,325...113,599,762
Ensembl chr 8:113,595,293...113,602,372 		JBrowse link
G Aco2 aconitase 2 multiple interactions
decreases expression 		ISO [naphthalene co-treated with CFTR gene mutant form] results in decreased expression of ACO2 protein
naphthalene results in decreased expression of ACO2 protein 		CTD PMID:19438287 NCBI chr 7:115,265,816...115,308,931
Ensembl chr 7:115,265,791...115,308,892 		JBrowse link
G Acp2 acid phosphatase 2, lysosomal multiple interactions
affects expression 		ISO [naphthalene co-treated with anthracene co-treated with phenanthrene co-treated with pyrene] affects the expression of ACP2 protein
naphthalene affects the expression of ACP2 protein 		CTD PMID:28803881 NCBI chr 3:97,630,654...97,642,601
Ensembl chr 3:97,631,326...97,642,565 		JBrowse link
G Acta1 actin, alpha 1, skeletal muscle affects binding ISO naphthalene metabolite binds to ACTA1 protein CTD PMID:15892573 PMID:16206326 NCBI chr19:68,781,168...68,784,194
Ensembl chr19:68,781,168...68,786,178 		JBrowse link
G Actb actin, beta affects binding
increases expression 		ISO naphthalene metabolite binds to ACTB protein
naphthalene results in increased expression of ACTB protein 		CTD PMID:15892573 PMID:19438287 NCBI chr12:16,776,664...16,779,634
Ensembl chr12:16,776,661...16,780,242 		JBrowse link
G Actr1b actin related protein 1B decreases expression ISO naphthalene results in decreased expression of ACTR1B protein CTD PMID:19438287 NCBI chr 9:46,424,677...46,434,341
Ensembl chr 9:46,424,678...46,434,341 		JBrowse link
G Ada adenosine deaminase increases expression ISO naphthalene results in increased expression of ADA mRNA CTD PMID:18978301 NCBI chr 3:172,818,174...172,842,283
Ensembl chr 3:172,818,176...172,842,293 		JBrowse link
G Adamts15 ADAM metallopeptidase with thrombospondin type 1 motif, 15 decreases expression EXP naphthalene analog results in decreased expression of ADAMTS15 mRNA CTD PMID:24976557 NCBI chr 8:37,566,064...37,589,446
Ensembl chr 8:37,566,065...37,589,446 		JBrowse link
G Adgra1 adhesion G protein-coupled receptor A1 decreases expression EXP naphthalene analog results in decreased expression of ADGRA1 mRNA CTD PMID:24976557 NCBI chr 1:204,059,218...204,102,869
Ensembl chr 1:204,059,367...204,102,869 		JBrowse link
G Adh1c alcohol dehydrogenase 1C (class I), gamma polypeptide decreases expression EXP naphthalene analog results in decreased expression of ADH1 mRNA CTD PMID:24976557 NCBI chr 2:229,470,703...229,482,291
Ensembl chr 2:229,470,703...229,482,291 		JBrowse link
G Adra2c adrenoceptor alpha 2C decreases expression EXP naphthalene analog results in decreased expression of ADRA2C mRNA CTD PMID:24976557 NCBI chr14:79,695,514...79,697,476
Ensembl chr14:79,694,995...79,706,656 		JBrowse link
G Ager advanced glycosylation end product-specific receptor affects binding ISO naphthalene metabolite binds to AGER protein CTD PMID:15892573 NCBI chr20:4,152,758...4,155,956
Ensembl chr20:4,151,965...4,155,685 		JBrowse link
G Ahr aryl hydrocarbon receptor increases activity
multiple interactions 		ISO naphthalene results in increased activity of AHR protein
[acenaphthene co-treated with anthracene co-treated with 1,12-benzoperylene co-treated with 1,2,5,6-dibenzanthracene co-treated with fluorene co-treated with naphthalene co-treated with phenanthrene] results in increased activity of AHR protein; [naphthalene co-treated with phenanthrene co-treated with anthracene co-treated with fluoranthene co-treated with pyrene] results in decreased expression of AHR protein; [phenanthrene co-treated with naphthalene] inhibits the reaction [Benzo(a)pyrene results in increased activity of AHR protein]; [pyrene co-treated with naphthalene] inhibits the reaction [Benzo(a)pyrene results in increased activity of AHR protein]; AHR protein affects the reaction [[naphthalene co-treated with phenanthrene co-treated with anthracene co-treated with fluoranthene co-treated with pyrene] results in decreased expression of AR protein]; AHR protein affects the reaction [[naphthalene co-treated with phenanthrene co-treated with anthracene co-treated with fluoranthene co-treated with pyrene] results in increased expression of ESR1 protein]; AHRR protein affects the reaction [[naphthalene co-treated with phenanthrene co-treated with anthracene co-treated with fluoranthene co-treated with pyrene] results in decreased expression of AHR protein]; naphthalene inhibits the reaction [Benzo(a)pyrene results in increased activity of AHR protein] 		CTD PMID:17665671 PMID:28710019 PMID:29502740 PMID:30980910 NCBI chr 6:57,961,423...57,998,901
Ensembl chr 6:57,961,423...57,998,901 		JBrowse link
G Ahrr aryl-hydrocarbon receptor repressor multiple interactions ISO [naphthalene co-treated with phenanthrene co-treated with anthracene co-treated with fluoranthene co-treated with pyrene] results in decreased expression of AHRR protein; AHRR protein affects the reaction [[naphthalene co-treated with phenanthrene co-treated with anthracene co-treated with fluoranthene co-treated with pyrene] results in decreased expression of AHR protein]; AHRR protein affects the reaction [[naphthalene co-treated with phenanthrene co-treated with anthracene co-treated with fluoranthene co-treated with pyrene] results in decreased expression of CYP1A1 protein] CTD PMID:28710019 PMID:30980910 NCBI chr 1:30,822,219...30,917,251
Ensembl chr 1:30,810,866...30,952,866 		JBrowse link
G Ahsg alpha-2-HS-glycoprotein increases expression ISO naphthalene results in increased expression of AHSG mRNA CTD PMID:18978301 NCBI chr11:91,625,975...91,632,583
Ensembl chr11:91,625,975...91,634,039 		JBrowse link
G Akr1b15 aldo-keto reductase family 1 member B15 increases expression EXP naphthalene analog results in increased expression of AKR1B8 mRNA CTD PMID:24976557 NCBI chr 4:63,964,421...63,976,995
Ensembl chr 4:63,960,880...63,978,349 		JBrowse link
G Akr7a3 aldo-keto reductase family 7 member A3 increases expression EXP naphthalene analog results in increased expression of AKR7A3 mRNA CTD PMID:24976557 NCBI chr 5:156,876,721...156,884,599
Ensembl chr 5:156,874,086...156,885,153 		JBrowse link
G Akt1 AKT serine/threonine kinase 1 affects response to substance
multiple interactions 		ISO AKT1 affects the susceptibility to naphthalene
[naphthalene co-treated with AKT1] results in increased expression of EIF4E protein; [naphthalene co-treated with AKT1] results in increased phosphorylation of EIF4E protein 		CTD PMID:22122896 NCBI chr 6:137,534,810...137,555,131
Ensembl chr 6:137,535,390...137,552,610 		JBrowse link
G Alb albumin affects binding
increases expression 		ISO naphthalene metabolite binds to ALB protein
naphthalene results in increased expression of ALB protein 		CTD PMID:15892573 PMID:16206326 PMID:19438287 NCBI chr14:17,891,564...17,907,043
Ensembl chr14:17,891,582...17,911,865 		JBrowse link
G Aldh1a1 aldehyde dehydrogenase 1 family, member A1 multiple interactions
decreases expression 		ISO [naphthalene co-treated with CFTR gene mutant form] results in decreased expression of ALDH1A1 mRNA; [naphthalene co-treated with CFTR gene mutant form] results in decreased expression of ALDH1A1 protein; CFTR gene mutant form affects the reaction [naphthalene results in decreased expression of ALDH1A1 protein]
naphthalene results in decreased expression of ALDH1A1 mRNA; naphthalene results in decreased expression of ALDH1A1 protein 		CTD PMID:19438287 NCBI chr 1:227,426,939...227,579,497
Ensembl chr 1:227,427,070...227,579,500 		JBrowse link
G Aldh2 aldehyde dehydrogenase 2 family member multiple interactions
decreases expression
increases reduction
decreases reduction 		ISO [naphthalene co-treated with CFTR gene mutant form] results in decreased expression of ALDH2 protein; CFTR gene mutant form affects the reaction [naphthalene results in decreased expression of ALDH2 protein]
naphthalene results in increased reduction of ALDH2 protein
naphthalene results in decreased reduction of ALDH2 protein 		CTD PMID:19438287 PMID:19843705 NCBI chr12:40,610,244...40,643,220
Ensembl chr12:40,610,224...40,643,219 		JBrowse link
G Aloxe3 arachidonate epidermal lipoxygenase 3 increases expression ISO naphthalene results in increased expression of ALOXE3 mRNA CTD PMID:18978301 NCBI chr10:54,329,224...54,353,167
Ensembl chr10:54,329,043...54,353,166 		JBrowse link
G Alpl alkaline phosphatase, biomineralization associated increases expression ISO naphthalene results in increased expression of ALPL mRNA CTD PMID:18978301 NCBI chr 5:155,234,770...155,289,785
Ensembl chr 5:155,234,775...155,254,167 		JBrowse link
G Angptl4 angiopoietin-like 4 increases expression ISO naphthalene results in increased expression of ANGPTL4 mRNA CTD PMID:18978301 NCBI chr 7:15,252,450...15,259,971
Ensembl chr 7:15,252,473...15,258,681 		JBrowse link
G Ankrd17 ankyrin repeat domain 17 increases expression ISO naphthalene results in increased expression of ANKRD17 mRNA CTD PMID:18978301 NCBI chr14:18,007,342...18,145,980
Ensembl chr14:18,008,859...18,145,980 		JBrowse link
G Anxa5 annexin A5 decreases reduction ISO naphthalene results in decreased reduction of ANXA5 protein CTD PMID:19843705 NCBI chr 2:121,242,133...121,272,935
Ensembl chr 2:121,242,136...121,281,400 		JBrowse link
G Aox4 aldehyde oxidase 4 decreases expression EXP naphthalene analog results in decreased expression of AOX4 mRNA CTD PMID:24976557 NCBI chr 9:67,255,437...67,312,364
Ensembl chr 9:67,255,437...67,312,364 		JBrowse link
G Apoc2 apolipoprotein C2 increases expression ISO naphthalene results in increased expression of APOC2 mRNA CTD PMID:18978301 NCBI chr 1:88,457,397...88,462,365
Ensembl chr 1:88,457,396...88,463,438 		JBrowse link
G Apod apolipoprotein D increases expression ISO naphthalene results in increased expression of APOD mRNA CTD PMID:18978301 NCBI chr11:82,936,216...82,957,264
Ensembl chr11:82,936,038...82,957,263 		JBrowse link
G Ar androgen receptor multiple interactions EXP
ISO 		naphthalene inhibits the reaction [Metribolone binds to AR protein]
[naphthalene co-treated with phenanthrene co-treated with anthracene co-treated with fluoranthene co-treated with pyrene] results in decreased expression of AR protein; AHR protein affects the reaction [[naphthalene co-treated with phenanthrene co-treated with anthracene co-treated with fluoranthene co-treated with pyrene] results in decreased expression of AR protein] 		CTD PMID:3695475 PMID:30980910 NCBI chr  X:67,135,317...67,304,476
Ensembl chr  X:67,135,317...67,304,467 		JBrowse link
G Areg amphiregulin increases expression ISO
EXP 		naphthalene results in increased expression of AREG mRNA
naphthalene analog results in increased expression of AREG mRNA 		CTD PMID:18978301 PMID:24976557 NCBI chr14:17,256,384...17,265,641
Ensembl chr14:17,256,384...17,265,641 		JBrowse link
G Arg1 arginase 1 increases expression ISO naphthalene results in increased expression of ARG1 mRNA CTD PMID:18978301 NCBI chr 1:22,295,093...22,307,720
Ensembl chr 1:22,295,322...22,307,713 		JBrowse link
G Arg2 arginase 2 increases expression ISO naphthalene results in increased expression of ARG2 mRNA CTD PMID:18978301 NCBI chr 6:103,669,001...103,694,375
Ensembl chr 6:103,668,988...103,694,375 		JBrowse link
G Arhgap24 Rho GTPase activating protein 24 increases expression ISO naphthalene results in increased expression of ARHGAP24 mRNA CTD PMID:18978301 NCBI chr14:7,105,200...7,488,437
Ensembl chr14:7,105,200...7,528,950 		JBrowse link
G Arid5a AT-rich interaction domain 5A increases expression ISO naphthalene results in increased expression of ARID5A mRNA CTD PMID:18978301 NCBI chr 9:46,030,513...46,058,729
Ensembl chr 9:46,030,548...46,045,363 		JBrowse link
G Arl4d ARF like GTPase 4D increases expression ISO naphthalene results in increased expression of ARL4D mRNA CTD PMID:18978301 NCBI chr10:87,092,276...87,103,079
Ensembl chr10:87,077,523...87,106,199 		JBrowse link
G Arl8a ARF like GTPase 8A increases expression ISO naphthalene results in increased expression of ARL8A mRNA CTD PMID:18978301 NCBI chr13:49,137,632...49,146,633
Ensembl chr13:49,137,632...49,146,633 		JBrowse link
G Arnt aryl hydrocarbon receptor nuclear translocator multiple interactions ISO [naphthalene co-treated with phenanthrene co-treated with anthracene co-treated with fluoranthene co-treated with pyrene] affects the expression of ARNT protein; [naphthalene co-treated with phenanthrene co-treated with anthracene co-treated with fluoranthene co-treated with pyrene] results in decreased expression of ARNT mRNA; [naphthalene co-treated with phenanthrene co-treated with anthracene co-treated with fluoranthene co-treated with pyrene] results in increased expression of ARNT mRNA CTD PMID:28710019 NCBI chr 2:185,686,703...185,745,546
Ensembl chr 2:185,680,683...185,745,546 		JBrowse link
G Ascl1 achaete-scute family bHLH transcription factor 1 multiple interactions
increases expression 		ISO ASCL1 protein inhibits the reaction [naphthalene results in decreased expression of CYP2F2 mRNA]; ASCL1 protein inhibits the reaction [naphthalene results in decreased expression of SCGB1A1 protein]; ASCL1 protein inhibits the reaction [naphthalene results in increased expression of SYP protein]
naphthalene results in increased expression of ASCL1 protein 		CTD PMID:20554700 NCBI chr 7:23,790,642...23,793,509
Ensembl chr 7:23,790,360...23,798,231 		JBrowse link
G Atf3 activating transcription factor 3 increases expression ISO naphthalene results in increased expression of ATF3 mRNA CTD PMID:18978301 NCBI chr13:105,274,103...105,331,653
Ensembl chr13:105,282,440...105,295,750 		JBrowse link
G Atp5f1a ATP synthase F1 subunit alpha decreases expression
multiple interactions 		ISO naphthalene results in decreased expression of ATP5F1A protein
[naphthalene co-treated with CFTR gene mutant form] results in decreased expression of ATP5F1A protein 		CTD PMID:19438287 NCBI chr18:73,567,537...73,575,473
Ensembl chr18:73,567,526...73,575,922 		JBrowse link
G Atp5f1b ATP synthase F1 subunit beta decreases expression
affects binding 		ISO naphthalene results in decreased expression of ATP5F1B protein
naphthalene metabolite binds to ATP5F1B protein 		CTD PMID:15892573 PMID:19438287 NCBI chr 7:1,100,058...1,106,461
Ensembl chr 7:1,099,860...1,106,462 		JBrowse link
G Atrx ATRX, chromatin remodeler increases expression EXP naphthalene analog results in increased expression of ATRX mRNA CTD PMID:24976557 NCBI chr  X:74,916,548...75,062,880
Ensembl chr  X:74,916,548...75,062,880 		JBrowse link
G Aurka aurora kinase A increases expression ISO naphthalene results in increased expression of AURKA mRNA CTD PMID:18978301 NCBI chr 3:181,546,742...181,562,890
Ensembl chr 3:181,546,742...181,562,771 		JBrowse link
G Aurkb aurora kinase B increases expression ISO naphthalene results in increased expression of AURKB mRNA CTD PMID:18978301 NCBI chr10:54,243,116...54,249,675
Ensembl chr10:54,242,850...54,252,285 		JBrowse link
G B9d1 B9 domain containing 1 increases expression ISO naphthalene results in increased expression of B9D1 mRNA CTD PMID:18978301 NCBI chr10:46,685,410...46,698,580
Ensembl chr10:46,686,133...46,695,428 		JBrowse link
G Bax BCL2 associated X, apoptosis regulator multiple interactions
affects expression 		ISO [naphthalene co-treated with anthracene co-treated with phenanthrene co-treated with pyrene] affects the expression of BAX protein
naphthalene affects the expression of BAX protein 		CTD PMID:28803881 NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:105,076,473...105,086,429 		JBrowse link
G Bcl2 BCL2, apoptosis regulator increases expression ISO naphthalene results in increased expression of BCL2 protein CTD PMID:14595851 NCBI chr13:23,204,464...23,366,900
Ensembl chr13:23,204,464...23,366,900 		JBrowse link
G Bfar bifunctional apoptosis regulator increases expression ISO naphthalene results in increased expression of BFAR mRNA CTD PMID:18978301 NCBI chr10:2,059,189...2,092,207
Ensembl chr10:2,059,058...2,094,183 		JBrowse link
G Birc5 baculoviral IAP repeat-containing 5 increases expression ISO naphthalene results in increased expression of BIRC5 mRNA CTD PMID:18978301 NCBI chr10:103,567,369...103,580,069
Ensembl chr10:103,572,080...103,582,155 		JBrowse link
G Bpifa1 BPI fold containing family A, member 1 decreases expression ISO naphthalene results in decreased expression of BPIFA1 mRNA CTD PMID:20522644 NCBI chr 3:163,087,965...163,093,708
Ensembl chr 3:163,087,965...163,093,708 		JBrowse link
G Bpifb4 BPI fold containing family B, member 4 decreases expression EXP naphthalene analog results in decreased expression of BPIFB4 mRNA CTD PMID:24976557 NCBI chr 3:162,881,478...162,908,207
Ensembl chr 3:162,881,437...162,908,207 		JBrowse link
G Bpifb6 BPI fold containing family B, member 6 decreases expression EXP naphthalene analog results in decreased expression of BPIFB6 mRNA CTD PMID:24976557 NCBI chr 3:162,841,640...162,855,471
Ensembl chr 3:162,841,644...162,855,470 		JBrowse link
G Calcb calcitonin-related polypeptide, beta increases expression ISO
EXP 		naphthalene results in increased expression of CALCB mRNA
naphthalene analog results in increased expression of CALCB mRNA 		CTD PMID:18978301 PMID:24976557 NCBI chr 1:178,399,634...178,404,654
Ensembl chr 1:178,399,785...178,404,654 		JBrowse link
G Camp cathelicidin antimicrobial peptide increases expression ISO naphthalene results in increased expression of CAMP mRNA CTD PMID:18978301 NCBI chr 8:118,720,184...118,721,998
Ensembl chr 8:118,720,184...118,721,998 		JBrowse link
G Cap1 cyclase associated actin cytoskeleton regulatory protein 1 multiple interactions ISO [naphthalene co-treated with CFTR gene mutant form] results in decreased expression of CAP1 protein CTD PMID:19438287 NCBI chr 5:140,427,265...140,507,678
Ensembl chr 5:140,427,269...140,453,470 		JBrowse link
G Capn13 calpain 13 increases expression EXP naphthalene analog results in increased expression of CAPN13 mRNA CTD PMID:24976557 NCBI chr 6:27,823,664...27,918,676
Ensembl chr 6:27,823,517...27,918,665 		JBrowse link
G Casp3 caspase 3 multiple interactions ISO [naphthalene co-treated with anthracene co-treated with phenanthrene co-treated with pyrene] results in increased expression of CASP3 protein CTD PMID:28803881 NCBI chr16:52,395,539...52,413,794
Ensembl chr16:52,395,540...52,413,732 		JBrowse link
G Casp9 caspase 9 multiple interactions ISO [naphthalene binds to pyrrolo(2,1-c)(1,4)benzodiazepine] which results in increased expression of CASP9 protein CTD PMID:21732540 Ensembl chr 5:159,391,188...159,409,648 JBrowse link
G Cbr2 carbonyl reductase 2 multiple interactions
decreases expression
increases reduction 		ISO [naphthalene co-treated with CFTR gene mutant form] results in decreased expression of CBR2 mRNA; [naphthalene co-treated with CFTR gene mutant form] results in decreased expression of CBR2 protein; CFTR gene mutant form affects the reaction [naphthalene results in decreased expression of CBR2 protein]
naphthalene results in decreased expression of CBR2 mRNA; naphthalene results in decreased expression of CBR2 protein
naphthalene results in increased reduction of CBR2 protein 		CTD PMID:19438287 PMID:19843705 NCBI chr10:106,508,964...106,511,614
Ensembl chr10:106,509,136...106,511,180 		JBrowse link
G Ccl12 C-C motif chemokine ligand 12 increases expression ISO naphthalene results in increased expression of CCL12 mRNA CTD PMID:18978301 NCBI chr10:67,567,876...67,569,426
Ensembl chr10:67,567,876...67,569,426 		JBrowse link
G Ccl17 C-C motif chemokine ligand 17 increases expression ISO naphthalene results in increased expression of CCL17 mRNA CTD PMID:18978301 NCBI chr19:10,208,120...10,218,340
Ensembl chr19:10,208,120...10,209,895 		JBrowse link
G Ccl2 C-C motif chemokine ligand 2 increases expression ISO naphthalene results in increased expression of CCL2 mRNA CTD PMID:18978301 NCBI chr10:67,503,077...67,504,875
Ensembl chr10:67,503,077...67,504,875 		JBrowse link
G Ccl3 C-C motif chemokine ligand 3 increases expression ISO naphthalene results in increased expression of CCL3 mRNA CTD PMID:18978301 NCBI chr10:68,948,889...68,950,439
Ensembl chr10:68,948,889...68,950,439 		JBrowse link
G Ccl7 C-C motif chemokine ligand 7 increases expression ISO naphthalene results in increased expression of CCL7 mRNA CTD PMID:18978301 NCBI chr10:67,514,095...67,515,945
Ensembl chr10:67,514,091...67,515,947 		JBrowse link
G Ccn1 cellular communication network factor 1 increases expression ISO naphthalene results in increased expression of CCN1 mRNA CTD PMID:18978301 NCBI chr 2:237,222,730...237,225,689
Ensembl chr 2:237,222,432...237,225,883 		JBrowse link
G Ccna2 cyclin A2 decreases expression
multiple interactions 		ISO naphthalene results in decreased expression of CCNA2 protein
[naphthalene co-treated with anthracene co-treated with phenanthrene co-treated with pyrene] results in decreased expression of CCNA2 protein 		CTD PMID:28803881 NCBI chr 2:121,355,363...121,361,762
Ensembl chr 2:121,355,363...121,361,701 		JBrowse link
G Ccnb2 cyclin B2 increases expression ISO naphthalene results in increased expression of CCNB2 mRNA CTD PMID:18978301 NCBI chr 8:79,968,459...79,981,717
Ensembl chr 8:79,968,465...79,981,682 		JBrowse link
G Ccnd1 cyclin D1 multiple interactions
increases expression 		ISO [naphthalene co-treated with anthracene co-treated with phenanthrene co-treated with pyrene] results in increased expression of CCND1 protein
naphthalene results in increased expression of CCND1 protein 		CTD PMID:28803881 NCBI chr 1:209,518,288...209,527,986
Ensembl chr 1:209,518,288...209,527,810 		JBrowse link
G Cct2 chaperonin containing TCP1 subunit 2 multiple interactions ISO [naphthalene co-treated with CFTR gene mutant form] results in decreased expression of CCT2 protein CTD PMID:19438287 NCBI chr 7:54,578,654...54,591,428
Ensembl chr 7:54,578,663...54,592,977 		JBrowse link
G Cct5 chaperonin containing TCP1 subunit 5 multiple interactions ISO [naphthalene co-treated with CFTR gene mutant form] results in decreased expression of CCT5 protein CTD PMID:19438287 NCBI chr 2:84,302,621...84,313,773
Ensembl chr 2:84,302,623...84,313,779 		JBrowse link
G Cd177 CD177 molecule increases expression ISO naphthalene results in increased expression of CD177 mRNA CTD PMID:18978301 NCBI chr 1:89,467,926...89,488,490
Ensembl chr 1:89,467,926...89,488,443 		JBrowse link
G Cdc20 cell division cycle 20 increases expression ISO naphthalene results in increased expression of CDC20 mRNA CTD PMID:18978301 NCBI chr 5:137,251,596...137,255,799
Ensembl chr 5:137,251,596...137,255,799 		JBrowse link
G Cdca3 cell division cycle associated 3 increases expression ISO naphthalene results in increased expression of CDCA3 mRNA CTD PMID:18978301 NCBI chr 4:159,321,203...159,325,072
Ensembl chr 4:159,321,014...159,325,068 		JBrowse link
G Cdca8 cell division cycle associated 8 increases expression ISO naphthalene results in increased expression of CDCA8 mRNA CTD PMID:18978301 NCBI chr 5:142,461,082...142,483,336
Ensembl chr 5:142,461,084...142,483,283 		JBrowse link
G Cdk1 cyclin-dependent kinase 1 increases expression ISO
EXP 		naphthalene results in increased expression of CDK1 mRNA
naphthalene analog results in increased expression of CDK1 mRNA 		CTD PMID:18978301 PMID:24976557 NCBI chr20:19,265,252...19,280,456
Ensembl chr20:19,265,289...19,280,455 		JBrowse link
G Cdk2 cyclin dependent kinase 2 multiple interactions
increases expression 		ISO [naphthalene co-treated with anthracene co-treated with phenanthrene co-treated with pyrene] results in increased expression of CDK2 protein
naphthalene results in increased expression of CDK2 protein 		CTD PMID:28803881 NCBI chr 7:1,714,392...1,721,964
Ensembl chr 7:1,714,392...1,721,878 		JBrowse link
G Cdkn1a cyclin-dependent kinase inhibitor 1A increases expression ISO naphthalene results in increased expression of CDKN1A mRNA CTD PMID:18978301 NCBI chr20:7,150,820...7,161,373
Ensembl chr20:7,153,958...7,164,969 		JBrowse link
G Cdkn1b cyclin-dependent kinase inhibitor 1B decreases expression ISO naphthalene results in decreased expression of CDKN1B protein CTD PMID:18687389 NCBI chr 4:169,491,273...169,496,500
Ensembl chr 4:169,490,876...169,496,498 		JBrowse link
G Ceacam4 CEA cell adhesion molecule 4 increases expression ISO naphthalene results in increased expression of CEACAM10 mRNA CTD PMID:18978301 NCBI chr 1:89,504,555...89,510,831
Ensembl chr 1:89,504,555...89,510,831 		JBrowse link
G Cenpm centromere protein M increases expression ISO naphthalene results in increased expression of CENPM mRNA CTD PMID:18978301 NCBI chr 7:115,628,117...115,639,401
Ensembl chr 7:115,628,129...115,643,866 		JBrowse link
G Cenpw centromere protein W increases expression EXP naphthalene analog results in increased expression of CENPW mRNA CTD PMID:24976557 NCBI chr 1:29,353,939...29,359,109
Ensembl chr 1:29,353,970...29,359,109 		JBrowse link
G Cfb complement factor B increases expression ISO naphthalene results in increased expression of CFB mRNA CTD PMID:18978301 NCBI chr20:3,975,271...3,981,138
Ensembl chr20:3,955,776...3,981,740 		JBrowse link
G Cftr CF transmembrane conductance regulator multiple interactions ISO [naphthalene co-treated with CFTR gene mutant form] results in decreased expression of ACO2 protein; [naphthalene co-treated with CFTR gene mutant form] results in decreased expression of ALDH1A1 mRNA; [naphthalene co-treated with CFTR gene mutant form] results in decreased expression of ALDH1A1 protein; [naphthalene co-treated with CFTR gene mutant form] results in decreased expression of ALDH2 protein; [naphthalene co-treated with CFTR gene mutant form] results in decreased expression of ATP5F1A protein; [naphthalene co-treated with CFTR gene mutant form] results in decreased expression of CAP1 protein; [naphthalene co-treated with CFTR gene mutant form] results in decreased expression of CBR2 mRNA; [naphthalene co-treated with CFTR gene mutant form] results in decreased expression of CBR2 protein; [naphthalene co-treated with CFTR gene mutant form] results in decreased expression of CCT2 protein; [naphthalene co-treated with CFTR gene mutant form] results in decreased expression of CCT5 protein; [naphthalene co-treated with CFTR gene mutant form] results in decreased expression of DPYSL2 protein; [naphthalene co-treated with CFTR gene mutant form] results in decreased expression of EEF2 protein; [naphthalene co-treated with CFTR gene mutant form] results in decreased expression of EHD4 protein; [naphthalene co-treated with CFTR gene mutant form] results in decreased expression of EZR protein; [naphthalene co-treated with CFTR gene mutant form] results in decreased expression of KRT16 protein; [naphthalene co-treated with CFTR gene mutant form] results in decreased expression of LDHB protein; [naphthalene co-treated with CFTR gene mutant form] results in decreased expression of LMNA protein; [naphthalene co-treated with CFTR gene mutant form] results in decreased expression of MSN protein; [naphthalene co-treated with CFTR gene mutant form] results in decreased expression of PKM protein; [naphthalene co-treated with CFTR gene mutant form] results in decreased expression of RDX protein; [naphthalene co-treated with CFTR gene mutant form] results in decreased expression of SEC14L3 protein; [naphthalene co-treated with CFTR gene mutant form] results in decreased expression of SELENBP1 protein; [naphthalene co-treated with CFTR gene mutant form] results in decreased expression of TCP1 protein; [naphthalene co-treated with CFTR gene mutant form] results in decreased expression of VAT1 protein; CFTR gene mutant form affects the reaction [naphthalene results in decreased expression of ALDH1A1 protein]; CFTR gene mutant form affects the reaction [naphthalene results in decreased expression of ALDH2 protein]; CFTR gene mutant form affects the reaction [naphthalene results in decreased expression of CBR2 protein] CTD PMID:19438287 NCBI chr 4:47,422,084...47,694,646
Ensembl chr 4:47,526,735...47,694,643 		JBrowse link
G Ch25h cholesterol 25-hydroxylase increases expression ISO naphthalene results in increased expression of CH25H mRNA CTD PMID:18978301 NCBI chr 1:241,428,048...241,429,366
Ensembl chr 1:241,331,619...241,431,190 		JBrowse link
G Chad chondroadherin decreases expression EXP naphthalene analog results in decreased expression of CHAD mRNA CTD PMID:24976557 NCBI chr10:80,009,045...80,012,816
Ensembl chr10:80,008,767...80,012,816 		JBrowse link
G Chi3l1 chitinase 3 like 1 increases expression ISO naphthalene results in increased expression of CHI3L1 mRNA CTD PMID:18978301 NCBI chr13:48,193,839...48,201,822
Ensembl chr13:48,193,800...48,201,825 		JBrowse link
G Cilk1 ciliogenesis associated kinase 1 increases expression ISO naphthalene results in increased expression of CILK1 mRNA CTD PMID:18978301 NCBI chr 8:87,868,294...87,922,995
Ensembl chr 8:87,868,156...87,922,995 		JBrowse link
G Ckb creatine kinase B increases expression ISO naphthalene results in increased expression of CKB mRNA CTD PMID:18978301 NCBI chr 6:136,550,583...136,553,464
Ensembl chr 6:136,549,844...136,553,478 		JBrowse link
G Cks1b CDC28 protein kinase regulatory subunit 1B increases expression ISO naphthalene results in increased expression of CKS1B mRNA CTD PMID:18978301 NCBI chr 2:177,130,751...177,135,333
Ensembl chr 2:177,130,777...177,135,365 		JBrowse link
G Cks2 CDC28 protein kinase regulatory subunit 2 increases expression EXP naphthalene analog results in increased expression of CKS2 mRNA CTD PMID:24976557 NCBI chr17:13,722,360...13,727,519
Ensembl chr17:13,722,361...13,727,519 		JBrowse link
G Clca1 chloride channel accessory 1 increases expression EXP naphthalene analog results in increased expression of CLCA1 mRNA CTD PMID:24976557 NCBI chr 2:236,599,022...236,624,714
Ensembl chr 2:236,599,022...236,624,714 		JBrowse link
G Clca4l chloride channel calcium activated 4-like increases expression EXP naphthalene analog results in increased expression of CLCA4L mRNA CTD PMID:24976557 NCBI chr 2:236,486,485...236,506,483
Ensembl chr 2:236,486,485...236,506,483 		JBrowse link
G Clcnkb chloride voltage-gated channel Kb increases expression ISO naphthalene results in increased expression of CLCNKB mRNA CTD PMID:18978301 NCBI chr 5:158,993,073...159,005,618
Ensembl chr 5:158,993,074...159,004,900 		JBrowse link
G Cldn1 claudin 1 decreases expression EXP naphthalene analog results in decreased expression of CLDN1 mRNA CTD PMID:24976557 NCBI chr11:87,926,376...87,941,533
Ensembl chr11:87,926,337...87,941,529 		JBrowse link
G Cldn10 claudin 10 decreases expression ISO naphthalene results in decreased expression of CLDN10 mRNA; naphthalene results in decreased expression of CLDN10 protein CTD PMID:18757308 NCBI chr15:102,269,858...102,361,589
Ensembl chr15:102,269,858...102,361,589 		JBrowse link
G Cldn2 claudin 2 multiple interactions ISO [gefitinib co-treated with naphthalene] affects the expression of CLDN2 mRNA CTD PMID:20935109 NCBI chr  X:108,248,383...108,258,847
Ensembl chr  X:108,237,676...108,262,377 		JBrowse link
G Cldn3 claudin 3 increases expression ISO naphthalene results in increased expression of CLDN3 mRNA CTD PMID:18978301 NCBI chr12:27,345,075...27,346,547
Ensembl chr12:27,345,076...27,348,841 		JBrowse link
G Cldn4 claudin 4 increases expression ISO naphthalene results in increased expression of CLDN4 mRNA CTD PMID:18978301 NCBI chr12:27,388,160...27,389,958
Ensembl chr12:27,387,981...27,389,958 		JBrowse link
G Clec11a C-type lectin domain containing 11A increases expression ISO naphthalene results in increased expression of CLEC11A mRNA CTD PMID:18978301 NCBI chr 1:103,938,029...103,941,170
Ensembl chr 1:103,935,185...103,946,784 		JBrowse link
G Clu clusterin increases expression ISO naphthalene results in increased expression of CLU mRNA CTD PMID:18978301 NCBI chr15:44,336,619...44,375,861
Ensembl chr15:44,359,914...44,375,860 		JBrowse link
G Col18a1 collagen type XVIII alpha 1 chain increases expression ISO naphthalene results in increased expression of COL18A1 mRNA CTD PMID:18978301 NCBI chr20:11,473,645...11,582,111
Ensembl chr20:11,473,645...11,582,112 		JBrowse link
G Col1a1 collagen type I alpha 1 chain increases expression ISO naphthalene results in increased expression of COL1A1 mRNA CTD PMID:18978301 NCBI chr10:80,380,458...80,397,461
Ensembl chr10:80,380,453...80,397,460 		JBrowse link
G Col1a2 collagen type I alpha 2 chain increases expression ISO naphthalene results in increased expression of COL1A2 mRNA CTD PMID:18978301 NCBI chr 4:33,518,557...33,553,484
Ensembl chr 4:33,518,420...33,553,995 		JBrowse link
G Col5a1 collagen type V alpha 1 chain increases expression ISO naphthalene results in increased expression of COL5A1 mRNA CTD PMID:18978301 NCBI chr 3:31,606,475...31,755,097
Ensembl chr 3:31,606,486...31,753,020 		JBrowse link
G Col5a2 collagen type V alpha 2 chain increases expression ISO naphthalene results in increased expression of COL5A2 mRNA CTD PMID:18978301 NCBI chr 9:54,940,768...55,090,151
Ensembl chr 9:54,940,764...55,090,150 		JBrowse link
G Col5a3 collagen type V alpha 3 chain increases expression ISO naphthalene results in increased expression of COL5A3 mRNA CTD PMID:18978301 NCBI chr 8:27,580,768...27,626,002
Ensembl chr 8:27,580,768...27,626,122 		JBrowse link
G Comt catechol-O-methyltransferase multiple interactions ISO [naphthalene co-treated with phenanthrene co-treated with anthracene co-treated with fluoranthene co-treated with pyrene] affects the expression of COMT mRNA; [naphthalene co-treated with phenanthrene co-treated with anthracene co-treated with fluoranthene co-treated with pyrene] results in increased expression of and affects the activity of COMT protein CTD PMID:28710019 NCBI chr11:96,072,371...96,091,956
Ensembl chr11:96,072,489...96,092,533 		JBrowse link
G Copg2 COPI coat complex subunit gamma 2 increases expression EXP naphthalene analog results in increased expression of COPG2 mRNA CTD PMID:24976557 NCBI chr 4:60,333,455...60,468,953
Ensembl chr 4:60,333,455...60,469,145 		JBrowse link
G Cpn1 carboxypeptidase N subunit 1 increases expression ISO naphthalene results in increased expression of CPN1 mRNA CTD PMID:18978301 NCBI chr 1:252,793,786...252,822,675
Ensembl chr 1:252,793,423...252,822,664 		JBrowse link
G Cpne8 copine 8 increases expression ISO naphthalene results in increased expression of CPNE8 mRNA CTD PMID:18978301 NCBI chr 7:123,494,864...123,669,060
Ensembl chr 7:123,494,865...123,669,060 		JBrowse link
G Cryaa crystallin, alpha A multiple interactions
increases cleavage 		EXP Thioctic Acid inhibits the reaction [naphthalene results in increased cleavage of CRYAA protein] CTD PMID:20597648 NCBI chr20:9,784,872...9,788,656
Ensembl chr20:9,784,857...9,788,654 		JBrowse link
G Cthrc1 collagen triple helix repeat containing 1 increases expression ISO naphthalene results in increased expression of CTHRC1 mRNA CTD PMID:18978301 NCBI chr 7:72,007,372...72,017,654
Ensembl chr 7:72,007,372...72,017,654 		JBrowse link
G Cxcl10 C-X-C motif chemokine ligand 10 increases expression ISO naphthalene results in increased expression of CXCL10 mRNA CTD PMID:18978301 NCBI chr14:15,989,066...15,991,263
Ensembl chr14:15,989,018...15,991,261 		JBrowse link
G Cxcl14 C-X-C motif chemokine ligand 14 increases expression ISO naphthalene results in increased expression of CXCL14 mRNA CTD PMID:18978301 NCBI chr17:8,323,150...8,331,176
Ensembl chr17:8,323,143...8,331,172 		JBrowse link
G Cxcl2 C-X-C motif chemokine ligand 2 increases expression ISO naphthalene results in increased expression of CXCL2 mRNA CTD PMID:18978301 NCBI chr14:17,465,210...17,467,255
Ensembl chr14:17,465,242...17,467,255 		JBrowse link
G Cxcl3 C-X-C motif chemokine ligand 3 increases expression ISO naphthalene results in increased expression of CXCL1 mRNA CTD PMID:18978301 NCBI chr14:17,571,900...17,573,624
Ensembl chr14:17,571,900...17,573,624 		JBrowse link
G Cyb5a cytochrome b5 type A decreases expression ISO naphthalene results in decreased expression of CYB5A protein CTD PMID:19438287 NCBI chr18:80,487,923...80,520,544
Ensembl chr18:14,453,966...14,455,094
Ensembl chr18:14,453,966...14,455,094 		JBrowse link
G Cycs cytochrome c, somatic increases reduction ISO naphthalene results in increased reduction of CYCS protein CTD PMID:12049837 NCBI chr 4:80,982,667...80,984,767
Ensembl chr 4:80,982,668...80,984,816
Ensembl chr18:80,982,668...80,984,816 		JBrowse link
G Cyp19a1 cytochrome P450, family 19, subfamily a, polypeptide 1 increases expression
decreases expression
multiple interactions 		ISO naphthalene results in increased expression of CYP19A1 protein
naphthalene results in decreased expression of CYP19A1 mRNA
[naphthalene co-treated with anthracene co-treated with phenanthrene co-treated with pyrene] affects the expression of CYP19A1 protein 		CTD PMID:28803881 PMID:31020322 NCBI chr 8:63,449,148...63,476,534
Ensembl chr 8:63,449,148...63,476,917 		JBrowse link
G Cyp1a1 cytochrome P450, family 1, subfamily a, polypeptide 1 increases expression
multiple interactions 		ISO naphthalene results in increased expression of CYP1A1 mRNA
[naphthalene co-treated with acenaphthene co-treated with 2-methylnaphthalene co-treated with 1-methylnaphthalene co-treated with Fluorine co-treated with phenanthrene] results in increased expression of CYP1A1 mRNA; [naphthalene co-treated with phenanthrene co-treated with anthracene co-treated with fluoranthene co-treated with pyrene] affects the expression of CYP1A1 mRNA; [naphthalene co-treated with phenanthrene co-treated with anthracene co-treated with fluoranthene co-treated with pyrene] affects the expression of CYP1A1 protein; [naphthalene co-treated with phenanthrene co-treated with anthracene co-treated with fluoranthene co-treated with pyrene] results in decreased expression of CYP1A1 protein; AHRR protein affects the reaction [[naphthalene co-treated with phenanthrene co-treated with anthracene co-treated with fluoranthene co-treated with pyrene] results in decreased expression of CYP1A1 protein] 		CTD PMID:20500019 PMID:28710019 PMID:30980910 PMID:38673911 NCBI chr 8:66,991,940...66,998,014
Ensembl chr 8:66,991,970...66,998,012 		JBrowse link
G Cyp1a2 cytochrome P450, family 1, subfamily a, polypeptide 2 multiple interactions
decreases activity 		ISO naphthalene inhibits the reaction [CYP1A2 protein results in increased chemical synthesis of 2-hydroxyestradiol]; naphthalene inhibits the reaction [CYP1A2 protein results in increased metabolism of Estradiol]
naphthalene analog results in decreased activity of CYP1A2 protein; naphthalene results in decreased activity of CYP1A2 protein 		CTD PMID:15916432 PMID:16790556 NCBI chr 8:66,971,261...66,978,149
Ensembl chr 8:66,971,261...66,978,149 		JBrowse link
G Cyp1b1 cytochrome P450, family 1, subfamily b, polypeptide 1 multiple interactions
increases expression 		ISO [naphthalene co-treated with acenaphthene co-treated with 2-methylnaphthalene co-treated with 1-methylnaphthalene co-treated with Fluorine co-treated with phenanthrene] results in increased expression of CYP1B1 mRNA; naphthalene binds to and results in decreased activity of CYP1B1 protein
naphthalene results in increased expression of CYP1B1 mRNA 		CTD PMID:19563207 PMID:27196671 PMID:38673911 NCBI chr 6:21,093,927...21,103,091
Ensembl chr 6:21,078,146...21,103,142 		JBrowse link
G Cyp2a1 cytochrome P450, family 2, subfamily a, polypeptide 1 increases metabolic processing
affects binding
multiple interactions
increases oxidation 		ISO CYP2A13 protein results in increased metabolism of naphthalene
naphthalene binds to CYP2A13 protein
[CYP2A13 protein results in increased oxidation of naphthalene] which results in increased abundance of 1-naphthol; [CYP2F1 protein co-treated with CYP2A13 protein] results in increased metabolism of naphthalene; CYP2F1 protein affects the reaction [CYP2A13 protein results in increased metabolism of naphthalene] 		CTD PMID:27137136 PMID:28599267 NCBI chr 1:91,359,278...91,372,554
Ensembl chr 1:91,359,272...91,389,730 		JBrowse link
G Cyp2c6 cytochrome P450, family 2, subfamily C, polypeptide 6 increases expression ISO naphthalene results in increased expression of CYP2C19 mRNA CTD PMID:20500019 NCBI chr 1:247,879,058...247,916,804
Ensembl chr 1:247,879,078...247,916,798 		JBrowse link
G Cyp2c79 cytochrome P450, family 2, subfamily c, polypeptide 79 increases expression ISO naphthalene results in increased expression of CYP2C8 mRNA CTD PMID:20500019
G Cyp2d4 cytochrome P450, family 2, subfamily d, polypeptide 4 increases expression ISO naphthalene results in increased expression of CYP2D6 mRNA CTD PMID:20500019 NCBI chr 7:115,762,662...115,771,832
Ensembl chr 7:115,761,696...115,771,837 		JBrowse link
G Cyp2e1 cytochrome P450, family 2, subfamily e, polypeptide 1 increases expression ISO naphthalene results in increased expression of CYP2E1 mRNA CTD PMID:20500019 NCBI chr 1:205,269,967...205,280,365
Ensembl chr 1:205,267,505...205,293,495 		JBrowse link
G Cyp2f4 cytochrome P450, family 2, subfamily f, polypeptide 4 increases abundance
decreases expression
increases metabolic processing
multiple interactions 		ISO
EXP 		CYP2F2 protein results in increased abundance of naphthalene metabolite
naphthalene results in decreased expression of CYP2F2 mRNA; naphthalene results in decreased expression of CYP2F2 protein
CYP2F2 protein results in increased metabolism of naphthalene
CYP2F2 protein results in increased metabolism of and results in increased susceptibility to naphthalene; Estradiol affects the reaction [CYP2F2 protein affects the abundance of naphthalene metabolite]
[CYP2F1 protein co-treated with CYP2A13 protein] results in increased metabolism of naphthalene; [FGF7 protein modified form results in decreased expression of CYP2F2 mRNA] which results in decreased susceptibility to naphthalene; ASCL1 protein inhibits the reaction [naphthalene results in decreased expression of CYP2F2 mRNA]; CYP2F1 protein affects the reaction [CYP2A13 protein results in increased metabolism of naphthalene] 		CTD PMID:9293621 PMID:15509722 PMID:16085760 PMID:18385170 PMID:18757308 More... NCBI chr 1:91,543,768...91,557,553
Ensembl chr 1:91,543,768...91,557,553 		JBrowse link
G Cyp2s1 cytochrome P450, family 2, subfamily s, polypeptide 1 affects metabolic processing ISO CYP2S1 protein affects the metabolism of naphthalene CTD PMID:16054184 NCBI chr 1:90,437,741...90,453,073
Ensembl chr 1:90,438,224...90,453,073 		JBrowse link
G Cyp3a2 cytochrome P450, family 3, subfamily a, polypeptide 2 increases expression ISO naphthalene results in increased expression of CYP3A4 mRNA CTD PMID:20500019 NCBI chr12:14,321,771...14,343,886
Ensembl chr12:14,321,771...14,343,857 		JBrowse link
G Cyp3a9 cytochrome P450, family 3, subfamily a, polypeptide 9 increases expression ISO naphthalene results in increased expression of CYP3A5 mRNA CTD PMID:20500019 NCBI chr12:21,919,955...21,960,160
Ensembl chr12:21,919,940...21,960,154 		JBrowse link
G Dctn5 dynactin subunit 5 increases expression ISO naphthalene results in increased expression of DCTN5 mRNA CTD PMID:18978301 NCBI chr 1:186,120,415...186,137,146
Ensembl chr 1:186,119,913...186,137,146 		JBrowse link
G Ddit4 DNA-damage-inducible transcript 4 increases expression ISO naphthalene results in increased expression of DDIT4 mRNA CTD PMID:18978301 NCBI chr20:28,434,938...28,437,037
Ensembl chr20:28,434,944...28,437,037 		JBrowse link
G Dera deoxyribose-phosphate aldolase increases expression ISO naphthalene results in increased expression of DERA mRNA CTD PMID:18978301 NCBI chr 4:172,394,971...172,473,746
Ensembl chr 4:172,394,962...172,490,142 		JBrowse link
G Dio3 iodothyronine deiodinase 3 increases expression ISO naphthalene results in increased expression of DIO3 mRNA CTD PMID:18978301 NCBI chr 6:135,107,072...135,108,933
Ensembl chr 6:135,107,074...135,107,985 		JBrowse link
G Dll1 delta like canonical Notch ligand 1 increases expression ISO naphthalene results in increased expression of DLL1 mRNA CTD PMID:18978301 NCBI chr 1:64,985,161...64,993,274
Ensembl chr 1:64,985,161...64,993,276 		JBrowse link
G Dpysl2 dihydropyrimidinase-like 2 multiple interactions ISO [naphthalene co-treated with CFTR gene mutant form] results in decreased expression of DPYSL2 protein CTD PMID:19438287 NCBI chr15:45,181,041...45,287,065
Ensembl chr15:45,181,041...45,287,065 		JBrowse link
G Dusp1 dual specificity phosphatase 1 increases expression ISO naphthalene results in increased expression of DUSP1 mRNA CTD PMID:18978301 NCBI chr10:17,184,853...17,187,646
Ensembl chr10:17,184,823...17,187,644 		JBrowse link
G Edn1 endothelin 1 increases expression ISO naphthalene results in increased expression of EDN1 mRNA CTD PMID:18978301 NCBI chr17:22,660,799...22,666,687
Ensembl chr17:22,660,799...22,666,687 		JBrowse link
G Edn2 endothelin 2 decreases expression ISO naphthalene results in decreased expression of EDN2 mRNA CTD PMID:18757308 NCBI chr 5:139,036,576...139,042,074
Ensembl chr 5:139,036,492...139,043,070 		JBrowse link
G Eef2 eukaryotic translation elongation factor 2 decreases expression
multiple interactions 		ISO naphthalene results in decreased expression of EEF2 protein
[naphthalene co-treated with CFTR gene mutant form] results in decreased expression of EEF2 protein 		CTD PMID:19438287 NCBI chr 7:9,183,836...9,196,255
Ensembl chr 7:9,183,961...9,189,544 		JBrowse link
G Egfr epidermal growth factor receptor multiple interactions ISO [gefitinib results in decreased activity of EGFR protein] which results in increased susceptibility to naphthalene CTD PMID:20935109 NCBI chr14:95,378,626...95,551,358
Ensembl chr14:95,378,626...95,551,358 		JBrowse link
G Egr2 early growth response 2 increases expression ISO naphthalene results in increased expression of EGR2 mRNA CTD PMID:18978301 NCBI chr20:21,050,149...21,055,201
Ensembl chr20:21,050,149...21,057,748 		JBrowse link
G Ehd1 EH-domain containing 1 decreases reduction ISO naphthalene results in decreased reduction of EHD1 protein CTD PMID:19843705 NCBI chr 1:213,009,113...213,031,488
Ensembl chr 1:213,008,049...213,031,485 		JBrowse link
G Ehd4 EH-domain containing 4 multiple interactions ISO [naphthalene co-treated with CFTR gene mutant form] results in decreased expression of EHD4 protein CTD PMID:19438287 NCBI chr 3:127,511,973...127,575,856
Ensembl chr 3:127,511,954...127,576,072 		JBrowse link
G Eif3a eukaryotic translation initiation factor 3, subunit A increases expression EXP naphthalene analog results in increased expression of EIF3A mRNA CTD PMID:24976557 NCBI chr 1:269,888,730...269,925,785
Ensembl chr 1:269,888,615...269,919,025 		JBrowse link
G Eif4e eukaryotic translation initiation factor 4E multiple interactions ISO [naphthalene co-treated with AKT1] results in increased expression of EIF4E protein; [naphthalene co-treated with AKT1] results in increased phosphorylation of EIF4E protein CTD PMID:22122896 NCBI chr 2:229,736,309...229,772,628
Ensembl chr 2:229,739,897...229,774,105 		JBrowse link
G Eln elastin increases expression ISO naphthalene results in increased expression of ELN mRNA CTD PMID:18978301 NCBI chr12:27,604,983...27,648,413
Ensembl chr12:27,604,680...27,648,413 		JBrowse link
G Enc1 ectodermal-neural cortex 1 increases expression EXP naphthalene analog results in increased expression of ENC1 mRNA CTD PMID:24976557 NCBI chr 2:30,285,274...30,297,194
Ensembl chr 2:30,283,736...30,315,721 		JBrowse link
G Ephx1 epoxide hydrolase 1 increases expression
increases response to substance
increases metabolic processing
multiple interactions 		ISO naphthalene results in increased expression of EPHX1 mRNA
EPHX1 results in increased susceptibility to naphthalene
EPHX1 protein results in increased metabolism of naphthalene
[EPHX1 protein results in increased metabolism of naphthalene] which results in increased chemical synthesis of 1,2-dihydroxy-1,2-dihydronaphthalene; [propionamide analog results in decreased activity of EPHX1 protein] which results in increased glutathionylation of naphthalene 		CTD PMID:18363382 PMID:20500019 PMID:26840748 NCBI chr13:95,246,079...95,275,852
Ensembl chr13:95,246,080...95,321,981 		JBrowse link
G Ephx2 epoxide hydrolase 2 increases expression ISO naphthalene results in increased expression of EPHX2 mRNA CTD PMID:20500019 NCBI chr15:44,465,447...44,503,157
Ensembl chr15:44,465,448...44,503,160 		JBrowse link
G Errfi1 ERBB receptor feedback inhibitor 1 increases expression ISO naphthalene results in increased expression of ERRFI1 mRNA CTD PMID:18978301 NCBI chr 5:166,606,841...166,620,124
Ensembl chr 5:166,606,834...166,620,432 		JBrowse link
G Esr1 estrogen receptor 1 multiple interactions ISO [naphthalene co-treated with phenanthrene co-treated with anthracene co-treated with fluoranthene co-treated with pyrene] results in increased expression of ESR1 protein; AHR protein affects the reaction [[naphthalene co-treated with phenanthrene co-treated with anthracene co-treated with fluoranthene co-treated with pyrene] results in increased expression of ESR1 protein] CTD PMID:30980910 NCBI chr 1:43,511,685...43,904,454
Ensembl chr 1:43,644,392...43,900,354 		JBrowse link
G Ezr ezrin decreases expression
multiple interactions 		ISO naphthalene results in decreased expression of EZR protein
[naphthalene co-treated with CFTR gene mutant form] results in decreased expression of EZR protein 		CTD PMID:19438287 NCBI chr 1:49,373,033...49,416,573
Ensembl chr 1:49,373,035...49,416,573 		JBrowse link
G F3 coagulation factor III, tissue factor increases expression ISO naphthalene results in increased expression of F3 mRNA CTD PMID:18978301 NCBI chr 2:212,511,675...212,523,375
Ensembl chr 2:212,511,680...212,523,369 		JBrowse link
G Fam83d family with sequence similarity 83, member D increases expression ISO naphthalene results in increased expression of FAM83D mRNA CTD PMID:18978301 NCBI chr 3:167,841,748...167,861,062
Ensembl chr 3:167,841,791...167,861,061 		JBrowse link
G Fbp1 fructose-bisphosphatase 1 increases expression ISO naphthalene results in increased expression of FBP1 mRNA CTD PMID:18978301 NCBI chr17:2,212,941...2,235,749
Ensembl chr17:2,213,492...2,235,746 		JBrowse link
G Fetub fetuin B increases expression ISO naphthalene results in increased expression of FETUB mRNA CTD PMID:18978301 NCBI chr11:91,586,750...91,599,789
Ensembl chr11:91,586,748...91,599,310 		JBrowse link
G Fgf7 fibroblast growth factor 7 multiple interactions ISO [FGF7 protein modified form results in decreased expression of CYP2F2 mRNA] which results in decreased susceptibility to naphthalene CTD PMID:18385170 NCBI chr 3:133,734,557...133,786,678
Ensembl chr 3:133,734,673...133,786,328 		JBrowse link
G Fgl1 fibrinogen-like 1 increases expression ISO naphthalene results in increased expression of FGL1 mRNA CTD PMID:18978301 NCBI chr16:57,824,127...57,854,413
Ensembl chr16:57,824,200...57,854,429 		JBrowse link
G Fkbp5 FKBP prolyl isomerase 5 increases expression ISO naphthalene results in increased expression of FKBP5 mRNA CTD PMID:18978301 NCBI chr20:6,458,931...6,577,227
Ensembl chr20:6,458,940...6,543,118 		JBrowse link
G Fmo3 flavin containing dimethylaniline monoxygenase 3 decreases expression ISO naphthalene results in decreased expression of FMO3 mRNA CTD PMID:18757308 NCBI chr13:77,838,899...77,868,869
Ensembl chr13:77,842,602...77,861,256 		JBrowse link
G Fos Fos proto-oncogene, AP-1 transcription factor subunit increases expression ISO naphthalene results in increased expression of FOS protein CTD PMID:14595851 NCBI chr 6:110,852,188...110,855,054
Ensembl chr 6:110,852,190...110,855,598 		JBrowse link
G Foxa1 forkhead box A1 increases expression ISO naphthalene results in increased expression of FOXA1 protein CTD PMID:16239640 NCBI chr 6:80,838,380...80,871,195
Ensembl chr 6:80,800,960...80,871,191 		JBrowse link
G Foxa2 forkhead box A2 increases expression ISO naphthalene results in increased expression of FOXA2 protein CTD PMID:16239640 NCBI chr 3:155,923,305...155,927,508
Ensembl chr 3:155,923,307...155,928,757 		JBrowse link
G Foxj1 forkhead box J1 affects expression
increases expression 		ISO naphthalene affects the expression of FOXJ1 protein
naphthalene results in increased expression of FOXJ1 mRNA 		CTD PMID:16239640 PMID:18978301 NCBI chr10:102,065,163...102,069,945
Ensembl chr10:102,065,170...102,069,241 		JBrowse link
G Ftl1 ferritin light chain 1 increases expression ISO naphthalene results in increased expression of FTL1 mRNA CTD PMID:18978301 NCBI chr 1:105,072,858...105,074,705
Ensembl chr  X:45,399,355...45,399,915
Ensembl chr 2:45,399,355...45,399,915
Ensembl chr 1:45,399,355...45,399,915 		JBrowse link
G Fus Fus RNA binding protein decreases expression ISO naphthalene results in decreased expression of FUS mRNA CTD PMID:14595851 NCBI chr 1:192,007,011...192,020,887
Ensembl chr 1:192,007,006...192,020,884 		JBrowse link
G Gabrp gamma-aminobutyric acid type A receptor subunit pi decreases expression ISO naphthalene results in decreased expression of GABRP mRNA CTD PMID:18757308 NCBI chr10:18,647,243...18,673,806
Ensembl chr10:18,647,243...18,673,727 		JBrowse link
G Gbp2 guanylate binding protein 2 increases expression ISO naphthalene results in increased expression of GBP2 mRNA CTD PMID:18978301 NCBI chr 2:234,005,727...234,021,812
Ensembl chr 2:234,008,590...234,021,810 		JBrowse link
G Gcgr glucagon receptor multiple interactions ISO naphthalene analog binds to and results in decreased activity of GCGR protein CTD PMID:16500101 NCBI chr10:106,306,803...106,314,970
Ensembl chr10:106,306,559...106,314,969 		JBrowse link
G Gclc glutamate-cysteine ligase, catalytic subunit multiple interactions
affects expression
decreases expression
increases expression
increases activity
decreases response to substance 		ISO
EXP 		Buthionine Sulfoximine inhibits the reaction [GCLC protein results in decreased susceptibility to naphthalene]; Buthionine Sulfoximine inhibits the reaction [naphthalene results in increased activity of GCLC protein]; naphthalene results in increased expression of and results in increased activity of GCLC protein
naphthalene affects the expression of GCLC mRNA
naphthalene results in decreased expression of GCLC mRNA
naphthalene analog results in increased expression of GCLC mRNA; naphthalene results in increased expression of GCLC mRNA 		CTD PMID:10900227 PMID:12805647 PMID:24563378 PMID:24976557 PMID:31020322 More... NCBI chr 8:87,510,251...87,548,896
Ensembl chr 8:87,510,463...87,548,893 		JBrowse link
G Gclm glutamate cysteine ligase, modifier subunit decreases expression
affects expression 		ISO naphthalene results in decreased expression of GCLM mRNA
naphthalene affects the expression of GCLM mRNA 		CTD PMID:31020322 PMID:38768835 NCBI chr 2:213,032,135...213,052,192
Ensembl chr 2:213,031,838...213,055,003 		JBrowse link
G Gdf15 growth differentiation factor 15 increases expression ISO
EXP 		naphthalene results in increased expression of GDF15 mRNA
naphthalene analog results in increased expression of GDF15 mRNA 		CTD PMID:18978301 PMID:24976557 NCBI chr16:18,838,436...18,842,022
Ensembl chr16:18,838,436...18,842,022 		JBrowse link
G Gfra3 GDNF family receptor alpha 3 decreases expression EXP naphthalene analog results in decreased expression of GFRA3 mRNA CTD PMID:24976557 NCBI chr18:26,571,952...26,600,225
Ensembl chr18:26,571,921...26,600,225 		JBrowse link
G Ggt1 gamma-glutamyltransferase 1 increases expression EXP naphthalene analog results in increased expression of GGT1 mRNA CTD PMID:24976557 NCBI chr20:13,074,141...13,103,551
Ensembl chr20:13,074,141...13,088,050 		JBrowse link
G Gins2 GINS complex subunit 2 increases expression ISO naphthalene results in increased expression of GINS2 mRNA CTD PMID:18978301 NCBI chr19:65,535,492...65,548,270
Ensembl chr19:65,535,492...65,548,052 		JBrowse link
G Gjb3 gap junction protein, beta 3 increases expression ISO naphthalene results in increased expression of GJB3 mRNA CTD PMID:18978301 NCBI chr 5:144,933,692...144,939,435
Ensembl chr 5:144,933,696...144,940,280 		JBrowse link
G Gjb5 gap junction protein, beta 5 increases expression ISO naphthalene results in increased expression of GJB5 mRNA CTD PMID:18978301 NCBI chr 5:144,965,133...144,968,051
Ensembl chr 5:144,964,751...144,984,021 		JBrowse link
G Gldc glycine decarboxylase increases expression ISO naphthalene results in increased expression of GLDC mRNA CTD PMID:18978301 NCBI chr 1:237,296,753...237,375,620
Ensembl chr 1:237,296,753...237,375,604 		JBrowse link
G Glrb glycine receptor, beta decreases expression EXP naphthalene analog results in decreased expression of GLRB mRNA CTD PMID:24976557 NCBI chr 2:168,432,736...168,505,614
Ensembl chr 2:168,432,736...168,505,614 		JBrowse link
G Gnmt glycine N-methyltransferase multiple interactions ISO [gefitinib co-treated with naphthalene] affects the expression of GNMT mRNA CTD PMID:20935109 NCBI chr 9:21,752,235...21,756,368
Ensembl chr 9:21,752,266...21,755,692 		JBrowse link
G Gp1bb glycoprotein Ib platelet subunit beta increases expression ISO naphthalene results in increased expression of GP1BB mRNA CTD PMID:18978301 NCBI chr11:95,882,561...95,883,738 JBrowse link
G Gpha2 glycoprotein hormone subunit alpha 2 decreases expression EXP naphthalene analog results in decreased expression of GPHA2 mRNA CTD PMID:24976557 NCBI chr 1:212,954,579...212,956,536
Ensembl chr 1:212,955,387...212,956,535 		JBrowse link
G Gpr182 G protein-coupled receptor 182 increases expression ISO naphthalene results in increased expression of GPR182 mRNA CTD PMID:18978301 NCBI chr 7:65,471,254...65,474,110
Ensembl chr 7:65,452,965...65,474,998 		JBrowse link
G Gpr19 G protein-coupled receptor 19 increases expression ISO naphthalene results in increased expression of GPR19 mRNA CTD PMID:18978301 NCBI chr 4:169,442,278...169,468,805
Ensembl chr 4:169,436,658...169,471,249 		JBrowse link
G Gpx1 glutathione peroxidase 1 decreases expression ISO naphthalene results in decreased expression of GPX1 mRNA CTD PMID:31020322 PMID:38768835 NCBI chr 8:117,905,462...117,906,588
Ensembl chr 8:117,905,280...117,906,581 		JBrowse link
G Gpx3 glutathione peroxidase 3 decreases expression ISO naphthalene results in decreased expression of GPX3 mRNA CTD PMID:31020322 NCBI chr10:39,529,335...39,537,406
Ensembl chr10:39,529,448...39,537,405 		JBrowse link
G Gpx4 glutathione peroxidase 4 decreases expression ISO naphthalene results in decreased expression of GPX4 mRNA CTD PMID:31020322 NCBI chr 7:10,300,833...10,303,629
Ensembl chr 7:10,300,832...10,303,629 		JBrowse link
G Gpx5 glutathione peroxidase 5 decreases expression ISO naphthalene results in decreased expression of GPX5 mRNA CTD PMID:31020322 NCBI chr17:48,131,853...48,138,801
Ensembl chr17:48,093,895...48,138,801 		JBrowse link
G Gpx6 glutathione peroxidase 6 decreases expression ISO naphthalene results in decreased expression of GPX6 mRNA CTD PMID:31020322 NCBI chr17:48,104,197...48,111,816
Ensembl chr17:48,104,197...48,111,007 		JBrowse link
G Gpx7 glutathione peroxidase 7 increases expression ISO naphthalene results in increased expression of GPX7 mRNA CTD PMID:18978301 PMID:31020322 NCBI chr 5:128,373,881...128,381,866
Ensembl chr 5:128,372,875...128,381,725 		JBrowse link
G Gsr glutathione-disulfide reductase decreases expression
affects expression
multiple interactions 		ISO naphthalene results in decreased expression of GSR mRNA
naphthalene affects the expression of GSR mRNA
[Ergothioneine co-treated with naphthalene] results in increased expression of GSR mRNA; naphthalene promotes the reaction [Ergothioneine results in decreased expression of GSR mRNA] 		CTD PMID:31020322 PMID:38768835 NCBI chr16:65,185,574...65,228,742
Ensembl chr16:65,185,574...65,228,394 		JBrowse link
G Gss glutathione synthetase decreases expression ISO naphthalene results in decreased expression of GSS mRNA CTD PMID:31020322 NCBI chr 3:164,508,005...164,538,343
Ensembl chr 3:164,508,005...164,538,306 		JBrowse link
G Gsta4 glutathione S-transferase alpha 4 decreases expression ISO naphthalene results in decreased expression of GSTA4 mRNA CTD PMID:31020322 NCBI chr 8:87,947,247...87,964,490
Ensembl chr 8:87,930,566...87,964,488 		JBrowse link
G Gstk1 glutathione S-transferase kappa 1 decreases expression ISO naphthalene results in decreased expression of GSTK1 mRNA CTD PMID:31020322 NCBI chr 4:72,085,532...72,089,934
Ensembl chr 4:72,085,531...72,089,927 		JBrowse link
G Gstm1 glutathione S-transferase mu 1 increases expression
decreases expression
affects expression 		ISO naphthalene results in increased expression of GSTM1 mRNA
naphthalene results in decreased expression of GSTM1 protein
naphthalene affects the expression of GSTM1 protein 		CTD PMID:10959795 PMID:19438287 PMID:20500019 NCBI chr 2:198,338,005...198,346,007
Ensembl chr 2:198,338,008...198,343,569 		JBrowse link
G Gstm2 glutathione S-transferase mu 2 affects expression
increases expression
decreases expression 		ISO naphthalene affects the expression of GSTM2 protein
naphthalene results in increased expression of GSTM5 mRNA
naphthalene results in decreased expression of GSTM2 mRNA 		CTD PMID:10959795 PMID:31020322 NCBI chr 2:198,312,179...198,316,962 JBrowse link
G Gstm4 glutathione S-transferase mu 4 decreases expression ISO naphthalene results in decreased expression of GSTM4 mRNA CTD PMID:31020322 NCBI chr 2:198,356,114...198,373,487
Ensembl chr 2:198,358,744...198,373,638 		JBrowse link
G Gstm5 glutathione S-transferase, mu 5 affects expression ISO naphthalene affects the expression of GSTM3 mRNA CTD PMID:31020322 NCBI chr 2:198,219,769...198,222,732
Ensembl chr 2:198,219,647...198,222,731 		JBrowse link
G Gsto2 glutathione S-transferase omega 2 decreases expression ISO naphthalene results in decreased expression of GSTO2 mRNA CTD PMID:31020322 NCBI chr 1:256,673,376...256,695,154
Ensembl chr 1:256,673,274...256,695,146 		JBrowse link
G Gstp1 glutathione S-transferase pi 1 increases expression
decreases expression 		ISO naphthalene results in increased expression of GSTP1 mRNA; naphthalene results in increased expression of GSTP1 protein
naphthalene results in decreased expression of GSTP1 mRNA 		CTD PMID:10959795 PMID:31020322 PMID:38768835 NCBI chr 1:210,767,237...210,770,242
Ensembl chr 1:210,767,237...210,769,705 		JBrowse link
G Gstt1 glutathione S-transferase theta 1 decreases expression ISO naphthalene results in decreased expression of GSTT1 mRNA CTD PMID:31020322 NCBI chr20:12,856,068...12,873,020
Ensembl chr20:12,856,083...12,873,019 		JBrowse link
G Hilpda hypoxia inducible lipid droplet-associated increases expression ISO naphthalene results in increased expression of HILPDA mRNA CTD PMID:18978301 NCBI chr 4:58,836,463...58,839,423
Ensembl chr 4:58,836,463...58,839,423 		JBrowse link
G Hmgb1 high mobility group box 1 increases expression ISO naphthalene results in increased expression of HMGB1 protein CTD PMID:21399660 NCBI chr12:11,009,236...11,015,941
Ensembl chr16:39,039,050...39,041,327
Ensembl chr12:39,039,050...39,041,327 		JBrowse link
G Hmox1 heme oxygenase 1 increases expression ISO
EXP 		naphthalene results in increased expression of HMOX1 mRNA; naphthalene results in increased expression of HMOX1 protein
naphthalene analog results in increased expression of HMOX1 mRNA; naphthalene results in increased expression of HMOX1 mRNA 		CTD PMID:14550745 PMID:18978301 PMID:24563378 PMID:24976557 NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,472,884...13,479,818 		JBrowse link
G Hrh2 histamine receptor H 2 decreases expression ISO naphthalene results in decreased expression of HRH2 mRNA CTD PMID:18757308 NCBI chr17:10,371,083...10,412,979
Ensembl chr17:10,371,083...10,391,041 		JBrowse link
G Hs3st1 heparan sulfate-glucosamine 3-sulfotransferase 1 increases expression ISO naphthalene results in increased expression of HS3ST1 mRNA CTD PMID:18978301 NCBI chr14:75,398,101...75,429,628
Ensembl chr14:75,398,026...75,436,848 		JBrowse link
G Hsd17b6 hydroxysteroid (17-beta) dehydrogenase 6 decreases expression EXP naphthalene analog results in decreased expression of HSD17B6 mRNA CTD PMID:24976557 NCBI chr 7:831,407...850,950
Ensembl chr 7:831,421...850,873 		JBrowse link
G Hspa1a heat shock protein family A (Hsp70) member 1A increases expression ISO naphthalene results in increased expression of HSPA1A mRNA CTD PMID:18978301 NCBI chr20:3,875,411...3,877,866
Ensembl chr20:3,855,780...3,877,979 		JBrowse link
G Hspa1b heat shock protein family A (Hsp70) member 1B increases expression ISO naphthalene results in increased expression of HSPA1B mRNA CTD PMID:18978301 NCBI chr20:3,859,756...3,863,800
Ensembl chr20:3,855,780...3,877,979 		JBrowse link
G Hspa5 heat shock protein family A (Hsp70) member 5 affects binding
increases reduction 		ISO naphthalene metabolite binds to HSPA5 protein
naphthalene results in increased reduction of HSPA5 protein 		CTD PMID:16206326 PMID:19843705 NCBI chr 3:38,453,016...38,457,475
Ensembl chr 3:38,453,041...38,458,790 		JBrowse link
G Hspb1 heat shock protein family B (small) member 1 increases expression ISO naphthalene results in increased expression of HSPB1 protein CTD PMID:14550745 NCBI chr12:26,430,640...26,432,301
Ensembl chr12:26,430,640...26,432,301 		JBrowse link
G Ier3 immediate early response 3 increases expression ISO
EXP 		naphthalene results in increased expression of IER3 mRNA
naphthalene analog results in increased expression of IER3 mRNA 		CTD PMID:22579512 PMID:24976557 NCBI chr20:2,933,173...2,934,377
Ensembl chr20:2,933,174...2,934,377 		JBrowse link
G Igf1 insulin-like growth factor 1 increases expression ISO naphthalene results in increased expression of IGF1 mRNA CTD PMID:18978301 NCBI chr 7:24,169,608...24,249,446
Ensembl chr 7:24,130,137...24,246,764 		JBrowse link
G Igfbp3 insulin-like growth factor binding protein 3 increases expression ISO
EXP 		naphthalene results in increased expression of IGFBP3 mRNA
naphthalene analog results in increased expression of IGFBP3 mRNA 		CTD PMID:18978301 PMID:24976557 NCBI chr14:86,270,208...86,277,944
Ensembl chr14:86,270,208...86,277,944 		JBrowse link
G Igfbp6 insulin-like growth factor binding protein 6 increases expression ISO naphthalene results in increased expression of IGFBP6 mRNA CTD PMID:18978301 NCBI chr 7:135,154,919...135,159,550
Ensembl chr 7:135,154,685...135,159,795 		JBrowse link
G Il11 interleukin 11 increases expression ISO naphthalene results in increased expression of IL11 mRNA CTD PMID:18978301 NCBI chr 1:78,098,622...78,104,915
Ensembl chr 1:78,096,930...78,104,915 		JBrowse link
G Il4 interleukin 4 increases expression ISO naphthalene results in increased expression of IL4 protein CTD PMID:12112628 NCBI chr10:38,272,003...38,277,549
Ensembl chr10:38,272,003...38,277,549 		JBrowse link
G Il4i1 interleukin 4 induced 1 increases expression ISO naphthalene results in increased expression of IL4I1 mRNA CTD PMID:18978301 NCBI chr 1:104,435,540...104,461,049
Ensembl chr 1:104,435,981...104,461,053 		JBrowse link
G Ints2 integrator complex subunit 2 increases expression ISO naphthalene results in increased expression of INTS2 mRNA CTD PMID:18978301 NCBI chr10:71,529,021...71,576,529
Ensembl chr10:71,401,151...71,575,206 		JBrowse link
G Ip6k3 inositol hexakisphosphate kinase 3 increases expression ISO naphthalene results in increased expression of IP6K3 mRNA CTD PMID:18978301 NCBI chr20:5,225,706...5,247,293
Ensembl chr20:5,226,134...5,273,392 		JBrowse link
G Isyna1 inositol-3-phosphate synthase 1 increases expression ISO naphthalene results in increased expression of ISYNA1 mRNA CTD PMID:18978301 NCBI chr16:18,873,119...18,876,116
Ensembl chr16:18,873,121...18,875,955 		JBrowse link
G Itga2b integrin subunit alpha 2b increases expression ISO naphthalene results in increased expression of ITGA2B mRNA CTD PMID:18978301 NCBI chr10:87,908,697...87,926,225
Ensembl chr10:87,908,697...87,925,833 		JBrowse link
G Jam2 junctional adhesion molecule 2 decreases expression EXP naphthalene analog results in decreased expression of JAM2 mRNA CTD PMID:24976557 NCBI chr11:37,316,287...37,366,517
Ensembl chr11:37,317,511...37,367,510 		JBrowse link
G Jun Jun proto-oncogene, AP-1 transcription factor subunit increases expression ISO naphthalene results in increased expression of JUN protein CTD PMID:14595851 NCBI chr 5:115,009,900...115,012,993
Ensembl chr 5:114,973,151...115,013,285 		JBrowse link
G Kcnj16 potassium inwardly-rectifying channel, subfamily J, member 16 decreases expression EXP naphthalene analog results in decreased expression of KCNJ16 mRNA CTD PMID:24976557 NCBI chr10:96,489,329...96,520,745
Ensembl chr10:96,460,331...96,566,075 		JBrowse link
G Kcnq1 potassium voltage-gated channel subfamily Q member 1 increases expression ISO naphthalene results in increased expression of KCNQ1 mRNA CTD PMID:18978301 NCBI chr 1:207,721,134...208,054,073
Ensembl chr 1:207,721,131...208,054,072 		JBrowse link
G Kif18b kinesin family member 18B increases expression ISO naphthalene results in increased expression of KIF18B mRNA CTD PMID:18978301 NCBI chr10:88,370,520...88,392,388
Ensembl chr10:88,370,524...88,389,691 		JBrowse link
G Kif22 kinesin family member 22 increases expression ISO naphthalene results in increased expression of KIF22 mRNA CTD PMID:18978301 NCBI chr 1:191,065,875...191,080,955
Ensembl chr 1:191,065,875...191,080,878 		JBrowse link
G Klf15 KLF transcription factor 15 increases expression ISO naphthalene results in increased expression of KLF15 mRNA CTD PMID:18978301 NCBI chr 4:124,522,652...124,535,613
Ensembl chr 4:124,522,909...124,542,373 		JBrowse link
G Krt10 keratin 10 increases reduction ISO naphthalene results in increased reduction of KRT10 protein CTD PMID:19843705 NCBI chr10:84,834,865...84,839,160
Ensembl chr10:84,834,840...84,839,160 		JBrowse link
G Krt16 keratin 16 multiple interactions ISO [naphthalene co-treated with CFTR gene mutant form] results in decreased expression of KRT16 protein CTD PMID:19438287 NCBI chr10:85,669,276...85,672,211
Ensembl chr10:85,669,276...85,672,211 		JBrowse link
G Krt19 keratin 19 increases expression ISO naphthalene results in increased expression of KRT19 protein CTD PMID:19438287 NCBI chr10:85,576,235...85,580,952
Ensembl chr10:85,576,235...85,580,952 		JBrowse link
G Krtap17-1 keratin associated protein 17-1 increases expression ISO naphthalene results in increased expression of KRTAP17-1 mRNA CTD PMID:18978301 NCBI chr10:85,424,325...85,425,039
Ensembl chr10:85,424,325...85,425,039 		JBrowse link
G Lasp1 LIM and SH3 protein 1 decreases expression ISO naphthalene results in decreased expression of LASP1 protein CTD PMID:19438287 NCBI chr10:83,290,820...83,331,989
Ensembl chr10:83,290,865...83,331,988 		JBrowse link
G Lbh LBH regulator of WNT signaling pathway increases expression ISO naphthalene results in increased expression of LBH mRNA CTD PMID:18978301 NCBI chr 6:28,321,040...28,344,855
Ensembl chr 6:28,321,040...28,370,238 		JBrowse link
G Ldhb lactate dehydrogenase B multiple interactions ISO [naphthalene co-treated with CFTR gene mutant form] results in decreased expression of LDHB protein CTD PMID:19438287 NCBI chr 4:177,159,389...177,177,408
Ensembl chr 4:177,159,392...177,177,408 		JBrowse link
G Lgals1 galectin 1 increases expression ISO naphthalene results in increased expression of LGALS1 mRNA CTD PMID:18978301 PMID:22579512 NCBI chr 7:112,365,695...112,368,801
Ensembl chr 7:112,361,850...112,368,800 		JBrowse link
G Lgals9 galectin 9 multiple interactions ISO [gefitinib co-treated with naphthalene] affects the expression of LGALS9 mRNA CTD PMID:20935109 NCBI chr10:64,405,044...64,428,249
Ensembl chr10:64,405,044...64,428,070 		JBrowse link
G Lmna lamin A/C multiple interactions
decreases expression 		ISO [naphthalene co-treated with CFTR gene mutant form] results in decreased expression of LMNA protein
naphthalene results in decreased expression of LMNA protein 		CTD PMID:19438287 NCBI chr 2:176,237,564...176,265,301
Ensembl chr 2:176,237,564...176,288,072 		JBrowse link
G Lox lysyl oxidase increases expression ISO naphthalene results in increased expression of LOX mRNA CTD PMID:18978301 NCBI chr18:48,162,889...48,175,640
Ensembl chr18:48,165,688...48,239,810 		JBrowse link
G Lrg1 leucine-rich alpha-2-glycoprotein 1 increases expression ISO naphthalene results in increased expression of LRG1 mRNA CTD PMID:18978301 NCBI chr 9:1,034,691...1,036,937
Ensembl chr 9:1,034,679...1,037,337 		JBrowse link
G Ly6a lymphocyte antigen 6 family member A increases expression ISO naphthalene results in increased expression of LY6A mRNA CTD PMID:18978301 NCBI chr 7:109,064,222...109,067,757 JBrowse link
G Macf1 microtubule-actin crosslinking factor 1 increases expression ISO naphthalene results in increased expression of MACF1 mRNA CTD PMID:18978301 NCBI chr 5:140,908,829...141,234,127
Ensembl chr 5:140,908,837...141,233,890 		JBrowse link
G Maff MAF bZIP transcription factor F increases expression EXP naphthalene analog results in increased expression of MAFF mRNA CTD PMID:24976557 NCBI chr 7:112,792,787...112,804,139
Ensembl chr 7:112,791,416...112,804,147 		JBrowse link
G Map3k6 mitogen-activated protein kinase kinase kinase 6 increases expression ISO naphthalene results in increased expression of MAP3K6 mRNA CTD PMID:18978301 NCBI chr 5:150,724,029...150,736,113
Ensembl chr 5:150,724,216...150,736,111 		JBrowse link
G Mark3 microtubule affinity regulating kinase 3 increases expression ISO naphthalene results in increased expression of MARK3 mRNA CTD PMID:18978301 NCBI chr 6:136,447,327...136,537,409
Ensembl chr 6:136,448,531...136,537,404 		JBrowse link
G Mc1r melanocortin 1 receptor affects binding ISO naphthalene analog binds to MC1R protein CTD PMID:11909711 NCBI chr19:68,360,950...68,363,877
Ensembl chr19:68,360,950...68,363,877 		JBrowse link
G Mc3r melanocortin 3 receptor affects binding ISO naphthalene analog binds to MC3R protein CTD PMID:11909711 NCBI chr 3:181,434,776...181,435,873
Ensembl chr 3:181,434,776...181,435,873 		JBrowse link
G Mc4r melanocortin 4 receptor affects binding ISO naphthalene analog binds to MC4R protein CTD PMID:11909711 NCBI chr18:62,689,798...62,691,685 JBrowse link
G Mc5r melanocortin 5 receptor affects binding ISO naphthalene analog binds to MC5R protein CTD PMID:11909711 NCBI chr18:64,185,013...64,190,054
Ensembl chr18:64,185,013...64,190,054 		JBrowse link
G Mfsd13a major facilitator superfamily domain containing 13A increases expression ISO naphthalene results in increased expression of MFSD13A mRNA CTD PMID:18978301 NCBI chr 1:255,158,338...255,177,731
Ensembl chr 1:255,152,543...255,177,733 		JBrowse link
G Mfsd2a MFSD2 lysolipid transporter A, lysophospholipid increases expression ISO naphthalene results in increased expression of MFSD2A mRNA CTD PMID:18978301 NCBI chr 5:140,510,933...140,525,828
Ensembl chr 5:140,510,953...140,525,916 		JBrowse link
G Mlph melanophilin increases expression ISO naphthalene results in increased expression of MLPH mRNA CTD PMID:18978301 NCBI chr 9:98,955,036...98,990,566
Ensembl chr 9:98,955,141...98,990,556 		JBrowse link
G Mmel1 membrane metallo-endopeptidase-like 1 decreases expression EXP naphthalene analog results in decreased expression of MMEL1 mRNA CTD PMID:24976557 NCBI chr 5:170,713,602...170,744,058
Ensembl chr 5:170,713,627...170,744,058 		JBrowse link
G Mmp23 matrix metallopeptidase 23 increases expression ISO naphthalene results in increased expression of MMP23 mRNA CTD PMID:18978301 NCBI chr 5:171,521,905...171,525,007
Ensembl chr 5:171,520,494...171,524,695 		JBrowse link
G Mmp9 matrix metallopeptidase 9 increases expression ISO naphthalene results in increased expression of MMP9 mRNA CTD PMID:18978301 NCBI chr 3:174,103,474...174,111,434
Ensembl chr 3:174,084,123...174,111,442 		JBrowse link
G Mov10 Mov10 RNA helicase increases expression ISO naphthalene results in increased expression of MOV10 mRNA CTD PMID:18978301 NCBI chr 2:194,982,014...195,003,513
Ensembl chr 2:194,982,014...195,003,442 		JBrowse link
G Mrc2 mannose receptor, C type 2 increases expression ISO naphthalene results in increased expression of MRC2 mRNA CTD PMID:18978301 NCBI chr10:90,761,751...90,823,055
Ensembl chr10:90,761,878...90,823,055 		JBrowse link
G Msn moesin multiple interactions
increases reduction 		ISO [naphthalene co-treated with CFTR gene mutant form] results in decreased expression of MSN protein
naphthalene results in increased reduction of MSN protein 		CTD PMID:19438287 PMID:19843705 NCBI chr  X:65,005,546...65,073,512
Ensembl chr  X:65,005,458...65,075,129 		JBrowse link
G Mt2 metallothionein 2 increases expression ISO naphthalene results in increased expression of MT2 mRNA CTD PMID:18978301 NCBI chr19:10,837,934...10,838,708
Ensembl chr19:10,837,927...10,838,709 		JBrowse link
G Muc1 mucin 1, cell surface associated decreases expression EXP naphthalene analog results in decreased expression of MUC1 mRNA CTD PMID:24976557 NCBI chr 2:176,933,312...176,938,497
Ensembl chr 2:176,933,047...176,938,491 		JBrowse link
G Mug1 murinoglobulin 1 multiple interactions ISO [gefitinib co-treated with naphthalene] affects the expression of MUG1 mRNA CTD PMID:20935109 NCBI chr 4:156,748,351...156,802,132 JBrowse link
G Mup5 major urinary protein 5 decreases expression EXP naphthalene analog results in decreased expression of MUP5 mRNA CTD PMID:24976557 NCBI chr 5:79,996,023...79,999,893 JBrowse link
G Mxd3 Max dimerization protein 3 increases expression ISO naphthalene results in increased expression of MXD3 mRNA CTD PMID:18978301 NCBI chr17:9,306,552...9,310,278
Ensembl chr17:9,302,321...9,310,278 		JBrowse link
G Mybl2 MYB proto-oncogene like 2 increases expression ISO naphthalene results in increased expression of MYBL2 mRNA CTD PMID:18978301 NCBI chr 3:172,124,765...172,153,221
Ensembl chr 3:172,116,550...172,153,221 		JBrowse link
G Myc MYC proto-oncogene, bHLH transcription factor increases expression ISO naphthalene results in increased expression of MYC mRNA CTD PMID:18978301 NCBI chr 7:95,483,105...95,488,031
Ensembl chr 7:95,483,105...95,488,028 		JBrowse link
G Myl11 myosin light chain 11 decreases expression EXP naphthalene analog results in decreased expression of MYLPF mRNA CTD PMID:24976557 NCBI chr 1:191,257,432...191,263,046
Ensembl chr 1:191,256,196...191,263,045 		JBrowse link
G Myt1 myelin transcription factor 1 increases expression ISO naphthalene results in increased expression of MYT1 mRNA CTD PMID:18978301 NCBI chr 3:189,263,569...189,327,844
Ensembl chr 3:189,263,467...189,327,844 		JBrowse link
G Ncapd2 non-SMC condensin I complex, subunit D2 increases expression ISO naphthalene results in increased expression of NCAPD2 mRNA CTD PMID:18978301 NCBI chr 4:159,655,051...159,677,938
Ensembl chr 4:159,655,051...159,677,938 		JBrowse link
G Nckap5 NCK-associated protein 5 decreases expression ISO naphthalene results in decreased expression of NCKAP5 mRNA CTD PMID:18757308 NCBI chr13:39,922,576...40,835,849
Ensembl chr13:39,922,737...40,835,521 		JBrowse link
G Ndc80 NDC80 kinetochore complex component decreases expression ISO naphthalene results in decreased expression of NDC80 mRNA CTD PMID:22579512 NCBI chr 9:118,853,806...118,887,582
Ensembl chr 9:118,853,806...118,887,568 		JBrowse link
G Ndufaf4 NADH:ubiquinone oxidoreductase complex assembly factor 4 multiple interactions ISO [gefitinib co-treated with naphthalene] affects the expression of NDUFAF4 mRNA CTD PMID:20935109 NCBI chr 5:43,401,795...43,406,967 JBrowse link
G Nfe2l2 NFE2 like bZIP transcription factor 2 increases activity ISO naphthalene results in increased activity of NFE2L2 protein CTD PMID:30114225 PMID:30203046 NCBI chr 3:81,001,529...81,031,165
Ensembl chr 3:81,001,529...81,029,090 		JBrowse link
G Nfic nuclear factor I/C increases expression ISO naphthalene results in increased expression of NFIC mRNA CTD PMID:18978301 NCBI chr 7:8,928,423...8,963,455
Ensembl chr 7:8,904,117...8,963,409 		JBrowse link
G Nfkb2 nuclear factor kappa B subunit 2 multiple interactions ISO [naphthalene co-treated with phenanthrene co-treated with anthracene co-treated with fluoranthene co-treated with pyrene] results in increased expression of NFKB2 protein CTD PMID:30980910 NCBI chr 1:255,106,010...255,114,649
Ensembl chr 1:255,107,374...255,114,637 		JBrowse link
G Ngf nerve growth factor decreases response to substance
increases expression 		ISO NGF protein results in decreased susceptibility to naphthalene
naphthalene results in increased expression of NGF mRNA 		CTD PMID:18978301 PMID:20075049 NCBI chr 2:192,589,580...192,642,971
Ensembl chr 2:192,589,582...192,643,834 		JBrowse link
G Nipsnap3b nipsnap homolog 3B increases expression EXP naphthalene analog results in increased expression of NIPSNAP3B mRNA CTD PMID:24976557 NCBI chr 5:72,446,945...72,465,090
Ensembl chr 5:72,432,957...72,465,544 		JBrowse link
G Nkd1 NKD inhibitor of WNT signaling pathway 1 increases expression ISO naphthalene results in increased expression of NKD1 mRNA CTD PMID:18978301 NCBI chr19:34,649,803...34,722,846 JBrowse link
G Nnat neuronatin increases expression ISO naphthalene results in increased expression of NNAT mRNA CTD PMID:18978301 NCBI chr 3:166,646,373...166,648,845
Ensembl chr 3:166,646,384...166,649,086 		JBrowse link
G Nos3 nitric oxide synthase 3 multiple interactions
increases expression 		ISO 1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [naphthalene results in increased expression of NOS3 mRNA]; 1-(2-(3-(4-methoxyphenyl)propoxy)-4-methoxyphenylethyl)-1H-imidazole inhibits the reaction [naphthalene results in increased expression of NOS3 protein]; nickel chloride inhibits the reaction [naphthalene results in increased expression of NOS3 protein]; Proadifen inhibits the reaction [naphthalene results in increased expression of NOS3 protein]
naphthalene results in increased expression of NOS3 mRNA; naphthalene results in increased expression of NOS3 protein 		CTD PMID:15183461 NCBI chr 4:11,686,088...11,706,604
Ensembl chr 4:11,686,268...11,706,664 		JBrowse link
G Nqo1 NAD(P)H quinone dehydrogenase 1 increases activity
increases expression 		EXP naphthalene results in increased activity of NQO1 protein
naphthalene results in increased expression of NQO1 mRNA 		CTD PMID:16906435 PMID:24563378 NCBI chr19:52,205,374...52,220,267
Ensembl chr19:52,205,314...52,220,260 		JBrowse link
G Nrg1 neuregulin 1 increases expression EXP naphthalene analog results in increased expression of NRG1 mRNA CTD PMID:24976557 NCBI chr16:65,954,084...67,007,484
Ensembl chr16:65,953,865...66,999,849 		JBrowse link
G Nrgn neurogranin decreases expression EXP naphthalene analog results in decreased expression of NRGN mRNA CTD PMID:24976557 NCBI chr 8:45,444,223...45,452,417
Ensembl chr 8:45,444,223...45,452,417 		JBrowse link
G Nrip3 nuclear receptor interacting protein 3 increases expression ISO naphthalene results in increased expression of NRIP3 mRNA CTD PMID:18978301 NCBI chr 1:173,224,532...173,249,829
Ensembl chr 1:173,224,532...173,251,769 		JBrowse link
G Ntrk2 neurotrophic receptor tyrosine kinase 2 increases expression ISO naphthalene results in increased expression of NTRK2 mRNA CTD PMID:18978301 NCBI chr17:5,560,558...5,875,899
Ensembl chr17:5,564,570...5,874,628 		JBrowse link
G Olfml3 olfactomedin-like 3 increases expression ISO naphthalene results in increased expression of OLFML3 mRNA CTD PMID:18978301 NCBI chr 2:193,932,665...193,935,494
Ensembl chr 2:193,932,665...193,935,494 		JBrowse link
G Or7a38e olfactory receptor family 7 subfamily A member 38E decreases expression EXP naphthalene analog results in decreased expression of OR7A38E mRNA CTD PMID:24976557 NCBI chr 7:11,436,501...11,437,433
Ensembl chr 7:11,436,501...11,437,433 		JBrowse link
G Orm1 orosomucoid 1 increases expression ISO naphthalene results in increased expression of ORM1 mRNA CTD PMID:18978301 NCBI chr 5:81,788,509...81,791,661
Ensembl chr 5:81,788,395...81,791,667 		JBrowse link
G Osgin1 oxidative stress induced growth inhibitor 1 increases expression ISO naphthalene results in increased expression of OSGIN1 mRNA CTD PMID:18978301 NCBI chr19:64,380,336...64,409,165
Ensembl chr19:64,401,173...64,409,162 		JBrowse link
G P4hb prolyl 4-hydroxylase subunit beta affects binding ISO naphthalene metabolite binds to P4HB protein CTD PMID:15892573 NCBI chr10:106,335,300...106,346,911
Ensembl chr10:106,335,300...106,346,911 		JBrowse link
G Pah phenylalanine hydroxylase decreases expression ISO naphthalene results in decreased expression of PAH mRNA CTD PMID:22579512 NCBI chr 7:23,793,096...23,885,631
Ensembl chr 7:23,792,781...23,885,627 		JBrowse link
G Pappa pappalysin 1 increases expression ISO naphthalene results in increased expression of PAPPA mRNA CTD PMID:18978301 NCBI chr 5:83,513,358...83,751,364
Ensembl chr 5:83,513,358...83,751,361 		JBrowse link
G Pask PAS domain containing serine/threonine kinase increases expression ISO naphthalene results in increased expression of PASK mRNA CTD PMID:18978301 NCBI chr 9:101,291,673...101,333,288
Ensembl chr 9:101,291,676...101,332,504 		JBrowse link
G Pbsn probasin increases expression EXP naphthalene analog results in increased expression of PBSN mRNA CTD PMID:24976557 NCBI chr  X:45,792,738...45,807,983
Ensembl chr  X:45,792,738...45,807,983 		JBrowse link
G Pclaf PCNA clamp associated factor increases expression EXP naphthalene analog results in increased expression of PCLAF mRNA CTD PMID:24976557 NCBI chr 8:75,311,028...75,328,108
Ensembl chr 8:75,315,707...75,328,106 		JBrowse link
G Pdia3 protein disulfide isomerase family A, member 3 affects binding ISO naphthalene metabolite binds to PDIA3 protein CTD PMID:15892573 PMID:16206326 NCBI chr 3:128,841,781...128,865,733
Ensembl chr 3:128,841,917...128,867,327 		JBrowse link
G Pf4 platelet factor 4 increases expression ISO naphthalene results in increased expression of PF4 mRNA CTD PMID:18978301 NCBI chr14:17,582,477...17,583,392
Ensembl chr14:17,582,477...17,583,392 		JBrowse link
G Pgf placental growth factor increases expression ISO naphthalene results in increased expression of PGF mRNA CTD PMID:18978301 NCBI chr 6:110,547,165...110,557,747
Ensembl chr 6:110,547,153...110,557,747 		JBrowse link
G Phf24 PHD finger protein 24 decreases expression EXP naphthalene analog results in decreased expression of PHF24 mRNA CTD PMID:24976557 NCBI chr 5:61,939,261...61,966,879
Ensembl chr 5:61,939,900...61,966,875 		JBrowse link
G Pkm pyruvate kinase M1/2 multiple interactions ISO [naphthalene co-treated with CFTR gene mutant form] results in decreased expression of PKM protein CTD PMID:19438287 NCBI chr 8:68,949,731...68,975,394
Ensembl chr 8:68,948,815...68,975,396 		JBrowse link
G Pla1a phospholipase A1 member A increases expression ISO naphthalene results in increased expression of PLA1A mRNA CTD PMID:18978301 NCBI chr11:75,825,626...75,863,296
Ensembl chr11:75,825,585...75,878,165 		JBrowse link
G Pla2g3 phospholipase A2, group III decreases expression EXP naphthalene analog results in decreased expression of PLA2G3 mRNA CTD PMID:24976557 NCBI chr14:82,589,908...82,597,542
Ensembl chr14:82,591,862...82,597,542 		JBrowse link
G Pla2g5 phospholipase A2, group V increases expression ISO naphthalene results in increased expression of PLA2G5 mRNA CTD PMID:18978301 NCBI chr 5:156,324,628...156,393,065
Ensembl chr 5:156,324,629...156,381,926 		JBrowse link
G Plat plasminogen activator, tissue type increases expression ISO naphthalene results in increased expression of PLAT mRNA CTD PMID:18978301 NCBI chr16:75,943,061...76,022,037
Ensembl chr16:75,943,064...75,967,696 		JBrowse link
G Plaur plasminogen activator, urokinase receptor increases expression ISO naphthalene results in increased expression of PLAUR mRNA CTD PMID:18978301 NCBI chr 1:89,181,363...89,196,308
Ensembl chr 1:89,178,453...89,198,130 		JBrowse link
G Pon1 paraoxonase 1 decreases expression ISO
EXP 		naphthalene results in decreased expression of PON1 mRNA
naphthalene analog results in decreased expression of PON1 mRNA 		CTD PMID:18757308 PMID:24976557 NCBI chr 4:34,261,312...34,292,327
Ensembl chr 4:34,261,289...34,287,924 		JBrowse link
G Por cytochrome p450 oxidoreductase decreases expression
decreases response to substance 		ISO naphthalene results in decreased expression of POR protein
POR gene mutant form results in decreased susceptibility to naphthalene 		CTD PMID:19438287 PMID:32974682 NCBI chr12:26,587,674...26,655,612
Ensembl chr12:26,587,674...26,635,809 		JBrowse link
G Ppara peroxisome proliferator activated receptor alpha decreases expression ISO naphthalene results in decreased expression of PPARA mRNA CTD PMID:25689681 NCBI chr 7:118,712,261...118,780,723
Ensembl chr 7:118,712,412...118,780,714 		JBrowse link
G Prdx1 peroxiredoxin 1 increases reduction ISO naphthalene results in increased reduction of PRDX1 protein CTD PMID:19843705 NCBI chr 5:135,383,906...135,399,504
Ensembl chr 5:135,383,906...135,399,504 		JBrowse link
G Prdx2 peroxiredoxin 2 affects binding ISO naphthalene metabolite binds to PRDX2 protein CTD PMID:15892573 NCBI chr19:40,085,788...40,091,083
Ensembl chr19:40,084,430...40,091,006 		JBrowse link
G Prdx6 peroxiredoxin 6 affects binding ISO naphthalene metabolite binds to PRDX6 protein CTD PMID:15892573 NCBI chr13:76,062,082...76,072,631
Ensembl chr13:76,061,554...76,072,657 		JBrowse link
G Prrx2 paired related homeobox 2 increases expression ISO naphthalene results in increased expression of PRRX2 mRNA CTD PMID:18978301 NCBI chr 3:34,530,331...34,566,284
Ensembl chr 3:34,520,173...34,566,284 		JBrowse link
G Prss22 serine protease 22 increases expression ISO naphthalene results in increased expression of PRSS22 mRNA CTD PMID:18978301 NCBI chr10:13,533,725...13,538,435
Ensembl chr10:13,533,725...13,538,435 		JBrowse link
G Prtn3 proteinase 3 increases expression ISO naphthalene results in increased expression of PRTN3 mRNA CTD PMID:18978301 NCBI chr 7:10,472,750...10,482,037
Ensembl chr 7:10,472,755...10,482,474 		JBrowse link
G Ptger1 prostaglandin E receptor 1 increases expression ISO naphthalene results in increased expression of PTGER1 mRNA CTD PMID:18978301 NCBI chr19:41,374,983...41,379,593
Ensembl chr19:41,374,471...41,378,284 		JBrowse link
G Ptk2b protein tyrosine kinase 2 beta increases expression ISO naphthalene results in increased expression of PTK2B mRNA CTD PMID:18978301 NCBI chr15:44,536,275...44,656,754
Ensembl chr15:44,531,249...44,656,806 		JBrowse link
G Pts 6-pyruvoyl-tetrahydropterin synthase decreases expression ISO naphthalene results in decreased expression of PTS protein CTD PMID:19438287 NCBI chr 8:59,767,234...59,774,265
Ensembl chr 8:59,765,185...59,774,265 		JBrowse link
G Ptx3 pentraxin 3 increases expression ISO naphthalene results in increased expression of PTX3 mRNA CTD PMID:18978301 NCBI chr 2:152,797,563...152,803,372
Ensembl chr 2:152,781,955...152,803,372 		JBrowse link
G Pura purine rich element binding protein A affects binding ISO naphthalene metabolite binds to PURA protein CTD PMID:15892573 NCBI chr18:28,159,103...28,179,539
Ensembl chr18:28,125,126...28,211,111 		JBrowse link
G Pycr1 pyrroline-5-carboxylate reductase 1 increases expression ISO naphthalene results in increased expression of PYCR1 mRNA CTD PMID:18978301 NCBI chr10:106,416,056...106,420,982
Ensembl chr10:106,412,576...106,423,393 		JBrowse link
G Qsox1 quiescin sulfhydryl oxidase 1 increases expression ISO naphthalene results in increased expression of QSOX1 mRNA CTD PMID:18978301 NCBI chr13:70,500,060...70,537,711
Ensembl chr13:70,500,060...70,537,733 		JBrowse link
G Raf1 Raf-1 proto-oncogene, serine/threonine kinase increases expression ISO naphthalene results in increased expression of RAF1 protein CTD PMID:14595851 NCBI chr 4:150,352,158...150,412,813
Ensembl chr 4:150,352,160...150,412,813 		JBrowse link
G Rangap1 RAN GTPase activating protein 1 decreases expression ISO naphthalene results in decreased expression of RANGAP1 protein CTD PMID:19438287 NCBI chr 7:115,104,820...115,130,564
Ensembl chr 7:115,104,823...115,130,564 		JBrowse link
G Rcn3 reticulocalbin 3 increases expression ISO naphthalene results in increased expression of RCN3 mRNA CTD PMID:18978301 NCBI chr 1:104,700,969...104,710,228
Ensembl chr 1:104,700,545...104,710,249 		JBrowse link
G Rdx radixin multiple interactions ISO [naphthalene co-treated with CFTR gene mutant form] results in decreased expression of RDX protein CTD PMID:19438287 NCBI chr 8:61,275,792...61,348,260
Ensembl chr 8:61,274,460...61,333,967 		JBrowse link
G Reg3b regenerating family member 3 beta increases expression EXP naphthalene analog results in increased expression of REG3A mRNA; naphthalene analog results in increased expression of REG3B mRNA CTD PMID:24976557 NCBI chr 4:112,419,776...112,423,014
Ensembl chr 4:112,419,776...112,423,014 		JBrowse link
G Rgs16 regulator of G-protein signaling 16 increases expression ISO naphthalene results in increased expression of RGS16 mRNA CTD PMID:18978301 NCBI chr13:68,421,480...68,443,312
Ensembl chr13:68,438,120...68,443,313 		JBrowse link
G Rhag Rh-associated glycoprotein decreases expression EXP naphthalene analog results in decreased expression of RHAG mRNA CTD PMID:24976557 NCBI chr 9:27,566,349...27,594,390
Ensembl chr 9:27,566,356...27,594,390 		JBrowse link
G Rhoc ras homolog family member C increases expression ISO naphthalene results in increased expression of RHOC mRNA CTD PMID:22579512 NCBI chr 2:194,975,586...194,981,637
Ensembl chr 2:194,975,242...194,983,745 		JBrowse link
G Rnf220 ring finger protein 220 increases expression ISO naphthalene results in increased expression of RNF220 mRNA CTD PMID:18978301 NCBI chr 5:135,975,739...136,198,017
Ensembl chr 5:135,975,739...136,197,858 		JBrowse link
G Rplp0 ribosomal protein lateral stalk subunit P0 affects binding ISO naphthalene metabolite binds to RPLP0 protein CTD PMID:16206326 NCBI chr12:46,715,121...46,718,390
Ensembl chr12:46,715,124...46,718,422 		JBrowse link
G Rps27a ribosomal protein S27a decreases expression ISO naphthalene results in decreased expression of RPS27A protein CTD PMID:19438287 NCBI chr14:107,486,664...107,488,941
Ensembl chr 5:138,465,088...138,466,080
Ensembl chr14:138,465,088...138,466,080
Ensembl chr 5:138,465,088...138,466,080 		JBrowse link
G Rpsa ribosomal protein SA affects binding ISO naphthalene metabolite binds to RPSA protein CTD PMID:16206326 NCBI chr 8:128,728,761...128,732,736
Ensembl chr 8:128,728,862...128,732,737 		JBrowse link
G Rras2 RAS related 2 increases expression ISO naphthalene results in increased expression of RRAS2 mRNA CTD PMID:18978301 NCBI chr 1:177,668,143...177,737,551
Ensembl chr 1:177,668,144...177,737,551 		JBrowse link
G S100a14 S100 calcium binding protein A14 increases expression ISO naphthalene results in increased expression of S100A14 mRNA CTD PMID:18978301 NCBI chr 2:178,305,976...178,308,004
Ensembl chr 2:178,306,025...178,307,999 		JBrowse link
G S100a6 S100 calcium binding protein A6 multiple interactions ISO [gefitinib co-treated with naphthalene] affects the expression of S100A6 mRNA CTD PMID:20935109 NCBI chr 2:178,398,189...178,399,763
Ensembl chr 2:178,398,481...178,399,762 		JBrowse link
G S100a8 S100 calcium binding protein A8 multiple interactions
increases expression 		ISO [gefitinib co-treated with naphthalene] affects the expression of S100A8 mRNA; [gefitinib co-treated with naphthalene] affects the expression of S100A8 protein
naphthalene results in increased expression of S100A8 mRNA; naphthalene results in increased expression of S100A8 protein 		CTD PMID:18978301 PMID:20935109 PMID:21399660 NCBI chr 2:178,464,095...178,465,223
Ensembl chr 2:178,464,702...178,465,221 		JBrowse link
G S100a9 S100 calcium binding protein A9 increases expression ISO naphthalene results in increased expression of S100A9 mRNA CTD PMID:18978301 NCBI chr 2:178,487,941...178,490,622
Ensembl chr 2:178,487,941...178,490,870 		JBrowse link
G Scgb1a1 secretoglobin family 1A member 1 multiple interactions
decreases expression 		ISO ASCL1 protein inhibits the reaction [naphthalene results in decreased expression of SCGB1A1 protein]
[Ergothioneine co-treated with naphthalene] results in decreased expression of SCGB1A1 mRNA
naphthalene results in decreased expression of SCGB1A1 mRNA; naphthalene results in decreased expression of SCGB1A1 protein 		CTD PMID:18757308 PMID:18978301 PMID:19213872 PMID:20522644 PMID:20554700 More... NCBI chr 1:215,406,138...215,409,686
Ensembl chr 1:215,406,138...215,409,686 		JBrowse link
G Scgb3a1 secretoglobin, family 3A, member 1 decreases expression ISO naphthalene results in decreased expression of SCGB3A1 mRNA CTD PMID:20522644 NCBI chr10:34,469,166...34,470,473
Ensembl chr10:34,468,002...34,470,583 		JBrowse link
G Scgb3a2 secretoglobin, family 3A, member 2 decreases expression ISO naphthalene results in decreased expression of SCGB3A2 mRNA CTD PMID:18757308 PMID:20522644 NCBI chr18:36,183,745...36,186,667
Ensembl chr18:36,183,698...36,186,742 		JBrowse link
G Sdcbp2 syndecan binding protein 2 increases expression ISO naphthalene results in increased expression of SDCBP2 mRNA CTD PMID:18978301 NCBI chr 3:160,521,309...160,558,452
Ensembl chr 3:160,530,927...160,558,446 		JBrowse link
G Sdf2l1 stromal cell-derived factor 2-like 1 increases expression ISO naphthalene results in increased expression of SDF2L1 mRNA CTD PMID:18978301 NCBI chr11:97,376,878...97,379,120
Ensembl chr11:97,376,878...97,379,120 		JBrowse link
G Sdha succinate dehydrogenase complex flavoprotein subunit A decreases expression ISO naphthalene results in decreased expression of SDHA protein CTD PMID:19438287 NCBI chr 1:30,764,553...30,789,523
Ensembl chr 1:30,764,590...30,790,121 		JBrowse link
G Sec14l3 SEC14-like lipid binding 3 multiple interactions ISO [naphthalene co-treated with CFTR gene mutant form] results in decreased expression of SEC14L3 protein CTD PMID:19438287 NCBI chr14:83,168,154...83,181,240
Ensembl chr14:83,168,208...83,179,654 		JBrowse link
G Selenbp1 selenium binding protein 1 multiple interactions ISO [naphthalene co-treated with CFTR gene mutant form] results in decreased expression of SELENBP1 protein CTD PMID:19438287 NCBI chr 2:185,183,022...185,193,612
Ensembl chr 2:185,183,004...185,194,295 		JBrowse link
G Sema7a semaphorin 7A (John Milton Hagen blood group) increases expression ISO naphthalene results in increased expression of SEMA7A mRNA CTD PMID:18978301 NCBI chr 8:67,244,318...67,267,060
Ensembl chr 8:67,243,824...67,267,058 		JBrowse link
G Serpina1f serpin family A member 1F affects binding ISO naphthalene metabolite binds to SERPINA1 protein CTD PMID:15892573 NCBI chr 6:128,585,697...128,591,902
Ensembl chr 6:128,585,697...128,591,902 		JBrowse link
G Serpine1 serpin family E member 1 increases expression ISO naphthalene results in increased expression of SERPINE1 mRNA CTD PMID:18978301 NCBI chr12:25,237,977...25,248,356
Ensembl chr12:25,237,952...25,248,357 		JBrowse link
G Sfn stratifin increases expression ISO naphthalene results in increased expression of SFN mRNA CTD PMID:18978301 NCBI chr 5:151,110,582...151,111,854
Ensembl chr 5:151,110,530...151,111,995 		JBrowse link
G Sfrp1 secreted frizzled-related protein 1 increases expression ISO naphthalene results in increased expression of SFRP1 mRNA CTD PMID:18978301 NCBI chr16:75,278,325...75,316,736
Ensembl chr16:75,278,325...75,316,736 		JBrowse link
G Sgk1 serum/glucocorticoid regulated kinase 1 increases expression ISO naphthalene results in increased expression of SGK1 mRNA CTD PMID:18978301 NCBI chr 1:24,799,391...24,916,886
Ensembl chr 1:24,799,396...24,807,231 		JBrowse link
G Slc10a3 solute carrier family 10, member 3 multiple interactions ISO [gefitinib co-treated with naphthalene] affects the expression of SLC10A3 mRNA CTD PMID:20935109 NCBI chr  X:157,306,043...157,309,849
Ensembl chr  X:157,303,915...157,309,793 		JBrowse link
G Slc22a2 solute carrier family 22 member 2 decreases expression EXP naphthalene analog results in decreased expression of SLC22A2 mRNA CTD PMID:24976557 NCBI chr 1:50,668,817...50,711,019
Ensembl chr 1:50,668,817...50,711,019 		JBrowse link
G Slc22a4 solute carrier family 22 member 4 increases expression
multiple interactions 		ISO naphthalene results in increased expression of SLC22A4 mRNA
[Ergothioneine co-treated with naphthalene] results in increased expression of SLC22A4 mRNA 		CTD PMID:38768835 NCBI chr10:38,634,098...38,687,409
Ensembl chr10:38,634,098...38,679,920 		JBrowse link
G Slc40a1 solute carrier family 40 member 1 increases expression EXP naphthalene analog results in increased expression of SLC40A1 mRNA CTD PMID:24976557 NCBI chr 9:55,525,457...55,633,463
Ensembl chr 9:55,525,532...55,543,460 		JBrowse link
G Slc45a3 solute carrier family 45, member 3 decreases expression EXP naphthalene analog results in decreased expression of SLC45A3 mRNA CTD PMID:24976557 NCBI chr13:45,959,467...45,979,763
Ensembl chr13:45,959,467...45,979,763 		JBrowse link
G Slc4a7 solute carrier family 4 member 7 increases expression EXP naphthalene analog results in increased expression of SLC4A7 mRNA CTD PMID:24976557 NCBI chr15:13,015,854...13,095,485
Ensembl chr15:13,015,854...13,095,292 		JBrowse link
G Slc7a11 solute carrier family 7 member 11 increases expression EXP naphthalene analog results in increased expression of SLC7A11 mRNA CTD PMID:24976557 NCBI chr 2:136,532,912...136,668,560
Ensembl chr 2:136,532,246...136,695,695 		JBrowse link
G Slc9a3 solute carrier family 9 member A3 decreases expression EXP naphthalene analog results in decreased expression of SLC9A3 mRNA CTD PMID:24976557 NCBI chr 1:30,953,215...30,996,209
Ensembl chr 1:30,953,216...30,996,002 		JBrowse link
G Slpi secretory leukocyte peptidase inhibitor increases expression ISO naphthalene results in increased expression of SLPI mRNA CTD PMID:18978301 NCBI chr 3:173,501,573...173,503,822
Ensembl chr 3:173,501,573...173,503,822 		JBrowse link
G Snta1 syntrophin, alpha 1 increases expression ISO naphthalene results in increased expression of SNTA1 mRNA CTD PMID:18978301 NCBI chr 3:163,336,509...163,366,954
Ensembl chr 3:163,336,516...163,366,927 		JBrowse link
G Son SON DNA and RNA binding protein increases expression ISO naphthalene results in increased expression of SON mRNA CTD PMID:18978301 NCBI chr11:44,336,818...44,409,127
Ensembl chr11:44,377,976...44,409,127 		JBrowse link
G Sox17 SRY-box transcription factor 17 increases expression ISO naphthalene results in increased expression of SOX17 protein CTD PMID:16239640 NCBI chr 5:19,814,345...19,819,859
Ensembl chr 5:19,814,360...19,819,854 		JBrowse link
G Sox2 SRY-box transcription factor 2 increases expression ISO naphthalene results in increased expression of SOX2 protein CTD PMID:16239640 NCBI chr 2:119,465,131...119,467,542
Ensembl chr 2:119,454,541...119,496,350 		JBrowse link
G Sphk1 sphingosine kinase 1 increases expression ISO naphthalene results in increased expression of SPHK1 mRNA CTD PMID:18978301 NCBI chr10:102,257,413...102,263,086
Ensembl chr10:102,258,975...102,263,082 		JBrowse link
G Spink5 serine peptidase inhibitor, Kazal type 5 decreases reduction ISO naphthalene results in decreased reduction of SPINK5 protein CTD PMID:19843705 NCBI chr18:36,515,347...36,584,038
Ensembl chr18:36,515,347...36,583,799 		JBrowse link
G Spon2 spondin 2 increases expression ISO naphthalene results in increased expression of SPON2 mRNA CTD PMID:18978301 NCBI chr14:81,713,070...81,742,510
Ensembl chr14:81,731,188...81,742,609 		JBrowse link
G Sprr1a small proline-rich protein 1A increases expression ISO naphthalene results in increased expression of SPRR1A mRNA CTD PMID:18978301 NCBI chr 2:180,750,709...180,752,625
Ensembl chr 2:180,750,709...180,752,991 		JBrowse link
G Srxn1 sulfiredoxin 1 increases expression EXP naphthalene analog results in increased expression of SRXN1 mRNA CTD PMID:24976557 NCBI chr 3:161,064,812...161,070,372
Ensembl chr 3:161,059,931...161,088,765 		JBrowse link
G Stat5b signal transducer and activator of transcription 5B decreases activity ISO naphthalene results in decreased activity of STAT5B protein CTD PMID:30114225 NCBI chr10:86,205,148...86,276,178
Ensembl chr10:86,207,293...86,275,990 		JBrowse link
G Sult1a1 sulfotransferase family 1A member 1 decreases expression EXP naphthalene analog results in decreased expression of SULT1A1 mRNA CTD PMID:24976557 NCBI chr 1:190,702,592...190,706,112
Ensembl chr 1:190,702,592...190,706,131 		JBrowse link
G Sval2 seminal vesicle antigen-like 2 increases expression EXP naphthalene analog results in increased expression of SVAL2 mRNA CTD PMID:24976557 NCBI chr 4:71,776,004...71,779,968
Ensembl chr 4:71,776,004...71,779,968 		JBrowse link
G Synpo synaptopodin multiple interactions ISO [gefitinib co-treated with naphthalene] affects the expression of SYNPO mRNA CTD PMID:20935109 NCBI chr18:56,326,369...56,347,359
Ensembl chr18:56,319,571...56,353,306 		JBrowse link
G Synpo2l synaptopodin 2-like increases expression ISO naphthalene results in increased expression of SYNPO2L mRNA CTD PMID:18978301 NCBI chr15:3,681,224...3,690,673
Ensembl chr15:3,681,104...3,690,673 		JBrowse link
G Syp synaptophysin multiple interactions
increases expression 		ISO ASCL1 protein inhibits the reaction [naphthalene results in increased expression of SYP protein] CTD PMID:20554700 NCBI chr  X:17,521,348...17,536,449
Ensembl chr  X:17,521,348...17,536,984 		JBrowse link
G Tcf19 transcription factor 19 increases expression ISO naphthalene results in increased expression of TCF19 mRNA CTD PMID:18978301 NCBI chr20:3,223,464...3,227,569
Ensembl chr20:3,223,324...3,230,060 		JBrowse link
G Tcf23 transcription factor 23 increases expression ISO naphthalene results in increased expression of TCF23 mRNA CTD PMID:18978301 NCBI chr 6:31,117,839...31,126,575
Ensembl chr 6:31,120,127...31,125,878 		JBrowse link
G Tcf7 transcription factor 7 increases expression ISO naphthalene results in increased expression of TCF7 mRNA CTD PMID:14595851 NCBI chr10:36,924,363...36,954,279
Ensembl chr10:36,924,363...36,954,279 		JBrowse link
G Tcp1 t-complex 1 multiple interactions ISO [naphthalene co-treated with CFTR gene mutant form] results in decreased expression of TCP1 protein CTD PMID:19438287 NCBI chr 1:50,376,848...50,384,527
Ensembl chr 1:50,376,848...50,384,527 		JBrowse link
G Tf transferrin increases expression ISO naphthalene results in increased expression of TRF protein CTD PMID:19438287 NCBI chr 8:112,668,667...112,695,376
Ensembl chr 8:112,647,642...112,695,400 		JBrowse link
G Tff1 trefoil factor 1 increases expression ISO naphthalene results in increased expression of TFF1 mRNA; naphthalene results in increased expression of TFF1 protein CTD PMID:19880587 NCBI chr20:9,237,095...9,240,956
Ensembl chr20:9,237,095...9,240,956 		JBrowse link
G Tff2 trefoil factor 2 increases expression ISO naphthalene results in increased expression of TFF2 protein CTD PMID:19880587 NCBI chr20:9,217,110...9,220,979
Ensembl chr20:9,217,121...9,220,979 		JBrowse link
G Tgm1 transglutaminase 1 increases expression ISO naphthalene results in increased expression of TGM1 mRNA CTD PMID:18978301 NCBI chr15:33,160,985...33,175,632
Ensembl chr15:33,160,987...33,174,463 		JBrowse link
G Tgm2 transglutaminase 2 decreases expression EXP naphthalene analog results in decreased expression of TGM2 mRNA CTD PMID:24976557 NCBI chr 3:167,192,612...167,221,845
Ensembl chr 3:167,192,612...167,304,240 		JBrowse link
G Thrsp thyroid hormone responsive decreases expression ISO naphthalene results in decreased expression of THRSP mRNA CTD PMID:18757308 NCBI chr 1:161,134,640...161,138,964
Ensembl chr 1:161,133,453...161,139,827 		JBrowse link
G Timp1 TIMP metallopeptidase inhibitor 1 increases expression ISO naphthalene results in increased expression of TIMP1 mRNA CTD PMID:18978301 PMID:22579512 NCBI chr  X:3,766,509...3,772,578
Ensembl chr  X:3,766,510...3,771,135 		JBrowse link
G Timp3 TIMP metallopeptidase inhibitor 3 increases expression ISO naphthalene results in increased expression of TIMP3 mRNA CTD PMID:18978301 NCBI chr 7:19,408,539...19,459,558
Ensembl chr 7:19,409,631...19,459,547 		JBrowse link
G Tinagl1 tubulointerstitial nephritis antigen-like 1 increases expression ISO naphthalene results in increased expression of TINAGL1 mRNA CTD PMID:18978301 NCBI chr 5:147,797,884...147,807,925
Ensembl chr 5:147,797,892...147,807,871 		JBrowse link
G Tk1 thymidine kinase 1 increases expression ISO naphthalene results in increased expression of TK1 mRNA CTD PMID:18978301 NCBI chr10:103,533,449...103,544,818
Ensembl chr10:103,533,449...103,556,228 		JBrowse link
G Tmeff1 transmembrane protein with EGF-like and two follistatin-like domains 1 increases expression EXP naphthalene analog results in increased expression of TMEFF1 mRNA CTD PMID:24976557 NCBI chr 5:67,706,269...67,792,022
Ensembl chr 5:67,706,269...67,792,021 		JBrowse link
G Tmem221 transmembrane protein 221 increases expression ISO naphthalene results in increased expression of TMEM221 mRNA CTD PMID:18978301 NCBI chr16:18,296,036...18,305,077
Ensembl chr16:18,295,931...18,305,246 		JBrowse link
G Tmem242 transmembrane protein 242 increases expression ISO naphthalene results in increased expression of TMEM242 mRNA CTD PMID:18978301 NCBI chr 1:48,397,865...48,424,639
Ensembl chr 1:48,397,865...48,424,633 		JBrowse link
G Tmem37 transmembrane protein 37 increases expression ISO naphthalene results in increased expression of TMEM37 mRNA CTD PMID:18978301 NCBI chr13:33,737,096...33,743,602
Ensembl chr13:33,736,308...33,743,747 		JBrowse link
G Tnc tenascin C increases expression ISO naphthalene results in increased expression of TNC mRNA; naphthalene results in increased expression of TNC protein CTD PMID:18978301 NCBI chr 5:82,391,340...82,476,197
Ensembl chr 5:82,391,340...82,476,131 		JBrowse link
G Tnf tumor necrosis factor multiple interactions ISO naphthalene inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of TNF protein]; naphthalene inhibits the reaction [SAA3 protein results in increased expression of TNF mRNA] CTD PMID:17526599 PMID:21399660 NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,626,532...3,629,303 		JBrowse link
G Tnfaip6 TNF alpha induced protein 6 increases expression ISO naphthalene results in increased expression of TNFAIP6 mRNA CTD PMID:18978301 NCBI chr 3:56,911,398...56,930,797
Ensembl chr 3:56,911,252...56,930,796 		JBrowse link
G Tnfrsf12a TNF receptor superfamily member 12A increases expression ISO naphthalene results in increased expression of TNFRSF12A mRNA CTD PMID:18978301 NCBI chr10:13,211,670...13,213,666
Ensembl chr10:13,211,673...13,213,704 		JBrowse link
G Tnnt1 troponin T1, slow skeletal type decreases expression EXP naphthalene analog results in decreased expression of TNNT1 mRNA CTD PMID:24976557 NCBI chr 1:78,349,035...78,359,394
Ensembl chr 1:78,349,035...78,359,394 		JBrowse link
G Tor2a torsin family 2, member A increases expression ISO naphthalene results in increased expression of TOR2A mRNA CTD PMID:18978301 NCBI chr 3:36,446,260...36,450,339
Ensembl chr 3:36,446,273...36,450,908 		JBrowse link
G Tp53 tumor protein p53 affects response to substance
multiple interactions 		ISO TRP53 protein affects the susceptibility to naphthalene
[naphthalene binds to pyrrolo(2,1-c)(1,4)benzodiazepine] which results in increased expression of TP53 protein 		CTD PMID:10802220 PMID:21732540 NCBI chr10:54,798,871...54,810,300
Ensembl chr10:54,798,851...54,810,299 		JBrowse link
G Tpm1 tropomyosin 1 affects binding ISO naphthalene metabolite binds to TPM1 protein CTD PMID:15892573 NCBI chr 8:76,516,654...76,543,661
Ensembl chr 8:76,511,871...76,543,468 		JBrowse link
G Traf7 TNF receptor associated factor 7 increases expression ISO naphthalene results in increased expression of TRAF7 mRNA CTD PMID:18978301 NCBI chr10:14,038,117...14,056,832
Ensembl chr10:14,038,117...14,056,694 		JBrowse link
G Trim23 tripartite motif-containing 23 multiple interactions ISO [gefitinib co-treated with naphthalene] affects the expression of TRIM23 mRNA CTD PMID:20935109 NCBI chr 2:37,036,193...37,069,024
Ensembl chr 2:37,035,477...37,069,526 		JBrowse link
G Trim54 tripartite motif-containing 54 increases expression ISO naphthalene results in increased expression of TRIM54 mRNA CTD PMID:18978301 NCBI chr 6:30,959,306...30,978,475
Ensembl chr 6:30,959,306...30,978,475 		JBrowse link
G Trmt2a tRNA methyltransferase 2 homolog A increases expression ISO naphthalene results in increased expression of TRMT2A mRNA CTD PMID:18978301 NCBI chr11:96,241,998...96,246,719
Ensembl chr11:96,242,001...96,246,609 		JBrowse link
G Trpa1 transient receptor potential cation channel, subfamily A, member 1 increases response to substance ISO TRPA1 results in increased susceptibility to naphthalene CTD PMID:20176620 NCBI chr 5:9,163,060...9,217,325
Ensembl chr 5:9,163,060...9,217,325 		JBrowse link
G Tsc22d1 TSC22 domain family, member 1 multiple interactions ISO [gefitinib co-treated with naphthalene] affects the expression of TSC22D1 mRNA CTD PMID:20935109 NCBI chr15:58,159,612...58,260,244
Ensembl chr15:58,159,952...58,183,322 		JBrowse link
G Ttc39b tetratricopeptide repeat domain 39B increases expression ISO naphthalene results in increased expression of TTC39B mRNA CTD PMID:18978301 NCBI chr 5:102,649,259...102,754,092
Ensembl chr 5:102,655,322...102,782,162 		JBrowse link
G Ttr transthyretin affects binding ISO naphthalene metabolite binds to TTR protein CTD PMID:16206326 NCBI chr18:12,216,684...12,225,972
Ensembl chr18:12,216,732...12,225,969 		JBrowse link
G Tuba1a tubulin, alpha 1A increases expression ISO naphthalene results in increased expression of TUBA1A protein CTD PMID:19438287 NCBI chr 7:131,992,151...131,996,850
Ensembl chr 7:131,968,770...131,996,035 		JBrowse link
G Tubb4a tubulin, beta 4A class IVa affects expression ISO naphthalene affects the expression of TUBB4A protein CTD PMID:16239640 NCBI chr 9:2,004,836...2,012,281
Ensembl chr 9:2,004,840...2,012,286 		JBrowse link
G Tubb6 tubulin, beta 6 class V increases expression ISO naphthalene results in increased expression of TUBB6 mRNA CTD PMID:18978301 NCBI chr18:63,213,287...63,222,926
Ensembl chr18:63,213,279...63,224,303 		JBrowse link
G Txnrd1 thioredoxin reductase 1 increases expression EXP naphthalene analog results in increased expression of TXNRD1 mRNA CTD PMID:24976557 NCBI chr 7:22,717,620...22,802,553
Ensembl chr 7:22,719,317...22,739,817 		JBrowse link
G Ubd ubiquitin D increases expression EXP naphthalene analog results in increased expression of UBD mRNA CTD PMID:24976557 NCBI chr20:1,390,734...1,392,685
Ensembl chr20:1,390,600...1,413,965 		JBrowse link
G Ubl4a ubiquitin-like 4A increases expression ISO naphthalene results in increased expression of UBL4A mRNA CTD PMID:18978301 NCBI chr  X:157,302,528...157,305,380
Ensembl chr  X:157,304,254...157,305,380 		JBrowse link
G Uchl1 ubiquitin C-terminal hydrolase L1 increases expression ISO naphthalene results in increased expression of UCHL1 mRNA; naphthalene results in increased expression of UCHL1 protein CTD PMID:18687389 PMID:18978301 NCBI chr14:41,838,859...41,849,743
Ensembl chr14:41,838,861...41,849,417 		JBrowse link
G Vat1 vesicle amine transport 1 multiple interactions ISO [naphthalene co-treated with CFTR gene mutant form] results in decreased expression of VAT1 protein CTD PMID:19438287 NCBI chr10:86,889,793...86,897,411
Ensembl chr10:86,889,793...86,897,411 		JBrowse link
G Vcl vinculin increases reduction ISO naphthalene results in increased reduction of VCL protein CTD PMID:19843705 NCBI chr15:3,315,069...3,404,891
Ensembl chr15:3,315,069...3,405,163 		JBrowse link
G Vcp valosin-containing protein affects binding ISO naphthalene metabolite binds to VCP protein CTD PMID:16206326 NCBI chr 5:62,005,984...62,025,387
Ensembl chr 5:62,005,985...62,025,387 		JBrowse link
G Wdr1 WD repeat domain 1 decreases expression ISO naphthalene results in decreased expression of WDR1 protein CTD PMID:19438287 NCBI chr14:76,470,238...76,504,086
Ensembl chr14:76,470,176...76,504,080 		JBrowse link
G Zc3h3 zinc finger CCCH type containing 3 multiple interactions ISO [gefitinib co-treated with naphthalene] affects the expression of ZC3H3 mRNA CTD PMID:20935109 NCBI chr 7:109,321,423...109,406,241
Ensembl chr 7:109,321,423...109,406,172 		JBrowse link
G Zfp414 zinc finger protein 414 increases expression ISO naphthalene results in increased expression of ZFP414 mRNA CTD PMID:18978301 NCBI chr 7:15,122,408...15,125,115
Ensembl chr 7:15,122,401...15,125,755 		JBrowse link
pentacene term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Ahr aryl hydrocarbon receptor increases activity
multiple interactions 		EXP pentacene results in increased activity of AHR protein
pentacene affects the reaction [Benzo(a)pyrene binds to AHR protein] 		CTD PMID:28104439 PMID:29471110 NCBI chr 6:57,961,423...57,998,901
Ensembl chr 6:57,961,423...57,998,901 		JBrowse link
phenanthrene term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Acp2 acid phosphatase 2, lysosomal multiple interactions
affects expression 		ISO [naphthalene co-treated with anthracene co-treated with phenanthrene co-treated with pyrene] affects the expression of ACP2 protein
phenanthrene affects the expression of ACP2 protein 		CTD PMID:28803881 NCBI chr 3:97,630,654...97,642,601
Ensembl chr 3:97,631,326...97,642,565 		JBrowse link
G Ahr aryl hydrocarbon receptor multiple interactions
affects binding
increases activity 		EXP
ISO 		phenanthrene binds to and results in increased activity of AHR protein
[phenanthrene co-treated with fluoranthene co-treated with pyrene] results in increased expression of AHR mRNA
phenanthrene binds to AHR protein
[acenaphthene co-treated with anthracene co-treated with 1,12-benzoperylene co-treated with 1,2,5,6-dibenzanthracene co-treated with fluorene co-treated with naphthalene co-treated with phenanthrene] results in increased activity of AHR protein; [naphthalene co-treated with phenanthrene co-treated with anthracene co-treated with fluoranthene co-treated with pyrene] results in decreased expression of AHR protein; [phenanthrene co-treated with naphthalene] inhibits the reaction [Benzo(a)pyrene results in increased activity of AHR protein]; [pyrene co-treated with phenanthrene] inhibits the reaction [Benzo(a)pyrene results in increased activity of AHR protein]; AHR protein affects the reaction [[naphthalene co-treated with phenanthrene co-treated with anthracene co-treated with fluoranthene co-treated with pyrene] results in decreased expression of AR protein]; AHR protein affects the reaction [[naphthalene co-treated with phenanthrene co-treated with anthracene co-treated with fluoranthene co-treated with pyrene] results in increased expression of ESR1 protein]; AHRR protein affects the reaction [[naphthalene co-treated with phenanthrene co-treated with anthracene co-treated with fluoranthene co-treated with pyrene] results in decreased expression of AHR protein]; phenanthrene inhibits the reaction [Benzo(a)pyrene results in increased activity of AHR protein]
phenanthrene results in increased activity of AHR protein 		CTD PMID:3024361 PMID:12850102 PMID:17665671 PMID:28710019 PMID:29502740 More... NCBI chr 6:57,961,423...57,998,901
Ensembl chr 6:57,961,423...57,998,901 		JBrowse link
G Ahrr aryl-hydrocarbon receptor repressor multiple interactions ISO [naphthalene co-treated with phenanthrene co-treated with anthracene co-treated with fluoranthene co-treated with pyrene] results in decreased expression of AHRR protein; AHRR protein affects the reaction [[naphthalene co-treated with phenanthrene co-treated with anthracene co-treated with fluoranthene co-treated with pyrene] results in decreased expression of AHR protein]; AHRR protein affects the reaction [[naphthalene co-treated with phenanthrene co-treated with anthracene co-treated with fluoranthene co-treated with pyrene] results in decreased expression of CYP1A1 protein] CTD PMID:28710019 PMID:30980910 NCBI chr 1:30,822,219...30,917,251
Ensembl chr 1:30,810,866...30,952,866 		JBrowse link
G Akr1c1 aldo-keto reductase family 1, member C1 decreases expression ISO phenanthrene results in decreased expression of AKR1C1 mRNA CTD PMID:38568856 NCBI chr17:70,720,397...70,747,285
Ensembl chr17:70,720,398...70,747,247 		JBrowse link
G Akt1 AKT serine/threonine kinase 1 increases phosphorylation ISO phenanthrene results in increased phosphorylation of AKT1 protein CTD PMID:34453960 NCBI chr 6:137,534,810...137,555,131
Ensembl chr 6:137,535,390...137,552,610 		JBrowse link
G Aldh3a1 aldehyde dehydrogenase 3 family, member A1 increases expression
decreases expression 		ISO phenanthrene results in increased expression of ALDH3A1 mRNA
phenanthrene results in decreased expression of ALDH3A1 mRNA 		CTD PMID:32890658 PMID:38568856 NCBI chr10:46,392,464...46,402,151
Ensembl chr10:46,392,411...46,402,151 		JBrowse link
G Alyref Aly/REF export factor decreases expression ISO phenanthrene results in decreased expression of ALYREF mRNA CTD PMID:38568856 NCBI chr10:106,369,750...106,373,395
Ensembl chr10:106,369,750...106,373,395 		JBrowse link
G Ankrd52 ankyrin repeat domain 52 decreases expression ISO phenanthrene results in decreased expression of ANKRD52 mRNA CTD PMID:38568856 NCBI chr 7:1,390,730...1,410,139
Ensembl chr 7:1,391,325...1,407,410 		JBrowse link
G Ar androgen receptor affects binding
multiple interactions 		EXP
ISO 		phenanthrene analog binds to AR protein
[naphthalene co-treated with phenanthrene co-treated with anthracene co-treated with fluoranthene co-treated with pyrene] results in decreased expression of AR protein; AHR protein affects the reaction [[naphthalene co-treated with phenanthrene co-treated with anthracene co-treated with fluoranthene co-treated with pyrene] results in decreased expression of AR protein]; phenanthrene inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; phenanthrene inhibits the reaction [Dihydrotestosterone results in increased activity of AR protein]
phenanthrene analog inhibits the reaction [Androgens binds to AR protein]; phenanthrene analog inhibits the reaction [Metribolone binds to AR protein]; phenanthrene inhibits the reaction [Metribolone binds to AR protein] 		CTD PMID:3695475 PMID:6323860 PMID:26022396 PMID:30980910 PMID:33049310 NCBI chr  X:67,135,317...67,304,476
Ensembl chr  X:67,135,317...67,304,467 		JBrowse link
G Arnt aryl hydrocarbon receptor nuclear translocator multiple interactions ISO [naphthalene co-treated with phenanthrene co-treated with anthracene co-treated with fluoranthene co-treated with pyrene] affects the expression of ARNT protein; [naphthalene co-treated with phenanthrene co-treated with anthracene co-treated with fluoranthene co-treated with pyrene] results in decreased expression of ARNT mRNA; [naphthalene co-treated with phenanthrene co-treated with anthracene co-treated with fluoranthene co-treated with pyrene] results in increased expression of ARNT mRNA CTD PMID:28710019 NCBI chr 2:185,686,703...185,745,546
Ensembl chr 2:185,680,683...185,745,546 		JBrowse link
G Atf4 activating transcription factor 4 decreases expression ISO phenanthrene results in decreased expression of ATF4 mRNA CTD PMID:38568856 NCBI chr 7:113,684,681...113,686,739
Ensembl chr 7:113,684,681...113,686,739 		JBrowse link
G Aven apoptosis and caspase activation inhibitor decreases expression ISO phenanthrene results in decreased expression of AVEN mRNA CTD PMID:38568856 NCBI chr 3:119,753,395...119,886,009
Ensembl chr 3:119,872,661...119,886,008 		JBrowse link
G Bax BCL2 associated X, apoptosis regulator multiple interactions
affects expression 		ISO [naphthalene co-treated with anthracene co-treated with phenanthrene co-treated with pyrene] affects the expression of BAX protein
phenanthrene affects the expression of BAX protein 		CTD PMID:28803881 NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:105,076,473...105,086,429 		JBrowse link
G Becn1 beclin 1 multiple interactions
decreases expression 		ISO Sirolimus inhibits the reaction [phenanthrene results in decreased expression of BECN1 mRNA] CTD PMID:34453960 NCBI chr10:86,731,649...86,747,002
Ensembl chr10:86,731,650...86,747,002 		JBrowse link
G Casp3 caspase 3 multiple interactions
increases expression 		ISO [naphthalene co-treated with anthracene co-treated with phenanthrene co-treated with pyrene] results in increased expression of CASP3 protein
phenanthrene results in increased expression of CASP3 protein 		CTD PMID:28803881 NCBI chr16:52,395,539...52,413,794
Ensembl chr16:52,395,540...52,413,732 		JBrowse link
G Cat catalase increases expression
multiple interactions
increases activity 		ISO phenanthrene results in increased expression of CAT protein
[phenanthrene co-treated with fluorene] results in increased activity of CAT protein
phenanthrene results in increased activity of CAT protein 		CTD PMID:20238386 PMID:32856796 NCBI chr 3:110,297,340...110,329,526
Ensembl chr 3:110,297,342...110,329,526 		JBrowse link
G Ccna2 cyclin A2 decreases expression
multiple interactions 		ISO phenanthrene results in decreased expression of CCNA2 protein
[naphthalene co-treated with anthracene co-treated with phenanthrene co-treated with pyrene] results in decreased expression of CCNA2 protein 		CTD PMID:28803881 NCBI chr 2:121,355,363...121,361,762
Ensembl chr 2:121,355,363...121,361,701 		JBrowse link
G Ccnd1 cyclin D1 multiple interactions
increases expression 		ISO [naphthalene co-treated with anthracene co-treated with phenanthrene co-treated with pyrene] results in increased expression of CCND1 protein
phenanthrene results in increased expression of CCND1 protein 		CTD PMID:28803881 NCBI chr 1:209,518,288...209,527,986
Ensembl chr 1:209,518,288...209,527,810 		JBrowse link
G Cdk2 cyclin dependent kinase 2 multiple interactions
increases expression 		ISO [naphthalene co-treated with anthracene co-treated with phenanthrene co-treated with pyrene] results in increased expression of CDK2 protein
phenanthrene results in increased expression of CDK2 protein 		CTD PMID:28803881 NCBI chr 7:1,714,392...1,721,964
Ensembl chr 7:1,714,392...1,721,878 		JBrowse link
G Cdkn1c cyclin-dependent kinase inhibitor 1C decreases expression ISO phenanthrene results in decreased expression of CDKN1C mRNA CTD PMID:38568856 NCBI chr 1:208,084,801...208,087,680
Ensembl chr 1:208,084,787...208,087,498 		JBrowse link
G Comt catechol-O-methyltransferase multiple interactions ISO [naphthalene co-treated with phenanthrene co-treated with anthracene co-treated with fluoranthene co-treated with pyrene] affects the expression of COMT mRNA; [naphthalene co-treated with phenanthrene co-treated with anthracene co-treated with fluoranthene co-treated with pyrene] results in increased expression of and affects the activity of COMT protein CTD PMID:28710019 NCBI chr11:96,072,371...96,091,956
Ensembl chr11:96,072,489...96,092,533 		JBrowse link
G Cpt1a carnitine palmitoyltransferase 1A decreases expression ISO phenanthrene results in decreased expression of CPT1A mRNA CTD PMID:38568856 NCBI chr 1:209,993,881...210,056,329
Ensembl chr 1:209,993,875...210,056,326 		JBrowse link
G Cul4b cullin 4B decreases expression ISO phenanthrene results in decreased expression of CUL4B mRNA CTD PMID:38568856 NCBI chr  X:122,154,332...122,192,299
Ensembl chr  X:122,154,332...122,192,299 		JBrowse link
G Cyp19a1 cytochrome P450, family 19, subfamily a, polypeptide 1 multiple interactions
increases expression 		ISO [naphthalene co-treated with anthracene co-treated with phenanthrene co-treated with pyrene] affects the expression of CYP19A1 protein
phenanthrene results in increased expression of CYP19A1 protein 		CTD PMID:28803881 NCBI chr 8:63,449,148...63,476,534
Ensembl chr 8:63,449,148...63,476,917 		JBrowse link
G Cyp1a1 cytochrome P450, family 1, subfamily a, polypeptide 1 multiple interactions
increases expression
increases oxidation
increases metabolic processing
increases activity 		ISO
EXP 		[CYP1A1 protein results in increased oxidation of phenanthrene] which results in increased abundance of 9-phenanthrol; [naphthalene co-treated with acenaphthene co-treated with 2-methylnaphthalene co-treated with 1-methylnaphthalene co-treated with Fluorine co-treated with phenanthrene] results in increased expression of CYP1A1 mRNA; [naphthalene co-treated with phenanthrene co-treated with anthracene co-treated with fluoranthene co-treated with pyrene] affects the expression of CYP1A1 mRNA; [naphthalene co-treated with phenanthrene co-treated with anthracene co-treated with fluoranthene co-treated with pyrene] affects the expression of CYP1A1 protein; [naphthalene co-treated with phenanthrene co-treated with anthracene co-treated with fluoranthene co-treated with pyrene] results in decreased expression of CYP1A1 protein; [phenanthrene co-treated with pyrene co-treated with Benzo(a)pyrene co-treated with benzo(k)fluoranthene co-treated with dibenzo(a,l)pyrene co-treated with benzo(b)fluoranthene] results in increased expression of CYP1A1 mRNA; AHRR protein affects the reaction [[naphthalene co-treated with phenanthrene co-treated with anthracene co-treated with fluoranthene co-treated with pyrene] results in decreased expression of CYP1A1 protein]; CYP1A1 protein results in increased metabolism of and results in increased activity of phenanthrene; GSTM1 gene polymorphism promotes the reaction [CYP1A1 gene polymorphism results in increased metabolism of phenanthrene]
phenanthrene results in increased expression of CYP1A1 mRNA
phenanthrene results in increased expression of CYP1A1 mRNA; phenanthrene results in increased expression of CYP1A1 protein
phenanthrene results in increased activity of CYP1A1 protein 		CTD PMID:15566942 PMID:16906435 PMID:17035385 PMID:19766613 PMID:27137136 More... NCBI chr 8:66,991,940...66,998,014
Ensembl chr 8:66,991,970...66,998,012 		JBrowse link
G Cyp1a2 cytochrome P450, family 1, subfamily a, polypeptide 2 increases activity
increases expression
increases oxidation
multiple interactions 		ISO phenanthrene results in increased activity of CYP1A2 protein
phenanthrene results in increased expression of CYP1A2 mRNA; phenanthrene results in increased expression of CYP1A2 protein
CYP1A2 protein results in increased oxidation of phenanthrene
[acenaphthylene co-treated with acenaphthene co-treated with dibenzofuran co-treated with fluorene co-treated with phenanthrene co-treated with anthracene] results in increased expression of CYP1A2 mRNA; CYP1A2 protein results in increased metabolism of and results in increased activity of phenanthrene
[CYP1A2 protein results in increased oxidation of phenanthrene] which results in increased abundance of 9-phenanthrol; CYP1A2 protein results in increased metabolism of and results in increased activity of phenanthrene 		CTD PMID:7750161 PMID:8001243 PMID:19766613 PMID:27137136 PMID:31181217 NCBI chr 8:66,971,261...66,978,149
Ensembl chr 8:66,971,261...66,978,149 		JBrowse link
G Cyp1b1 cytochrome P450, family 1, subfamily b, polypeptide 1 multiple interactions
increases expression
increases oxidation
decreases metabolic processing 		ISO [CYP1B1 protein results in increased oxidation of phenanthrene] which results in increased abundance of 9-phenanthrol; [naphthalene co-treated with acenaphthene co-treated with 2-methylnaphthalene co-treated with 1-methylnaphthalene co-treated with Fluorine co-treated with phenanthrene] results in increased expression of CYP1B1 mRNA; [phenanthrene co-treated with pyrene co-treated with Benzo(a)pyrene co-treated with benzo(k)fluoranthene co-treated with dibenzo(a,l)pyrene co-treated with benzo(b)fluoranthene] results in increased expression of CYP1B1 mRNA; CYP1B1 protein results in increased metabolism of and results in increased activity of phenanthrene; phenanthrene binds to and results in decreased activity of CYP1B1 protein
phenanthrene results in increased expression of CYP1B1 mRNA
CYP1B1 gene polymorphism results in decreased metabolism of phenanthrene 		CTD PMID:15566942 PMID:17035385 PMID:19563207 PMID:19766613 PMID:27137136 More... NCBI chr 6:21,093,927...21,103,091
Ensembl chr 6:21,078,146...21,103,142 		JBrowse link
G Cyp2a1 cytochrome P450, family 2, subfamily a, polypeptide 1 increases oxidation
affects binding
multiple interactions 		ISO CYP2A13 protein results in increased oxidation of phenanthrene
phenanthrene binds to CYP2A13 protein
[CYP2A13 protein results in increased oxidation of phenanthrene] which results in increased abundance of 9-phenanthrol 		CTD PMID:27137136 NCBI chr 1:91,359,278...91,372,554
Ensembl chr 1:91,359,272...91,389,730 		JBrowse link
G Cyp2b3 cytochrome P450, family 2, subfamily b, polypeptide 3 increases expression
multiple interactions 		ISO phenanthrene results in increased expression of CYP2B6 mRNA
phenanthrene results in increased expression of CYP2B10 mRNA; phenanthrene results in increased expression of CYP2B10 protein
NR1I3 gene mutant form inhibits the reaction [phenanthrene results in increased expression of CYP2B10 mRNA]; NR1I3 gene mutant form inhibits the reaction [phenanthrene results in increased expression of CYP2B10 protein] 		CTD PMID:31181217 NCBI chr 1:90,780,468...90,859,852 JBrowse link
G Cyp2d4 cytochrome P450, family 2, subfamily d, polypeptide 4 increases metabolic processing ISO CYP2D6 protein results in increased metabolism of phenanthrene CTD PMID:9429232 NCBI chr 7:115,762,662...115,771,832
Ensembl chr 7:115,761,696...115,771,837 		JBrowse link
G Cyp2e1 cytochrome P450, family 2, subfamily e, polypeptide 1 multiple interactions ISO CYP2E1 protein results in increased metabolism of and results in increased activity of phenanthrene CTD PMID:19766613 NCBI chr 1:205,269,967...205,280,365
Ensembl chr 1:205,267,505...205,293,495 		JBrowse link
G Eef1a1 eukaryotic translation elongation factor 1 alpha 1 decreases expression ISO phenanthrene results in decreased expression of EEF1A1 mRNA CTD PMID:38568856 NCBI chr 8:88,221,839...88,225,688
Ensembl chr 8:88,221,843...88,225,072 		JBrowse link
G Egr1 early growth response 1 increases expression ISO phenanthrene results in increased expression of EGR1 protein CTD PMID:15342960 NCBI chr18:26,737,078...26,740,877
Ensembl chr18:26,736,838...26,740,843 		JBrowse link
G Eif4e eukaryotic translation initiation factor 4E increases expression ISO phenanthrene results in increased expression of EIF4E mRNA CTD PMID:34453960 NCBI chr 2:229,736,309...229,772,628
Ensembl chr 2:229,739,897...229,774,105 		JBrowse link
G Esr1 estrogen receptor 1 multiple interactions ISO [naphthalene co-treated with phenanthrene co-treated with anthracene co-treated with fluoranthene co-treated with pyrene] results in increased expression of ESR1 protein; AHR protein affects the reaction [[naphthalene co-treated with phenanthrene co-treated with anthracene co-treated with fluoranthene co-treated with pyrene] results in increased expression of ESR1 protein]; phenanthrene analog binds to and results in decreased activity of ESR1 protein; phenanthrene binds to and results in increased activity of ESR1 protein CTD PMID:12672240 PMID:30980910 PMID:33049310 NCBI chr 1:43,511,685...43,904,454
Ensembl chr 1:43,644,392...43,900,354 		JBrowse link
G Esr2 estrogen receptor 2 affects binding ISO phenanthrene analog binds to ESR2 protein CTD PMID:12672240 NCBI chr 6:100,589,553...100,645,240
Ensembl chr 6:100,545,206...100,644,709 		JBrowse link
G Foxp3 forkhead box P3 decreases expression EXP phenanthrene results in decreased expression of FOXP3 mRNA; phenanthrene results in decreased expression of FOXP3 protein CTD PMID:31456356 NCBI chr  X:17,580,380...17,601,181
Ensembl chr  X:17,580,380...17,595,894 		JBrowse link
G Foxp4 forkhead box P4 decreases expression ISO phenanthrene results in decreased expression of FOXP4 mRNA CTD PMID:38568856 NCBI chr 9:20,556,270...20,612,967
Ensembl chr 9:20,556,270...20,612,967 		JBrowse link
G Gjb1 gap junction protein, beta 1 decreases expression EXP phenanthrene results in decreased expression of GJB1 protein CTD PMID:25268939 NCBI chr  X:70,541,845...70,549,776
Ensembl chr  X:70,541,862...70,549,843 		JBrowse link
G Gnas GNAS complex locus increases expression ISO phenanthrene results in increased expression of GNAS mRNA CTD PMID:38568856 NCBI chr 3:183,489,648...183,554,570
Ensembl chr 3:183,503,243...183,554,536 		JBrowse link
G Gsk3a glycogen synthase kinase 3 alpha decreases expression ISO phenanthrene results in decreased expression of GSK3A mRNA CTD PMID:38568856 NCBI chr 1:89,943,669...89,953,514
Ensembl chr 1:89,943,669...89,953,593 		JBrowse link
G Gsr glutathione-disulfide reductase increases expression ISO phenanthrene results in increased expression of GSR protein CTD PMID:20238386 NCBI chr16:65,185,574...65,228,742
Ensembl chr16:65,185,574...65,228,394 		JBrowse link
G Gsta1 glutathione S-transferase alpha 1 increases expression ISO phenanthrene results in increased expression of GSTA1 mRNA CTD PMID:32890658 NCBI chr 9:31,199,887...31,216,606
Ensembl chr 9:31,199,888...31,211,528 		JBrowse link
G Gstm1 glutathione S-transferase mu 1 multiple interactions
affects metabolic processing 		ISO GSTM1 gene polymorphism promotes the reaction [CYP1A1 gene polymorphism results in increased metabolism of phenanthrene]
GSTM1 protein affects the metabolism of phenanthrene 		CTD PMID:17035385 PMID:22674470 NCBI chr 2:198,338,005...198,346,007
Ensembl chr 2:198,338,008...198,343,569 		JBrowse link
G Gstm5 glutathione S-transferase, mu 5 multiple interactions
increases expression 		ISO NR1I3 gene mutant form inhibits the reaction [phenanthrene results in increased expression of GSTM3 mRNA] CTD PMID:31181217 NCBI chr 2:198,219,769...198,222,732
Ensembl chr 2:198,219,647...198,222,731 		JBrowse link
G Hmga2 high mobility group AT-hook 2 decreases expression ISO phenanthrene results in decreased expression of HMGA2 mRNA CTD PMID:38568856 NCBI chr 7:57,762,710...57,884,555
Ensembl chr 7:57,765,675...57,880,341 		JBrowse link
G Icam1 intercellular adhesion molecule 1 increases expression
multiple interactions 		ISO phenanthrene results in increased expression of ICAM1 protein
[phenanthrene co-treated with fluoranthene co-treated with pyrene] results in increased expression of ICAM1 mRNA; [phenanthrene co-treated with fluoranthene co-treated with pyrene] results in increased expression of ICAM1 protein 		CTD PMID:22313677 PMID:37888695 NCBI chr 8:27,829,688...27,841,618
Ensembl chr 8:27,829,161...27,841,617 		JBrowse link
G Ier3 immediate early response 3 increases expression
decreases expression 		ISO phenanthrene results in increased expression of IER3 mRNA
phenanthrene results in decreased expression of IER3 mRNA 		CTD PMID:22579512 PMID:38568856 NCBI chr20:2,933,173...2,934,377
Ensembl chr20:2,933,174...2,934,377 		JBrowse link
G Ifng interferon gamma multiple interactions ISO [phenanthrene co-treated with fluoranthene co-treated with pyrene] results in increased expression of IFNG protein CTD PMID:37888695 NCBI chr 7:55,789,180...55,793,216
Ensembl chr 7:55,761,736...55,793,216 		JBrowse link
G Ighe immunoglobulin heavy constant epsilon affects expression
increases expression 		ISO phenanthrene affects the expression of IGHE mRNA alternative form
phenanthrene results in increased expression of IGHE mRNA; phenanthrene results in increased expression of IGHE protein 		CTD PMID:9070347
G Il10 interleukin 10 decreases expression EXP phenanthrene results in decreased expression of IL10 mRNA; phenanthrene results in decreased expression of IL10 protein CTD PMID:31456356 NCBI chr13:45,024,921...45,029,586
Ensembl chr13:45,025,087...45,029,580 		JBrowse link
G Il1b interleukin 1 beta multiple interactions ISO [phenanthrene co-treated with fluoranthene co-treated with pyrene] results in increased expression of IL1B protein CTD PMID:37888695 NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:137,030,205...137,036,601 		JBrowse link
G Il6 interleukin 6 increases expression
multiple interactions 		EXP
ISO 		phenanthrene results in increased expression of IL6 mRNA; phenanthrene results in increased expression of IL6 protein
[phenanthrene co-treated with fluoranthene co-treated with pyrene] results in increased expression of IL6 protein
[fluorene co-treated with phenanthrene] results in increased expression of IL6 mRNA; [fluorene co-treated with phenanthrene] results in increased expression of IL6 protein 		CTD PMID:31456356 PMID:32856796 PMID:37888695 NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,889,999...5,894,610 		JBrowse link
G Krt16 keratin 16 decreases expression ISO phenanthrene results in decreased expression of KRT16 mRNA CTD PMID:38568856 NCBI chr10:85,669,276...85,672,211
Ensembl chr10:85,669,276...85,672,211 		JBrowse link
G Krt5 keratin 5 decreases expression ISO phenanthrene results in decreased expression of KRT5 mRNA CTD PMID:38568856 NCBI chr 7:134,724,840...134,730,569
Ensembl chr 7:134,724,840...134,730,569 		JBrowse link
G Lama3 laminin subunit alpha 3 increases expression ISO phenanthrene results in increased expression of LAMA3 mRNA CTD PMID:38568856 NCBI chr18:3,797,898...4,033,021
Ensembl chr18:3,797,939...4,026,449 		JBrowse link
G Lama5 laminin subunit alpha 5 decreases expression ISO phenanthrene results in decreased expression of LAMA5 mRNA CTD PMID:38568856 NCBI chr 3:187,647,904...187,695,974
Ensembl chr 3:187,647,904...187,696,173 		JBrowse link
G Lgals1 galectin 1 increases expression ISO phenanthrene results in increased expression of LGALS1 mRNA CTD PMID:22579512 NCBI chr 7:112,365,695...112,368,801
Ensembl chr 7:112,361,850...112,368,800 		JBrowse link
G Mcam melanoma cell adhesion molecule decreases expression ISO phenanthrene results in decreased expression of MCAM mRNA CTD PMID:38568856 NCBI chr 8:53,376,225...53,384,407
Ensembl chr 8:53,376,197...53,384,406 		JBrowse link
G Mllt1 MLLT1, super elongation complex subunit decreases expression ISO phenanthrene results in decreased expression of MLLT1 mRNA CTD PMID:38568856 NCBI chr 9:1,818,204...1,863,091
Ensembl chr 9:1,818,204...1,863,089 		JBrowse link
G Mt-nd3 mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 3 decreases expression ISO phenanthrene results in decreased expression of ND3 mRNA CTD PMID:38568856 NCBI chr MT:9,451...9,798
Ensembl chr MT:9,436...9,783 		JBrowse link
G Mt2 metallothionein 2 decreases expression ISO phenanthrene results in decreased expression of MT2A mRNA CTD PMID:38568856 NCBI chr19:10,837,934...10,838,708
Ensembl chr19:10,837,927...10,838,709 		JBrowse link
G Nacc1 nucleus accumbens associated 1 decreases expression ISO phenanthrene results in decreased expression of NACC1 mRNA CTD PMID:38568856 NCBI chr19:40,373,436...40,391,351
Ensembl chr19:40,373,449...40,391,347 		JBrowse link
G Ndc80 NDC80 kinetochore complex component decreases expression ISO phenanthrene results in decreased expression of NDC80 mRNA CTD PMID:22579512 NCBI chr 9:118,853,806...118,887,582
Ensembl chr 9:118,853,806...118,887,568 		JBrowse link
G Nfe2l2 NFE2 like bZIP transcription factor 2 multiple interactions ISO [phenanthrene co-treated with fluoranthene co-treated with pyrene] results in increased expression of NFE2L2 mRNA CTD PMID:37888695 NCBI chr 3:81,001,529...81,031,165
Ensembl chr 3:81,001,529...81,029,090 		JBrowse link
G Nfkb2 nuclear factor kappa B subunit 2 multiple interactions ISO [naphthalene co-treated with phenanthrene co-treated with anthracene co-treated with fluoranthene co-treated with pyrene] results in increased expression of NFKB2 protein CTD PMID:30980910 NCBI chr 1:255,106,010...255,114,649
Ensembl chr 1:255,107,374...255,114,637 		JBrowse link
G Niban2 niban apoptosis regulator 2 decreases expression ISO phenanthrene results in decreased expression of NIBAN2 mRNA CTD PMID:38568856 NCBI chr 3:36,572,356...36,621,968
Ensembl chr 3:36,572,377...36,621,967 		JBrowse link
G Nlgn1 neuroligin 1 decreases expression ISO phenanthrene results in decreased expression of NLGN1 mRNA CTD PMID:34453960 NCBI chr 2:110,184,987...111,110,316
Ensembl chr 2:110,186,573...110,909,984 		JBrowse link
G Nqo1 NAD(P)H quinone dehydrogenase 1 increases activity
increases expression 		EXP
ISO 		phenanthrene results in increased activity of NQO1 protein
phenanthrene results in increased expression of NQO1 mRNA 		CTD PMID:16906435 PMID:31181217 NCBI chr19:52,205,374...52,220,267
Ensembl chr19:52,205,314...52,220,260 		JBrowse link
G Nr1i2 nuclear receptor subfamily 1, group I, member 2 multiple interactions ISO phenanthrene binds to and results in increased activity of NR1I2 protein CTD PMID:33049310 NCBI chr11:75,965,717...76,006,733
Ensembl chr11:75,965,632...76,002,380 		JBrowse link
G Nr1i3 nuclear receptor subfamily 1, group I, member 3 increases activity
multiple interactions 		ISO phenanthrene results in increased activity of NR1I3 protein
NR1I3 gene mutant form inhibits the reaction [phenanthrene results in increased expression of CYP2B10 mRNA]; NR1I3 gene mutant form inhibits the reaction [phenanthrene results in increased expression of CYP2B10 protein]; NR1I3 gene mutant form inhibits the reaction [phenanthrene results in increased expression of CYP3A11 mRNA]; NR1I3 gene mutant form inhibits the reaction [phenanthrene results in increased expression of GSTM3 mRNA]; NR1I3 gene mutant form inhibits the reaction [phenanthrene results in increased expression of SULT2A1 mRNA]; NR1I3 gene mutant form inhibits the reaction [phenanthrene results in increased expression of UGT1A1 mRNA] 		CTD PMID:28927721 PMID:31181217 NCBI chr13:86,165,327...86,170,362
Ensembl chr13:86,165,349...86,170,370 		JBrowse link
G Pah phenylalanine hydroxylase decreases expression ISO phenanthrene results in decreased expression of PAH mRNA CTD PMID:22579512 NCBI chr 7:23,793,096...23,885,631
Ensembl chr 7:23,792,781...23,885,627 		JBrowse link
G Parp1 poly (ADP-ribose) polymerase 1 increases cleavage ISO phenanthrene results in increased cleavage of PARP1 protein CTD PMID:21132278 NCBI chr13:94,839,484...94,871,295
Ensembl chr13:94,839,433...94,871,567 		JBrowse link
G Pgr progesterone receptor multiple interactions ISO phenanthrene inhibits the reaction [16 alpha-ethyl-21-hydroxy-19-nor-4-pregnene-3,20-dione results in increased activity of PGR protein] CTD PMID:26022396 NCBI chr 8:14,354,398...14,413,271
Ensembl chr 8:14,354,398...14,413,271 		JBrowse link
G Pou5f1 POU class 5 homeobox 1 multiple interactions
decreases expression 		ISO phenanthrene affects the reaction [Tretinoin results in decreased expression of POU5F1 protein]
phenanthrene results in decreased expression of POU5F1 protein 		CTD PMID:21111795 NCBI chr20:3,227,836...3,232,598
Ensembl chr20:3,227,837...3,232,598 		JBrowse link
G Rela RELA proto-oncogene, NF-kB subunit multiple interactions ISO [phenanthrene co-treated with fluoranthene co-treated with pyrene] results in increased expression of RELA mRNA CTD PMID:37888695 NCBI chr 1:212,354,336...212,364,815
Ensembl chr 1:212,333,035...212,364,817 		JBrowse link
G Rhoc ras homolog family member C increases expression ISO phenanthrene results in increased expression of RHOC mRNA CTD PMID:22579512 NCBI chr 2:194,975,586...194,981,637
Ensembl chr 2:194,975,242...194,983,745 		JBrowse link
G Rnf44 ring finger protein 44 decreases expression ISO phenanthrene results in decreased expression of RNF44 mRNA CTD PMID:38568856 NCBI chr17:9,925,100...9,939,496
Ensembl chr17:9,930,375...9,939,478 		JBrowse link
G Rpl24 ribosomal protein L24 decreases expression ISO phenanthrene results in decreased expression of RPL24 mRNA CTD PMID:38568856 NCBI chr11:58,122,997...58,128,405
Ensembl chr11:58,122,997...58,128,405 		JBrowse link
G Rpl27a ribosomal protein L27A decreases expression ISO phenanthrene results in decreased expression of RPL27A mRNA CTD PMID:38568856 NCBI chr 1:172,971,957...172,977,591 JBrowse link
G Rpl28 ribosomal protein L28 decreases expression ISO phenanthrene results in decreased expression of RPL28 mRNA CTD PMID:38568856 NCBI chr 1:78,080,945...78,083,532
Ensembl chr 1:78,080,945...78,083,771 		JBrowse link
G Rpl30 ribosomal protein L30 decreases expression ISO phenanthrene results in decreased expression of RPL30 mRNA CTD PMID:38568856 NCBI chr 7:67,533,420...67,536,555
Ensembl chr 7:67,465,332...67,536,555 		JBrowse link
G Rpl37a ribosomal protein L37A decreases expression ISO phenanthrene results in decreased expression of RPL37A mRNA CTD PMID:38568856 NCBI chr 9:81,748,091...81,750,174
Ensembl chr 9:81,748,103...81,751,975 		JBrowse link
G Rpl39 ribosomal protein L39 decreases expression ISO phenanthrene results in decreased expression of RPL39 mRNA CTD PMID:38568856 NCBI chr  X:121,192,901...121,195,896
Ensembl chr 7:31,721,884...31,722,039
Ensembl chr15:31,721,884...31,722,039
Ensembl chr  X:31,721,884...31,722,039 		JBrowse link
G Rpl5 ribosomal protein L5 decreases expression ISO phenanthrene results in decreased expression of RPL5 mRNA CTD PMID:38568856 NCBI chr14:1,988,792...1,995,236
Ensembl chr14:1,988,793...1,995,225 		JBrowse link
G Rpl7a ribosomal protein L7A decreases expression ISO phenanthrene results in decreased expression of RPL7A mRNA CTD PMID:38568856 NCBI chr 3:30,637,136...30,639,778
Ensembl chr 3:30,637,059...30,639,791
Ensembl chr18:30,637,059...30,639,791 		JBrowse link
G Rplp2 ribosomal protein lateral stalk subunit P2 decreases expression ISO phenanthrene results in decreased expression of RPLP2 mRNA CTD PMID:38568856 NCBI chr 1:205,975,598...205,978,192
Ensembl chr 1:205,975,894...205,978,191 		JBrowse link
G Rps12 ribosomal protein S12 decreases expression ISO phenanthrene results in decreased expression of RPS12 mRNA CTD PMID:38568856 NCBI chr 1:23,499,943...23,502,234
Ensembl chr 1:23,500,073...23,502,235 		JBrowse link
G Rps15a ribosomal protein S15a decreases expression ISO phenanthrene results in decreased expression of RPS15A mRNA CTD PMID:38568856 NCBI chr 1:181,854,396...181,861,330
Ensembl chr 1:181,854,396...181,861,201 		JBrowse link
G Rps21-ps1 ribosomal protein S21, pseudogene 1 decreases expression ISO phenanthrene results in decreased expression of RPS21 mRNA CTD PMID:38568856 NCBI chr 5:158,670,141...158,670,484
Ensembl chr 5:158,670,116...158,670,490 		JBrowse link
G Rps29 ribosomal protein S29 decreases expression ISO phenanthrene results in decreased expression of RPS29 mRNA CTD PMID:38568856 NCBI chr 6:93,371,293...93,372,731
Ensembl chr13:87,816,954...87,817,267
Ensembl chr 6:87,816,954...87,817,267 		JBrowse link
G Rpsa ribosomal protein SA decreases expression ISO phenanthrene results in decreased expression of RPSA mRNA CTD PMID:38568856 NCBI chr 8:128,728,761...128,732,736
Ensembl chr 8:128,728,862...128,732,737 		JBrowse link
G RT1-CE16 RT1 class I, locus CE16 decreases expression ISO phenanthrene results in decreased expression of HLA-A mRNA CTD PMID:38568856 NCBI chr20:3,261,656...3,265,548 JBrowse link
G S100a13 S100 calcium binding protein A13 decreases expression ISO phenanthrene results in decreased expression of S100A13 mRNA CTD PMID:38568856 NCBI chr 2:178,297,020...178,303,514
Ensembl chr 2:178,296,917...178,303,507 		JBrowse link
G S100a8 S100 calcium binding protein A8 decreases expression ISO phenanthrene results in decreased expression of S100A8 mRNA CTD PMID:38568856 NCBI chr 2:178,464,095...178,465,223
Ensembl chr 2:178,464,702...178,465,221 		JBrowse link
G Sele selectin E multiple interactions ISO [phenanthrene co-treated with fluoranthene co-treated with pyrene] results in increased expression of SELE mRNA CTD PMID:37888695 NCBI chr13:78,935,997...78,945,905
Ensembl chr13:78,936,036...78,945,903 		JBrowse link
G Sf3a2 splicing factor 3A subunit 2 decreases expression ISO phenanthrene results in decreased expression of SF3A2 mRNA CTD PMID:38568856 NCBI chr 7:9,560,182...9,566,205
Ensembl chr 7:9,560,182...9,566,205 		JBrowse link
G Shank3 SH3 and multiple ankyrin repeat domains 3 multiple interactions
decreases expression 		ISO Sirolimus inhibits the reaction [phenanthrene results in decreased expression of SHANK3 mRNA] CTD PMID:34453960 NCBI chr 7:122,448,323...122,518,623
Ensembl chr 7:122,448,323...122,510,410 		JBrowse link
G Sod2 superoxide dismutase 2 increases expression ISO phenanthrene results in increased expression of SOD2 protein CTD PMID:20238386 NCBI chr 1:50,043,323...50,050,168
Ensembl chr 1:50,043,325...50,050,168 		JBrowse link
G Sult2a1 sulfotransferase family 2A member 1 increases expression
multiple interactions 		ISO phenanthrene results in increased expression of SULT2A1 mRNA
NR1I3 gene mutant form inhibits the reaction [phenanthrene results in increased expression of SULT2A1 mRNA] 		CTD PMID:31181217 NCBI chr 1:84,582,011...84,639,001 JBrowse link
G Tgfb1 transforming growth factor, beta 1 decreases expression EXP phenanthrene results in decreased expression of TGFB1 mRNA; phenanthrene results in decreased expression of TGFB1 protein CTD PMID:31456356 NCBI chr 1:90,324,312...90,340,627
Ensembl chr 1:90,324,046...90,340,899 		JBrowse link
G Timp1 TIMP metallopeptidase inhibitor 1 increases expression ISO phenanthrene results in increased expression of TIMP1 mRNA CTD PMID:22579512 NCBI chr  X:3,766,509...3,772,578
Ensembl chr  X:3,766,510...3,771,135 		JBrowse link
G Timp2 TIMP metallopeptidase inhibitor 2 decreases expression ISO phenanthrene results in decreased expression of TIMP2 mRNA CTD PMID:38568856 NCBI chr10:104,041,604...104,089,214
Ensembl chr10:104,041,604...104,089,214 		JBrowse link
G Tmt1a thiol methyltransferase 1A decreases expression ISO phenanthrene results in decreased expression of METTL7A mRNA CTD PMID:38568856 NCBI chr 7:133,330,141...133,377,172
Ensembl chr 7:133,330,447...133,338,959 		JBrowse link
G Tnf tumor necrosis factor multiple interactions
increases expression 		ISO
EXP 		[fluorene co-treated with phenanthrene] results in increased expression of TNF mRNA; [fluorene co-treated with phenanthrene] results in increased expression of TNF protein; TNF protein promotes the reaction [phenanthrene results in increased expression of CXCL8 mRNA]
[phenanthrene co-treated with fluoranthene co-treated with pyrene] results in increased expression of TNF protein
phenanthrene results in increased expression of TNF protein
phenanthrene results in increased expression of TNF mRNA; phenanthrene results in increased expression of TNF protein 		CTD PMID:18434080 PMID:31456356 PMID:32856796 PMID:34453960 PMID:37888695 NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,626,532...3,629,303 		JBrowse link
G Tpt1 tumor protein, translationally-controlled 1 decreases expression ISO phenanthrene results in decreased expression of TPT1 mRNA CTD PMID:38568856 NCBI chr15:57,562,217...57,568,968
Ensembl chr15:57,566,067...57,569,554 		JBrowse link
G Tuba1c tubulin, alpha 1C decreases expression ISO phenanthrene results in decreased expression of TUBA1C mRNA CTD PMID:38568856 NCBI chr 7:131,636,974...132,078,589
Ensembl chr 7:132,070,536...132,079,311 		JBrowse link
G Ugt1a1 UDP glucuronosyltransferase family 1 member A1 increases expression
multiple interactions 		ISO phenanthrene results in increased expression of UGT1A1 mRNA
NR1I3 gene mutant form inhibits the reaction [phenanthrene results in increased expression of UGT1A1 mRNA] 		CTD PMID:31181217 NCBI chr 9:96,249,143...96,256,264
Ensembl chr 9:96,144,786...96,256,264 		JBrowse link
G Ugt1a6a UDP glucuronosyltransferase family 1 member A6a multiple interactions ISO [phenanthrene co-treated with pyrene co-treated with Benzo(a)pyrene co-treated with benzo(k)fluoranthene co-treated with dibenzo(a,l)pyrene co-treated with benzo(b)fluoranthene] results in increased expression of UGT1A6 mRNA CTD PMID:15566942 NCBI chr 9:96,195,018...96,256,264
Ensembl chr 9:96,144,786...96,256,264 		JBrowse link
G Vcam1 vascular cell adhesion molecule 1 multiple interactions ISO [phenanthrene co-treated with fluoranthene co-treated with pyrene] results in increased expression of VCAM1 mRNA; [phenanthrene co-treated with fluoranthene co-treated with pyrene] results in increased expression of VCAM1 protein CTD PMID:37888695 NCBI chr 2:206,723,050...206,742,783
Ensembl chr 2:206,723,044...206,742,801 		JBrowse link
G Vegfb vascular endothelial growth factor B decreases expression ISO phenanthrene results in decreased expression of VEGFB mRNA CTD PMID:38568856 NCBI chr 1:213,601,570...213,607,254
Ensembl chr 1:213,600,966...213,607,152 		JBrowse link
G Zbed6 zinc finger, BED-type containing 6 decreases expression ISO phenanthrene results in decreased expression of ZBED6 mRNA CTD PMID:38568856 NCBI chr13:47,659,269...47,665,540
Ensembl chr13:47,658,667...47,668,221 		JBrowse link
picene term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Abcc5 ATP binding cassette subfamily C member 5 increases expression ISO picene results in increased expression of ABCC5 mRNA CTD PMID:32251684 NCBI chr11:93,975,579...94,071,659
Ensembl chr11:93,978,274...94,071,655 		JBrowse link
G Abhd2 abhydrolase domain containing 2, acylglycerol lipase decreases expression ISO picene results in decreased expression of ABHD2 mRNA CTD PMID:32251684 NCBI chr 1:142,626,748...142,707,892
Ensembl chr 1:142,626,732...142,712,674 		JBrowse link
G Adora1 adenosine A1 receptor decreases expression ISO picene results in decreased expression of ADORA1 mRNA CTD PMID:32251684 NCBI chr13:48,210,922...48,247,826
Ensembl chr13:48,213,273...48,247,190 		JBrowse link
G Ahr aryl hydrocarbon receptor affects binding
increases activity
multiple interactions 		EXP picene binds to AHR protein
picene results in increased activity of AHR protein
picene inhibits the reaction [Benzo(a)pyrene binds to AHR protein]; picene inhibits the reaction [Tetrachlorodibenzodioxin binds to AHR protein] 		CTD PMID:3024361 PMID:28104439 PMID:29471110 NCBI chr 6:57,961,423...57,998,901
Ensembl chr 6:57,961,423...57,998,901 		JBrowse link
G Ahrr aryl-hydrocarbon receptor repressor increases expression ISO picene results in increased expression of AHRR mRNA CTD PMID:32251684 NCBI chr 1:30,822,219...30,917,251
Ensembl chr 1:30,810,866...30,952,866 		JBrowse link
G Aldh1a3 aldehyde dehydrogenase 1 family, member A3 increases expression ISO picene results in increased expression of ALDH1A3 mRNA CTD PMID:32251684 NCBI chr 1:129,392,516...129,436,552
Ensembl chr 1:129,392,516...129,427,777 		JBrowse link
G Aldh3a1 aldehyde dehydrogenase 3 family, member A1 increases expression ISO picene results in increased expression of ALDH3A1 mRNA CTD PMID:32251684 NCBI chr10:46,392,464...46,402,151
Ensembl chr10:46,392,411...46,402,151 		JBrowse link
G Amer2 APC membrane recruitment protein 2 increases expression ISO picene results in increased expression of AMER2 mRNA CTD PMID:32251684 NCBI chr15:38,701,509...38,711,817
Ensembl chr15:38,701,657...38,705,633 		JBrowse link
G Atoh8 atonal bHLH transcription factor 8 increases expression ISO picene results in increased expression of ATOH8 mRNA CTD PMID:32251684 NCBI chr 4:105,818,203...105,850,379
Ensembl chr 4:105,818,203...105,850,379 		JBrowse link
G Bpifa5 BPI fold containing family A, member 5 increases expression ISO picene results in increased expression of BPIFA4P mRNA CTD PMID:32251684 NCBI chr 3:163,106,258...163,113,039
Ensembl chr 3:163,106,258...163,113,038 		JBrowse link
G Ccng2 cyclin G2 increases expression ISO picene results in increased expression of CCNG2 mRNA CTD PMID:32251684 NCBI chr14:15,088,694...15,097,190
Ensembl chr14:15,088,695...15,096,206 		JBrowse link
G Cebpb CCAAT/enhancer binding protein beta decreases expression ISO picene results in decreased expression of CEBPB mRNA CTD PMID:32251684 NCBI chr 3:176,817,005...176,818,436
Ensembl chr 3:176,816,859...176,838,072 		JBrowse link
G Celsr2 cadherin, EGF LAG seven-pass G-type receptor 2 decreases expression ISO picene results in decreased expression of CELSR2 mRNA CTD PMID:32251684 NCBI chr 2:198,717,333...198,741,689
Ensembl chr 2:198,717,896...198,741,581 		JBrowse link
G Cntnap3 contactin associated protein family member 3 increases expression ISO picene results in increased expression of CNTNAP3 mRNA CTD PMID:32251684 NCBI chr17:273,137...461,233
Ensembl chr17:273,137...461,233 		JBrowse link
G Ctsd cathepsin D decreases expression ISO picene results in decreased expression of CTSD mRNA CTD PMID:32251684 NCBI chr 1:206,956,945...206,968,821
Ensembl chr 1:206,956,944...206,968,821 		JBrowse link
G Cxcl12 C-X-C motif chemokine ligand 12 decreases expression ISO picene results in decreased expression of CXCL12 mRNA CTD PMID:32251684 NCBI chr 4:152,060,781...152,073,628
Ensembl chr 4:152,060,780...152,073,627 		JBrowse link
G Cyp1a1 cytochrome P450, family 1, subfamily a, polypeptide 1 increases expression EXP
ISO 		picene results in increased expression of CYP1A1 protein
picene results in increased expression of CYP1A1 mRNA 		CTD PMID:28104439 PMID:32251684 NCBI chr 8:66,991,940...66,998,014
Ensembl chr 8:66,991,970...66,998,012 		JBrowse link
G Ddit4 DNA-damage-inducible transcript 4 increases expression ISO picene results in increased expression of DDIT4 mRNA CTD PMID:32251684 NCBI chr20:28,434,938...28,437,037
Ensembl chr20:28,434,944...28,437,037 		JBrowse link
G Esr1 estrogen receptor 1 affects binding ISO picene binds to ESR1 protein CTD PMID:32251684 NCBI chr 1:43,511,685...43,904,454
Ensembl chr 1:43,644,392...43,900,354 		JBrowse link
G Fam47e family with sequence similarity 47, member E decreases expression ISO picene results in decreased expression of FAM47E mRNA CTD PMID:32251684 NCBI chr14:15,769,441...15,805,911
Ensembl chr14:15,769,050...15,806,061 		JBrowse link
G Fmn1 formin 1 decreases expression ISO picene results in decreased expression of FMN1 mRNA CTD PMID:32251684 NCBI chr 3:120,555,445...120,939,978
Ensembl chr 3:120,555,431...120,933,124 		JBrowse link
G Gdf1 growth differentiation factor 1 increases expression ISO picene results in increased expression of GDF1 mRNA CTD PMID:32251684 NCBI chr16:19,131,271...19,146,480
Ensembl chr16:19,131,276...19,146,480 		JBrowse link
G H1f4 H1.4 linker histone, cluster member increases expression ISO picene results in increased expression of H1-4 mRNA CTD PMID:32251684 NCBI chr17:41,914,425...41,915,206
Ensembl chr17:41,914,431...41,916,129 		JBrowse link
G H1f5 H1.5 linker histone, cluster member increases expression ISO picene results in increased expression of H1-5 mRNA CTD PMID:32251684 NCBI chr17:47,421,875...47,422,905
Ensembl chr17:47,421,843...47,477,387 		JBrowse link
G H2ac22 H2A clustered histone 22 increases expression ISO picene results in increased expression of HIST1H2AH mRNA CTD PMID:32251684 NCBI chr17:41,812,378...41,812,875
Ensembl chr17:41,797,862...41,812,946 		JBrowse link
G H4f3 H1.3 linker histone, cluster member increases expression ISO picene results in increased expression of H1-3 mRNA CTD PMID:32251684 NCBI chr17:41,979,562...41,980,341
Ensembl chr17:41,796,116...41,980,485 		JBrowse link
G Ier3 immediate early response 3 increases expression ISO picene results in increased expression of IER3 mRNA CTD PMID:32251684 NCBI chr20:2,933,173...2,934,377
Ensembl chr20:2,933,174...2,934,377 		JBrowse link
G Kcnk6 potassium two pore domain channel subfamily K member 6 decreases expression ISO picene results in decreased expression of KCNK6 mRNA CTD PMID:32251684 NCBI chr 1:93,652,888...93,661,419 JBrowse link
G Klhl23 kelch-like family member 23 decreases expression ISO picene results in decreased expression of PHOSPHO2-KLHL23 mRNA CTD PMID:32251684 NCBI chr 3:74,988,778...75,002,347
Ensembl chr 3:74,988,704...75,024,200 		JBrowse link
G Krt19 keratin 19 decreases expression ISO picene results in decreased expression of KRT19 mRNA CTD PMID:32251684 NCBI chr10:85,576,235...85,580,952
Ensembl chr10:85,576,235...85,580,952 		JBrowse link
G Myc MYC proto-oncogene, bHLH transcription factor increases expression ISO picene results in increased expression of MYC mRNA CTD PMID:32251684 NCBI chr 7:95,483,105...95,488,031
Ensembl chr 7:95,483,105...95,488,028 		JBrowse link
G Notch3 notch receptor 3 increases expression ISO picene results in increased expression of NOTCH3 mRNA CTD PMID:32251684 NCBI chr 7:11,783,550...11,834,585
Ensembl chr 7:11,784,272...11,834,778 		JBrowse link
G Pgr progesterone receptor decreases expression ISO picene results in decreased expression of PGR mRNA CTD PMID:32251684 NCBI chr 8:14,354,398...14,413,271
Ensembl chr 8:14,354,398...14,413,271 		JBrowse link
G Pkib cAMP-dependent protein kinase inhibitor beta decreases expression ISO picene results in decreased expression of PKIB mRNA CTD PMID:32251684 NCBI chr20:37,511,564...37,608,607
Ensembl chr20:37,512,822...37,608,401 		JBrowse link
G Rara retinoic acid receptor, alpha decreases expression ISO picene results in decreased expression of RARA mRNA CTD PMID:32251684 NCBI chr10:84,379,780...84,424,371
Ensembl chr10:84,389,622...84,425,160 		JBrowse link
G Ret ret proto-oncogene decreases expression ISO picene results in decreased expression of RET mRNA CTD PMID:32251684 NCBI chr 4:152,998,344...153,040,556
Ensembl chr 4:152,998,812...153,040,556 		JBrowse link
G Rn7sl1 RNA component of signal recognition particle 7SL1 increases expression ISO picene results in increased expression of RN7SL1 mRNA CTD PMID:32251684 NCBI chr 6:93,372,872...93,373,170
Ensembl chr 6:93,372,868...93,373,167 		JBrowse link
G Rnu4-1 RNA, U4 small nuclear 1 increases expression ISO picene results in increased expression of RNU4-1 mRNA CTD PMID:32251684 NCBI chr12:46,786,790...46,786,930
Ensembl chr12:46,786,790...46,786,930 		JBrowse link
G Rnu4-2 RNA, U4 small nuclear 2 increases expression ISO picene results in increased expression of RNU4-2 mRNA CTD PMID:32251684 NCBI chr 5:129,492,858...129,492,998
Ensembl chr 5:129,492,858...129,492,998 		JBrowse link
G Rnvu1-7 RNA, variant U1 small nuclear 7 increases expression ISO picene results in increased expression of RNVU1-7 mRNA CTD PMID:32251684 NCBI chr18:82,176,131...82,176,273
Ensembl chr18:82,176,131...82,176,273 		JBrowse link
G Rpph1 ribonuclease P RNA component H1 increases expression ISO picene results in increased expression of RPPH1 mRNA CTD PMID:32251684 NCBI chr15:26,507,232...26,507,488
Ensembl chr15:26,507,215...26,507,512 		JBrowse link
G Runx2 RUNX family transcription factor 2 increases expression ISO picene results in increased expression of RUNX2 mRNA CTD PMID:32251684 NCBI chr 9:23,661,278...23,990,248
Ensembl chr 9:23,664,952...23,990,027 		JBrowse link
G Scarna10 small Cajal body-specific RNA 10 increases expression ISO picene results in increased expression of SCARNA10 mRNA CTD PMID:32251684 NCBI chr 4:159,672,790...159,673,117
Ensembl chr 4:159,672,790...159,673,117 		JBrowse link
G Scarna13 small Cajal body-specific RNA 13 increases expression ISO picene results in increased expression of SCARNA13 mRNA CTD PMID:32251684 NCBI chr 6:129,751,555...129,751,829
Ensembl chr 6:129,751,555...129,751,829 		JBrowse link
G Scarna16 small Cajal body-specific RNA 16 increases expression ISO picene results in increased expression of SCARNA16 mRNA CTD PMID:32251684 NCBI chr 5:147,908,870...147,909,057 JBrowse link
G Scarna2 small Cajal body-specific RNA 2 increases expression ISO picene results in increased expression of SCARNA2 mRNA CTD PMID:32251684 NCBI chr 2:198,877,726...198,878,141
Ensembl chr 2:198,877,726...198,878,141 		JBrowse link
G Sema3b semaphorin 3B decreases expression ISO picene results in decreased expression of SEMA3B mRNA CTD PMID:32251684 NCBI chr 8:117,150,307...117,161,570
Ensembl chr 8:117,150,589...117,157,658 		JBrowse link
G Siah2 siah E3 ubiquitin protein ligase 2 decreases expression ISO picene results in decreased expression of SIAH2 mRNA CTD PMID:32251684 NCBI chr 2:145,063,847...145,081,675
Ensembl chr 2:145,063,857...145,081,873 		JBrowse link
G Slc34a3 solute carrier family 34 member 3 increases expression ISO picene results in increased expression of SLC34A3 mRNA CTD PMID:32251684 NCBI chr 3:28,442,455...28,447,997
Ensembl chr 3:28,442,457...28,447,997 		JBrowse link
G Slc7a2 solute carrier family 7 member 2 decreases expression ISO picene results in decreased expression of SLC7A2 mRNA CTD PMID:32251684 NCBI chr16:58,115,991...58,174,256
Ensembl chr16:58,120,968...58,174,256 		JBrowse link
G Snora73b small nucleolar RNA, H/ACA box 73b increases expression ISO picene results in increased expression of SNORA73B mRNA CTD PMID:32251684 NCBI chr 5:149,829,190...149,829,393
Ensembl chr 5:149,829,190...149,829,393 		JBrowse link
G Stc2 stanniocalcin 2 increases expression ISO picene results in increased expression of STC2 mRNA CTD PMID:32251684 NCBI chr10:16,755,508...16,765,275
Ensembl chr10:16,755,267...16,767,447 		JBrowse link
G Tfap2c transcription factor AP-2 gamma decreases expression ISO picene results in decreased expression of TFAP2C mRNA CTD PMID:32251684 NCBI chr 3:181,733,524...181,742,412
Ensembl chr 3:181,733,419...181,741,404 		JBrowse link
G Tspear thrombospondin-type laminin G domain and EAR repeats increases expression ISO picene results in increased expression of TSPEAR mRNA CTD PMID:32251684 NCBI chr20:10,771,365...10,944,285
Ensembl chr20:10,771,371...10,943,708 		JBrowse link
G Wnt4 Wnt family member 4 decreases expression ISO picene results in decreased expression of WNT4 mRNA CTD PMID:32251684 NCBI chr 5:154,797,245...154,818,565
Ensembl chr 5:154,797,311...154,817,128 		JBrowse link
G Xbp1 X-box binding protein 1 decreases expression ISO picene results in decreased expression of XBP1 mRNA CTD PMID:32251684 NCBI chr14:84,604,623...84,609,707
Ensembl chr14:84,604,107...84,609,706 		JBrowse link
tetraphene term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G A1cf APOBEC1 complementation factor decreases expression ISO benz(a)anthracene results in decreased expression of A1CF mRNA CTD PMID:26377693 NCBI chr 1:239,149,436...239,242,460
Ensembl chr 1:239,149,493...239,236,817 		JBrowse link
G Aaas aladin WD repeat nucleoporin multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of AAAS mRNA CTD PMID:27858113 NCBI chr 7:135,342,901...135,362,545
Ensembl chr 7:135,342,901...135,362,545 		JBrowse link
G Aasdh aminoadipate-semialdehyde dehydrogenase affects expression ISO benz(a)anthracene affects the expression of AASDH mRNA CTD PMID:26377693 NCBI chr14:31,609,488...31,636,066
Ensembl chr14:31,609,528...31,636,500 		JBrowse link
G Aatk apoptosis-associated tyrosine kinase increases expression ISO benz(a)anthracene results in increased expression of AATK mRNA CTD PMID:26377693 NCBI chr10:105,789,171...105,825,634
Ensembl chr10:105,785,469...105,825,618 		JBrowse link
G Abcc3 ATP binding cassette subfamily C member 3 increases expression ISO benz(a)anthracene results in increased expression of ABCC3 mRNA CTD PMID:26377693 NCBI chr10:79,793,571...79,839,528
Ensembl chr10:79,793,583...79,839,494 		JBrowse link
G Abcc5 ATP binding cassette subfamily C member 5 decreases expression
multiple interactions 		ISO benz(a)anthracene results in decreased expression of ABCC5 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of ABCC5 mRNA 		CTD PMID:26377693 PMID:27858113 NCBI chr11:93,975,579...94,071,659
Ensembl chr11:93,978,274...94,071,655 		JBrowse link
G Abcc9 ATP binding cassette subfamily C member 9 decreases expression ISO benz(a)anthracene results in decreased expression of ABCC9 mRNA CTD PMID:26377693 NCBI chr 4:177,262,848...177,386,837
Ensembl chr 4:177,262,848...177,386,348 		JBrowse link
G Abhd15 abhydrolase domain containing 15 increases expression ISO benz(a)anthracene results in increased expression of ABHD15 mRNA CTD PMID:26377693 NCBI chr10:62,861,335...62,866,726
Ensembl chr10:62,861,317...62,868,540 		JBrowse link
G Abhd6 abhydrolase domain containing 6, acylglycerol lipase increases expression ISO benz(a)anthracene results in increased expression of ABHD6 mRNA CTD PMID:26377693 NCBI chr15:19,289,967...19,337,500
Ensembl chr15:19,289,969...19,337,193 		JBrowse link
G Abi3bp ABI family member 3 binding protein multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of ABI3BP mRNA CTD PMID:27858113 NCBI chr11:57,381,282...57,597,989
Ensembl chr11:57,381,422...57,598,120 		JBrowse link
G Ablim1 actin-binding LIM protein 1 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of ABLIM1 mRNA CTD PMID:27858113 NCBI chr 1:266,088,868...266,377,169
Ensembl chr 1:266,088,870...266,377,098 		JBrowse link
G Abraxas2 abraxas 2, BRISC complex subunit decreases expression
multiple interactions 		ISO benz(a)anthracene results in decreased expression of ABRAXAS2 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of ABRAXAS2 mRNA 		CTD PMID:26377693 PMID:27858113 NCBI chr 1:197,077,177...197,102,753
Ensembl chr 1:197,077,158...197,102,757 		JBrowse link
G Accs 1-aminocyclopropane-1-carboxylate synthase increases expression ISO benz(a)anthracene results in increased expression of ACCS mRNA CTD PMID:26377693 NCBI chr 3:100,261,940...100,276,400
Ensembl chr 3:100,261,941...100,296,514 		JBrowse link
G Acin1 apoptotic chromatin condensation inducer 1 decreases expression
multiple interactions 		ISO benz(a)anthracene results in decreased expression of ACIN1 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of ACIN1 mRNA 		CTD PMID:26377693 PMID:27858113 NCBI chr15:32,072,121...32,117,004
Ensembl chr15:32,072,123...32,117,166 		JBrowse link
G Ackr3 atypical chemokine receptor 3 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of CXCR7 mRNA CTD PMID:27858113 NCBI chr 9:98,247,300...98,258,877
Ensembl chr 9:98,246,605...98,260,214 		JBrowse link
G Acot1 acyl-CoA thioesterase 1 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of ACOT1 mRNA CTD PMID:27858113 NCBI chr 6:109,367,274...109,375,268
Ensembl chr 6:109,367,268...109,380,749 		JBrowse link
G Acox1 acyl-CoA oxidase 1 increases expression
multiple interactions 		ISO benz(a)anthracene results in increased expression of ACOX1 mRNA; benz(a)anthracene results in increased expression of ACOX1 protein
benz(a)anthracene promotes the reaction [[ACOX1 protein results in increased metabolism of Palmitoyl Coenzyme A] which results in increased chemical synthesis of Hydrogen Peroxide] 		CTD PMID:10497882 NCBI chr10:101,905,083...101,930,136
Ensembl chr10:101,905,083...101,930,136 		JBrowse link
G Acoxl acyl-CoA oxidase-like decreases expression
multiple interactions 		ISO benz(a)anthracene results in decreased expression of ACOXL mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of ACOXL mRNA 		CTD PMID:26377693 PMID:27858113 NCBI chr 3:135,514,340...135,820,291
Ensembl chr 3:135,514,275...135,820,291 		JBrowse link
G Acrbp acrosin binding protein affects expression ISO benz(a)anthracene affects the expression of ACRBP mRNA CTD PMID:26377693 NCBI chr 4:159,537,395...159,550,454
Ensembl chr 4:159,537,391...159,550,454 		JBrowse link
G Acvr1b activin A receptor type 1B increases expression ISO benz(a)anthracene results in increased expression of ACVR1B mRNA CTD PMID:26377693 NCBI chr 7:134,164,987...134,208,389
Ensembl chr 7:134,164,991...134,208,388 		JBrowse link
G Adam22 ADAM metallopeptidase domain 22 increases expression ISO benz(a)anthracene results in increased expression of ADAM22 mRNA CTD PMID:26377693 NCBI chr 4:26,670,984...26,925,843
Ensembl chr 4:26,671,112...26,925,843 		JBrowse link
G Adamdec1 ADAM-like, decysin 1 increases expression ISO benz(a)anthracene results in increased expression of ADAMDEC1 mRNA CTD PMID:26377693 NCBI chr15:47,076,011...47,097,065
Ensembl chr15:47,076,019...47,097,065 		JBrowse link
G Adamts14 ADAM metallopeptidase with thrombospondin type 1 motif, 14 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of ADAMTS14 mRNA CTD PMID:27858113 NCBI chr20:29,685,876...29,762,685
Ensembl chr20:29,685,876...29,762,682 		JBrowse link
G Adcy7 adenylate cyclase 7 increases expression ISO benz(a)anthracene results in increased expression of ADCY7 mRNA CTD PMID:26377693 NCBI chr19:34,913,154...34,972,366
Ensembl chr19:34,914,322...34,936,743 		JBrowse link
G Add3 adducin 3 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of ADD3 mRNA CTD PMID:27858113 NCBI chr 1:262,152,722...262,260,504
Ensembl chr 1:262,154,996...262,260,504 		JBrowse link
G Adgre4 adhesion G protein-coupled receptor E4 increases expression ISO benz(a)anthracene results in increased expression of ADGRE4 mRNA CTD PMID:26377693 NCBI chr 9:10,085,258...10,240,346
Ensembl chr 9:10,085,352...10,240,229 		JBrowse link
G Adgrl4 adhesion G protein-coupled receptor L4 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of ADGRL4 mRNA CTD PMID:27858113 NCBI chr 2:243,014,927...243,117,226
Ensembl chr 2:243,014,796...243,117,222 		JBrowse link
G Adm adrenomedullin decreases expression
multiple interactions 		ISO benz(a)anthracene results in decreased expression of ADM mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of ADM mRNA 		CTD PMID:26377693 PMID:27858113 NCBI chr 1:174,164,178...174,182,372
Ensembl chr 1:174,178,773...174,182,371 		JBrowse link
G Adora1 adenosine A1 receptor increases expression ISO benz(a)anthracene results in increased expression of ADORA1 mRNA CTD PMID:26377693 NCBI chr13:48,210,922...48,247,826
Ensembl chr13:48,213,273...48,247,190 		JBrowse link
G Adra1b adrenoceptor alpha 1B decreases expression ISO benz(a)anthracene results in decreased expression of ADRA1B mRNA CTD PMID:26377693 NCBI chr10:28,756,461...28,874,831
Ensembl chr10:28,756,461...28,814,347 		JBrowse link
G Adrb3 adrenoceptor beta 3 affects expression ISO benz(a)anthracene affects the expression of ADRB3 mRNA CTD PMID:26377693 NCBI chr16:71,544,603...71,547,410
Ensembl chr16:71,542,567...71,547,420 		JBrowse link
G Aen apoptosis enhancing nuclease multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of AEN mRNA CTD PMID:27858113 NCBI chr 1:142,224,499...142,233,902
Ensembl chr 1:142,224,493...142,233,898 		JBrowse link
G Agbl2 AGBL carboxypeptidase 2 increases expression
multiple interactions 		ISO benz(a)anthracene results in increased expression of AGBL2 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of AGBL2 mRNA 		CTD PMID:26377693 PMID:27858113 NCBI chr 3:97,220,654...97,255,905
Ensembl chr 3:97,220,781...97,255,904 		JBrowse link
G Ago2 argonaute RISC catalytic component 2 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of AGO2 mRNA CTD PMID:27858113 NCBI chr 7:106,907,209...106,994,124
Ensembl chr 7:106,918,125...106,993,980 		JBrowse link
G Ago4 argonaute RISC component 4 decreases expression ISO benz(a)anthracene results in decreased expression of AGO4 mRNA CTD PMID:26377693 NCBI chr 5:144,064,949...144,110,422
Ensembl chr 5:144,064,949...144,110,402 		JBrowse link
G Agrp agouti related neuropeptide increases expression ISO benz(a)anthracene results in increased expression of AGRP mRNA CTD PMID:26377693 NCBI chr19:50,357,899...50,396,758
Ensembl chr19:50,357,905...50,358,698 		JBrowse link
G Agtr1a angiotensin II receptor, type 1a increases expression ISO benz(a)anthracene results in increased expression of AGTR1A mRNA CTD PMID:26377693 NCBI chr17:34,383,397...34,435,523
Ensembl chr17:34,381,467...34,435,660 		JBrowse link
G Ahcyl2 adenosylhomocysteinase-like 2 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of AHCYL2 mRNA CTD PMID:27858113 NCBI chr 4:59,348,747...59,498,503
Ensembl chr 4:59,348,217...59,498,502 		JBrowse link
G Ahnak AHNAK nucleoprotein decreases expression
multiple interactions 		ISO benz(a)anthracene results in decreased expression of AHNAK mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of AHNAK mRNA 		CTD PMID:26377693 PMID:27858113 NCBI chr 1:215,311,289...215,400,010
Ensembl chr 1:215,321,931...215,400,675 		JBrowse link
G Ahnak2 AHNAK nucleoprotein 2 decreases expression ISO benz(a)anthracene results in decreased expression of AHNAK2 mRNA CTD PMID:26377693 NCBI chr 6:137,648,867...137,697,580
Ensembl chr 6:137,652,537...137,675,546 		JBrowse link
G Ahr aryl hydrocarbon receptor affects response to substance
affects binding
increases activity
multiple interactions
increases response to substance 		ISO
EXP 		AHR affects the susceptibility to benz(a)anthracene
benz(a)anthracene binds to AHR protein
benz(a)anthracene results in increased activity of AHR protein
AHR affects the reaction [benz(a)anthracene results in increased expression of CCNA2 protein]; AHR affects the reaction [benz(a)anthracene results in increased expression of CYP1A1 mRNA]; benz(a)anthracene binds to and results in increased activity of AHR protein; benz(a)anthracene inhibits the reaction [Tetrachlorodibenzodioxin binds to AHR protein]
AHR protein affects the reaction [benz(a)anthracene inhibits the reaction [EGF protein binds to EGFR protein]]; benz(a)anthracene binds to and results in increased activity of AHR protein; benz(a)anthracene inhibits the reaction [Tetrachlorodibenzodioxin binds to AHR protein]
[benz(a)anthracene co-treated with Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene co-treated with pyrene] results in increased activity of AHR protein; [benz(a)anthracene co-treated with Benzo(a)pyrene co-treated with benzo(j)fluoranthene co-treated with benzo(k)fluoranthene co-treated with chrysene co-treated with fluoranthene co-treated with pyrene] promotes the reaction [indeno(1,2,3-cd)pyrene results in increased activity of AHR protein]; [benz(a)anthracene co-treated with Benzo(a)pyrene co-treated with benzo(j)fluoranthene co-treated with benzo(k)fluoranthene co-treated with chrysene co-treated with indeno(1,2,3-cd)pyrene co-treated with fluoranthene] promotes the reaction [pyrene results in increased activity of AHR protein]; [benz(a)anthracene co-treated with Benzo(a)pyrene co-treated with benzo(j)fluoranthene co-treated with benzo(k)fluoranthene co-treated with chrysene co-treated with indeno(1,2,3-cd)pyrene co-treated with pyrene] promotes the reaction [fluoranthene results in increased activity of AHR protein]; [benz(a)anthracene co-treated with Benzo(a)pyrene co-treated with benzo(j)fluoranthene co-treated with benzo(k)fluoranthene co-treated with indeno(1,2,3-cd)pyrene co-treated with fluoranthene co-treated with pyrene] promotes the reaction [chrysene results in increased activity of AHR protein]; [benz(a)anthracene co-treated with Benzo(a)pyrene co-treated with benzo(j)fluoranthene co-treated with chrysene co-treated with indeno(1,2,3-cd)pyrene co-treated with fluoranthene co-treated with pyrene] promotes the reaction [benzo(k)fluoranthene results in increased activity of AHR protein]; [benz(a)anthracene co-treated with Benzo(a)pyrene co-treated with benzo(k)fluoranthene co-treated with chrysene co-treated with indeno(1,2,3-cd)pyrene co-treated with fluoranthene co-treated with pyrene] promotes the reaction [benzo(j)fluoranthene results in increased activity of AHR protein]; [benz(a)anthracene co-treated with benzo(j)fluoranthene co-treated with benzo(k)fluoranthene co-treated with chrysene co-treated with indeno(1,2,3-cd)pyrene co-treated with fluoranthene co-treated with pyrene] promotes the reaction [Benzo(a)pyrene results in increased activity of AHR protein]; [benz(a)anthracene co-treated with TNF protein] results in increased activity of AHR protein; [Benzo(a)pyrene co-treated with benzo(j)fluoranthene co-treated with benzo(k)fluoranthene co-treated with chrysene co-treated with indeno(1,2,3-cd)pyrene co-treated with fluoranthene co-treated with pyrene] promotes the reaction [benz(a)anthracene results in increased activity of AHR protein]; AHR protein affects the reaction [[benz(a)anthracene co-treated with TNF protein] results in increased expression of IL6]; AHR protein affects the reaction [benz(a)anthracene results in increased expression of CYP1B1 mRNA]; AHR protein promotes the reaction [benz(a)anthracene results in increased activity of CYP1A1 protein]; benz(a)anthracene promotes the reaction [AHR protein results in increased expression of CYP1A1 mRNA]
AHR results in increased susceptibility to benz(a)anthracene 		CTD PMID:1650214 PMID:1654865 PMID:1658612 PMID:2154949 PMID:3005314 More... NCBI chr 6:57,961,423...57,998,901
Ensembl chr 6:57,961,423...57,998,901 		JBrowse link
G Ahrr aryl-hydrocarbon receptor repressor increases expression
multiple interactions 		ISO benz(a)anthracene results in increased expression of AHRR mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of AHRR mRNA 		CTD PMID:26377693 PMID:27858113 NCBI chr 1:30,822,219...30,917,251
Ensembl chr 1:30,810,866...30,952,866 		JBrowse link
G Aif1 allograft inflammatory factor 1 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of AIF1 mRNA CTD PMID:27858113 NCBI chr20:3,651,435...3,657,341
Ensembl chr20:3,652,243...3,657,339 		JBrowse link
G Aifm3 AIF family member 3 increases expression ISO benz(a)anthracene results in increased expression of AIFM3 mRNA CTD PMID:26377693 NCBI chr11:97,009,100...97,030,601
Ensembl chr11:97,008,426...97,023,334 		JBrowse link
G Akap13 A-kinase anchoring protein 13 decreases expression ISO benz(a)anthracene results in decreased expression of AKAP13 mRNA CTD PMID:26377693 NCBI chr 1:138,722,445...139,029,401
Ensembl chr 1:138,724,150...139,029,401 		JBrowse link
G Akap7 A-kinase anchoring protein 7 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of AKAP7 mRNA CTD PMID:27858113 NCBI chr 1:21,906,503...22,168,663
Ensembl chr 1:21,906,676...22,037,090 		JBrowse link
G Akap8 A-kinase anchoring protein 8 increases expression ISO benz(a)anthracene results in increased expression of AKAP8 mRNA CTD PMID:26377693 NCBI chr 7:11,966,769...11,983,056
Ensembl chr 7:11,966,772...11,982,900 		JBrowse link
G Akap8l A-kinase anchoring protein 8 like increases expression ISO benz(a)anthracene results in increased expression of AKAP8L mRNA CTD PMID:26377693 NCBI chr 7:11,983,215...12,012,843
Ensembl chr 7:11,982,721...12,012,811 		JBrowse link
G Akr1b10 aldo-keto reductase family 1 member B10 increases expression ISO benz(a)anthracene results in increased expression of AKR1B10 mRNA CTD PMID:22236718 NCBI chr 4:64,005,632...64,027,860
Ensembl chr 4:64,007,420...64,020,847 		JBrowse link
G Akr1c1 aldo-keto reductase family 1, member C1 increases expression ISO benz(a)anthracene results in increased expression of AKR1C1 mRNA CTD PMID:17253728 PMID:22236718 NCBI chr17:70,720,397...70,747,285
Ensembl chr17:70,720,398...70,747,247 		JBrowse link
G Akr1c14 aldo-keto reductase family 1, member C14 increases expression EXP benz(a)anthracene results in increased expression of AKR1C14 mRNA CTD PMID:18205319 NCBI chr17:71,066,197...71,083,184
Ensembl chr17:71,066,200...71,083,157 		JBrowse link
G Akr1c3 aldo-keto reductase family 1, member C3 increases expression ISO benz(a)anthracene results in increased expression of AKR1C3 mRNA CTD PMID:22236718 NCBI chr17:71,020,884...71,037,779
Ensembl chr17:70,970,900...71,048,438 		JBrowse link
G Aldh1l1 aldehyde dehydrogenase 1 family, member L1 decreases expression ISO benz(a)anthracene results in decreased expression of ALDH1L1 mRNA CTD PMID:26377693 NCBI chr 4:124,617,182...124,663,674
Ensembl chr 4:124,617,217...124,664,704 		JBrowse link
G Aldh3a1 aldehyde dehydrogenase 3 family, member A1 increases expression ISO benz(a)anthracene results in increased expression of ALDH3A1 mRNA CTD PMID:32890658 NCBI chr10:46,392,464...46,402,151
Ensembl chr10:46,392,411...46,402,151 		JBrowse link
G Alg6 ALG6, alpha-1,3-glucosyltransferase increases expression ISO benz(a)anthracene results in increased expression of ALG6 mRNA CTD PMID:26377693 NCBI chr 5:119,520,415...119,606,365
Ensembl chr 5:119,520,430...119,606,659 		JBrowse link
G Alkal1 ALK and LTK ligand 1 increases expression ISO benz(a)anthracene results in increased expression of ALKAL1 mRNA CTD PMID:26377693 NCBI chr 5:17,806,601...17,836,789
Ensembl chr 5:17,806,608...17,836,843 		JBrowse link
G Alox12 arachidonate 12-lipoxygenase, 12S type increases expression ISO benz(a)anthracene results in increased expression of ALOX12 mRNA CTD PMID:26377693 NCBI chr10:55,456,923...55,469,239
Ensembl chr10:55,456,928...55,469,199 		JBrowse link
G Alox5 arachidonate 5-lipoxygenase increases expression ISO benz(a)anthracene results in increased expression of ALOX5 mRNA CTD PMID:26377693 NCBI chr 4:151,203,948...151,251,126
Ensembl chr 4:151,203,949...151,251,126 		JBrowse link
G Alpl alkaline phosphatase, biomineralization associated increases expression ISO benz(a)anthracene results in increased expression of ALPL mRNA CTD PMID:26377693 NCBI chr 5:155,234,770...155,289,785
Ensembl chr 5:155,234,775...155,254,167 		JBrowse link
G Als2cl ALS2 C-terminal like affects expression ISO benz(a)anthracene affects the expression of ALS2CL mRNA CTD PMID:26377693 NCBI chr 8:119,746,498...119,762,824
Ensembl chr 8:119,743,248...119,762,843 		JBrowse link
G Amdhd2 amidohydrolase domain containing 2 increases expression ISO benz(a)anthracene results in increased expression of AMDHD2 mRNA CTD PMID:26377693 NCBI chr10:13,692,136...13,700,632
Ensembl chr10:13,692,146...13,700,632 		JBrowse link
G Angpt2 angiopoietin 2 increases expression ISO benz(a)anthracene results in increased expression of ANGPT2 mRNA CTD PMID:26377693 NCBI chr16:77,790,760...77,841,241
Ensembl chr16:77,790,563...77,841,239 		JBrowse link
G Angptl4 angiopoietin-like 4 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of ANGPTL4 mRNA CTD PMID:27858113 NCBI chr 7:15,252,450...15,259,971
Ensembl chr 7:15,252,473...15,258,681 		JBrowse link
G Ank3 ankyrin 3 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of ANK3 mRNA CTD PMID:27858113 NCBI chr20:18,601,307...19,224,790
Ensembl chr20:18,601,826...19,084,879 		JBrowse link
G Ankrd12 ankyrin repeat domain 12 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of ANKRD12 mRNA CTD PMID:27858113 NCBI chr 9:113,030,127...113,134,816
Ensembl chr 9:113,030,919...113,134,762 		JBrowse link
G Ankrd16 ankyrin repeat domain 16 affects expression ISO benz(a)anthracene affects the expression of ANKRD16 mRNA CTD PMID:26377693 NCBI chr17:71,645,171...71,658,377
Ensembl chr17:71,647,107...71,658,377 		JBrowse link
G Ankzf1 ankyrin repeat and zinc finger peptidyl tRNA hydrolase 1 increases expression ISO benz(a)anthracene results in increased expression of ANKZF1 mRNA CTD PMID:26377693 NCBI chr 9:84,136,862...84,143,830
Ensembl chr 9:84,136,862...84,145,091 		JBrowse link
G Anp32a acidic nuclear phosphoprotein 32 family member A increases expression ISO benz(a)anthracene results in increased expression of ANP32A mRNA CTD PMID:26377693 NCBI chr 8:71,724,578...71,760,922
Ensembl chr 8:71,724,531...71,760,922 		JBrowse link
G Anpep alanyl aminopeptidase, membrane multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of ANPEP mRNA CTD PMID:27858113 NCBI chr 1:143,176,645...143,219,447
Ensembl chr 1:143,176,645...143,195,101 		JBrowse link
G Anxa10 annexin A10 increases expression ISO benz(a)anthracene results in increased expression of ANXA10 mRNA CTD PMID:26377693 NCBI chr16:32,505,025...32,571,961
Ensembl chr16:32,467,126...32,571,961 		JBrowse link
G Ap5s1 adaptor related protein complex 5 subunit sigma 1 increases expression ISO benz(a)anthracene results in increased expression of AP5S1 mRNA CTD PMID:26377693 NCBI chr 3:138,882,634...138,885,940
Ensembl chr 3:138,882,634...138,888,899 		JBrowse link